data_1iyy_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1iyy _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.471 ' O ' ' SG ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.541 0.686 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 31.4 p 38.93 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.912 0.863 . . . . 0.0 110.264 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -102.5 -1.44 30.53 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.361 -0.837 . . . . 0.0 109.307 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.541 ' CG ' HG23 ' A' ' 89' ' ' VAL . 23.0 m-85 -115.07 65.73 0.68 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.9 . . . . 0.0 109.225 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.514 ' CG2' ' O ' ' A' ' 5' ' ' THR . 11.5 t -86.78 92.46 8.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.94 . . . . 0.0 109.741 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.9 m -104.24 155.75 18.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.119 -0.988 . . . . 0.0 109.236 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.411 ' O ' ' CB ' ' A' ' 8' ' ' SER . . . 47.43 29.3 5.29 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.436 ' O ' ' OD1' ' A' ' 9' ' ' ASN . 5.0 m 70.44 43.84 0.76 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -1.14 . . . . 0.0 109.422 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 11' ' ' TYR . 83.0 m-20 -136.97 86.33 2.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.136 -0.978 . . . . 0.0 109.547 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.425 ' HA ' ' CB ' ' A' ' 5' ' ' THR . 0.5 OUTLIER -54.9 88.26 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.498 -0.751 . . . . 0.0 109.395 179.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.527 ' CZ ' ' HB2' ' A' ' 63' ' ' SER . 1.9 m-85 -79.68 144.51 33.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.311 -0.868 . . . . 0.0 108.924 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.547 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -78.58 122.48 25.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.376 -0.827 . . . . 0.0 109.568 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.6 p -59.03 -26.62 64.72 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 83.4 p -78.93 -28.55 43.84 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.74 -27.4 40.55 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 12' ' ' SER . 13.5 t -66.6 -29.9 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.432 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 1.9 t -64.4 -46.21 84.26 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.93 -51.81 67.69 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.485 ' CB ' HD12 ' A' ' 61' ' ' ILE . . . -66.41 -18.81 65.58 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.585 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -71.11 -36.65 72.23 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -82.0 -1.72 49.19 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.54 -54.82 5.33 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.353 -0.842 . . . . 0.0 108.914 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.519 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -72.89 -18.5 79.01 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.44 ' O ' ' C ' ' A' ' 25' ' ' GLN . 14.6 t80 -80.22 -60.52 2.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.557 -0.966 . . . . 0.0 109.348 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.7 OUTLIER -41.64 -35.38 0.74 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.319 -0.863 . . . . 0.0 109.614 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.453 ' CD1' ' HB3' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -75.23 -47.13 29.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 0.0 109.65 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.583 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 11.5 t60 -56.25 -37.44 69.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.368 -0.833 . . . . 0.0 110.941 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -85.41 -31.47 22.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.027 -1.046 . . . . 0.0 109.48 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.429 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 0.5 OUTLIER -68.09 -20.51 64.95 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.274 -0.891 . . . . 0.0 109.366 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.23 -19.02 25.08 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.453 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 1.7 tp10 -63.01 -154.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.234 -1.156 . . . . 0.0 109.492 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.679 HG23 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -162.69 174.47 12.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.336 -0.852 . . . . 0.0 109.408 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 35' ' ' SER . 18.0 m -130.4 158.1 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.276 -0.89 . . . . 0.0 109.383 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.403 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . 55.63 -89.21 0.01 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER 171.04 32.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.327 -1.102 . . . . 0.0 109.725 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 37' ' ' SER . 1.6 m-80 -152.64 25.29 0.58 Allowed 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.106 -0.996 . . . . 0.0 109.666 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.679 ' HA ' HG23 ' A' ' 32' ' ' THR . 1.0 OUTLIER 47.95 92.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.018 -1.051 . . . . 0.0 108.887 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.68 ' CD2' ' CE2' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -79.34 -47.29 1.58 Allowed Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.261 -0.9 . . . . 0.0 110.765 -179.367 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 32.6 Cg_endo -74.71 108.04 2.61 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 120.95 1.1 . . . . 0.0 109.349 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.62 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -125.74 -174.8 3.17 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.459 -179.11 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -104.6 131.28 52.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.346 -0.846 . . . . 0.0 109.42 -179.526 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.572 ' CZ ' ' HA ' ' A' ' 44' ' ' ASN . 11.9 t80 -97.33 137.83 35.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.272 -0.893 . . . . 0.0 109.259 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.523 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -89.85 -32.49 16.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.144 -0.973 . . . . 0.0 109.776 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.572 ' HA ' ' CZ ' ' A' ' 42' ' ' TYR . 20.1 t30 77.2 135.59 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.591 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.445 ' O ' ' C ' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -159.5 -38.11 0.06 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.307 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.6 OUTLIER -38.72 -73.02 0.05 Allowed 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.623 -0.673 . . . . 0.0 110.069 -179.582 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 155.41 61.72 0.01 OUTLIER Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.485 ' CD1' ' OD1' ' A' ' 44' ' ' ASN . 48.6 m-85 -90.74 -168.01 1.97 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.299 -1.118 . . . . 0.0 109.332 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 50' ' ' PHE . 5.0 p30 -145.05 26.59 1.34 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.52 ' CB ' ' OH ' ' A' ' 56' ' ' TYR . 20.9 m-30 -45.6 173.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.503 -0.748 . . . . 0.0 109.769 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.4 m -146.53 30.3 1.01 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.357 -0.839 . . . . 0.0 109.088 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.53 HG11 ' OD1' ' A' ' 81' ' ' ASN . 97.2 t -96.28 -92.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.338 -0.851 . . . . 0.0 109.545 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.404 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 66.9 m -142.63 -172.93 3.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.074 -1.016 . . . . 0.0 109.962 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.581 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -85.49 -49.25 0.56 Allowed Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.364 -0.835 . . . . 0.0 111.61 -179.175 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 54' ' ' SER . 33.5 Cg_endo -74.09 83.41 1.64 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 121.863 1.708 . . . . 0.0 110.396 -177.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.546 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 7.1 m-85 -79.38 -177.96 6.01 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.645 0.736 . . . . 0.0 110.022 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.583 ' CE2' ' NE2' ' A' ' 27' ' ' HIS . 97.6 m-85 -157.95 152.33 24.63 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.555 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 19.2 mt-10 -119.63 143.17 47.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.991 -1.068 . . . . 0.0 111.124 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.6 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 21.3 t-105 -160.75 138.81 7.21 Favored Pre-proline 0 N--CA 1.49 1.57 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.6 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.2 Cg_endo -69.22 142.59 50.74 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.338 2.025 . . . . 0.0 111.861 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.491 ' C ' HD21 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -119.57 131.64 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.491 HD21 ' C ' ' A' ' 61' ' ' ILE . 0.9 OUTLIER -123.13 167.49 13.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.191 -0.943 . . . . 0.0 109.576 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.527 ' HB2' ' CZ ' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -135.72 17.47 3.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.368 -0.833 . . . . 0.0 109.25 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.25 -54.2 0.2 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.284 -0.885 . . . . 0.0 109.423 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . -67.42 -98.16 0.03 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 3.0 t0 175.49 -162.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -1.161 . . . . 0.0 109.538 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.41 ' O ' ' OG ' ' A' ' 69' ' ' SER . 8.5 t -52.55 136.47 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.304 -0.873 . . . . 0.0 109.568 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.68 ' CE2' ' CD2' ' A' ' 38' ' ' TYR . 28.9 t80 -52.92 117.84 3.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.2 -0.937 . . . . 0.0 109.254 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -177.19 74.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.404 -0.81 . . . . 0.0 109.662 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.52 62.12 0.31 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.31 -136.29 3.91 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.2 m -166.29 101.63 0.7 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.309 -1.112 . . . . 0.0 109.186 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.534 ' HG3' ' CD1' ' A' ' 68' ' ' TYR . 35.8 Cg_endo -77.82 -81.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.435 2.09 . . . . 0.0 110.685 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.39 -176.89 4.86 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . 56.47 -122.03 1.65 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.101 -1.235 . . . . 0.0 109.555 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 75' ' ' ALA . 87.2 m-20 -41.4 146.85 0.19 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.848 -1.158 . . . . 0.0 110.167 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.486 ' O ' HG12 ' A' ' 90' ' ' ILE . 2.6 tpp180 -176.37 90.12 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.455 -0.778 . . . . 0.0 109.219 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 89' ' ' VAL . 7.5 p -65.04 144.63 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.097 -1.002 . . . . 0.0 109.547 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.588 HG13 ' N ' ' A' ' 80' ' ' PHE . 24.7 t -104.84 167.48 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.345 -0.847 . . . . 0.0 109.642 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.588 ' N ' HG13 ' A' ' 79' ' ' VAL . 13.8 p90 -164.53 -173.39 3.03 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.409 -178.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.53 ' OD1' HG11 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -124.07 -81.15 0.63 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.066 -1.022 . . . . 0.0 110.267 -179.395 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -158.74 21.55 0.22 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.312 -0.867 . . . . 0.0 109.484 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.471 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 4.4 m120 -140.39 23.89 2.31 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 83' ' ' ASN . 5.0 p30 52.83 19.92 1.45 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.468 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 51.8 mm-40 -60.62 -111.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 85' ' ' GLN . 0.2 OUTLIER 172.84 110.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 110.693 178.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.537 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . . . -79.62 -38.92 32.75 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 148.69 156.71 7.24 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.541 HG23 ' CG ' ' A' ' 4' ' ' TYR . 94.8 t -87.14 113.48 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -1.155 . . . . 0.0 109.411 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.52 HD11 ' CG2' ' A' ' 79' ' ' VAL . 0.9 OUTLIER -109.27 154.54 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.421 -0.8 . . . . 0.0 109.142 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 100' ' ' PHE . 4.6 t -107.79 146.82 31.67 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.033 -1.042 . . . . 0.0 110.418 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.59 ' CD2' ' HB2' ' A' ' 98' ' ' ASN . 16.1 t60 -116.76 66.05 0.72 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 1.9 m 178.42 -29.65 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.746 -0.596 . . . . 0.0 109.717 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.88 10.79 44.92 Favored Glycine 0 N--CA 1.494 2.504 0 O-C-N 120.993 -1.067 . . . . 0.0 110.638 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -141.15 147.06 37.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.016 -1.285 . . . . 0.0 109.669 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 95' ' ' ALA . 1.2 p -43.03 133.3 3.8 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 98' ' ' ASN . . . 62.84 35.03 91.42 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 107.949 -2.061 . . . . 0.0 107.949 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.59 ' HB2' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 34.71 41.66 0.06 Allowed 'General case' 0 C--N 1.309 -1.177 0 O-C-N 122.105 -0.644 . . . . 0.0 110.349 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -56.93 166.55 0.98 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.123 -0.986 . . . . 0.0 108.623 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.521 ' O ' ' CG1' ' A' ' 101' ' ' VAL . 0.3 OUTLIER -91.44 147.51 22.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.933 -1.104 . . . . 0.0 109.839 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.521 ' CG1' ' O ' ' A' ' 100' ' ' PHE . 17.4 m -161.38 133.97 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 101' ' ' VAL . 35.8 mt-10 -43.26 135.17 3.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.964 . . . . 0.0 109.448 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 1.5 m -60.73 121.3 11.92 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.246 -0.908 . . . . 0.0 109.325 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.556 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 7.1 p 173.27 137.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.37 -0.832 . . . . 0.0 109.906 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -115.72 -29.57 6.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 0.0 109.505 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.635 ' CD2' HG23 ' A' ' 89' ' ' VAL . 13.0 m-85 -87.11 93.66 9.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.955 . . . . 0.0 109.233 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.3 m -126.76 141.08 51.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.144 -0.972 . . . . 0.0 109.869 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -143.98 14.98 1.71 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.122 0.963 . . . . 0.0 109.785 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 177.88 50.0 0.07 OUTLIER Glycine 0 C--N 1.281 -2.526 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.449 ' O ' ' OG ' ' A' ' 8' ' ' SER . 3.3 t 55.0 20.47 3.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.47 -1.018 . . . . 0.0 109.201 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.541 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 25.8 m-80 -74.5 -34.41 63.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 0.0 109.627 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.437 ' O ' ' SG ' ' A' ' 10' ' ' CYS . 46.5 t 61.52 52.03 3.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.116 -0.99 . . . . 0.0 109.621 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.541 ' CE1' ' HB3' ' A' ' 9' ' ' ASN . 7.6 m-30 -80.61 129.97 34.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.303 -0.873 . . . . 0.0 109.073 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 3.9 m -88.57 137.96 31.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.167 -0.958 . . . . 0.0 110.11 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 p -53.55 -23.33 10.33 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.0 t -77.33 -38.16 51.0 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.357 -0.839 . . . . 0.0 108.94 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -70.86 -28.86 64.89 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 7.5 t -70.28 -31.2 46.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 C-N-CA 119.602 -0.839 . . . . 0.0 108.777 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.09 -45.62 92.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.598 -0.689 . . . . 0.0 109.433 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.62 -48.92 79.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 108.806 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.589 ' CB ' HD11 ' A' ' 61' ' ' ILE . . . -72.32 -12.22 61.04 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.554 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -83.9 -28.36 27.97 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.348 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -82.22 -14.55 55.36 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.438 -0.789 . . . . 0.0 109.099 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 26' ' ' LEU . . . -76.9 -52.94 8.55 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.279 -0.888 . . . . 0.0 109.062 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.499 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -66.16 -30.56 77.08 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.869 -1.693 . . . . 0.0 108.869 179.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.585 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 5.2 t80 -72.11 -70.65 0.32 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.415 -1.05 . . . . 0.0 108.982 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -40.71 -57.85 1.79 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.444 -0.785 . . . . 0.0 109.656 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.436 HD13 ' HB2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -46.55 -46.44 19.35 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.048 -1.032 . . . . 0.0 109.262 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -58.81 -48.69 80.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.454 -0.779 . . . . 0.0 110.86 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -86.7 12.04 11.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.134 -0.979 . . . . 0.0 109.939 -179.151 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 55.1 t0 -104.48 -11.82 16.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.076 -1.015 . . . . 0.0 109.364 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.51 -5.12 61.53 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.436 ' HB2' HD13 ' A' ' 26' ' ' LEU . 5.5 mm-40 -87.81 -176.82 5.64 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.298 -1.119 . . . . 0.0 109.367 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.593 ' CG2' ' CB ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -145.15 178.5 8.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -0.966 . . . . 0.0 109.677 179.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 34' ' ' GLY . 27.4 m -100.3 -126.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.322 -0.861 . . . . 0.0 109.441 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -43.5 -47.55 7.14 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER 163.99 -34.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -1.106 . . . . 0.0 109.638 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.449 ' N ' ' ND2' ' A' ' 36' ' ' ASN . 0.6 OUTLIER -75.96 -11.84 60.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 0.0 110.008 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.593 ' CB ' ' CG2' ' A' ' 32' ' ' THR . 1.1 p 69.29 121.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.026 -1.047 . . . . 0.0 108.916 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.735 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -98.3 -19.24 0.21 Allowed Pre-proline 0 N--CA 1.495 1.808 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -179.102 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.735 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 37.4 Cg_endo -79.82 102.03 1.43 Allowed 'Trans proline' 0 C--N 1.318 -1.056 0 C-N-CA 121.275 1.316 . . . . 0.0 113.426 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.589 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -128.77 137.43 51.54 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.072 -1.017 . . . . 0.0 109.748 177.184 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 2.5 ptmt -51.14 143.51 10.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 110.292 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.532 ' CZ ' ' HA ' ' A' ' 44' ' ' ASN . 4.4 t80 -114.45 102.01 9.68 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 44' ' ' ASN . 0.3 OUTLIER -74.77 21.66 0.11 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.901 -1.124 . . . . 0.0 111.582 -178.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.532 ' HA ' ' CZ ' ' A' ' 42' ' ' TYR . 1.2 m-20 60.42 148.63 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.66 -1.275 . . . . 0.0 109.612 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.483 ' CD2' ' O ' ' A' ' 44' ' ' ASN . 0.2 OUTLIER -174.39 -57.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.933 . . . . 0.0 109.614 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.532 ' OE2' ' CG1' ' A' ' 101' ' ' VAL . 0.2 OUTLIER -37.44 -55.99 1.03 Allowed 'General case' 0 C--N 1.308 -1.204 0 O-C-N 121.616 -0.677 . . . . 0.0 110.293 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.21 51.69 0.08 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.506 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 11.3 m-85 -91.43 -170.1 2.52 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.301 -1.117 . . . . 0.0 108.629 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -150.49 44.9 0.87 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.095 -1.003 . . . . 0.0 110.308 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.52 -179.5 5.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.954 -1.091 . . . . 0.0 109.236 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.4 m -153.22 56.68 0.77 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.237 -0.914 . . . . 0.0 109.466 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.477 ' O ' ' CB ' ' A' ' 53' ' ' SER . 37.4 t -94.62 -27.0 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.258 -0.901 . . . . 0.0 109.647 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.505 ' OG ' ' HD2' ' A' ' 55' ' ' PRO . 4.1 t 167.55 162.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.028 -1.045 . . . . 0.0 109.57 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.543 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -75.82 -59.71 1.14 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.094 -1.004 . . . . 0.0 110.646 -179.27 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.543 ' CD ' ' CB ' ' A' ' 54' ' ' SER . 36.0 Cg_endo -71.34 84.37 0.94 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 121.959 1.773 . . . . 0.0 110.623 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.585 ' CE1' ' CB ' ' A' ' 87' ' ' ALA . 38.3 m-85 -79.62 -171.04 2.62 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.648 0.737 . . . . 0.0 109.904 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.584 ' CD2' ' O ' ' A' ' 56' ' ' TYR . 76.9 m-85 -160.82 151.04 17.79 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.455 ' OE2' ' HB2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -120.79 140.39 51.78 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.901 -1.124 . . . . 0.0 110.543 -178.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.63 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 3.7 t-105 -155.99 146.34 15.97 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.63 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.8 Cg_endo -68.32 130.58 21.48 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.098 1.866 . . . . 0.0 111.43 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.589 HD11 ' CB ' ' A' ' 19' ' ' ALA . 0.2 OUTLIER -97.84 132.54 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.505 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.9 OUTLIER -123.81 165.01 18.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 0.0 109.342 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 11' ' ' TYR . 27.1 t -120.26 37.42 4.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 108.97 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.39 -172.91 3.07 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.404 -0.81 . . . . 0.0 109.638 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -96.28 50.48 1.66 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -150.04 147.34 27.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.09 -1.241 . . . . 0.0 109.432 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.421 HG12 ' CZ2' ' A' ' 59' ' ' TRP . 81.0 t -92.18 152.27 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.89 . . . . 0.0 109.252 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.53 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 44.4 t80 -59.79 132.17 53.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.201 -0.937 . . . . 0.0 109.573 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.1 t -155.91 20.36 0.38 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.303 -0.873 . . . . 0.0 109.246 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.5 89.75 1.41 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -162.65 -39.52 0.02 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.435 ' O ' ' OG ' ' A' ' 72' ' ' SER . 28.1 p -158.17 102.14 1.73 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.16 -1.2 . . . . 0.0 109.326 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -75.15 114.14 3.94 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.336 2.024 . . . . 0.0 110.158 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.42 ' HA2' ' CD2' ' A' ' 92' ' ' HIS . . . 109.83 -125.08 7.44 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.455 ' N ' ' HB2' ' A' ' 92' ' ' HIS . . . 51.01 -174.06 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.201 -1.176 . . . . 0.0 109.638 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.451 ' C ' ' O ' ' A' ' 75' ' ' ALA . 65.8 m-20 -37.89 143.16 0.12 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.649 0.738 . . . . 0.0 110.681 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.503 ' CA ' HG23 ' A' ' 61' ' ' ILE . 2.0 ttt180 -153.95 133.65 12.96 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.419 ' CG2' HD11 ' A' ' 86' ' ' LEU . 10.8 p -119.24 130.08 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.928 -1.107 . . . . 0.0 110.461 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.559 ' CG1' ' N ' ' A' ' 80' ' ' PHE . 12.9 t -89.5 163.25 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 CA-C-O 122.298 1.047 . . . . 0.0 109.857 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.559 ' N ' ' CG1' ' A' ' 79' ' ' VAL . 34.4 p90 -159.74 -168.47 2.27 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.52 ' OD1' ' HG2' ' A' ' 82' ' ' GLU . 1.2 p30 -122.07 -44.79 2.27 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.866 -1.134 . . . . 0.0 111.004 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.585 ' O ' ' CZ ' ' A' ' 24' ' ' TYR . 2.1 pt-20 161.21 -21.54 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.419 ' C ' ' CG ' ' A' ' 84' ' ' ASN . 1.8 m-20 -92.16 20.27 6.11 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.581 ' OD1' ' CE2' ' A' ' 24' ' ' TYR . 0.0 OUTLIER 63.62 8.08 3.46 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.7 -0.625 . . . . 0.0 109.686 -179.474 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.41 ' O ' ' O ' ' A' ' 84' ' ' ASN . 13.6 mt-30 -60.66 -160.32 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.451 HD23 ' HG3' ' A' ' 20' ' ' GLN . 0.1 OUTLIER -137.84 117.42 12.99 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.488 -1.382 . . . . 0.0 110.755 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.585 ' CB ' ' CE1' ' A' ' 56' ' ' TYR . . . -83.92 -43.23 15.47 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 170.48 163.69 24.94 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.635 HG23 ' CD2' ' A' ' 4' ' ' TYR . 75.1 t -115.93 99.22 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.021 -1.282 . . . . 0.0 109.388 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.464 HG21 ' C ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -88.37 -173.39 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.398 -0.814 . . . . 0.0 109.401 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.479 ' CG2' ' O ' ' A' ' 91' ' ' THR . 5.9 t -148.9 121.43 8.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.986 -1.071 . . . . 0.0 110.213 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.455 ' HB2' ' N ' ' A' ' 75' ' ' ALA . 2.4 m-70 -78.99 79.13 5.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.549 -0.719 . . . . 0.0 109.291 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 98' ' ' ASN . 0.6 OUTLIER 177.36 -28.56 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.171 -0.956 . . . . 0.0 110.095 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.8 -16.31 16.69 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.561 ' CB ' ' CB ' ' A' ' 99' ' ' ASN . . . -122.52 178.15 5.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.104 -1.233 . . . . 0.0 109.412 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 98' ' ' ASN . 1.0 OUTLIER -40.95 157.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.449 -0.782 . . . . 0.0 109.31 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 96' ' ' SER . . . 43.97 -95.18 0.01 OUTLIER Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -127.28 -73.91 0.6 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.346 -1.091 . . . . 0.0 109.347 179.339 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.561 ' CB ' ' CB ' ' A' ' 95' ' ' ALA . 0.9 OUTLIER 59.33 120.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.044 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.562 ' CD2' ' O ' ' A' ' 100' ' ' PHE . 38.3 p90 -98.76 117.53 33.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.843 -1.161 . . . . 0.0 110.705 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.532 ' CG1' ' OE2' ' A' ' 46' ' ' GLU . 18.0 m -128.91 158.2 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 101' ' ' VAL . 4.3 pt-20 -43.42 138.81 2.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 109.37 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.1 OUTLIER -75.73 176.8 7.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.63 -179.645 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.081 -0.962 . . . . 0.0 109.523 -179.9 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.482 ' O ' ' SG ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.414 0.626 . . . . 0.0 109.724 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 21.6 p 36.78 91.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.603 0.716 . . . . 0.0 110.224 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -97.86 1.63 48.38 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.418 ' CD2' HG22 ' A' ' 89' ' ' VAL . 16.1 m-85 -104.28 78.1 1.47 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.482 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.1 m -84.31 93.98 8.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.427 ' O ' ' C ' ' A' ' 7' ' ' GLY . 2.8 m -120.65 155.03 34.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 109.474 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 6' ' ' CYS . . . 43.8 27.21 0.91 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 1.4 m 68.94 50.59 0.59 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.292 -1.122 . . . . 0.0 109.582 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -144.55 126.53 15.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.171 -0.956 . . . . 0.0 109.598 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.428 ' C ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -82.99 84.07 7.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -0.831 . . . . 0.0 109.02 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.43 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 4.2 m-30 -79.82 138.68 37.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.41 -0.806 . . . . 0.0 109.661 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.559 ' O ' HG21 ' A' ' 16' ' ' VAL . 2.0 t -80.73 123.28 28.07 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.696 -0.627 . . . . 0.0 109.92 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.18 -24.37 0.45 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 109.221 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.6 t -81.53 -41.1 22.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.983 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -67.62 -28.32 67.64 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.559 HG21 ' O ' ' A' ' 12' ' ' SER . 1.9 t -68.39 -29.64 44.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.512 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 21.5 t -62.63 -46.13 89.66 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -59.43 5.02 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.561 ' CB ' HD11 ' A' ' 61' ' ' ILE . . . -61.83 -16.42 50.04 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.555 ' OE1' HG13 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -73.56 -33.81 64.85 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.296 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.62 1.65 53.08 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.0 -62.28 1.73 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.249 -0.907 . . . . 0.0 109.04 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.459 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -60.89 -16.49 47.17 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -82.42 -64.91 1.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.342 -1.093 . . . . 0.0 109.248 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -47.42 -52.43 16.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.353 -0.842 . . . . 0.0 109.745 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.484 ' CD1' ' HB3' ' A' ' 31' ' ' GLU . 2.7 tp -59.72 -38.46 81.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.292 -0.88 . . . . 0.0 109.397 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.649 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 66.1 t60 -68.7 -20.13 64.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.006 -1.059 . . . . 0.0 110.29 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -87.19 -21.97 25.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.057 -1.027 . . . . 0.0 109.507 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 9.9 t70 -89.05 -12.26 41.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.267 -0.896 . . . . 0.0 109.502 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.35 0.84 59.01 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.484 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 5.6 tp10 -67.95 -144.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -1.175 . . . . 0.0 109.517 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.587 ' CG2' ' CB ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -167.26 -174.6 2.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.058 -1.026 . . . . 0.0 109.619 -179.73 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 m -105.03 -104.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 109.631 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -77.13 -38.19 30.49 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 2.2 t 162.83 -36.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.437 -1.037 . . . . 0.0 109.385 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.418 ' O ' ' O ' ' A' ' 37' ' ' SER . 5.4 m120 -68.82 -16.5 63.8 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.327 -0.858 . . . . 0.0 109.262 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.587 ' CB ' ' CG2' ' A' ' 32' ' ' THR . 8.1 t 63.09 126.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.271 -0.893 . . . . 0.0 109.431 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.623 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -117.99 -27.41 0.08 OUTLIER Pre-proline 0 N--CA 1.499 2.001 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -178.56 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 37.0 Cg_endo -79.34 100.72 1.35 Allowed 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 121.062 1.175 . . . . 0.0 112.724 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.597 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -135.92 160.61 38.07 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.115 -0.991 . . . . 0.0 108.747 177.439 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -62.72 139.83 58.69 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.128 -0.982 . . . . 0.0 110.232 -179.272 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.578 ' CD2' ' OD1' ' A' ' 44' ' ' ASN . 9.2 t80 -101.41 150.26 23.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.365 -0.834 . . . . 0.0 108.784 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 1.1 m-20 -107.51 -15.55 14.58 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.014 -1.054 . . . . 0.0 110.357 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.578 ' OD1' ' CD2' ' A' ' 42' ' ' TYR . 22.8 m-80 60.26 92.17 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.026 -1.046 . . . . 0.0 109.215 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -122.83 28.19 7.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.194 -0.941 . . . . 0.0 109.626 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.558 ' OE2' ' CE1' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -101.42 -65.67 0.96 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.784 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.46 ' N ' ' CG ' ' A' ' 46' ' ' GLU . . . 144.34 35.38 0.07 OUTLIER Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.558 ' CE1' ' OE2' ' A' ' 46' ' ' GLU . 15.9 m-85 -61.71 -171.07 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.92 6.75 4.66 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 118.102 -1.439 . . . . 0.0 110.292 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.534 ' CZ ' ' CD2' ' A' ' 48' ' ' PHE . 1.8 p90 -96.32 -169.98 2.01 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.996 -1.065 . . . . 0.0 109.347 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 50' ' ' PHE . 6.5 t 167.95 45.21 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.272 -0.893 . . . . 0.0 109.527 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -44.54 -27.73 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 109.252 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.542 ' O ' ' CE1' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -170.99 165.98 7.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.391 -0.818 . . . . 0.0 109.66 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.57 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -78.04 -51.2 1.72 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.323 -0.86 . . . . 0.0 111.044 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 54' ' ' SER . 32.9 Cg_endo -72.77 92.41 0.79 Allowed 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.856 1.704 . . . . 0.0 109.5 -177.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.612 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 2.2 m-30 -91.85 -170.96 2.72 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.961 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.649 ' CE1' ' NE2' ' A' ' 27' ' ' HIS . 61.1 m-85 -164.29 105.55 0.88 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -74.76 139.4 43.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 109.384 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.67 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 14.6 t-105 -159.84 141.03 9.24 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.67 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.4 Cg_endo -68.16 131.21 23.06 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 C-N-CA 122.156 1.904 . . . . 0.0 111.433 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.561 HD11 ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -106.44 128.2 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.705 -0.622 . . . . 0.0 109.42 -179.614 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.474 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 1.2 mt -125.03 164.28 20.52 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.306 -0.872 . . . . 0.0 109.352 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.435 ' O ' ' OG ' ' A' ' 63' ' ' SER . 2.2 t -118.51 16.55 13.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.145 -0.972 . . . . 0.0 109.077 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.45 -156.9 0.57 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.597 -0.689 . . . . 0.0 109.487 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -116.0 54.81 0.57 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -163.32 107.17 1.03 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -1.184 . . . . 0.0 109.709 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.417 HG13 ' HZ2' ' A' ' 59' ' ' TRP . 43.5 t -47.76 160.01 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.216 -0.927 . . . . 0.0 109.099 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.548 ' C ' ' CD1' ' A' ' 68' ' ' TYR . 6.5 t80 -49.1 119.24 3.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.915 -1.116 . . . . 0.0 109.388 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -168.08 39.41 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.432 -0.793 . . . . 0.0 109.127 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.71 -0.97 6.86 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -83.95 -153.66 17.06 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.47 131.51 74.45 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.235 -1.156 . . . . 0.0 109.408 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.413 ' O ' ' O ' ' A' ' 74' ' ' GLY . 36.4 Cg_endo -79.85 -89.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.547 2.164 . . . . 0.0 110.753 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 76' ' ' ASP . . . -59.06 -112.55 0.01 OUTLIER Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.476 ' O ' ' OG1' ' A' ' 91' ' ' THR . . . 50.9 -87.23 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.383 -1.069 . . . . 0.0 110.415 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 74' ' ' GLY . 1.0 OUTLIER -117.32 116.37 27.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.928 -1.108 . . . . 0.0 109.988 -179.582 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.562 ' NH1' ' CE1' ' A' ' 38' ' ' TYR . 2.3 mtm-85 -128.78 138.14 51.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.139 -0.976 . . . . 0.0 109.138 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.555 HG13 ' OE1' ' A' ' 20' ' ' GLN . 9.8 p -123.62 142.85 38.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.459 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 23.4 t -110.59 165.88 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 122.188 0.994 . . . . 0.0 111.02 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.525 ' CE1' ' HB2' ' A' ' 57' ' ' TYR . 22.7 p90 -161.95 -170.48 2.54 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.258 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.45 ' O ' ' CD2' ' A' ' 57' ' ' TYR . 20.0 t30 -124.35 -82.15 0.64 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.006 -1.059 . . . . 0.0 109.929 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -158.08 18.68 0.24 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.409 -0.807 . . . . 0.0 109.6 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.487 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 2.7 m-20 -153.5 26.11 0.51 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.518 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 0.4 OUTLIER 53.4 19.65 1.7 Allowed 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.362 0.601 . . . . 0.0 109.557 -179.649 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.595 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -46.83 -35.32 6.19 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.093 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.595 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 92.43 110.09 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.549 0.69 . . . . 0.0 111.152 179.044 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.549 ' HB2' ' CE2' ' A' ' 56' ' ' TYR . . . -87.42 -42.22 12.99 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 151.21 146.01 4.24 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.418 HG22 ' CD2' ' A' ' 4' ' ' TYR . 61.1 t -86.8 88.81 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.029 -1.277 . . . . 0.0 109.462 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 77' ' ' ARG . 1.1 pt -79.39 170.24 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.315 -0.866 . . . . 0.0 108.785 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 75' ' ' ALA . 12.1 t -135.97 141.26 44.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.075 -1.016 . . . . 0.0 110.274 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.576 ' CD2' ' HB2' ' A' ' 98' ' ' ASN . 2.9 t60 -92.77 76.02 4.91 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 1.2 m 171.76 148.38 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.17 -20.69 46.29 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -126.43 151.9 47.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.122 -1.222 . . . . 0.0 109.665 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 95' ' ' ALA . 20.3 m -41.57 125.78 2.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.47 -0.769 . . . . 0.0 109.321 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.487 ' O ' ' C ' ' A' ' 98' ' ' ASN . . . 65.33 40.5 96.53 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.576 ' HB2' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 32.9 52.4 0.31 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 122.053 -0.675 . . . . 0.0 110.209 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -57.27 167.39 0.93 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.214 -0.929 . . . . 0.0 109.222 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.418 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -88.78 122.05 31.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.143 -0.973 . . . . 0.0 109.664 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.458 HG12 ' OE2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -136.06 152.85 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.267 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.92 131.28 49.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.14 -0.975 . . . . 0.0 109.491 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 89.8 m -54.18 148.05 11.93 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.26 -0.9 . . . . 0.0 109.627 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 109.573 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.511 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.511 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 1.6 p 165.3 126.86 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.26 -0.9 . . . . 0.0 110.291 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -96.21 -29.68 13.9 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.574 ' CD1' ' CG2' ' A' ' 89' ' ' VAL . 18.0 m-85 -91.81 103.69 16.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.479 -0.763 . . . . 0.0 109.11 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.4 m -125.83 123.92 39.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.096 -1.003 . . . . 0.0 109.89 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.8 m -103.57 16.91 25.28 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.093 0.949 . . . . 0.0 109.61 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 152.82 -88.46 0.13 Allowed Glycine 0 C--N 1.284 -2.355 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.3 m -138.4 42.14 2.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -1.146 . . . . 0.0 109.684 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.418 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 1.0 OUTLIER -103.73 -26.33 12.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.183 -0.948 . . . . 0.0 109.38 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.1 t 60.18 57.78 2.85 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.38 -0.825 . . . . 0.0 109.675 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.519 ' CE1' ' HB3' ' A' ' 63' ' ' SER . 6.2 m-30 -87.88 114.02 24.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.39 -0.819 . . . . 0.0 108.874 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.506 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -85.99 138.35 32.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.062 -1.023 . . . . 0.0 109.98 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 p -48.82 -23.13 0.97 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.369 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.8 m -77.81 -41.33 37.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.113 -0.992 . . . . 0.0 109.543 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -71.68 -28.76 63.94 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.506 HG21 ' O ' ' A' ' 12' ' ' SER . 41.4 t -65.32 -24.93 35.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.4 t -66.97 -44.59 80.08 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.72 -38.46 85.16 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.655 ' CB ' HD13 ' A' ' 61' ' ' ILE . . . -81.31 -13.99 57.81 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.573 ' OE1' ' CG ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -82.13 -27.91 32.5 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.394 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -83.32 -13.21 55.59 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.13 -50.78 20.83 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.441 -0.787 . . . . 0.0 109.266 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.514 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -77.29 -29.02 57.01 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.579 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 3.2 t80 -71.37 -27.84 63.63 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.436 -1.038 . . . . 0.0 109.114 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.455 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 1.9 tt0 -74.16 -63.04 1.31 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.112 -0.992 . . . . 0.0 108.951 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 tp -46.47 -34.74 5.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.349 -0.845 . . . . 0.0 108.972 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.576 ' NE2' ' CZ ' ' A' ' 57' ' ' TYR . 2.0 t60 -65.52 -59.23 4.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.477 -0.765 . . . . 0.0 110.093 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -83.02 10.22 8.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.246 -0.909 . . . . 0.0 109.759 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 45.7 t0 -95.84 -23.76 16.76 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.956 . . . . 0.0 109.61 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.97 -0.66 84.41 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.4 ' C ' ' OG1' ' A' ' 32' ' ' THR . 1.0 OUTLIER -97.56 -146.33 0.31 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.191 -1.182 . . . . 0.0 109.367 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.485 ' CG2' ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -168.99 -177.17 2.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -0.938 . . . . 0.0 109.523 -179.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.471 ' HB ' ' HA ' ' A' ' 69' ' ' SER . 0.3 OUTLIER -92.54 -100.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 109.057 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.505 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -94.19 30.87 7.16 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 1.0 OUTLIER 78.21 1.39 2.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.525 -0.986 . . . . 0.0 109.334 -179.482 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.53 ' O ' ' CB ' ' A' ' 37' ' ' SER . 0.5 OUTLIER -93.18 -19.36 21.53 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.334 -0.853 . . . . 0.0 109.743 -179.651 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 36' ' ' ASN . 0.8 OUTLIER 76.45 93.34 0.07 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 109.294 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.605 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -85.77 -43.53 0.62 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 111.238 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 32.9 Cg_endo -75.46 108.41 2.69 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 120.927 1.085 . . . . 0.0 110.045 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.605 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -123.79 124.68 43.23 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.3 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.523 ' HA ' ' CD1' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -49.63 125.06 10.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.387 -0.821 . . . . 0.0 110.72 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 2.1 t80 -88.83 159.45 17.71 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.433 ' O ' ' CZ ' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -169.6 35.61 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 4.2 m-20 -90.21 -171.48 3.13 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.681 0.753 . . . . 0.0 110.233 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.558 ' CG ' ' C ' ' A' ' 44' ' ' ASN . 0.2 OUTLIER -158.68 24.32 0.22 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.4 OUTLIER -36.37 -67.24 0.18 Allowed 'General case' 0 C--N 1.31 -1.144 0 O-C-N 121.784 -0.573 . . . . 0.0 110.176 -179.235 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.446 ' O ' ' OE2' ' A' ' 102' ' ' GLU . . . -167.01 41.86 0.25 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.563 ' HB3' ' CE2' ' A' ' 50' ' ' PHE . 65.7 m-85 -100.88 158.15 16.2 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.276 -1.132 . . . . 0.0 109.254 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -125.5 11.0 7.95 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.229 -0.92 . . . . 0.0 109.59 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.563 ' CE2' ' HB3' ' A' ' 48' ' ' PHE . 2.3 p90 -78.19 165.0 24.45 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.142 -0.973 . . . . 0.0 109.363 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 52' ' ' VAL . 33.3 t -144.39 34.76 1.19 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.214 -0.929 . . . . 0.0 109.594 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.529 HG11 ' HB3' ' A' ' 81' ' ' ASN . 59.8 t -44.41 -45.98 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.264 -0.898 . . . . 0.0 109.058 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.417 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 0.1 OUTLIER 172.5 157.0 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.765 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.575 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -59.28 -51.25 82.86 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.408 -0.807 . . . . 0.0 110.623 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 54' ' ' SER . 35.6 Cg_endo -75.6 83.15 1.96 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.046 1.83 . . . . 0.0 110.27 -178.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.608 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 48.7 m-85 -79.35 -172.02 3.0 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.322 0.582 . . . . 0.0 110.148 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.608 ' CG ' ' O ' ' A' ' 56' ' ' TYR . 34.3 m-85 -165.02 118.39 1.24 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.572 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -95.53 146.03 24.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 0.0 110.17 -179.36 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.602 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 8.8 t-105 -160.36 142.97 9.76 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.602 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.2 Cg_endo -67.79 138.67 45.52 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.067 1.844 . . . . 0.0 111.309 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.655 HD13 ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -110.35 133.0 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.465 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.504 ' O ' HD11 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -125.89 169.48 12.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.312 -0.867 . . . . 0.0 109.29 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.519 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 2.2 p -122.94 28.45 7.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.309 -0.869 . . . . 0.0 109.056 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.77 -12.28 8.47 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.468 -0.77 . . . . 0.0 109.446 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.82 29.46 59.2 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 67' ' ' VAL . 5.8 t0 -102.56 -3.67 26.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -1.157 . . . . 0.0 109.758 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' A' ' 66' ' ' ASP . 3.4 t 55.55 166.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.947 . . . . 0.0 109.42 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.44 ' HB2' ' HG2' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -115.18 120.96 41.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.903 . . . . 0.0 109.565 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.471 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -140.01 78.57 1.67 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.874 . . . . 0.0 109.527 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 71' ' ' GLY . . . 161.34 37.42 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 70' ' ' GLY . . . 41.95 -145.52 0.74 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.8 t 64.42 74.19 0.42 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.177 -1.19 . . . . 0.0 109.533 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.4 ' HA ' ' OH ' ' A' ' 38' ' ' TYR . 34.6 Cg_endo -77.5 -177.27 3.72 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.596 2.197 . . . . 0.0 110.321 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 173.84 76.19 0.05 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.538 ' HA ' ' N ' ' A' ' 92' ' ' HIS . . . 67.39 -143.12 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.205 -1.174 . . . . 0.0 109.813 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.527 ' O ' ' O ' ' A' ' 75' ' ' ALA . 49.8 m-20 14.29 113.54 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.504 ' O ' ' O ' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -162.86 128.95 3.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.129 -0.982 . . . . 0.0 109.264 178.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.576 HG21 HD23 ' A' ' 86' ' ' LEU . 4.6 p -116.49 140.01 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.749 -1.219 . . . . 0.0 109.227 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.498 HG11 ' HA ' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -105.0 -175.36 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 122.371 1.081 . . . . 0.0 110.628 -179.235 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.573 ' CG ' ' OE1' ' A' ' 20' ' ' GLN . 26.1 p90 179.81 -169.15 0.12 Allowed 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.529 ' HB3' HG11 ' A' ' 52' ' ' VAL . 1.7 p30 -123.09 -39.73 2.46 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.998 -1.064 . . . . 0.0 110.231 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.579 ' O ' ' CZ ' ' A' ' 24' ' ' TYR . 4.4 pt-20 159.51 -26.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.474 ' O ' ' CB ' ' A' ' 84' ' ' ASN . 0.5 OUTLIER -86.33 -5.24 59.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.338 -0.851 . . . . 0.0 109.089 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 83' ' ' ASN . 7.7 t-20 74.7 30.32 1.02 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.37 -0.831 . . . . 0.0 109.702 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.525 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -74.07 -25.74 60.0 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.218 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.576 HD23 HG21 ' A' ' 78' ' ' VAL . 0.2 OUTLIER 81.81 110.76 0.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.389 0.614 . . . . 0.0 110.195 179.306 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.406 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . . . -78.94 -39.49 34.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.389 -0.82 . . . . 0.0 109.048 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.443 ' N ' ' CD1' ' A' ' 86' ' ' LEU . . . 162.49 169.53 25.99 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.574 ' CG2' ' CD1' ' A' ' 4' ' ' TYR . 47.5 t -100.09 87.77 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.265 -1.138 . . . . 0.0 109.559 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.504 ' O ' ' O ' ' A' ' 77' ' ' ARG . 4.4 pt -90.15 146.28 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -0.864 . . . . 0.0 109.411 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 99' ' ' ASN . 9.9 t -123.17 135.19 54.21 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.625 -1.297 . . . . 0.0 110.489 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.687 ' CE1' ' CE2' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -86.39 75.66 9.76 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.368 -0.833 . . . . 0.0 109.187 179.241 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 2.3 m -179.66 -31.87 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.335 -0.853 . . . . 0.0 109.233 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -68.43 -6.99 51.5 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.438 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -139.53 123.14 17.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.136 -1.214 . . . . 0.0 109.547 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.454 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.3 OUTLIER 47.69 -165.64 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.159 -0.963 . . . . 0.0 109.156 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 96' ' ' SER . . . -40.62 -66.29 0.88 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.601 ' O ' ' CE1' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -153.58 89.5 1.34 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.27 -1.135 . . . . 0.0 109.08 179.445 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 91' ' ' THR . 0.9 OUTLIER -112.25 141.1 46.36 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.442 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.687 ' CE2' ' CE1' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -75.08 138.05 41.85 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.994 -1.066 . . . . 0.0 109.558 -179.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.53 ' CG1' ' O ' ' A' ' 100' ' ' PHE . 30.3 m -160.17 145.57 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.344 -0.848 . . . . 0.0 109.005 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.538 ' HG3' ' CD1' ' A' ' 48' ' ' PHE . 1.4 mp0 -45.46 124.26 4.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.545 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.47 130.78 40.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 109.613 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 67.6 p . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.334 -0.854 . . . . 0.0 109.514 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.495 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.8 p 164.83 124.52 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.28 -0.887 . . . . 0.0 110.06 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -104.03 -7.24 20.44 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.46 -0.775 . . . . 0.0 109.067 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.54 ' CD1' ' HB ' ' A' ' 89' ' ' VAL . 17.2 m-85 -104.71 110.09 22.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.936 . . . . 0.0 109.382 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 82.8 p -142.31 118.4 10.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.285 -0.885 . . . . 0.0 109.804 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -124.44 11.6 8.66 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 122.317 1.056 . . . . 0.0 109.436 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 8' ' ' SER . . . -160.94 32.74 0.38 Allowed Glycine 0 C--N 1.282 -2.454 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 3.9 t 70.95 9.32 6.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.316 -1.108 . . . . 0.0 109.315 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -78.1 178.06 7.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 109.556 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 51.8 t -127.74 70.22 1.33 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.341 -0.849 . . . . 0.0 109.084 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.403 ' HB2' ' O ' ' A' ' 4' ' ' TYR . 3.5 m-85 -79.63 118.68 21.68 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.262 -0.899 . . . . 0.0 109.543 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 48.8 m -80.21 133.76 36.05 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.491 -0.756 . . . . 0.0 109.958 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.95 -30.32 10.11 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 t -73.43 -38.99 65.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.362 -0.836 . . . . 0.0 109.076 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -67.95 -26.04 65.75 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 19.4 t -77.15 -29.08 16.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.429 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 0.2 OUTLIER -67.66 -37.84 82.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.422 -0.799 . . . . 0.0 109.382 179.688 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -47.05 86.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.133 -0.98 . . . . 0.0 108.433 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.492 ' CB ' HD11 ' A' ' 61' ' ' ILE . . . -73.25 -17.98 61.28 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.573 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -76.45 -32.13 58.25 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.438 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -79.12 -8.31 58.88 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.29 -55.92 4.06 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.352 -0.843 . . . . 0.0 108.843 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.565 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -68.22 -20.86 73.56 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.577 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 1.0 OUTLIER -81.84 -58.08 3.15 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.586 -0.949 . . . . 0.0 109.521 -179.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -49.15 -36.45 19.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.13 -0.981 . . . . 0.0 109.486 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.567 HD11 ' CB ' ' A' ' 31' ' ' GLU . 1.2 mm? -72.61 -40.24 66.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.351 -0.843 . . . . 0.0 109.278 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.664 ' CE1' ' CE1' ' A' ' 57' ' ' TYR . 2.6 t60 -61.38 -32.78 72.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.438 -0.789 . . . . 0.0 110.433 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.509 ' OE1' ' CZ ' ' A' ' 24' ' ' TYR . 4.2 pt-20 -86.69 -26.23 24.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.951 -1.093 . . . . 0.0 109.812 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -84.86 -6.54 59.35 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.1 -1.0 . . . . 0.0 109.547 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.79 -28.31 6.59 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.567 ' CB ' HD11 ' A' ' 26' ' ' LEU . 3.1 mm-40 -58.61 -166.94 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.172 -1.193 . . . . 0.0 109.454 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.49 ' HB ' ' HA ' ' A' ' 37' ' ' SER . 0.4 OUTLIER -155.83 -93.61 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.886 . . . . 0.0 109.524 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.588 ' CG2' ' CA ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -134.67 -167.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.129 -0.982 . . . . 0.0 109.318 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -40.73 -37.41 1.3 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 t -176.37 -51.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -1.186 . . . . 0.0 109.814 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.548 ' O ' ' CB ' ' A' ' 37' ' ' SER . 35.3 m120 -51.39 -86.0 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.156 -0.965 . . . . 0.0 109.645 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.588 ' CA ' ' CG2' ' A' ' 33' ' ' VAL . 0.3 OUTLIER 160.33 -178.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.537 ' C ' ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER 175.46 -49.38 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.917 -1.114 . . . . 0.0 112.302 178.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 31.4 Cg_endo -75.3 100.55 1.38 Allowed 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 121.215 1.276 . . . . 0.0 112.094 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.537 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -140.72 137.12 33.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.693 -0.629 . . . . 0.0 109.356 178.66 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -42.77 133.84 3.42 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.396 -0.815 . . . . 0.0 110.318 -179.059 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.586 ' OH ' ' CD1' ' A' ' 100' ' ' PHE . 30.2 t80 -94.09 159.43 15.16 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.385 -0.822 . . . . 0.0 109.031 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' A' ' 44' ' ' ASN . 7.9 m-80 -106.63 -39.98 5.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.073 -1.017 . . . . 0.0 110.11 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.514 ' CA ' ' CE2' ' A' ' 42' ' ' TYR . 0.1 OUTLIER 62.92 127.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.11 -0.993 . . . . 0.0 108.764 -179.49 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.482 ' O ' ' C ' ' A' ' 46' ' ' GLU . 1.4 m-85 -161.68 -36.25 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.093 -1.004 . . . . 0.0 110.052 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.482 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -34.75 -72.83 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.671 -0.643 . . . . 0.0 110.412 -179.322 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 171.2 56.46 0.04 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.424 ' C ' ' OD1' ' A' ' 49' ' ' ASP . 90.6 m-85 -86.66 177.97 7.19 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.204 -1.174 . . . . 0.0 108.407 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.424 ' OD1' ' C ' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -131.19 11.25 4.99 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.986 -1.071 . . . . 0.0 110.095 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 87' ' ' ALA . 0.7 OUTLIER -88.61 -174.95 4.76 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.036 -1.04 . . . . 0.0 109.201 179.542 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.0 m -173.86 40.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.212 -0.93 . . . . 0.0 109.521 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.0 t -52.24 -39.42 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.296 -0.878 . . . . 0.0 109.284 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.5 ' OG ' ' CB ' ' A' ' 81' ' ' ASN . 32.9 p -177.86 151.37 0.69 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 109.671 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.578 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -59.2 -52.74 72.39 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.333 -0.854 . . . . 0.0 110.08 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 54' ' ' SER . 35.9 Cg_endo -75.48 86.54 1.46 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.989 1.792 . . . . 0.0 109.511 -178.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.604 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 10.6 m-85 -78.84 -169.15 1.66 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.664 ' CE1' ' CE1' ' A' ' 27' ' ' HIS . 66.0 m-85 -162.72 106.73 1.11 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 40' ' ' HIS . 4.1 pt-20 -78.87 137.22 37.57 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.743 0.782 . . . . 0.0 110.726 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.618 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 26.6 t-105 -160.82 139.82 7.71 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.618 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.8 Cg_endo -70.35 158.95 54.61 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.273 1.982 . . . . 0.0 111.749 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.492 HD11 ' CB ' ' A' ' 19' ' ' ALA . 0.2 OUTLIER -132.41 136.6 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.525 -0.734 . . . . 0.0 109.225 -179.547 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.498 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -121.31 174.96 6.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.106 -0.996 . . . . 0.0 109.775 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.67 31.6 4.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.911 . . . . 0.0 109.189 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.94 -58.72 2.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.376 -0.828 . . . . 0.0 109.399 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.31 52.37 0.03 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -156.67 150.55 24.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -1.175 . . . . 0.0 109.548 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.3 t -83.66 133.25 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.351 -0.843 . . . . 0.0 109.351 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.553 ' CD2' ' HB2' ' A' ' 60' ' ' PRO . 0.7 OUTLIER -56.06 135.67 52.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -0.954 . . . . 0.0 109.508 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.441 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -151.58 52.35 0.83 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.264 -0.897 . . . . 0.0 109.265 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.38 158.21 33.28 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.74 79.18 0.63 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.3 m 53.77 87.4 0.14 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.238 -1.154 . . . . 0.0 109.767 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.6 170.47 19.16 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.653 2.235 . . . . 0.0 110.261 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.14 -164.25 12.49 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 69.38 -162.08 0.18 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.29 -1.123 . . . . 0.0 110.488 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 91' ' ' THR . 38.9 m-20 -46.98 165.86 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.678 0.751 . . . . 0.0 110.787 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.509 ' O ' HG12 ' A' ' 90' ' ' ILE . 36.1 ttm180 -172.82 104.68 0.14 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.678 ' CG2' HD13 ' A' ' 86' ' ' LEU . 4.2 p -79.68 152.22 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.895 -1.128 . . . . 0.0 110.154 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.57 HG11 ' N ' ' A' ' 80' ' ' PHE . 44.7 t -120.32 165.13 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.879 0.847 . . . . 0.0 109.83 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.573 ' CD1' ' OE1' ' A' ' 20' ' ' GLN . 8.4 p90 -165.63 -169.49 1.57 Allowed 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.746 -0.781 . . . . 0.0 109.426 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.571 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 1.9 p30 -122.28 -46.47 2.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.009 -1.057 . . . . 0.0 110.48 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.577 ' O ' ' CZ ' ' A' ' 24' ' ' TYR . 0.7 OUTLIER 163.31 -23.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -179.674 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.414 ' HB3' ' OE1' ' A' ' 85' ' ' GLN . 1.9 m-20 -86.95 14.29 7.63 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.469 ' O ' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER 71.93 6.3 5.57 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.442 -0.787 . . . . 0.0 109.048 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -58.38 -162.34 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 178.766 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.678 HD13 ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -143.55 107.72 4.75 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.663 -1.273 . . . . 0.0 110.567 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.556 ' O ' ' CD2' ' A' ' 50' ' ' PHE . . . -69.27 -36.73 77.41 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 149.46 162.77 10.6 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.54 ' HB ' ' CD1' ' A' ' 4' ' ' TYR . 41.8 t -101.07 87.95 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -1.149 . . . . 0.0 109.547 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -82.6 154.0 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.561 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 100' ' ' PHE . 9.5 t -110.73 162.47 14.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.979 -1.075 . . . . 0.0 110.808 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.615 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 2.0 t60 -119.66 53.88 1.03 Allowed 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 40.7 m -172.55 125.82 0.5 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.497 -0.752 . . . . 0.0 109.229 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 119.72 -14.93 10.56 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 98' ' ' ASN . . . -117.74 86.41 2.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.18 -1.188 . . . . 0.0 109.546 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER 42.11 74.13 0.12 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.545 -0.722 . . . . 0.0 109.119 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.55 -76.9 0.73 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.761 -1.735 . . . . 0.0 108.761 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.615 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -150.17 -84.08 0.09 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.258 -1.142 . . . . 0.0 109.43 179.717 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 91' ' ' THR . 1.6 t30 63.57 152.11 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.348 -0.845 . . . . 0.0 109.124 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.586 ' CD1' ' OH ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -96.53 143.78 27.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 109.776 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.7 m -158.03 131.41 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.475 -0.766 . . . . 0.0 109.159 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -45.45 126.15 6.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.34 -0.85 . . . . 0.0 109.559 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 1.3 m -49.05 165.85 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.259 -0.901 . . . . 0.0 109.645 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.489 1.482 0 O-C-N 121.27 -0.893 . . . . 0.0 109.508 -179.864 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 32.1 p -173.74 115.19 0.23 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.191 -0.943 . . . . 0.0 110.07 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -78.11 -45.38 23.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 0.0 109.212 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.554 ' CE1' ' HB ' ' A' ' 89' ' ' VAL . 28.1 m-85 -74.07 95.82 2.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.0 109.029 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -108.56 67.64 0.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 110.008 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.408 ' O ' ' C ' ' A' ' 7' ' ' GLY . 4.1 m -84.16 156.64 21.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 109.071 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 6' ' ' CYS . . . 44.6 -107.8 0.16 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.5 p -142.5 41.25 1.6 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.172 -1.193 . . . . 0.0 109.459 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -118.89 140.59 49.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 0.0 109.566 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -89.86 66.88 7.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -78.76 114.82 18.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 0.0 108.855 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.614 ' O ' HG23 ' A' ' 16' ' ' VAL . 1.0 OUTLIER -88.73 148.78 23.8 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.321 -0.862 . . . . 0.0 110.505 -179.181 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -13.39 18.38 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.85 -36.49 12.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.26 -0.9 . . . . 0.0 109.75 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.15 -30.55 62.32 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.987 -1.071 . . . . 0.0 108.117 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 12' ' ' SER . 3.8 t -62.38 -31.1 50.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.11 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 t -58.57 -45.24 89.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.282 -0.886 . . . . 0.0 109.866 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.9 m -65.73 -52.02 54.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.578 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.549 ' CB ' ' CD1' ' A' ' 61' ' ' ILE . . . -74.36 -6.6 49.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.287 -0.883 . . . . 0.0 109.579 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.601 ' NE2' ' CD1' ' A' ' 80' ' ' PHE . 4.3 tp60 -99.69 -15.85 18.38 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.39 -17.72 29.9 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.12 -57.82 3.65 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.42 -28.33 6.41 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.538 ' CE1' ' HA ' ' A' ' 82' ' ' GLU . 24.7 t80 -77.35 -48.4 17.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.602 -0.94 . . . . 0.0 109.596 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.09 -40.97 67.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.126 -0.984 . . . . 0.0 108.858 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.5 ' CD1' ' O ' ' A' ' 31' ' ' GLU . 1.9 tm? -65.84 -43.61 87.99 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.613 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 19.5 t60 -67.55 -17.9 64.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.368 -0.833 . . . . 0.0 109.765 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.95 11.19 31.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 109.579 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -122.63 -0.22 9.21 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.346 -0.846 . . . . 0.0 109.451 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.85 21.03 58.07 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.5 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 3.4 mt-10 -102.35 -166.99 1.34 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.366 -1.079 . . . . 0.0 109.36 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.493 ' CG2' ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -147.26 173.66 12.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.242 -0.911 . . . . 0.0 109.513 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.8 m -89.02 -138.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.41 -0.806 . . . . 0.0 108.968 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.5 33.49 5.99 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.6 p -161.43 -154.3 0.34 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -1.152 . . . . 0.0 109.955 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.416 ' O ' ' CB ' ' A' ' 37' ' ' SER . 2.2 m120 -53.32 -60.98 2.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 110.101 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.493 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 0.6 OUTLIER 168.76 108.34 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.404 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.724 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.4 OUTLIER -82.51 -34.31 0.65 Allowed Pre-proline 0 C--O 1.2 -1.507 0 O-C-N 121.01 -1.056 . . . . 0.0 112.221 -178.804 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 35.9 Cg_endo -79.13 109.05 2.47 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 N-CA-C 109.874 -0.856 . . . . 0.0 109.874 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.724 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -133.58 177.53 7.63 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.559 ' HB2' ' CE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -97.51 129.73 44.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.058 -1.027 . . . . 0.0 110.456 -178.626 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.53 ' HB2' ' HG3' ' A' ' 58' ' ' GLU . 10.6 t80 -94.38 168.84 10.63 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.63 ' ND2' ' CE1' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -145.33 18.41 1.54 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.019 -1.051 . . . . 0.0 110.129 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 62.03 108.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.069 -1.019 . . . . 0.0 109.738 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.63 ' CE1' ' ND2' ' A' ' 43' ' ' ASN . 3.3 m-30 -114.91 -4.9 12.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.331 -0.855 . . . . 0.0 109.44 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.552 ' CD ' ' CE1' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -110.88 -33.86 6.4 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.115 -0.991 . . . . 0.0 108.787 -179.431 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.01 28.65 2.81 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.552 ' CE1' ' CD ' ' A' ' 46' ' ' GLU . 48.3 m-85 -61.66 -168.18 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 4.8 m-20 -139.1 -44.15 0.46 Allowed 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 118.557 -1.257 . . . . 0.0 109.771 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 49' ' ' ASP . 20.0 m-85 64.17 177.58 0.18 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.323 -0.86 . . . . 0.0 109.478 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.9 -18.58 17.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.232 -0.917 . . . . 0.0 109.07 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.505 HG23 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -98.0 -176.49 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.338 -0.851 . . . . 0.0 108.896 179.609 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.455 ' HA ' ' OH ' ' A' ' 56' ' ' TYR . 12.6 t -151.37 86.42 1.35 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.108 -0.995 . . . . 0.0 109.52 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.589 ' CB ' ' HD2' ' A' ' 55' ' ' PRO . 0.3 OUTLIER -172.58 -176.56 0.34 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.072 -1.018 . . . . 0.0 109.53 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.589 ' HD2' ' CB ' ' A' ' 54' ' ' SER . 29.4 Cg_endo -71.79 96.36 0.76 Allowed 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 121.489 1.459 . . . . 0.0 108.55 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.559 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 24.0 m-85 -75.95 -170.94 1.5 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.777 0.798 . . . . 0.0 110.694 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.613 ' CE2' ' NE2' ' A' ' 27' ' ' HIS . 49.4 m-85 -150.72 147.18 27.03 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.624 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 1.2 mp0 -96.96 146.29 25.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.872 -1.142 . . . . 0.0 110.365 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.603 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 46.3 t-105 -159.45 135.7 6.36 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.603 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 31.9 Cg_endo -72.75 148.68 47.04 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 121.922 1.748 . . . . 0.0 111.115 -178.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.549 ' CD1' ' CB ' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -122.53 142.19 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.531 ' H ' HD13 ' A' ' 61' ' ' ILE . 1.4 mt -122.51 -170.67 2.12 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.249 -0.907 . . . . 0.0 109.383 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.57 54.8 0.93 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 108.928 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -157.75 -43.8 0.06 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.391 -0.818 . . . . 0.0 109.464 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.98 39.45 3.56 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.3 18.22 17.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -1.146 . . . . 0.0 109.464 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 t 62.3 167.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.902 . . . . 0.0 109.693 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.546 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 6.1 t80 -106.86 139.13 41.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.343 -0.848 . . . . 0.0 109.591 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.8 m -122.46 -20.21 6.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.243 -0.911 . . . . 0.0 109.636 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 163.73 148.27 5.35 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 144.3 -142.95 11.51 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.445 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 20.3 m -51.89 118.15 11.26 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.217 -1.166 . . . . 0.0 109.323 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.518 ' O ' ' NH1' ' A' ' 77' ' ' ARG . 35.7 Cg_endo -77.72 -75.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.452 2.101 . . . . 0.0 110.571 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 73' ' ' PRO . . . -59.13 -117.83 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . 49.54 -167.18 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.278 -1.131 . . . . 0.0 109.704 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 75' ' ' ALA . 1.1 m-20 -42.04 147.82 0.21 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.276 -0.89 . . . . 0.0 109.864 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.518 ' NH1' ' O ' ' A' ' 73' ' ' PRO . 2.2 ttm180 -164.82 70.84 0.17 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.421 -0.799 . . . . 0.0 109.372 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.532 ' CG2' ' OE1' ' A' ' 20' ' ' GLN . 10.9 p -44.72 149.75 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 109.284 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.569 ' CG1' ' CB ' ' A' ' 87' ' ' ALA . 0.4 OUTLIER -121.0 171.92 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.02 -1.05 . . . . 0.0 110.338 -179.484 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.601 ' CD1' ' NE2' ' A' ' 20' ' ' GLN . 19.2 p90 -172.04 -167.52 0.49 Allowed 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.102 -178.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.522 ' N ' ' OD1' ' A' ' 81' ' ' ASN . 0.2 OUTLIER -132.54 -78.47 0.5 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.829 -1.17 . . . . 0.0 109.837 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.538 ' HA ' ' CE1' ' A' ' 24' ' ' TYR . 10.3 pt-20 -160.76 24.58 0.14 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.37 -0.831 . . . . 0.0 109.176 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.442 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 4.3 m120 -146.03 17.55 1.4 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.456 -0.777 . . . . 0.0 109.241 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.442 ' CG ' ' O ' ' A' ' 83' ' ' ASN . 8.3 p30 47.45 25.68 0.65 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.42 -0.8 . . . . 0.0 109.216 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.568 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -70.29 -27.6 64.53 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.568 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER 85.87 115.87 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.58 0.705 . . . . 0.0 110.739 179.044 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.569 ' CB ' ' CG1' ' A' ' 79' ' ' VAL . . . -96.3 -30.72 13.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.507 -0.746 . . . . 0.0 108.999 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.416 ' N ' ' CD1' ' A' ' 86' ' ' LEU . . . 158.08 -153.77 24.92 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.554 ' HB ' ' CE1' ' A' ' 4' ' ' TYR . 42.8 t -147.09 127.72 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.025 -1.279 . . . . 0.0 109.795 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.509 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -114.34 144.91 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.553 -0.717 . . . . 0.0 109.142 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.461 HG22 HG22 ' A' ' 101' ' ' VAL . 6.2 t -133.43 123.93 26.19 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.091 -1.006 . . . . 0.0 109.933 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.565 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -79.37 84.05 5.33 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.541 -0.724 . . . . 0.0 109.477 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.403 ' OG1' ' C ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 176.1 127.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.423 -0.798 . . . . 0.0 109.251 179.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.98 -18.3 28.93 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 99' ' ' ASN . . . -115.46 90.78 3.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.364 -1.08 . . . . 0.0 109.413 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.4 OUTLIER 43.95 78.95 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 109.346 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.91 -88.91 1.59 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.565 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -125.56 -90.55 0.55 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.213 -1.169 . . . . 0.0 109.376 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 98' ' ' ASN . 0.7 OUTLIER 61.08 136.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -0.961 . . . . 0.0 109.059 -179.584 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.515 ' CD1' ' ND1' ' A' ' 92' ' ' HIS . 21.8 m-85 -79.66 155.28 28.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.834 -1.166 . . . . 0.0 110.195 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -160.7 133.85 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.141 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -54.5 126.15 22.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.336 -0.853 . . . . 0.0 109.611 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 1.3 m -68.48 109.29 3.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.408 -0.808 . . . . 0.0 109.819 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.944 . . . . 0.0 109.477 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.507 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.8 p 167.14 130.33 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.218 -0.926 . . . . 0.0 110.065 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -103.87 -9.83 18.66 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.443 -0.786 . . . . 0.0 109.344 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.602 ' CD2' ' CG2' ' A' ' 89' ' ' VAL . 19.4 m-85 -109.54 132.16 54.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.308 -0.87 . . . . 0.0 109.247 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 m -155.82 113.37 3.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.134 -0.979 . . . . 0.0 109.611 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.4 m -94.27 17.35 12.93 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 122.112 0.958 . . . . 0.0 109.691 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.91 -71.44 0.2 Allowed Glycine 0 C--N 1.283 -2.378 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.7 m -162.62 49.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.314 -1.11 . . . . 0.0 109.239 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.557 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . 6.9 m120 -103.12 -28.88 11.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.308 -0.87 . . . . 0.0 109.771 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 44.4 t 59.42 63.07 1.63 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.132 -0.98 . . . . 0.0 109.102 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.557 ' CE2' ' CB ' ' A' ' 9' ' ' ASN . 40.8 m-85 -79.13 122.41 26.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.445 -0.784 . . . . 0.0 109.144 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -79.59 133.23 36.43 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.422 -0.799 . . . . 0.0 109.61 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.5 t -52.48 -19.93 2.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.202 -0.936 . . . . 0.0 109.063 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.54 -36.8 18.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 110.015 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -74.59 -27.13 60.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.009 -1.057 . . . . 0.0 108.194 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 19.3 t -69.5 -33.18 55.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -34.91 78.62 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -38.01 82.48 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.595 ' CB ' HD11 ' A' ' 61' ' ' ILE . . . -84.91 -7.67 59.07 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.571 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -90.73 -28.12 18.5 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.276 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -79.5 -11.83 59.89 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.663 ' HB1' HG11 ' A' ' 67' ' ' VAL . . . -80.22 -39.1 29.77 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.542 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -85.52 -15.46 66.06 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -88.7 -58.51 2.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.392 -1.064 . . . . 0.0 109.13 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -53.56 -35.2 60.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 109.298 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.17 -46.96 69.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.328 -0.858 . . . . 0.0 109.222 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -49.85 -42.27 47.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.413 -0.804 . . . . 0.0 110.229 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.39 -20.67 27.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.128 -0.983 . . . . 0.0 110.037 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.463 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 28.2 t0 -74.99 -20.23 59.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.128 -0.982 . . . . 0.0 109.54 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.92 19.7 78.54 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 29' ' ' ASP . 0.8 OUTLIER -103.91 -169.3 1.61 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.346 -1.09 . . . . 0.0 109.472 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.523 ' CG2' ' CB ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -135.67 -170.69 2.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.322 -0.861 . . . . 0.0 109.288 179.71 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.43 ' CG1' ' HA ' ' A' ' 69' ' ' SER . 64.2 t -89.86 -98.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.304 -0.873 . . . . 0.0 109.321 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -124.52 -8.64 5.77 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER 163.72 -46.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.281 -1.129 . . . . 0.0 109.315 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 37' ' ' SER . 1.6 m-80 -82.19 5.37 20.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.608 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.523 ' CB ' ' CG2' ' A' ' 32' ' ' THR . 81.6 p 45.29 -162.15 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.931 . . . . 0.0 108.876 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.587 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER 167.01 -44.31 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.142 -0.974 . . . . 0.0 111.911 179.243 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 31.1 Cg_endo -74.42 99.75 1.24 Allowed 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.466 1.444 . . . . 0.0 112.274 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.543 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -144.76 -173.89 4.19 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.284 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.536 ' HB2' ' CE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -96.45 126.04 41.37 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.041 -1.037 . . . . 0.0 109.966 -179.167 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.558 ' CE2' ' HA ' ' A' ' 44' ' ' ASN . 8.2 t80 -105.22 139.45 39.86 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.505 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 9.5 m120 -70.41 -46.71 63.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.171 -0.956 . . . . 0.0 110.098 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.558 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 0.2 OUTLIER 76.47 55.85 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.269 -0.894 . . . . 0.0 109.008 -179.403 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -106.09 46.84 0.9 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.269 -0.895 . . . . 0.0 109.483 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.529 ' OE2' ' CG1' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -101.12 -28.76 12.51 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.659 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.33 19.98 3.07 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.609 ' CD2' ' CZ ' ' A' ' 50' ' ' PHE . 59.7 m-85 -63.41 -169.15 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -154.43 36.54 0.42 Allowed 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 118.565 -1.254 . . . . 0.0 109.918 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.609 ' CZ ' ' CD2' ' A' ' 48' ' ' PHE . 6.7 m-85 -62.16 -175.14 0.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.038 -1.039 . . . . 0.0 109.41 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 p -144.72 35.38 1.15 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.384 -0.822 . . . . 0.0 109.038 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.8 t -92.9 -71.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.334 -0.853 . . . . 0.0 109.826 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 t -161.68 178.15 9.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.796 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.569 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -79.24 -51.45 1.26 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.349 -0.844 . . . . 0.0 110.654 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 54' ' ' SER . 34.6 Cg_endo -76.06 85.62 1.63 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 121.992 1.795 . . . . 0.0 110.352 -177.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.585 ' O ' ' CD1' ' A' ' 57' ' ' TYR . 48.2 m-85 -79.12 -178.37 6.11 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.394 0.616 . . . . 0.0 109.862 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.585 ' CD1' ' O ' ' A' ' 56' ' ' TYR . 48.3 m-85 -150.88 145.01 25.37 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -104.21 138.52 40.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.234 -0.916 . . . . 0.0 110.6 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.633 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 22.6 t-105 -160.8 138.93 7.23 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.633 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.9 Cg_endo -67.53 142.22 58.35 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.119 1.88 . . . . 0.0 111.274 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.595 HD11 ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -118.63 131.67 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.729 -0.607 . . . . 0.0 109.417 -179.263 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.522 ' O ' HD12 ' A' ' 61' ' ' ILE . 2.9 mt -120.89 165.51 15.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.225 -0.922 . . . . 0.0 109.756 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.546 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 92.9 p -111.11 -1.88 16.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.086 -1.009 . . . . 0.0 108.816 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.58 -37.93 62.8 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.606 -0.683 . . . . 0.0 109.507 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.25 46.15 1.1 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.15 146.44 27.67 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.312 -1.11 . . . . 0.0 109.36 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.663 HG11 ' HB1' ' A' ' 22' ' ' ALA . 73.8 t -66.35 136.44 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.156 -0.965 . . . . 0.0 109.343 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.517 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 20.1 t80 -47.91 147.4 2.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.894 . . . . 0.0 109.638 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.43 ' HA ' ' CG1' ' A' ' 33' ' ' VAL . 5.4 t -174.82 54.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.529 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.2 119.45 4.62 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.1 -133.19 2.8 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.1 114.55 63.5 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.26 -1.141 . . . . 0.0 109.451 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.02 121.05 5.99 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.336 2.024 . . . . 0.0 110.362 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.516 ' O ' ' NH1' ' A' ' 77' ' ' ARG . . . 110.61 -138.48 14.95 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.479 ' N ' ' HB2' ' A' ' 92' ' ' HIS . . . 64.04 -86.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -1.116 . . . . 0.0 110.222 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.432 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 7.4 m-20 -132.52 110.48 10.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.939 -1.1 . . . . 0.0 110.157 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.522 ' CZ ' ' HB3' ' A' ' 60' ' ' PRO . 3.7 mpt_? -116.58 146.12 42.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.448 -0.782 . . . . 0.0 109.024 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.6 p -113.95 134.8 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.053 -1.029 . . . . 0.0 109.33 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.554 ' CG1' ' N ' ' A' ' 80' ' ' PHE . 58.4 t -97.4 166.04 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-O 121.95 0.881 . . . . 0.0 110.472 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.571 ' CD1' ' OE1' ' A' ' 20' ' ' GLN . 7.1 p90 -164.83 -171.44 2.28 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -126.23 -83.47 0.62 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.842 -1.161 . . . . 0.0 109.977 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -151.43 8.59 0.53 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.418 -0.801 . . . . 0.0 110.37 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -138.34 15.07 2.79 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.907 -1.121 . . . . 0.0 108.562 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.459 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 38.4 t30 59.04 30.97 20.92 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.42 -0.8 . . . . 0.0 109.063 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.561 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -63.84 -26.4 68.6 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.067 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.561 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER 85.81 109.0 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.488 0.661 . . . . 0.0 110.652 179.05 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.543 ' O ' ' CD1' ' A' ' 50' ' ' PHE . . . -83.04 -37.79 23.43 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 153.01 168.25 16.69 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.602 ' CG2' ' CD2' ' A' ' 4' ' ' TYR . 44.9 t -104.46 102.36 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.158 -1.201 . . . . 0.0 109.343 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.463 HG13 ' HB3' ' A' ' 100' ' ' PHE . 0.5 OUTLIER -93.31 168.44 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.428 -0.795 . . . . 0.0 109.889 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.523 HG22 HG23 ' A' ' 101' ' ' VAL . 5.4 t -106.48 -173.41 2.29 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.456 -0.778 . . . . 0.0 110.387 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.523 ' CE1' ' CE1' ' A' ' 100' ' ' PHE . 0.5 OUTLIER -148.82 62.95 1.06 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.506 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 1.2 m 172.79 -28.61 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.758 -0.589 . . . . 0.0 109.883 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.9 -9.2 52.37 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 120.033 -1.079 . . . . 0.0 110.654 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -120.1 176.7 5.31 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.932 -1.334 . . . . 0.0 109.805 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.2 OUTLIER -41.53 124.37 2.43 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.676 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.18 -88.69 0.12 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 107.962 -2.055 . . . . 0.0 107.962 -178.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -165.56 38.24 0.06 Allowed 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.088 -1.243 . . . . 0.0 109.444 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 98' ' ' ASN . 12.3 t-20 -50.72 179.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.077 -1.015 . . . . 0.0 108.762 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -106.1 146.84 29.66 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.857 -1.152 . . . . 0.0 109.197 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.531 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -160.27 140.88 3.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -39.42 138.67 0.64 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.549 -0.719 . . . . 0.0 110.132 -179.119 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.415 ' SG ' ' HB ' ' A' ' 91' ' ' THR . 4.2 m -94.48 97.82 10.42 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.355 -0.841 . . . . 0.0 109.568 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 109.28 179.902 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.229 0.538 . . . . 0.0 109.654 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 32.0 p 178.2 133.02 0.07 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.356 -0.84 . . . . 0.0 109.843 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -94.96 -35.57 11.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 0.0 108.987 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.676 ' CD2' HG22 ' A' ' 89' ' ' VAL . 66.8 m-85 -92.34 81.87 4.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.36 -0.837 . . . . 0.0 109.017 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.482 ' CG2' ' O ' ' A' ' 5' ' ' THR . 9.8 t -93.98 89.56 6.11 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.321 -0.862 . . . . 0.0 110.149 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.436 ' CB ' ' OD1' ' A' ' 76' ' ' ASP . 0.1 OUTLIER -89.57 -165.05 1.25 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.904 . . . . 0.0 109.0 179.369 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.446 ' O ' ' OG ' ' A' ' 8' ' ' SER . . . -59.13 95.56 0.07 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.454 ' O ' ' OG ' ' A' ' 8' ' ' SER . 4.5 p 65.7 49.2 1.78 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -1.159 . . . . 0.0 109.648 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.432 ' ND2' ' OD2' ' A' ' 76' ' ' ASP . 0.2 OUTLIER -123.8 -71.85 0.7 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.358 -0.839 . . . . 0.0 109.283 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.46 ' C ' ' CB ' ' A' ' 2' ' ' CYS . 50.6 t 53.01 51.69 15.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 109.654 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.527 ' CD1' ' HB3' ' A' ' 63' ' ' SER . 4.3 m-85 -93.43 144.59 25.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.411 -0.805 . . . . 0.0 108.951 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -83.64 134.4 34.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 110.095 -179.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.489 ' HA ' HG23 ' A' ' 16' ' ' VAL . 4.2 p -50.85 -25.4 4.47 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.43 -42.63 61.78 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.316 -0.865 . . . . 0.0 108.944 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.31 -19.42 61.04 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.489 HG23 ' HA ' ' A' ' 13' ' ' SER . 12.2 t -78.81 -29.02 14.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.412 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 0.6 OUTLIER -65.44 -34.39 78.18 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.228 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -53.7 27.54 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.543 ' CB ' HD11 ' A' ' 61' ' ' ILE . . . -62.08 -18.28 60.21 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.543 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -76.13 -37.48 57.97 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.289 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -74.64 -3.27 30.2 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.07 -63.21 1.39 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.378 -0.826 . . . . 0.0 108.776 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.573 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -62.38 -16.88 55.49 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.413 ' CD1' ' C ' ' A' ' 24' ' ' TYR . 1.1 t80 -83.34 -62.65 1.53 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.562 -0.963 . . . . 0.0 109.014 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 2.8 tt0 -48.38 -34.38 10.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.169 -0.957 . . . . 0.0 108.88 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.476 HD13 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -69.46 -44.57 70.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.506 -0.747 . . . . 0.0 109.51 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -59.27 -38.11 79.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.47 -0.769 . . . . 0.0 110.297 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -89.6 -14.79 34.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.105 -0.997 . . . . 0.0 110.352 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -83.48 -10.71 58.18 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.102 -0.999 . . . . 0.0 109.214 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 63.2 11.44 39.4 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -88.02 -144.66 0.13 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.403 -1.057 . . . . 0.0 109.057 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.476 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -167.67 175.22 7.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.002 -1.061 . . . . 0.0 109.688 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.17 -94.68 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.235 -0.915 . . . . 0.0 109.87 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.402 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -88.77 32.83 4.4 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 1.2 m 67.61 8.59 6.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.195 -1.179 . . . . 0.0 109.332 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.4 ' O ' ' CB ' ' A' ' 37' ' ' SER . 2.4 m120 -102.03 -14.42 17.15 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.198 -0.939 . . . . 0.0 109.503 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.435 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 0.9 OUTLIER 68.28 105.15 0.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.866 . . . . 0.0 109.255 -179.763 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.599 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -116.66 -33.16 0.08 OUTLIER Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 114.274 1.212 . . . . 0.0 114.274 -178.443 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 36.4 Cg_endo -80.62 101.88 1.35 Allowed 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.291 1.327 . . . . 0.0 112.734 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.594 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -135.11 -167.3 1.97 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.104 -0.997 . . . . 0.0 109.259 177.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 8.8 ptmm? -76.33 179.03 6.06 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.496 -0.753 . . . . 0.0 109.654 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.706 ' CE1' ' CD1' ' A' ' 100' ' ' PHE . 7.0 t80 -139.21 98.02 3.42 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.322 -0.861 . . . . 0.0 108.894 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.528 ' O ' ' CE1' ' A' ' 45' ' ' TYR . 8.1 m120 -61.29 -20.2 62.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.423 -0.798 . . . . 0.0 109.772 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.613 ' O ' ' CB ' ' A' ' 45' ' ' TYR . 10.2 p-10 40.24 -144.0 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.534 -0.729 . . . . 0.0 109.901 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.613 ' CB ' ' O ' ' A' ' 44' ' ' ASN . 18.4 m-30 107.11 -20.76 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.559 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 2.2 tm-20 -40.4 -33.46 0.26 Allowed 'General case' 0 C--N 1.309 -1.189 0 O-C-N 121.06 -1.025 . . . . 0.0 110.343 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.73 -15.74 0.72 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.559 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -104.02 159.91 15.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.104 -1.233 . . . . 0.0 108.815 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.491 ' C ' ' CG ' ' A' ' 50' ' ' PHE . 1.4 t0 -143.88 -36.3 0.35 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.199 -0.938 . . . . 0.0 109.837 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.491 ' CG ' ' C ' ' A' ' 49' ' ' ASP . 5.5 m-85 74.82 177.63 0.22 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.137 -0.977 . . . . 0.0 109.457 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.98 41.2 3.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.177 -0.952 . . . . 0.0 109.535 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.438 ' CG1' ' HB2' ' A' ' 81' ' ' ASN . 3.3 t -100.97 -72.19 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.334 -0.854 . . . . 0.0 109.337 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.442 ' O ' ' CE2' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -159.09 167.91 27.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.093 -1.004 . . . . 0.0 110.174 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.57 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -75.99 -52.32 2.62 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.462 -0.774 . . . . 0.0 110.364 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 54' ' ' SER . 35.5 Cg_endo -76.42 83.6 2.01 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.055 1.837 . . . . 0.0 109.72 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.646 ' CE1' ' HB1' ' A' ' 87' ' ' ALA . 31.1 m-85 -79.51 176.2 9.91 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.549 0.69 . . . . 0.0 110.05 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.574 ' CD1' ' O ' ' A' ' 81' ' ' ASN . 89.9 m-85 -142.56 129.03 20.14 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.11 136.57 32.94 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.906 0.86 . . . . 0.0 111.063 -178.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.632 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 39.3 t-105 -160.39 135.79 5.83 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.632 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.6 Cg_endo -70.21 147.1 59.26 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.055 1.837 . . . . 0.0 111.272 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.548 ' CD1' ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -110.0 130.05 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.565 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.548 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 1.1 mt -138.61 119.3 14.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.347 -0.845 . . . . 0.0 108.953 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.527 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.3 t -126.34 73.67 1.39 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.685 -0.634 . . . . 0.0 109.429 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 173.43 -31.57 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.152 -0.967 . . . . 0.0 109.371 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.18 -74.81 0.83 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.05 -150.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -1.145 . . . . 0.0 109.529 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.429 ' O ' ' N ' ' A' ' 69' ' ' SER . 13.6 t -96.51 145.1 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.336 -0.853 . . . . 0.0 109.492 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.465 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 82.3 t80 -50.28 97.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.0 109.467 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 67' ' ' VAL . 1.2 p -132.66 26.88 4.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 109.437 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.19 79.69 0.42 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -156.25 -123.12 0.78 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.8 t -127.22 102.07 24.47 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.256 -1.143 . . . . 0.0 109.246 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.505 ' HB2' ' OH ' ' A' ' 38' ' ' TYR . 34.2 Cg_endo -76.55 -159.07 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.323 2.016 . . . . 0.0 110.551 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.483 ' O ' ' N ' ' A' ' 76' ' ' ASP . . . 66.09 -145.87 48.36 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.527 ' O ' ' OG1' ' A' ' 91' ' ' THR . . . 48.11 -95.18 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.08 -1.247 . . . . 0.0 109.768 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' A' ' 74' ' ' GLY . 59.7 m-20 -111.05 139.91 46.03 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.861 -1.149 . . . . 0.0 110.208 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.528 ' CA ' HG22 ' A' ' 61' ' ' ILE . 57.8 mtp180 -156.91 159.32 38.02 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.1 p -134.74 145.1 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.804 -1.185 . . . . 0.0 110.03 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 80' ' ' PHE . 3.0 t -106.24 165.05 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 122.106 0.955 . . . . 0.0 109.861 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.615 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 4.0 p90 -156.09 -169.02 2.93 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.753 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.574 ' O ' ' CD1' ' A' ' 57' ' ' TYR . 10.6 t30 -107.41 -80.05 0.57 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.007 -1.058 . . . . 0.0 110.179 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.459 ' HG3' ' ND2' ' A' ' 81' ' ' ASN . 1.3 pp20? -167.85 23.62 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.428 -0.795 . . . . 0.0 109.546 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.515 ' O ' ' CB ' ' A' ' 84' ' ' ASN . 1.2 m120 -149.49 21.72 0.93 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 109.072 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 83' ' ' ASN . 0.1 OUTLIER 80.72 8.11 1.27 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.55 -0.719 . . . . 0.0 109.438 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 84' ' ' ASN . 6.3 mp0 -56.91 -165.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -0.985 . . . . 0.0 108.943 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.56 107.6 5.72 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.957 -1.089 . . . . 0.0 110.098 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.646 ' HB1' ' CE1' ' A' ' 56' ' ' TYR . . . -80.87 -43.01 20.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.427 -0.796 . . . . 0.0 108.925 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 162.26 142.47 3.4 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.676 HG22 ' CD2' ' A' ' 4' ' ' TYR . 60.1 t -81.95 97.26 3.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.116 -1.226 . . . . 0.0 109.976 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.5 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -78.6 179.85 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.105 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.755 HG21 HG23 ' A' ' 101' ' ' VAL . 12.4 t -135.81 -131.98 0.15 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.916 -1.115 . . . . 0.0 108.457 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.597 ' CD2' ' CB ' ' A' ' 95' ' ' ALA . 0.2 OUTLIER 163.57 42.32 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 -179.657 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.4 m -77.55 97.27 4.99 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.695 0.759 . . . . 0.0 109.713 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.502 ' O ' ' C ' ' A' ' 95' ' ' ALA . . . 93.55 -29.91 7.91 Favored Glycine 0 C--N 1.297 -1.592 0 N-CA-C 107.753 -2.139 . . . . 0.0 107.753 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.597 ' CB ' ' CD2' ' A' ' 92' ' ' HIS . . . 34.45 -154.97 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.3 -0.529 . . . . 0.0 109.873 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.455 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.6 OUTLIER 46.01 47.53 12.67 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -179.034 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.98 -25.64 2.65 Favored Glycine 0 N--CA 1.483 1.828 0 N-CA-C 106.026 -2.83 . . . . 0.0 106.026 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.656 ' O ' HG11 ' A' ' 101' ' ' VAL . 7.8 m120 -105.65 -29.77 9.9 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.497 ' C ' ' O ' ' A' ' 98' ' ' ASN . 11.5 p-10 37.21 -146.1 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.706 ' CD1' ' CE1' ' A' ' 42' ' ' TYR . 5.3 m-85 -75.78 77.15 2.73 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.755 HG23 HG21 ' A' ' 91' ' ' THR . 0.0 OUTLIER -85.36 131.82 33.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.392 -0.818 . . . . 0.0 108.969 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -43.71 151.51 0.19 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.527 -1.358 . . . . 0.0 109.717 -179.049 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 1.2 m -75.71 92.25 2.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.924 . . . . 0.0 109.37 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.869 . . . . 0.0 109.437 -179.934 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.51 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.51 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 1.8 p 163.37 121.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.355 -0.841 . . . . 0.0 109.67 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -105.4 3.52 29.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.91 . . . . 0.0 109.431 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.516 ' CD1' ' CG2' ' A' ' 89' ' ' VAL . 11.4 m-85 -119.69 104.63 10.42 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.119 -0.988 . . . . 0.0 109.625 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.406 ' O ' ' HB3' ' A' ' 103' ' ' CYS . 98.5 m -143.85 123.34 13.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.093 -1.004 . . . . 0.0 109.421 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -91.97 9.81 31.56 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.163 -0.961 . . . . 0.0 109.945 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.39 -62.64 0.06 OUTLIER Glycine 0 C--N 1.282 -2.43 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 m -174.46 30.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -1.129 . . . . 0.0 109.51 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.512 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 8.4 m-80 -80.02 -24.49 40.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.923 . . . . 0.0 109.371 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 37.8 t 58.87 68.49 0.81 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.37 -0.832 . . . . 0.0 109.574 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.512 ' CE1' ' HB3' ' A' ' 9' ' ' ASN . 11.0 m-85 -89.47 132.94 34.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.131 -0.98 . . . . 0.0 109.259 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 15.3 t -83.07 130.5 35.13 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.368 -0.832 . . . . 0.0 109.859 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 p -56.36 -17.57 8.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.304 -0.872 . . . . 0.0 109.287 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.7 -32.55 21.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.89 . . . . 0.0 109.575 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.471 ' O ' ' OG1' ' A' ' 18' ' ' THR . 0.5 OUTLIER -77.13 -37.33 54.26 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.305 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 28.8 t -51.9 -37.44 21.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.99 -43.29 99.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.576 -0.702 . . . . 0.0 109.339 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -59.17 -47.4 85.44 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.491 ' CB ' HD11 ' A' ' 61' ' ' ILE . . . -70.82 -15.2 62.63 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.59 ' NE2' ' CG1' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -89.65 -12.77 38.65 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.533 -0.729 . . . . 0.0 109.096 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -94.1 -20.92 19.46 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.08 -61.24 2.05 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.532 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -55.93 -24.94 43.99 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -73.83 -46.4 45.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.623 -0.928 . . . . 0.0 109.256 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.444 ' O ' ' HB2' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -66.16 -63.63 1.04 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.373 -0.829 . . . . 0.0 108.906 179.757 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.503 HD22 ' O ' ' A' ' 32' ' ' THR . 3.3 tp -44.2 -33.93 1.7 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.302 -0.874 . . . . 0.0 109.068 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.618 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -63.86 -59.77 4.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.323 -0.861 . . . . 0.0 109.254 179.772 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.5 11.84 7.98 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.511 -0.743 . . . . 0.0 109.542 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -100.53 -24.01 14.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -0.919 . . . . 0.0 109.448 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.0 -16.76 45.57 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.43 -148.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.247 -1.149 . . . . 0.0 109.277 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.524 HG21 ' HA ' ' A' ' 37' ' ' SER . 0.1 OUTLIER -170.61 -176.09 2.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.397 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.0 m -89.74 -126.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.143 -0.973 . . . . 0.0 109.606 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -130.34 -4.04 4.58 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.085 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.86 -93.09 0.43 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.023 -1.281 . . . . 0.0 109.128 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -130.62 58.78 1.68 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.321 -0.862 . . . . 0.0 108.969 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.524 ' HA ' HG21 ' A' ' 32' ' ' THR . 4.2 t 57.71 -158.75 0.27 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.309 -0.87 . . . . 0.0 109.019 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.586 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER 166.84 -43.96 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 112.168 179.284 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 32.0 Cg_endo -75.2 100.66 1.39 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.353 1.368 . . . . 0.0 112.367 -178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.553 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -143.93 175.12 10.26 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.143 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -72.25 157.76 37.1 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.044 -1.035 . . . . 0.0 110.044 -179.391 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.575 ' OH ' ' CD1' ' A' ' 100' ' ' PHE . 87.3 t80 -145.93 89.6 1.91 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.438 -0.789 . . . . 0.0 109.19 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.522 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 32.3 m120 -52.29 -88.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.171 -0.956 . . . . 0.0 110.169 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.524 ' N ' ' OD1' ' A' ' 44' ' ' ASN . 2.4 p30 161.97 135.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.175 -0.953 . . . . 0.0 109.276 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -131.05 -0.91 4.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.077 -1.014 . . . . 0.0 109.862 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -100.73 -19.35 16.07 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.191 -0.943 . . . . 0.0 108.62 -179.789 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.26 23.88 7.1 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.563 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 18.4 m-85 -63.85 87.16 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 50' ' ' PHE . 5.7 t70 -54.57 -32.25 58.2 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.839 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.563 ' CE1' ' HB3' ' A' ' 48' ' ' PHE . 9.8 m-30 44.93 -170.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.357 -0.84 . . . . 0.0 109.607 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -151.55 32.28 0.57 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -0.951 . . . . 0.0 109.454 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.5 t -113.48 -86.62 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.833 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.576 ' O ' ' CZ ' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -152.76 164.89 36.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.103 -0.998 . . . . 0.0 109.762 -179.77 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.577 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -62.22 -51.96 70.26 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.386 -0.821 . . . . 0.0 110.395 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 54' ' ' SER . 36.3 Cg_endo -76.18 80.77 2.6 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.072 1.848 . . . . 0.0 110.716 -178.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.576 ' CZ ' ' O ' ' A' ' 53' ' ' SER . 93.3 m-85 -78.85 -164.63 0.62 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.618 ' CE1' ' NE2' ' A' ' 27' ' ' HIS . 60.4 m-85 -156.1 113.94 3.31 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.519 -0.738 . . . . 0.0 109.266 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.453 ' HA ' HG13 ' A' ' 79' ' ' VAL . 10.1 pt-20 -82.91 137.59 34.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.254 -0.904 . . . . 0.0 110.447 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.619 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 10.0 t-105 -160.7 140.65 8.27 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.619 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.5 Cg_endo -69.75 130.52 19.5 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.202 1.935 . . . . 0.0 111.45 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.491 HD11 ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -111.56 130.25 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.461 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -120.7 168.71 11.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.157 -0.964 . . . . 0.0 109.595 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.442 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 12.3 t -121.38 26.92 8.59 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.7 -55.74 0.05 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.601 -0.687 . . . . 0.0 109.309 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -72.95 -4.34 62.28 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.417 ' C ' ' OD1' ' A' ' 66' ' ' ASP . 49.5 t0 60.51 -99.88 0.1 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -1.161 . . . . 0.0 109.731 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.9 t -81.26 151.97 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.957 -1.089 . . . . 0.0 109.473 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.521 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 31.5 t80 -82.68 124.23 30.01 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.131 -0.98 . . . . 0.0 109.833 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 99.8 p -119.97 -3.19 10.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.464 -0.773 . . . . 0.0 109.266 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.49 130.64 3.49 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 154.39 86.47 0.06 OUTLIER Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.0 t 51.73 93.03 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.181 -1.188 . . . . 0.0 109.767 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.57 -169.4 0.77 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.708 2.272 . . . . 0.0 110.818 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.446 ' O ' ' CB ' ' A' ' 75' ' ' ALA . . . 77.64 -170.17 54.93 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.45 ' C ' ' OG1' ' A' ' 91' ' ' THR . . . 71.63 -162.21 0.13 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.149 -1.206 . . . . 0.0 110.765 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.503 ' N ' ' OG1' ' A' ' 91' ' ' THR . 14.9 m-20 -36.51 154.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.547 0.689 . . . . 0.0 111.106 -178.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.603 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 10.0 ttm105 -177.92 70.4 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.484 -0.76 . . . . 0.0 109.019 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.59 ' CG1' ' NE2' ' A' ' 20' ' ' GLN . 1.4 p -53.72 166.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.813 -1.179 . . . . 0.0 109.741 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.453 HG11 ' H ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -126.84 176.88 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.275 -0.89 . . . . 0.0 109.838 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.611 ' CE1' ' O ' ' A' ' 57' ' ' TYR . 8.7 p90 -164.51 -171.69 2.43 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.125 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -129.4 -80.08 0.56 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.038 -1.039 . . . . 0.0 110.06 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -149.2 11.12 0.8 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.374 -0.829 . . . . 0.0 110.235 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.49 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 3.6 t-20 -147.74 15.64 1.1 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.026 -1.046 . . . . 0.0 109.567 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.49 ' OD1' ' O ' ' A' ' 83' ' ' ASN . 0.2 OUTLIER 68.16 12.42 8.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.307 -0.871 . . . . 0.0 109.363 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.547 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 1.8 mt-30 -45.95 -31.87 2.43 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.547 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER 85.13 104.1 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.479 0.657 . . . . 0.0 109.952 179.569 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.52 ' HB1' ' CD1' ' A' ' 56' ' ' TYR . . . -77.34 -33.62 55.41 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.372 -0.83 . . . . 0.0 109.14 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 149.55 160.87 9.43 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.516 ' CG2' ' CD1' ' A' ' 4' ' ' TYR . 4.9 t -85.97 106.06 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.203 -1.174 . . . . 0.0 110.127 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.603 ' CG1' ' O ' ' A' ' 77' ' ' ARG . 14.6 pt -108.38 138.71 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.643 HG22 HG23 ' A' ' 101' ' ' VAL . 4.4 t -120.88 175.06 6.23 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.959 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.565 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -115.36 68.62 0.71 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.407 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 92' ' ' HIS . 13.7 t 172.5 158.93 0.11 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 98.48 -21.4 46.19 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.772 -1.204 . . . . 0.0 110.403 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -125.32 -171.92 2.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.056 -1.261 . . . . 0.0 109.423 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 95' ' ' ALA . 20.4 m -42.02 111.18 0.21 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -0.842 . . . . 0.0 108.905 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 63.76 -105.68 1.16 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.565 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -132.14 35.35 3.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.241 -1.152 . . . . 0.0 108.771 178.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.469 ' O ' ' O ' ' A' ' 98' ' ' ASN . 4.4 t-20 -45.58 170.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.306 -0.871 . . . . 0.0 109.436 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.575 ' CD1' ' OH ' ' A' ' 42' ' ' TYR . 13.1 m-85 -92.4 149.19 21.56 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.212 -0.93 . . . . 0.0 109.534 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.643 HG23 HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -156.12 148.56 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 103' ' ' CYS . 1.0 OUTLIER -82.38 122.08 27.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.431 -0.793 . . . . 0.0 109.857 -179.584 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.415 ' O ' ' CG2' ' A' ' 104' ' ' THR . 80.5 m -43.51 121.23 2.21 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.325 -0.859 . . . . 0.0 109.538 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.415 ' CG2' ' O ' ' A' ' 103' ' ' CYS . 13.7 p . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.124 -0.985 . . . . 0.0 109.535 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.432 ' C ' ' SG ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.293 0.568 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 0.8 OUTLIER 174.0 124.56 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.306 -0.871 . . . . 0.0 110.152 179.685 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -87.53 -36.39 17.62 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.356 -0.84 . . . . 0.0 109.051 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.644 ' CG ' HG23 ' A' ' 89' ' ' VAL . 41.5 m-85 -82.35 115.66 21.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.355 -0.84 . . . . 0.0 109.394 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 9' ' ' ASN . 1.1 p -150.18 122.88 8.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.403 -0.811 . . . . 0.0 109.643 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -112.08 10.28 20.36 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.241 1.02 . . . . 0.0 109.641 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 172.73 -96.23 0.11 Allowed Glycine 0 C--N 1.282 -2.445 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -123.2 23.4 9.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -1.109 . . . . 0.0 109.231 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.461 ' O ' HG23 ' A' ' 5' ' ' THR . 4.5 m-80 -96.76 106.57 18.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.895 . . . . 0.0 109.819 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 47.8 t -78.33 78.47 4.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.346 -0.846 . . . . 0.0 109.417 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -98.31 110.15 22.78 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.432 -0.792 . . . . 0.0 109.003 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -84.66 128.95 34.86 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.174 -0.954 . . . . 0.0 109.956 -179.619 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 12' ' ' SER . 1.1 p -41.17 -27.6 0.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 12' ' ' SER . 5.3 t -69.74 -50.43 43.54 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.349 -0.844 . . . . 0.0 109.623 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.34 -22.74 65.58 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 17.8 t -78.0 -29.47 15.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.7 t -61.39 -46.44 90.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.568 -0.708 . . . . 0.0 109.412 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.2 -53.26 60.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.923 . . . . 0.0 108.606 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.97 -15.49 63.74 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.581 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -74.89 -37.99 61.99 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.531 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.8 -6.05 52.82 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.91 -62.13 1.8 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.375 -0.828 . . . . 0.0 109.075 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.497 ' HA3' ' CD2' ' A' ' 59' ' ' TRP . . . -58.33 -25.15 57.17 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.484 ' CE2' ' O ' ' A' ' 82' ' ' GLU . 2.8 t80 -73.15 -44.49 59.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.408 -1.054 . . . . 0.0 109.44 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' A' ' 26' ' ' LEU . 0.7 OUTLIER -55.7 -69.68 0.13 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.487 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.459 ' CD1' ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -42.38 -45.19 4.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.415 -0.803 . . . . 0.0 109.971 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -52.7 -54.6 31.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.299 -0.875 . . . . 0.0 110.518 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.66 -3.07 49.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.099 -1.001 . . . . 0.0 109.9 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -87.2 8.01 25.81 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.108 -0.995 . . . . 0.0 109.618 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 48.86 27.53 6.53 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.434 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -125.67 -158.21 0.83 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.458 -1.025 . . . . 0.0 109.405 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.459 ' N ' ' CD1' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -147.62 -174.64 4.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.915 . . . . 0.0 109.256 179.727 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' A' ' 34' ' ' GLY . 33.8 m -103.71 171.68 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.065 -1.022 . . . . 0.0 109.831 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -45.04 -38.39 6.05 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 36' ' ' ASN . 0.6 OUTLIER -78.51 175.55 10.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -1.098 . . . . 0.0 109.474 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.456 ' O ' ' HB2' ' A' ' 37' ' ' SER . 20.2 m-20 -43.86 -48.19 8.33 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.261 -0.899 . . . . 0.0 109.115 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.577 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 5.8 t 176.04 -164.12 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.591 ' CA ' ' CE1' ' A' ' 40' ' ' HIS . 0.2 OUTLIER 170.19 -45.12 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.083 -1.01 . . . . 0.0 112.213 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 31.7 Cg_endo -75.41 97.0 1.06 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 121.002 1.134 . . . . 0.0 111.656 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.591 ' CE1' ' CA ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -139.61 -179.52 5.96 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.534 ' HA ' ' CD1' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -69.6 162.12 28.24 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.333 -0.854 . . . . 0.0 110.038 -179.32 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.527 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 18.1 t80 -127.61 152.85 47.13 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.525 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 3.3 p-10 -165.59 95.48 0.63 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.977 -1.077 . . . . 0.0 109.829 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.527 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 0.6 OUTLIER -135.71 -41.12 0.69 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.335 -0.853 . . . . 0.0 109.433 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.58 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 0.0 OUTLIER 42.65 26.47 0.07 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.402 -0.811 . . . . 0.0 110.018 179.696 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -39.95 -27.63 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 O-C-N 121.319 -0.863 . . . . 0.0 109.984 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 45' ' ' TYR . . . 167.69 -23.82 0.11 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.537 ' CZ ' ' HA ' ' A' ' 101' ' ' VAL . 0.1 OUTLIER -92.46 49.94 1.55 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.447 -1.031 . . . . 0.0 109.211 179.591 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.53 103.14 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -0.879 . . . . 0.0 109.454 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.58 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 12.7 m-85 -65.87 164.09 15.6 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.259 -0.901 . . . . 0.0 109.306 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.3 t -108.63 23.45 14.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 0.0 109.868 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.478 ' CG1' ' HB3' ' A' ' 81' ' ' ASN . 14.2 t -80.53 -58.48 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.091 -1.006 . . . . 0.0 109.377 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -175.38 172.12 2.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 109.682 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.557 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -69.57 -53.41 12.57 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.357 -0.839 . . . . 0.0 110.155 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 54' ' ' SER . 35.8 Cg_endo -74.82 90.39 1.07 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.972 1.781 . . . . 0.0 110.034 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 30.3 m-85 -78.61 -170.34 2.06 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.534 ' CD1' ' HA ' ' A' ' 41' ' ' LYS . 57.9 m-85 -157.7 111.92 2.61 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -82.52 139.82 33.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.454 -0.779 . . . . 0.0 110.388 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.656 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 35.7 t-105 -160.86 139.36 7.42 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.656 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 32.0 Cg_endo -71.02 145.26 49.41 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.215 1.943 . . . . 0.0 111.434 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.495 ' C ' ' CD2' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -108.38 138.15 36.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.495 ' CD2' ' C ' ' A' ' 61' ' ' ILE . 1.1 mt -124.91 168.69 12.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.044 -1.035 . . . . 0.0 109.965 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.16 0.17 9.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.035 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.69 -166.54 1.42 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.383 -0.823 . . . . 0.0 109.197 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.27 59.2 0.48 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.433 ' O ' HD13 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -158.9 106.18 1.82 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.173 -1.193 . . . . 0.0 109.799 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.449 HG11 ' HZ2' ' A' ' 59' ' ' TRP . 77.5 t -52.4 143.41 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -0.893 . . . . 0.0 108.931 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.579 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 42.9 t80 -45.95 120.85 2.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.875 -1.141 . . . . 0.0 109.43 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.6 p -165.95 29.9 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.464 -0.773 . . . . 0.0 109.291 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -116.03 -67.08 0.4 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.434 ' C ' ' OG ' ' A' ' 72' ' ' SER . . . 148.47 151.44 5.46 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.434 ' OG ' ' C ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER 51.11 92.62 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.37 -1.077 . . . . 0.0 110.085 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.534 ' CD ' ' OH ' ' A' ' 38' ' ' TYR . 35.0 Cg_endo -79.11 -72.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.897 2.398 . . . . 0.0 109.642 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.68 98.1 2.35 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.543 ' HA ' ' N ' ' A' ' 92' ' ' HIS . . . 61.69 -149.88 0.39 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.292 -1.122 . . . . 0.0 110.262 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.542 ' O ' ' O ' ' A' ' 75' ' ' ALA . 2.4 m-20 28.29 108.62 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 121.524 0.678 . . . . 0.0 112.584 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.468 ' NH1' ' CE1' ' A' ' 38' ' ' TYR . 2.0 ttm-85 -154.0 111.28 3.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.014 -1.053 . . . . 0.0 109.003 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.458 HG21 ' O ' ' A' ' 88' ' ' GLY . 7.7 p -91.34 154.99 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.059 -1.026 . . . . 0.0 109.495 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 87' ' ' ALA . 52.6 t -120.35 166.98 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.275 -0.891 . . . . 0.0 109.923 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.581 ' CD1' ' OE1' ' A' ' 20' ' ' GLN . 10.8 p90 -169.6 -177.32 2.69 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.755 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.543 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -124.25 -38.79 2.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.433 -0.792 . . . . 0.0 109.529 -179.728 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.543 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 4.0 mt-10 162.44 -27.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.442 -0.786 . . . . 0.0 108.936 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.49 ' HB3' ' HG2' ' A' ' 85' ' ' GLN . 1.1 t-20 -98.58 19.76 14.05 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.516 -0.74 . . . . 0.0 109.135 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 6.2 p30 52.42 23.29 2.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.827 -0.545 . . . . 0.0 110.028 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.543 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 1.6 mt-30 -55.2 -31.82 61.73 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.543 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER 84.79 104.54 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.406 0.622 . . . . 0.0 110.912 179.135 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.58 ' O ' ' CD1' ' A' ' 50' ' ' PHE . . . -73.26 -44.58 59.07 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.458 ' O ' HG21 ' A' ' 78' ' ' VAL . . . 166.43 -154.38 24.84 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.924 -1.671 . . . . 0.0 108.924 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.644 HG23 ' CG ' ' A' ' 4' ' ' TYR . 34.9 t -138.1 81.19 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.093 -1.239 . . . . 0.0 109.532 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.481 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 0.7 OUTLIER -80.06 152.14 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.333 -0.854 . . . . 0.0 108.802 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.518 ' OG1' ' HB3' ' A' ' 75' ' ' ALA . 0.8 OUTLIER -116.38 138.96 50.92 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.108 -0.995 . . . . 0.0 111.378 -178.256 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.558 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.1 OUTLIER -86.62 59.3 5.56 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.543 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.487 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 3.5 m -176.32 -31.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.208 -0.932 . . . . 0.0 109.692 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.72 -17.23 13.78 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -121.81 174.17 7.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -1.167 . . . . 0.0 109.747 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 95' ' ' ALA . 2.7 t -39.86 128.18 2.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.575 -0.703 . . . . 0.0 109.317 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 63.38 -88.59 0.06 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.558 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -139.44 -64.24 0.5 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -1.182 . . . . 0.0 109.552 179.685 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 98' ' ' ASN . 1.0 OUTLIER 47.35 -172.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.138 -0.977 . . . . 0.0 109.189 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -131.38 131.89 44.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.154 -0.966 . . . . 0.0 109.708 179.595 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.537 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 0.7 OUTLIER -147.25 131.66 10.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.353 -0.842 . . . . 0.0 108.856 179.385 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -51.97 133.79 32.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.901 . . . . 0.0 109.817 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 8.0 m -65.48 148.52 51.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.321 -0.862 . . . . 0.0 109.569 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 31.2 p . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 116.719 -1.61 . . . . 0.0 109.408 179.906 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.533 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 1.8 p 163.52 142.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.355 -0.84 . . . . 0.0 109.545 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' A' ' 3' ' ' ASP . 41.7 t0 -104.51 -41.66 5.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 109.559 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.641 ' CG ' ' CG2' ' A' ' 89' ' ' VAL . 34.6 m-85 -83.36 128.76 34.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.924 . . . . 0.0 109.54 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -137.19 110.38 7.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.303 -0.873 . . . . 0.0 109.274 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.3 m -106.51 13.79 27.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.12 -0.987 . . . . 0.0 109.95 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 128.73 92.59 0.71 Allowed Glycine 0 C--N 1.283 -2.369 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 54.18 27.74 8.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.368 -1.078 . . . . 0.0 109.532 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -93.59 -43.74 8.54 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.303 -0.873 . . . . 0.0 109.496 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 10' ' ' CYS . 47.8 t 49.98 49.28 20.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 109.219 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.576 ' CE1' ' OG ' ' A' ' 63' ' ' SER . 6.4 m-30 -87.38 120.6 28.84 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.433 -0.792 . . . . 0.0 109.38 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 14' ' ' SER . 17.8 t -85.18 118.34 24.67 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.267 -0.895 . . . . 0.0 109.235 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 12' ' ' SER . 3.7 p -41.52 -26.16 0.06 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.557 -0.715 . . . . 0.0 109.614 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -61.67 -54.92 36.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.147 -0.971 . . . . 0.0 109.185 179.407 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -69.8 -25.91 64.0 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.72 HG12 ' NE2' ' A' ' 20' ' ' GLN . 18.9 t -68.24 -25.07 30.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.509 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 0.1 OUTLIER -65.45 -44.5 87.05 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.3 m -59.2 -51.16 71.18 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.42 ' CB ' ' CD1' ' A' ' 61' ' ' ILE . . . -65.94 -16.42 63.85 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.72 ' NE2' HG12 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -82.26 -25.14 34.35 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.611 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.37 -7.83 58.15 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.298 -0.876 . . . . 0.0 108.664 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.7 -63.72 1.28 Allowed 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.553 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -50.9 -30.17 21.64 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.451 ' O ' ' HB3' ' A' ' 27' ' ' HIS . 3.1 t80 -74.14 -56.31 5.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.386 -1.067 . . . . 0.0 108.816 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.465 ' HG2' ' OD1' ' A' ' 29' ' ' ASP . 5.0 tt0 -53.05 -67.64 0.24 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.422 -0.799 . . . . 0.0 109.126 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 25' ' ' GLN . 4.8 tp -42.96 -37.21 1.8 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.301 -0.875 . . . . 0.0 109.598 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.63 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 3.2 t60 -61.51 -53.18 59.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.174 -0.954 . . . . 0.0 110.134 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -86.93 6.9 29.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.352 -0.843 . . . . 0.0 110.122 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.465 ' OD1' ' HG2' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -98.04 -16.85 19.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.022 -1.049 . . . . 0.0 109.579 -179.79 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.16 -11.15 58.77 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.53 ' HG3' ' N ' ' A' ' 32' ' ' THR . 31.9 tp10 -84.96 164.86 18.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -1.134 . . . . 0.0 109.201 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.53 ' N ' ' HG3' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -129.85 171.44 12.72 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.498 -0.751 . . . . 0.0 109.798 -179.746 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.442 ' CG1' ' O ' ' A' ' 68' ' ' TYR . 33.0 m -81.27 166.8 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.437 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.87 -29.32 42.16 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.92 -144.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -1.141 . . . . 0.0 109.204 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.457 ' O ' ' CB ' ' A' ' 37' ' ' SER . 2.9 m120 -102.11 60.49 0.85 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.961 -1.087 . . . . 0.0 109.803 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.52 ' O ' ' CB ' ' A' ' 38' ' ' TYR . 6.2 t 70.97 -168.97 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.553 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.634 ' CZ ' ' CB ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER 165.07 -41.96 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.33 -0.856 . . . . 0.0 112.206 178.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 31.4 Cg_endo -75.35 100.07 1.33 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.096 1.197 . . . . 0.0 111.977 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.542 ' CD2' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -145.35 176.92 9.21 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.577 -0.702 . . . . 0.0 109.252 178.691 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.545 ' HA ' ' CD1' ' A' ' 57' ' ' TYR . 0.7 OUTLIER -59.27 161.63 5.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.32 -0.863 . . . . 0.0 109.968 -179.497 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.584 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 44.9 t80 -134.29 68.19 1.49 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.45 -0.781 . . . . 0.0 109.023 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.453 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 1.3 m-20 -86.55 61.88 7.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.18 -0.95 . . . . 0.0 109.151 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 1.8 m120 -89.74 -78.26 0.37 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.557 -0.714 . . . . 0.0 110.515 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.527 ' CB ' ' O ' ' A' ' 44' ' ' ASN . 3.1 m-85 79.49 29.19 0.33 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.47 -0.769 . . . . 0.0 108.953 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -36.24 -71.21 0.08 Allowed 'General case' 0 C--N 1.308 -1.198 0 O-C-N 121.749 -0.594 . . . . 0.0 110.23 -179.603 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.19 44.2 0.55 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.07 169.17 18.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -1.137 . . . . 0.0 109.545 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -112.51 -31.86 6.66 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.534 ' CB ' ' OH ' ' A' ' 56' ' ' TYR . 8.3 m-30 55.41 178.13 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.408 -0.808 . . . . 0.0 109.567 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.48 37.57 1.01 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.312 -0.867 . . . . 0.0 109.092 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.472 ' CG2' ' HA ' ' A' ' 87' ' ' ALA . 41.1 t -110.12 -82.61 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.394 -0.816 . . . . 0.0 109.708 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.438 ' OG ' ' HD2' ' A' ' 55' ' ' PRO . 4.7 t -163.15 154.08 16.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.164 -0.96 . . . . 0.0 109.855 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.587 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -55.9 -50.66 85.94 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.398 -0.814 . . . . 0.0 110.442 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 54' ' ' SER . 35.8 Cg_endo -75.82 84.44 1.78 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.018 1.812 . . . . 0.0 110.156 -178.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.534 ' OH ' ' CB ' ' A' ' 50' ' ' PHE . 49.2 m-85 -81.81 -169.52 2.39 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.821 0.82 . . . . 0.0 109.879 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.63 ' CE1' ' NE2' ' A' ' 27' ' ' HIS . 70.2 m-85 -156.75 109.05 2.5 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.417 ' N ' ' HB2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -76.2 138.51 40.7 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.844 0.83 . . . . 0.0 110.911 -178.048 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.62 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 34.8 t-105 -160.58 137.26 6.49 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.62 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.5 Cg_endo -67.67 151.84 78.66 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.986 1.791 . . . . 0.0 110.592 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.589 HD12 ' H ' ' A' ' 62' ' ' LEU . 1.3 tp -122.13 138.7 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.421 -0.8 . . . . 0.0 110.023 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.589 ' H ' HD12 ' A' ' 61' ' ' ILE . 0.7 OUTLIER -124.34 -175.54 3.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.385 -0.822 . . . . 0.0 108.896 179.476 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.576 ' OG ' ' CE1' ' A' ' 11' ' ' TYR . 16.6 p -146.72 55.1 1.12 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.01 -1.056 . . . . 0.0 109.636 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.31 30.94 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.464 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 47.31 90.0 0.01 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -161.16 -36.33 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.256 -1.143 . . . . 0.0 110.025 -179.681 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.459 ' CB ' ' O ' ' A' ' 66' ' ' ASP . 4.4 t 71.81 140.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.119 -0.988 . . . . 0.0 108.958 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.518 ' CE2' ' CD2' ' A' ' 38' ' ' TYR . 71.9 t80 -65.45 107.03 1.54 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.113 -0.992 . . . . 0.0 110.109 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.414 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 1.2 m -123.11 30.39 6.38 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.77 77.93 1.07 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -159.31 -96.69 0.12 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.3 p -123.43 94.82 46.09 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.22 -1.164 . . . . 0.0 109.858 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.634 ' CB ' ' CZ ' ' A' ' 38' ' ' TYR . 36.2 Cg_endo -79.48 -61.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.585 2.19 . . . . 0.0 110.359 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 73' ' ' PRO . . . -60.21 -146.43 0.01 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 91' ' ' THR . . . 65.03 -84.98 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.37 -1.077 . . . . 0.0 109.939 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -124.59 100.33 6.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.163 -0.96 . . . . 0.0 109.574 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.487 ' HD2' ' HB3' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -117.68 152.47 35.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 108.893 179.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.534 ' CG1' ' NE2' ' A' ' 20' ' ' GLN . 1.4 p -117.2 -173.88 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.053 -1.03 . . . . 0.0 109.496 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.59 ' CG1' ' N ' ' A' ' 80' ' ' PHE . 6.8 t -147.21 166.8 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.167 -0.958 . . . . 0.0 110.009 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.59 ' N ' ' CG1' ' A' ' 79' ' ' VAL . 3.8 p90 -166.61 -176.26 3.47 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.522 ' O ' ' CD2' ' A' ' 57' ' ' TYR . 11.5 t30 -118.68 -80.16 0.61 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.927 -1.108 . . . . 0.0 109.754 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -158.55 20.59 0.22 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.462 -0.774 . . . . 0.0 109.419 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.502 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 0.3 OUTLIER -150.84 18.37 0.79 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.292 -0.88 . . . . 0.0 108.842 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.502 ' OD1' ' O ' ' A' ' 83' ' ' ASN . 0.2 OUTLIER 67.34 14.16 9.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.594 -0.692 . . . . 0.0 109.349 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.477 ' O ' ' HB3' ' A' ' 86' ' ' LEU . 1.8 mt-30 -51.72 -26.85 10.23 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' A' ' 85' ' ' GLN . 0.7 OUTLIER 66.49 116.31 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.539 0.685 . . . . 0.0 110.041 179.745 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.526 ' HB3' HG11 ' A' ' 79' ' ' VAL . . . -79.05 -34.43 43.77 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.426 ' HA2' ' OH ' ' A' ' 4' ' ' TYR . . . 146.13 176.64 20.16 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.641 ' CG2' ' CG ' ' A' ' 4' ' ' TYR . 54.7 t -100.52 147.29 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.996 -1.296 . . . . 0.0 110.055 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.495 ' HB ' ' CB ' ' A' ' 100' ' ' PHE . 0.9 OUTLIER -141.09 162.5 22.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.537 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 75' ' ' ALA . 5.8 t -129.59 127.17 40.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.711 -1.243 . . . . 0.0 111.545 -178.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.596 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.1 OUTLIER -79.01 75.35 5.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.532 -0.73 . . . . 0.0 109.177 179.055 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 1.1 m 173.44 -28.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.204 -0.935 . . . . 0.0 109.263 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.53 -11.17 33.69 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.515 ' HB2' ' HB3' ' A' ' 99' ' ' ASN . . . -125.48 176.86 6.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.097 -1.237 . . . . 0.0 109.725 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER -42.99 131.7 4.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.411 -0.806 . . . . 0.0 109.109 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.51 -89.03 0.05 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.596 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -136.22 -79.7 0.41 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -1.118 . . . . 0.0 109.106 179.319 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.515 ' HB3' ' HB2' ' A' ' 95' ' ' ALA . 0.3 OUTLIER 58.51 152.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.231 -0.918 . . . . 0.0 109.054 -179.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.513 ' CZ ' ' OD1' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -109.02 126.99 53.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.741 -1.224 . . . . 0.0 110.58 -179.412 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -129.55 140.45 49.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.469 ' OE2' ' CE1' ' A' ' 50' ' ' PHE . 5.8 mm-40 -52.47 122.56 9.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.384 -0.823 . . . . 0.0 109.703 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 1.7 m -70.55 129.92 40.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.352 -0.842 . . . . 0.0 109.462 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 40.1 p . . . . . 0 N--CA 1.488 1.467 0 O-C-N 121.187 -0.946 . . . . 0.0 109.367 179.912 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.426 ' C ' ' SG ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.392 0.615 . . . . 0.0 109.651 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 11' ' ' TYR . 0.8 OUTLIER 173.54 126.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.319 -0.863 . . . . 0.0 109.838 179.788 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -121.43 -3.87 9.38 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.417 -0.802 . . . . 0.0 109.29 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.567 ' CG ' HG23 ' A' ' 89' ' ' VAL . 57.4 m-85 -103.52 85.98 2.56 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.913 . . . . 0.0 109.192 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.48 ' OG1' ' HA ' ' A' ' 10' ' ' CYS . 33.9 m -117.52 129.53 55.86 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.269 -0.894 . . . . 0.0 110.255 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.1 m -133.07 12.21 4.26 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.191 0.996 . . . . 0.0 109.156 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.53 35.77 0.09 OUTLIER Glycine 0 C--N 1.282 -2.454 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 67.6 25.0 8.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.308 -1.113 . . . . 0.0 109.16 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.474 ' O ' ' C ' ' A' ' 10' ' ' CYS . 0.9 OUTLIER -89.43 -17.63 28.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.412 -0.805 . . . . 0.0 109.746 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.48 ' HA ' ' OG1' ' A' ' 5' ' ' THR . 0.8 OUTLIER 40.03 79.09 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 O-C-N 121.543 -0.723 . . . . 0.0 109.315 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.478 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 11.6 m-85 -78.91 134.3 36.89 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.499 ' HG ' ' HB2' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -78.58 129.57 34.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.567 -0.708 . . . . 0.0 109.804 -179.316 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -17.75 5.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.336 -0.852 . . . . 0.0 109.312 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.94 -30.69 15.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 0.0 109.571 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.499 ' HB2' ' HG ' ' A' ' 12' ' ' SER . 1.5 m-20 -74.47 -31.51 62.26 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 3.5 t -65.09 -25.44 37.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.444 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 0.1 OUTLIER -72.27 -40.15 67.84 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.537 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.77 -53.08 62.11 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.482 ' CB ' HD11 ' A' ' 61' ' ' ILE . . . -63.22 -25.42 68.32 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.574 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -70.09 -30.37 67.57 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.137 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -81.02 -12.68 59.31 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.19 -47.22 13.72 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.55 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -74.69 -28.62 62.78 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -75.65 -39.41 57.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.504 -0.998 . . . . 0.0 109.198 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 2.1 tt0 -69.73 -57.71 4.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.171 -0.955 . . . . 0.0 108.509 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.74 -36.23 24.98 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -67.37 -39.4 85.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.426 -0.796 . . . . 0.0 109.512 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.65 -2.77 47.98 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.317 -0.864 . . . . 0.0 109.057 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -101.8 0.5 35.84 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.266 -0.896 . . . . 0.0 109.509 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 54.21 26.07 34.77 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -106.06 -164.11 0.99 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.252 -1.146 . . . . 0.0 109.605 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.568 ' CG2' ' CB ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -142.3 175.97 9.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.357 -0.839 . . . . 0.0 109.337 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.55 HG21 ' CA ' ' A' ' 37' ' ' SER . 22.3 m -87.99 -156.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.212 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -40.07 -35.9 0.77 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER 167.15 -27.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.119 -1.224 . . . . 0.0 109.549 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 37' ' ' SER . 11.1 m-80 -81.73 8.89 8.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.171 -0.956 . . . . 0.0 109.533 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.568 ' CB ' ' CG2' ' A' ' 32' ' ' THR . 0.8 OUTLIER 46.2 -169.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.226 -0.921 . . . . 0.0 108.968 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.565 ' CD1' ' HD3' ' A' ' 60' ' ' PRO . 0.1 OUTLIER 169.42 -47.18 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.428 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.951 179.247 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 30.7 Cg_endo -73.48 99.38 1.13 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.525 1.483 . . . . 0.0 112.453 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.543 ' CD2' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -144.7 175.16 10.37 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -63.04 157.66 21.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.959 -1.088 . . . . 0.0 110.213 -179.214 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.592 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -129.09 132.31 47.39 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.478 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.424 ' O ' ' C ' ' A' ' 44' ' ' ASN . 1.4 p-10 -123.15 -22.63 5.11 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.814 -1.179 . . . . 0.0 109.635 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.631 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 1.0 OUTLIER 45.28 -160.23 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.284 -0.885 . . . . 0.0 108.919 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.631 ' CG ' ' O ' ' A' ' 44' ' ' ASN . 0.9 OUTLIER 171.43 -26.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.536 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.3 OUTLIER -32.09 -59.85 0.28 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 121.307 0.575 . . . . 0.0 110.42 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.04 54.68 0.01 OUTLIER Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.49 ' CZ ' ' HA ' ' A' ' 101' ' ' VAL . 62.8 m-85 -108.64 142.78 38.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -1.128 . . . . 0.0 109.611 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -108.89 76.31 1.0 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -0.903 . . . . 0.0 109.615 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.428 ' HB3' ' OH ' ' A' ' 56' ' ' TYR . 18.8 m-30 -66.63 -178.53 0.72 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.188 -0.945 . . . . 0.0 109.003 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.5 t -140.41 17.38 2.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.865 . . . . 0.0 108.976 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.527 ' HB ' ' CE1' ' A' ' 56' ' ' TYR . 57.4 t -88.1 -82.67 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.44 -0.788 . . . . 0.0 109.617 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.583 ' O ' ' CE2' ' A' ' 56' ' ' TYR . 61.1 m -160.21 -174.22 4.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -0.925 . . . . 0.0 109.902 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.574 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -81.66 -52.45 0.78 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.316 -0.865 . . . . 0.0 110.717 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 54' ' ' SER . 35.2 Cg_endo -75.49 88.14 1.31 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.07 1.847 . . . . 0.0 110.201 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.587 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 21.9 m-85 -89.17 -167.89 2.01 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.587 ' CG ' ' O ' ' A' ' 56' ' ' TYR . 84.0 m-85 -160.88 114.91 2.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.507 -0.746 . . . . 0.0 109.328 179.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.451 ' CD ' ' NH1' ' A' ' 77' ' ' ARG . 3.0 pt-20 -80.0 142.41 35.03 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.292 -0.88 . . . . 0.0 110.909 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.62 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 22.1 t-105 -160.77 138.63 7.1 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.62 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 31.8 Cg_endo -70.15 161.36 46.27 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.059 1.839 . . . . 0.0 111.429 -178.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.482 HD11 ' CB ' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -133.34 135.74 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.679 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 68' ' ' TYR . 0.3 OUTLIER -118.72 161.49 20.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -0.913 . . . . 0.0 109.608 -179.864 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.1 26.05 5.2 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.463 -0.773 . . . . 0.0 109.287 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.22 -62.72 0.78 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.359 -0.838 . . . . 0.0 109.45 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -93.15 -108.52 1.87 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 67' ' ' VAL . 8.9 t70 -179.45 134.12 0.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -1.159 . . . . 0.0 109.521 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 66' ' ' ASP . 2.8 t 62.79 133.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -0.902 . . . . 0.0 109.804 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.535 ' HA ' HD12 ' A' ' 62' ' ' LEU . 43.3 t80 -75.51 105.75 6.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.015 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.1 m -112.87 16.57 19.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.131 -0.981 . . . . 0.0 109.812 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.54 52.72 0.23 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -110.95 -112.3 3.35 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.82 108.94 43.78 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.193 -1.18 . . . . 0.0 109.421 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.65 -161.81 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.467 2.112 . . . . 0.0 110.483 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.71 -175.76 0.32 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.476 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . 61.85 -150.05 0.38 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -1.136 . . . . 0.0 110.198 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' ' 75' ' ' ALA . 12.0 m-20 -32.27 148.73 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.56 0.695 . . . . 0.0 111.435 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.577 ' NH2' ' CE2' ' A' ' 100' ' ' PHE . 8.3 ttp180 -176.38 86.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.46 ' CG2' HD12 ' A' ' 86' ' ' LEU . 8.8 p -72.38 143.16 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.894 . . . . 0.0 109.688 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.573 HG13 ' CG ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -109.19 177.63 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.105 -0.997 . . . . 0.0 109.679 179.864 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.575 ' CE1' ' O ' ' A' ' 57' ' ' TYR . 14.0 p90 -174.76 -169.19 0.4 Allowed 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.0 -178.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -128.88 -80.99 0.57 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.374 -0.829 . . . . 0.0 109.728 -179.497 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.45 ' CG ' ' C ' ' A' ' 81' ' ' ASN . 0.3 OUTLIER -158.6 19.69 0.22 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.457 -0.777 . . . . 0.0 109.412 -179.804 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.456 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 0.8 OUTLIER -150.34 28.85 0.72 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.469 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 5.4 p30 51.7 20.8 1.19 Allowed 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.542 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 2.4 mt-30 -47.53 -38.38 14.0 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.542 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 82.19 104.16 0.06 Allowed 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.469 0.652 . . . . 0.0 110.565 179.135 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.518 ' HB1' ' CE1' ' A' ' 56' ' ' TYR . . . -76.24 -31.92 58.62 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 140.23 163.81 9.66 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.567 HG23 ' CG ' ' A' ' 4' ' ' TYR . 58.9 t -94.73 124.47 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.068 -1.254 . . . . 0.0 109.491 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.491 ' CG1' ' O ' ' A' ' 77' ' ' ARG . 1.0 OUTLIER -118.14 176.31 3.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.268 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 75' ' ' ALA . 8.3 t -144.16 147.34 33.55 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.045 -1.034 . . . . 0.0 110.419 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.642 ' NE2' ' CE2' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -96.88 76.71 2.75 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.535 -0.728 . . . . 0.0 109.134 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.431 ' OG1' ' C ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 176.17 123.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 0.0 109.809 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 116.33 -0.6 20.65 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 99' ' ' ASN . . . -139.51 93.42 2.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.13 -1.218 . . . . 0.0 109.776 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER 41.65 85.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.427 -0.796 . . . . 0.0 109.743 179.642 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.17 -77.54 2.07 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.592 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -144.54 -77.02 0.22 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.161 -1.199 . . . . 0.0 109.892 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 0.3 OUTLIER 59.43 155.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 108.535 -179.097 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.642 ' CE2' ' NE2' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -103.69 136.98 42.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.949 -1.095 . . . . 0.0 110.267 -179.521 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.49 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 0.9 OUTLIER -146.13 157.98 11.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.167 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 103' ' ' CYS . 12.4 pt-20 -60.5 130.72 48.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.149 -0.969 . . . . 0.0 109.737 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.422 ' C ' ' O ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -42.35 114.53 0.58 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.452 -0.78 . . . . 0.0 109.635 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.136 -0.935 . . . . 0.0 109.405 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.431 ' O ' ' SG ' ' A' ' 10' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.266 0.555 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.447 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.9 OUTLIER 169.72 115.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -0.862 . . . . 0.0 109.862 179.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -78.72 -31.65 46.51 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.338 -0.851 . . . . 0.0 108.981 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.563 ' CD2' ' CG2' ' A' ' 89' ' ' VAL . 18.3 m-85 -98.96 96.28 7.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.38 -0.825 . . . . 0.0 108.908 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.487 ' CG2' ' HA ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -116.61 105.69 12.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.186 -0.947 . . . . 0.0 109.873 -179.705 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.583 ' O ' ' C ' ' A' ' 7' ' ' GLY . 87.4 m -82.85 -173.87 4.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.287 -0.883 . . . . 0.0 108.867 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.583 ' C ' ' O ' ' A' ' 6' ' ' CYS . . . 7.69 -77.26 0.0 OUTLIER Glycine 0 N--CA 1.507 3.372 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 6' ' ' CYS . 3.7 p -161.08 55.36 0.29 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.228 -1.16 . . . . 0.0 109.468 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.424 ' N ' ' OD1' ' A' ' 9' ' ' ASN . 1.5 m-20 -117.28 -144.65 0.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.353 -0.842 . . . . 0.0 109.741 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.487 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 46.5 t -162.44 60.46 0.22 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.132 -0.98 . . . . 0.0 109.152 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.528 ' CZ ' ' HB3' ' A' ' 63' ' ' SER . 6.1 m-85 -86.78 113.2 22.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.5 -0.75 . . . . 0.0 109.333 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.496 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -87.94 131.41 34.61 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.255 -0.903 . . . . 0.0 109.835 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 12' ' ' SER . 1.8 p -45.33 -37.17 4.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.607 -0.683 . . . . 0.0 109.445 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.4 -47.26 84.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.376 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.16 -23.94 61.36 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.501 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 63.0 t -65.19 -31.97 56.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.6 t -61.66 -45.65 93.12 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.668 -0.645 . . . . 0.0 109.449 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.07 -49.53 77.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.121 -0.987 . . . . 0.0 108.608 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.522 ' CB ' HD11 ' A' ' 61' ' ' ILE . . . -71.08 -12.85 61.73 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.587 ' OE1' ' CG ' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -80.6 -34.07 35.44 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.506 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.98 -13.65 59.94 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.61 -41.13 65.92 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.592 ' CA ' ' CD2' ' A' ' 59' ' ' TRP . . . -81.72 -32.7 29.42 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.201 -1.559 . . . . 0.0 109.201 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.493 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 9.9 t80 -67.61 -40.8 84.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.426 -1.043 . . . . 0.0 109.758 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.406 ' O ' ' C ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -60.97 -66.53 0.52 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.912 . . . . 0.0 108.966 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.512 ' CD1' ' HB3' ' A' ' 31' ' ' GLU . 0.9 OUTLIER -43.85 -44.56 6.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.458 -0.776 . . . . 0.0 109.0 179.242 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.422 ' HB3' ' O ' ' A' ' 24' ' ' TYR . 2.0 t60 -49.75 -68.06 0.21 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.738 -0.601 . . . . 0.0 110.678 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -76.68 2.23 14.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.252 -0.905 . . . . 0.0 110.004 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.452 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 1.1 m-20 -82.93 -28.89 29.58 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.195 -0.941 . . . . 0.0 109.775 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.73 -15.33 63.32 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.512 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 3.2 tp10 -83.43 -149.0 0.09 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -1.154 . . . . 0.0 109.249 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.548 ' CG2' ' CB ' ' A' ' 37' ' ' SER . 0.3 OUTLIER -159.19 -172.34 3.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.133 -0.979 . . . . 0.0 109.386 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.419 HG23 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -82.94 -95.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.924 . . . . 0.0 109.496 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.469 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -115.2 -20.31 5.61 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.6 OUTLIER 167.21 -42.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.157 -1.202 . . . . 0.0 109.728 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 37' ' ' SER . 95.1 m-20 -77.25 -10.3 59.33 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.216 -0.928 . . . . 0.0 109.523 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.548 ' CB ' ' CG2' ' A' ' 32' ' ' THR . 4.0 p 62.08 135.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 109.183 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.597 ' C ' ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -121.44 -33.71 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.077 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -178.748 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 36.3 Cg_endo -80.31 101.5 1.34 Allowed 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 121.304 1.336 . . . . 0.0 112.611 -178.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.597 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -138.78 134.95 34.13 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.244 -0.91 . . . . 0.0 109.801 177.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.567 ' HB2' ' CE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -51.02 131.02 26.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.166 -0.959 . . . . 0.0 109.384 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.523 ' CZ ' ' HA ' ' A' ' 44' ' ' ASN . 4.1 t80 -113.51 140.84 47.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.282 -0.886 . . . . 0.0 109.172 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.509 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 3.7 m-80 -85.87 -90.63 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.191 -0.943 . . . . 0.0 109.739 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.523 ' HA ' ' CZ ' ' A' ' 42' ' ' TYR . 0.7 OUTLIER 174.49 148.05 0.07 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 109.39 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.412 ' O ' ' C ' ' A' ' 46' ' ' GLU . 11.2 m-85 -139.69 -72.61 0.38 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.239 -0.913 . . . . 0.0 109.331 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.595 ' CB ' ' CZ ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -40.34 -37.83 0.72 Allowed 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.512 -0.743 . . . . 0.0 109.853 -179.604 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.86 62.22 0.75 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.595 ' CZ ' ' CB ' ' A' ' 46' ' ' GLU . 23.9 m-85 -90.78 -168.01 1.97 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.246 -1.149 . . . . 0.0 108.885 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.34 -39.36 2.2 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.152 -0.968 . . . . 0.0 109.538 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.527 ' CB ' ' OH ' ' A' ' 56' ' ' TYR . 18.3 m-85 47.26 -168.55 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.21 -0.931 . . . . 0.0 109.393 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.83 31.76 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 109.502 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.0 t -108.52 -66.61 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.927 . . . . 0.0 109.513 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.425 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 70.7 m -165.31 -179.9 5.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.088 -1.008 . . . . 0.0 110.049 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.576 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -79.51 -50.32 1.31 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.534 -0.728 . . . . 0.0 110.761 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 54' ' ' SER . 35.4 Cg_endo -75.79 81.36 2.39 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.986 1.791 . . . . 0.0 110.374 -178.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.594 ' O ' ' CD1' ' A' ' 57' ' ' TYR . 36.5 m-85 -79.27 -171.62 2.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.696 -0.628 . . . . 0.0 109.832 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.594 ' CD1' ' O ' ' A' ' 56' ' ' TYR . 68.0 m-85 -155.4 158.44 38.64 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 77' ' ' ARG . 2.6 pt-20 -117.86 139.17 51.49 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.938 -1.102 . . . . 0.0 110.303 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.604 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 26.8 t-105 -159.9 138.64 7.8 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.604 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.5 Cg_endo -69.71 141.37 45.25 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.224 1.949 . . . . 0.0 111.469 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.522 HD11 ' CB ' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -109.31 140.3 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.499 ' CD2' ' C ' ' A' ' 61' ' ' ILE . 0.9 OUTLIER -126.23 163.26 23.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.951 . . . . 0.0 109.764 -179.619 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . 9.3 t -132.99 25.91 4.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.358 -0.839 . . . . 0.0 109.351 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.69 -46.62 0.12 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.354 -0.841 . . . . 0.0 109.314 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . -78.52 -101.21 0.21 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 1.6 t0 175.61 -62.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -1.132 . . . . 0.0 109.569 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.7 t -127.84 126.18 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 109.756 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.535 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 6.2 t80 -63.44 136.31 57.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.158 -0.964 . . . . 0.0 109.304 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 p -161.44 53.31 0.26 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.55 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.498 ' O ' ' CE1' ' A' ' 68' ' ' TYR . . . 126.24 -165.96 19.21 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.74 -157.51 41.86 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.9 t -120.01 120.14 30.48 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.331 -1.099 . . . . 0.0 109.44 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.427 ' HB2' ' OH ' ' A' ' 38' ' ' TYR . 34.7 Cg_endo -77.73 172.91 14.93 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.295 1.996 . . . . 0.0 110.669 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.0 134.58 2.13 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.503 ' HA ' ' N ' ' A' ' 92' ' ' HIS . . . 55.88 -153.18 0.35 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -1.151 . . . . 0.0 109.479 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.498 ' O ' ' O ' ' A' ' 75' ' ' ALA . 45.6 m-20 20.75 106.74 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.488 ' O ' ' O ' ' A' ' 90' ' ' ILE . 6.9 mtp-105 -160.06 135.38 8.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.154 -0.966 . . . . 0.0 108.584 178.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 p -123.99 135.1 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.739 -1.225 . . . . 0.0 109.638 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.574 ' CG1' ' N ' ' A' ' 80' ' ' PHE . 29.9 t -92.39 166.13 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.973 0.892 . . . . 0.0 109.808 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.587 ' CG ' ' OE1' ' A' ' 20' ' ' GLN . 3.2 p90 -161.53 -178.92 6.92 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.189 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -112.48 -81.75 0.59 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 109.692 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.493 ' O ' ' CZ ' ' A' ' 24' ' ' TYR . 2.5 pt-20 -162.64 21.78 0.09 Allowed 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.483 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 2.4 m-20 -140.61 29.5 1.93 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 83' ' ' ASN . 10.5 p30 46.95 24.5 0.37 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.502 0.668 . . . . 0.0 109.22 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 26.7 mm-40 -63.61 -106.73 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 174.42 114.55 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.739 179.081 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.487 ' HB2' ' HB ' ' A' ' 79' ' ' VAL . . . -89.79 -42.24 11.4 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 161.28 155.0 7.67 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.563 ' CG2' ' CD2' ' A' ' 4' ' ' TYR . 32.0 t -92.05 88.72 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.334 -1.098 . . . . 0.0 109.285 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.488 ' O ' ' O ' ' A' ' 77' ' ' ARG . 1.2 pt -90.88 156.2 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.432 -0.793 . . . . 0.0 109.527 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.434 HG22 HG23 ' A' ' 101' ' ' VAL . 13.0 t -122.2 137.01 54.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.859 -1.151 . . . . 0.0 110.245 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.623 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -81.56 67.58 7.58 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.294 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 0.0 OUTLIER 177.54 164.02 0.58 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.045 -1.034 . . . . 0.0 109.668 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.84 22.11 75.21 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -155.81 51.84 0.56 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -1.149 . . . . 0.0 109.353 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.7 m 68.07 93.66 0.07 Allowed 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.53 -83.9 1.1 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.623 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -139.07 -83.18 0.28 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -1.181 . . . . 0.0 109.177 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.47 ' O ' ' O ' ' A' ' 98' ' ' ASN . 1.1 m-20 61.23 137.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.329 -0.857 . . . . 0.0 109.292 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.618 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 0.3 OUTLIER -85.85 151.63 23.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.117 -0.989 . . . . 0.0 109.385 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 90' ' ' ILE . 3.2 m -160.63 136.93 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.409 -0.807 . . . . 0.0 109.073 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -53.21 123.75 12.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.243 -0.911 . . . . 0.0 109.588 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -76.04 83.0 2.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.295 -0.878 . . . . 0.0 109.688 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.127 -0.983 . . . . 0.0 109.42 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 6.0 t 62.38 91.93 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.881 . . . . 0.0 109.836 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -105.84 2.66 27.92 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.449 -0.782 . . . . 0.0 109.032 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.477 ' CG ' HG21 ' A' ' 89' ' ' VAL . 28.8 m-85 -121.14 67.89 0.88 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.267 -0.896 . . . . 0.0 109.402 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.487 ' O ' ' HB3' ' A' ' 103' ' ' CYS . 11.6 p -79.74 124.62 28.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.905 . . . . 0.0 109.192 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.1 m -113.31 17.14 18.77 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.011 0.91 . . . . 0.0 110.069 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 136.02 -93.25 0.23 Allowed Glycine 0 C--N 1.282 -2.459 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.9 m -119.82 28.66 7.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -1.102 . . . . 0.0 109.29 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.453 ' O ' ' C ' ' A' ' 10' ' ' CYS . 1.7 m120 -111.53 -36.64 5.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 109.619 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' ASN . 1.7 t 41.33 80.4 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.413 -0.804 . . . . 0.0 109.469 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.633 ' CE2' ' CB ' ' A' ' 63' ' ' SER . 2.7 m-85 -86.6 148.34 25.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -0.833 . . . . 0.0 110.148 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 0.6 OUTLIER -80.05 128.11 33.09 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.639 -0.663 . . . . 0.0 109.839 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.3 p -56.96 -18.52 13.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.921 . . . . 0.0 108.969 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.05 -30.33 15.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.264 -0.897 . . . . 0.0 109.592 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -73.55 -30.97 63.39 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.485 ' HA ' HD12 ' A' ' 61' ' ' ILE . 3.9 t -60.82 -32.07 51.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.03 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.3 t -60.38 -46.83 88.58 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.486 -0.759 . . . . 0.0 110.031 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -42.67 93.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.103 -0.998 . . . . 0.0 108.967 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.595 ' CB ' HD13 ' A' ' 61' ' ' ILE . . . -78.2 -11.63 59.94 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.511 -0.743 . . . . 0.0 109.16 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -86.67 -26.6 24.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.367 -0.833 . . . . 0.0 108.984 179.617 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -83.98 -10.19 58.11 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.382 -0.824 . . . . 0.0 109.181 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.61 -47.43 17.15 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.35 -0.844 . . . . 0.0 109.276 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.551 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -75.29 -16.86 80.37 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.462 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 6.2 t80 -87.0 -63.4 1.31 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.444 -1.033 . . . . 0.0 109.544 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.9 OUTLIER -46.95 -58.59 3.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.272 -0.893 . . . . 0.0 109.766 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.428 ' CD1' ' HB3' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -51.73 -47.08 64.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.295 -0.878 . . . . 0.0 109.773 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.628 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 2.9 t60 -52.9 -62.19 1.81 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.389 -0.82 . . . . 0.0 110.918 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -72.28 -7.23 48.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 109.735 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 13.7 t70 -78.46 -14.23 59.47 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.196 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.94 0.28 59.79 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.428 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 2.6 tp10 -94.43 -145.27 0.25 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.3 -1.118 . . . . 0.0 109.4 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.58 ' CG2' ' CB ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -163.62 179.51 7.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 109.573 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.1 m -89.41 -120.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 109.305 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.57 -42.35 95.64 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 169.72 -38.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.311 -1.111 . . . . 0.0 109.549 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 37' ' ' SER . 5.4 m120 -65.46 -11.79 46.37 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.23 -0.919 . . . . 0.0 109.674 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.58 ' CB ' ' CG2' ' A' ' 32' ' ' THR . 0.7 OUTLIER 59.66 114.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 0.0 109.129 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.668 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -107.65 -27.39 0.18 Allowed Pre-proline 0 N--CA 1.498 1.966 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -178.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.668 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 36.5 Cg_endo -79.4 102.51 1.51 Allowed 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 121.318 1.345 . . . . 0.0 113.167 -178.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.601 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -131.2 165.31 23.62 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.16 -0.962 . . . . 0.0 109.179 177.263 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.602 ' HB2' ' CE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -73.79 132.28 42.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 109.31 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.565 ' OH ' ' CD2' ' A' ' 100' ' ' PHE . 26.9 t80 -100.97 134.26 44.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.367 -0.833 . . . . 0.0 109.351 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -103.24 -8.64 20.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.185 -0.947 . . . . 0.0 109.728 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.552 ' HA ' ' CZ ' ' A' ' 42' ' ' TYR . 2.2 m120 62.16 175.0 0.13 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.692 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.458 ' O ' ' C ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -179.15 -45.25 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.388 -0.82 . . . . 0.0 108.986 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.576 ' OE1' ' CZ ' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -38.52 -44.4 0.95 Allowed 'General case' 0 C--N 1.307 -1.242 0 O-C-N 121.696 -0.627 . . . . 0.0 109.945 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.55 47.12 0.09 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.576 ' CZ ' ' OE1' ' A' ' 46' ' ' GLU . 16.0 m-85 -106.58 139.76 40.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -1.184 . . . . 0.0 109.379 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.64 -30.85 11.53 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.285 -0.884 . . . . 0.0 109.262 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.552 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 30.1 m-85 50.93 -170.52 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.42 -0.8 . . . . 0.0 109.743 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.21 44.42 0.48 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.362 -0.836 . . . . 0.0 109.364 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.544 HG13 ' OD1' ' A' ' 81' ' ' ASN . 54.8 t -121.53 -45.34 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.263 -0.898 . . . . 0.0 109.636 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.579 ' O ' ' CE1' ' A' ' 56' ' ' TYR . 0.6 OUTLIER 167.72 -176.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.111 -0.993 . . . . 0.0 109.936 -179.64 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.505 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -86.4 -54.41 0.4 Allowed Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.373 -0.829 . . . . 0.0 111.646 -179.051 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 54' ' ' SER . 33.7 Cg_endo -73.1 86.02 1.16 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.045 1.83 . . . . 0.0 110.607 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.579 ' CE1' ' O ' ' A' ' 53' ' ' SER . 3.7 m-30 -87.21 -173.5 4.44 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.461 0.648 . . . . 0.0 110.054 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.628 ' CE2' ' NE2' ' A' ' 27' ' ' HIS . 75.7 m-85 -156.63 116.67 3.57 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -77.54 140.74 39.78 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.83 0.824 . . . . 0.0 110.968 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.606 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 20.9 t-105 -160.64 137.53 6.59 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.606 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.7 Cg_endo -68.94 147.05 67.26 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.138 1.892 . . . . 0.0 111.424 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.595 HD13 ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -121.09 126.0 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.536 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.496 ' CD2' ' C ' ' A' ' 61' ' ' ILE . 0.3 OUTLIER -122.72 166.1 15.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.278 -0.889 . . . . 0.0 109.284 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.633 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -130.91 7.42 4.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.289 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.97 -69.85 0.54 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.259 -0.901 . . . . 0.0 109.338 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 158.31 60.61 0.01 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -175.58 139.29 0.42 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -1.17 . . . . 0.0 109.461 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.444 HG13 ' HZ2' ' A' ' 59' ' ' TRP . 91.5 t -77.3 147.6 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.0 109.441 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.479 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 0.7 OUTLIER -65.38 166.61 9.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 109.749 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.7 m -169.2 49.87 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.434 -0.791 . . . . 0.0 109.14 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.45 114.91 0.92 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 72' ' ' SER . . . -178.64 39.4 0.08 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 1.4 p 75.14 109.7 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.248 -1.148 . . . . 0.0 109.584 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.526 ' CA ' ' OH ' ' A' ' 38' ' ' TYR . 36.2 Cg_endo -79.41 119.68 4.23 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.49 2.127 . . . . 0.0 110.555 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 92' ' ' HIS . . . 170.0 -168.9 41.77 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . 47.74 -154.77 0.07 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -1.166 . . . . 0.0 110.506 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.44 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 51.8 m-20 -39.53 129.26 1.9 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.549 0.69 . . . . 0.0 109.619 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.515 ' CZ ' ' HB3' ' A' ' 60' ' ' PRO . 23.4 mmt-85 -158.43 122.25 3.99 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.498 ' CG2' HG23 ' A' ' 89' ' ' VAL . 0.9 OUTLIER -105.25 148.61 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.263 -0.898 . . . . 0.0 109.812 -178.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.529 HG12 ' H ' ' A' ' 80' ' ' PHE . 2.0 t -121.52 174.55 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.962 0.886 . . . . 0.0 109.673 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.529 ' H ' HG12 ' A' ' 79' ' ' VAL . 4.4 p90 -173.92 -167.87 0.38 Allowed 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.354 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.558 ' OD1' ' CE1' ' A' ' 56' ' ' TYR . 3.1 m120 -120.49 -80.57 0.62 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.266 -0.897 . . . . 0.0 109.794 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.412 ' OE1' ' O ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -163.43 23.98 0.08 Allowed 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 84' ' ' ASN . 24.8 m-80 -148.91 16.28 0.96 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.483 -0.761 . . . . 0.0 109.056 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.439 ' CG ' ' O ' ' A' ' 84' ' ' ASN . 2.9 t-20 62.32 13.89 6.35 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.366 -0.834 . . . . 0.0 109.348 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.562 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -46.89 -32.08 3.54 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.67 -1.234 . . . . 0.0 107.67 179.315 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.562 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.2 OUTLIER 84.95 110.58 0.05 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.534 0.683 . . . . 0.0 110.528 179.211 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.552 ' O ' ' CD1' ' A' ' 50' ' ' PHE . . . -82.63 -43.48 16.93 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 158.93 -161.14 31.71 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.498 HG23 ' CG2' ' A' ' 78' ' ' VAL . 39.1 t -134.96 92.46 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -1.179 . . . . 0.0 109.252 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 77' ' ' ARG . 0.6 OUTLIER -94.41 151.45 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.4 -0.812 . . . . 0.0 109.858 -179.668 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.2 t -125.85 134.58 51.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 109.731 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.695 ' CD2' ' CD1' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -82.61 74.64 9.57 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.323 -0.86 . . . . 0.0 108.99 179.733 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 7.9 m -169.68 135.37 1.49 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.492 -0.755 . . . . 0.0 109.466 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 93.42 24.11 22.36 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 98' ' ' ASN . . . -156.51 91.5 1.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.132 -1.217 . . . . 0.0 109.682 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 95' ' ' ALA . 1.7 t 43.78 79.35 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.304 -0.873 . . . . 0.0 109.314 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.62 -70.5 3.16 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.587 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -148.76 -82.15 0.12 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -1.1 . . . . 0.0 109.318 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 4.3 m-20 60.73 138.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.372 -0.83 . . . . 0.0 109.315 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.695 ' CD1' ' CD2' ' A' ' 92' ' ' HIS . 0.6 OUTLIER -79.12 148.86 32.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.058 -1.026 . . . . 0.0 109.85 -179.588 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -151.94 114.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.411 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 101' ' ' VAL . 1.7 pt-20 -43.71 131.26 5.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.326 -0.859 . . . . 0.0 109.575 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 5' ' ' THR . 84.0 m -72.31 106.26 4.39 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.324 -0.86 . . . . 0.0 109.401 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.826 -1.083 . . . . 0.0 109.54 -179.833 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 15.3 p 176.45 98.12 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.108 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -67.66 -19.41 65.19 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.319 -0.863 . . . . 0.0 108.895 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.552 ' CG ' HG23 ' A' ' 89' ' ' VAL . 39.4 m-85 -103.46 81.55 1.93 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.419 ' O ' ' CG2' ' A' ' 5' ' ' THR . 46.8 m -101.1 69.44 1.3 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.397 -0.814 . . . . 0.0 110.473 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.518 ' O ' ' N ' ' A' ' 8' ' ' SER . 3.9 m -80.6 154.58 27.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.036 -1.04 . . . . 0.0 108.505 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 6' ' ' CYS . . . 44.06 -94.98 0.01 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 6' ' ' CYS . 2.4 t -159.28 40.85 0.21 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -1.114 . . . . 0.0 109.1 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.407 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 2.8 m-80 -94.88 -35.88 11.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.919 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.431 ' C ' ' CB ' ' A' ' 2' ' ' CYS . 42.3 t 56.46 59.98 3.35 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.065 -1.022 . . . . 0.0 108.637 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.516 ' CE2' ' HB2' ' A' ' 63' ' ' SER . 2.9 m-30 -89.49 144.27 26.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.432 -0.792 . . . . 0.0 110.177 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 4.0 m -82.85 133.81 35.12 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.578 -0.701 . . . . 0.0 109.966 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.503 ' HA ' HG21 ' A' ' 16' ' ' VAL . 83.1 p -62.56 -23.39 66.97 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.0 t -79.47 -33.1 42.61 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.444 ' HB2' ' HB2' ' A' ' 12' ' ' SER . 5.4 m-20 -77.38 -27.27 52.46 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.503 HG21 ' HA ' ' A' ' 13' ' ' SER . 25.6 t -63.58 -24.27 35.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.0 t -66.52 -42.83 86.67 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.7 -42.27 99.55 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.603 ' CB ' ' CD1' ' A' ' 61' ' ' ILE . . . -74.33 -14.44 60.89 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.539 ' OE1' ' CB ' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -82.27 -30.6 30.55 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.498 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.62 -13.69 59.7 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.31 -58.53 3.24 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.502 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -61.64 -22.46 61.78 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.458 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 16.8 t80 -75.84 -37.32 59.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.555 -0.967 . . . . 0.0 109.127 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -69.74 -46.34 66.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.836 . . . . 0.0 108.849 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.5 tp -71.54 -18.06 62.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.392 -0.817 . . . . 0.0 108.87 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.621 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 55.1 t60 -89.66 -20.5 23.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.516 -0.74 . . . . 0.0 109.397 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.17 -23.26 24.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 109.338 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -97.78 -10.09 25.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.355 -0.84 . . . . 0.0 109.508 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.75 18.74 70.62 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.564 ' CG ' ' N ' ' A' ' 32' ' ' THR . 34.1 tt0 -88.8 167.08 13.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -1.171 . . . . 0.0 109.646 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.564 ' N ' ' CG ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -104.01 166.68 10.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.504 -0.747 . . . . 0.0 109.412 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -102.56 -79.06 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.062 -1.024 . . . . 0.0 109.685 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -72.62 -44.05 41.5 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.5 OUTLIER 163.32 -33.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.326 -1.102 . . . . 0.0 109.327 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 37' ' ' SER . 58.6 m-20 -76.77 -77.2 0.15 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.255 -0.903 . . . . 0.0 109.184 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 36' ' ' ASN . 0.1 OUTLIER 158.1 128.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.614 ' C ' ' CE1' ' A' ' 40' ' ' HIS . 0.2 OUTLIER -120.43 -37.31 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.838 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -178.593 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 35.1 Cg_endo -80.42 101.93 1.37 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 120.975 1.117 . . . . 0.0 112.485 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.614 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -132.12 -172.05 2.79 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.365 -0.835 . . . . 0.0 109.267 178.121 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.474 ' O ' ' OE2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -81.74 158.22 24.26 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.824 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.512 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 1.2 t80 -121.38 124.1 43.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.102 -0.998 . . . . 0.0 109.747 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -110.24 -75.22 0.63 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 108.543 179.295 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.512 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 0.4 OUTLIER 77.15 -76.03 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.363 -0.836 . . . . 0.0 110.458 179.002 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 56.66 45.69 21.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.925 -1.109 . . . . 0.0 109.115 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.512 ' CG ' ' CE2' ' A' ' 48' ' ' PHE . 0.8 OUTLIER -94.2 -28.42 15.64 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.249 -0.907 . . . . 0.0 109.306 -179.668 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 159.84 -23.61 0.29 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.512 ' CE2' ' CG ' ' A' ' 46' ' ' GLU . 3.5 p90 -111.87 139.74 47.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.431 -1.041 . . . . 0.0 109.225 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 50' ' ' PHE . 2.4 m-20 -122.8 -23.79 4.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.682 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.517 ' CB ' ' O ' ' A' ' 49' ' ' ASP . 3.1 m-85 80.54 173.82 0.13 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.363 -0.835 . . . . 0.0 109.382 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.9 p -120.74 39.48 3.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.219 -0.925 . . . . 0.0 109.625 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.439 ' CG2' ' HA ' ' A' ' 87' ' ' ALA . 15.0 t -98.58 -67.14 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.157 -0.964 . . . . 0.0 109.505 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.444 ' O ' ' CE2' ' A' ' 56' ' ' TYR . 0.2 OUTLIER -165.55 174.98 9.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.097 -1.002 . . . . 0.0 109.996 -179.702 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.58 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -79.22 -51.04 1.3 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.46 -0.775 . . . . 0.0 110.61 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 54' ' ' SER . 36.2 Cg_endo -76.25 82.85 2.12 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.94 1.76 . . . . 0.0 110.208 -178.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.541 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 49.0 m-85 -79.35 -178.15 6.09 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.561 0.696 . . . . 0.0 109.712 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.621 ' CE1' ' NE2' ' A' ' 27' ' ' HIS . 97.1 m-85 -158.13 135.63 10.32 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.474 ' OE2' ' O ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -96.03 140.5 30.68 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.094 -1.003 . . . . 0.0 111.589 -178.115 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.661 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 27.5 t-105 -160.81 139.29 7.42 Favored Pre-proline 0 N--CA 1.495 1.799 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.661 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 31.6 Cg_endo -70.09 143.15 48.39 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.161 1.907 . . . . 0.0 111.321 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.603 ' CD1' ' CB ' ' A' ' 19' ' ' ALA . 0.2 OUTLIER -107.02 116.29 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.56 -0.712 . . . . 0.0 109.512 -179.638 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.555 ' N ' HD11 ' A' ' 61' ' ' ILE . 0.7 OUTLIER -116.94 164.04 15.3 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.296 -0.878 . . . . 0.0 108.985 179.494 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.516 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -172.48 56.32 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.55 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 177.14 36.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.271 -0.893 . . . . 0.0 109.118 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.04 -70.31 0.08 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -173.74 167.75 4.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.202 -1.175 . . . . 0.0 109.77 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.8 t -62.59 150.1 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.331 -0.856 . . . . 0.0 109.298 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.532 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 17.1 t80 -52.0 138.86 24.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.966 -1.084 . . . . 0.0 109.533 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.458 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 5.0 t -159.9 21.9 0.17 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.393 -0.817 . . . . 0.0 109.69 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 130.98 154.7 7.98 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.91 -133.5 6.8 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.97 131.07 21.98 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.145 -1.209 . . . . 0.0 109.175 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.492 ' HA ' ' OH ' ' A' ' 38' ' ' TYR . 36.2 Cg_endo -79.48 -172.57 1.57 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.406 2.071 . . . . 0.0 111.012 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 75' ' ' ALA . . . 74.52 -167.74 54.68 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 74' ' ' GLY . . . 77.6 -152.02 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.246 -1.149 . . . . 0.0 110.459 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.422 ' O ' ' HB3' ' A' ' 77' ' ' ARG . 5.1 m-20 -62.24 162.65 9.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.391 -0.818 . . . . 0.0 109.811 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.57 ' O ' HG12 ' A' ' 90' ' ' ILE . 0.9 OUTLIER 175.1 96.59 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.176 -0.952 . . . . 0.0 109.149 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.602 HG21 HD23 ' A' ' 86' ' ' LEU . 2.6 p -77.02 140.12 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.884 -1.135 . . . . 0.0 110.579 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.577 ' CG1' ' N ' ' A' ' 80' ' ' PHE . 16.7 t -92.53 169.44 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.577 ' CE1' ' O ' ' A' ' 57' ' ' TYR . 4.6 p90 -162.84 -173.31 3.43 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.629 -0.829 . . . . 0.0 109.502 -178.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.41 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 11.0 t-20 -124.0 -81.77 0.64 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.17 -0.956 . . . . 0.0 109.405 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.458 ' O ' ' CZ ' ' A' ' 24' ' ' TYR . 65.9 mt-10 -156.4 12.82 0.29 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.459 -0.776 . . . . 0.0 110.317 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.5 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 0.1 OUTLIER -137.9 6.01 2.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.023 -1.048 . . . . 0.0 109.489 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.5 ' OD1' ' O ' ' A' ' 83' ' ' ASN . 0.3 OUTLIER 70.91 16.14 6.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.448 -0.783 . . . . 0.0 109.441 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.586 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -53.72 -31.29 47.69 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.383 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.602 HD23 HG21 ' A' ' 78' ' ' VAL . 0.6 OUTLIER 89.21 103.28 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.686 0.755 . . . . 0.0 110.599 179.226 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.447 ' CB ' HG11 ' A' ' 79' ' ' VAL . . . -70.97 -52.59 18.85 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.424 ' O ' HG22 ' A' ' 78' ' ' VAL . . . 169.25 171.29 34.79 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.552 HG23 ' CG ' ' A' ' 4' ' ' TYR . 64.3 t -102.91 124.69 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.937 -1.331 . . . . 0.0 109.906 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.57 HG12 ' O ' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -125.59 153.22 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.331 -0.856 . . . . 0.0 108.696 179.553 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 99' ' ' ASN . 6.3 t -117.07 165.49 13.32 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.026 -1.046 . . . . 0.0 110.019 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.62 ' NE2' ' CD2' ' A' ' 100' ' ' PHE . 0.4 OUTLIER -121.11 67.27 0.87 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.437 -0.789 . . . . 0.0 109.28 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 7.4 m -168.81 126.22 1.01 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.462 -0.773 . . . . 0.0 109.292 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 107.96 -20.57 31.03 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 98' ' ' ASN . . . -105.83 93.94 4.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.211 -1.17 . . . . 0.0 109.681 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 95' ' ' ALA . 51.7 m 41.59 52.58 3.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.511 -0.743 . . . . 0.0 109.477 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.1 -73.29 0.21 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.604 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -144.38 -81.96 0.16 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.259 -1.142 . . . . 0.0 109.472 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 91' ' ' THR . 0.8 OUTLIER 57.06 159.29 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.317 -0.864 . . . . 0.0 109.15 -179.519 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.62 ' CD2' ' NE2' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -96.61 145.17 25.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.902 -1.124 . . . . 0.0 110.04 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.443 ' O ' ' C ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -155.97 130.55 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.293 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 101' ' ' VAL . 2.3 pt-20 -39.98 136.83 1.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.468 -0.77 . . . . 0.0 110.124 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.99 123.83 29.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.395 -0.816 . . . . 0.0 109.382 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.1 p . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.171 -0.955 . . . . 0.0 109.38 179.844 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.443 ' O ' ' SG ' ' A' ' 10' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 0.8 OUTLIER 173.94 106.91 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.279 -0.888 . . . . 0.0 110.398 179.558 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -79.66 -14.74 58.57 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.638 ' CG ' HG23 ' A' ' 89' ' ' VAL . 16.2 m-85 -112.8 126.94 55.97 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.337 -0.852 . . . . 0.0 109.051 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -152.83 109.32 3.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.235 -0.916 . . . . 0.0 109.744 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 103' ' ' CYS . 29.9 m -95.44 16.81 15.96 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.066 0.936 . . . . 0.0 109.557 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.65 -146.47 6.31 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 p -88.17 15.11 7.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.208 -1.172 . . . . 0.0 109.304 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -79.67 -168.18 1.49 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.322 -0.861 . . . . 0.0 109.664 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 1' ' ' ALA . 45.6 t -149.55 74.3 1.22 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.5 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 4.2 m-85 -80.44 124.6 29.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.393 -0.817 . . . . 0.0 110.041 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 0.6 OUTLIER -83.79 124.79 31.28 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.502 -0.749 . . . . 0.0 109.63 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 12' ' ' SER . 28.3 t -46.39 -25.67 0.69 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.239 -0.913 . . . . 0.0 108.754 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.3 t -76.91 -43.36 35.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 109.285 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.41 -26.09 67.07 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.49 ' HA ' HD12 ' A' ' 61' ' ' ILE . 3.0 t -72.87 -32.99 42.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.91 -42.31 97.83 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -47.32 86.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 108.628 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.6 ' CB ' HD13 ' A' ' 61' ' ' ILE . . . -75.9 -10.59 59.55 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.635 ' NE2' ' CG ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -83.17 -30.61 27.68 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.922 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.25 -16.73 54.07 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.38 -47.27 61.7 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.498 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -73.14 -31.21 61.88 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.684 -1.766 . . . . 0.0 108.684 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -68.23 -32.15 72.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.46 -1.024 . . . . 0.0 109.171 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -73.36 -47.9 38.57 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.6 tp -65.25 -21.2 66.71 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -85.65 -24.76 26.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.526 -0.734 . . . . 0.0 109.516 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -88.12 -11.55 46.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.319 -0.863 . . . . 0.0 109.403 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -107.88 -11.57 15.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.374 -0.829 . . . . 0.0 109.721 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.64 14.89 77.71 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.27 -157.17 0.16 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -1.207 . . . . 0.0 109.379 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.62 HG23 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -158.19 166.79 31.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.322 -0.861 . . . . 0.0 109.254 179.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -110.33 -70.44 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.144 -0.973 . . . . 0.0 109.585 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -85.93 16.45 42.15 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 66.36 19.73 10.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.132 -1.217 . . . . 0.0 109.114 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -120.92 5.58 10.42 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.402 -0.811 . . . . 0.0 109.293 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.62 ' HA ' HG23 ' A' ' 32' ' ' THR . 0.3 OUTLIER 68.3 73.51 0.29 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.224 -0.922 . . . . 0.0 108.653 -179.179 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.654 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -71.67 -45.33 12.63 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.117 -0.99 . . . . 0.0 110.938 -179.367 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 35.3 Cg_endo -77.15 106.61 2.27 Favored 'Trans proline' 0 C--N 1.3 -1.993 0 C-N-CA 120.855 1.037 . . . . 0.0 109.873 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.654 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -127.09 -175.37 3.41 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -107.13 143.34 35.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.943 -1.098 . . . . 0.0 110.367 -179.454 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.504 ' HB2' ' HG3' ' A' ' 58' ' ' GLU . 12.0 t80 -104.11 161.59 13.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.503 -0.748 . . . . 0.0 109.245 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.431 ' O ' ' O ' ' A' ' 44' ' ' ASN . 0.5 OUTLIER -123.83 -16.22 6.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.124 -0.985 . . . . 0.0 109.567 179.615 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.543 ' O ' ' CD2' ' A' ' 45' ' ' TYR . 0.7 OUTLIER 62.1 130.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.556 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.543 ' CD2' ' O ' ' A' ' 44' ' ' ASN . 5.6 m-85 -161.44 -38.54 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.399 -0.813 . . . . 0.0 109.126 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.667 ' OE2' HG12 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -37.93 -68.36 0.16 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.469 0.652 . . . . 0.0 110.131 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.56 61.14 0.01 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -89.62 -174.75 4.44 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.358 -1.084 . . . . 0.0 108.61 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -117.09 -20.4 9.32 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.897 -1.127 . . . . 0.0 110.043 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.511 ' C ' ' CD1' ' A' ' 50' ' ' PHE . 10.1 p90 -80.74 179.97 7.54 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.129 -0.982 . . . . 0.0 109.438 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.449 ' HA ' ' OH ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -177.4 57.08 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.259 -0.9 . . . . 0.0 109.254 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.525 HG13 ' HB2' ' A' ' 85' ' ' GLN . 42.3 t -45.03 -63.13 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.165 -0.959 . . . . 0.0 109.023 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.75 -178.97 7.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.312 -0.868 . . . . 0.0 109.95 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.58 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -79.7 -50.09 1.29 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.405 -0.809 . . . . 0.0 110.81 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 54' ' ' SER . 34.5 Cg_endo -75.28 83.62 1.83 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.991 1.794 . . . . 0.0 109.764 -178.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.493 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 10.1 m-85 -81.68 179.82 7.68 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.745 0.783 . . . . 0.0 110.804 -178.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.54 ' HA ' ' O ' ' A' ' 40' ' ' HIS . 64.4 m-85 -157.26 117.12 3.43 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.563 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -96.66 147.66 23.66 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.266 -0.896 . . . . 0.0 110.489 -178.584 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.642 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 4.1 t-105 -160.75 143.93 9.83 Favored Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.642 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 28.4 Cg_endo -66.35 133.03 31.17 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.336 2.024 . . . . 0.0 112.091 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.6 HD13 ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -118.31 115.66 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.704 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.878 HD12 ' O ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -118.58 163.75 16.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.107 -0.996 . . . . 0.0 109.13 179.761 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.1 t -131.53 36.17 3.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.484 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.73 6.8 12.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.18 -0.95 . . . . 0.0 109.618 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.71 -32.7 7.26 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.878 ' O ' HD12 ' A' ' 62' ' ' LEU . 11.9 m-20 -98.97 91.39 5.01 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.23 -1.159 . . . . 0.0 109.375 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.584 ' O ' ' CD1' ' A' ' 68' ' ' TYR . 43.4 t -65.02 156.75 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 109.857 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 67' ' ' VAL . 48.6 p90 39.17 -162.69 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.598 0.713 . . . . 0.0 110.023 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.492 ' N ' ' CD2' ' A' ' 68' ' ' TYR . 29.0 t 53.11 173.22 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.342 -0.849 . . . . 0.0 109.427 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.63 -160.45 15.99 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.66 41.32 2.25 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 t -161.26 85.95 1.72 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.221 -1.164 . . . . 0.0 109.306 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.476 ' HA ' ' OH ' ' A' ' 38' ' ' TYR . 35.5 Cg_endo -79.95 44.05 1.64 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.789 2.326 . . . . 0.0 111.022 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.465 ' O ' ' CB ' ' A' ' 75' ' ' ALA . . . -173.03 -167.52 33.05 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' A' ' 74' ' ' GLY . . . 72.28 -141.89 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.117 -1.225 . . . . 0.0 110.162 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.465 ' C ' ' O ' ' A' ' 75' ' ' ALA . 1.2 m-20 -34.2 131.14 0.31 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.444 -0.785 . . . . 0.0 111.21 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.475 ' O ' HG12 ' A' ' 90' ' ' ILE . 6.5 ttm-85 -167.24 110.11 0.68 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.469 -0.769 . . . . 0.0 108.989 179.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.497 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 4.3 p -71.95 164.62 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.069 -1.019 . . . . 0.0 109.67 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.608 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 4.0 t -130.52 171.36 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.973 0.892 . . . . 0.0 109.961 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.635 ' CG ' ' NE2' ' A' ' 20' ' ' GLN . 24.0 p90 -174.02 -172.46 0.72 Allowed 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.418 ' CG ' ' N ' ' A' ' 82' ' ' GLU . 2.9 t30 -125.33 -84.9 0.64 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.962 -1.087 . . . . 0.0 109.794 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.418 ' N ' ' CG ' ' A' ' 81' ' ' ASN . 6.9 mt-10 -142.16 0.55 1.36 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.494 -0.753 . . . . 0.0 109.919 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 84' ' ' ASN . 8.7 m-20 -131.4 4.81 4.35 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 108.895 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 83' ' ' ASN . 5.5 t30 75.1 32.43 0.77 Allowed 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.334 -0.854 . . . . 0.0 109.192 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.543 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -62.16 -33.16 73.98 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.46 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.543 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER 84.99 103.95 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.488 0.661 . . . . 0.0 110.994 178.937 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.608 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . . . -74.54 -27.8 60.68 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 148.14 -149.03 21.04 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.638 HG23 ' CG ' ' A' ' 4' ' ' TYR . 72.5 t -129.85 87.71 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.254 -1.145 . . . . 0.0 109.639 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.526 ' HB ' ' HB3' ' A' ' 100' ' ' PHE . 12.2 pt -79.4 136.24 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.514 -0.741 . . . . 0.0 109.221 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 75' ' ' ALA . 13.1 t -130.5 118.54 21.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.91 . . . . 0.0 110.296 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.691 ' CD2' ' CE1' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -84.01 76.42 10.06 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.368 -0.832 . . . . 0.0 108.848 179.279 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 1.4 m 178.96 -30.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.553 -0.717 . . . . 0.0 109.404 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -59.04 -15.01 27.23 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -117.96 163.68 16.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.186 -1.185 . . . . 0.0 109.553 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 95' ' ' ALA . 3.7 m -42.92 120.33 1.75 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 109.008 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.97 -82.84 1.64 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.654 -1.779 . . . . 0.0 108.654 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.621 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -151.9 -86.81 0.07 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.318 -1.107 . . . . 0.0 109.287 179.419 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.472 ' O ' ' O ' ' A' ' 98' ' ' ASN . 4.0 m-80 61.04 129.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 108.937 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.691 ' CE1' ' CD2' ' A' ' 92' ' ' HIS . 57.0 m-85 -85.33 125.58 33.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.891 -1.131 . . . . 0.0 110.292 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.667 HG12 ' OE2' ' A' ' 46' ' ' GLU . 1.2 m -142.69 137.51 27.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.445 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 24.0 pt-20 -61.52 123.61 18.35 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.164 -0.96 . . . . 0.0 109.221 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.421 ' HB3' ' HA ' ' A' ' 6' ' ' CYS . 84.7 m -56.93 161.01 3.17 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.151 -0.968 . . . . 0.0 109.398 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.479 0 O-C-N 121.22 -0.925 . . . . 0.0 109.492 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 27.2 p -178.77 88.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.145 -0.972 . . . . 0.0 109.956 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -89.9 2.72 54.71 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.296 -0.878 . . . . 0.0 109.285 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -126.57 105.74 8.94 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.112 -0.992 . . . . 0.0 109.637 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.4 ' O ' ' CG2' ' A' ' 5' ' ' THR . 6.0 t -136.43 106.79 6.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.892 . . . . 0.0 109.318 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.445 ' SG ' ' HB ' ' A' ' 91' ' ' THR . 57.3 m -93.47 17.14 11.99 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.17 0.986 . . . . 0.0 109.63 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.48 -111.77 0.32 Allowed Glycine 0 C--N 1.282 -2.432 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.14 3.93 12.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.15 -1.206 . . . . 0.0 109.271 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.562 ' O ' ' N ' ' A' ' 11' ' ' TYR . 3.9 m120 -92.51 68.12 4.79 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.246 -0.909 . . . . 0.0 109.411 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -49.74 89.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.575 ' CZ ' ' OG ' ' A' ' 63' ' ' SER . 4.0 m-30 -83.17 144.6 29.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.456 -0.778 . . . . 0.0 110.173 -178.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 0.1 OUTLIER -79.18 127.84 32.54 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.818 -0.551 . . . . 0.0 110.042 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.35 -43.19 61.74 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.9 m -62.68 -34.52 77.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.378 -0.826 . . . . 0.0 108.958 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -69.22 -31.1 69.45 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 12' ' ' SER . 6.7 t -58.82 -25.43 29.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.429 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 20.3 t -74.4 -40.6 61.93 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -40.44 80.36 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.652 ' CB ' HD11 ' A' ' 61' ' ' ILE . . . -77.06 -26.43 53.56 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.522 ' CA ' ' OE1' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -75.03 -16.62 60.59 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.056 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -92.62 -11.71 33.54 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.95 -56.2 3.95 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.524 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -69.16 -24.13 76.02 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.565 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 11.0 t80 -77.99 -53.33 7.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.501 -1.0 . . . . 0.0 109.048 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 1.1 tm0? -45.64 -47.15 14.89 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.559 ' CD1' ' N ' ' A' ' 32' ' ' THR . 1.0 OUTLIER -59.79 -48.87 79.93 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.389 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.465 ' NE2' ' CZ ' ' A' ' 57' ' ' TYR . 9.1 t60 -59.06 -14.51 9.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.264 -0.898 . . . . 0.0 110.367 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -96.0 -28.18 14.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.89 -1.131 . . . . 0.0 109.957 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.39 8.0 45.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.115 -0.99 . . . . 0.0 109.432 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 48.62 34.07 13.62 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.475 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -102.17 -147.72 0.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -1.169 . . . . 0.0 109.429 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.559 ' N ' ' CD1' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -157.87 -178.19 7.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.064 -1.022 . . . . 0.0 110.016 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 34' ' ' GLY . 25.8 m -98.81 -139.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.878 . . . . 0.0 109.515 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -42.27 -51.41 5.32 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 173.62 -31.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.263 -1.14 . . . . 0.0 109.635 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.465 ' O ' ' OG ' ' A' ' 37' ' ' SER . 5.8 m120 -74.82 -7.38 53.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.25 -0.906 . . . . 0.0 109.573 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.521 ' HA ' HG21 ' A' ' 32' ' ' THR . 2.4 p 71.84 -165.33 0.13 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -0.922 . . . . 0.0 109.481 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.589 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.2 OUTLIER 167.64 -45.03 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.482 -0.761 . . . . 0.0 111.269 179.435 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 31.8 Cg_endo -76.59 100.68 1.42 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 121.482 1.455 . . . . 0.0 112.025 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.587 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -140.33 163.44 32.77 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.591 -0.693 . . . . 0.0 109.513 178.735 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -58.06 154.13 13.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.795 -1.19 . . . . 0.0 108.664 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.583 ' CE2' ' HB2' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -136.74 155.22 50.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.124 -0.985 . . . . 0.0 110.044 -178.562 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.552 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 0.7 OUTLIER -137.82 -71.99 0.42 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.537 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.62 ' ND2' ' CE2' ' A' ' 100' ' ' PHE . 1.0 OUTLIER 80.18 -69.66 0.1 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.593 -0.692 . . . . 0.0 111.411 178.318 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.52 ' CE2' ' HB3' ' A' ' 43' ' ' ASN . 86.6 m-85 67.41 9.12 6.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 108.846 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.494 ' OE1' ' CZ ' ' A' ' 48' ' ' PHE . 0.4 OUTLIER -39.33 -50.72 2.05 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 121.557 -0.715 . . . . 0.0 109.809 -179.725 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 159.37 36.71 0.02 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.494 ' CZ ' ' OE1' ' A' ' 46' ' ' GLU . 7.5 m-85 -115.64 -179.91 3.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.243 -1.151 . . . . 0.0 109.346 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -128.73 -34.68 1.96 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.464 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.528 ' CB ' ' OH ' ' A' ' 56' ' ' TYR . 16.8 m-30 55.21 179.12 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 109.916 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.6 p -139.76 21.04 2.5 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' A' ' 81' ' ' ASN . 77.1 t -95.42 -92.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.544 -0.722 . . . . 0.0 109.843 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.7 m -166.27 -168.84 1.29 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.976 . . . . 0.0 110.047 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.587 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -77.78 -50.74 1.89 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.614 -0.679 . . . . 0.0 111.056 -179.816 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 54' ' ' SER . 32.5 Cg_endo -73.01 92.38 0.81 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 121.897 1.731 . . . . 0.0 110.168 -177.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.585 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 17.4 m-85 -94.66 -169.15 1.96 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.589 ' O ' ' CE1' ' A' ' 80' ' ' PHE . 70.4 m-85 -161.66 106.94 1.3 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.1 140.24 39.05 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.836 0.827 . . . . 0.0 110.921 -178.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.626 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 31.3 t-105 -160.35 137.02 6.52 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.626 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.9 Cg_endo -69.08 145.89 62.59 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.092 1.862 . . . . 0.0 111.484 -178.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.652 HD11 ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -110.88 128.49 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.56 -0.713 . . . . 0.0 109.527 -179.339 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -124.82 161.33 26.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.153 -0.967 . . . . 0.0 109.261 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.575 ' OG ' ' CZ ' ' A' ' 11' ' ' TYR . 53.8 m -133.42 5.73 3.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.303 -0.873 . . . . 0.0 109.398 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.37 -71.48 0.73 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.917 . . . . 0.0 109.202 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -74.32 -92.83 0.14 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 53.4 t0 179.87 -36.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.289 -1.124 . . . . 0.0 109.758 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.04 155.48 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.162 -0.961 . . . . 0.0 109.89 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.467 ' CE2' ' CD2' ' A' ' 38' ' ' TYR . 54.1 t80 -71.57 115.06 10.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.908 . . . . 0.0 109.397 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.6 t -152.74 -43.43 0.1 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.38 -0.825 . . . . 0.0 109.278 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.31 -27.44 57.9 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.419 ' O ' ' OG ' ' A' ' 72' ' ' SER . . . 101.14 -163.97 18.2 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.502 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 18.2 p 55.82 60.81 8.5 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.305 -1.115 . . . . 0.0 109.846 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.502 ' HD3' ' N ' ' A' ' 72' ' ' SER . 36.8 Cg_endo -79.59 -159.05 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.651 2.234 . . . . 0.0 110.436 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.456 ' O ' ' HB1' ' A' ' 75' ' ' ALA . . . 92.2 -171.65 34.15 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 91' ' ' THR . . . 70.86 -80.85 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.482 -1.011 . . . . 0.0 110.377 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.467 ' HB3' ' CG2' ' A' ' 61' ' ' ILE . 54.6 m-20 -113.66 135.17 54.22 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.015 -1.053 . . . . 0.0 109.698 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.557 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 4.6 mtt180 -155.99 84.82 1.01 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.313 -0.867 . . . . 0.0 109.073 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.481 ' CG1' ' OE1' ' A' ' 20' ' ' GLN . 14.6 p -77.93 150.44 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.975 -1.078 . . . . 0.0 109.484 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.448 HG11 ' O ' ' A' ' 57' ' ' TYR . 3.0 t -111.62 173.35 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.364 -0.835 . . . . 0.0 109.418 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.589 ' CE1' ' O ' ' A' ' 57' ' ' TYR . 4.4 p90 -164.24 -171.47 2.41 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.221 -178.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.464 ' HB2' ' CG1' ' A' ' 52' ' ' VAL . 16.8 t30 -121.08 -83.08 0.66 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.026 -1.046 . . . . 0.0 109.99 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.565 ' O ' ' CZ ' ' A' ' 24' ' ' TYR . 42.0 mt-10 -141.91 -9.44 0.91 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.402 -0.811 . . . . 0.0 110.862 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -131.77 25.06 4.69 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.907 -1.121 . . . . 0.0 108.882 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.455 ' O ' ' C ' ' A' ' 85' ' ' GLN . 3.1 m120 62.37 21.73 12.75 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.495 -0.753 . . . . 0.0 109.506 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.568 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -44.11 -30.23 0.73 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.562 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.568 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER 85.18 103.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.553 0.692 . . . . 0.0 110.904 178.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.441 ' CB ' ' CE1' ' A' ' 56' ' ' TYR . . . -79.41 -33.21 42.85 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 139.73 145.3 4.67 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.466 HG22 ' HB ' ' A' ' 78' ' ' VAL . 61.2 t -80.57 118.88 29.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.144 -1.209 . . . . 0.0 109.282 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.616 HD12 ' HB2' ' A' ' 100' ' ' PHE . 0.4 OUTLIER -104.45 179.12 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.925 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.484 ' O ' ' O ' ' A' ' 99' ' ' ASN . 1.5 t -138.0 135.3 35.82 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.354 -1.338 . . . . 0.0 111.916 -178.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.611 ' CE1' ' CD1' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -86.19 62.34 7.38 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.553 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.468 HG21 HG21 ' A' ' 91' ' ' THR . 6.8 t -176.2 25.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.385 -0.822 . . . . 0.0 110.314 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.19 10.56 17.48 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.525 ' CB ' ' HB2' ' A' ' 99' ' ' ASN . . . -153.29 -174.42 4.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -1.152 . . . . 0.0 109.554 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 95' ' ' ALA . 1.9 t -42.71 113.98 0.53 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.343 -0.848 . . . . 0.0 109.718 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.46 -81.84 0.82 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.581 ' HB2' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -138.36 -76.32 0.38 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -1.138 . . . . 0.0 109.722 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.525 ' HB2' ' CB ' ' A' ' 95' ' ' ALA . 1.0 OUTLIER 59.94 154.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -178.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.62 ' CE2' ' ND2' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -114.36 118.75 34.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.711 -1.243 . . . . 0.0 110.961 -179.233 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.443 ' O ' ' C ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -125.51 139.83 50.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 107.85 -1.166 . . . . 0.0 107.85 178.357 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -41.82 140.01 1.11 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.137 -0.977 . . . . 0.0 110.347 -178.672 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.442 ' O ' ' OE1' ' A' ' 102' ' ' GLU . 0.5 OUTLIER -56.36 109.03 0.54 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.419 -0.801 . . . . 0.0 109.478 179.716 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 109.538 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.427 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 8.5 p 173.96 99.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.931 . . . . 0.0 109.862 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -101.51 -9.42 21.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.349 -0.844 . . . . 0.0 109.311 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.663 ' CD2' HG22 ' A' ' 89' ' ' VAL . 18.8 m-85 -106.14 82.15 1.72 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.115 -0.991 . . . . 0.0 109.163 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.443 ' CB ' ' O ' ' A' ' 9' ' ' ASN . 76.3 p -89.83 131.51 35.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -0.852 . . . . 0.0 109.719 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.516 ' CB ' ' OD1' ' A' ' 76' ' ' ASP . 4.0 m -143.55 157.76 44.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.348 -0.845 . . . . 0.0 109.138 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 8' ' ' SER . . . 44.95 32.94 3.4 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 7' ' ' GLY . 0.6 OUTLIER 68.53 49.18 0.77 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.323 -1.104 . . . . 0.0 109.573 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.443 ' O ' ' CB ' ' A' ' 5' ' ' THR . 25.2 m120 -136.3 172.91 12.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.185 -0.947 . . . . 0.0 110.032 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -127.48 81.87 2.05 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.487 ' CE2' ' HB2' ' A' ' 63' ' ' SER . 2.9 m-85 -79.0 138.28 37.96 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.476 -0.765 . . . . 0.0 109.826 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 0.8 OUTLIER -79.62 124.74 28.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.607 -0.683 . . . . 0.0 109.767 -179.709 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.64 -21.94 3.01 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.559 -0.856 . . . . 0.0 108.975 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 t -82.28 -36.64 26.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.384 -0.822 . . . . 0.0 109.328 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -69.48 -33.79 73.39 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 12' ' ' SER . 5.0 t -58.66 -38.4 71.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.422 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 0.9 OUTLIER -63.71 -31.63 72.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.616 -0.677 . . . . 0.0 109.487 179.547 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -56.78 9.13 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.533 ' CB ' ' CD1' ' A' ' 61' ' ' ILE . . . -63.62 -17.25 62.69 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.57 ' OE1' ' CG ' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -77.43 -36.0 53.53 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -74.13 -6.31 46.94 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.19 -53.6 5.39 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.549 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -68.33 -27.77 73.59 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.484 ' C ' ' CD1' ' A' ' 24' ' ' TYR . 1.3 t80 -76.31 -60.02 2.51 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.502 -0.999 . . . . 0.0 109.599 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 14.6 mt-30 -57.58 -31.67 66.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.032 -1.042 . . . . 0.0 109.137 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.529 ' CD1' ' HB3' ' A' ' 31' ' ' GLU . 9.2 tp -74.01 -28.89 61.67 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 108.54 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.423 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 14.0 t60 -79.5 -21.91 44.68 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.422 -0.799 . . . . 0.0 109.448 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -89.31 -31.93 17.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.322 -0.861 . . . . 0.0 109.464 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -80.93 -13.77 58.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.94 . . . . 0.0 109.579 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.24 36.34 27.61 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.571 ' O ' HG23 ' A' ' 32' ' ' THR . 0.3 OUTLIER -105.49 -158.78 0.68 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.252 -1.146 . . . . 0.0 109.791 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 31' ' ' GLU . 1.1 p -168.22 -172.18 1.69 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 35' ' ' SER . 33.7 m -125.38 152.35 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.08 -1.012 . . . . 0.0 110.377 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 48.79 -88.54 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.541 ' N ' ' O ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -175.09 28.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.417 -1.049 . . . . 0.0 109.346 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.472 ' O ' ' OG ' ' A' ' 37' ' ' SER . 5.2 m-20 -138.0 23.64 2.82 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.339 -0.85 . . . . 0.0 109.159 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.532 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 75.8 p 48.98 -165.98 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.416 -0.803 . . . . 0.0 109.692 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.629 ' CE2' ' NH1' ' A' ' 77' ' ' ARG . 0.0 OUTLIER 168.7 -44.88 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.549 -0.719 . . . . 0.0 111.541 179.212 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 33.2 Cg_endo -76.77 100.75 1.43 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 121.377 1.385 . . . . 0.0 111.986 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.552 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -140.4 -170.15 2.93 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.682 -0.636 . . . . 0.0 109.349 178.642 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 11.5 ptmt -75.51 163.84 26.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.406 -0.809 . . . . 0.0 110.395 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.54 ' CE2' ' HA ' ' A' ' 44' ' ' ASN . 85.7 t80 -142.83 93.88 2.57 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 44' ' ' ASN . 0.5 OUTLIER -81.79 37.91 0.49 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.12 -0.987 . . . . 0.0 110.752 -179.053 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.54 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER 39.92 -160.99 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.216 -0.927 . . . . 0.0 109.948 179.394 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.457 ' CB ' ' O ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER 167.25 -67.31 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.4 -0.813 . . . . 0.0 109.217 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -38.96 -52.63 1.78 Allowed 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.519 -0.738 . . . . 0.0 110.016 -179.784 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.07 51.18 0.05 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.519 ' CZ ' ' HA ' ' A' ' 101' ' ' VAL . 21.0 m-85 -101.09 115.09 29.66 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.178 -1.189 . . . . 0.0 109.523 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.04 88.94 7.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.411 -0.806 . . . . 0.0 109.18 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.482 ' CZ ' ' CB ' ' A' ' 48' ' ' PHE . 60.6 m-85 -78.87 -172.46 3.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.358 -0.839 . . . . 0.0 109.657 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 84.2 p -153.48 42.25 0.56 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 109.3 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 86' ' ' LEU . 38.3 t -114.65 -41.63 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.32 -0.862 . . . . 0.0 109.518 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.488 ' O ' ' CE1' ' A' ' 56' ' ' TYR . 0.6 OUTLIER 176.7 -174.47 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.147 -0.971 . . . . 0.0 109.75 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.505 ' CB ' ' HD3' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -91.97 -56.24 0.25 Allowed Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.247 -0.908 . . . . 0.0 111.518 -179.231 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.505 ' HD3' ' CB ' ' A' ' 54' ' ' SER . 35.4 Cg_endo -75.17 89.3 1.18 Allowed 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.913 1.742 . . . . 0.0 110.082 -177.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.628 ' CE2' ' CB ' ' A' ' 87' ' ' ALA . 4.0 m-30 -84.82 -179.52 7.11 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.433 0.635 . . . . 0.0 109.982 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.583 ' O ' ' CE1' ' A' ' 80' ' ' PHE . 87.2 m-85 -151.86 130.38 12.21 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.477 -0.765 . . . . 0.0 109.098 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.513 ' OE1' ' NH2' ' A' ' 77' ' ' ARG . 12.7 pt-20 -89.11 133.7 34.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 0.0 110.917 -178.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.637 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 20.0 t-105 -160.25 139.52 8.02 Favored Pre-proline 0 N--CA 1.491 1.6 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.637 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 32.8 Cg_endo -72.11 152.88 57.06 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.482 2.121 . . . . 0.0 111.897 -178.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.533 ' CD1' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -115.48 122.3 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.544 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 0.6 OUTLIER -117.58 169.81 9.25 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.098 -1.001 . . . . 0.0 109.429 179.611 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.487 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 6.6 t -121.26 39.06 3.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 108.799 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.64 -31.13 5.28 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.569 -0.707 . . . . 0.0 109.356 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.23 12.56 59.84 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 67' ' ' VAL . 0.6 OUTLIER -106.16 9.89 32.1 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.212 -1.169 . . . . 0.0 109.595 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.521 HG11 ' CZ2' ' A' ' 59' ' ' TRP . 91.9 t 60.8 143.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.169 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.55 ' CE2' ' CE2' ' A' ' 38' ' ' TYR . 16.7 t80 -55.53 108.79 0.47 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.124 -0.985 . . . . 0.0 109.402 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.68 48.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.408 -0.808 . . . . 0.0 109.325 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -149.38 -52.72 0.02 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 167.78 -167.61 40.15 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.68 68.05 1.4 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.296 -1.12 . . . . 0.0 109.324 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.72 155.74 27.4 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.742 2.295 . . . . 0.0 110.944 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 75' ' ' ALA . . . 74.99 -149.84 40.06 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 74' ' ' GLY . . . 80.17 -77.95 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.503 -0.998 . . . . 0.0 109.989 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.516 ' OD1' ' CB ' ' A' ' 6' ' ' CYS . 41.8 m-20 -131.28 134.91 46.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.019 -1.05 . . . . 0.0 110.333 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.629 ' NH1' ' CE2' ' A' ' 38' ' ' TYR . 1.6 mtt180 -138.42 123.92 19.56 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.52 HG23 HG21 ' A' ' 89' ' ' VAL . 4.7 p -112.52 120.84 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.958 -1.089 . . . . 0.0 108.896 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.583 ' CG2' ' CD1' ' A' ' 90' ' ' ILE . 14.8 t -79.05 170.61 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 122.083 0.944 . . . . 0.0 110.266 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.583 ' CE1' ' O ' ' A' ' 57' ' ' TYR . 3.2 p90 -164.19 -171.36 2.38 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.463 ' OD1' ' HB3' ' A' ' 53' ' ' SER . 7.3 t30 -123.95 -81.41 0.64 Allowed 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.229 -0.989 . . . . 0.0 109.949 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.457 ' OE2' ' O ' ' A' ' 81' ' ' ASN . 66.7 mm-40 -159.24 18.08 0.18 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.288 -0.882 . . . . 0.0 109.645 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.465 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 3.8 m-20 -136.79 24.25 3.09 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.479 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 8.5 p30 48.02 23.32 0.48 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.586 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -67.68 -90.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.444 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.586 ' HB2' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 165.39 106.8 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.132 -0.98 . . . . 0.0 110.36 178.674 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.628 ' CB ' ' CE2' ' A' ' 56' ' ' TYR . . . -74.97 -42.09 58.29 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 162.74 154.13 7.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.663 HG22 ' CD2' ' A' ' 4' ' ' TYR . 40.2 t -93.3 105.33 16.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 120.843 -1.387 . . . . 0.0 110.164 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.583 ' CD1' ' CG2' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -99.43 172.64 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.214 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 75' ' ' ALA . 2.8 t -145.02 141.07 28.59 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.668 -1.27 . . . . 0.0 111.261 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.525 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -88.68 55.95 3.58 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.306 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.414 HG21 HG21 ' A' ' 91' ' ' THR . 5.8 t -168.4 23.09 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.157 -0.964 . . . . 0.0 110.309 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -125.81 23.99 5.83 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -177.89 117.93 0.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.407 -1.054 . . . . 0.0 109.506 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.459 ' O ' ' C ' ' A' ' 97' ' ' GLY . 2.5 m 46.06 -159.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.114 -0.991 . . . . 0.0 109.21 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 96' ' ' SER . . . -39.02 -50.64 2.68 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.525 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -152.12 -76.02 0.13 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.107 -1.231 . . . . 0.0 109.605 179.74 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.472 ' O ' ' O ' ' A' ' 98' ' ' ASN . 0.2 OUTLIER 60.91 146.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.135 -0.978 . . . . 0.0 108.772 -179.476 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.509 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -93.5 125.78 38.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.857 -1.152 . . . . 0.0 110.451 -179.51 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.519 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -145.22 137.68 21.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.512 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.454 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.0 OUTLIER -44.36 129.83 6.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.229 -0.919 . . . . 0.0 109.477 -179.598 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.442 ' SG ' ' HB ' ' A' ' 91' ' ' THR . 12.6 m -54.13 98.36 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.196 -0.94 . . . . 0.0 109.425 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 109.478 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 1' ' ' ALA . 25.6 p 174.29 156.64 0.14 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.346 -0.846 . . . . 0.0 109.776 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.72 -40.75 2.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.344 -0.847 . . . . 0.0 109.105 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.641 ' CE1' ' CG2' ' A' ' 89' ' ' VAL . 15.1 m-85 -82.24 127.17 32.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.348 -0.845 . . . . 0.0 109.656 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.46 ' O ' ' SG ' ' A' ' 103' ' ' CYS . 0.2 OUTLIER -133.44 129.6 37.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.375 -0.828 . . . . 0.0 109.194 179.727 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 98.3 m -139.38 16.56 2.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.118 -0.989 . . . . 0.0 110.079 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.14 42.9 0.07 OUTLIER Glycine 0 C--N 1.284 -2.348 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.09 12.34 4.93 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.281 -1.129 . . . . 0.0 109.29 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -84.22 -171.97 3.91 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.216 -0.928 . . . . 0.0 109.13 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.432 ' C ' ' CB ' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -131.47 67.09 1.53 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.248 -0.908 . . . . 0.0 109.047 -179.902 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 63' ' ' SER . 36.2 m-85 -79.3 120.32 23.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.0 108.802 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 0.4 OUTLIER -91.84 137.2 32.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.911 . . . . 0.0 110.407 -179.164 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.42 ' HA ' HG22 ' A' ' 16' ' ' VAL . 57.7 p -51.75 -21.9 3.14 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.9 t -84.45 -35.86 22.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.307 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.3 -23.5 60.29 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 12' ' ' SER . 2.7 t -74.58 -31.5 27.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -45.15 95.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -0.777 . . . . 0.0 109.034 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.1 m -60.09 -42.64 95.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.218 -0.926 . . . . 0.0 108.801 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.541 ' CB ' ' CD1' ' A' ' 61' ' ' ILE . . . -76.43 -13.28 60.12 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.475 ' NE2' ' O ' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -87.31 -21.99 25.4 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.1 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -85.59 -12.49 51.38 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.34 -56.04 4.32 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.349 -0.845 . . . . 0.0 109.261 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.53 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -66.56 -21.12 70.53 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.491 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 0.9 OUTLIER -81.38 -62.4 1.66 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.459 -1.024 . . . . 0.0 109.158 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 1.6 tt0 -44.3 -43.36 7.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.149 -0.97 . . . . 0.0 109.247 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.413 ' CD1' ' C ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -64.15 -43.84 93.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.252 -0.905 . . . . 0.0 109.12 179.726 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.621 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 28.3 t60 -68.07 -14.54 63.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.841 . . . . 0.0 110.102 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -95.65 -26.31 15.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.012 -1.055 . . . . 0.0 110.01 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 26.3 t0 -88.15 -10.48 49.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.161 -0.962 . . . . 0.0 109.73 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.09 0.78 66.46 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.413 ' C ' ' CD1' ' A' ' 26' ' ' LEU . 2.5 mm-40 -79.34 -169.29 1.82 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.159 -1.201 . . . . 0.0 109.281 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.527 ' CG2' ' CB ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -127.37 178.21 6.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.774 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.517 ' CG2' ' HD3' ' A' ' 39' ' ' PRO . 60.1 t -82.31 -98.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.401 -0.812 . . . . 0.0 110.277 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.528 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -122.01 57.64 0.61 Allowed Glycine 0 N--CA 1.488 2.114 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.186 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER 78.96 -10.63 1.32 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.51 -0.994 . . . . 0.0 110.512 179.416 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -112.1 -6.8 14.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.894 -1.129 . . . . 0.0 109.515 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.527 ' CB ' ' CG2' ' A' ' 32' ' ' THR . 8.0 t 58.13 -175.06 0.08 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.238 -0.914 . . . . 0.0 109.316 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.588 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER 168.27 -44.94 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 111.495 179.324 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 31.8 Cg_endo -75.58 100.65 1.39 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.409 1.406 . . . . 0.0 111.976 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.533 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -144.39 -178.28 5.9 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.584 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.548 ' HA ' ' CD2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -74.85 154.02 38.44 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -125.62 145.72 50.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.992 -1.067 . . . . 0.0 110.249 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.444 ' O ' ' C ' ' A' ' 44' ' ' ASN . 41.1 t-20 -117.49 66.02 0.74 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 43' ' ' ASN . 0.6 OUTLIER -40.0 147.72 0.09 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.501 -0.749 . . . . 0.0 110.146 -179.369 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.459 ' O ' ' C ' ' A' ' 46' ' ' GLU . 98.2 m-85 -118.57 -44.73 2.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.403 -0.811 . . . . 0.0 108.999 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -38.63 -47.93 1.39 Allowed 'General case' 0 C--N 1.309 -1.18 0 O-C-N 121.599 -0.688 . . . . 0.0 109.915 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.16 48.38 0.06 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.555 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 86.7 m-85 -96.17 90.82 5.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.244 -1.151 . . . . 0.0 108.964 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.59 82.51 1.77 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.925 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' A' ' 48' ' ' PHE . 4.8 m-85 -78.33 -169.22 1.57 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.369 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.1 m -109.6 17.12 21.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.305 -0.872 . . . . 0.0 109.419 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 64.1 t -77.06 -60.13 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.356 -0.84 . . . . 0.0 109.48 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.414 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -172.11 161.77 5.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.105 -0.997 . . . . 0.0 109.715 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.575 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -72.18 -51.99 7.6 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.477 -0.764 . . . . 0.0 110.227 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 54' ' ' SER . 36.4 Cg_endo -76.24 87.0 1.47 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 121.939 1.759 . . . . 0.0 109.858 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.563 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 38.1 m-85 -79.04 -174.44 4.07 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.698 -0.627 . . . . 0.0 109.67 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.621 ' CE2' ' NE2' ' A' ' 27' ' ' HIS . 83.2 m-85 -154.93 134.63 12.77 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.429 ' HB2' ' HE ' ' A' ' 77' ' ' ARG . 3.9 pt-20 -96.75 144.3 26.88 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 122.053 0.93 . . . . 0.0 111.845 -177.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.647 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 32.2 t-105 -161.19 136.04 5.46 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.647 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.4 Cg_endo -69.57 147.2 63.59 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 121.864 1.709 . . . . 0.0 111.479 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.541 ' CD1' ' CB ' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -119.02 137.4 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.779 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.604 HD21 ' CD1' ' A' ' 68' ' ' TYR . 0.8 OUTLIER -120.27 172.79 7.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.128 -0.983 . . . . 0.0 109.701 -179.301 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . 5.4 p -119.45 29.64 7.51 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.187 -0.946 . . . . 0.0 108.768 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.96 -148.99 0.39 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.48 -0.762 . . . . 0.0 109.541 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -121.75 72.14 0.38 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -170.99 155.42 4.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -1.12 . . . . 0.0 109.769 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.474 HG13 ' HZ2' ' A' ' 59' ' ' TRP . 23.6 t -93.81 154.91 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.852 . . . . 0.0 109.291 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.604 ' CD1' HD21 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -72.79 84.46 1.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.95 -1.094 . . . . 0.0 110.025 -179.506 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.5 t -81.0 -5.4 57.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.306 -0.871 . . . . 0.0 109.125 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -174.82 -144.14 4.78 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.17 -157.15 31.62 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.455 ' OG ' ' HD2' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -127.25 156.52 74.6 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.199 -1.177 . . . . 0.0 109.502 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.455 ' HD2' ' OG ' ' A' ' 72' ' ' SER . 35.5 Cg_endo -77.88 -175.15 2.55 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.643 2.229 . . . . 0.0 110.379 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.422 ' O ' ' HB1' ' A' ' 75' ' ' ALA . . . 88.01 -167.1 35.95 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.462 ' N ' ' HB2' ' A' ' 92' ' ' HIS . . . 66.33 -83.94 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.706 -0.879 . . . . 0.0 109.987 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -137.12 157.28 47.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.044 -1.035 . . . . 0.0 109.753 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.482 ' O ' HG12 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -170.35 114.75 0.48 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.246 -0.909 . . . . 0.0 109.338 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 88' ' ' GLY . 14.1 p -90.77 134.09 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.07 -1.019 . . . . 0.0 109.173 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.572 ' CG1' ' N ' ' A' ' 80' ' ' PHE . 20.1 t -98.88 165.32 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 122.174 0.988 . . . . 0.0 110.313 -179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.572 ' N ' ' CG1' ' A' ' 79' ' ' VAL . 20.1 p90 -163.16 -168.46 1.74 Allowed 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -178.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.52 ' O ' ' CB ' ' A' ' 82' ' ' GLU . 3.7 p30 -128.73 -44.38 1.34 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.791 -1.193 . . . . 0.0 110.387 -179.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 0.2 OUTLIER 163.1 -25.89 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.379 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.468 ' HB3' ' HG2' ' A' ' 85' ' ' GLN . 1.2 t-20 -90.9 0.5 57.48 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.454 ' HB3' ' O ' ' A' ' 83' ' ' ASN . 37.6 t30 64.84 28.32 12.81 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.541 -0.724 . . . . 0.0 109.56 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.557 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -70.06 -27.56 64.74 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.557 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.3 OUTLIER 88.06 114.18 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.603 0.716 . . . . 0.0 110.197 179.42 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.51 ' HB1' ' CE1' ' A' ' 56' ' ' TYR . . . -87.38 -44.87 11.05 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.566 ' O ' HG23 ' A' ' 78' ' ' VAL . . . 166.1 -158.99 32.14 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.641 ' CG2' ' CE1' ' A' ' 4' ' ' TYR . 23.5 t -140.44 99.39 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.088 -1.243 . . . . 0.0 110.076 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.553 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -80.94 145.27 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.177 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.519 HG21 HG23 ' A' ' 101' ' ' VAL . 9.7 t -130.53 132.05 45.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.867 -1.146 . . . . 0.0 110.884 -179.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.578 ' ND1' ' O ' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -91.76 79.24 5.38 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.646 -0.658 . . . . 0.0 109.534 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 3.0 m -175.07 118.23 0.18 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.183 -0.948 . . . . 0.0 109.603 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 113.86 2.89 23.69 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.411 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -144.87 146.53 32.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.135 -1.215 . . . . 0.0 109.731 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 95' ' ' ALA . 34.5 m -44.5 143.02 1.42 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.346 -0.846 . . . . 0.0 109.055 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.461 ' O ' ' C ' ' A' ' 98' ' ' ASN . . . 50.54 38.6 35.62 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.578 ' O ' ' ND1' ' A' ' 92' ' ' HIS . 0.2 OUTLIER 36.02 44.18 0.24 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.947 -0.737 . . . . 0.0 110.041 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -47.52 132.8 13.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.983 -1.073 . . . . 0.0 109.167 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.553 ' CD1' ' HB ' ' A' ' 90' ' ' ILE . 19.3 m-85 -60.03 134.57 57.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.034 -1.041 . . . . 0.0 109.924 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.519 HG23 HG21 ' A' ' 91' ' ' THR . 0.0 OUTLIER -137.61 130.84 42.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.865 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.477 ' CG ' ' O ' ' A' ' 102' ' ' GLU . 1.5 pt-20 -55.15 111.22 0.81 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.281 -0.887 . . . . 0.0 109.268 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 5' ' ' THR . 0.5 OUTLIER -55.33 146.38 19.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.342 -0.849 . . . . 0.0 109.917 -179.484 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 74.6 p . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.36 -0.838 . . . . 0.0 109.489 -179.993 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.439 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.258 0.551 . . . . 0.0 109.618 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.4 p 168.75 145.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.259 -0.901 . . . . 0.0 110.183 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -120.2 -27.67 5.23 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.542 -0.724 . . . . 0.0 109.086 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.581 ' CE1' ' CG2' ' A' ' 89' ' ' VAL . 19.4 m-85 -88.61 112.16 22.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 109.312 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 9' ' ' ASN . 80.1 m -140.32 120.2 13.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.341 -0.849 . . . . 0.0 109.337 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 69.3 m -118.05 16.71 14.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 122.171 0.986 . . . . 0.0 109.682 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 169.09 60.88 0.03 OUTLIER Glycine 0 C--N 1.282 -2.421 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.07 15.72 7.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.322 -1.105 . . . . 0.0 109.147 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.412 ' O ' ' OG1' ' A' ' 5' ' ' THR . 12.0 m-80 -81.19 131.74 35.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.415 -0.803 . . . . 0.0 109.723 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.3 t -97.83 58.89 1.42 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.836 . . . . 0.0 109.007 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.504 ' CE1' ' HB2' ' A' ' 63' ' ' SER . 7.5 m-30 -79.92 127.73 32.6 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.525 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -85.03 138.76 32.24 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.183 -0.948 . . . . 0.0 110.188 -179.223 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.46 -18.76 7.68 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.1 t -89.4 -31.24 17.84 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.521 -0.737 . . . . 0.0 109.153 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.31 -34.83 68.39 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 20' ' ' GLN . 2.6 t -57.56 -35.18 49.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.04 -40.95 77.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.558 -0.714 . . . . 0.0 109.258 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.17 -55.98 13.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.332 -0.855 . . . . 0.0 109.137 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.41 -4.15 24.76 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.485 -0.759 . . . . 0.0 109.264 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.627 ' NE2' ' CD1' ' A' ' 80' ' ' PHE . 5.6 tp60 -101.57 -8.49 21.83 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.64 -9.14 19.41 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.333 -0.854 . . . . 0.0 109.248 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.6 -36.97 28.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 109.133 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 27' ' ' HIS . . . -72.03 -9.66 71.82 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.511 ' CE1' ' O ' ' A' ' 82' ' ' GLU . 18.4 t80 -101.36 -49.59 4.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.442 -1.034 . . . . 0.0 109.347 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -52.18 -38.58 58.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.876 . . . . 0.0 109.339 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.469 ' CD1' ' C ' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -79.89 -45.11 19.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.473 -0.767 . . . . 0.0 109.138 179.754 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.575 ' ND1' ' N ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -45.41 -39.06 6.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.584 -0.697 . . . . 0.0 110.326 -179.713 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.575 ' N ' ' ND1' ' A' ' 27' ' ' HIS . 3.4 tp10 -94.29 -40.28 10.06 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.257 -0.902 . . . . 0.0 109.128 -178.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 28' ' ' GLU . 19.9 t0 -47.81 -23.76 0.82 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.434 ' N ' ' C ' ' A' ' 28' ' ' GLU . . . 80.5 14.16 80.49 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.469 ' C ' ' CD1' ' A' ' 26' ' ' LEU . 0.9 OUTLIER -103.17 -170.11 1.74 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.232 -1.158 . . . . 0.0 109.176 179.789 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.545 HG21 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -137.41 174.41 10.63 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.204 -0.935 . . . . 0.0 109.648 -179.868 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.468 ' O ' ' C ' ' A' ' 34' ' ' GLY . 14.1 m -81.13 -162.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.876 . . . . 0.0 109.252 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -34.92 -57.6 0.79 Allowed Glycine 0 N--CA 1.498 2.779 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.73 30.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.321 -1.105 . . . . 0.0 109.724 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 37' ' ' SER . 1.2 m120 -134.16 6.45 3.61 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.214 -0.929 . . . . 0.0 109.356 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.545 ' HA ' HG21 ' A' ' 32' ' ' THR . 0.2 OUTLIER 47.39 -173.64 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.234 -0.916 . . . . 0.0 109.357 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.593 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER 164.45 -44.15 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.641 -0.662 . . . . 0.0 111.415 179.522 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 30.7 Cg_endo -73.83 99.62 1.18 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 121.295 1.33 . . . . 0.0 112.294 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.57 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -141.36 179.36 6.83 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.078 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.448 ' HA ' ' CD1' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -69.36 149.67 48.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.971 -1.081 . . . . 0.0 109.797 -179.336 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 1.5 t80 -115.3 146.57 41.38 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -156.94 91.3 1.19 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.997 -1.065 . . . . 0.0 109.711 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 2.2 t-20 -113.88 -51.56 2.78 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.351 -0.843 . . . . 0.0 109.599 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.453 ' O ' ' C ' ' A' ' 46' ' ' GLU . 40.7 m-85 50.44 22.65 1.07 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.133 -0.98 . . . . 0.0 109.055 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 48' ' ' PHE . 1.1 tm-20 -38.7 -61.31 0.73 Allowed 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.64 -0.662 . . . . 0.0 109.992 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.42 ' C ' ' CD1' ' A' ' 48' ' ' PHE . . . -177.09 45.18 0.1 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.486 ' CZ ' ' HB3' ' A' ' 46' ' ' GLU . 0.7 OUTLIER -124.89 168.05 13.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -1.134 . . . . 0.0 109.479 -179.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 50' ' ' PHE . 11.1 t70 -124.42 68.7 1.08 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.345 -0.847 . . . . 0.0 109.156 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.541 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 17.4 m-85 -52.52 -171.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.445 -0.785 . . . . 0.0 109.859 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 99.6 p -158.12 37.29 0.25 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.387 -0.821 . . . . 0.0 109.323 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 86' ' ' LEU . 97.4 t -108.97 -73.79 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.227 -0.92 . . . . 0.0 109.738 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.2 177.74 8.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.173 -0.955 . . . . 0.0 110.211 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.588 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -78.99 -50.92 1.36 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.658 -0.651 . . . . 0.0 111.13 -179.88 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 54' ' ' SER . 32.4 Cg_endo -72.56 93.57 0.76 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.861 1.707 . . . . 0.0 109.881 -177.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.59 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 4.5 m-85 -87.06 -176.82 5.86 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.509 0.671 . . . . 0.0 110.009 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.59 ' CG ' ' O ' ' A' ' 56' ' ' TYR . 81.7 m-85 -160.65 118.58 2.49 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 42' ' ' TYR . 0.7 OUTLIER -83.77 142.05 30.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.142 -0.974 . . . . 0.0 111.125 -178.554 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.638 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 26.0 t-105 -161.16 139.31 7.14 Favored Pre-proline 0 N--CA 1.494 1.746 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.638 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.8 Cg_endo -68.35 144.61 62.64 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.003 1.802 . . . . 0.0 111.362 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.588 HD11 ' N ' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -109.59 136.66 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.645 -0.659 . . . . 0.0 109.326 -179.501 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.588 ' N ' HD11 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -125.89 -177.7 4.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.297 -0.877 . . . . 0.0 109.417 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.504 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -117.57 -14.09 10.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.075 -1.016 . . . . 0.0 108.815 179.676 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.32 -58.53 3.23 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.584 -0.698 . . . . 0.0 109.189 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 114.21 10.59 13.39 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -89.51 13.81 12.95 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.212 -1.169 . . . . 0.0 109.488 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 66' ' ' ASP . 99.6 t 61.77 131.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.274 -0.891 . . . . 0.0 109.527 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.502 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 34.6 t80 -46.81 107.32 0.1 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.235 -0.916 . . . . 0.0 109.469 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.3 16.07 6.09 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.175 -0.953 . . . . 0.0 109.468 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.6 65.18 0.02 OUTLIER Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.09 147.53 19.21 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.85 124.57 8.06 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.266 -1.138 . . . . 0.0 109.326 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.02 150.56 26.59 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.452 2.101 . . . . 0.0 110.732 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 75' ' ' ALA . . . 106.2 -175.03 21.0 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 74' ' ' GLY . . . 79.84 -70.54 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.431 -1.04 . . . . 0.0 110.546 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -134.95 152.22 51.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.741 -1.225 . . . . 0.0 110.107 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.545 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 7.4 mtt180 -163.47 105.68 0.98 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.42 -0.8 . . . . 0.0 108.981 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.545 HG21 ' OE1' ' A' ' 20' ' ' GLN . 8.1 p -89.45 144.59 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.986 -1.071 . . . . 0.0 109.479 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.563 ' CG1' ' N ' ' A' ' 80' ' ' PHE . 35.5 t -112.52 166.08 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.35 -0.844 . . . . 0.0 109.771 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.628 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 1.5 p90 -151.71 -178.2 6.57 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.517 ' ND2' ' HG2' ' A' ' 82' ' ' GLU . 16.9 p-10 -109.79 -47.16 3.39 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.019 -1.05 . . . . 0.0 109.857 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.517 ' HG2' ' ND2' ' A' ' 81' ' ' ASN . 0.6 OUTLIER 167.15 -25.07 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.442 ' HB3' ' HG2' ' A' ' 85' ' ' GLN . 1.1 t30 -92.49 8.86 36.88 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.47 -0.769 . . . . 0.0 108.967 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' A' ' 83' ' ' ASN . 25.8 t-20 63.33 13.42 7.01 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.42 -0.8 . . . . 0.0 110.137 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.522 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 3.7 mt-30 -57.13 -82.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.852 -1.155 . . . . 0.0 107.968 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER 165.28 108.87 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.398 -0.814 . . . . 0.0 110.684 178.466 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.541 ' O ' ' CD1' ' A' ' 50' ' ' PHE . . . -74.97 -44.09 50.27 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 146.55 149.18 4.92 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.689 -1.765 . . . . 0.0 108.689 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.581 ' CG2' ' CE1' ' A' ' 4' ' ' TYR . 38.9 t -88.64 131.44 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.161 -1.199 . . . . 0.0 109.744 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.545 ' CG1' ' O ' ' A' ' 77' ' ' ARG . 0.2 OUTLIER -123.85 178.01 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.54 HG21 HG21 ' A' ' 93' ' ' THR . 2.7 t -138.48 145.85 41.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.813 -1.179 . . . . 0.0 111.195 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.582 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.1 OUTLIER -93.25 76.94 4.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.621 -0.674 . . . . 0.0 109.557 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.54 HG21 HG21 ' A' ' 91' ' ' THR . 7.1 t 176.52 -27.25 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.411 -0.806 . . . . 0.0 110.434 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.488 ' HA3' HG22 ' A' ' 101' ' ' VAL . . . -65.14 -7.01 29.19 Favored Glycine 0 N--CA 1.493 2.434 0 O-C-N 121.125 -0.984 . . . . 0.0 110.673 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.481 ' CB ' ' HB2' ' A' ' 99' ' ' ASN . . . -133.71 164.86 26.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.884 -1.362 . . . . 0.0 110.056 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 95' ' ' ALA . 11.1 p -41.7 120.95 1.61 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.58 -0.7 . . . . 0.0 109.26 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.8 -78.0 2.05 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.846 -1.701 . . . . 0.0 108.846 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.582 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -160.52 -68.07 0.07 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.268 -1.137 . . . . 0.0 109.551 179.751 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.481 ' HB2' ' CB ' ' A' ' 95' ' ' ALA . 0.3 OUTLIER 57.05 -173.36 0.08 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.135 -0.978 . . . . 0.0 109.142 -179.711 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.642 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -132.87 113.81 13.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.021 -1.049 . . . . 0.0 110.103 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.514 HG23 HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -123.64 136.74 59.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.334 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.443 ' OE2' ' HB3' ' A' ' 48' ' ' PHE . 2.2 mt-10 -56.11 120.47 7.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.286 -0.884 . . . . 0.0 109.728 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.2 176.33 0.34 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.898 . . . . 0.0 109.462 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 19.0 p . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.972 -1.014 . . . . 0.0 109.588 -179.901 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.465 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.8 p 167.17 115.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.924 . . . . 0.0 109.8 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 14.9 t70 -108.72 4.71 24.06 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.398 -0.814 . . . . 0.0 109.363 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.542 ' CD1' ' HB ' ' A' ' 89' ' ' VAL . 5.4 m-85 -104.99 71.35 0.95 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.548 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -86.84 124.44 33.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.179 -0.95 . . . . 0.0 109.388 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 92.5 m -122.24 16.66 10.67 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 122.096 0.951 . . . . 0.0 109.684 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 152.73 -62.09 0.39 Allowed Glycine 0 C--N 1.283 -2.383 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.6 m -166.98 36.03 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.347 -1.09 . . . . 0.0 109.065 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.461 ' O ' ' C ' ' A' ' 10' ' ' CYS . 2.0 m-80 -111.44 -27.74 8.49 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.356 -0.84 . . . . 0.0 109.803 -179.565 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.461 ' C ' ' O ' ' A' ' 9' ' ' ASN . 1.1 t 40.4 76.44 0.07 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.365 -0.834 . . . . 0.0 109.311 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.424 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 2.8 m-85 -79.57 150.34 31.11 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.417 -0.802 . . . . 0.0 109.297 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.561 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -80.47 132.1 35.66 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.432 -0.793 . . . . 0.0 109.62 -179.874 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.2 p -63.33 -13.96 44.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.127 -0.983 . . . . 0.0 109.04 179.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.81 -27.05 13.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.31 -0.869 . . . . 0.0 109.028 179.695 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 12' ' ' SER . 17.8 t0 -74.91 -34.2 62.11 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.278 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.561 HG21 ' O ' ' A' ' 12' ' ' SER . 2.8 t -56.47 -36.67 48.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.13 -41.11 87.46 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.37 -45.66 92.15 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.157 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.596 ' CB ' HD11 ' A' ' 61' ' ' ILE . . . -75.97 -8.29 56.6 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.075 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.59 ' OE1' ' CG ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -90.58 -25.96 19.92 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.383 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.96 -13.13 59.17 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.31 -57.0 3.56 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.543 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -62.11 -25.69 66.62 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 178.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.583 ' CE1' ' O ' ' A' ' 82' ' ' GLU . 10.2 t80 -75.72 -59.87 2.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.477 -1.013 . . . . 0.0 109.451 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.404 ' O ' ' C ' ' A' ' 26' ' ' LEU . 1.8 tp60 -55.14 -61.51 2.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.859 . . . . 0.0 109.262 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.572 HD13 ' HB3' ' A' ' 31' ' ' GLU . 2.6 mm? -44.83 -37.3 3.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.392 -0.818 . . . . 0.0 109.57 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -66.14 -54.79 21.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.439 -0.788 . . . . 0.0 111.182 -179.145 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -86.8 13.02 9.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.216 -0.928 . . . . 0.0 110.249 -178.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -108.35 -2.81 18.86 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.079 -1.013 . . . . 0.0 109.581 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.71 -8.76 76.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.572 ' HB3' HD13 ' A' ' 26' ' ' LEU . 2.4 tp10 -97.7 -152.19 0.39 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.231 -1.158 . . . . 0.0 109.474 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.462 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -177.27 -93.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.165 -0.96 . . . . 0.0 109.411 179.976 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.502 ' CG1' ' O ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -156.5 -168.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.147 -0.971 . . . . 0.0 109.476 179.835 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 35' ' ' SER . . . -63.67 87.14 0.06 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.535 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.455 ' C ' ' O ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER 40.2 43.27 1.35 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.486 -1.008 . . . . 0.0 109.788 179.772 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.417 ' O ' ' C ' ' A' ' 37' ' ' SER . 2.2 m120 -122.63 -25.25 4.74 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.103 -0.998 . . . . 0.0 109.726 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 36' ' ' ASN . 0.9 OUTLIER 45.27 76.82 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.16 -0.962 . . . . 0.0 109.211 -179.762 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.717 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -98.93 -23.37 0.22 Allowed Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -179.068 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.717 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 37.5 Cg_endo -80.28 100.87 1.29 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 C-N-CA 121.476 1.451 . . . . 0.0 113.577 -178.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.604 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -127.53 -176.51 3.77 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.12 -0.987 . . . . 0.0 108.722 176.897 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.1 OUTLIER -100.18 144.36 29.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.097 -1.002 . . . . 0.0 109.455 179.94 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.541 ' CE2' ' HA ' ' A' ' 44' ' ' ASN . 4.4 t80 -110.52 135.94 50.42 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.201 -0.937 . . . . 0.0 109.535 -179.655 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.553 ' OD1' ' CD2' ' A' ' 45' ' ' TYR . 2.7 p30 -92.16 3.67 54.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.899 . . . . 0.0 109.893 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.541 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 7.1 p-10 42.22 104.79 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.651 0.738 . . . . 0.0 111.2 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.553 ' CD2' ' OD1' ' A' ' 43' ' ' ASN . 0.9 OUTLIER -131.88 -33.23 1.39 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.071 -1.018 . . . . 0.0 109.823 179.206 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.485 ' OE1' ' CZ ' ' A' ' 48' ' ' PHE . 0.1 OUTLIER -38.17 -53.2 1.44 Allowed 'General case' 0 C--N 1.309 -1.176 0 O-C-N 121.481 -0.762 . . . . 0.0 110.159 -179.556 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.87 48.53 0.04 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.485 ' CZ ' ' OE1' ' A' ' 46' ' ' GLU . 24.8 m-85 -104.61 144.83 31.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -1.141 . . . . 0.0 109.337 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 50' ' ' PHE . 1.1 m-20 -119.07 49.58 1.31 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.292 -0.88 . . . . 0.0 109.433 179.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.462 ' O ' ' O ' ' A' ' 49' ' ' ASP . 21.7 m-85 -50.36 -178.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.385 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.1 p -133.93 18.26 3.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -0.859 . . . . 0.0 109.003 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 66.6 t -85.74 -82.0 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.372 -0.83 . . . . 0.0 109.532 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.31 177.98 10.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.004 -1.06 . . . . 0.0 110.147 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.555 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -79.5 -52.54 1.12 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.473 -0.767 . . . . 0.0 110.884 -179.889 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 54' ' ' SER . 33.1 Cg_endo -73.07 95.11 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.016 1.81 . . . . 0.0 109.844 -177.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.461 ' CE1' ' CB ' ' A' ' 87' ' ' ALA . 5.7 m-85 -95.94 -179.28 4.64 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.63 0.728 . . . . 0.0 110.276 -178.913 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.577 ' CD2' ' O ' ' A' ' 81' ' ' ASN . 96.5 m-85 -152.73 131.61 12.49 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.392 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.464 ' CG ' ' CD2' ' A' ' 40' ' ' HIS . 0.5 OUTLIER -91.91 142.19 27.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 110.815 -178.837 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.63 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 24.1 t-105 -160.26 137.74 6.99 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.63 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.6 Cg_endo -69.78 149.52 66.89 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.175 1.917 . . . . 0.0 111.423 -179.042 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.596 HD11 ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -120.5 129.13 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.607 -0.683 . . . . 0.0 109.349 -179.672 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.503 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -118.84 172.29 7.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.287 179.514 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.81 27.79 6.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.117 -0.99 . . . . 0.0 108.847 179.688 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.91 -12.46 17.5 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.564 -0.71 . . . . 0.0 109.318 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.66 -10.22 68.72 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 2.9 m-20 -97.55 172.95 7.41 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.216 -1.167 . . . . 0.0 110.022 -179.542 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.453 HG11 ' CZ2' ' A' ' 59' ' ' TRP . 93.7 t -90.09 150.08 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.525 ' C ' ' CD1' ' A' ' 68' ' ' TYR . 13.6 t80 -47.31 118.75 2.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.955 -1.091 . . . . 0.0 109.69 -179.479 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.455 ' O ' ' OG ' ' A' ' 69' ' ' SER . 1.7 t -135.38 13.88 3.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.489 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 132.57 140.59 4.48 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 137.86 -128.24 4.18 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.8 p -69.55 120.98 80.77 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.225 -1.162 . . . . 0.0 109.334 179.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.69 -57.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.279 1.986 . . . . 0.0 110.443 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.48 ' HA2' ' NE ' ' A' ' 77' ' ' ARG . . . -97.34 -113.02 3.05 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 91' ' ' THR . . . 60.23 -85.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.352 -1.087 . . . . 0.0 110.561 179.521 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.406 ' C ' ' HD2' ' A' ' 77' ' ' ARG . 36.6 m-20 -122.95 131.5 53.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.848 -1.158 . . . . 0.0 110.39 -179.173 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.48 ' NE ' ' HA2' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -151.88 106.66 3.24 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.331 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 89' ' ' VAL . 7.3 p -78.81 137.98 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 110.454 -178.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.572 HG11 ' N ' ' A' ' 80' ' ' PHE . 39.8 t -97.55 166.67 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.01 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.59 ' CG ' ' OE1' ' A' ' 20' ' ' GLN . 5.7 p90 -163.46 -174.33 3.7 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 118.822 -1.151 . . . . 0.0 110.281 -178.002 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.577 ' O ' ' CD2' ' A' ' 57' ' ' TYR . 3.2 t-20 -109.11 -80.13 0.58 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.28 -0.888 . . . . 0.0 109.766 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.583 ' O ' ' CE1' ' A' ' 24' ' ' TYR . 10.8 pt-20 -161.9 23.36 0.11 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 109.448 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.453 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 4.0 t-20 -151.7 51.38 0.81 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.552 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.453 ' CG ' ' O ' ' A' ' 83' ' ' ASN . 16.6 p30 44.86 26.95 0.23 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.446 ' OE1' ' HB3' ' A' ' 81' ' ' ASN . 14.0 mt-30 -64.4 -163.18 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.206 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.444 ' C ' ' CD1' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -144.48 104.37 4.06 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.787 -1.196 . . . . 0.0 110.573 179.913 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.462 ' O ' ' CG ' ' A' ' 50' ' ' PHE . . . -81.68 -36.85 28.28 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 150.91 138.34 2.82 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.542 ' HB ' ' CD1' ' A' ' 4' ' ' TYR . 36.9 t -83.04 100.0 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.181 -1.188 . . . . 0.0 109.67 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.502 ' HB ' ' HB3' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -87.01 159.83 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.4 -0.813 . . . . 0.0 108.845 179.481 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 75' ' ' ALA . 15.1 t -122.16 159.79 26.47 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.941 -1.099 . . . . 0.0 110.886 -178.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.577 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 0.1 OUTLIER -115.5 71.9 0.78 Allowed 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.434 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.445 ' OG1' ' C ' ' A' ' 92' ' ' HIS . 0.2 OUTLIER -176.61 133.13 0.21 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.416 -0.802 . . . . 0.0 109.294 -179.812 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 94.98 -6.97 69.74 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -120.54 147.29 45.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.157 -1.202 . . . . 0.0 109.727 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 95' ' ' ALA . 49.2 m -44.03 118.09 1.38 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.28 -0.887 . . . . 0.0 108.901 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.486 ' O ' ' C ' ' A' ' 98' ' ' ASN . . . 64.36 43.7 96.47 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.219 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.577 ' O ' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 32.92 40.75 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.987 -0.714 . . . . 0.0 110.446 179.711 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 97' ' ' GLY . 3.0 t-20 -54.69 167.55 0.35 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.141 -0.975 . . . . 0.0 109.279 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.502 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -74.83 150.38 39.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.132 -0.98 . . . . 0.0 109.344 179.993 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -161.02 122.54 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.417 -0.802 . . . . 0.0 109.086 179.687 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 101' ' ' VAL . 3.6 pt-20 -41.8 131.48 3.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.387 -0.821 . . . . 0.0 109.861 -179.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.421 ' SG ' ' HB ' ' A' ' 91' ' ' THR . 0.7 OUTLIER -92.81 121.41 34.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.37 -0.831 . . . . 0.0 109.253 -179.981 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.8 p . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.623 -1.18 . . . . 0.0 109.445 179.955 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.495 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.6 p 166.49 138.06 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.169 -0.957 . . . . 0.0 110.141 179.705 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -115.4 -20.05 10.44 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.381 -0.824 . . . . 0.0 109.069 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.576 ' CG ' HG21 ' A' ' 89' ' ' VAL . 13.7 m-85 -95.65 109.71 21.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.313 -0.867 . . . . 0.0 109.371 179.839 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 9' ' ' ASN . 1.2 p -144.25 143.79 31.2 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.966 . . . . 0.0 109.642 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.61 8.16 4.92 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.148 0.975 . . . . 0.0 109.904 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.28 55.2 0.2 Allowed Glycine 0 C--N 1.278 -2.69 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m 55.15 19.06 2.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.45 -1.029 . . . . 0.0 109.134 -179.524 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.402 ' O ' HG23 ' A' ' 5' ' ' THR . 0.6 OUTLIER -75.07 -156.88 0.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.434 -0.791 . . . . 0.0 109.091 179.929 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.4 t -155.49 58.14 0.63 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.117 -0.99 . . . . 0.0 109.766 -180.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 63' ' ' SER . 3.3 m-85 -84.51 115.3 22.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.341 -0.849 . . . . 0.0 108.925 179.527 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.554 ' O ' HG21 ' A' ' 16' ' ' VAL . 30.2 t -81.71 136.17 35.48 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.252 -0.905 . . . . 0.0 110.222 -179.259 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.1 p -49.05 -31.41 7.7 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.497 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.2 t -70.64 -40.99 72.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.532 -0.73 . . . . 0.0 109.278 179.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -66.42 -30.25 70.57 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.172 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.554 HG21 ' O ' ' A' ' 12' ' ' SER . 3.2 t -68.35 -32.9 57.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 119.519 -0.872 . . . . 0.0 108.823 179.315 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.8 -46.68 77.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.481 -0.762 . . . . 0.0 109.584 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.63 -55.66 28.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.2 -0.937 . . . . 0.0 109.251 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.566 ' CB ' ' CD1' ' A' ' 61' ' ' ILE . . . -72.05 -3.51 23.4 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.388 -0.82 . . . . 0.0 109.37 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.627 ' NE2' ' CD1' ' A' ' 80' ' ' PHE . 6.3 tp60 -100.96 -15.96 17.33 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 179.333 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.452 ' HA ' ' OD1' ' A' ' 84' ' ' ASN . . . -93.12 -15.1 26.4 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.0 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.05 -47.67 23.82 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.402 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -60.89 -24.91 63.23 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 179.351 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.435 ' CD2' ' OD1' ' A' ' 84' ' ' ASN . 19.9 t80 -83.21 -36.05 24.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.521 -0.987 . . . . 0.0 109.26 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -49.89 72.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.304 -0.872 . . . . 0.0 108.838 179.492 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.61 -40.57 95.28 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.313 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.51 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 2.2 t60 -62.52 -20.9 65.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.389 -0.819 . . . . 0.0 109.42 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.79 -30.85 16.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.948 . . . . 0.0 109.806 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.77 9.91 33.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.127 -0.983 . . . . 0.0 109.46 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 46.8 24.12 1.75 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.1 -137.59 0.09 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.211 -1.17 . . . . 0.0 109.016 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.531 HG21 ' HG ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -173.59 170.34 4.1 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.899 -1.126 . . . . 0.0 109.45 -179.938 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.417 ' HB ' ' HA ' ' A' ' 69' ' ' SER . 33.2 m -83.26 -138.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.316 -0.865 . . . . 0.0 109.276 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -46.88 -49.35 17.43 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.75 -32.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.487 -1.007 . . . . 0.0 109.188 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -69.47 -8.82 50.21 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.386 -0.821 . . . . 0.0 109.79 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.531 ' HG ' HG21 ' A' ' 32' ' ' THR . 0.8 OUTLIER 67.66 -172.69 0.19 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.096 -1.002 . . . . 0.0 108.908 -179.64 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.561 ' CD1' ' HD3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER 167.53 -45.05 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.186 -0.946 . . . . 0.0 112.435 179.114 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 32.3 Cg_endo -74.71 100.37 1.33 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 121.416 1.41 . . . . 0.0 112.538 -178.512 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.549 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -142.53 -174.04 4.03 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.674 -0.641 . . . . 0.0 109.535 178.463 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.606 ' HB2' ' CE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -94.66 124.16 38.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.346 -0.846 . . . . 0.0 109.903 -179.398 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.47 ' CE1' ' CZ ' ' A' ' 100' ' ' PHE . 10.5 t80 -105.8 143.59 33.74 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.118 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.577 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 74.0 m-20 -78.47 -106.61 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.905 -1.122 . . . . 0.0 109.287 -179.674 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.577 ' CB ' ' O ' ' A' ' 43' ' ' ASN . 5.9 p30 154.42 95.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.478 -0.764 . . . . 0.0 109.188 179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 1.4 p90 -124.6 -28.15 3.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -0.981 . . . . 0.0 109.632 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 45' ' ' TYR . 1.9 tm-20 -40.62 -65.7 0.39 Allowed 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.383 -0.823 . . . . 0.0 109.909 -179.647 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.92 59.75 0.01 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.413 ' CE1' ' HA ' ' A' ' 101' ' ' VAL . 84.8 m-85 -98.63 154.76 17.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.31 -1.112 . . . . 0.0 109.3 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.58 45.16 2.51 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.266 -0.897 . . . . 0.0 109.273 179.589 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.538 ' CG ' ' O ' ' A' ' 87' ' ' ALA . 14.4 m-85 -61.37 -167.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 109.869 -179.716 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.07 27.75 0.85 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.523 -0.736 . . . . 0.0 109.213 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.578 ' CG1' ' ND2' ' A' ' 81' ' ' ASN . 93.7 t -101.05 -80.08 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.191 -0.943 . . . . 0.0 109.741 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.412 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 86.6 p -158.39 178.01 10.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.169 -0.957 . . . . 0.0 110.189 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.601 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -83.3 -46.94 0.81 Allowed Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.592 -0.692 . . . . 0.0 111.536 -179.558 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 54' ' ' SER . 32.0 Cg_endo -73.03 83.93 1.37 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.899 1.733 . . . . 0.0 110.409 -178.004 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.583 ' CE1' ' CB ' ' A' ' 87' ' ' ALA . 10.1 m-85 -86.23 -175.22 5.42 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.826 0.822 . . . . 0.0 110.769 -179.156 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.606 ' CE2' ' HB2' ' A' ' 41' ' ' LYS . 47.8 m-85 -151.96 126.09 9.22 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -88.1 138.42 31.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.921 -1.112 . . . . 0.0 110.627 -178.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.615 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 21.1 t-105 -160.62 138.55 7.18 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 179.407 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.615 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.6 Cg_endo -69.54 154.47 68.56 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.33 2.02 . . . . 0.0 111.496 -178.817 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.566 ' CD1' ' CB ' ' A' ' 19' ' ' ALA . 0.2 OUTLIER -129.12 129.07 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.594 -0.691 . . . . 0.0 109.823 -179.17 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.496 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -123.15 167.65 13.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.243 -0.911 . . . . 0.0 108.776 179.191 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . 84.1 p -127.92 65.97 1.36 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.101 -0.999 . . . . 0.0 109.355 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.23 25.34 0.11 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.391 -0.818 . . . . 0.0 109.57 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 51.1 45.26 51.58 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -121.89 -27.73 4.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.316 -1.108 . . . . 0.0 109.669 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 t 62.37 174.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.14 -0.975 . . . . 0.0 109.153 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.531 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 29.0 t80 -96.4 106.0 18.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.078 -1.014 . . . . 0.0 109.682 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.417 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 0.8 OUTLIER -151.89 21.27 0.69 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.353 -0.842 . . . . 0.0 109.366 -179.977 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.17 -91.06 1.44 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.82 57.21 0.04 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.46 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -140.58 63.04 20.16 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.236 -1.155 . . . . 0.0 109.224 179.894 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.526 ' CB ' ' OH ' ' A' ' 38' ' ' TYR . 34.8 Cg_endo -78.62 163.46 26.66 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.856 2.371 . . . . 0.0 111.051 -179.607 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 75' ' ' ALA . . . 131.47 133.34 3.47 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.969 -1.11 . . . . 0.0 110.544 179.236 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.535 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . 70.41 -150.57 0.1 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.431 -1.041 . . . . 0.0 110.971 178.779 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.535 ' C ' ' O ' ' A' ' 75' ' ' ALA . 96.2 m-20 -7.08 126.46 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 CA-C-O 121.686 0.755 . . . . 0.0 112.837 -179.317 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.5 ' O ' HG12 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -161.89 80.71 0.56 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.962 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.456 HG23 HG23 ' A' ' 89' ' ' VAL . 7.5 p -62.47 145.54 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.87 -1.144 . . . . 0.0 109.303 -179.587 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.536 HG13 ' N ' ' A' ' 80' ' ' PHE . 68.2 t -113.06 165.78 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.346 -0.847 . . . . 0.0 109.843 -179.463 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.627 ' CD1' ' NE2' ' A' ' 20' ' ' GLN . 2.1 p90 -156.25 -174.98 5.19 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.56 -178.483 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.578 ' ND2' ' CG1' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -116.22 -82.07 0.62 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.061 -1.025 . . . . 0.0 109.967 -179.576 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -153.08 10.64 0.46 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.358 -0.839 . . . . 0.0 110.401 -179.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.448 ' O ' ' CB ' ' A' ' 84' ' ' ASN . 45.3 t-20 -135.06 7.32 3.42 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.175 -0.953 . . . . 0.0 108.835 179.309 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 85' ' ' GLN . 6.2 m-80 72.28 9.36 5.88 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.373 -0.829 . . . . 0.0 109.451 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 1.8 mm100 -49.38 -92.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.555 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.543 ' O ' ' CG2' ' A' ' 52' ' ' VAL . 0.1 OUTLIER 170.72 106.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 0.0 110.716 178.681 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.583 ' CB ' ' CE1' ' A' ' 56' ' ' TYR . . . -82.72 -30.86 28.81 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.292 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 146.9 -165.96 28.43 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.576 HG21 ' CG ' ' A' ' 4' ' ' TYR . 73.3 t -134.1 102.24 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.312 -1.111 . . . . 0.0 109.203 179.748 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.523 ' CD1' ' CG2' ' A' ' 79' ' ' VAL . 0.4 OUTLIER -104.5 153.99 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 109.273 -179.731 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 100' ' ' PHE . 10.2 t -122.65 137.33 54.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.095 -1.003 . . . . 0.0 110.275 -179.455 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.438 ' CE1' ' CD2' ' A' ' 100' ' ' PHE . 1.8 m-70 -80.6 75.33 7.49 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.428 -0.795 . . . . 0.0 108.908 179.175 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.5 t -173.97 158.41 3.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.544 -0.723 . . . . 0.0 109.393 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 87.04 -14.58 56.91 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.491 ' CB ' ' HB2' ' A' ' 99' ' ' ASN . . . -131.67 114.78 15.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -1.137 . . . . 0.0 109.22 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.468 ' O ' ' C ' ' A' ' 97' ' ' GLY . 7.4 p 46.09 -160.5 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.008 -1.058 . . . . 0.0 108.963 -179.762 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 96' ' ' SER . . . -40.38 -45.12 3.25 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.468 ' O ' ' O ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -155.68 -74.89 0.1 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.213 -1.169 . . . . 0.0 109.506 179.517 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.491 ' HB2' ' CB ' ' A' ' 95' ' ' ALA . 1.3 m-80 62.34 132.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.153 -0.967 . . . . 0.0 108.62 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.482 ' CB ' HG13 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -92.75 141.52 28.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.921 -1.112 . . . . 0.0 109.851 -179.79 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 102' ' ' GLU . 4.2 m -152.12 148.94 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.793 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 101' ' ' VAL . 0.6 OUTLIER -43.44 141.1 1.46 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.09 -1.006 . . . . 0.0 109.64 -179.675 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -55.04 144.18 24.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.399 -0.813 . . . . 0.0 109.597 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.488 1.472 0 O-C-N 121.245 -0.909 . . . . 0.0 109.514 179.891 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.321 0.581 . . . . 0.0 109.666 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 28.9 p 178.18 105.87 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.378 -0.826 . . . . 0.0 109.606 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -68.31 -52.39 34.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.97 -1.081 . . . . 0.0 109.147 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.48 ' CG ' ' CG2' ' A' ' 89' ' ' VAL . 60.3 m-85 -92.95 105.92 17.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.411 -0.806 . . . . 0.0 109.347 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 9' ' ' ASN . 2.3 t -134.26 128.66 34.29 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.945 -1.097 . . . . 0.0 109.836 -179.866 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.484 ' SG ' ' OG1' ' A' ' 91' ' ' THR . 2.0 t -96.34 -164.79 1.19 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.357 -0.84 . . . . 0.0 109.036 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.404 ' O ' ' CB ' ' A' ' 8' ' ' SER . . . -54.26 96.26 0.03 OUTLIER Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -179.126 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.52 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 0.8 OUTLIER 70.07 54.01 0.35 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.361 -1.082 . . . . 0.0 109.837 179.272 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 8' ' ' SER . 2.1 m120 -155.69 89.42 1.17 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.398 -0.813 . . . . 0.0 109.182 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.423 ' C ' ' CB ' ' A' ' 2' ' ' CYS . 0.4 OUTLIER -74.51 79.63 1.95 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.385 -0.822 . . . . 0.0 109.181 -179.599 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.466 ' O ' ' O ' ' A' ' 4' ' ' TYR . 3.2 m-85 -94.46 126.09 39.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.043 -1.036 . . . . 0.0 109.131 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.565 ' O ' HG21 ' A' ' 16' ' ' VAL . 18.6 t -89.35 130.28 35.75 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 110.118 -179.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 12' ' ' SER . 4.2 t -46.22 -25.84 0.68 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.505 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.7 t -69.09 -47.4 65.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.4 -0.812 . . . . 0.0 109.314 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -26.49 65.53 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.129 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.565 HG21 ' O ' ' A' ' 12' ' ' SER . 13.5 t -69.09 -36.03 71.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.263 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.2 t -56.64 -47.04 80.59 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.452 -0.78 . . . . 0.0 109.668 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.08 -54.03 51.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.025 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.519 ' CB ' HD11 ' A' ' 61' ' ' ILE . . . -68.22 -12.24 60.64 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.454 -0.779 . . . . 0.0 109.061 179.545 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.502 ' OE1' ' CG ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -83.56 -27.82 29.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 0.0 108.647 179.605 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.84 -14.16 54.82 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.428 -0.795 . . . . 0.0 108.881 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.76 -56.01 5.09 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.416 -0.802 . . . . 0.0 109.355 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.551 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -66.82 -28.13 73.64 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.578 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.437 ' CE1' ' O ' ' A' ' 82' ' ' GLU . 7.0 t80 -71.89 -40.06 69.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.538 -0.977 . . . . 0.0 109.614 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.88 -51.95 54.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.049 -1.032 . . . . 0.0 109.389 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.48 ' HB3' ' CG ' ' A' ' 39' ' ' PRO . 0.8 OUTLIER -52.18 -44.02 64.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.298 -0.876 . . . . 0.0 109.404 179.768 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.624 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 3.1 t60 -53.01 -53.73 45.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.414 -0.804 . . . . 0.0 110.14 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -82.73 -1.58 51.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.331 -0.856 . . . . 0.0 109.802 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.466 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -92.67 -1.5 56.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.719 -179.836 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 51.06 37.6 37.24 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -128.67 -152.46 0.52 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.34 -1.094 . . . . 0.0 109.367 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.564 HG22 ' CB ' ' A' ' 37' ' ' SER . 0.6 OUTLIER -159.28 -175.91 5.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.337 -0.852 . . . . 0.0 109.197 179.901 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 35' ' ' SER . 16.6 m -130.72 160.56 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.033 -1.042 . . . . 0.0 109.803 -179.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 53.28 -89.2 0.01 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 33' ' ' VAL . 2.1 p -177.29 25.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.324 -1.103 . . . . 0.0 109.99 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.433 ' O ' ' OG ' ' A' ' 37' ' ' SER . 3.6 m-20 -147.84 13.16 1.02 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.056 -1.027 . . . . 0.0 109.514 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.564 ' CB ' HG22 ' A' ' 32' ' ' THR . 3.3 p 64.4 -170.25 0.19 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -0.879 . . . . 0.0 109.542 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.584 ' C ' ' CE1' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 170.33 -44.99 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.419 -0.801 . . . . 0.0 111.66 178.621 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 34.2 Cg_endo -77.36 101.08 1.46 Allowed 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 121.314 1.342 . . . . 0.0 111.858 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.584 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -138.56 -175.27 4.07 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.396 -0.815 . . . . 0.0 109.546 178.65 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -78.55 141.97 37.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.366 -0.834 . . . . 0.0 109.73 -179.563 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.594 ' OH ' ' CD1' ' A' ' 100' ' ' PHE . 13.7 t80 -100.61 128.86 46.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.412 -0.805 . . . . 0.0 109.284 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 44' ' ' ASN . 1.7 t30 -93.4 -4.75 50.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.192 -0.942 . . . . 0.0 109.636 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.557 ' HA ' ' CZ ' ' A' ' 42' ' ' TYR . 0.5 OUTLIER 40.06 93.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.486 -0.759 . . . . 0.0 109.951 179.952 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.464 ' O ' ' C ' ' A' ' 46' ' ' GLU . 75.4 m-85 -86.77 -38.43 16.9 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.35 -0.844 . . . . 0.0 109.842 -179.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.501 ' OE1' ' CE1' ' A' ' 48' ' ' PHE . 0.9 OUTLIER -38.7 -46.53 1.25 Allowed 'General case' 0 C--N 1.309 -1.193 0 O-C-N 121.413 -0.804 . . . . 0.0 110.039 -179.593 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.5 62.44 0.57 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 -179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.501 ' CE1' ' OE1' ' A' ' 46' ' ' GLU . 51.7 m-85 -97.32 179.9 4.73 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.28 -1.13 . . . . 0.0 108.987 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -117.12 -41.98 2.96 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.221 -0.924 . . . . 0.0 108.89 179.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.579 ' CD2' ' O ' ' A' ' 87' ' ' ALA . 4.4 m-85 47.33 -170.92 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.481 -0.762 . . . . 0.0 109.777 179.549 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -146.55 20.22 1.33 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.477 -0.764 . . . . 0.0 108.961 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.478 ' HB ' ' CE1' ' A' ' 56' ' ' TYR . 46.9 t -92.91 -83.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.366 -0.834 . . . . 0.0 109.569 -179.783 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 52' ' ' VAL . 69.9 m -166.87 -175.66 3.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.129 -0.982 . . . . 0.0 109.985 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.572 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -79.07 -51.19 1.32 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.51 -0.743 . . . . 0.0 111.007 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 54' ' ' SER . 33.3 Cg_endo -73.44 89.1 0.96 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.911 1.741 . . . . 0.0 109.768 -177.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.524 ' O ' ' CD2' ' A' ' 57' ' ' TYR . 5.9 m-85 -90.04 -168.63 2.18 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.581 0.705 . . . . 0.0 110.144 -178.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.624 ' CE1' ' NE2' ' A' ' 27' ' ' HIS . 72.9 m-85 -158.66 120.29 3.48 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.176 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -88.68 137.9 31.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 110.838 -178.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.628 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 41.0 t-105 -161.03 137.8 6.45 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.416 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.628 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 33.1 Cg_endo -71.66 148.43 53.07 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.242 1.961 . . . . 0.0 111.446 -178.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.519 HD11 ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -111.53 125.48 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.855 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.485 HD21 ' C ' ' A' ' 61' ' ' ILE . 1.5 mt -121.06 165.53 15.18 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.11 -0.994 . . . . 0.0 109.537 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 11' ' ' TYR . 22.9 t -129.16 48.0 2.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.469 -0.769 . . . . 0.0 109.252 179.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.35 21.8 3.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.406 -0.809 . . . . 0.0 109.396 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 54.74 44.2 80.31 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.57 116.28 5.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -1.132 . . . . 0.0 109.534 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.513 HG13 ' CZ2' ' A' ' 59' ' ' TRP . 54.3 t -54.51 148.48 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.209 -0.932 . . . . 0.0 109.43 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.492 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 58.5 t80 -56.91 154.13 9.95 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.226 -0.921 . . . . 0.0 109.572 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.414 ' N ' ' CG ' ' A' ' 68' ' ' TYR . 1.2 t -158.68 -53.2 0.06 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.361 -0.837 . . . . 0.0 109.383 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -166.31 79.49 0.12 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 72' ' ' SER . . . 162.06 142.56 3.43 Favored Glycine 0 N--CA 1.49 2.279 0 O-C-N 121.113 -1.228 . . . . 0.0 110.055 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.485 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 1.7 m 42.99 61.65 9.39 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.429 -1.042 . . . . 0.0 110.033 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.485 ' HD3' ' N ' ' A' ' 72' ' ' SER . 36.3 Cg_endo -78.89 -48.21 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.627 2.218 . . . . 0.0 110.551 179.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.495 ' CA ' ' CB ' ' A' ' 92' ' ' HIS . . . -82.06 -135.66 2.13 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.493 ' O ' ' OG1' ' A' ' 91' ' ' THR . . . 64.76 -83.78 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.448 -1.031 . . . . 0.0 110.552 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.435 ' OD1' ' HB2' ' A' ' 6' ' ' CYS . 6.1 m-20 -119.02 139.99 50.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.757 -1.214 . . . . 0.0 109.956 -179.357 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.451 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 69.0 mtt180 -152.09 134.19 15.03 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.596 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.0 p -114.36 138.98 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.062 -1.024 . . . . 0.0 109.288 179.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.565 ' CG1' ' N ' ' A' ' 80' ' ' PHE . 43.1 t -104.51 167.46 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.36 -0.838 . . . . 0.0 109.654 -179.618 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.597 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 4.4 p90 -163.95 -172.82 2.95 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.398 -178.169 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 82' ' ' GLU . 46.7 t-20 -122.06 -46.52 2.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.018 -1.051 . . . . 0.0 109.653 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 81' ' ' ASN . 5.2 pt-20 166.85 -27.3 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.46 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 1.4 m-20 -100.37 27.54 5.65 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.074 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 83' ' ' ASN . 2.5 p-10 46.24 27.52 0.57 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.358 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.568 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 1.2 mt-30 -54.65 -32.02 58.47 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.568 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 85.94 105.25 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.587 0.708 . . . . 0.0 110.532 179.075 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.579 ' O ' ' CD2' ' A' ' 50' ' ' PHE . . . -80.49 -43.44 20.82 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 156.19 159.04 9.15 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.48 ' CG2' ' CG ' ' A' ' 4' ' ' TYR . 58.1 t -96.39 92.37 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.185 -1.185 . . . . 0.0 109.706 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.533 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 0.4 OUTLIER -78.83 173.65 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.576 -0.703 . . . . 0.0 109.33 179.736 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' A' ' 75' ' ' ALA . 5.6 t -132.25 146.04 51.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.04 -1.038 . . . . 0.0 111.013 -179.035 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.569 ' CD2' ' HB2' ' A' ' 98' ' ' ASN . 0.1 OUTLIER -93.39 62.72 3.44 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.363 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.488 ' N ' ' HA ' ' A' ' 98' ' ' ASN . 2.6 t 178.92 24.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.806 -179.29 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -131.44 27.22 3.78 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.47 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -158.92 97.28 1.4 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.222 -1.164 . . . . 0.0 110.533 -179.65 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.47 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER 36.33 54.32 1.03 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.802 -0.561 . . . . 0.0 110.331 179.316 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 93' ' ' THR . . . 122.92 -87.72 0.4 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.569 ' HB2' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -138.16 -69.52 0.44 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.181 -1.188 . . . . 0.0 109.828 179.949 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.503 ' O ' ' HA ' ' A' ' 92' ' ' HIS . 1.1 t30 44.82 -167.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 0.0 108.774 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.64 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -130.12 114.83 16.22 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.838 -1.164 . . . . 0.0 110.805 179.916 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' A' ' 102' ' ' GLU . 1.6 m -130.27 128.03 63.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.375 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 101' ' ' VAL . 4.0 mt-10 -42.98 105.66 0.05 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.331 -0.856 . . . . 0.0 109.879 -179.416 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.7 107.27 3.4 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.299 -0.876 . . . . 0.0 109.562 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 109.402 179.982 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.223 0.535 . . . . 0.0 109.767 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.7 p 164.96 99.62 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.259 -0.9 . . . . 0.0 110.06 179.559 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -78.78 -2.9 41.73 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.394 -0.816 . . . . 0.0 108.992 179.472 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.48 ' CD2' HG21 ' A' ' 89' ' ' VAL . 8.0 m-85 -118.9 107.04 13.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.949 . . . . 0.0 109.681 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.0 m -142.38 143.04 32.52 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.429 ' SG ' ' OD1' ' A' ' 76' ' ' ASP . 80.8 m -123.51 15.31 9.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.048 -1.033 . . . . 0.0 110.339 -179.499 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.29 -88.56 0.1 OUTLIER Glycine 0 C--N 1.28 -2.554 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.78 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.43 26.67 7.24 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.351 -1.087 . . . . 0.0 109.504 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -106.58 131.63 53.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.706 -179.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 1' ' ' ALA . 43.3 t -104.28 75.95 1.29 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.53 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 3.5 m-85 -83.48 126.48 32.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.852 . . . . 0.0 110.253 -179.139 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 0.7 OUTLIER -81.92 125.83 31.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.645 -0.659 . . . . 0.0 109.65 179.851 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.49 -22.93 0.82 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.16 -0.963 . . . . 0.0 109.194 179.659 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.97 -39.43 26.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.94 . . . . 0.0 110.097 -179.704 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.34 -35.1 75.58 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.556 HG11 HG12 ' A' ' 61' ' ' ILE . 2.9 t -58.81 -26.41 32.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.057 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.7 t -63.09 -43.98 97.02 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -34.47 77.97 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.083 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.602 ' CB ' HD13 ' A' ' 61' ' ' ILE . . . -84.8 -10.04 57.58 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.059 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.512 ' NE2' ' O ' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -91.88 -21.49 20.58 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.272 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -88.32 -8.84 54.49 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 26' ' ' LEU . . . -81.04 -56.16 4.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.12 -0.988 . . . . 0.0 108.835 179.679 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.4 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -61.8 -20.46 59.74 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 179.384 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.515 ' CE1' ' HA ' ' A' ' 82' ' ' GLU . 34.0 t80 -87.28 -69.84 0.66 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.375 -1.073 . . . . 0.0 109.565 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -42.54 -52.7 4.66 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.257 -0.902 . . . . 0.0 109.398 179.9 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.51 HD13 ' CB ' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -56.92 -42.63 80.3 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.427 -0.796 . . . . 0.0 109.155 179.837 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.525 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 5.3 t60 -53.65 -52.67 59.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.352 -0.843 . . . . 0.0 110.102 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 39.5 tp10 -84.38 -2.53 57.28 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.138 -0.976 . . . . 0.0 109.575 -179.56 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.422 ' HB3' ' HA ' ' A' ' 26' ' ' LEU . 38.0 t70 -94.93 -7.81 38.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.175 -0.953 . . . . 0.0 109.365 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.26 -40.12 3.04 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.517 ' O ' ' CG2' ' A' ' 32' ' ' THR . 1.1 mp0 -65.64 -173.9 0.18 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -1.138 . . . . 0.0 109.277 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.517 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 7.2 p -161.53 -94.75 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.181 -0.95 . . . . 0.0 109.503 179.595 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.5 m -135.62 -114.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.982 -1.074 . . . . 0.0 109.785 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.516 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -97.42 44.75 1.83 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.5 OUTLIER 76.19 24.33 1.14 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.446 -1.032 . . . . 0.0 109.547 179.886 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -119.73 7.54 11.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -0.903 . . . . 0.0 109.677 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.431 ' HA ' HG22 ' A' ' 32' ' ' THR . 52.1 p 45.32 88.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.252 -0.905 . . . . 0.0 109.88 179.94 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.623 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -91.61 -40.2 0.38 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.314 -0.866 . . . . 0.0 111.736 -179.686 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 33.7 Cg_endo -76.08 109.76 2.94 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 120.986 1.124 . . . . 0.0 110.086 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.578 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -128.27 -173.23 2.89 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.203 -179.396 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -103.37 141.95 35.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.093 -1.004 . . . . 0.0 110.059 -179.622 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.452 ' HB2' ' HG2' ' A' ' 58' ' ' GLU . 68.3 t80 -107.05 160.09 15.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.205 -0.934 . . . . 0.0 109.228 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.564 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 0.4 OUTLIER -109.95 -84.98 0.55 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.095 -1.003 . . . . 0.0 109.776 -179.91 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.581 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 6.1 p30 155.99 135.07 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.581 ' CD1' ' O ' ' A' ' 44' ' ' ASN . 19.6 m-85 -152.41 -64.88 0.17 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.068 -1.02 . . . . 0.0 109.414 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -40.64 -53.87 2.68 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.374 -0.829 . . . . 0.0 109.529 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 48' ' ' PHE . . . 140.52 -73.66 0.38 Allowed Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.613 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.54 ' HB3' ' CE2' ' A' ' 50' ' ' PHE . 70.7 m-85 66.91 157.09 0.11 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.406 -1.055 . . . . 0.0 108.389 -179.873 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -108.71 27.78 9.08 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.715 -1.194 . . . . 0.0 110.381 -178.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.54 ' CE2' ' HB3' ' A' ' 48' ' ' PHE . 8.1 p90 -125.22 -174.32 3.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.984 -1.073 . . . . 0.0 109.697 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -170.08 54.81 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.268 -0.895 . . . . 0.0 109.304 -179.679 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.475 ' HB ' ' CE1' ' A' ' 56' ' ' TYR . 29.9 t -43.45 -66.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.198 -0.939 . . . . 0.0 109.524 -179.82 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.463 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -164.18 -172.89 2.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.135 -0.978 . . . . 0.0 109.767 -179.816 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.506 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -79.6 -54.97 0.9 Allowed Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.266 -0.896 . . . . 0.0 111.223 -179.255 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 54' ' ' SER . 34.4 Cg_endo -72.42 87.02 0.95 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.877 1.718 . . . . 0.0 109.979 -178.114 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.538 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 9.3 m-85 -87.13 178.1 7.0 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.233 0.54 . . . . 0.0 109.639 -179.38 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.538 ' CD1' ' C ' ' A' ' 56' ' ' TYR . 94.0 m-85 -156.71 129.56 7.77 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.364 -0.835 . . . . 0.0 109.576 179.62 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.479 ' HG3' ' ND1' ' A' ' 40' ' ' HIS . 0.2 OUTLIER -99.86 138.18 37.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -0.94 . . . . 0.0 109.663 -179.933 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.605 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 21.1 t-105 -155.69 136.64 9.1 Favored Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.605 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.8 Cg_endo -71.5 137.29 30.24 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 C-N-CA 122.168 1.912 . . . . 0.0 111.801 -178.224 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.602 HD13 ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -110.93 133.51 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.96 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.52 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 0.3 OUTLIER -131.93 158.69 40.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -0.9 . . . . 0.0 109.158 179.921 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 98.1 p -122.83 27.4 7.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.911 . . . . 0.0 108.88 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -153.87 -39.08 0.1 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.454 -0.779 . . . . 0.0 109.356 -179.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 66' ' ' ASP . . . -88.98 -9.99 67.1 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.494 ' O ' ' CB ' ' A' ' 67' ' ' VAL . 67.8 t0 48.09 96.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -1.124 . . . . 0.0 109.56 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.494 ' CB ' ' O ' ' A' ' 66' ' ' ASP . 2.9 t 75.62 135.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.545 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.492 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 45.9 t80 -81.39 150.34 28.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.903 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.451 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 4.8 t -165.47 -42.3 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.422 -0.799 . . . . 0.0 109.285 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -158.09 124.49 1.4 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.89 -145.29 12.65 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.85 107.77 60.9 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.285 -1.126 . . . . 0.0 109.636 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.477 ' CB ' ' OH ' ' A' ' 38' ' ' TYR . 35.7 Cg_endo -77.12 -175.63 2.76 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.534 2.156 . . . . 0.0 110.534 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.457 ' O ' ' CB ' ' A' ' 75' ' ' ALA . . . 93.35 -175.64 36.3 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 74' ' ' GLY . . . 71.52 -144.91 0.06 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.141 -1.211 . . . . 0.0 110.108 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.429 ' OD1' ' SG ' ' A' ' 6' ' ' CYS . 5.7 m-20 -44.11 151.54 0.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.354 -0.841 . . . . 0.0 110.986 -179.135 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.525 ' NH2' ' CE1' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -164.95 111.84 0.99 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.104 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.494 HG23 HD21 ' A' ' 86' ' ' LEU . 13.9 p -92.56 129.25 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.821 -1.175 . . . . 0.0 110.312 -178.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.535 ' CG1' ' N ' ' A' ' 80' ' ' PHE . 55.2 t -98.39 167.36 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.467 -0.771 . . . . 0.0 109.145 179.569 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.567 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 4.7 p90 -168.48 -170.76 1.3 Allowed 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.662 -178.082 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.456 ' ND2' ' CB ' ' A' ' 53' ' ' SER . 1.0 OUTLIER -129.71 -42.4 1.29 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.172 -0.955 . . . . 0.0 110.056 -179.341 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.515 ' HA ' ' CE1' ' A' ' 24' ' ' TYR . 7.6 pt-20 166.26 -27.31 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.737 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.46 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -100.84 26.08 7.27 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.489 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.469 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 8.5 p30 48.7 25.27 0.95 Allowed 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.45 0.643 . . . . 0.0 109.636 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.535 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 3.0 mt-30 -55.35 -36.16 66.01 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.535 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER 83.59 104.11 0.05 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.557 0.694 . . . . 0.0 110.694 179.142 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.492 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . . . -76.81 -34.0 57.96 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.783 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 150.34 151.52 5.56 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.48 HG21 ' CD2' ' A' ' 4' ' ' TYR . 85.9 t -89.34 88.07 2.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.268 -1.136 . . . . 0.0 109.696 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 77' ' ' ARG . 0.8 OUTLIER -78.97 158.26 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.276 -0.89 . . . . 0.0 108.789 179.681 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 100' ' ' PHE . 9.5 t -119.22 168.48 10.84 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.043 -1.036 . . . . 0.0 110.642 -179.1 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.622 ' NE2' ' CE2' ' A' ' 100' ' ' PHE . 0.3 OUTLIER -120.98 68.98 0.88 Allowed 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 3.1 m -175.75 -30.37 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.401 -0.812 . . . . 0.0 110.183 -179.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.42 17.17 40.41 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.161 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.476 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -153.98 121.2 5.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -1.164 . . . . 0.0 109.482 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.476 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.9 OUTLIER 39.28 -156.38 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.367 -0.833 . . . . 0.0 109.49 179.68 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 96' ' ' SER . . . -41.39 -59.99 2.49 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 179.341 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.58 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -167.43 32.65 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.243 -1.151 . . . . 0.0 109.27 179.251 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.436 ' O ' ' O ' ' A' ' 98' ' ' ASN . 1.4 t30 -48.14 173.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.99 -1.068 . . . . 0.0 109.251 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.622 ' CE2' ' NE2' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -100.13 144.13 29.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.1 -1.0 . . . . 0.0 109.528 -179.94 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 100' ' ' PHE . 10.3 m -158.02 137.19 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.377 -0.827 . . . . 0.0 108.899 179.624 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.87 96.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.098 -1.001 . . . . 0.0 109.554 -179.59 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.453 ' N ' ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -48.41 126.77 11.97 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.298 -0.876 . . . . 0.0 109.464 179.832 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.837 -1.078 . . . . 0.0 109.483 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.471 ' O ' ' SG ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.541 0.686 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 31.4 p 38.93 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.912 0.863 . . . . 0.0 110.264 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -102.5 -1.44 30.53 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.361 -0.837 . . . . 0.0 109.307 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.541 ' CG ' HG23 ' A' ' 89' ' ' VAL . 23.0 m-85 -115.07 65.73 0.68 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.9 . . . . 0.0 109.225 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.514 ' CG2' ' O ' ' A' ' 5' ' ' THR . 11.5 t -86.78 92.46 8.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.94 . . . . 0.0 109.741 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.9 m -104.24 155.75 18.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.119 -0.988 . . . . 0.0 109.236 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.411 ' O ' ' CB ' ' A' ' 8' ' ' SER . . . 47.43 29.3 5.29 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.436 ' O ' ' OD1' ' A' ' 9' ' ' ASN . 5.0 m 70.44 43.84 0.76 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -1.14 . . . . 0.0 109.422 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 11' ' ' TYR . 83.0 m-20 -136.97 86.33 2.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.136 -0.978 . . . . 0.0 109.547 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.425 ' HA ' ' CB ' ' A' ' 5' ' ' THR . 0.5 OUTLIER -54.9 88.26 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.498 -0.751 . . . . 0.0 109.395 179.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.527 ' CZ ' ' HB2' ' A' ' 63' ' ' SER . 1.9 m-85 -79.68 144.51 33.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.311 -0.868 . . . . 0.0 108.924 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.547 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -78.58 122.48 25.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.376 -0.827 . . . . 0.0 109.568 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.6 p -59.03 -26.62 64.72 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 83.4 p -78.93 -28.55 43.84 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.74 -27.4 40.55 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 12' ' ' SER . 13.5 t -66.6 -29.9 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.432 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 1.9 t -64.4 -46.21 84.26 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.93 -51.81 67.69 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.485 ' CB ' HD12 ' A' ' 61' ' ' ILE . . . -66.41 -18.81 65.58 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.585 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -71.11 -36.65 72.23 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -82.0 -1.72 49.19 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.54 -54.82 5.33 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.353 -0.842 . . . . 0.0 108.914 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.519 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -72.89 -18.5 79.01 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.44 ' O ' ' C ' ' A' ' 25' ' ' GLN . 14.6 t80 -80.22 -60.52 2.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.557 -0.966 . . . . 0.0 109.348 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.7 OUTLIER -41.64 -35.38 0.74 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.319 -0.863 . . . . 0.0 109.614 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.453 ' CD1' ' HB3' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -75.23 -47.13 29.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 0.0 109.65 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.583 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 11.5 t60 -56.25 -37.44 69.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.368 -0.833 . . . . 0.0 110.941 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -85.41 -31.47 22.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.027 -1.046 . . . . 0.0 109.48 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.429 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 0.5 OUTLIER -68.09 -20.51 64.95 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.274 -0.891 . . . . 0.0 109.366 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.23 -19.02 25.08 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.453 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 1.7 tp10 -63.01 -154.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.234 -1.156 . . . . 0.0 109.492 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.679 HG23 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -162.69 174.47 12.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.336 -0.852 . . . . 0.0 109.408 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 35' ' ' SER . 18.0 m -130.4 158.1 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.276 -0.89 . . . . 0.0 109.383 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.403 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . 55.63 -89.21 0.01 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER 171.04 32.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.327 -1.102 . . . . 0.0 109.725 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 37' ' ' SER . 1.6 m-80 -152.64 25.29 0.58 Allowed 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.106 -0.996 . . . . 0.0 109.666 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.679 ' HA ' HG23 ' A' ' 32' ' ' THR . 1.0 OUTLIER 47.95 92.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.018 -1.051 . . . . 0.0 108.887 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.68 ' CD2' ' CE2' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -79.34 -47.29 1.58 Allowed Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.261 -0.9 . . . . 0.0 110.765 -179.367 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 32.6 Cg_endo -74.71 108.04 2.61 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 120.95 1.1 . . . . 0.0 109.349 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.62 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -125.74 -174.8 3.17 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.459 -179.11 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -104.6 131.28 52.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.346 -0.846 . . . . 0.0 109.42 -179.526 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.572 ' CZ ' ' HA ' ' A' ' 44' ' ' ASN . 11.9 t80 -97.33 137.83 35.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.272 -0.893 . . . . 0.0 109.259 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.523 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -89.85 -32.49 16.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.144 -0.973 . . . . 0.0 109.776 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.572 ' HA ' ' CZ ' ' A' ' 42' ' ' TYR . 20.1 t30 77.2 135.59 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.591 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.445 ' O ' ' C ' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -159.5 -38.11 0.06 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.307 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.6 OUTLIER -38.72 -73.02 0.05 Allowed 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.623 -0.673 . . . . 0.0 110.069 -179.582 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 155.41 61.72 0.01 OUTLIER Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.485 ' CD1' ' OD1' ' A' ' 44' ' ' ASN . 48.6 m-85 -90.74 -168.01 1.97 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.299 -1.118 . . . . 0.0 109.332 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 50' ' ' PHE . 5.0 p30 -145.05 26.59 1.34 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.52 ' CB ' ' OH ' ' A' ' 56' ' ' TYR . 20.9 m-30 -45.6 173.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.503 -0.748 . . . . 0.0 109.769 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.4 m -146.53 30.3 1.01 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.357 -0.839 . . . . 0.0 109.088 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.53 HG11 ' OD1' ' A' ' 81' ' ' ASN . 97.2 t -96.28 -92.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.338 -0.851 . . . . 0.0 109.545 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.404 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 66.9 m -142.63 -172.93 3.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.074 -1.016 . . . . 0.0 109.962 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.581 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -85.49 -49.25 0.56 Allowed Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.364 -0.835 . . . . 0.0 111.61 -179.175 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 54' ' ' SER . 33.5 Cg_endo -74.09 83.41 1.64 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 121.863 1.708 . . . . 0.0 110.396 -177.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.546 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 7.1 m-85 -79.38 -177.96 6.01 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.645 0.736 . . . . 0.0 110.022 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.583 ' CE2' ' NE2' ' A' ' 27' ' ' HIS . 97.6 m-85 -157.95 152.33 24.63 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.555 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 19.2 mt-10 -119.63 143.17 47.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.991 -1.068 . . . . 0.0 111.124 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.6 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 21.3 t-105 -160.75 138.81 7.21 Favored Pre-proline 0 N--CA 1.49 1.57 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.6 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.2 Cg_endo -69.22 142.59 50.74 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.338 2.025 . . . . 0.0 111.861 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.491 ' C ' HD21 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -119.57 131.64 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.491 HD21 ' C ' ' A' ' 61' ' ' ILE . 0.9 OUTLIER -123.13 167.49 13.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.191 -0.943 . . . . 0.0 109.576 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.527 ' HB2' ' CZ ' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -135.72 17.47 3.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.368 -0.833 . . . . 0.0 109.25 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.25 -54.2 0.2 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.284 -0.885 . . . . 0.0 109.423 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . -67.42 -98.16 0.03 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 3.0 t0 175.49 -162.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -1.161 . . . . 0.0 109.538 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.41 ' O ' ' OG ' ' A' ' 69' ' ' SER . 8.5 t -52.55 136.47 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.304 -0.873 . . . . 0.0 109.568 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.68 ' CE2' ' CD2' ' A' ' 38' ' ' TYR . 28.9 t80 -52.92 117.84 3.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.2 -0.937 . . . . 0.0 109.254 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -177.19 74.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.404 -0.81 . . . . 0.0 109.662 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.52 62.12 0.31 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.31 -136.29 3.91 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.2 m -166.29 101.63 0.7 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.309 -1.112 . . . . 0.0 109.186 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.534 ' HG3' ' CD1' ' A' ' 68' ' ' TYR . 35.8 Cg_endo -77.82 -81.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.435 2.09 . . . . 0.0 110.685 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.39 -176.89 4.86 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . 56.47 -122.03 1.65 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.101 -1.235 . . . . 0.0 109.555 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 75' ' ' ALA . 87.2 m-20 -41.4 146.85 0.19 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.848 -1.158 . . . . 0.0 110.167 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.486 ' O ' HG12 ' A' ' 90' ' ' ILE . 2.6 tpp180 -176.37 90.12 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.455 -0.778 . . . . 0.0 109.219 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 89' ' ' VAL . 7.5 p -65.04 144.63 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.097 -1.002 . . . . 0.0 109.547 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.588 HG13 ' N ' ' A' ' 80' ' ' PHE . 24.7 t -104.84 167.48 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.345 -0.847 . . . . 0.0 109.642 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.588 ' N ' HG13 ' A' ' 79' ' ' VAL . 13.8 p90 -164.53 -173.39 3.03 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.409 -178.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.53 ' OD1' HG11 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -124.07 -81.15 0.63 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.066 -1.022 . . . . 0.0 110.267 -179.395 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -158.74 21.55 0.22 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.312 -0.867 . . . . 0.0 109.484 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.471 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 4.4 m120 -140.39 23.89 2.31 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 83' ' ' ASN . 5.0 p30 52.83 19.92 1.45 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.468 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 51.8 mm-40 -60.62 -111.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 85' ' ' GLN . 0.2 OUTLIER 172.84 110.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 110.693 178.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.537 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . . . -79.62 -38.92 32.75 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 148.69 156.71 7.24 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.541 HG23 ' CG ' ' A' ' 4' ' ' TYR . 94.8 t -87.14 113.48 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -1.155 . . . . 0.0 109.411 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.52 HD11 ' CG2' ' A' ' 79' ' ' VAL . 0.9 OUTLIER -109.27 154.54 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.421 -0.8 . . . . 0.0 109.142 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 100' ' ' PHE . 4.6 t -107.79 146.82 31.67 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.033 -1.042 . . . . 0.0 110.418 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.59 ' CD2' ' HB2' ' A' ' 98' ' ' ASN . 16.1 t60 -116.76 66.05 0.72 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 1.9 m 178.42 -29.65 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.746 -0.596 . . . . 0.0 109.717 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.88 10.79 44.92 Favored Glycine 0 N--CA 1.494 2.504 0 O-C-N 120.993 -1.067 . . . . 0.0 110.638 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -141.15 147.06 37.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.016 -1.285 . . . . 0.0 109.669 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 95' ' ' ALA . 1.2 p -43.03 133.3 3.8 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 98' ' ' ASN . . . 62.84 35.03 91.42 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 107.949 -2.061 . . . . 0.0 107.949 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.59 ' HB2' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 34.71 41.66 0.06 Allowed 'General case' 0 C--N 1.309 -1.177 0 O-C-N 122.105 -0.644 . . . . 0.0 110.349 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -56.93 166.55 0.98 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.123 -0.986 . . . . 0.0 108.623 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.521 ' O ' ' CG1' ' A' ' 101' ' ' VAL . 0.3 OUTLIER -91.44 147.51 22.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.933 -1.104 . . . . 0.0 109.839 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.521 ' CG1' ' O ' ' A' ' 100' ' ' PHE . 17.4 m -161.38 133.97 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 101' ' ' VAL . 35.8 mt-10 -43.26 135.17 3.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.964 . . . . 0.0 109.448 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 1.5 m -60.73 121.3 11.92 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.246 -0.908 . . . . 0.0 109.325 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.556 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 7.1 p 173.27 137.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.37 -0.832 . . . . 0.0 109.906 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -115.72 -29.57 6.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 0.0 109.505 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.635 ' CD2' HG23 ' A' ' 89' ' ' VAL . 13.0 m-85 -87.11 93.66 9.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.955 . . . . 0.0 109.233 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.3 m -126.76 141.08 51.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.144 -0.972 . . . . 0.0 109.869 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -143.98 14.98 1.71 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.122 0.963 . . . . 0.0 109.785 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 177.88 50.0 0.07 OUTLIER Glycine 0 C--N 1.281 -2.526 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.449 ' O ' ' OG ' ' A' ' 8' ' ' SER . 3.3 t 55.0 20.47 3.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.47 -1.018 . . . . 0.0 109.201 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.541 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 25.8 m-80 -74.5 -34.41 63.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 0.0 109.627 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.437 ' O ' ' SG ' ' A' ' 10' ' ' CYS . 46.5 t 61.52 52.03 3.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.116 -0.99 . . . . 0.0 109.621 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.541 ' CE1' ' HB3' ' A' ' 9' ' ' ASN . 7.6 m-30 -80.61 129.97 34.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.303 -0.873 . . . . 0.0 109.073 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 3.9 m -88.57 137.96 31.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.167 -0.958 . . . . 0.0 110.11 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 p -53.55 -23.33 10.33 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.0 t -77.33 -38.16 51.0 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.357 -0.839 . . . . 0.0 108.94 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -70.86 -28.86 64.89 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 7.5 t -70.28 -31.2 46.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 C-N-CA 119.602 -0.839 . . . . 0.0 108.777 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.09 -45.62 92.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.598 -0.689 . . . . 0.0 109.433 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.62 -48.92 79.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 108.806 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.589 ' CB ' HD11 ' A' ' 61' ' ' ILE . . . -72.32 -12.22 61.04 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.554 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -83.9 -28.36 27.97 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.348 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -82.22 -14.55 55.36 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.438 -0.789 . . . . 0.0 109.099 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 26' ' ' LEU . . . -76.9 -52.94 8.55 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.279 -0.888 . . . . 0.0 109.062 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.499 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -66.16 -30.56 77.08 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.869 -1.693 . . . . 0.0 108.869 179.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.585 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 5.2 t80 -72.11 -70.65 0.32 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.415 -1.05 . . . . 0.0 108.982 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -40.71 -57.85 1.79 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.444 -0.785 . . . . 0.0 109.656 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.436 HD13 ' HB2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -46.55 -46.44 19.35 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.048 -1.032 . . . . 0.0 109.262 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -58.81 -48.69 80.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.454 -0.779 . . . . 0.0 110.86 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -86.7 12.04 11.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.134 -0.979 . . . . 0.0 109.939 -179.151 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 55.1 t0 -104.48 -11.82 16.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.076 -1.015 . . . . 0.0 109.364 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.51 -5.12 61.53 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.436 ' HB2' HD13 ' A' ' 26' ' ' LEU . 5.5 mm-40 -87.81 -176.82 5.64 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.298 -1.119 . . . . 0.0 109.367 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.593 ' CG2' ' CB ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -145.15 178.5 8.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -0.966 . . . . 0.0 109.677 179.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 34' ' ' GLY . 27.4 m -100.3 -126.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.322 -0.861 . . . . 0.0 109.441 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -43.5 -47.55 7.14 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER 163.99 -34.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -1.106 . . . . 0.0 109.638 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.449 ' N ' ' ND2' ' A' ' 36' ' ' ASN . 0.6 OUTLIER -75.96 -11.84 60.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 0.0 110.008 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.593 ' CB ' ' CG2' ' A' ' 32' ' ' THR . 1.1 p 69.29 121.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.026 -1.047 . . . . 0.0 108.916 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.735 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -98.3 -19.24 0.21 Allowed Pre-proline 0 N--CA 1.495 1.808 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -179.102 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.735 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 37.4 Cg_endo -79.82 102.03 1.43 Allowed 'Trans proline' 0 C--N 1.318 -1.056 0 C-N-CA 121.275 1.316 . . . . 0.0 113.426 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.589 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -128.77 137.43 51.54 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.072 -1.017 . . . . 0.0 109.748 177.184 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 2.5 ptmt -51.14 143.51 10.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 110.292 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.532 ' CZ ' ' HA ' ' A' ' 44' ' ' ASN . 4.4 t80 -114.45 102.01 9.68 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 44' ' ' ASN . 0.3 OUTLIER -74.77 21.66 0.11 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.901 -1.124 . . . . 0.0 111.582 -178.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.532 ' HA ' ' CZ ' ' A' ' 42' ' ' TYR . 1.2 m-20 60.42 148.63 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.66 -1.275 . . . . 0.0 109.612 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.483 ' CD2' ' O ' ' A' ' 44' ' ' ASN . 0.2 OUTLIER -174.39 -57.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.933 . . . . 0.0 109.614 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.532 ' OE2' ' CG1' ' A' ' 101' ' ' VAL . 0.2 OUTLIER -37.44 -55.99 1.03 Allowed 'General case' 0 C--N 1.308 -1.204 0 O-C-N 121.616 -0.677 . . . . 0.0 110.293 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.21 51.69 0.08 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.506 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 11.3 m-85 -91.43 -170.1 2.52 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.301 -1.117 . . . . 0.0 108.629 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -150.49 44.9 0.87 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.095 -1.003 . . . . 0.0 110.308 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.52 -179.5 5.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.954 -1.091 . . . . 0.0 109.236 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.4 m -153.22 56.68 0.77 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.237 -0.914 . . . . 0.0 109.466 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.477 ' O ' ' CB ' ' A' ' 53' ' ' SER . 37.4 t -94.62 -27.0 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.258 -0.901 . . . . 0.0 109.647 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.505 ' OG ' ' HD2' ' A' ' 55' ' ' PRO . 4.1 t 167.55 162.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.028 -1.045 . . . . 0.0 109.57 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.543 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -75.82 -59.71 1.14 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.094 -1.004 . . . . 0.0 110.646 -179.27 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.543 ' CD ' ' CB ' ' A' ' 54' ' ' SER . 36.0 Cg_endo -71.34 84.37 0.94 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 121.959 1.773 . . . . 0.0 110.623 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.585 ' CE1' ' CB ' ' A' ' 87' ' ' ALA . 38.3 m-85 -79.62 -171.04 2.62 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.648 0.737 . . . . 0.0 109.904 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.584 ' CD2' ' O ' ' A' ' 56' ' ' TYR . 76.9 m-85 -160.82 151.04 17.79 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.455 ' OE2' ' HB2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -120.79 140.39 51.78 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.901 -1.124 . . . . 0.0 110.543 -178.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.63 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 3.7 t-105 -155.99 146.34 15.97 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.63 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.8 Cg_endo -68.32 130.58 21.48 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.098 1.866 . . . . 0.0 111.43 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.589 HD11 ' CB ' ' A' ' 19' ' ' ALA . 0.2 OUTLIER -97.84 132.54 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.505 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.9 OUTLIER -123.81 165.01 18.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 0.0 109.342 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 11' ' ' TYR . 27.1 t -120.26 37.42 4.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 108.97 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.39 -172.91 3.07 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.404 -0.81 . . . . 0.0 109.638 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -96.28 50.48 1.66 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -150.04 147.34 27.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.09 -1.241 . . . . 0.0 109.432 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.421 HG12 ' CZ2' ' A' ' 59' ' ' TRP . 81.0 t -92.18 152.27 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.89 . . . . 0.0 109.252 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.53 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 44.4 t80 -59.79 132.17 53.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.201 -0.937 . . . . 0.0 109.573 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.1 t -155.91 20.36 0.38 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.303 -0.873 . . . . 0.0 109.246 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.5 89.75 1.41 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -162.65 -39.52 0.02 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.435 ' O ' ' OG ' ' A' ' 72' ' ' SER . 28.1 p -158.17 102.14 1.73 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.16 -1.2 . . . . 0.0 109.326 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -75.15 114.14 3.94 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.336 2.024 . . . . 0.0 110.158 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.42 ' HA2' ' CD2' ' A' ' 92' ' ' HIS . . . 109.83 -125.08 7.44 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.455 ' N ' ' HB2' ' A' ' 92' ' ' HIS . . . 51.01 -174.06 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.201 -1.176 . . . . 0.0 109.638 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.451 ' C ' ' O ' ' A' ' 75' ' ' ALA . 65.8 m-20 -37.89 143.16 0.12 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.649 0.738 . . . . 0.0 110.681 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.503 ' CA ' HG23 ' A' ' 61' ' ' ILE . 2.0 ttt180 -153.95 133.65 12.96 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.419 ' CG2' HD11 ' A' ' 86' ' ' LEU . 10.8 p -119.24 130.08 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.928 -1.107 . . . . 0.0 110.461 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.559 ' CG1' ' N ' ' A' ' 80' ' ' PHE . 12.9 t -89.5 163.25 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 CA-C-O 122.298 1.047 . . . . 0.0 109.857 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.559 ' N ' ' CG1' ' A' ' 79' ' ' VAL . 34.4 p90 -159.74 -168.47 2.27 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.52 ' OD1' ' HG2' ' A' ' 82' ' ' GLU . 1.2 p30 -122.07 -44.79 2.27 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.866 -1.134 . . . . 0.0 111.004 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.585 ' O ' ' CZ ' ' A' ' 24' ' ' TYR . 2.1 pt-20 161.21 -21.54 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.419 ' C ' ' CG ' ' A' ' 84' ' ' ASN . 1.8 m-20 -92.16 20.27 6.11 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.581 ' OD1' ' CE2' ' A' ' 24' ' ' TYR . 0.0 OUTLIER 63.62 8.08 3.46 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.7 -0.625 . . . . 0.0 109.686 -179.474 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.41 ' O ' ' O ' ' A' ' 84' ' ' ASN . 13.6 mt-30 -60.66 -160.32 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.451 HD23 ' HG3' ' A' ' 20' ' ' GLN . 0.1 OUTLIER -137.84 117.42 12.99 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.488 -1.382 . . . . 0.0 110.755 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.585 ' CB ' ' CE1' ' A' ' 56' ' ' TYR . . . -83.92 -43.23 15.47 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 170.48 163.69 24.94 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.635 HG23 ' CD2' ' A' ' 4' ' ' TYR . 75.1 t -115.93 99.22 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.021 -1.282 . . . . 0.0 109.388 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.464 HG21 ' C ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -88.37 -173.39 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.398 -0.814 . . . . 0.0 109.401 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.479 ' CG2' ' O ' ' A' ' 91' ' ' THR . 5.9 t -148.9 121.43 8.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.986 -1.071 . . . . 0.0 110.213 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.455 ' HB2' ' N ' ' A' ' 75' ' ' ALA . 2.4 m-70 -78.99 79.13 5.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.549 -0.719 . . . . 0.0 109.291 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 98' ' ' ASN . 0.6 OUTLIER 177.36 -28.56 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.171 -0.956 . . . . 0.0 110.095 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.8 -16.31 16.69 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.561 ' CB ' ' CB ' ' A' ' 99' ' ' ASN . . . -122.52 178.15 5.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.104 -1.233 . . . . 0.0 109.412 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 98' ' ' ASN . 1.0 OUTLIER -40.95 157.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.449 -0.782 . . . . 0.0 109.31 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 96' ' ' SER . . . 43.97 -95.18 0.01 OUTLIER Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -127.28 -73.91 0.6 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.346 -1.091 . . . . 0.0 109.347 179.339 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.561 ' CB ' ' CB ' ' A' ' 95' ' ' ALA . 0.9 OUTLIER 59.33 120.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.044 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.562 ' CD2' ' O ' ' A' ' 100' ' ' PHE . 38.3 p90 -98.76 117.53 33.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.843 -1.161 . . . . 0.0 110.705 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.532 ' CG1' ' OE2' ' A' ' 46' ' ' GLU . 18.0 m -128.91 158.2 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 101' ' ' VAL . 4.3 pt-20 -43.42 138.81 2.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 109.37 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.1 OUTLIER -75.73 176.8 7.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.63 -179.645 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.081 -0.962 . . . . 0.0 109.523 -179.9 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.482 ' O ' ' SG ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.414 0.626 . . . . 0.0 109.724 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 21.6 p 36.78 91.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.603 0.716 . . . . 0.0 110.224 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -97.86 1.63 48.38 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.418 ' CD2' HG22 ' A' ' 89' ' ' VAL . 16.1 m-85 -104.28 78.1 1.47 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.482 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.1 m -84.31 93.98 8.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.427 ' O ' ' C ' ' A' ' 7' ' ' GLY . 2.8 m -120.65 155.03 34.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 109.474 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 6' ' ' CYS . . . 43.8 27.21 0.91 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 1.4 m 68.94 50.59 0.59 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.292 -1.122 . . . . 0.0 109.582 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -144.55 126.53 15.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.171 -0.956 . . . . 0.0 109.598 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.428 ' C ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -82.99 84.07 7.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -0.831 . . . . 0.0 109.02 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.43 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 4.2 m-30 -79.82 138.68 37.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.41 -0.806 . . . . 0.0 109.661 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.559 ' O ' HG21 ' A' ' 16' ' ' VAL . 2.0 t -80.73 123.28 28.07 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.696 -0.627 . . . . 0.0 109.92 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.18 -24.37 0.45 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 109.221 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.6 t -81.53 -41.1 22.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.983 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -67.62 -28.32 67.64 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.559 HG21 ' O ' ' A' ' 12' ' ' SER . 1.9 t -68.39 -29.64 44.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.512 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 21.5 t -62.63 -46.13 89.66 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -59.43 5.02 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.561 ' CB ' HD11 ' A' ' 61' ' ' ILE . . . -61.83 -16.42 50.04 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.555 ' OE1' HG13 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -73.56 -33.81 64.85 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.296 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.62 1.65 53.08 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.0 -62.28 1.73 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.249 -0.907 . . . . 0.0 109.04 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.459 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -60.89 -16.49 47.17 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -82.42 -64.91 1.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.342 -1.093 . . . . 0.0 109.248 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -47.42 -52.43 16.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.353 -0.842 . . . . 0.0 109.745 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.484 ' CD1' ' HB3' ' A' ' 31' ' ' GLU . 2.7 tp -59.72 -38.46 81.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.292 -0.88 . . . . 0.0 109.397 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.649 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 66.1 t60 -68.7 -20.13 64.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.006 -1.059 . . . . 0.0 110.29 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -87.19 -21.97 25.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.057 -1.027 . . . . 0.0 109.507 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 9.9 t70 -89.05 -12.26 41.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.267 -0.896 . . . . 0.0 109.502 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.35 0.84 59.01 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.484 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 5.6 tp10 -67.95 -144.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -1.175 . . . . 0.0 109.517 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.587 ' CG2' ' CB ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -167.26 -174.6 2.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.058 -1.026 . . . . 0.0 109.619 -179.73 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 m -105.03 -104.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 109.631 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -77.13 -38.19 30.49 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 2.2 t 162.83 -36.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.437 -1.037 . . . . 0.0 109.385 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.418 ' O ' ' O ' ' A' ' 37' ' ' SER . 5.4 m120 -68.82 -16.5 63.8 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.327 -0.858 . . . . 0.0 109.262 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.587 ' CB ' ' CG2' ' A' ' 32' ' ' THR . 8.1 t 63.09 126.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.271 -0.893 . . . . 0.0 109.431 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.623 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -117.99 -27.41 0.08 OUTLIER Pre-proline 0 N--CA 1.499 2.001 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -178.56 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 37.0 Cg_endo -79.34 100.72 1.35 Allowed 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 121.062 1.175 . . . . 0.0 112.724 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.597 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -135.92 160.61 38.07 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.115 -0.991 . . . . 0.0 108.747 177.439 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -62.72 139.83 58.69 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.128 -0.982 . . . . 0.0 110.232 -179.272 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.578 ' CD2' ' OD1' ' A' ' 44' ' ' ASN . 9.2 t80 -101.41 150.26 23.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.365 -0.834 . . . . 0.0 108.784 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 1.1 m-20 -107.51 -15.55 14.58 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.014 -1.054 . . . . 0.0 110.357 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.578 ' OD1' ' CD2' ' A' ' 42' ' ' TYR . 22.8 m-80 60.26 92.17 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.026 -1.046 . . . . 0.0 109.215 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -122.83 28.19 7.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.194 -0.941 . . . . 0.0 109.626 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.558 ' OE2' ' CE1' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -101.42 -65.67 0.96 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.784 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.46 ' N ' ' CG ' ' A' ' 46' ' ' GLU . . . 144.34 35.38 0.07 OUTLIER Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.558 ' CE1' ' OE2' ' A' ' 46' ' ' GLU . 15.9 m-85 -61.71 -171.07 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.92 6.75 4.66 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 118.102 -1.439 . . . . 0.0 110.292 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.534 ' CZ ' ' CD2' ' A' ' 48' ' ' PHE . 1.8 p90 -96.32 -169.98 2.01 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.996 -1.065 . . . . 0.0 109.347 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 50' ' ' PHE . 6.5 t 167.95 45.21 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.272 -0.893 . . . . 0.0 109.527 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -44.54 -27.73 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 109.252 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.542 ' O ' ' CE1' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -170.99 165.98 7.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.391 -0.818 . . . . 0.0 109.66 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.57 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -78.04 -51.2 1.72 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.323 -0.86 . . . . 0.0 111.044 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 54' ' ' SER . 32.9 Cg_endo -72.77 92.41 0.79 Allowed 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.856 1.704 . . . . 0.0 109.5 -177.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.612 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 2.2 m-30 -91.85 -170.96 2.72 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.961 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.649 ' CE1' ' NE2' ' A' ' 27' ' ' HIS . 61.1 m-85 -164.29 105.55 0.88 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -74.76 139.4 43.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 109.384 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.67 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 14.6 t-105 -159.84 141.03 9.24 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.67 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.4 Cg_endo -68.16 131.21 23.06 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 C-N-CA 122.156 1.904 . . . . 0.0 111.433 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.561 HD11 ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -106.44 128.2 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.705 -0.622 . . . . 0.0 109.42 -179.614 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.474 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 1.2 mt -125.03 164.28 20.52 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.306 -0.872 . . . . 0.0 109.352 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.435 ' O ' ' OG ' ' A' ' 63' ' ' SER . 2.2 t -118.51 16.55 13.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.145 -0.972 . . . . 0.0 109.077 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.45 -156.9 0.57 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.597 -0.689 . . . . 0.0 109.487 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -116.0 54.81 0.57 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -163.32 107.17 1.03 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -1.184 . . . . 0.0 109.709 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.417 HG13 ' HZ2' ' A' ' 59' ' ' TRP . 43.5 t -47.76 160.01 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.216 -0.927 . . . . 0.0 109.099 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.548 ' C ' ' CD1' ' A' ' 68' ' ' TYR . 6.5 t80 -49.1 119.24 3.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.915 -1.116 . . . . 0.0 109.388 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -168.08 39.41 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.432 -0.793 . . . . 0.0 109.127 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.71 -0.97 6.86 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -83.95 -153.66 17.06 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.47 131.51 74.45 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.235 -1.156 . . . . 0.0 109.408 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.413 ' O ' ' O ' ' A' ' 74' ' ' GLY . 36.4 Cg_endo -79.85 -89.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.547 2.164 . . . . 0.0 110.753 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 76' ' ' ASP . . . -59.06 -112.55 0.01 OUTLIER Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.476 ' O ' ' OG1' ' A' ' 91' ' ' THR . . . 50.9 -87.23 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.383 -1.069 . . . . 0.0 110.415 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 74' ' ' GLY . 1.0 OUTLIER -117.32 116.37 27.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.928 -1.108 . . . . 0.0 109.988 -179.582 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.562 ' NH1' ' CE1' ' A' ' 38' ' ' TYR . 2.3 mtm-85 -128.78 138.14 51.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.139 -0.976 . . . . 0.0 109.138 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.555 HG13 ' OE1' ' A' ' 20' ' ' GLN . 9.8 p -123.62 142.85 38.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.459 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 23.4 t -110.59 165.88 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 122.188 0.994 . . . . 0.0 111.02 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.525 ' CE1' ' HB2' ' A' ' 57' ' ' TYR . 22.7 p90 -161.95 -170.48 2.54 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.258 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.45 ' O ' ' CD2' ' A' ' 57' ' ' TYR . 20.0 t30 -124.35 -82.15 0.64 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.006 -1.059 . . . . 0.0 109.929 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -158.08 18.68 0.24 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.409 -0.807 . . . . 0.0 109.6 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.487 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 2.7 m-20 -153.5 26.11 0.51 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.518 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 0.4 OUTLIER 53.4 19.65 1.7 Allowed 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.362 0.601 . . . . 0.0 109.557 -179.649 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.595 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -46.83 -35.32 6.19 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.093 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.595 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 92.43 110.09 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.549 0.69 . . . . 0.0 111.152 179.044 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.549 ' HB2' ' CE2' ' A' ' 56' ' ' TYR . . . -87.42 -42.22 12.99 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 151.21 146.01 4.24 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.418 HG22 ' CD2' ' A' ' 4' ' ' TYR . 61.1 t -86.8 88.81 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.029 -1.277 . . . . 0.0 109.462 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 77' ' ' ARG . 1.1 pt -79.39 170.24 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.315 -0.866 . . . . 0.0 108.785 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 75' ' ' ALA . 12.1 t -135.97 141.26 44.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.075 -1.016 . . . . 0.0 110.274 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.576 ' CD2' ' HB2' ' A' ' 98' ' ' ASN . 2.9 t60 -92.77 76.02 4.91 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 1.2 m 171.76 148.38 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.17 -20.69 46.29 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -126.43 151.9 47.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.122 -1.222 . . . . 0.0 109.665 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 95' ' ' ALA . 20.3 m -41.57 125.78 2.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.47 -0.769 . . . . 0.0 109.321 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.487 ' O ' ' C ' ' A' ' 98' ' ' ASN . . . 65.33 40.5 96.53 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.576 ' HB2' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 32.9 52.4 0.31 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 122.053 -0.675 . . . . 0.0 110.209 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -57.27 167.39 0.93 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.214 -0.929 . . . . 0.0 109.222 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.418 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -88.78 122.05 31.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.143 -0.973 . . . . 0.0 109.664 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.458 HG12 ' OE2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -136.06 152.85 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.267 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.92 131.28 49.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.14 -0.975 . . . . 0.0 109.491 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 89.8 m -54.18 148.05 11.93 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.26 -0.9 . . . . 0.0 109.627 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 109.573 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.511 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.511 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 1.6 p 165.3 126.86 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.26 -0.9 . . . . 0.0 110.291 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -96.21 -29.68 13.9 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.574 ' CD1' ' CG2' ' A' ' 89' ' ' VAL . 18.0 m-85 -91.81 103.69 16.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.479 -0.763 . . . . 0.0 109.11 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.4 m -125.83 123.92 39.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.096 -1.003 . . . . 0.0 109.89 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.8 m -103.57 16.91 25.28 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.093 0.949 . . . . 0.0 109.61 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 152.82 -88.46 0.13 Allowed Glycine 0 C--N 1.284 -2.355 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.3 m -138.4 42.14 2.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -1.146 . . . . 0.0 109.684 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.418 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 1.0 OUTLIER -103.73 -26.33 12.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.183 -0.948 . . . . 0.0 109.38 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.1 t 60.18 57.78 2.85 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.38 -0.825 . . . . 0.0 109.675 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.519 ' CE1' ' HB3' ' A' ' 63' ' ' SER . 6.2 m-30 -87.88 114.02 24.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.39 -0.819 . . . . 0.0 108.874 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.506 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -85.99 138.35 32.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.062 -1.023 . . . . 0.0 109.98 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 p -48.82 -23.13 0.97 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.369 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.8 m -77.81 -41.33 37.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.113 -0.992 . . . . 0.0 109.543 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -71.68 -28.76 63.94 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.506 HG21 ' O ' ' A' ' 12' ' ' SER . 41.4 t -65.32 -24.93 35.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.4 t -66.97 -44.59 80.08 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.72 -38.46 85.16 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.655 ' CB ' HD13 ' A' ' 61' ' ' ILE . . . -81.31 -13.99 57.81 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.573 ' OE1' ' CG ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -82.13 -27.91 32.5 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.394 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -83.32 -13.21 55.59 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.13 -50.78 20.83 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.441 -0.787 . . . . 0.0 109.266 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.514 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -77.29 -29.02 57.01 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.579 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 3.2 t80 -71.37 -27.84 63.63 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.436 -1.038 . . . . 0.0 109.114 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.455 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 1.9 tt0 -74.16 -63.04 1.31 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.112 -0.992 . . . . 0.0 108.951 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 tp -46.47 -34.74 5.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.349 -0.845 . . . . 0.0 108.972 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.576 ' NE2' ' CZ ' ' A' ' 57' ' ' TYR . 2.0 t60 -65.52 -59.23 4.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.477 -0.765 . . . . 0.0 110.093 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -83.02 10.22 8.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.246 -0.909 . . . . 0.0 109.759 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 45.7 t0 -95.84 -23.76 16.76 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.956 . . . . 0.0 109.61 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.97 -0.66 84.41 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.4 ' C ' ' OG1' ' A' ' 32' ' ' THR . 1.0 OUTLIER -97.56 -146.33 0.31 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.191 -1.182 . . . . 0.0 109.367 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.485 ' CG2' ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -168.99 -177.17 2.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -0.938 . . . . 0.0 109.523 -179.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.471 ' HB ' ' HA ' ' A' ' 69' ' ' SER . 0.3 OUTLIER -92.54 -100.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 109.057 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.505 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -94.19 30.87 7.16 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 1.0 OUTLIER 78.21 1.39 2.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.525 -0.986 . . . . 0.0 109.334 -179.482 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.53 ' O ' ' CB ' ' A' ' 37' ' ' SER . 0.5 OUTLIER -93.18 -19.36 21.53 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.334 -0.853 . . . . 0.0 109.743 -179.651 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 36' ' ' ASN . 0.8 OUTLIER 76.45 93.34 0.07 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 109.294 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.605 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -85.77 -43.53 0.62 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 111.238 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 32.9 Cg_endo -75.46 108.41 2.69 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 120.927 1.085 . . . . 0.0 110.045 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.605 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -123.79 124.68 43.23 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.3 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.523 ' HA ' ' CD1' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -49.63 125.06 10.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.387 -0.821 . . . . 0.0 110.72 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 2.1 t80 -88.83 159.45 17.71 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.433 ' O ' ' CZ ' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -169.6 35.61 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 4.2 m-20 -90.21 -171.48 3.13 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.681 0.753 . . . . 0.0 110.233 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.558 ' CG ' ' C ' ' A' ' 44' ' ' ASN . 0.2 OUTLIER -158.68 24.32 0.22 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.4 OUTLIER -36.37 -67.24 0.18 Allowed 'General case' 0 C--N 1.31 -1.144 0 O-C-N 121.784 -0.573 . . . . 0.0 110.176 -179.235 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.446 ' O ' ' OE2' ' A' ' 102' ' ' GLU . . . -167.01 41.86 0.25 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.563 ' HB3' ' CE2' ' A' ' 50' ' ' PHE . 65.7 m-85 -100.88 158.15 16.2 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.276 -1.132 . . . . 0.0 109.254 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -125.5 11.0 7.95 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.229 -0.92 . . . . 0.0 109.59 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.563 ' CE2' ' HB3' ' A' ' 48' ' ' PHE . 2.3 p90 -78.19 165.0 24.45 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.142 -0.973 . . . . 0.0 109.363 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 52' ' ' VAL . 33.3 t -144.39 34.76 1.19 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.214 -0.929 . . . . 0.0 109.594 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.529 HG11 ' HB3' ' A' ' 81' ' ' ASN . 59.8 t -44.41 -45.98 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.264 -0.898 . . . . 0.0 109.058 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.417 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 0.1 OUTLIER 172.5 157.0 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.765 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.575 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -59.28 -51.25 82.86 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.408 -0.807 . . . . 0.0 110.623 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 54' ' ' SER . 35.6 Cg_endo -75.6 83.15 1.96 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.046 1.83 . . . . 0.0 110.27 -178.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.608 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 48.7 m-85 -79.35 -172.02 3.0 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.322 0.582 . . . . 0.0 110.148 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.608 ' CG ' ' O ' ' A' ' 56' ' ' TYR . 34.3 m-85 -165.02 118.39 1.24 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.572 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -95.53 146.03 24.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 0.0 110.17 -179.36 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.602 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 8.8 t-105 -160.36 142.97 9.76 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.602 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.2 Cg_endo -67.79 138.67 45.52 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.067 1.844 . . . . 0.0 111.309 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.655 HD13 ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -110.35 133.0 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.465 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.504 ' O ' HD11 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -125.89 169.48 12.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.312 -0.867 . . . . 0.0 109.29 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.519 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 2.2 p -122.94 28.45 7.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.309 -0.869 . . . . 0.0 109.056 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.77 -12.28 8.47 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.468 -0.77 . . . . 0.0 109.446 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.82 29.46 59.2 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 67' ' ' VAL . 5.8 t0 -102.56 -3.67 26.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -1.157 . . . . 0.0 109.758 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' A' ' 66' ' ' ASP . 3.4 t 55.55 166.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.947 . . . . 0.0 109.42 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.44 ' HB2' ' HG2' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -115.18 120.96 41.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.903 . . . . 0.0 109.565 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.471 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -140.01 78.57 1.67 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.874 . . . . 0.0 109.527 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 71' ' ' GLY . . . 161.34 37.42 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 70' ' ' GLY . . . 41.95 -145.52 0.74 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.8 t 64.42 74.19 0.42 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.177 -1.19 . . . . 0.0 109.533 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.4 ' HA ' ' OH ' ' A' ' 38' ' ' TYR . 34.6 Cg_endo -77.5 -177.27 3.72 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.596 2.197 . . . . 0.0 110.321 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 173.84 76.19 0.05 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.538 ' HA ' ' N ' ' A' ' 92' ' ' HIS . . . 67.39 -143.12 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.205 -1.174 . . . . 0.0 109.813 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.527 ' O ' ' O ' ' A' ' 75' ' ' ALA . 49.8 m-20 14.29 113.54 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.504 ' O ' ' O ' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -162.86 128.95 3.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.129 -0.982 . . . . 0.0 109.264 178.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.576 HG21 HD23 ' A' ' 86' ' ' LEU . 4.6 p -116.49 140.01 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.749 -1.219 . . . . 0.0 109.227 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.498 HG11 ' HA ' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -105.0 -175.36 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 122.371 1.081 . . . . 0.0 110.628 -179.235 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.573 ' CG ' ' OE1' ' A' ' 20' ' ' GLN . 26.1 p90 179.81 -169.15 0.12 Allowed 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.529 ' HB3' HG11 ' A' ' 52' ' ' VAL . 1.7 p30 -123.09 -39.73 2.46 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.998 -1.064 . . . . 0.0 110.231 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.579 ' O ' ' CZ ' ' A' ' 24' ' ' TYR . 4.4 pt-20 159.51 -26.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.474 ' O ' ' CB ' ' A' ' 84' ' ' ASN . 0.5 OUTLIER -86.33 -5.24 59.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.338 -0.851 . . . . 0.0 109.089 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 83' ' ' ASN . 7.7 t-20 74.7 30.32 1.02 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.37 -0.831 . . . . 0.0 109.702 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.525 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -74.07 -25.74 60.0 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.218 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.576 HD23 HG21 ' A' ' 78' ' ' VAL . 0.2 OUTLIER 81.81 110.76 0.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.389 0.614 . . . . 0.0 110.195 179.306 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.406 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . . . -78.94 -39.49 34.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.389 -0.82 . . . . 0.0 109.048 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.443 ' N ' ' CD1' ' A' ' 86' ' ' LEU . . . 162.49 169.53 25.99 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.574 ' CG2' ' CD1' ' A' ' 4' ' ' TYR . 47.5 t -100.09 87.77 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.265 -1.138 . . . . 0.0 109.559 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.504 ' O ' ' O ' ' A' ' 77' ' ' ARG . 4.4 pt -90.15 146.28 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -0.864 . . . . 0.0 109.411 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 99' ' ' ASN . 9.9 t -123.17 135.19 54.21 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.625 -1.297 . . . . 0.0 110.489 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.687 ' CE1' ' CE2' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -86.39 75.66 9.76 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.368 -0.833 . . . . 0.0 109.187 179.241 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 2.3 m -179.66 -31.87 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.335 -0.853 . . . . 0.0 109.233 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -68.43 -6.99 51.5 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.438 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -139.53 123.14 17.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.136 -1.214 . . . . 0.0 109.547 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.454 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.3 OUTLIER 47.69 -165.64 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.159 -0.963 . . . . 0.0 109.156 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 96' ' ' SER . . . -40.62 -66.29 0.88 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.601 ' O ' ' CE1' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -153.58 89.5 1.34 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.27 -1.135 . . . . 0.0 109.08 179.445 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 91' ' ' THR . 0.9 OUTLIER -112.25 141.1 46.36 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.442 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.687 ' CE2' ' CE1' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -75.08 138.05 41.85 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.994 -1.066 . . . . 0.0 109.558 -179.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.53 ' CG1' ' O ' ' A' ' 100' ' ' PHE . 30.3 m -160.17 145.57 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.344 -0.848 . . . . 0.0 109.005 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.538 ' HG3' ' CD1' ' A' ' 48' ' ' PHE . 1.4 mp0 -45.46 124.26 4.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.545 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.47 130.78 40.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 109.613 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 67.6 p . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.334 -0.854 . . . . 0.0 109.514 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.495 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.8 p 164.83 124.52 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.28 -0.887 . . . . 0.0 110.06 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -104.03 -7.24 20.44 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.46 -0.775 . . . . 0.0 109.067 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.54 ' CD1' ' HB ' ' A' ' 89' ' ' VAL . 17.2 m-85 -104.71 110.09 22.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.936 . . . . 0.0 109.382 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 82.8 p -142.31 118.4 10.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.285 -0.885 . . . . 0.0 109.804 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -124.44 11.6 8.66 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 122.317 1.056 . . . . 0.0 109.436 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 8' ' ' SER . . . -160.94 32.74 0.38 Allowed Glycine 0 C--N 1.282 -2.454 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 3.9 t 70.95 9.32 6.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.316 -1.108 . . . . 0.0 109.315 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -78.1 178.06 7.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 109.556 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 51.8 t -127.74 70.22 1.33 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.341 -0.849 . . . . 0.0 109.084 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.403 ' HB2' ' O ' ' A' ' 4' ' ' TYR . 3.5 m-85 -79.63 118.68 21.68 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.262 -0.899 . . . . 0.0 109.543 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 48.8 m -80.21 133.76 36.05 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.491 -0.756 . . . . 0.0 109.958 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.95 -30.32 10.11 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 t -73.43 -38.99 65.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.362 -0.836 . . . . 0.0 109.076 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -67.95 -26.04 65.75 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 19.4 t -77.15 -29.08 16.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.429 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 0.2 OUTLIER -67.66 -37.84 82.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.422 -0.799 . . . . 0.0 109.382 179.688 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -47.05 86.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.133 -0.98 . . . . 0.0 108.433 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.492 ' CB ' HD11 ' A' ' 61' ' ' ILE . . . -73.25 -17.98 61.28 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.573 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -76.45 -32.13 58.25 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.438 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -79.12 -8.31 58.88 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.29 -55.92 4.06 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.352 -0.843 . . . . 0.0 108.843 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.565 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -68.22 -20.86 73.56 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.577 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 1.0 OUTLIER -81.84 -58.08 3.15 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.586 -0.949 . . . . 0.0 109.521 -179.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -49.15 -36.45 19.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.13 -0.981 . . . . 0.0 109.486 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.567 HD11 ' CB ' ' A' ' 31' ' ' GLU . 1.2 mm? -72.61 -40.24 66.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.351 -0.843 . . . . 0.0 109.278 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.664 ' CE1' ' CE1' ' A' ' 57' ' ' TYR . 2.6 t60 -61.38 -32.78 72.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.438 -0.789 . . . . 0.0 110.433 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.509 ' OE1' ' CZ ' ' A' ' 24' ' ' TYR . 4.2 pt-20 -86.69 -26.23 24.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.951 -1.093 . . . . 0.0 109.812 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -84.86 -6.54 59.35 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.1 -1.0 . . . . 0.0 109.547 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.79 -28.31 6.59 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.567 ' CB ' HD11 ' A' ' 26' ' ' LEU . 3.1 mm-40 -58.61 -166.94 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.172 -1.193 . . . . 0.0 109.454 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.49 ' HB ' ' HA ' ' A' ' 37' ' ' SER . 0.4 OUTLIER -155.83 -93.61 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.886 . . . . 0.0 109.524 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.588 ' CG2' ' CA ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -134.67 -167.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.129 -0.982 . . . . 0.0 109.318 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -40.73 -37.41 1.3 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 t -176.37 -51.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -1.186 . . . . 0.0 109.814 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.548 ' O ' ' CB ' ' A' ' 37' ' ' SER . 35.3 m120 -51.39 -86.0 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.156 -0.965 . . . . 0.0 109.645 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.588 ' CA ' ' CG2' ' A' ' 33' ' ' VAL . 0.3 OUTLIER 160.33 -178.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.537 ' C ' ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER 175.46 -49.38 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.917 -1.114 . . . . 0.0 112.302 178.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 31.4 Cg_endo -75.3 100.55 1.38 Allowed 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 121.215 1.276 . . . . 0.0 112.094 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.537 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -140.72 137.12 33.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.693 -0.629 . . . . 0.0 109.356 178.66 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -42.77 133.84 3.42 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.396 -0.815 . . . . 0.0 110.318 -179.059 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.586 ' OH ' ' CD1' ' A' ' 100' ' ' PHE . 30.2 t80 -94.09 159.43 15.16 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.385 -0.822 . . . . 0.0 109.031 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' A' ' 44' ' ' ASN . 7.9 m-80 -106.63 -39.98 5.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.073 -1.017 . . . . 0.0 110.11 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.514 ' CA ' ' CE2' ' A' ' 42' ' ' TYR . 0.1 OUTLIER 62.92 127.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.11 -0.993 . . . . 0.0 108.764 -179.49 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.482 ' O ' ' C ' ' A' ' 46' ' ' GLU . 1.4 m-85 -161.68 -36.25 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.093 -1.004 . . . . 0.0 110.052 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.482 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -34.75 -72.83 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.671 -0.643 . . . . 0.0 110.412 -179.322 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 171.2 56.46 0.04 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.424 ' C ' ' OD1' ' A' ' 49' ' ' ASP . 90.6 m-85 -86.66 177.97 7.19 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.204 -1.174 . . . . 0.0 108.407 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.424 ' OD1' ' C ' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -131.19 11.25 4.99 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.986 -1.071 . . . . 0.0 110.095 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 87' ' ' ALA . 0.7 OUTLIER -88.61 -174.95 4.76 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.036 -1.04 . . . . 0.0 109.201 179.542 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.0 m -173.86 40.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.212 -0.93 . . . . 0.0 109.521 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.0 t -52.24 -39.42 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.296 -0.878 . . . . 0.0 109.284 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.5 ' OG ' ' CB ' ' A' ' 81' ' ' ASN . 32.9 p -177.86 151.37 0.69 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 109.671 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.578 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -59.2 -52.74 72.39 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.333 -0.854 . . . . 0.0 110.08 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 54' ' ' SER . 35.9 Cg_endo -75.48 86.54 1.46 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.989 1.792 . . . . 0.0 109.511 -178.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.604 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 10.6 m-85 -78.84 -169.15 1.66 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.664 ' CE1' ' CE1' ' A' ' 27' ' ' HIS . 66.0 m-85 -162.72 106.73 1.11 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 40' ' ' HIS . 4.1 pt-20 -78.87 137.22 37.57 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.743 0.782 . . . . 0.0 110.726 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.618 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 26.6 t-105 -160.82 139.82 7.71 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.618 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.8 Cg_endo -70.35 158.95 54.61 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.273 1.982 . . . . 0.0 111.749 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.492 HD11 ' CB ' ' A' ' 19' ' ' ALA . 0.2 OUTLIER -132.41 136.6 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.525 -0.734 . . . . 0.0 109.225 -179.547 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.498 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -121.31 174.96 6.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.106 -0.996 . . . . 0.0 109.775 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.67 31.6 4.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.911 . . . . 0.0 109.189 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.94 -58.72 2.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.376 -0.828 . . . . 0.0 109.399 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.31 52.37 0.03 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -156.67 150.55 24.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -1.175 . . . . 0.0 109.548 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.3 t -83.66 133.25 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.351 -0.843 . . . . 0.0 109.351 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.553 ' CD2' ' HB2' ' A' ' 60' ' ' PRO . 0.7 OUTLIER -56.06 135.67 52.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -0.954 . . . . 0.0 109.508 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.441 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -151.58 52.35 0.83 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.264 -0.897 . . . . 0.0 109.265 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.38 158.21 33.28 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.74 79.18 0.63 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.3 m 53.77 87.4 0.14 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.238 -1.154 . . . . 0.0 109.767 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.6 170.47 19.16 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.653 2.235 . . . . 0.0 110.261 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.14 -164.25 12.49 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 69.38 -162.08 0.18 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.29 -1.123 . . . . 0.0 110.488 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 91' ' ' THR . 38.9 m-20 -46.98 165.86 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.678 0.751 . . . . 0.0 110.787 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.509 ' O ' HG12 ' A' ' 90' ' ' ILE . 36.1 ttm180 -172.82 104.68 0.14 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.678 ' CG2' HD13 ' A' ' 86' ' ' LEU . 4.2 p -79.68 152.22 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.895 -1.128 . . . . 0.0 110.154 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.57 HG11 ' N ' ' A' ' 80' ' ' PHE . 44.7 t -120.32 165.13 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.879 0.847 . . . . 0.0 109.83 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.573 ' CD1' ' OE1' ' A' ' 20' ' ' GLN . 8.4 p90 -165.63 -169.49 1.57 Allowed 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.746 -0.781 . . . . 0.0 109.426 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.571 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 1.9 p30 -122.28 -46.47 2.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.009 -1.057 . . . . 0.0 110.48 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.577 ' O ' ' CZ ' ' A' ' 24' ' ' TYR . 0.7 OUTLIER 163.31 -23.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -179.674 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.414 ' HB3' ' OE1' ' A' ' 85' ' ' GLN . 1.9 m-20 -86.95 14.29 7.63 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.469 ' O ' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER 71.93 6.3 5.57 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.442 -0.787 . . . . 0.0 109.048 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -58.38 -162.34 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 178.766 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.678 HD13 ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -143.55 107.72 4.75 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.663 -1.273 . . . . 0.0 110.567 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.556 ' O ' ' CD2' ' A' ' 50' ' ' PHE . . . -69.27 -36.73 77.41 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 149.46 162.77 10.6 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.54 ' HB ' ' CD1' ' A' ' 4' ' ' TYR . 41.8 t -101.07 87.95 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -1.149 . . . . 0.0 109.547 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -82.6 154.0 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.561 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 100' ' ' PHE . 9.5 t -110.73 162.47 14.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.979 -1.075 . . . . 0.0 110.808 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.615 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 2.0 t60 -119.66 53.88 1.03 Allowed 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 40.7 m -172.55 125.82 0.5 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.497 -0.752 . . . . 0.0 109.229 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 119.72 -14.93 10.56 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 98' ' ' ASN . . . -117.74 86.41 2.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.18 -1.188 . . . . 0.0 109.546 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER 42.11 74.13 0.12 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.545 -0.722 . . . . 0.0 109.119 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.55 -76.9 0.73 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.761 -1.735 . . . . 0.0 108.761 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.615 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -150.17 -84.08 0.09 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.258 -1.142 . . . . 0.0 109.43 179.717 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 91' ' ' THR . 1.6 t30 63.57 152.11 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.348 -0.845 . . . . 0.0 109.124 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.586 ' CD1' ' OH ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -96.53 143.78 27.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 109.776 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.7 m -158.03 131.41 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.475 -0.766 . . . . 0.0 109.159 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -45.45 126.15 6.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.34 -0.85 . . . . 0.0 109.559 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 1.3 m -49.05 165.85 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.259 -0.901 . . . . 0.0 109.645 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.489 1.482 0 O-C-N 121.27 -0.893 . . . . 0.0 109.508 -179.864 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 32.1 p -173.74 115.19 0.23 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.191 -0.943 . . . . 0.0 110.07 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -78.11 -45.38 23.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 0.0 109.212 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.554 ' CE1' ' HB ' ' A' ' 89' ' ' VAL . 28.1 m-85 -74.07 95.82 2.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.0 109.029 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -108.56 67.64 0.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 110.008 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.408 ' O ' ' C ' ' A' ' 7' ' ' GLY . 4.1 m -84.16 156.64 21.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 109.071 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 6' ' ' CYS . . . 44.6 -107.8 0.16 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.5 p -142.5 41.25 1.6 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.172 -1.193 . . . . 0.0 109.459 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -118.89 140.59 49.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 0.0 109.566 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -89.86 66.88 7.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -78.76 114.82 18.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 0.0 108.855 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.614 ' O ' HG23 ' A' ' 16' ' ' VAL . 1.0 OUTLIER -88.73 148.78 23.8 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.321 -0.862 . . . . 0.0 110.505 -179.181 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -13.39 18.38 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.85 -36.49 12.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.26 -0.9 . . . . 0.0 109.75 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.15 -30.55 62.32 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.987 -1.071 . . . . 0.0 108.117 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 12' ' ' SER . 3.8 t -62.38 -31.1 50.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.11 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 t -58.57 -45.24 89.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.282 -0.886 . . . . 0.0 109.866 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.9 m -65.73 -52.02 54.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.578 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.549 ' CB ' ' CD1' ' A' ' 61' ' ' ILE . . . -74.36 -6.6 49.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.287 -0.883 . . . . 0.0 109.579 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.601 ' NE2' ' CD1' ' A' ' 80' ' ' PHE . 4.3 tp60 -99.69 -15.85 18.38 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.39 -17.72 29.9 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.12 -57.82 3.65 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.42 -28.33 6.41 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.538 ' CE1' ' HA ' ' A' ' 82' ' ' GLU . 24.7 t80 -77.35 -48.4 17.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.602 -0.94 . . . . 0.0 109.596 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.09 -40.97 67.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.126 -0.984 . . . . 0.0 108.858 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.5 ' CD1' ' O ' ' A' ' 31' ' ' GLU . 1.9 tm? -65.84 -43.61 87.99 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.613 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 19.5 t60 -67.55 -17.9 64.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.368 -0.833 . . . . 0.0 109.765 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.95 11.19 31.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 109.579 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -122.63 -0.22 9.21 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.346 -0.846 . . . . 0.0 109.451 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.85 21.03 58.07 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.5 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 3.4 mt-10 -102.35 -166.99 1.34 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.366 -1.079 . . . . 0.0 109.36 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.493 ' CG2' ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -147.26 173.66 12.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.242 -0.911 . . . . 0.0 109.513 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.8 m -89.02 -138.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.41 -0.806 . . . . 0.0 108.968 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.5 33.49 5.99 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.6 p -161.43 -154.3 0.34 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -1.152 . . . . 0.0 109.955 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.416 ' O ' ' CB ' ' A' ' 37' ' ' SER . 2.2 m120 -53.32 -60.98 2.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 110.101 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.493 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 0.6 OUTLIER 168.76 108.34 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.404 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.724 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.4 OUTLIER -82.51 -34.31 0.65 Allowed Pre-proline 0 C--O 1.2 -1.507 0 O-C-N 121.01 -1.056 . . . . 0.0 112.221 -178.804 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 35.9 Cg_endo -79.13 109.05 2.47 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 N-CA-C 109.874 -0.856 . . . . 0.0 109.874 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.724 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -133.58 177.53 7.63 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.559 ' HB2' ' CE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -97.51 129.73 44.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.058 -1.027 . . . . 0.0 110.456 -178.626 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.53 ' HB2' ' HG3' ' A' ' 58' ' ' GLU . 10.6 t80 -94.38 168.84 10.63 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.63 ' ND2' ' CE1' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -145.33 18.41 1.54 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.019 -1.051 . . . . 0.0 110.129 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 62.03 108.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.069 -1.019 . . . . 0.0 109.738 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.63 ' CE1' ' ND2' ' A' ' 43' ' ' ASN . 3.3 m-30 -114.91 -4.9 12.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.331 -0.855 . . . . 0.0 109.44 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.552 ' CD ' ' CE1' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -110.88 -33.86 6.4 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.115 -0.991 . . . . 0.0 108.787 -179.431 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.01 28.65 2.81 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.552 ' CE1' ' CD ' ' A' ' 46' ' ' GLU . 48.3 m-85 -61.66 -168.18 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 4.8 m-20 -139.1 -44.15 0.46 Allowed 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 118.557 -1.257 . . . . 0.0 109.771 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 49' ' ' ASP . 20.0 m-85 64.17 177.58 0.18 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.323 -0.86 . . . . 0.0 109.478 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.9 -18.58 17.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.232 -0.917 . . . . 0.0 109.07 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.505 HG23 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -98.0 -176.49 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.338 -0.851 . . . . 0.0 108.896 179.609 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.455 ' HA ' ' OH ' ' A' ' 56' ' ' TYR . 12.6 t -151.37 86.42 1.35 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.108 -0.995 . . . . 0.0 109.52 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.589 ' CB ' ' HD2' ' A' ' 55' ' ' PRO . 0.3 OUTLIER -172.58 -176.56 0.34 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.072 -1.018 . . . . 0.0 109.53 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.589 ' HD2' ' CB ' ' A' ' 54' ' ' SER . 29.4 Cg_endo -71.79 96.36 0.76 Allowed 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 121.489 1.459 . . . . 0.0 108.55 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.559 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 24.0 m-85 -75.95 -170.94 1.5 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.777 0.798 . . . . 0.0 110.694 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.613 ' CE2' ' NE2' ' A' ' 27' ' ' HIS . 49.4 m-85 -150.72 147.18 27.03 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.624 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 1.2 mp0 -96.96 146.29 25.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.872 -1.142 . . . . 0.0 110.365 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.603 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 46.3 t-105 -159.45 135.7 6.36 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.603 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 31.9 Cg_endo -72.75 148.68 47.04 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 121.922 1.748 . . . . 0.0 111.115 -178.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.549 ' CD1' ' CB ' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -122.53 142.19 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.531 ' H ' HD13 ' A' ' 61' ' ' ILE . 1.4 mt -122.51 -170.67 2.12 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.249 -0.907 . . . . 0.0 109.383 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.57 54.8 0.93 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 108.928 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -157.75 -43.8 0.06 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.391 -0.818 . . . . 0.0 109.464 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.98 39.45 3.56 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.3 18.22 17.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -1.146 . . . . 0.0 109.464 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 t 62.3 167.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.902 . . . . 0.0 109.693 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.546 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 6.1 t80 -106.86 139.13 41.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.343 -0.848 . . . . 0.0 109.591 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.8 m -122.46 -20.21 6.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.243 -0.911 . . . . 0.0 109.636 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 163.73 148.27 5.35 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 144.3 -142.95 11.51 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.445 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 20.3 m -51.89 118.15 11.26 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.217 -1.166 . . . . 0.0 109.323 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.518 ' O ' ' NH1' ' A' ' 77' ' ' ARG . 35.7 Cg_endo -77.72 -75.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.452 2.101 . . . . 0.0 110.571 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 73' ' ' PRO . . . -59.13 -117.83 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . 49.54 -167.18 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.278 -1.131 . . . . 0.0 109.704 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 75' ' ' ALA . 1.1 m-20 -42.04 147.82 0.21 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.276 -0.89 . . . . 0.0 109.864 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.518 ' NH1' ' O ' ' A' ' 73' ' ' PRO . 2.2 ttm180 -164.82 70.84 0.17 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.421 -0.799 . . . . 0.0 109.372 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.532 ' CG2' ' OE1' ' A' ' 20' ' ' GLN . 10.9 p -44.72 149.75 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 109.284 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.569 ' CG1' ' CB ' ' A' ' 87' ' ' ALA . 0.4 OUTLIER -121.0 171.92 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.02 -1.05 . . . . 0.0 110.338 -179.484 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.601 ' CD1' ' NE2' ' A' ' 20' ' ' GLN . 19.2 p90 -172.04 -167.52 0.49 Allowed 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.102 -178.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.522 ' N ' ' OD1' ' A' ' 81' ' ' ASN . 0.2 OUTLIER -132.54 -78.47 0.5 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.829 -1.17 . . . . 0.0 109.837 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.538 ' HA ' ' CE1' ' A' ' 24' ' ' TYR . 10.3 pt-20 -160.76 24.58 0.14 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.37 -0.831 . . . . 0.0 109.176 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.442 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 4.3 m120 -146.03 17.55 1.4 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.456 -0.777 . . . . 0.0 109.241 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.442 ' CG ' ' O ' ' A' ' 83' ' ' ASN . 8.3 p30 47.45 25.68 0.65 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.42 -0.8 . . . . 0.0 109.216 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.568 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -70.29 -27.6 64.53 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.568 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER 85.87 115.87 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.58 0.705 . . . . 0.0 110.739 179.044 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.569 ' CB ' ' CG1' ' A' ' 79' ' ' VAL . . . -96.3 -30.72 13.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.507 -0.746 . . . . 0.0 108.999 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.416 ' N ' ' CD1' ' A' ' 86' ' ' LEU . . . 158.08 -153.77 24.92 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.554 ' HB ' ' CE1' ' A' ' 4' ' ' TYR . 42.8 t -147.09 127.72 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.025 -1.279 . . . . 0.0 109.795 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.509 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -114.34 144.91 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.553 -0.717 . . . . 0.0 109.142 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.461 HG22 HG22 ' A' ' 101' ' ' VAL . 6.2 t -133.43 123.93 26.19 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.091 -1.006 . . . . 0.0 109.933 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.565 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -79.37 84.05 5.33 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.541 -0.724 . . . . 0.0 109.477 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.403 ' OG1' ' C ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 176.1 127.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.423 -0.798 . . . . 0.0 109.251 179.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.98 -18.3 28.93 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 99' ' ' ASN . . . -115.46 90.78 3.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.364 -1.08 . . . . 0.0 109.413 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.4 OUTLIER 43.95 78.95 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 109.346 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.91 -88.91 1.59 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.565 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -125.56 -90.55 0.55 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.213 -1.169 . . . . 0.0 109.376 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 98' ' ' ASN . 0.7 OUTLIER 61.08 136.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -0.961 . . . . 0.0 109.059 -179.584 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.515 ' CD1' ' ND1' ' A' ' 92' ' ' HIS . 21.8 m-85 -79.66 155.28 28.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.834 -1.166 . . . . 0.0 110.195 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -160.7 133.85 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.141 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -54.5 126.15 22.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.336 -0.853 . . . . 0.0 109.611 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 1.3 m -68.48 109.29 3.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.408 -0.808 . . . . 0.0 109.819 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.944 . . . . 0.0 109.477 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.507 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.8 p 167.14 130.33 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.218 -0.926 . . . . 0.0 110.065 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -103.87 -9.83 18.66 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.443 -0.786 . . . . 0.0 109.344 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.602 ' CD2' ' CG2' ' A' ' 89' ' ' VAL . 19.4 m-85 -109.54 132.16 54.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.308 -0.87 . . . . 0.0 109.247 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 m -155.82 113.37 3.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.134 -0.979 . . . . 0.0 109.611 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.4 m -94.27 17.35 12.93 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 122.112 0.958 . . . . 0.0 109.691 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.91 -71.44 0.2 Allowed Glycine 0 C--N 1.283 -2.378 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.7 m -162.62 49.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.314 -1.11 . . . . 0.0 109.239 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.557 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . 6.9 m120 -103.12 -28.88 11.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.308 -0.87 . . . . 0.0 109.771 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 44.4 t 59.42 63.07 1.63 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.132 -0.98 . . . . 0.0 109.102 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.557 ' CE2' ' CB ' ' A' ' 9' ' ' ASN . 40.8 m-85 -79.13 122.41 26.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.445 -0.784 . . . . 0.0 109.144 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -79.59 133.23 36.43 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.422 -0.799 . . . . 0.0 109.61 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.5 t -52.48 -19.93 2.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.202 -0.936 . . . . 0.0 109.063 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.54 -36.8 18.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 110.015 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -74.59 -27.13 60.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.009 -1.057 . . . . 0.0 108.194 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 19.3 t -69.5 -33.18 55.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -34.91 78.62 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -38.01 82.48 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.595 ' CB ' HD11 ' A' ' 61' ' ' ILE . . . -84.91 -7.67 59.07 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.571 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -90.73 -28.12 18.5 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.276 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -79.5 -11.83 59.89 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.663 ' HB1' HG11 ' A' ' 67' ' ' VAL . . . -80.22 -39.1 29.77 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.542 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -85.52 -15.46 66.06 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -88.7 -58.51 2.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.392 -1.064 . . . . 0.0 109.13 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -53.56 -35.2 60.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 109.298 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.17 -46.96 69.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.328 -0.858 . . . . 0.0 109.222 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -49.85 -42.27 47.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.413 -0.804 . . . . 0.0 110.229 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.39 -20.67 27.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.128 -0.983 . . . . 0.0 110.037 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.463 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 28.2 t0 -74.99 -20.23 59.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.128 -0.982 . . . . 0.0 109.54 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.92 19.7 78.54 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 29' ' ' ASP . 0.8 OUTLIER -103.91 -169.3 1.61 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.346 -1.09 . . . . 0.0 109.472 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.523 ' CG2' ' CB ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -135.67 -170.69 2.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.322 -0.861 . . . . 0.0 109.288 179.71 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.43 ' CG1' ' HA ' ' A' ' 69' ' ' SER . 64.2 t -89.86 -98.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.304 -0.873 . . . . 0.0 109.321 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -124.52 -8.64 5.77 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER 163.72 -46.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.281 -1.129 . . . . 0.0 109.315 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 37' ' ' SER . 1.6 m-80 -82.19 5.37 20.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.608 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.523 ' CB ' ' CG2' ' A' ' 32' ' ' THR . 81.6 p 45.29 -162.15 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.931 . . . . 0.0 108.876 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.587 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER 167.01 -44.31 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.142 -0.974 . . . . 0.0 111.911 179.243 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 31.1 Cg_endo -74.42 99.75 1.24 Allowed 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.466 1.444 . . . . 0.0 112.274 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.543 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -144.76 -173.89 4.19 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.284 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.536 ' HB2' ' CE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -96.45 126.04 41.37 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.041 -1.037 . . . . 0.0 109.966 -179.167 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.558 ' CE2' ' HA ' ' A' ' 44' ' ' ASN . 8.2 t80 -105.22 139.45 39.86 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.505 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 9.5 m120 -70.41 -46.71 63.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.171 -0.956 . . . . 0.0 110.098 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.558 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 0.2 OUTLIER 76.47 55.85 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.269 -0.894 . . . . 0.0 109.008 -179.403 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -106.09 46.84 0.9 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.269 -0.895 . . . . 0.0 109.483 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.529 ' OE2' ' CG1' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -101.12 -28.76 12.51 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.659 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.33 19.98 3.07 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.609 ' CD2' ' CZ ' ' A' ' 50' ' ' PHE . 59.7 m-85 -63.41 -169.15 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -154.43 36.54 0.42 Allowed 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 118.565 -1.254 . . . . 0.0 109.918 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.609 ' CZ ' ' CD2' ' A' ' 48' ' ' PHE . 6.7 m-85 -62.16 -175.14 0.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.038 -1.039 . . . . 0.0 109.41 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 p -144.72 35.38 1.15 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.384 -0.822 . . . . 0.0 109.038 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.8 t -92.9 -71.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.334 -0.853 . . . . 0.0 109.826 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 t -161.68 178.15 9.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.796 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.569 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -79.24 -51.45 1.26 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.349 -0.844 . . . . 0.0 110.654 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 54' ' ' SER . 34.6 Cg_endo -76.06 85.62 1.63 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 121.992 1.795 . . . . 0.0 110.352 -177.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.585 ' O ' ' CD1' ' A' ' 57' ' ' TYR . 48.2 m-85 -79.12 -178.37 6.11 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.394 0.616 . . . . 0.0 109.862 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.585 ' CD1' ' O ' ' A' ' 56' ' ' TYR . 48.3 m-85 -150.88 145.01 25.37 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -104.21 138.52 40.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.234 -0.916 . . . . 0.0 110.6 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.633 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 22.6 t-105 -160.8 138.93 7.23 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.633 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.9 Cg_endo -67.53 142.22 58.35 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.119 1.88 . . . . 0.0 111.274 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.595 HD11 ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -118.63 131.67 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.729 -0.607 . . . . 0.0 109.417 -179.263 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.522 ' O ' HD12 ' A' ' 61' ' ' ILE . 2.9 mt -120.89 165.51 15.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.225 -0.922 . . . . 0.0 109.756 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.546 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 92.9 p -111.11 -1.88 16.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.086 -1.009 . . . . 0.0 108.816 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.58 -37.93 62.8 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.606 -0.683 . . . . 0.0 109.507 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.25 46.15 1.1 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.15 146.44 27.67 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.312 -1.11 . . . . 0.0 109.36 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.663 HG11 ' HB1' ' A' ' 22' ' ' ALA . 73.8 t -66.35 136.44 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.156 -0.965 . . . . 0.0 109.343 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.517 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 20.1 t80 -47.91 147.4 2.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.894 . . . . 0.0 109.638 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.43 ' HA ' ' CG1' ' A' ' 33' ' ' VAL . 5.4 t -174.82 54.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.529 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.2 119.45 4.62 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.1 -133.19 2.8 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.1 114.55 63.5 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.26 -1.141 . . . . 0.0 109.451 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.02 121.05 5.99 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.336 2.024 . . . . 0.0 110.362 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.516 ' O ' ' NH1' ' A' ' 77' ' ' ARG . . . 110.61 -138.48 14.95 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.479 ' N ' ' HB2' ' A' ' 92' ' ' HIS . . . 64.04 -86.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -1.116 . . . . 0.0 110.222 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.432 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 7.4 m-20 -132.52 110.48 10.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.939 -1.1 . . . . 0.0 110.157 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.522 ' CZ ' ' HB3' ' A' ' 60' ' ' PRO . 3.7 mpt_? -116.58 146.12 42.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.448 -0.782 . . . . 0.0 109.024 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.6 p -113.95 134.8 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.053 -1.029 . . . . 0.0 109.33 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.554 ' CG1' ' N ' ' A' ' 80' ' ' PHE . 58.4 t -97.4 166.04 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-O 121.95 0.881 . . . . 0.0 110.472 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.571 ' CD1' ' OE1' ' A' ' 20' ' ' GLN . 7.1 p90 -164.83 -171.44 2.28 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -126.23 -83.47 0.62 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.842 -1.161 . . . . 0.0 109.977 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -151.43 8.59 0.53 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.418 -0.801 . . . . 0.0 110.37 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -138.34 15.07 2.79 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.907 -1.121 . . . . 0.0 108.562 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.459 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 38.4 t30 59.04 30.97 20.92 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.42 -0.8 . . . . 0.0 109.063 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.561 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -63.84 -26.4 68.6 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.067 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.561 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER 85.81 109.0 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.488 0.661 . . . . 0.0 110.652 179.05 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.543 ' O ' ' CD1' ' A' ' 50' ' ' PHE . . . -83.04 -37.79 23.43 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 153.01 168.25 16.69 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.602 ' CG2' ' CD2' ' A' ' 4' ' ' TYR . 44.9 t -104.46 102.36 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.158 -1.201 . . . . 0.0 109.343 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.463 HG13 ' HB3' ' A' ' 100' ' ' PHE . 0.5 OUTLIER -93.31 168.44 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.428 -0.795 . . . . 0.0 109.889 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.523 HG22 HG23 ' A' ' 101' ' ' VAL . 5.4 t -106.48 -173.41 2.29 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.456 -0.778 . . . . 0.0 110.387 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.523 ' CE1' ' CE1' ' A' ' 100' ' ' PHE . 0.5 OUTLIER -148.82 62.95 1.06 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.506 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 1.2 m 172.79 -28.61 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.758 -0.589 . . . . 0.0 109.883 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.9 -9.2 52.37 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 120.033 -1.079 . . . . 0.0 110.654 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -120.1 176.7 5.31 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.932 -1.334 . . . . 0.0 109.805 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.2 OUTLIER -41.53 124.37 2.43 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.676 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.18 -88.69 0.12 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 107.962 -2.055 . . . . 0.0 107.962 -178.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -165.56 38.24 0.06 Allowed 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.088 -1.243 . . . . 0.0 109.444 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 98' ' ' ASN . 12.3 t-20 -50.72 179.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.077 -1.015 . . . . 0.0 108.762 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -106.1 146.84 29.66 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.857 -1.152 . . . . 0.0 109.197 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.531 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -160.27 140.88 3.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -39.42 138.67 0.64 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.549 -0.719 . . . . 0.0 110.132 -179.119 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.415 ' SG ' ' HB ' ' A' ' 91' ' ' THR . 4.2 m -94.48 97.82 10.42 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.355 -0.841 . . . . 0.0 109.568 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 109.28 179.902 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.229 0.538 . . . . 0.0 109.654 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 32.0 p 178.2 133.02 0.07 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.356 -0.84 . . . . 0.0 109.843 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -94.96 -35.57 11.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 0.0 108.987 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.676 ' CD2' HG22 ' A' ' 89' ' ' VAL . 66.8 m-85 -92.34 81.87 4.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.36 -0.837 . . . . 0.0 109.017 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.482 ' CG2' ' O ' ' A' ' 5' ' ' THR . 9.8 t -93.98 89.56 6.11 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.321 -0.862 . . . . 0.0 110.149 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.436 ' CB ' ' OD1' ' A' ' 76' ' ' ASP . 0.1 OUTLIER -89.57 -165.05 1.25 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.904 . . . . 0.0 109.0 179.369 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.446 ' O ' ' OG ' ' A' ' 8' ' ' SER . . . -59.13 95.56 0.07 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.454 ' O ' ' OG ' ' A' ' 8' ' ' SER . 4.5 p 65.7 49.2 1.78 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -1.159 . . . . 0.0 109.648 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.432 ' ND2' ' OD2' ' A' ' 76' ' ' ASP . 0.2 OUTLIER -123.8 -71.85 0.7 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.358 -0.839 . . . . 0.0 109.283 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.46 ' C ' ' CB ' ' A' ' 2' ' ' CYS . 50.6 t 53.01 51.69 15.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 109.654 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.527 ' CD1' ' HB3' ' A' ' 63' ' ' SER . 4.3 m-85 -93.43 144.59 25.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.411 -0.805 . . . . 0.0 108.951 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -83.64 134.4 34.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 110.095 -179.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.489 ' HA ' HG23 ' A' ' 16' ' ' VAL . 4.2 p -50.85 -25.4 4.47 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.43 -42.63 61.78 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.316 -0.865 . . . . 0.0 108.944 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.31 -19.42 61.04 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.489 HG23 ' HA ' ' A' ' 13' ' ' SER . 12.2 t -78.81 -29.02 14.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.412 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 0.6 OUTLIER -65.44 -34.39 78.18 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.228 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -53.7 27.54 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.543 ' CB ' HD11 ' A' ' 61' ' ' ILE . . . -62.08 -18.28 60.21 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.543 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -76.13 -37.48 57.97 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.289 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -74.64 -3.27 30.2 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.07 -63.21 1.39 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.378 -0.826 . . . . 0.0 108.776 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.573 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -62.38 -16.88 55.49 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.413 ' CD1' ' C ' ' A' ' 24' ' ' TYR . 1.1 t80 -83.34 -62.65 1.53 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.562 -0.963 . . . . 0.0 109.014 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 2.8 tt0 -48.38 -34.38 10.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.169 -0.957 . . . . 0.0 108.88 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.476 HD13 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -69.46 -44.57 70.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.506 -0.747 . . . . 0.0 109.51 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -59.27 -38.11 79.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.47 -0.769 . . . . 0.0 110.297 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -89.6 -14.79 34.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.105 -0.997 . . . . 0.0 110.352 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -83.48 -10.71 58.18 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.102 -0.999 . . . . 0.0 109.214 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 63.2 11.44 39.4 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -88.02 -144.66 0.13 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.403 -1.057 . . . . 0.0 109.057 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.476 ' N ' HD13 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -167.67 175.22 7.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.002 -1.061 . . . . 0.0 109.688 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.17 -94.68 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.235 -0.915 . . . . 0.0 109.87 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.402 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -88.77 32.83 4.4 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 1.2 m 67.61 8.59 6.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.195 -1.179 . . . . 0.0 109.332 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.4 ' O ' ' CB ' ' A' ' 37' ' ' SER . 2.4 m120 -102.03 -14.42 17.15 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.198 -0.939 . . . . 0.0 109.503 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.435 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 0.9 OUTLIER 68.28 105.15 0.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.866 . . . . 0.0 109.255 -179.763 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.599 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -116.66 -33.16 0.08 OUTLIER Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 114.274 1.212 . . . . 0.0 114.274 -178.443 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 36.4 Cg_endo -80.62 101.88 1.35 Allowed 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.291 1.327 . . . . 0.0 112.734 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.594 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -135.11 -167.3 1.97 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.104 -0.997 . . . . 0.0 109.259 177.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 8.8 ptmm? -76.33 179.03 6.06 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.496 -0.753 . . . . 0.0 109.654 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.706 ' CE1' ' CD1' ' A' ' 100' ' ' PHE . 7.0 t80 -139.21 98.02 3.42 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.322 -0.861 . . . . 0.0 108.894 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.528 ' O ' ' CE1' ' A' ' 45' ' ' TYR . 8.1 m120 -61.29 -20.2 62.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.423 -0.798 . . . . 0.0 109.772 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.613 ' O ' ' CB ' ' A' ' 45' ' ' TYR . 10.2 p-10 40.24 -144.0 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.534 -0.729 . . . . 0.0 109.901 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.613 ' CB ' ' O ' ' A' ' 44' ' ' ASN . 18.4 m-30 107.11 -20.76 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.559 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 2.2 tm-20 -40.4 -33.46 0.26 Allowed 'General case' 0 C--N 1.309 -1.189 0 O-C-N 121.06 -1.025 . . . . 0.0 110.343 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.73 -15.74 0.72 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.559 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -104.02 159.91 15.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.104 -1.233 . . . . 0.0 108.815 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.491 ' C ' ' CG ' ' A' ' 50' ' ' PHE . 1.4 t0 -143.88 -36.3 0.35 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.199 -0.938 . . . . 0.0 109.837 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.491 ' CG ' ' C ' ' A' ' 49' ' ' ASP . 5.5 m-85 74.82 177.63 0.22 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.137 -0.977 . . . . 0.0 109.457 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.98 41.2 3.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.177 -0.952 . . . . 0.0 109.535 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.438 ' CG1' ' HB2' ' A' ' 81' ' ' ASN . 3.3 t -100.97 -72.19 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.334 -0.854 . . . . 0.0 109.337 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.442 ' O ' ' CE2' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -159.09 167.91 27.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.093 -1.004 . . . . 0.0 110.174 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.57 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -75.99 -52.32 2.62 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.462 -0.774 . . . . 0.0 110.364 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 54' ' ' SER . 35.5 Cg_endo -76.42 83.6 2.01 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.055 1.837 . . . . 0.0 109.72 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.646 ' CE1' ' HB1' ' A' ' 87' ' ' ALA . 31.1 m-85 -79.51 176.2 9.91 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.549 0.69 . . . . 0.0 110.05 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.574 ' CD1' ' O ' ' A' ' 81' ' ' ASN . 89.9 m-85 -142.56 129.03 20.14 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.11 136.57 32.94 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.906 0.86 . . . . 0.0 111.063 -178.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.632 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 39.3 t-105 -160.39 135.79 5.83 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.632 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.6 Cg_endo -70.21 147.1 59.26 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.055 1.837 . . . . 0.0 111.272 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.548 ' CD1' ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -110.0 130.05 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.565 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.548 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 1.1 mt -138.61 119.3 14.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.347 -0.845 . . . . 0.0 108.953 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.527 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.3 t -126.34 73.67 1.39 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.685 -0.634 . . . . 0.0 109.429 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 173.43 -31.57 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.152 -0.967 . . . . 0.0 109.371 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.18 -74.81 0.83 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.05 -150.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -1.145 . . . . 0.0 109.529 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.429 ' O ' ' N ' ' A' ' 69' ' ' SER . 13.6 t -96.51 145.1 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.336 -0.853 . . . . 0.0 109.492 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.465 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 82.3 t80 -50.28 97.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.0 109.467 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 67' ' ' VAL . 1.2 p -132.66 26.88 4.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 109.437 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.19 79.69 0.42 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -156.25 -123.12 0.78 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.8 t -127.22 102.07 24.47 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.256 -1.143 . . . . 0.0 109.246 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.505 ' HB2' ' OH ' ' A' ' 38' ' ' TYR . 34.2 Cg_endo -76.55 -159.07 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.323 2.016 . . . . 0.0 110.551 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.483 ' O ' ' N ' ' A' ' 76' ' ' ASP . . . 66.09 -145.87 48.36 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.527 ' O ' ' OG1' ' A' ' 91' ' ' THR . . . 48.11 -95.18 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.08 -1.247 . . . . 0.0 109.768 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' A' ' 74' ' ' GLY . 59.7 m-20 -111.05 139.91 46.03 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.861 -1.149 . . . . 0.0 110.208 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.528 ' CA ' HG22 ' A' ' 61' ' ' ILE . 57.8 mtp180 -156.91 159.32 38.02 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.1 p -134.74 145.1 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.804 -1.185 . . . . 0.0 110.03 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 80' ' ' PHE . 3.0 t -106.24 165.05 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 122.106 0.955 . . . . 0.0 109.861 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.615 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 4.0 p90 -156.09 -169.02 2.93 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.753 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.574 ' O ' ' CD1' ' A' ' 57' ' ' TYR . 10.6 t30 -107.41 -80.05 0.57 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.007 -1.058 . . . . 0.0 110.179 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.459 ' HG3' ' ND2' ' A' ' 81' ' ' ASN . 1.3 pp20? -167.85 23.62 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.428 -0.795 . . . . 0.0 109.546 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.515 ' O ' ' CB ' ' A' ' 84' ' ' ASN . 1.2 m120 -149.49 21.72 0.93 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 109.072 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 83' ' ' ASN . 0.1 OUTLIER 80.72 8.11 1.27 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.55 -0.719 . . . . 0.0 109.438 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 84' ' ' ASN . 6.3 mp0 -56.91 -165.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -0.985 . . . . 0.0 108.943 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.56 107.6 5.72 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.957 -1.089 . . . . 0.0 110.098 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.646 ' HB1' ' CE1' ' A' ' 56' ' ' TYR . . . -80.87 -43.01 20.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.427 -0.796 . . . . 0.0 108.925 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 162.26 142.47 3.4 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.676 HG22 ' CD2' ' A' ' 4' ' ' TYR . 60.1 t -81.95 97.26 3.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.116 -1.226 . . . . 0.0 109.976 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.5 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -78.6 179.85 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.105 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.755 HG21 HG23 ' A' ' 101' ' ' VAL . 12.4 t -135.81 -131.98 0.15 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.916 -1.115 . . . . 0.0 108.457 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.597 ' CD2' ' CB ' ' A' ' 95' ' ' ALA . 0.2 OUTLIER 163.57 42.32 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 -179.657 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.4 m -77.55 97.27 4.99 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.695 0.759 . . . . 0.0 109.713 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.502 ' O ' ' C ' ' A' ' 95' ' ' ALA . . . 93.55 -29.91 7.91 Favored Glycine 0 C--N 1.297 -1.592 0 N-CA-C 107.753 -2.139 . . . . 0.0 107.753 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.597 ' CB ' ' CD2' ' A' ' 92' ' ' HIS . . . 34.45 -154.97 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.3 -0.529 . . . . 0.0 109.873 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.455 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.6 OUTLIER 46.01 47.53 12.67 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -179.034 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.98 -25.64 2.65 Favored Glycine 0 N--CA 1.483 1.828 0 N-CA-C 106.026 -2.83 . . . . 0.0 106.026 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.656 ' O ' HG11 ' A' ' 101' ' ' VAL . 7.8 m120 -105.65 -29.77 9.9 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.497 ' C ' ' O ' ' A' ' 98' ' ' ASN . 11.5 p-10 37.21 -146.1 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.706 ' CD1' ' CE1' ' A' ' 42' ' ' TYR . 5.3 m-85 -75.78 77.15 2.73 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.755 HG23 HG21 ' A' ' 91' ' ' THR . 0.0 OUTLIER -85.36 131.82 33.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.392 -0.818 . . . . 0.0 108.969 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -43.71 151.51 0.19 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.527 -1.358 . . . . 0.0 109.717 -179.049 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 1.2 m -75.71 92.25 2.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.924 . . . . 0.0 109.37 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.869 . . . . 0.0 109.437 -179.934 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.51 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.51 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 1.8 p 163.37 121.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.355 -0.841 . . . . 0.0 109.67 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -105.4 3.52 29.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.91 . . . . 0.0 109.431 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.516 ' CD1' ' CG2' ' A' ' 89' ' ' VAL . 11.4 m-85 -119.69 104.63 10.42 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.119 -0.988 . . . . 0.0 109.625 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.406 ' O ' ' HB3' ' A' ' 103' ' ' CYS . 98.5 m -143.85 123.34 13.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.093 -1.004 . . . . 0.0 109.421 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -91.97 9.81 31.56 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.163 -0.961 . . . . 0.0 109.945 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.39 -62.64 0.06 OUTLIER Glycine 0 C--N 1.282 -2.43 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 m -174.46 30.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -1.129 . . . . 0.0 109.51 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.512 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 8.4 m-80 -80.02 -24.49 40.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.923 . . . . 0.0 109.371 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 37.8 t 58.87 68.49 0.81 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.37 -0.832 . . . . 0.0 109.574 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.512 ' CE1' ' HB3' ' A' ' 9' ' ' ASN . 11.0 m-85 -89.47 132.94 34.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.131 -0.98 . . . . 0.0 109.259 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 15.3 t -83.07 130.5 35.13 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.368 -0.832 . . . . 0.0 109.859 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 p -56.36 -17.57 8.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.304 -0.872 . . . . 0.0 109.287 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.7 -32.55 21.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.89 . . . . 0.0 109.575 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.471 ' O ' ' OG1' ' A' ' 18' ' ' THR . 0.5 OUTLIER -77.13 -37.33 54.26 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.305 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 28.8 t -51.9 -37.44 21.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.99 -43.29 99.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.576 -0.702 . . . . 0.0 109.339 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -59.17 -47.4 85.44 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.491 ' CB ' HD11 ' A' ' 61' ' ' ILE . . . -70.82 -15.2 62.63 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.59 ' NE2' ' CG1' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -89.65 -12.77 38.65 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.533 -0.729 . . . . 0.0 109.096 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -94.1 -20.92 19.46 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.08 -61.24 2.05 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.532 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -55.93 -24.94 43.99 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -73.83 -46.4 45.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.623 -0.928 . . . . 0.0 109.256 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.444 ' O ' ' HB2' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -66.16 -63.63 1.04 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.373 -0.829 . . . . 0.0 108.906 179.757 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.503 HD22 ' O ' ' A' ' 32' ' ' THR . 3.3 tp -44.2 -33.93 1.7 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.302 -0.874 . . . . 0.0 109.068 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.618 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -63.86 -59.77 4.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.323 -0.861 . . . . 0.0 109.254 179.772 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.5 11.84 7.98 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.511 -0.743 . . . . 0.0 109.542 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -100.53 -24.01 14.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -0.919 . . . . 0.0 109.448 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.0 -16.76 45.57 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.43 -148.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.247 -1.149 . . . . 0.0 109.277 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.524 HG21 ' HA ' ' A' ' 37' ' ' SER . 0.1 OUTLIER -170.61 -176.09 2.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.397 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.0 m -89.74 -126.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.143 -0.973 . . . . 0.0 109.606 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -130.34 -4.04 4.58 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.085 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.86 -93.09 0.43 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.023 -1.281 . . . . 0.0 109.128 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -130.62 58.78 1.68 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.321 -0.862 . . . . 0.0 108.969 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.524 ' HA ' HG21 ' A' ' 32' ' ' THR . 4.2 t 57.71 -158.75 0.27 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.309 -0.87 . . . . 0.0 109.019 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.586 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER 166.84 -43.96 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 112.168 179.284 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 32.0 Cg_endo -75.2 100.66 1.39 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.353 1.368 . . . . 0.0 112.367 -178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.553 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -143.93 175.12 10.26 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.143 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -72.25 157.76 37.1 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.044 -1.035 . . . . 0.0 110.044 -179.391 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.575 ' OH ' ' CD1' ' A' ' 100' ' ' PHE . 87.3 t80 -145.93 89.6 1.91 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.438 -0.789 . . . . 0.0 109.19 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.522 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 32.3 m120 -52.29 -88.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.171 -0.956 . . . . 0.0 110.169 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.524 ' N ' ' OD1' ' A' ' 44' ' ' ASN . 2.4 p30 161.97 135.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.175 -0.953 . . . . 0.0 109.276 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -131.05 -0.91 4.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.077 -1.014 . . . . 0.0 109.862 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -100.73 -19.35 16.07 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.191 -0.943 . . . . 0.0 108.62 -179.789 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.26 23.88 7.1 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.563 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 18.4 m-85 -63.85 87.16 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 50' ' ' PHE . 5.7 t70 -54.57 -32.25 58.2 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.839 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.563 ' CE1' ' HB3' ' A' ' 48' ' ' PHE . 9.8 m-30 44.93 -170.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.357 -0.84 . . . . 0.0 109.607 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -151.55 32.28 0.57 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -0.951 . . . . 0.0 109.454 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.5 t -113.48 -86.62 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.833 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.576 ' O ' ' CZ ' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -152.76 164.89 36.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.103 -0.998 . . . . 0.0 109.762 -179.77 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.577 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -62.22 -51.96 70.26 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.386 -0.821 . . . . 0.0 110.395 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 54' ' ' SER . 36.3 Cg_endo -76.18 80.77 2.6 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.072 1.848 . . . . 0.0 110.716 -178.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.576 ' CZ ' ' O ' ' A' ' 53' ' ' SER . 93.3 m-85 -78.85 -164.63 0.62 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.618 ' CE1' ' NE2' ' A' ' 27' ' ' HIS . 60.4 m-85 -156.1 113.94 3.31 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.519 -0.738 . . . . 0.0 109.266 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.453 ' HA ' HG13 ' A' ' 79' ' ' VAL . 10.1 pt-20 -82.91 137.59 34.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.254 -0.904 . . . . 0.0 110.447 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.619 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 10.0 t-105 -160.7 140.65 8.27 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.619 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.5 Cg_endo -69.75 130.52 19.5 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.202 1.935 . . . . 0.0 111.45 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.491 HD11 ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -111.56 130.25 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.461 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -120.7 168.71 11.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.157 -0.964 . . . . 0.0 109.595 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.442 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 12.3 t -121.38 26.92 8.59 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.7 -55.74 0.05 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.601 -0.687 . . . . 0.0 109.309 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -72.95 -4.34 62.28 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.417 ' C ' ' OD1' ' A' ' 66' ' ' ASP . 49.5 t0 60.51 -99.88 0.1 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -1.161 . . . . 0.0 109.731 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.9 t -81.26 151.97 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.957 -1.089 . . . . 0.0 109.473 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.521 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 31.5 t80 -82.68 124.23 30.01 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.131 -0.98 . . . . 0.0 109.833 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 99.8 p -119.97 -3.19 10.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.464 -0.773 . . . . 0.0 109.266 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.49 130.64 3.49 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 154.39 86.47 0.06 OUTLIER Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.0 t 51.73 93.03 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.181 -1.188 . . . . 0.0 109.767 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.57 -169.4 0.77 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.708 2.272 . . . . 0.0 110.818 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.446 ' O ' ' CB ' ' A' ' 75' ' ' ALA . . . 77.64 -170.17 54.93 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.45 ' C ' ' OG1' ' A' ' 91' ' ' THR . . . 71.63 -162.21 0.13 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.149 -1.206 . . . . 0.0 110.765 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.503 ' N ' ' OG1' ' A' ' 91' ' ' THR . 14.9 m-20 -36.51 154.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.547 0.689 . . . . 0.0 111.106 -178.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.603 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 10.0 ttm105 -177.92 70.4 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.484 -0.76 . . . . 0.0 109.019 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.59 ' CG1' ' NE2' ' A' ' 20' ' ' GLN . 1.4 p -53.72 166.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.813 -1.179 . . . . 0.0 109.741 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.453 HG11 ' H ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -126.84 176.88 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.275 -0.89 . . . . 0.0 109.838 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.611 ' CE1' ' O ' ' A' ' 57' ' ' TYR . 8.7 p90 -164.51 -171.69 2.43 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.125 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -129.4 -80.08 0.56 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.038 -1.039 . . . . 0.0 110.06 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -149.2 11.12 0.8 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.374 -0.829 . . . . 0.0 110.235 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.49 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 3.6 t-20 -147.74 15.64 1.1 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.026 -1.046 . . . . 0.0 109.567 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.49 ' OD1' ' O ' ' A' ' 83' ' ' ASN . 0.2 OUTLIER 68.16 12.42 8.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.307 -0.871 . . . . 0.0 109.363 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.547 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 1.8 mt-30 -45.95 -31.87 2.43 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.547 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER 85.13 104.1 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.479 0.657 . . . . 0.0 109.952 179.569 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.52 ' HB1' ' CD1' ' A' ' 56' ' ' TYR . . . -77.34 -33.62 55.41 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.372 -0.83 . . . . 0.0 109.14 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 149.55 160.87 9.43 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.516 ' CG2' ' CD1' ' A' ' 4' ' ' TYR . 4.9 t -85.97 106.06 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.203 -1.174 . . . . 0.0 110.127 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.603 ' CG1' ' O ' ' A' ' 77' ' ' ARG . 14.6 pt -108.38 138.71 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.643 HG22 HG23 ' A' ' 101' ' ' VAL . 4.4 t -120.88 175.06 6.23 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.959 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.565 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -115.36 68.62 0.71 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.407 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 92' ' ' HIS . 13.7 t 172.5 158.93 0.11 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 98.48 -21.4 46.19 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.772 -1.204 . . . . 0.0 110.403 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -125.32 -171.92 2.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.056 -1.261 . . . . 0.0 109.423 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 95' ' ' ALA . 20.4 m -42.02 111.18 0.21 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -0.842 . . . . 0.0 108.905 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 63.76 -105.68 1.16 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.565 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -132.14 35.35 3.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.241 -1.152 . . . . 0.0 108.771 178.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.469 ' O ' ' O ' ' A' ' 98' ' ' ASN . 4.4 t-20 -45.58 170.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.306 -0.871 . . . . 0.0 109.436 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.575 ' CD1' ' OH ' ' A' ' 42' ' ' TYR . 13.1 m-85 -92.4 149.19 21.56 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.212 -0.93 . . . . 0.0 109.534 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.643 HG23 HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -156.12 148.56 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 103' ' ' CYS . 1.0 OUTLIER -82.38 122.08 27.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.431 -0.793 . . . . 0.0 109.857 -179.584 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.415 ' O ' ' CG2' ' A' ' 104' ' ' THR . 80.5 m -43.51 121.23 2.21 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.325 -0.859 . . . . 0.0 109.538 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.415 ' CG2' ' O ' ' A' ' 103' ' ' CYS . 13.7 p . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.124 -0.985 . . . . 0.0 109.535 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.432 ' C ' ' SG ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.293 0.568 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 0.8 OUTLIER 174.0 124.56 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.306 -0.871 . . . . 0.0 110.152 179.685 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -87.53 -36.39 17.62 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.356 -0.84 . . . . 0.0 109.051 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.644 ' CG ' HG23 ' A' ' 89' ' ' VAL . 41.5 m-85 -82.35 115.66 21.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.355 -0.84 . . . . 0.0 109.394 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 9' ' ' ASN . 1.1 p -150.18 122.88 8.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.403 -0.811 . . . . 0.0 109.643 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -112.08 10.28 20.36 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.241 1.02 . . . . 0.0 109.641 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 172.73 -96.23 0.11 Allowed Glycine 0 C--N 1.282 -2.445 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -123.2 23.4 9.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -1.109 . . . . 0.0 109.231 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.461 ' O ' HG23 ' A' ' 5' ' ' THR . 4.5 m-80 -96.76 106.57 18.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.895 . . . . 0.0 109.819 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 47.8 t -78.33 78.47 4.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.346 -0.846 . . . . 0.0 109.417 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -98.31 110.15 22.78 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.432 -0.792 . . . . 0.0 109.003 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -84.66 128.95 34.86 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.174 -0.954 . . . . 0.0 109.956 -179.619 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 12' ' ' SER . 1.1 p -41.17 -27.6 0.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 12' ' ' SER . 5.3 t -69.74 -50.43 43.54 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.349 -0.844 . . . . 0.0 109.623 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.34 -22.74 65.58 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 17.8 t -78.0 -29.47 15.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.7 t -61.39 -46.44 90.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.568 -0.708 . . . . 0.0 109.412 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.2 -53.26 60.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.923 . . . . 0.0 108.606 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.97 -15.49 63.74 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.581 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -74.89 -37.99 61.99 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.531 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.8 -6.05 52.82 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.91 -62.13 1.8 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.375 -0.828 . . . . 0.0 109.075 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.497 ' HA3' ' CD2' ' A' ' 59' ' ' TRP . . . -58.33 -25.15 57.17 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.484 ' CE2' ' O ' ' A' ' 82' ' ' GLU . 2.8 t80 -73.15 -44.49 59.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.408 -1.054 . . . . 0.0 109.44 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' A' ' 26' ' ' LEU . 0.7 OUTLIER -55.7 -69.68 0.13 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.487 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.459 ' CD1' ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -42.38 -45.19 4.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.415 -0.803 . . . . 0.0 109.971 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -52.7 -54.6 31.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.299 -0.875 . . . . 0.0 110.518 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.66 -3.07 49.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.099 -1.001 . . . . 0.0 109.9 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -87.2 8.01 25.81 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.108 -0.995 . . . . 0.0 109.618 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 48.86 27.53 6.53 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.434 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -125.67 -158.21 0.83 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.458 -1.025 . . . . 0.0 109.405 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.459 ' N ' ' CD1' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -147.62 -174.64 4.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.915 . . . . 0.0 109.256 179.727 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' A' ' 34' ' ' GLY . 33.8 m -103.71 171.68 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.065 -1.022 . . . . 0.0 109.831 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -45.04 -38.39 6.05 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 36' ' ' ASN . 0.6 OUTLIER -78.51 175.55 10.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -1.098 . . . . 0.0 109.474 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.456 ' O ' ' HB2' ' A' ' 37' ' ' SER . 20.2 m-20 -43.86 -48.19 8.33 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.261 -0.899 . . . . 0.0 109.115 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.577 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 5.8 t 176.04 -164.12 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.591 ' CA ' ' CE1' ' A' ' 40' ' ' HIS . 0.2 OUTLIER 170.19 -45.12 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.083 -1.01 . . . . 0.0 112.213 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 31.7 Cg_endo -75.41 97.0 1.06 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 121.002 1.134 . . . . 0.0 111.656 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.591 ' CE1' ' CA ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -139.61 -179.52 5.96 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.534 ' HA ' ' CD1' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -69.6 162.12 28.24 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.333 -0.854 . . . . 0.0 110.038 -179.32 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.527 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 18.1 t80 -127.61 152.85 47.13 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.525 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 3.3 p-10 -165.59 95.48 0.63 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.977 -1.077 . . . . 0.0 109.829 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.527 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 0.6 OUTLIER -135.71 -41.12 0.69 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.335 -0.853 . . . . 0.0 109.433 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.58 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 0.0 OUTLIER 42.65 26.47 0.07 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.402 -0.811 . . . . 0.0 110.018 179.696 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -39.95 -27.63 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 O-C-N 121.319 -0.863 . . . . 0.0 109.984 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 45' ' ' TYR . . . 167.69 -23.82 0.11 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.537 ' CZ ' ' HA ' ' A' ' 101' ' ' VAL . 0.1 OUTLIER -92.46 49.94 1.55 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.447 -1.031 . . . . 0.0 109.211 179.591 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.53 103.14 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -0.879 . . . . 0.0 109.454 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.58 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 12.7 m-85 -65.87 164.09 15.6 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.259 -0.901 . . . . 0.0 109.306 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.3 t -108.63 23.45 14.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 0.0 109.868 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.478 ' CG1' ' HB3' ' A' ' 81' ' ' ASN . 14.2 t -80.53 -58.48 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.091 -1.006 . . . . 0.0 109.377 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -175.38 172.12 2.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 109.682 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.557 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -69.57 -53.41 12.57 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.357 -0.839 . . . . 0.0 110.155 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 54' ' ' SER . 35.8 Cg_endo -74.82 90.39 1.07 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.972 1.781 . . . . 0.0 110.034 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 30.3 m-85 -78.61 -170.34 2.06 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.534 ' CD1' ' HA ' ' A' ' 41' ' ' LYS . 57.9 m-85 -157.7 111.92 2.61 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -82.52 139.82 33.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.454 -0.779 . . . . 0.0 110.388 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.656 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 35.7 t-105 -160.86 139.36 7.42 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.656 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 32.0 Cg_endo -71.02 145.26 49.41 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.215 1.943 . . . . 0.0 111.434 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.495 ' C ' ' CD2' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -108.38 138.15 36.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.495 ' CD2' ' C ' ' A' ' 61' ' ' ILE . 1.1 mt -124.91 168.69 12.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.044 -1.035 . . . . 0.0 109.965 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.16 0.17 9.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.035 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.69 -166.54 1.42 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.383 -0.823 . . . . 0.0 109.197 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.27 59.2 0.48 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.433 ' O ' HD13 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -158.9 106.18 1.82 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.173 -1.193 . . . . 0.0 109.799 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.449 HG11 ' HZ2' ' A' ' 59' ' ' TRP . 77.5 t -52.4 143.41 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -0.893 . . . . 0.0 108.931 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.579 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 42.9 t80 -45.95 120.85 2.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.875 -1.141 . . . . 0.0 109.43 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.6 p -165.95 29.9 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.464 -0.773 . . . . 0.0 109.291 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -116.03 -67.08 0.4 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.434 ' C ' ' OG ' ' A' ' 72' ' ' SER . . . 148.47 151.44 5.46 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.434 ' OG ' ' C ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER 51.11 92.62 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.37 -1.077 . . . . 0.0 110.085 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.534 ' CD ' ' OH ' ' A' ' 38' ' ' TYR . 35.0 Cg_endo -79.11 -72.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.897 2.398 . . . . 0.0 109.642 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.68 98.1 2.35 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.543 ' HA ' ' N ' ' A' ' 92' ' ' HIS . . . 61.69 -149.88 0.39 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.292 -1.122 . . . . 0.0 110.262 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.542 ' O ' ' O ' ' A' ' 75' ' ' ALA . 2.4 m-20 28.29 108.62 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 121.524 0.678 . . . . 0.0 112.584 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.468 ' NH1' ' CE1' ' A' ' 38' ' ' TYR . 2.0 ttm-85 -154.0 111.28 3.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.014 -1.053 . . . . 0.0 109.003 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.458 HG21 ' O ' ' A' ' 88' ' ' GLY . 7.7 p -91.34 154.99 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.059 -1.026 . . . . 0.0 109.495 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 87' ' ' ALA . 52.6 t -120.35 166.98 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.275 -0.891 . . . . 0.0 109.923 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.581 ' CD1' ' OE1' ' A' ' 20' ' ' GLN . 10.8 p90 -169.6 -177.32 2.69 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.755 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.543 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -124.25 -38.79 2.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.433 -0.792 . . . . 0.0 109.529 -179.728 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.543 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 4.0 mt-10 162.44 -27.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.442 -0.786 . . . . 0.0 108.936 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.49 ' HB3' ' HG2' ' A' ' 85' ' ' GLN . 1.1 t-20 -98.58 19.76 14.05 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.516 -0.74 . . . . 0.0 109.135 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 6.2 p30 52.42 23.29 2.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.827 -0.545 . . . . 0.0 110.028 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.543 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 1.6 mt-30 -55.2 -31.82 61.73 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.543 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER 84.79 104.54 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.406 0.622 . . . . 0.0 110.912 179.135 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.58 ' O ' ' CD1' ' A' ' 50' ' ' PHE . . . -73.26 -44.58 59.07 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.458 ' O ' HG21 ' A' ' 78' ' ' VAL . . . 166.43 -154.38 24.84 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.924 -1.671 . . . . 0.0 108.924 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.644 HG23 ' CG ' ' A' ' 4' ' ' TYR . 34.9 t -138.1 81.19 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.093 -1.239 . . . . 0.0 109.532 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.481 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 0.7 OUTLIER -80.06 152.14 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.333 -0.854 . . . . 0.0 108.802 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.518 ' OG1' ' HB3' ' A' ' 75' ' ' ALA . 0.8 OUTLIER -116.38 138.96 50.92 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.108 -0.995 . . . . 0.0 111.378 -178.256 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.558 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.1 OUTLIER -86.62 59.3 5.56 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.543 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.487 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 3.5 m -176.32 -31.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.208 -0.932 . . . . 0.0 109.692 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.72 -17.23 13.78 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -121.81 174.17 7.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -1.167 . . . . 0.0 109.747 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 95' ' ' ALA . 2.7 t -39.86 128.18 2.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.575 -0.703 . . . . 0.0 109.317 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 63.38 -88.59 0.06 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.558 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -139.44 -64.24 0.5 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -1.182 . . . . 0.0 109.552 179.685 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 98' ' ' ASN . 1.0 OUTLIER 47.35 -172.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.138 -0.977 . . . . 0.0 109.189 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -131.38 131.89 44.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.154 -0.966 . . . . 0.0 109.708 179.595 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.537 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 0.7 OUTLIER -147.25 131.66 10.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.353 -0.842 . . . . 0.0 108.856 179.385 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -51.97 133.79 32.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.901 . . . . 0.0 109.817 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 8.0 m -65.48 148.52 51.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.321 -0.862 . . . . 0.0 109.569 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 31.2 p . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 116.719 -1.61 . . . . 0.0 109.408 179.906 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.533 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 1.8 p 163.52 142.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.355 -0.84 . . . . 0.0 109.545 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' A' ' 3' ' ' ASP . 41.7 t0 -104.51 -41.66 5.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 109.559 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.641 ' CG ' ' CG2' ' A' ' 89' ' ' VAL . 34.6 m-85 -83.36 128.76 34.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.924 . . . . 0.0 109.54 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -137.19 110.38 7.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.303 -0.873 . . . . 0.0 109.274 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.3 m -106.51 13.79 27.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.12 -0.987 . . . . 0.0 109.95 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 128.73 92.59 0.71 Allowed Glycine 0 C--N 1.283 -2.369 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 54.18 27.74 8.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.368 -1.078 . . . . 0.0 109.532 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -93.59 -43.74 8.54 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.303 -0.873 . . . . 0.0 109.496 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 10' ' ' CYS . 47.8 t 49.98 49.28 20.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 109.219 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.576 ' CE1' ' OG ' ' A' ' 63' ' ' SER . 6.4 m-30 -87.38 120.6 28.84 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.433 -0.792 . . . . 0.0 109.38 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 14' ' ' SER . 17.8 t -85.18 118.34 24.67 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.267 -0.895 . . . . 0.0 109.235 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 12' ' ' SER . 3.7 p -41.52 -26.16 0.06 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.557 -0.715 . . . . 0.0 109.614 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -61.67 -54.92 36.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.147 -0.971 . . . . 0.0 109.185 179.407 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -69.8 -25.91 64.0 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.72 HG12 ' NE2' ' A' ' 20' ' ' GLN . 18.9 t -68.24 -25.07 30.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.509 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 0.1 OUTLIER -65.45 -44.5 87.05 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.3 m -59.2 -51.16 71.18 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.42 ' CB ' ' CD1' ' A' ' 61' ' ' ILE . . . -65.94 -16.42 63.85 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.72 ' NE2' HG12 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -82.26 -25.14 34.35 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.611 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.37 -7.83 58.15 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.298 -0.876 . . . . 0.0 108.664 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.7 -63.72 1.28 Allowed 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.553 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -50.9 -30.17 21.64 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.451 ' O ' ' HB3' ' A' ' 27' ' ' HIS . 3.1 t80 -74.14 -56.31 5.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.386 -1.067 . . . . 0.0 108.816 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.465 ' HG2' ' OD1' ' A' ' 29' ' ' ASP . 5.0 tt0 -53.05 -67.64 0.24 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.422 -0.799 . . . . 0.0 109.126 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 25' ' ' GLN . 4.8 tp -42.96 -37.21 1.8 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.301 -0.875 . . . . 0.0 109.598 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.63 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 3.2 t60 -61.51 -53.18 59.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.174 -0.954 . . . . 0.0 110.134 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -86.93 6.9 29.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.352 -0.843 . . . . 0.0 110.122 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.465 ' OD1' ' HG2' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -98.04 -16.85 19.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.022 -1.049 . . . . 0.0 109.579 -179.79 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.16 -11.15 58.77 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.53 ' HG3' ' N ' ' A' ' 32' ' ' THR . 31.9 tp10 -84.96 164.86 18.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -1.134 . . . . 0.0 109.201 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.53 ' N ' ' HG3' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -129.85 171.44 12.72 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.498 -0.751 . . . . 0.0 109.798 -179.746 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.442 ' CG1' ' O ' ' A' ' 68' ' ' TYR . 33.0 m -81.27 166.8 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.437 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.87 -29.32 42.16 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.92 -144.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -1.141 . . . . 0.0 109.204 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.457 ' O ' ' CB ' ' A' ' 37' ' ' SER . 2.9 m120 -102.11 60.49 0.85 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.961 -1.087 . . . . 0.0 109.803 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.52 ' O ' ' CB ' ' A' ' 38' ' ' TYR . 6.2 t 70.97 -168.97 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.553 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.634 ' CZ ' ' CB ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER 165.07 -41.96 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.33 -0.856 . . . . 0.0 112.206 178.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 31.4 Cg_endo -75.35 100.07 1.33 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.096 1.197 . . . . 0.0 111.977 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.542 ' CD2' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -145.35 176.92 9.21 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.577 -0.702 . . . . 0.0 109.252 178.691 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.545 ' HA ' ' CD1' ' A' ' 57' ' ' TYR . 0.7 OUTLIER -59.27 161.63 5.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.32 -0.863 . . . . 0.0 109.968 -179.497 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.584 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 44.9 t80 -134.29 68.19 1.49 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.45 -0.781 . . . . 0.0 109.023 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.453 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 1.3 m-20 -86.55 61.88 7.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.18 -0.95 . . . . 0.0 109.151 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 1.8 m120 -89.74 -78.26 0.37 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.557 -0.714 . . . . 0.0 110.515 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.527 ' CB ' ' O ' ' A' ' 44' ' ' ASN . 3.1 m-85 79.49 29.19 0.33 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.47 -0.769 . . . . 0.0 108.953 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -36.24 -71.21 0.08 Allowed 'General case' 0 C--N 1.308 -1.198 0 O-C-N 121.749 -0.594 . . . . 0.0 110.23 -179.603 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.19 44.2 0.55 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.07 169.17 18.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -1.137 . . . . 0.0 109.545 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -112.51 -31.86 6.66 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.534 ' CB ' ' OH ' ' A' ' 56' ' ' TYR . 8.3 m-30 55.41 178.13 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.408 -0.808 . . . . 0.0 109.567 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.48 37.57 1.01 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.312 -0.867 . . . . 0.0 109.092 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.472 ' CG2' ' HA ' ' A' ' 87' ' ' ALA . 41.1 t -110.12 -82.61 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.394 -0.816 . . . . 0.0 109.708 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.438 ' OG ' ' HD2' ' A' ' 55' ' ' PRO . 4.7 t -163.15 154.08 16.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.164 -0.96 . . . . 0.0 109.855 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.587 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -55.9 -50.66 85.94 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.398 -0.814 . . . . 0.0 110.442 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 54' ' ' SER . 35.8 Cg_endo -75.82 84.44 1.78 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.018 1.812 . . . . 0.0 110.156 -178.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.534 ' OH ' ' CB ' ' A' ' 50' ' ' PHE . 49.2 m-85 -81.81 -169.52 2.39 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.821 0.82 . . . . 0.0 109.879 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.63 ' CE1' ' NE2' ' A' ' 27' ' ' HIS . 70.2 m-85 -156.75 109.05 2.5 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.417 ' N ' ' HB2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -76.2 138.51 40.7 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.844 0.83 . . . . 0.0 110.911 -178.048 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.62 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 34.8 t-105 -160.58 137.26 6.49 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.62 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.5 Cg_endo -67.67 151.84 78.66 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.986 1.791 . . . . 0.0 110.592 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.589 HD12 ' H ' ' A' ' 62' ' ' LEU . 1.3 tp -122.13 138.7 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.421 -0.8 . . . . 0.0 110.023 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.589 ' H ' HD12 ' A' ' 61' ' ' ILE . 0.7 OUTLIER -124.34 -175.54 3.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.385 -0.822 . . . . 0.0 108.896 179.476 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.576 ' OG ' ' CE1' ' A' ' 11' ' ' TYR . 16.6 p -146.72 55.1 1.12 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.01 -1.056 . . . . 0.0 109.636 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.31 30.94 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.464 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 47.31 90.0 0.01 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -161.16 -36.33 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.256 -1.143 . . . . 0.0 110.025 -179.681 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.459 ' CB ' ' O ' ' A' ' 66' ' ' ASP . 4.4 t 71.81 140.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.119 -0.988 . . . . 0.0 108.958 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.518 ' CE2' ' CD2' ' A' ' 38' ' ' TYR . 71.9 t80 -65.45 107.03 1.54 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.113 -0.992 . . . . 0.0 110.109 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.414 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 1.2 m -123.11 30.39 6.38 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.77 77.93 1.07 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -159.31 -96.69 0.12 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.3 p -123.43 94.82 46.09 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.22 -1.164 . . . . 0.0 109.858 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.634 ' CB ' ' CZ ' ' A' ' 38' ' ' TYR . 36.2 Cg_endo -79.48 -61.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.585 2.19 . . . . 0.0 110.359 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 73' ' ' PRO . . . -60.21 -146.43 0.01 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 91' ' ' THR . . . 65.03 -84.98 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.37 -1.077 . . . . 0.0 109.939 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -124.59 100.33 6.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.163 -0.96 . . . . 0.0 109.574 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.487 ' HD2' ' HB3' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -117.68 152.47 35.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 108.893 179.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.534 ' CG1' ' NE2' ' A' ' 20' ' ' GLN . 1.4 p -117.2 -173.88 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.053 -1.03 . . . . 0.0 109.496 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.59 ' CG1' ' N ' ' A' ' 80' ' ' PHE . 6.8 t -147.21 166.8 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.167 -0.958 . . . . 0.0 110.009 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.59 ' N ' ' CG1' ' A' ' 79' ' ' VAL . 3.8 p90 -166.61 -176.26 3.47 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.522 ' O ' ' CD2' ' A' ' 57' ' ' TYR . 11.5 t30 -118.68 -80.16 0.61 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.927 -1.108 . . . . 0.0 109.754 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -158.55 20.59 0.22 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.462 -0.774 . . . . 0.0 109.419 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.502 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 0.3 OUTLIER -150.84 18.37 0.79 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.292 -0.88 . . . . 0.0 108.842 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.502 ' OD1' ' O ' ' A' ' 83' ' ' ASN . 0.2 OUTLIER 67.34 14.16 9.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.594 -0.692 . . . . 0.0 109.349 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.477 ' O ' ' HB3' ' A' ' 86' ' ' LEU . 1.8 mt-30 -51.72 -26.85 10.23 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' A' ' 85' ' ' GLN . 0.7 OUTLIER 66.49 116.31 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.539 0.685 . . . . 0.0 110.041 179.745 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.526 ' HB3' HG11 ' A' ' 79' ' ' VAL . . . -79.05 -34.43 43.77 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.426 ' HA2' ' OH ' ' A' ' 4' ' ' TYR . . . 146.13 176.64 20.16 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.641 ' CG2' ' CG ' ' A' ' 4' ' ' TYR . 54.7 t -100.52 147.29 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.996 -1.296 . . . . 0.0 110.055 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.495 ' HB ' ' CB ' ' A' ' 100' ' ' PHE . 0.9 OUTLIER -141.09 162.5 22.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.537 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 75' ' ' ALA . 5.8 t -129.59 127.17 40.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.711 -1.243 . . . . 0.0 111.545 -178.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.596 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.1 OUTLIER -79.01 75.35 5.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.532 -0.73 . . . . 0.0 109.177 179.055 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 1.1 m 173.44 -28.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.204 -0.935 . . . . 0.0 109.263 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.53 -11.17 33.69 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.515 ' HB2' ' HB3' ' A' ' 99' ' ' ASN . . . -125.48 176.86 6.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.097 -1.237 . . . . 0.0 109.725 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER -42.99 131.7 4.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.411 -0.806 . . . . 0.0 109.109 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.51 -89.03 0.05 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.596 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -136.22 -79.7 0.41 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -1.118 . . . . 0.0 109.106 179.319 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.515 ' HB3' ' HB2' ' A' ' 95' ' ' ALA . 0.3 OUTLIER 58.51 152.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.231 -0.918 . . . . 0.0 109.054 -179.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.513 ' CZ ' ' OD1' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -109.02 126.99 53.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.741 -1.224 . . . . 0.0 110.58 -179.412 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -129.55 140.45 49.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.469 ' OE2' ' CE1' ' A' ' 50' ' ' PHE . 5.8 mm-40 -52.47 122.56 9.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.384 -0.823 . . . . 0.0 109.703 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 1.7 m -70.55 129.92 40.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.352 -0.842 . . . . 0.0 109.462 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 40.1 p . . . . . 0 N--CA 1.488 1.467 0 O-C-N 121.187 -0.946 . . . . 0.0 109.367 179.912 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.426 ' C ' ' SG ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.392 0.615 . . . . 0.0 109.651 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 11' ' ' TYR . 0.8 OUTLIER 173.54 126.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.319 -0.863 . . . . 0.0 109.838 179.788 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -121.43 -3.87 9.38 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.417 -0.802 . . . . 0.0 109.29 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.567 ' CG ' HG23 ' A' ' 89' ' ' VAL . 57.4 m-85 -103.52 85.98 2.56 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.913 . . . . 0.0 109.192 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.48 ' OG1' ' HA ' ' A' ' 10' ' ' CYS . 33.9 m -117.52 129.53 55.86 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.269 -0.894 . . . . 0.0 110.255 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.1 m -133.07 12.21 4.26 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.191 0.996 . . . . 0.0 109.156 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.53 35.77 0.09 OUTLIER Glycine 0 C--N 1.282 -2.454 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 67.6 25.0 8.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.308 -1.113 . . . . 0.0 109.16 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.474 ' O ' ' C ' ' A' ' 10' ' ' CYS . 0.9 OUTLIER -89.43 -17.63 28.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.412 -0.805 . . . . 0.0 109.746 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.48 ' HA ' ' OG1' ' A' ' 5' ' ' THR . 0.8 OUTLIER 40.03 79.09 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 O-C-N 121.543 -0.723 . . . . 0.0 109.315 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.478 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 11.6 m-85 -78.91 134.3 36.89 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.499 ' HG ' ' HB2' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -78.58 129.57 34.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.567 -0.708 . . . . 0.0 109.804 -179.316 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -17.75 5.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.336 -0.852 . . . . 0.0 109.312 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.94 -30.69 15.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 0.0 109.571 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.499 ' HB2' ' HG ' ' A' ' 12' ' ' SER . 1.5 m-20 -74.47 -31.51 62.26 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 3.5 t -65.09 -25.44 37.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.444 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 0.1 OUTLIER -72.27 -40.15 67.84 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.537 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.77 -53.08 62.11 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.482 ' CB ' HD11 ' A' ' 61' ' ' ILE . . . -63.22 -25.42 68.32 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.574 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -70.09 -30.37 67.57 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.137 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -81.02 -12.68 59.31 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.19 -47.22 13.72 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.55 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -74.69 -28.62 62.78 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -75.65 -39.41 57.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.504 -0.998 . . . . 0.0 109.198 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 2.1 tt0 -69.73 -57.71 4.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.171 -0.955 . . . . 0.0 108.509 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.74 -36.23 24.98 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -67.37 -39.4 85.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.426 -0.796 . . . . 0.0 109.512 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.65 -2.77 47.98 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.317 -0.864 . . . . 0.0 109.057 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -101.8 0.5 35.84 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.266 -0.896 . . . . 0.0 109.509 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 54.21 26.07 34.77 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -106.06 -164.11 0.99 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.252 -1.146 . . . . 0.0 109.605 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.568 ' CG2' ' CB ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -142.3 175.97 9.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.357 -0.839 . . . . 0.0 109.337 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.55 HG21 ' CA ' ' A' ' 37' ' ' SER . 22.3 m -87.99 -156.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.212 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -40.07 -35.9 0.77 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER 167.15 -27.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.119 -1.224 . . . . 0.0 109.549 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 37' ' ' SER . 11.1 m-80 -81.73 8.89 8.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.171 -0.956 . . . . 0.0 109.533 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.568 ' CB ' ' CG2' ' A' ' 32' ' ' THR . 0.8 OUTLIER 46.2 -169.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.226 -0.921 . . . . 0.0 108.968 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.565 ' CD1' ' HD3' ' A' ' 60' ' ' PRO . 0.1 OUTLIER 169.42 -47.18 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.428 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.951 179.247 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 30.7 Cg_endo -73.48 99.38 1.13 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.525 1.483 . . . . 0.0 112.453 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.543 ' CD2' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -144.7 175.16 10.37 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -63.04 157.66 21.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.959 -1.088 . . . . 0.0 110.213 -179.214 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.592 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -129.09 132.31 47.39 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.478 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.424 ' O ' ' C ' ' A' ' 44' ' ' ASN . 1.4 p-10 -123.15 -22.63 5.11 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.814 -1.179 . . . . 0.0 109.635 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.631 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 1.0 OUTLIER 45.28 -160.23 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.284 -0.885 . . . . 0.0 108.919 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.631 ' CG ' ' O ' ' A' ' 44' ' ' ASN . 0.9 OUTLIER 171.43 -26.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.536 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.3 OUTLIER -32.09 -59.85 0.28 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 121.307 0.575 . . . . 0.0 110.42 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.04 54.68 0.01 OUTLIER Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.49 ' CZ ' ' HA ' ' A' ' 101' ' ' VAL . 62.8 m-85 -108.64 142.78 38.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -1.128 . . . . 0.0 109.611 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -108.89 76.31 1.0 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -0.903 . . . . 0.0 109.615 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.428 ' HB3' ' OH ' ' A' ' 56' ' ' TYR . 18.8 m-30 -66.63 -178.53 0.72 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.188 -0.945 . . . . 0.0 109.003 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.5 t -140.41 17.38 2.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.865 . . . . 0.0 108.976 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.527 ' HB ' ' CE1' ' A' ' 56' ' ' TYR . 57.4 t -88.1 -82.67 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.44 -0.788 . . . . 0.0 109.617 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.583 ' O ' ' CE2' ' A' ' 56' ' ' TYR . 61.1 m -160.21 -174.22 4.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -0.925 . . . . 0.0 109.902 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.574 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -81.66 -52.45 0.78 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.316 -0.865 . . . . 0.0 110.717 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 54' ' ' SER . 35.2 Cg_endo -75.49 88.14 1.31 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.07 1.847 . . . . 0.0 110.201 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.587 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 21.9 m-85 -89.17 -167.89 2.01 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.587 ' CG ' ' O ' ' A' ' 56' ' ' TYR . 84.0 m-85 -160.88 114.91 2.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.507 -0.746 . . . . 0.0 109.328 179.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.451 ' CD ' ' NH1' ' A' ' 77' ' ' ARG . 3.0 pt-20 -80.0 142.41 35.03 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.292 -0.88 . . . . 0.0 110.909 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.62 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 22.1 t-105 -160.77 138.63 7.1 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.62 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 31.8 Cg_endo -70.15 161.36 46.27 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.059 1.839 . . . . 0.0 111.429 -178.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.482 HD11 ' CB ' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -133.34 135.74 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.679 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 68' ' ' TYR . 0.3 OUTLIER -118.72 161.49 20.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -0.913 . . . . 0.0 109.608 -179.864 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.1 26.05 5.2 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.463 -0.773 . . . . 0.0 109.287 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.22 -62.72 0.78 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.359 -0.838 . . . . 0.0 109.45 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -93.15 -108.52 1.87 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 67' ' ' VAL . 8.9 t70 -179.45 134.12 0.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -1.159 . . . . 0.0 109.521 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 66' ' ' ASP . 2.8 t 62.79 133.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -0.902 . . . . 0.0 109.804 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.535 ' HA ' HD12 ' A' ' 62' ' ' LEU . 43.3 t80 -75.51 105.75 6.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.015 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.1 m -112.87 16.57 19.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.131 -0.981 . . . . 0.0 109.812 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.54 52.72 0.23 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -110.95 -112.3 3.35 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.82 108.94 43.78 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.193 -1.18 . . . . 0.0 109.421 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.65 -161.81 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.467 2.112 . . . . 0.0 110.483 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.71 -175.76 0.32 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.476 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . 61.85 -150.05 0.38 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -1.136 . . . . 0.0 110.198 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' ' 75' ' ' ALA . 12.0 m-20 -32.27 148.73 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.56 0.695 . . . . 0.0 111.435 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.577 ' NH2' ' CE2' ' A' ' 100' ' ' PHE . 8.3 ttp180 -176.38 86.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.46 ' CG2' HD12 ' A' ' 86' ' ' LEU . 8.8 p -72.38 143.16 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.894 . . . . 0.0 109.688 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.573 HG13 ' CG ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -109.19 177.63 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.105 -0.997 . . . . 0.0 109.679 179.864 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.575 ' CE1' ' O ' ' A' ' 57' ' ' TYR . 14.0 p90 -174.76 -169.19 0.4 Allowed 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.0 -178.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -128.88 -80.99 0.57 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.374 -0.829 . . . . 0.0 109.728 -179.497 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.45 ' CG ' ' C ' ' A' ' 81' ' ' ASN . 0.3 OUTLIER -158.6 19.69 0.22 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.457 -0.777 . . . . 0.0 109.412 -179.804 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.456 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 0.8 OUTLIER -150.34 28.85 0.72 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.469 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 5.4 p30 51.7 20.8 1.19 Allowed 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.542 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 2.4 mt-30 -47.53 -38.38 14.0 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.542 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 82.19 104.16 0.06 Allowed 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.469 0.652 . . . . 0.0 110.565 179.135 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.518 ' HB1' ' CE1' ' A' ' 56' ' ' TYR . . . -76.24 -31.92 58.62 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 140.23 163.81 9.66 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.567 HG23 ' CG ' ' A' ' 4' ' ' TYR . 58.9 t -94.73 124.47 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.068 -1.254 . . . . 0.0 109.491 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.491 ' CG1' ' O ' ' A' ' 77' ' ' ARG . 1.0 OUTLIER -118.14 176.31 3.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.268 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 75' ' ' ALA . 8.3 t -144.16 147.34 33.55 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.045 -1.034 . . . . 0.0 110.419 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.642 ' NE2' ' CE2' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -96.88 76.71 2.75 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.535 -0.728 . . . . 0.0 109.134 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.431 ' OG1' ' C ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 176.17 123.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 0.0 109.809 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 116.33 -0.6 20.65 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 99' ' ' ASN . . . -139.51 93.42 2.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.13 -1.218 . . . . 0.0 109.776 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER 41.65 85.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.427 -0.796 . . . . 0.0 109.743 179.642 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.17 -77.54 2.07 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.592 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -144.54 -77.02 0.22 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.161 -1.199 . . . . 0.0 109.892 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 0.3 OUTLIER 59.43 155.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 108.535 -179.097 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.642 ' CE2' ' NE2' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -103.69 136.98 42.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.949 -1.095 . . . . 0.0 110.267 -179.521 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.49 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 0.9 OUTLIER -146.13 157.98 11.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.167 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 103' ' ' CYS . 12.4 pt-20 -60.5 130.72 48.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.149 -0.969 . . . . 0.0 109.737 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.422 ' C ' ' O ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -42.35 114.53 0.58 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.452 -0.78 . . . . 0.0 109.635 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.136 -0.935 . . . . 0.0 109.405 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.431 ' O ' ' SG ' ' A' ' 10' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.266 0.555 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.447 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.9 OUTLIER 169.72 115.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -0.862 . . . . 0.0 109.862 179.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -78.72 -31.65 46.51 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.338 -0.851 . . . . 0.0 108.981 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.563 ' CD2' ' CG2' ' A' ' 89' ' ' VAL . 18.3 m-85 -98.96 96.28 7.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.38 -0.825 . . . . 0.0 108.908 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.487 ' CG2' ' HA ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -116.61 105.69 12.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.186 -0.947 . . . . 0.0 109.873 -179.705 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.583 ' O ' ' C ' ' A' ' 7' ' ' GLY . 87.4 m -82.85 -173.87 4.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.287 -0.883 . . . . 0.0 108.867 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.583 ' C ' ' O ' ' A' ' 6' ' ' CYS . . . 7.69 -77.26 0.0 OUTLIER Glycine 0 N--CA 1.507 3.372 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 6' ' ' CYS . 3.7 p -161.08 55.36 0.29 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.228 -1.16 . . . . 0.0 109.468 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.424 ' N ' ' OD1' ' A' ' 9' ' ' ASN . 1.5 m-20 -117.28 -144.65 0.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.353 -0.842 . . . . 0.0 109.741 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.487 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 46.5 t -162.44 60.46 0.22 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.132 -0.98 . . . . 0.0 109.152 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.528 ' CZ ' ' HB3' ' A' ' 63' ' ' SER . 6.1 m-85 -86.78 113.2 22.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.5 -0.75 . . . . 0.0 109.333 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.496 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -87.94 131.41 34.61 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.255 -0.903 . . . . 0.0 109.835 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 12' ' ' SER . 1.8 p -45.33 -37.17 4.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.607 -0.683 . . . . 0.0 109.445 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.4 -47.26 84.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.376 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.16 -23.94 61.36 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.501 ' O ' ' HB2' ' A' ' 20' ' ' GLN . 63.0 t -65.19 -31.97 56.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.6 t -61.66 -45.65 93.12 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.668 -0.645 . . . . 0.0 109.449 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.07 -49.53 77.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.121 -0.987 . . . . 0.0 108.608 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.522 ' CB ' HD11 ' A' ' 61' ' ' ILE . . . -71.08 -12.85 61.73 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.587 ' OE1' ' CG ' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -80.6 -34.07 35.44 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.506 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.98 -13.65 59.94 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.61 -41.13 65.92 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.592 ' CA ' ' CD2' ' A' ' 59' ' ' TRP . . . -81.72 -32.7 29.42 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.201 -1.559 . . . . 0.0 109.201 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.493 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 9.9 t80 -67.61 -40.8 84.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.426 -1.043 . . . . 0.0 109.758 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.406 ' O ' ' C ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -60.97 -66.53 0.52 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.912 . . . . 0.0 108.966 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.512 ' CD1' ' HB3' ' A' ' 31' ' ' GLU . 0.9 OUTLIER -43.85 -44.56 6.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.458 -0.776 . . . . 0.0 109.0 179.242 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.422 ' HB3' ' O ' ' A' ' 24' ' ' TYR . 2.0 t60 -49.75 -68.06 0.21 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.738 -0.601 . . . . 0.0 110.678 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -76.68 2.23 14.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.252 -0.905 . . . . 0.0 110.004 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.452 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 1.1 m-20 -82.93 -28.89 29.58 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.195 -0.941 . . . . 0.0 109.775 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.73 -15.33 63.32 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.512 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 3.2 tp10 -83.43 -149.0 0.09 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -1.154 . . . . 0.0 109.249 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.548 ' CG2' ' CB ' ' A' ' 37' ' ' SER . 0.3 OUTLIER -159.19 -172.34 3.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.133 -0.979 . . . . 0.0 109.386 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.419 HG23 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -82.94 -95.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.924 . . . . 0.0 109.496 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.469 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -115.2 -20.31 5.61 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.6 OUTLIER 167.21 -42.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.157 -1.202 . . . . 0.0 109.728 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 37' ' ' SER . 95.1 m-20 -77.25 -10.3 59.33 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.216 -0.928 . . . . 0.0 109.523 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.548 ' CB ' ' CG2' ' A' ' 32' ' ' THR . 4.0 p 62.08 135.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 109.183 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.597 ' C ' ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -121.44 -33.71 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.077 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -178.748 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 36.3 Cg_endo -80.31 101.5 1.34 Allowed 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 121.304 1.336 . . . . 0.0 112.611 -178.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.597 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -138.78 134.95 34.13 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.244 -0.91 . . . . 0.0 109.801 177.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.567 ' HB2' ' CE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -51.02 131.02 26.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.166 -0.959 . . . . 0.0 109.384 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.523 ' CZ ' ' HA ' ' A' ' 44' ' ' ASN . 4.1 t80 -113.51 140.84 47.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.282 -0.886 . . . . 0.0 109.172 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.509 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 3.7 m-80 -85.87 -90.63 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.191 -0.943 . . . . 0.0 109.739 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.523 ' HA ' ' CZ ' ' A' ' 42' ' ' TYR . 0.7 OUTLIER 174.49 148.05 0.07 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 109.39 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.412 ' O ' ' C ' ' A' ' 46' ' ' GLU . 11.2 m-85 -139.69 -72.61 0.38 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.239 -0.913 . . . . 0.0 109.331 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.595 ' CB ' ' CZ ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -40.34 -37.83 0.72 Allowed 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.512 -0.743 . . . . 0.0 109.853 -179.604 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.86 62.22 0.75 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.595 ' CZ ' ' CB ' ' A' ' 46' ' ' GLU . 23.9 m-85 -90.78 -168.01 1.97 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.246 -1.149 . . . . 0.0 108.885 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.34 -39.36 2.2 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.152 -0.968 . . . . 0.0 109.538 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.527 ' CB ' ' OH ' ' A' ' 56' ' ' TYR . 18.3 m-85 47.26 -168.55 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.21 -0.931 . . . . 0.0 109.393 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.83 31.76 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 109.502 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.0 t -108.52 -66.61 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.927 . . . . 0.0 109.513 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.425 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 70.7 m -165.31 -179.9 5.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.088 -1.008 . . . . 0.0 110.049 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.576 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -79.51 -50.32 1.31 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.534 -0.728 . . . . 0.0 110.761 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 54' ' ' SER . 35.4 Cg_endo -75.79 81.36 2.39 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.986 1.791 . . . . 0.0 110.374 -178.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.594 ' O ' ' CD1' ' A' ' 57' ' ' TYR . 36.5 m-85 -79.27 -171.62 2.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.696 -0.628 . . . . 0.0 109.832 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.594 ' CD1' ' O ' ' A' ' 56' ' ' TYR . 68.0 m-85 -155.4 158.44 38.64 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 77' ' ' ARG . 2.6 pt-20 -117.86 139.17 51.49 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.938 -1.102 . . . . 0.0 110.303 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.604 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 26.8 t-105 -159.9 138.64 7.8 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.604 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.5 Cg_endo -69.71 141.37 45.25 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.224 1.949 . . . . 0.0 111.469 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.522 HD11 ' CB ' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -109.31 140.3 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.499 ' CD2' ' C ' ' A' ' 61' ' ' ILE . 0.9 OUTLIER -126.23 163.26 23.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.951 . . . . 0.0 109.764 -179.619 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . 9.3 t -132.99 25.91 4.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.358 -0.839 . . . . 0.0 109.351 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.69 -46.62 0.12 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.354 -0.841 . . . . 0.0 109.314 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . -78.52 -101.21 0.21 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 1.6 t0 175.61 -62.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -1.132 . . . . 0.0 109.569 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.7 t -127.84 126.18 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 109.756 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.535 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 6.2 t80 -63.44 136.31 57.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.158 -0.964 . . . . 0.0 109.304 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 p -161.44 53.31 0.26 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.55 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.498 ' O ' ' CE1' ' A' ' 68' ' ' TYR . . . 126.24 -165.96 19.21 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.74 -157.51 41.86 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.9 t -120.01 120.14 30.48 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.331 -1.099 . . . . 0.0 109.44 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.427 ' HB2' ' OH ' ' A' ' 38' ' ' TYR . 34.7 Cg_endo -77.73 172.91 14.93 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.295 1.996 . . . . 0.0 110.669 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.0 134.58 2.13 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.503 ' HA ' ' N ' ' A' ' 92' ' ' HIS . . . 55.88 -153.18 0.35 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -1.151 . . . . 0.0 109.479 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.498 ' O ' ' O ' ' A' ' 75' ' ' ALA . 45.6 m-20 20.75 106.74 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.488 ' O ' ' O ' ' A' ' 90' ' ' ILE . 6.9 mtp-105 -160.06 135.38 8.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.154 -0.966 . . . . 0.0 108.584 178.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 p -123.99 135.1 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.739 -1.225 . . . . 0.0 109.638 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.574 ' CG1' ' N ' ' A' ' 80' ' ' PHE . 29.9 t -92.39 166.13 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.973 0.892 . . . . 0.0 109.808 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.587 ' CG ' ' OE1' ' A' ' 20' ' ' GLN . 3.2 p90 -161.53 -178.92 6.92 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.189 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -112.48 -81.75 0.59 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 109.692 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.493 ' O ' ' CZ ' ' A' ' 24' ' ' TYR . 2.5 pt-20 -162.64 21.78 0.09 Allowed 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.483 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 2.4 m-20 -140.61 29.5 1.93 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 83' ' ' ASN . 10.5 p30 46.95 24.5 0.37 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.502 0.668 . . . . 0.0 109.22 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 26.7 mm-40 -63.61 -106.73 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 174.42 114.55 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.739 179.081 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.487 ' HB2' ' HB ' ' A' ' 79' ' ' VAL . . . -89.79 -42.24 11.4 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 161.28 155.0 7.67 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.563 ' CG2' ' CD2' ' A' ' 4' ' ' TYR . 32.0 t -92.05 88.72 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.334 -1.098 . . . . 0.0 109.285 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.488 ' O ' ' O ' ' A' ' 77' ' ' ARG . 1.2 pt -90.88 156.2 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.432 -0.793 . . . . 0.0 109.527 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.434 HG22 HG23 ' A' ' 101' ' ' VAL . 13.0 t -122.2 137.01 54.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.859 -1.151 . . . . 0.0 110.245 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.623 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -81.56 67.58 7.58 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.294 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 0.0 OUTLIER 177.54 164.02 0.58 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.045 -1.034 . . . . 0.0 109.668 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.84 22.11 75.21 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -155.81 51.84 0.56 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -1.149 . . . . 0.0 109.353 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.7 m 68.07 93.66 0.07 Allowed 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.53 -83.9 1.1 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.623 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -139.07 -83.18 0.28 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -1.181 . . . . 0.0 109.177 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.47 ' O ' ' O ' ' A' ' 98' ' ' ASN . 1.1 m-20 61.23 137.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.329 -0.857 . . . . 0.0 109.292 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.618 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 0.3 OUTLIER -85.85 151.63 23.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.117 -0.989 . . . . 0.0 109.385 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 90' ' ' ILE . 3.2 m -160.63 136.93 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.409 -0.807 . . . . 0.0 109.073 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -53.21 123.75 12.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.243 -0.911 . . . . 0.0 109.588 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -76.04 83.0 2.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.295 -0.878 . . . . 0.0 109.688 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.127 -0.983 . . . . 0.0 109.42 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 6.0 t 62.38 91.93 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.881 . . . . 0.0 109.836 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -105.84 2.66 27.92 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.449 -0.782 . . . . 0.0 109.032 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.477 ' CG ' HG21 ' A' ' 89' ' ' VAL . 28.8 m-85 -121.14 67.89 0.88 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.267 -0.896 . . . . 0.0 109.402 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.487 ' O ' ' HB3' ' A' ' 103' ' ' CYS . 11.6 p -79.74 124.62 28.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.905 . . . . 0.0 109.192 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.1 m -113.31 17.14 18.77 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.011 0.91 . . . . 0.0 110.069 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 136.02 -93.25 0.23 Allowed Glycine 0 C--N 1.282 -2.459 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.9 m -119.82 28.66 7.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -1.102 . . . . 0.0 109.29 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.453 ' O ' ' C ' ' A' ' 10' ' ' CYS . 1.7 m120 -111.53 -36.64 5.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 109.619 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' ASN . 1.7 t 41.33 80.4 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.413 -0.804 . . . . 0.0 109.469 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.633 ' CE2' ' CB ' ' A' ' 63' ' ' SER . 2.7 m-85 -86.6 148.34 25.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -0.833 . . . . 0.0 110.148 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 0.6 OUTLIER -80.05 128.11 33.09 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.639 -0.663 . . . . 0.0 109.839 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.3 p -56.96 -18.52 13.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.921 . . . . 0.0 108.969 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.05 -30.33 15.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.264 -0.897 . . . . 0.0 109.592 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -73.55 -30.97 63.39 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.485 ' HA ' HD12 ' A' ' 61' ' ' ILE . 3.9 t -60.82 -32.07 51.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.03 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.3 t -60.38 -46.83 88.58 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.486 -0.759 . . . . 0.0 110.031 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -42.67 93.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.103 -0.998 . . . . 0.0 108.967 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.595 ' CB ' HD13 ' A' ' 61' ' ' ILE . . . -78.2 -11.63 59.94 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.511 -0.743 . . . . 0.0 109.16 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -86.67 -26.6 24.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.367 -0.833 . . . . 0.0 108.984 179.617 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -83.98 -10.19 58.11 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.382 -0.824 . . . . 0.0 109.181 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.61 -47.43 17.15 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.35 -0.844 . . . . 0.0 109.276 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.551 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -75.29 -16.86 80.37 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.462 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 6.2 t80 -87.0 -63.4 1.31 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.444 -1.033 . . . . 0.0 109.544 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.9 OUTLIER -46.95 -58.59 3.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.272 -0.893 . . . . 0.0 109.766 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.428 ' CD1' ' HB3' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -51.73 -47.08 64.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.295 -0.878 . . . . 0.0 109.773 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.628 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 2.9 t60 -52.9 -62.19 1.81 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.389 -0.82 . . . . 0.0 110.918 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -72.28 -7.23 48.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 109.735 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 13.7 t70 -78.46 -14.23 59.47 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.196 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.94 0.28 59.79 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.428 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 2.6 tp10 -94.43 -145.27 0.25 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.3 -1.118 . . . . 0.0 109.4 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.58 ' CG2' ' CB ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -163.62 179.51 7.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 109.573 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.1 m -89.41 -120.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 109.305 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.57 -42.35 95.64 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 169.72 -38.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.311 -1.111 . . . . 0.0 109.549 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 37' ' ' SER . 5.4 m120 -65.46 -11.79 46.37 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.23 -0.919 . . . . 0.0 109.674 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.58 ' CB ' ' CG2' ' A' ' 32' ' ' THR . 0.7 OUTLIER 59.66 114.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 0.0 109.129 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.668 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -107.65 -27.39 0.18 Allowed Pre-proline 0 N--CA 1.498 1.966 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -178.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.668 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 36.5 Cg_endo -79.4 102.51 1.51 Allowed 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 121.318 1.345 . . . . 0.0 113.167 -178.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.601 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -131.2 165.31 23.62 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.16 -0.962 . . . . 0.0 109.179 177.263 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.602 ' HB2' ' CE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -73.79 132.28 42.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 109.31 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.565 ' OH ' ' CD2' ' A' ' 100' ' ' PHE . 26.9 t80 -100.97 134.26 44.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.367 -0.833 . . . . 0.0 109.351 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -103.24 -8.64 20.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.185 -0.947 . . . . 0.0 109.728 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.552 ' HA ' ' CZ ' ' A' ' 42' ' ' TYR . 2.2 m120 62.16 175.0 0.13 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.692 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.458 ' O ' ' C ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -179.15 -45.25 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.388 -0.82 . . . . 0.0 108.986 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.576 ' OE1' ' CZ ' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -38.52 -44.4 0.95 Allowed 'General case' 0 C--N 1.307 -1.242 0 O-C-N 121.696 -0.627 . . . . 0.0 109.945 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.55 47.12 0.09 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.576 ' CZ ' ' OE1' ' A' ' 46' ' ' GLU . 16.0 m-85 -106.58 139.76 40.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -1.184 . . . . 0.0 109.379 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.64 -30.85 11.53 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.285 -0.884 . . . . 0.0 109.262 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.552 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 30.1 m-85 50.93 -170.52 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.42 -0.8 . . . . 0.0 109.743 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.21 44.42 0.48 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.362 -0.836 . . . . 0.0 109.364 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.544 HG13 ' OD1' ' A' ' 81' ' ' ASN . 54.8 t -121.53 -45.34 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.263 -0.898 . . . . 0.0 109.636 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.579 ' O ' ' CE1' ' A' ' 56' ' ' TYR . 0.6 OUTLIER 167.72 -176.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.111 -0.993 . . . . 0.0 109.936 -179.64 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.505 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -86.4 -54.41 0.4 Allowed Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.373 -0.829 . . . . 0.0 111.646 -179.051 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 54' ' ' SER . 33.7 Cg_endo -73.1 86.02 1.16 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.045 1.83 . . . . 0.0 110.607 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.579 ' CE1' ' O ' ' A' ' 53' ' ' SER . 3.7 m-30 -87.21 -173.5 4.44 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.461 0.648 . . . . 0.0 110.054 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.628 ' CE2' ' NE2' ' A' ' 27' ' ' HIS . 75.7 m-85 -156.63 116.67 3.57 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -77.54 140.74 39.78 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.83 0.824 . . . . 0.0 110.968 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.606 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 20.9 t-105 -160.64 137.53 6.59 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.606 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.7 Cg_endo -68.94 147.05 67.26 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.138 1.892 . . . . 0.0 111.424 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.595 HD13 ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -121.09 126.0 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.536 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.496 ' CD2' ' C ' ' A' ' 61' ' ' ILE . 0.3 OUTLIER -122.72 166.1 15.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.278 -0.889 . . . . 0.0 109.284 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.633 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -130.91 7.42 4.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.289 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.97 -69.85 0.54 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.259 -0.901 . . . . 0.0 109.338 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 158.31 60.61 0.01 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -175.58 139.29 0.42 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -1.17 . . . . 0.0 109.461 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.444 HG13 ' HZ2' ' A' ' 59' ' ' TRP . 91.5 t -77.3 147.6 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.0 109.441 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.479 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 0.7 OUTLIER -65.38 166.61 9.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 109.749 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.7 m -169.2 49.87 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.434 -0.791 . . . . 0.0 109.14 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.45 114.91 0.92 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 72' ' ' SER . . . -178.64 39.4 0.08 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 1.4 p 75.14 109.7 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.248 -1.148 . . . . 0.0 109.584 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.526 ' CA ' ' OH ' ' A' ' 38' ' ' TYR . 36.2 Cg_endo -79.41 119.68 4.23 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.49 2.127 . . . . 0.0 110.555 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 92' ' ' HIS . . . 170.0 -168.9 41.77 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . 47.74 -154.77 0.07 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -1.166 . . . . 0.0 110.506 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.44 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 51.8 m-20 -39.53 129.26 1.9 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.549 0.69 . . . . 0.0 109.619 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.515 ' CZ ' ' HB3' ' A' ' 60' ' ' PRO . 23.4 mmt-85 -158.43 122.25 3.99 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.498 ' CG2' HG23 ' A' ' 89' ' ' VAL . 0.9 OUTLIER -105.25 148.61 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.263 -0.898 . . . . 0.0 109.812 -178.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.529 HG12 ' H ' ' A' ' 80' ' ' PHE . 2.0 t -121.52 174.55 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.962 0.886 . . . . 0.0 109.673 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.529 ' H ' HG12 ' A' ' 79' ' ' VAL . 4.4 p90 -173.92 -167.87 0.38 Allowed 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.354 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.558 ' OD1' ' CE1' ' A' ' 56' ' ' TYR . 3.1 m120 -120.49 -80.57 0.62 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.266 -0.897 . . . . 0.0 109.794 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.412 ' OE1' ' O ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -163.43 23.98 0.08 Allowed 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 84' ' ' ASN . 24.8 m-80 -148.91 16.28 0.96 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.483 -0.761 . . . . 0.0 109.056 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.439 ' CG ' ' O ' ' A' ' 84' ' ' ASN . 2.9 t-20 62.32 13.89 6.35 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.366 -0.834 . . . . 0.0 109.348 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.562 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -46.89 -32.08 3.54 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.67 -1.234 . . . . 0.0 107.67 179.315 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.562 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.2 OUTLIER 84.95 110.58 0.05 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.534 0.683 . . . . 0.0 110.528 179.211 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.552 ' O ' ' CD1' ' A' ' 50' ' ' PHE . . . -82.63 -43.48 16.93 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 158.93 -161.14 31.71 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.498 HG23 ' CG2' ' A' ' 78' ' ' VAL . 39.1 t -134.96 92.46 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -1.179 . . . . 0.0 109.252 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 77' ' ' ARG . 0.6 OUTLIER -94.41 151.45 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.4 -0.812 . . . . 0.0 109.858 -179.668 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.2 t -125.85 134.58 51.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 109.731 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.695 ' CD2' ' CD1' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -82.61 74.64 9.57 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.323 -0.86 . . . . 0.0 108.99 179.733 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 7.9 m -169.68 135.37 1.49 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.492 -0.755 . . . . 0.0 109.466 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 93.42 24.11 22.36 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 98' ' ' ASN . . . -156.51 91.5 1.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.132 -1.217 . . . . 0.0 109.682 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 95' ' ' ALA . 1.7 t 43.78 79.35 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.304 -0.873 . . . . 0.0 109.314 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.62 -70.5 3.16 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.587 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -148.76 -82.15 0.12 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -1.1 . . . . 0.0 109.318 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 4.3 m-20 60.73 138.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.372 -0.83 . . . . 0.0 109.315 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.695 ' CD1' ' CD2' ' A' ' 92' ' ' HIS . 0.6 OUTLIER -79.12 148.86 32.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.058 -1.026 . . . . 0.0 109.85 -179.588 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -151.94 114.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.411 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 101' ' ' VAL . 1.7 pt-20 -43.71 131.26 5.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.326 -0.859 . . . . 0.0 109.575 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 5' ' ' THR . 84.0 m -72.31 106.26 4.39 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.324 -0.86 . . . . 0.0 109.401 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.826 -1.083 . . . . 0.0 109.54 -179.833 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 15.3 p 176.45 98.12 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.108 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -67.66 -19.41 65.19 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.319 -0.863 . . . . 0.0 108.895 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.552 ' CG ' HG23 ' A' ' 89' ' ' VAL . 39.4 m-85 -103.46 81.55 1.93 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.419 ' O ' ' CG2' ' A' ' 5' ' ' THR . 46.8 m -101.1 69.44 1.3 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.397 -0.814 . . . . 0.0 110.473 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.518 ' O ' ' N ' ' A' ' 8' ' ' SER . 3.9 m -80.6 154.58 27.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.036 -1.04 . . . . 0.0 108.505 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 6' ' ' CYS . . . 44.06 -94.98 0.01 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 6' ' ' CYS . 2.4 t -159.28 40.85 0.21 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -1.114 . . . . 0.0 109.1 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.407 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 2.8 m-80 -94.88 -35.88 11.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.919 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.431 ' C ' ' CB ' ' A' ' 2' ' ' CYS . 42.3 t 56.46 59.98 3.35 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.065 -1.022 . . . . 0.0 108.637 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.516 ' CE2' ' HB2' ' A' ' 63' ' ' SER . 2.9 m-30 -89.49 144.27 26.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.432 -0.792 . . . . 0.0 110.177 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 4.0 m -82.85 133.81 35.12 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.578 -0.701 . . . . 0.0 109.966 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.503 ' HA ' HG21 ' A' ' 16' ' ' VAL . 83.1 p -62.56 -23.39 66.97 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.0 t -79.47 -33.1 42.61 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.444 ' HB2' ' HB2' ' A' ' 12' ' ' SER . 5.4 m-20 -77.38 -27.27 52.46 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.503 HG21 ' HA ' ' A' ' 13' ' ' SER . 25.6 t -63.58 -24.27 35.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.0 t -66.52 -42.83 86.67 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.7 -42.27 99.55 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.603 ' CB ' ' CD1' ' A' ' 61' ' ' ILE . . . -74.33 -14.44 60.89 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.539 ' OE1' ' CB ' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -82.27 -30.6 30.55 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.498 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.62 -13.69 59.7 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.31 -58.53 3.24 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.502 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -61.64 -22.46 61.78 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.458 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 16.8 t80 -75.84 -37.32 59.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.555 -0.967 . . . . 0.0 109.127 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -69.74 -46.34 66.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.836 . . . . 0.0 108.849 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.5 tp -71.54 -18.06 62.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.392 -0.817 . . . . 0.0 108.87 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.621 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 55.1 t60 -89.66 -20.5 23.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.516 -0.74 . . . . 0.0 109.397 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.17 -23.26 24.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 109.338 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -97.78 -10.09 25.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.355 -0.84 . . . . 0.0 109.508 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.75 18.74 70.62 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.564 ' CG ' ' N ' ' A' ' 32' ' ' THR . 34.1 tt0 -88.8 167.08 13.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -1.171 . . . . 0.0 109.646 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.564 ' N ' ' CG ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -104.01 166.68 10.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.504 -0.747 . . . . 0.0 109.412 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -102.56 -79.06 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.062 -1.024 . . . . 0.0 109.685 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -72.62 -44.05 41.5 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.5 OUTLIER 163.32 -33.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.326 -1.102 . . . . 0.0 109.327 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 37' ' ' SER . 58.6 m-20 -76.77 -77.2 0.15 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.255 -0.903 . . . . 0.0 109.184 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 36' ' ' ASN . 0.1 OUTLIER 158.1 128.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.614 ' C ' ' CE1' ' A' ' 40' ' ' HIS . 0.2 OUTLIER -120.43 -37.31 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.838 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -178.593 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 35.1 Cg_endo -80.42 101.93 1.37 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 120.975 1.117 . . . . 0.0 112.485 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.614 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -132.12 -172.05 2.79 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.365 -0.835 . . . . 0.0 109.267 178.121 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.474 ' O ' ' OE2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -81.74 158.22 24.26 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.824 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.512 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 1.2 t80 -121.38 124.1 43.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.102 -0.998 . . . . 0.0 109.747 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -110.24 -75.22 0.63 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 108.543 179.295 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.512 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 0.4 OUTLIER 77.15 -76.03 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.363 -0.836 . . . . 0.0 110.458 179.002 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 56.66 45.69 21.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.925 -1.109 . . . . 0.0 109.115 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.512 ' CG ' ' CE2' ' A' ' 48' ' ' PHE . 0.8 OUTLIER -94.2 -28.42 15.64 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.249 -0.907 . . . . 0.0 109.306 -179.668 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 159.84 -23.61 0.29 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.512 ' CE2' ' CG ' ' A' ' 46' ' ' GLU . 3.5 p90 -111.87 139.74 47.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.431 -1.041 . . . . 0.0 109.225 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 50' ' ' PHE . 2.4 m-20 -122.8 -23.79 4.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.682 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.517 ' CB ' ' O ' ' A' ' 49' ' ' ASP . 3.1 m-85 80.54 173.82 0.13 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.363 -0.835 . . . . 0.0 109.382 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.9 p -120.74 39.48 3.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.219 -0.925 . . . . 0.0 109.625 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.439 ' CG2' ' HA ' ' A' ' 87' ' ' ALA . 15.0 t -98.58 -67.14 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.157 -0.964 . . . . 0.0 109.505 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.444 ' O ' ' CE2' ' A' ' 56' ' ' TYR . 0.2 OUTLIER -165.55 174.98 9.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.097 -1.002 . . . . 0.0 109.996 -179.702 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.58 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -79.22 -51.04 1.3 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.46 -0.775 . . . . 0.0 110.61 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 54' ' ' SER . 36.2 Cg_endo -76.25 82.85 2.12 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.94 1.76 . . . . 0.0 110.208 -178.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.541 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 49.0 m-85 -79.35 -178.15 6.09 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.561 0.696 . . . . 0.0 109.712 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.621 ' CE1' ' NE2' ' A' ' 27' ' ' HIS . 97.1 m-85 -158.13 135.63 10.32 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.474 ' OE2' ' O ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -96.03 140.5 30.68 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.094 -1.003 . . . . 0.0 111.589 -178.115 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.661 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 27.5 t-105 -160.81 139.29 7.42 Favored Pre-proline 0 N--CA 1.495 1.799 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.661 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 31.6 Cg_endo -70.09 143.15 48.39 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.161 1.907 . . . . 0.0 111.321 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.603 ' CD1' ' CB ' ' A' ' 19' ' ' ALA . 0.2 OUTLIER -107.02 116.29 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.56 -0.712 . . . . 0.0 109.512 -179.638 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.555 ' N ' HD11 ' A' ' 61' ' ' ILE . 0.7 OUTLIER -116.94 164.04 15.3 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.296 -0.878 . . . . 0.0 108.985 179.494 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.516 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -172.48 56.32 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.55 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 177.14 36.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.271 -0.893 . . . . 0.0 109.118 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.04 -70.31 0.08 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -173.74 167.75 4.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.202 -1.175 . . . . 0.0 109.77 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.8 t -62.59 150.1 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.331 -0.856 . . . . 0.0 109.298 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.532 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 17.1 t80 -52.0 138.86 24.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.966 -1.084 . . . . 0.0 109.533 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.458 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 5.0 t -159.9 21.9 0.17 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.393 -0.817 . . . . 0.0 109.69 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 130.98 154.7 7.98 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.91 -133.5 6.8 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.97 131.07 21.98 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.145 -1.209 . . . . 0.0 109.175 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.492 ' HA ' ' OH ' ' A' ' 38' ' ' TYR . 36.2 Cg_endo -79.48 -172.57 1.57 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.406 2.071 . . . . 0.0 111.012 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 75' ' ' ALA . . . 74.52 -167.74 54.68 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 74' ' ' GLY . . . 77.6 -152.02 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.246 -1.149 . . . . 0.0 110.459 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.422 ' O ' ' HB3' ' A' ' 77' ' ' ARG . 5.1 m-20 -62.24 162.65 9.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.391 -0.818 . . . . 0.0 109.811 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.57 ' O ' HG12 ' A' ' 90' ' ' ILE . 0.9 OUTLIER 175.1 96.59 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.176 -0.952 . . . . 0.0 109.149 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.602 HG21 HD23 ' A' ' 86' ' ' LEU . 2.6 p -77.02 140.12 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.884 -1.135 . . . . 0.0 110.579 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.577 ' CG1' ' N ' ' A' ' 80' ' ' PHE . 16.7 t -92.53 169.44 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.577 ' CE1' ' O ' ' A' ' 57' ' ' TYR . 4.6 p90 -162.84 -173.31 3.43 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.629 -0.829 . . . . 0.0 109.502 -178.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.41 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 11.0 t-20 -124.0 -81.77 0.64 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.17 -0.956 . . . . 0.0 109.405 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.458 ' O ' ' CZ ' ' A' ' 24' ' ' TYR . 65.9 mt-10 -156.4 12.82 0.29 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.459 -0.776 . . . . 0.0 110.317 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.5 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 0.1 OUTLIER -137.9 6.01 2.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.023 -1.048 . . . . 0.0 109.489 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.5 ' OD1' ' O ' ' A' ' 83' ' ' ASN . 0.3 OUTLIER 70.91 16.14 6.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.448 -0.783 . . . . 0.0 109.441 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.586 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -53.72 -31.29 47.69 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.383 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.602 HD23 HG21 ' A' ' 78' ' ' VAL . 0.6 OUTLIER 89.21 103.28 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.686 0.755 . . . . 0.0 110.599 179.226 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.447 ' CB ' HG11 ' A' ' 79' ' ' VAL . . . -70.97 -52.59 18.85 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.424 ' O ' HG22 ' A' ' 78' ' ' VAL . . . 169.25 171.29 34.79 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.552 HG23 ' CG ' ' A' ' 4' ' ' TYR . 64.3 t -102.91 124.69 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.937 -1.331 . . . . 0.0 109.906 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.57 HG12 ' O ' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -125.59 153.22 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.331 -0.856 . . . . 0.0 108.696 179.553 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 99' ' ' ASN . 6.3 t -117.07 165.49 13.32 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.026 -1.046 . . . . 0.0 110.019 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.62 ' NE2' ' CD2' ' A' ' 100' ' ' PHE . 0.4 OUTLIER -121.11 67.27 0.87 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.437 -0.789 . . . . 0.0 109.28 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 7.4 m -168.81 126.22 1.01 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.462 -0.773 . . . . 0.0 109.292 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 107.96 -20.57 31.03 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 98' ' ' ASN . . . -105.83 93.94 4.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.211 -1.17 . . . . 0.0 109.681 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 95' ' ' ALA . 51.7 m 41.59 52.58 3.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.511 -0.743 . . . . 0.0 109.477 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.1 -73.29 0.21 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.604 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -144.38 -81.96 0.16 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.259 -1.142 . . . . 0.0 109.472 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 91' ' ' THR . 0.8 OUTLIER 57.06 159.29 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.317 -0.864 . . . . 0.0 109.15 -179.519 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.62 ' CD2' ' NE2' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -96.61 145.17 25.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.902 -1.124 . . . . 0.0 110.04 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.443 ' O ' ' C ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -155.97 130.55 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.293 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 101' ' ' VAL . 2.3 pt-20 -39.98 136.83 1.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.468 -0.77 . . . . 0.0 110.124 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.99 123.83 29.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.395 -0.816 . . . . 0.0 109.382 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.1 p . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.171 -0.955 . . . . 0.0 109.38 179.844 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.443 ' O ' ' SG ' ' A' ' 10' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 0.8 OUTLIER 173.94 106.91 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.279 -0.888 . . . . 0.0 110.398 179.558 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -79.66 -14.74 58.57 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.638 ' CG ' HG23 ' A' ' 89' ' ' VAL . 16.2 m-85 -112.8 126.94 55.97 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.337 -0.852 . . . . 0.0 109.051 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -152.83 109.32 3.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.235 -0.916 . . . . 0.0 109.744 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 103' ' ' CYS . 29.9 m -95.44 16.81 15.96 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.066 0.936 . . . . 0.0 109.557 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.65 -146.47 6.31 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 p -88.17 15.11 7.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.208 -1.172 . . . . 0.0 109.304 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -79.67 -168.18 1.49 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.322 -0.861 . . . . 0.0 109.664 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 1' ' ' ALA . 45.6 t -149.55 74.3 1.22 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.5 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 4.2 m-85 -80.44 124.6 29.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.393 -0.817 . . . . 0.0 110.041 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 0.6 OUTLIER -83.79 124.79 31.28 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.502 -0.749 . . . . 0.0 109.63 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 12' ' ' SER . 28.3 t -46.39 -25.67 0.69 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.239 -0.913 . . . . 0.0 108.754 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.3 t -76.91 -43.36 35.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 109.285 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.41 -26.09 67.07 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.49 ' HA ' HD12 ' A' ' 61' ' ' ILE . 3.0 t -72.87 -32.99 42.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.91 -42.31 97.83 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -47.32 86.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 108.628 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.6 ' CB ' HD13 ' A' ' 61' ' ' ILE . . . -75.9 -10.59 59.55 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.635 ' NE2' ' CG ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -83.17 -30.61 27.68 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.922 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.25 -16.73 54.07 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.38 -47.27 61.7 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.498 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -73.14 -31.21 61.88 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.684 -1.766 . . . . 0.0 108.684 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -68.23 -32.15 72.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.46 -1.024 . . . . 0.0 109.171 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -73.36 -47.9 38.57 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.6 tp -65.25 -21.2 66.71 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -85.65 -24.76 26.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.526 -0.734 . . . . 0.0 109.516 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -88.12 -11.55 46.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.319 -0.863 . . . . 0.0 109.403 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -107.88 -11.57 15.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.374 -0.829 . . . . 0.0 109.721 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.64 14.89 77.71 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.27 -157.17 0.16 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -1.207 . . . . 0.0 109.379 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.62 HG23 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -158.19 166.79 31.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.322 -0.861 . . . . 0.0 109.254 179.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -110.33 -70.44 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.144 -0.973 . . . . 0.0 109.585 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -85.93 16.45 42.15 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 66.36 19.73 10.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.132 -1.217 . . . . 0.0 109.114 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -120.92 5.58 10.42 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.402 -0.811 . . . . 0.0 109.293 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.62 ' HA ' HG23 ' A' ' 32' ' ' THR . 0.3 OUTLIER 68.3 73.51 0.29 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.224 -0.922 . . . . 0.0 108.653 -179.179 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.654 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -71.67 -45.33 12.63 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.117 -0.99 . . . . 0.0 110.938 -179.367 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 35.3 Cg_endo -77.15 106.61 2.27 Favored 'Trans proline' 0 C--N 1.3 -1.993 0 C-N-CA 120.855 1.037 . . . . 0.0 109.873 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.654 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -127.09 -175.37 3.41 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -107.13 143.34 35.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.943 -1.098 . . . . 0.0 110.367 -179.454 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.504 ' HB2' ' HG3' ' A' ' 58' ' ' GLU . 12.0 t80 -104.11 161.59 13.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.503 -0.748 . . . . 0.0 109.245 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.431 ' O ' ' O ' ' A' ' 44' ' ' ASN . 0.5 OUTLIER -123.83 -16.22 6.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.124 -0.985 . . . . 0.0 109.567 179.615 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.543 ' O ' ' CD2' ' A' ' 45' ' ' TYR . 0.7 OUTLIER 62.1 130.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.556 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.543 ' CD2' ' O ' ' A' ' 44' ' ' ASN . 5.6 m-85 -161.44 -38.54 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.399 -0.813 . . . . 0.0 109.126 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.667 ' OE2' HG12 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -37.93 -68.36 0.16 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.469 0.652 . . . . 0.0 110.131 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.56 61.14 0.01 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -89.62 -174.75 4.44 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.358 -1.084 . . . . 0.0 108.61 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -117.09 -20.4 9.32 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.897 -1.127 . . . . 0.0 110.043 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.511 ' C ' ' CD1' ' A' ' 50' ' ' PHE . 10.1 p90 -80.74 179.97 7.54 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.129 -0.982 . . . . 0.0 109.438 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.449 ' HA ' ' OH ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -177.4 57.08 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.259 -0.9 . . . . 0.0 109.254 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.525 HG13 ' HB2' ' A' ' 85' ' ' GLN . 42.3 t -45.03 -63.13 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.165 -0.959 . . . . 0.0 109.023 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.75 -178.97 7.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.312 -0.868 . . . . 0.0 109.95 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.58 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -79.7 -50.09 1.29 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.405 -0.809 . . . . 0.0 110.81 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 54' ' ' SER . 34.5 Cg_endo -75.28 83.62 1.83 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.991 1.794 . . . . 0.0 109.764 -178.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.493 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 10.1 m-85 -81.68 179.82 7.68 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.745 0.783 . . . . 0.0 110.804 -178.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.54 ' HA ' ' O ' ' A' ' 40' ' ' HIS . 64.4 m-85 -157.26 117.12 3.43 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.563 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -96.66 147.66 23.66 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.266 -0.896 . . . . 0.0 110.489 -178.584 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.642 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 4.1 t-105 -160.75 143.93 9.83 Favored Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.642 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 28.4 Cg_endo -66.35 133.03 31.17 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.336 2.024 . . . . 0.0 112.091 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.6 HD13 ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -118.31 115.66 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.704 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.878 HD12 ' O ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -118.58 163.75 16.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.107 -0.996 . . . . 0.0 109.13 179.761 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.1 t -131.53 36.17 3.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.484 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.73 6.8 12.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.18 -0.95 . . . . 0.0 109.618 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.71 -32.7 7.26 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.878 ' O ' HD12 ' A' ' 62' ' ' LEU . 11.9 m-20 -98.97 91.39 5.01 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.23 -1.159 . . . . 0.0 109.375 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.584 ' O ' ' CD1' ' A' ' 68' ' ' TYR . 43.4 t -65.02 156.75 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 109.857 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 67' ' ' VAL . 48.6 p90 39.17 -162.69 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.598 0.713 . . . . 0.0 110.023 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.492 ' N ' ' CD2' ' A' ' 68' ' ' TYR . 29.0 t 53.11 173.22 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.342 -0.849 . . . . 0.0 109.427 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.63 -160.45 15.99 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.66 41.32 2.25 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 t -161.26 85.95 1.72 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.221 -1.164 . . . . 0.0 109.306 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.476 ' HA ' ' OH ' ' A' ' 38' ' ' TYR . 35.5 Cg_endo -79.95 44.05 1.64 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.789 2.326 . . . . 0.0 111.022 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.465 ' O ' ' CB ' ' A' ' 75' ' ' ALA . . . -173.03 -167.52 33.05 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' A' ' 74' ' ' GLY . . . 72.28 -141.89 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.117 -1.225 . . . . 0.0 110.162 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.465 ' C ' ' O ' ' A' ' 75' ' ' ALA . 1.2 m-20 -34.2 131.14 0.31 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.444 -0.785 . . . . 0.0 111.21 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.475 ' O ' HG12 ' A' ' 90' ' ' ILE . 6.5 ttm-85 -167.24 110.11 0.68 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.469 -0.769 . . . . 0.0 108.989 179.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.497 ' CG2' ' N ' ' A' ' 79' ' ' VAL . 4.3 p -71.95 164.62 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.069 -1.019 . . . . 0.0 109.67 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.608 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 4.0 t -130.52 171.36 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.973 0.892 . . . . 0.0 109.961 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.635 ' CG ' ' NE2' ' A' ' 20' ' ' GLN . 24.0 p90 -174.02 -172.46 0.72 Allowed 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.418 ' CG ' ' N ' ' A' ' 82' ' ' GLU . 2.9 t30 -125.33 -84.9 0.64 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.962 -1.087 . . . . 0.0 109.794 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.418 ' N ' ' CG ' ' A' ' 81' ' ' ASN . 6.9 mt-10 -142.16 0.55 1.36 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.494 -0.753 . . . . 0.0 109.919 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 84' ' ' ASN . 8.7 m-20 -131.4 4.81 4.35 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 108.895 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 83' ' ' ASN . 5.5 t30 75.1 32.43 0.77 Allowed 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.334 -0.854 . . . . 0.0 109.192 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.543 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -62.16 -33.16 73.98 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.46 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.543 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER 84.99 103.95 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.488 0.661 . . . . 0.0 110.994 178.937 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.608 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . . . -74.54 -27.8 60.68 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 148.14 -149.03 21.04 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.638 HG23 ' CG ' ' A' ' 4' ' ' TYR . 72.5 t -129.85 87.71 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.254 -1.145 . . . . 0.0 109.639 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.526 ' HB ' ' HB3' ' A' ' 100' ' ' PHE . 12.2 pt -79.4 136.24 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.514 -0.741 . . . . 0.0 109.221 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 75' ' ' ALA . 13.1 t -130.5 118.54 21.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.91 . . . . 0.0 110.296 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.691 ' CD2' ' CE1' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -84.01 76.42 10.06 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.368 -0.832 . . . . 0.0 108.848 179.279 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 1.4 m 178.96 -30.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.553 -0.717 . . . . 0.0 109.404 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -59.04 -15.01 27.23 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -117.96 163.68 16.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.186 -1.185 . . . . 0.0 109.553 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 95' ' ' ALA . 3.7 m -42.92 120.33 1.75 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 109.008 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.97 -82.84 1.64 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.654 -1.779 . . . . 0.0 108.654 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.621 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -151.9 -86.81 0.07 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.318 -1.107 . . . . 0.0 109.287 179.419 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.472 ' O ' ' O ' ' A' ' 98' ' ' ASN . 4.0 m-80 61.04 129.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 108.937 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.691 ' CE1' ' CD2' ' A' ' 92' ' ' HIS . 57.0 m-85 -85.33 125.58 33.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.891 -1.131 . . . . 0.0 110.292 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.667 HG12 ' OE2' ' A' ' 46' ' ' GLU . 1.2 m -142.69 137.51 27.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.445 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 24.0 pt-20 -61.52 123.61 18.35 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.164 -0.96 . . . . 0.0 109.221 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.421 ' HB3' ' HA ' ' A' ' 6' ' ' CYS . 84.7 m -56.93 161.01 3.17 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.151 -0.968 . . . . 0.0 109.398 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.479 0 O-C-N 121.22 -0.925 . . . . 0.0 109.492 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 27.2 p -178.77 88.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.145 -0.972 . . . . 0.0 109.956 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -89.9 2.72 54.71 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.296 -0.878 . . . . 0.0 109.285 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -126.57 105.74 8.94 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.112 -0.992 . . . . 0.0 109.637 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.4 ' O ' ' CG2' ' A' ' 5' ' ' THR . 6.0 t -136.43 106.79 6.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.892 . . . . 0.0 109.318 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.445 ' SG ' ' HB ' ' A' ' 91' ' ' THR . 57.3 m -93.47 17.14 11.99 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.17 0.986 . . . . 0.0 109.63 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.48 -111.77 0.32 Allowed Glycine 0 C--N 1.282 -2.432 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.14 3.93 12.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.15 -1.206 . . . . 0.0 109.271 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.562 ' O ' ' N ' ' A' ' 11' ' ' TYR . 3.9 m120 -92.51 68.12 4.79 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.246 -0.909 . . . . 0.0 109.411 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -49.74 89.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.575 ' CZ ' ' OG ' ' A' ' 63' ' ' SER . 4.0 m-30 -83.17 144.6 29.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.456 -0.778 . . . . 0.0 110.173 -178.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 0.1 OUTLIER -79.18 127.84 32.54 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.818 -0.551 . . . . 0.0 110.042 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.35 -43.19 61.74 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.9 m -62.68 -34.52 77.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.378 -0.826 . . . . 0.0 108.958 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -69.22 -31.1 69.45 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 12' ' ' SER . 6.7 t -58.82 -25.43 29.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.429 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 20.3 t -74.4 -40.6 61.93 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -40.44 80.36 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.652 ' CB ' HD11 ' A' ' 61' ' ' ILE . . . -77.06 -26.43 53.56 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.522 ' CA ' ' OE1' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -75.03 -16.62 60.59 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.056 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -92.62 -11.71 33.54 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.95 -56.2 3.95 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.524 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -69.16 -24.13 76.02 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.565 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 11.0 t80 -77.99 -53.33 7.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.501 -1.0 . . . . 0.0 109.048 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 1.1 tm0? -45.64 -47.15 14.89 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.559 ' CD1' ' N ' ' A' ' 32' ' ' THR . 1.0 OUTLIER -59.79 -48.87 79.93 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.389 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.465 ' NE2' ' CZ ' ' A' ' 57' ' ' TYR . 9.1 t60 -59.06 -14.51 9.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.264 -0.898 . . . . 0.0 110.367 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -96.0 -28.18 14.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.89 -1.131 . . . . 0.0 109.957 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.39 8.0 45.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.115 -0.99 . . . . 0.0 109.432 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 48.62 34.07 13.62 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.475 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -102.17 -147.72 0.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -1.169 . . . . 0.0 109.429 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.559 ' N ' ' CD1' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -157.87 -178.19 7.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.064 -1.022 . . . . 0.0 110.016 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 34' ' ' GLY . 25.8 m -98.81 -139.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.878 . . . . 0.0 109.515 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -42.27 -51.41 5.32 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 173.62 -31.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.263 -1.14 . . . . 0.0 109.635 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.465 ' O ' ' OG ' ' A' ' 37' ' ' SER . 5.8 m120 -74.82 -7.38 53.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.25 -0.906 . . . . 0.0 109.573 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.521 ' HA ' HG21 ' A' ' 32' ' ' THR . 2.4 p 71.84 -165.33 0.13 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -0.922 . . . . 0.0 109.481 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.589 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.2 OUTLIER 167.64 -45.03 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.482 -0.761 . . . . 0.0 111.269 179.435 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 31.8 Cg_endo -76.59 100.68 1.42 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 121.482 1.455 . . . . 0.0 112.025 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.587 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -140.33 163.44 32.77 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.591 -0.693 . . . . 0.0 109.513 178.735 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -58.06 154.13 13.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.795 -1.19 . . . . 0.0 108.664 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.583 ' CE2' ' HB2' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -136.74 155.22 50.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.124 -0.985 . . . . 0.0 110.044 -178.562 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.552 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 0.7 OUTLIER -137.82 -71.99 0.42 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.537 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.62 ' ND2' ' CE2' ' A' ' 100' ' ' PHE . 1.0 OUTLIER 80.18 -69.66 0.1 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.593 -0.692 . . . . 0.0 111.411 178.318 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.52 ' CE2' ' HB3' ' A' ' 43' ' ' ASN . 86.6 m-85 67.41 9.12 6.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 108.846 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.494 ' OE1' ' CZ ' ' A' ' 48' ' ' PHE . 0.4 OUTLIER -39.33 -50.72 2.05 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 121.557 -0.715 . . . . 0.0 109.809 -179.725 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 159.37 36.71 0.02 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.494 ' CZ ' ' OE1' ' A' ' 46' ' ' GLU . 7.5 m-85 -115.64 -179.91 3.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.243 -1.151 . . . . 0.0 109.346 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -128.73 -34.68 1.96 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.464 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.528 ' CB ' ' OH ' ' A' ' 56' ' ' TYR . 16.8 m-30 55.21 179.12 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 109.916 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.6 p -139.76 21.04 2.5 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' A' ' 81' ' ' ASN . 77.1 t -95.42 -92.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.544 -0.722 . . . . 0.0 109.843 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.7 m -166.27 -168.84 1.29 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.976 . . . . 0.0 110.047 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.587 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -77.78 -50.74 1.89 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.614 -0.679 . . . . 0.0 111.056 -179.816 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 54' ' ' SER . 32.5 Cg_endo -73.01 92.38 0.81 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 121.897 1.731 . . . . 0.0 110.168 -177.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.585 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 17.4 m-85 -94.66 -169.15 1.96 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.589 ' O ' ' CE1' ' A' ' 80' ' ' PHE . 70.4 m-85 -161.66 106.94 1.3 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.1 140.24 39.05 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.836 0.827 . . . . 0.0 110.921 -178.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.626 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 31.3 t-105 -160.35 137.02 6.52 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.626 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.9 Cg_endo -69.08 145.89 62.59 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.092 1.862 . . . . 0.0 111.484 -178.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.652 HD11 ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -110.88 128.49 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.56 -0.713 . . . . 0.0 109.527 -179.339 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -124.82 161.33 26.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.153 -0.967 . . . . 0.0 109.261 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.575 ' OG ' ' CZ ' ' A' ' 11' ' ' TYR . 53.8 m -133.42 5.73 3.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.303 -0.873 . . . . 0.0 109.398 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.37 -71.48 0.73 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.917 . . . . 0.0 109.202 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -74.32 -92.83 0.14 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 53.4 t0 179.87 -36.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.289 -1.124 . . . . 0.0 109.758 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.04 155.48 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.162 -0.961 . . . . 0.0 109.89 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.467 ' CE2' ' CD2' ' A' ' 38' ' ' TYR . 54.1 t80 -71.57 115.06 10.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.908 . . . . 0.0 109.397 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.6 t -152.74 -43.43 0.1 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.38 -0.825 . . . . 0.0 109.278 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.31 -27.44 57.9 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.419 ' O ' ' OG ' ' A' ' 72' ' ' SER . . . 101.14 -163.97 18.2 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.502 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 18.2 p 55.82 60.81 8.5 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.305 -1.115 . . . . 0.0 109.846 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.502 ' HD3' ' N ' ' A' ' 72' ' ' SER . 36.8 Cg_endo -79.59 -159.05 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.651 2.234 . . . . 0.0 110.436 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.456 ' O ' ' HB1' ' A' ' 75' ' ' ALA . . . 92.2 -171.65 34.15 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 91' ' ' THR . . . 70.86 -80.85 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.482 -1.011 . . . . 0.0 110.377 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.467 ' HB3' ' CG2' ' A' ' 61' ' ' ILE . 54.6 m-20 -113.66 135.17 54.22 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.015 -1.053 . . . . 0.0 109.698 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.557 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 4.6 mtt180 -155.99 84.82 1.01 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.313 -0.867 . . . . 0.0 109.073 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.481 ' CG1' ' OE1' ' A' ' 20' ' ' GLN . 14.6 p -77.93 150.44 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.975 -1.078 . . . . 0.0 109.484 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.448 HG11 ' O ' ' A' ' 57' ' ' TYR . 3.0 t -111.62 173.35 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.364 -0.835 . . . . 0.0 109.418 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.589 ' CE1' ' O ' ' A' ' 57' ' ' TYR . 4.4 p90 -164.24 -171.47 2.41 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.221 -178.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.464 ' HB2' ' CG1' ' A' ' 52' ' ' VAL . 16.8 t30 -121.08 -83.08 0.66 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.026 -1.046 . . . . 0.0 109.99 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.565 ' O ' ' CZ ' ' A' ' 24' ' ' TYR . 42.0 mt-10 -141.91 -9.44 0.91 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.402 -0.811 . . . . 0.0 110.862 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -131.77 25.06 4.69 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.907 -1.121 . . . . 0.0 108.882 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.455 ' O ' ' C ' ' A' ' 85' ' ' GLN . 3.1 m120 62.37 21.73 12.75 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.495 -0.753 . . . . 0.0 109.506 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.568 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -44.11 -30.23 0.73 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.562 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.568 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER 85.18 103.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.553 0.692 . . . . 0.0 110.904 178.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.441 ' CB ' ' CE1' ' A' ' 56' ' ' TYR . . . -79.41 -33.21 42.85 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 139.73 145.3 4.67 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.466 HG22 ' HB ' ' A' ' 78' ' ' VAL . 61.2 t -80.57 118.88 29.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.144 -1.209 . . . . 0.0 109.282 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.616 HD12 ' HB2' ' A' ' 100' ' ' PHE . 0.4 OUTLIER -104.45 179.12 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.925 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.484 ' O ' ' O ' ' A' ' 99' ' ' ASN . 1.5 t -138.0 135.3 35.82 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.354 -1.338 . . . . 0.0 111.916 -178.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.611 ' CE1' ' CD1' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -86.19 62.34 7.38 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.553 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.468 HG21 HG21 ' A' ' 91' ' ' THR . 6.8 t -176.2 25.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.385 -0.822 . . . . 0.0 110.314 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.19 10.56 17.48 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.525 ' CB ' ' HB2' ' A' ' 99' ' ' ASN . . . -153.29 -174.42 4.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -1.152 . . . . 0.0 109.554 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 95' ' ' ALA . 1.9 t -42.71 113.98 0.53 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.343 -0.848 . . . . 0.0 109.718 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.46 -81.84 0.82 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.581 ' HB2' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -138.36 -76.32 0.38 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -1.138 . . . . 0.0 109.722 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.525 ' HB2' ' CB ' ' A' ' 95' ' ' ALA . 1.0 OUTLIER 59.94 154.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -178.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.62 ' CE2' ' ND2' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -114.36 118.75 34.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.711 -1.243 . . . . 0.0 110.961 -179.233 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.443 ' O ' ' C ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -125.51 139.83 50.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 107.85 -1.166 . . . . 0.0 107.85 178.357 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -41.82 140.01 1.11 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.137 -0.977 . . . . 0.0 110.347 -178.672 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.442 ' O ' ' OE1' ' A' ' 102' ' ' GLU . 0.5 OUTLIER -56.36 109.03 0.54 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.419 -0.801 . . . . 0.0 109.478 179.716 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 109.538 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.427 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 8.5 p 173.96 99.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.931 . . . . 0.0 109.862 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -101.51 -9.42 21.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.349 -0.844 . . . . 0.0 109.311 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.663 ' CD2' HG22 ' A' ' 89' ' ' VAL . 18.8 m-85 -106.14 82.15 1.72 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.115 -0.991 . . . . 0.0 109.163 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.443 ' CB ' ' O ' ' A' ' 9' ' ' ASN . 76.3 p -89.83 131.51 35.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -0.852 . . . . 0.0 109.719 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.516 ' CB ' ' OD1' ' A' ' 76' ' ' ASP . 4.0 m -143.55 157.76 44.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.348 -0.845 . . . . 0.0 109.138 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 8' ' ' SER . . . 44.95 32.94 3.4 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 7' ' ' GLY . 0.6 OUTLIER 68.53 49.18 0.77 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.323 -1.104 . . . . 0.0 109.573 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.443 ' O ' ' CB ' ' A' ' 5' ' ' THR . 25.2 m120 -136.3 172.91 12.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.185 -0.947 . . . . 0.0 110.032 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -127.48 81.87 2.05 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.487 ' CE2' ' HB2' ' A' ' 63' ' ' SER . 2.9 m-85 -79.0 138.28 37.96 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.476 -0.765 . . . . 0.0 109.826 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 0.8 OUTLIER -79.62 124.74 28.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.607 -0.683 . . . . 0.0 109.767 -179.709 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.64 -21.94 3.01 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.559 -0.856 . . . . 0.0 108.975 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 t -82.28 -36.64 26.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.384 -0.822 . . . . 0.0 109.328 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -69.48 -33.79 73.39 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 12' ' ' SER . 5.0 t -58.66 -38.4 71.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.422 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 0.9 OUTLIER -63.71 -31.63 72.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.616 -0.677 . . . . 0.0 109.487 179.547 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -56.78 9.13 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.533 ' CB ' ' CD1' ' A' ' 61' ' ' ILE . . . -63.62 -17.25 62.69 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.57 ' OE1' ' CG ' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -77.43 -36.0 53.53 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -74.13 -6.31 46.94 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.19 -53.6 5.39 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.549 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -68.33 -27.77 73.59 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.484 ' C ' ' CD1' ' A' ' 24' ' ' TYR . 1.3 t80 -76.31 -60.02 2.51 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.502 -0.999 . . . . 0.0 109.599 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 14.6 mt-30 -57.58 -31.67 66.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.032 -1.042 . . . . 0.0 109.137 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.529 ' CD1' ' HB3' ' A' ' 31' ' ' GLU . 9.2 tp -74.01 -28.89 61.67 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 108.54 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.423 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 14.0 t60 -79.5 -21.91 44.68 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.422 -0.799 . . . . 0.0 109.448 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -89.31 -31.93 17.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.322 -0.861 . . . . 0.0 109.464 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -80.93 -13.77 58.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.94 . . . . 0.0 109.579 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.24 36.34 27.61 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.571 ' O ' HG23 ' A' ' 32' ' ' THR . 0.3 OUTLIER -105.49 -158.78 0.68 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.252 -1.146 . . . . 0.0 109.791 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 31' ' ' GLU . 1.1 p -168.22 -172.18 1.69 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 35' ' ' SER . 33.7 m -125.38 152.35 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.08 -1.012 . . . . 0.0 110.377 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 48.79 -88.54 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.541 ' N ' ' O ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -175.09 28.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.417 -1.049 . . . . 0.0 109.346 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.472 ' O ' ' OG ' ' A' ' 37' ' ' SER . 5.2 m-20 -138.0 23.64 2.82 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.339 -0.85 . . . . 0.0 109.159 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.532 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 75.8 p 48.98 -165.98 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.416 -0.803 . . . . 0.0 109.692 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.629 ' CE2' ' NH1' ' A' ' 77' ' ' ARG . 0.0 OUTLIER 168.7 -44.88 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.549 -0.719 . . . . 0.0 111.541 179.212 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 33.2 Cg_endo -76.77 100.75 1.43 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 121.377 1.385 . . . . 0.0 111.986 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.552 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -140.4 -170.15 2.93 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.682 -0.636 . . . . 0.0 109.349 178.642 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 11.5 ptmt -75.51 163.84 26.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.406 -0.809 . . . . 0.0 110.395 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.54 ' CE2' ' HA ' ' A' ' 44' ' ' ASN . 85.7 t80 -142.83 93.88 2.57 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 44' ' ' ASN . 0.5 OUTLIER -81.79 37.91 0.49 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.12 -0.987 . . . . 0.0 110.752 -179.053 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.54 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER 39.92 -160.99 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.216 -0.927 . . . . 0.0 109.948 179.394 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.457 ' CB ' ' O ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER 167.25 -67.31 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.4 -0.813 . . . . 0.0 109.217 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -38.96 -52.63 1.78 Allowed 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.519 -0.738 . . . . 0.0 110.016 -179.784 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.07 51.18 0.05 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.519 ' CZ ' ' HA ' ' A' ' 101' ' ' VAL . 21.0 m-85 -101.09 115.09 29.66 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.178 -1.189 . . . . 0.0 109.523 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.04 88.94 7.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.411 -0.806 . . . . 0.0 109.18 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.482 ' CZ ' ' CB ' ' A' ' 48' ' ' PHE . 60.6 m-85 -78.87 -172.46 3.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.358 -0.839 . . . . 0.0 109.657 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 84.2 p -153.48 42.25 0.56 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 109.3 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 86' ' ' LEU . 38.3 t -114.65 -41.63 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.32 -0.862 . . . . 0.0 109.518 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.488 ' O ' ' CE1' ' A' ' 56' ' ' TYR . 0.6 OUTLIER 176.7 -174.47 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.147 -0.971 . . . . 0.0 109.75 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.505 ' CB ' ' HD3' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -91.97 -56.24 0.25 Allowed Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.247 -0.908 . . . . 0.0 111.518 -179.231 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.505 ' HD3' ' CB ' ' A' ' 54' ' ' SER . 35.4 Cg_endo -75.17 89.3 1.18 Allowed 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.913 1.742 . . . . 0.0 110.082 -177.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.628 ' CE2' ' CB ' ' A' ' 87' ' ' ALA . 4.0 m-30 -84.82 -179.52 7.11 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.433 0.635 . . . . 0.0 109.982 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.583 ' O ' ' CE1' ' A' ' 80' ' ' PHE . 87.2 m-85 -151.86 130.38 12.21 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.477 -0.765 . . . . 0.0 109.098 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.513 ' OE1' ' NH2' ' A' ' 77' ' ' ARG . 12.7 pt-20 -89.11 133.7 34.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 0.0 110.917 -178.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.637 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 20.0 t-105 -160.25 139.52 8.02 Favored Pre-proline 0 N--CA 1.491 1.6 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.637 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 32.8 Cg_endo -72.11 152.88 57.06 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.482 2.121 . . . . 0.0 111.897 -178.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.533 ' CD1' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -115.48 122.3 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.544 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 0.6 OUTLIER -117.58 169.81 9.25 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.098 -1.001 . . . . 0.0 109.429 179.611 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.487 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 6.6 t -121.26 39.06 3.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 108.799 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.64 -31.13 5.28 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.569 -0.707 . . . . 0.0 109.356 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.23 12.56 59.84 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 67' ' ' VAL . 0.6 OUTLIER -106.16 9.89 32.1 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.212 -1.169 . . . . 0.0 109.595 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.521 HG11 ' CZ2' ' A' ' 59' ' ' TRP . 91.9 t 60.8 143.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.169 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.55 ' CE2' ' CE2' ' A' ' 38' ' ' TYR . 16.7 t80 -55.53 108.79 0.47 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.124 -0.985 . . . . 0.0 109.402 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.68 48.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.408 -0.808 . . . . 0.0 109.325 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -149.38 -52.72 0.02 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 167.78 -167.61 40.15 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.68 68.05 1.4 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.296 -1.12 . . . . 0.0 109.324 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.72 155.74 27.4 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.742 2.295 . . . . 0.0 110.944 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 75' ' ' ALA . . . 74.99 -149.84 40.06 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 74' ' ' GLY . . . 80.17 -77.95 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.503 -0.998 . . . . 0.0 109.989 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.516 ' OD1' ' CB ' ' A' ' 6' ' ' CYS . 41.8 m-20 -131.28 134.91 46.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.019 -1.05 . . . . 0.0 110.333 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.629 ' NH1' ' CE2' ' A' ' 38' ' ' TYR . 1.6 mtt180 -138.42 123.92 19.56 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.52 HG23 HG21 ' A' ' 89' ' ' VAL . 4.7 p -112.52 120.84 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.958 -1.089 . . . . 0.0 108.896 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.583 ' CG2' ' CD1' ' A' ' 90' ' ' ILE . 14.8 t -79.05 170.61 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 122.083 0.944 . . . . 0.0 110.266 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.583 ' CE1' ' O ' ' A' ' 57' ' ' TYR . 3.2 p90 -164.19 -171.36 2.38 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.463 ' OD1' ' HB3' ' A' ' 53' ' ' SER . 7.3 t30 -123.95 -81.41 0.64 Allowed 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.229 -0.989 . . . . 0.0 109.949 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.457 ' OE2' ' O ' ' A' ' 81' ' ' ASN . 66.7 mm-40 -159.24 18.08 0.18 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.288 -0.882 . . . . 0.0 109.645 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.465 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 3.8 m-20 -136.79 24.25 3.09 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.479 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 8.5 p30 48.02 23.32 0.48 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.586 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -67.68 -90.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.444 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.586 ' HB2' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 165.39 106.8 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.132 -0.98 . . . . 0.0 110.36 178.674 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.628 ' CB ' ' CE2' ' A' ' 56' ' ' TYR . . . -74.97 -42.09 58.29 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 162.74 154.13 7.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.663 HG22 ' CD2' ' A' ' 4' ' ' TYR . 40.2 t -93.3 105.33 16.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 120.843 -1.387 . . . . 0.0 110.164 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.583 ' CD1' ' CG2' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -99.43 172.64 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.214 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 75' ' ' ALA . 2.8 t -145.02 141.07 28.59 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.668 -1.27 . . . . 0.0 111.261 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.525 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -88.68 55.95 3.58 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.306 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.414 HG21 HG21 ' A' ' 91' ' ' THR . 5.8 t -168.4 23.09 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.157 -0.964 . . . . 0.0 110.309 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -125.81 23.99 5.83 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -177.89 117.93 0.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.407 -1.054 . . . . 0.0 109.506 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.459 ' O ' ' C ' ' A' ' 97' ' ' GLY . 2.5 m 46.06 -159.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.114 -0.991 . . . . 0.0 109.21 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 96' ' ' SER . . . -39.02 -50.64 2.68 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.525 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -152.12 -76.02 0.13 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.107 -1.231 . . . . 0.0 109.605 179.74 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.472 ' O ' ' O ' ' A' ' 98' ' ' ASN . 0.2 OUTLIER 60.91 146.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.135 -0.978 . . . . 0.0 108.772 -179.476 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.509 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -93.5 125.78 38.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.857 -1.152 . . . . 0.0 110.451 -179.51 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.519 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -145.22 137.68 21.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.512 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.454 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.0 OUTLIER -44.36 129.83 6.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.229 -0.919 . . . . 0.0 109.477 -179.598 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.442 ' SG ' ' HB ' ' A' ' 91' ' ' THR . 12.6 m -54.13 98.36 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.196 -0.94 . . . . 0.0 109.425 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 109.478 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 1' ' ' ALA . 25.6 p 174.29 156.64 0.14 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.346 -0.846 . . . . 0.0 109.776 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.72 -40.75 2.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.344 -0.847 . . . . 0.0 109.105 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.641 ' CE1' ' CG2' ' A' ' 89' ' ' VAL . 15.1 m-85 -82.24 127.17 32.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.348 -0.845 . . . . 0.0 109.656 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.46 ' O ' ' SG ' ' A' ' 103' ' ' CYS . 0.2 OUTLIER -133.44 129.6 37.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.375 -0.828 . . . . 0.0 109.194 179.727 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 98.3 m -139.38 16.56 2.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.118 -0.989 . . . . 0.0 110.079 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.14 42.9 0.07 OUTLIER Glycine 0 C--N 1.284 -2.348 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.09 12.34 4.93 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.281 -1.129 . . . . 0.0 109.29 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -84.22 -171.97 3.91 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.216 -0.928 . . . . 0.0 109.13 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.432 ' C ' ' CB ' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -131.47 67.09 1.53 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.248 -0.908 . . . . 0.0 109.047 -179.902 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 63' ' ' SER . 36.2 m-85 -79.3 120.32 23.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.0 108.802 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 0.4 OUTLIER -91.84 137.2 32.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.911 . . . . 0.0 110.407 -179.164 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.42 ' HA ' HG22 ' A' ' 16' ' ' VAL . 57.7 p -51.75 -21.9 3.14 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.9 t -84.45 -35.86 22.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.307 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.3 -23.5 60.29 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 12' ' ' SER . 2.7 t -74.58 -31.5 27.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -45.15 95.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -0.777 . . . . 0.0 109.034 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.1 m -60.09 -42.64 95.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.218 -0.926 . . . . 0.0 108.801 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.541 ' CB ' ' CD1' ' A' ' 61' ' ' ILE . . . -76.43 -13.28 60.12 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.475 ' NE2' ' O ' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -87.31 -21.99 25.4 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.1 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -85.59 -12.49 51.38 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.34 -56.04 4.32 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.349 -0.845 . . . . 0.0 109.261 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.53 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -66.56 -21.12 70.53 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.491 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 0.9 OUTLIER -81.38 -62.4 1.66 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.459 -1.024 . . . . 0.0 109.158 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 1.6 tt0 -44.3 -43.36 7.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.149 -0.97 . . . . 0.0 109.247 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.413 ' CD1' ' C ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -64.15 -43.84 93.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.252 -0.905 . . . . 0.0 109.12 179.726 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.621 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 28.3 t60 -68.07 -14.54 63.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.841 . . . . 0.0 110.102 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -95.65 -26.31 15.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.012 -1.055 . . . . 0.0 110.01 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 26.3 t0 -88.15 -10.48 49.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.161 -0.962 . . . . 0.0 109.73 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.09 0.78 66.46 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.413 ' C ' ' CD1' ' A' ' 26' ' ' LEU . 2.5 mm-40 -79.34 -169.29 1.82 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.159 -1.201 . . . . 0.0 109.281 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.527 ' CG2' ' CB ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -127.37 178.21 6.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.774 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.517 ' CG2' ' HD3' ' A' ' 39' ' ' PRO . 60.1 t -82.31 -98.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.401 -0.812 . . . . 0.0 110.277 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.528 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -122.01 57.64 0.61 Allowed Glycine 0 N--CA 1.488 2.114 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.186 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER 78.96 -10.63 1.32 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.51 -0.994 . . . . 0.0 110.512 179.416 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -112.1 -6.8 14.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.894 -1.129 . . . . 0.0 109.515 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.527 ' CB ' ' CG2' ' A' ' 32' ' ' THR . 8.0 t 58.13 -175.06 0.08 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.238 -0.914 . . . . 0.0 109.316 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.588 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER 168.27 -44.94 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 111.495 179.324 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 31.8 Cg_endo -75.58 100.65 1.39 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.409 1.406 . . . . 0.0 111.976 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.533 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -144.39 -178.28 5.9 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.584 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.548 ' HA ' ' CD2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -74.85 154.02 38.44 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -125.62 145.72 50.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.992 -1.067 . . . . 0.0 110.249 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.444 ' O ' ' C ' ' A' ' 44' ' ' ASN . 41.1 t-20 -117.49 66.02 0.74 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 43' ' ' ASN . 0.6 OUTLIER -40.0 147.72 0.09 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.501 -0.749 . . . . 0.0 110.146 -179.369 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.459 ' O ' ' C ' ' A' ' 46' ' ' GLU . 98.2 m-85 -118.57 -44.73 2.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.403 -0.811 . . . . 0.0 108.999 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -38.63 -47.93 1.39 Allowed 'General case' 0 C--N 1.309 -1.18 0 O-C-N 121.599 -0.688 . . . . 0.0 109.915 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.16 48.38 0.06 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.555 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 86.7 m-85 -96.17 90.82 5.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.244 -1.151 . . . . 0.0 108.964 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.59 82.51 1.77 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.925 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' A' ' 48' ' ' PHE . 4.8 m-85 -78.33 -169.22 1.57 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.369 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.1 m -109.6 17.12 21.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.305 -0.872 . . . . 0.0 109.419 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 64.1 t -77.06 -60.13 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.356 -0.84 . . . . 0.0 109.48 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.414 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -172.11 161.77 5.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.105 -0.997 . . . . 0.0 109.715 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.575 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -72.18 -51.99 7.6 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.477 -0.764 . . . . 0.0 110.227 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 54' ' ' SER . 36.4 Cg_endo -76.24 87.0 1.47 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 121.939 1.759 . . . . 0.0 109.858 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.563 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 38.1 m-85 -79.04 -174.44 4.07 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.698 -0.627 . . . . 0.0 109.67 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.621 ' CE2' ' NE2' ' A' ' 27' ' ' HIS . 83.2 m-85 -154.93 134.63 12.77 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.429 ' HB2' ' HE ' ' A' ' 77' ' ' ARG . 3.9 pt-20 -96.75 144.3 26.88 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 122.053 0.93 . . . . 0.0 111.845 -177.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.647 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 32.2 t-105 -161.19 136.04 5.46 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.647 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.4 Cg_endo -69.57 147.2 63.59 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 121.864 1.709 . . . . 0.0 111.479 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.541 ' CD1' ' CB ' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -119.02 137.4 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.779 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.604 HD21 ' CD1' ' A' ' 68' ' ' TYR . 0.8 OUTLIER -120.27 172.79 7.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.128 -0.983 . . . . 0.0 109.701 -179.301 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . 5.4 p -119.45 29.64 7.51 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.187 -0.946 . . . . 0.0 108.768 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.96 -148.99 0.39 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.48 -0.762 . . . . 0.0 109.541 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -121.75 72.14 0.38 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -170.99 155.42 4.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -1.12 . . . . 0.0 109.769 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.474 HG13 ' HZ2' ' A' ' 59' ' ' TRP . 23.6 t -93.81 154.91 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.852 . . . . 0.0 109.291 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.604 ' CD1' HD21 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -72.79 84.46 1.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.95 -1.094 . . . . 0.0 110.025 -179.506 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.5 t -81.0 -5.4 57.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.306 -0.871 . . . . 0.0 109.125 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -174.82 -144.14 4.78 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.17 -157.15 31.62 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.455 ' OG ' ' HD2' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -127.25 156.52 74.6 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.199 -1.177 . . . . 0.0 109.502 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.455 ' HD2' ' OG ' ' A' ' 72' ' ' SER . 35.5 Cg_endo -77.88 -175.15 2.55 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.643 2.229 . . . . 0.0 110.379 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.422 ' O ' ' HB1' ' A' ' 75' ' ' ALA . . . 88.01 -167.1 35.95 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.462 ' N ' ' HB2' ' A' ' 92' ' ' HIS . . . 66.33 -83.94 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.706 -0.879 . . . . 0.0 109.987 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -137.12 157.28 47.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.044 -1.035 . . . . 0.0 109.753 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.482 ' O ' HG12 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -170.35 114.75 0.48 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.246 -0.909 . . . . 0.0 109.338 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 88' ' ' GLY . 14.1 p -90.77 134.09 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.07 -1.019 . . . . 0.0 109.173 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.572 ' CG1' ' N ' ' A' ' 80' ' ' PHE . 20.1 t -98.88 165.32 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 122.174 0.988 . . . . 0.0 110.313 -179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.572 ' N ' ' CG1' ' A' ' 79' ' ' VAL . 20.1 p90 -163.16 -168.46 1.74 Allowed 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -178.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.52 ' O ' ' CB ' ' A' ' 82' ' ' GLU . 3.7 p30 -128.73 -44.38 1.34 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.791 -1.193 . . . . 0.0 110.387 -179.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 0.2 OUTLIER 163.1 -25.89 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.379 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.468 ' HB3' ' HG2' ' A' ' 85' ' ' GLN . 1.2 t-20 -90.9 0.5 57.48 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.454 ' HB3' ' O ' ' A' ' 83' ' ' ASN . 37.6 t30 64.84 28.32 12.81 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.541 -0.724 . . . . 0.0 109.56 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.557 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -70.06 -27.56 64.74 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.557 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.3 OUTLIER 88.06 114.18 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.603 0.716 . . . . 0.0 110.197 179.42 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.51 ' HB1' ' CE1' ' A' ' 56' ' ' TYR . . . -87.38 -44.87 11.05 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.566 ' O ' HG23 ' A' ' 78' ' ' VAL . . . 166.1 -158.99 32.14 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.641 ' CG2' ' CE1' ' A' ' 4' ' ' TYR . 23.5 t -140.44 99.39 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.088 -1.243 . . . . 0.0 110.076 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.553 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -80.94 145.27 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.177 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.519 HG21 HG23 ' A' ' 101' ' ' VAL . 9.7 t -130.53 132.05 45.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.867 -1.146 . . . . 0.0 110.884 -179.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.578 ' ND1' ' O ' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -91.76 79.24 5.38 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.646 -0.658 . . . . 0.0 109.534 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 3.0 m -175.07 118.23 0.18 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.183 -0.948 . . . . 0.0 109.603 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 113.86 2.89 23.69 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.411 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -144.87 146.53 32.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.135 -1.215 . . . . 0.0 109.731 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 95' ' ' ALA . 34.5 m -44.5 143.02 1.42 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.346 -0.846 . . . . 0.0 109.055 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.461 ' O ' ' C ' ' A' ' 98' ' ' ASN . . . 50.54 38.6 35.62 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.578 ' O ' ' ND1' ' A' ' 92' ' ' HIS . 0.2 OUTLIER 36.02 44.18 0.24 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.947 -0.737 . . . . 0.0 110.041 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -47.52 132.8 13.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.983 -1.073 . . . . 0.0 109.167 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.553 ' CD1' ' HB ' ' A' ' 90' ' ' ILE . 19.3 m-85 -60.03 134.57 57.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.034 -1.041 . . . . 0.0 109.924 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.519 HG23 HG21 ' A' ' 91' ' ' THR . 0.0 OUTLIER -137.61 130.84 42.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.865 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.477 ' CG ' ' O ' ' A' ' 102' ' ' GLU . 1.5 pt-20 -55.15 111.22 0.81 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.281 -0.887 . . . . 0.0 109.268 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 5' ' ' THR . 0.5 OUTLIER -55.33 146.38 19.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.342 -0.849 . . . . 0.0 109.917 -179.484 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 74.6 p . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.36 -0.838 . . . . 0.0 109.489 -179.993 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.439 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.258 0.551 . . . . 0.0 109.618 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.4 p 168.75 145.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.259 -0.901 . . . . 0.0 110.183 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -120.2 -27.67 5.23 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.542 -0.724 . . . . 0.0 109.086 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.581 ' CE1' ' CG2' ' A' ' 89' ' ' VAL . 19.4 m-85 -88.61 112.16 22.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 109.312 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 9' ' ' ASN . 80.1 m -140.32 120.2 13.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.341 -0.849 . . . . 0.0 109.337 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 69.3 m -118.05 16.71 14.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 122.171 0.986 . . . . 0.0 109.682 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 169.09 60.88 0.03 OUTLIER Glycine 0 C--N 1.282 -2.421 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.07 15.72 7.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.322 -1.105 . . . . 0.0 109.147 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.412 ' O ' ' OG1' ' A' ' 5' ' ' THR . 12.0 m-80 -81.19 131.74 35.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.415 -0.803 . . . . 0.0 109.723 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.3 t -97.83 58.89 1.42 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.836 . . . . 0.0 109.007 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.504 ' CE1' ' HB2' ' A' ' 63' ' ' SER . 7.5 m-30 -79.92 127.73 32.6 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.525 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -85.03 138.76 32.24 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.183 -0.948 . . . . 0.0 110.188 -179.223 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.46 -18.76 7.68 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.1 t -89.4 -31.24 17.84 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.521 -0.737 . . . . 0.0 109.153 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.31 -34.83 68.39 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 20' ' ' GLN . 2.6 t -57.56 -35.18 49.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.04 -40.95 77.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.558 -0.714 . . . . 0.0 109.258 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.17 -55.98 13.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.332 -0.855 . . . . 0.0 109.137 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.41 -4.15 24.76 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.485 -0.759 . . . . 0.0 109.264 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.627 ' NE2' ' CD1' ' A' ' 80' ' ' PHE . 5.6 tp60 -101.57 -8.49 21.83 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.64 -9.14 19.41 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.333 -0.854 . . . . 0.0 109.248 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.6 -36.97 28.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 109.133 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 27' ' ' HIS . . . -72.03 -9.66 71.82 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.511 ' CE1' ' O ' ' A' ' 82' ' ' GLU . 18.4 t80 -101.36 -49.59 4.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.442 -1.034 . . . . 0.0 109.347 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -52.18 -38.58 58.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.876 . . . . 0.0 109.339 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.469 ' CD1' ' C ' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -79.89 -45.11 19.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.473 -0.767 . . . . 0.0 109.138 179.754 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.575 ' ND1' ' N ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -45.41 -39.06 6.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.584 -0.697 . . . . 0.0 110.326 -179.713 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.575 ' N ' ' ND1' ' A' ' 27' ' ' HIS . 3.4 tp10 -94.29 -40.28 10.06 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.257 -0.902 . . . . 0.0 109.128 -178.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 28' ' ' GLU . 19.9 t0 -47.81 -23.76 0.82 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.434 ' N ' ' C ' ' A' ' 28' ' ' GLU . . . 80.5 14.16 80.49 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.469 ' C ' ' CD1' ' A' ' 26' ' ' LEU . 0.9 OUTLIER -103.17 -170.11 1.74 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.232 -1.158 . . . . 0.0 109.176 179.789 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.545 HG21 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -137.41 174.41 10.63 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.204 -0.935 . . . . 0.0 109.648 -179.868 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.468 ' O ' ' C ' ' A' ' 34' ' ' GLY . 14.1 m -81.13 -162.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.876 . . . . 0.0 109.252 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -34.92 -57.6 0.79 Allowed Glycine 0 N--CA 1.498 2.779 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.73 30.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.321 -1.105 . . . . 0.0 109.724 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 37' ' ' SER . 1.2 m120 -134.16 6.45 3.61 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.214 -0.929 . . . . 0.0 109.356 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.545 ' HA ' HG21 ' A' ' 32' ' ' THR . 0.2 OUTLIER 47.39 -173.64 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.234 -0.916 . . . . 0.0 109.357 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.593 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER 164.45 -44.15 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.641 -0.662 . . . . 0.0 111.415 179.522 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 30.7 Cg_endo -73.83 99.62 1.18 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 121.295 1.33 . . . . 0.0 112.294 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.57 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -141.36 179.36 6.83 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.078 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.448 ' HA ' ' CD1' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -69.36 149.67 48.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.971 -1.081 . . . . 0.0 109.797 -179.336 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 1.5 t80 -115.3 146.57 41.38 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -156.94 91.3 1.19 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.997 -1.065 . . . . 0.0 109.711 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 2.2 t-20 -113.88 -51.56 2.78 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.351 -0.843 . . . . 0.0 109.599 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.453 ' O ' ' C ' ' A' ' 46' ' ' GLU . 40.7 m-85 50.44 22.65 1.07 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.133 -0.98 . . . . 0.0 109.055 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 48' ' ' PHE . 1.1 tm-20 -38.7 -61.31 0.73 Allowed 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.64 -0.662 . . . . 0.0 109.992 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.42 ' C ' ' CD1' ' A' ' 48' ' ' PHE . . . -177.09 45.18 0.1 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.486 ' CZ ' ' HB3' ' A' ' 46' ' ' GLU . 0.7 OUTLIER -124.89 168.05 13.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -1.134 . . . . 0.0 109.479 -179.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 50' ' ' PHE . 11.1 t70 -124.42 68.7 1.08 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.345 -0.847 . . . . 0.0 109.156 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.541 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 17.4 m-85 -52.52 -171.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.445 -0.785 . . . . 0.0 109.859 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 99.6 p -158.12 37.29 0.25 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.387 -0.821 . . . . 0.0 109.323 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 86' ' ' LEU . 97.4 t -108.97 -73.79 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.227 -0.92 . . . . 0.0 109.738 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.2 177.74 8.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.173 -0.955 . . . . 0.0 110.211 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.588 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -78.99 -50.92 1.36 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.658 -0.651 . . . . 0.0 111.13 -179.88 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 54' ' ' SER . 32.4 Cg_endo -72.56 93.57 0.76 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.861 1.707 . . . . 0.0 109.881 -177.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.59 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 4.5 m-85 -87.06 -176.82 5.86 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.509 0.671 . . . . 0.0 110.009 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.59 ' CG ' ' O ' ' A' ' 56' ' ' TYR . 81.7 m-85 -160.65 118.58 2.49 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 42' ' ' TYR . 0.7 OUTLIER -83.77 142.05 30.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.142 -0.974 . . . . 0.0 111.125 -178.554 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.638 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 26.0 t-105 -161.16 139.31 7.14 Favored Pre-proline 0 N--CA 1.494 1.746 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.638 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.8 Cg_endo -68.35 144.61 62.64 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.003 1.802 . . . . 0.0 111.362 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.588 HD11 ' N ' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -109.59 136.66 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.645 -0.659 . . . . 0.0 109.326 -179.501 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.588 ' N ' HD11 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -125.89 -177.7 4.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.297 -0.877 . . . . 0.0 109.417 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.504 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -117.57 -14.09 10.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.075 -1.016 . . . . 0.0 108.815 179.676 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.32 -58.53 3.23 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.584 -0.698 . . . . 0.0 109.189 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 114.21 10.59 13.39 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -89.51 13.81 12.95 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.212 -1.169 . . . . 0.0 109.488 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 66' ' ' ASP . 99.6 t 61.77 131.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.274 -0.891 . . . . 0.0 109.527 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.502 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 34.6 t80 -46.81 107.32 0.1 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.235 -0.916 . . . . 0.0 109.469 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.3 16.07 6.09 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.175 -0.953 . . . . 0.0 109.468 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.6 65.18 0.02 OUTLIER Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.09 147.53 19.21 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.85 124.57 8.06 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.266 -1.138 . . . . 0.0 109.326 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.02 150.56 26.59 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.452 2.101 . . . . 0.0 110.732 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 75' ' ' ALA . . . 106.2 -175.03 21.0 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 74' ' ' GLY . . . 79.84 -70.54 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.431 -1.04 . . . . 0.0 110.546 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -134.95 152.22 51.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.741 -1.225 . . . . 0.0 110.107 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.545 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 7.4 mtt180 -163.47 105.68 0.98 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.42 -0.8 . . . . 0.0 108.981 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.545 HG21 ' OE1' ' A' ' 20' ' ' GLN . 8.1 p -89.45 144.59 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.986 -1.071 . . . . 0.0 109.479 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.563 ' CG1' ' N ' ' A' ' 80' ' ' PHE . 35.5 t -112.52 166.08 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.35 -0.844 . . . . 0.0 109.771 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.628 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 1.5 p90 -151.71 -178.2 6.57 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.517 ' ND2' ' HG2' ' A' ' 82' ' ' GLU . 16.9 p-10 -109.79 -47.16 3.39 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.019 -1.05 . . . . 0.0 109.857 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.517 ' HG2' ' ND2' ' A' ' 81' ' ' ASN . 0.6 OUTLIER 167.15 -25.07 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.442 ' HB3' ' HG2' ' A' ' 85' ' ' GLN . 1.1 t30 -92.49 8.86 36.88 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.47 -0.769 . . . . 0.0 108.967 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' A' ' 83' ' ' ASN . 25.8 t-20 63.33 13.42 7.01 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.42 -0.8 . . . . 0.0 110.137 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.522 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 3.7 mt-30 -57.13 -82.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.852 -1.155 . . . . 0.0 107.968 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER 165.28 108.87 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.398 -0.814 . . . . 0.0 110.684 178.466 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.541 ' O ' ' CD1' ' A' ' 50' ' ' PHE . . . -74.97 -44.09 50.27 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 146.55 149.18 4.92 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.689 -1.765 . . . . 0.0 108.689 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.581 ' CG2' ' CE1' ' A' ' 4' ' ' TYR . 38.9 t -88.64 131.44 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.161 -1.199 . . . . 0.0 109.744 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.545 ' CG1' ' O ' ' A' ' 77' ' ' ARG . 0.2 OUTLIER -123.85 178.01 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.54 HG21 HG21 ' A' ' 93' ' ' THR . 2.7 t -138.48 145.85 41.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.813 -1.179 . . . . 0.0 111.195 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.582 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.1 OUTLIER -93.25 76.94 4.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.621 -0.674 . . . . 0.0 109.557 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.54 HG21 HG21 ' A' ' 91' ' ' THR . 7.1 t 176.52 -27.25 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.411 -0.806 . . . . 0.0 110.434 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.488 ' HA3' HG22 ' A' ' 101' ' ' VAL . . . -65.14 -7.01 29.19 Favored Glycine 0 N--CA 1.493 2.434 0 O-C-N 121.125 -0.984 . . . . 0.0 110.673 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.481 ' CB ' ' HB2' ' A' ' 99' ' ' ASN . . . -133.71 164.86 26.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.884 -1.362 . . . . 0.0 110.056 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 95' ' ' ALA . 11.1 p -41.7 120.95 1.61 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.58 -0.7 . . . . 0.0 109.26 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.8 -78.0 2.05 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.846 -1.701 . . . . 0.0 108.846 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.582 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -160.52 -68.07 0.07 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.268 -1.137 . . . . 0.0 109.551 179.751 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.481 ' HB2' ' CB ' ' A' ' 95' ' ' ALA . 0.3 OUTLIER 57.05 -173.36 0.08 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.135 -0.978 . . . . 0.0 109.142 -179.711 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.642 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -132.87 113.81 13.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.021 -1.049 . . . . 0.0 110.103 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.514 HG23 HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -123.64 136.74 59.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.334 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.443 ' OE2' ' HB3' ' A' ' 48' ' ' PHE . 2.2 mt-10 -56.11 120.47 7.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.286 -0.884 . . . . 0.0 109.728 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.2 176.33 0.34 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.898 . . . . 0.0 109.462 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 19.0 p . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.972 -1.014 . . . . 0.0 109.588 -179.901 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.465 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.8 p 167.17 115.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.924 . . . . 0.0 109.8 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 14.9 t70 -108.72 4.71 24.06 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.398 -0.814 . . . . 0.0 109.363 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.542 ' CD1' ' HB ' ' A' ' 89' ' ' VAL . 5.4 m-85 -104.99 71.35 0.95 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.548 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -86.84 124.44 33.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.179 -0.95 . . . . 0.0 109.388 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 92.5 m -122.24 16.66 10.67 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 122.096 0.951 . . . . 0.0 109.684 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 152.73 -62.09 0.39 Allowed Glycine 0 C--N 1.283 -2.383 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.6 m -166.98 36.03 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.347 -1.09 . . . . 0.0 109.065 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.461 ' O ' ' C ' ' A' ' 10' ' ' CYS . 2.0 m-80 -111.44 -27.74 8.49 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.356 -0.84 . . . . 0.0 109.803 -179.565 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.461 ' C ' ' O ' ' A' ' 9' ' ' ASN . 1.1 t 40.4 76.44 0.07 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.365 -0.834 . . . . 0.0 109.311 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.424 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 2.8 m-85 -79.57 150.34 31.11 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.417 -0.802 . . . . 0.0 109.297 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.561 ' O ' HG21 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -80.47 132.1 35.66 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.432 -0.793 . . . . 0.0 109.62 -179.874 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.2 p -63.33 -13.96 44.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.127 -0.983 . . . . 0.0 109.04 179.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.81 -27.05 13.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.31 -0.869 . . . . 0.0 109.028 179.695 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 12' ' ' SER . 17.8 t0 -74.91 -34.2 62.11 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.278 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.561 HG21 ' O ' ' A' ' 12' ' ' SER . 2.8 t -56.47 -36.67 48.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.13 -41.11 87.46 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.37 -45.66 92.15 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.157 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.596 ' CB ' HD11 ' A' ' 61' ' ' ILE . . . -75.97 -8.29 56.6 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.075 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.59 ' OE1' ' CG ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -90.58 -25.96 19.92 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.383 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.96 -13.13 59.17 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.31 -57.0 3.56 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.543 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -62.11 -25.69 66.62 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 178.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.583 ' CE1' ' O ' ' A' ' 82' ' ' GLU . 10.2 t80 -75.72 -59.87 2.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.477 -1.013 . . . . 0.0 109.451 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.404 ' O ' ' C ' ' A' ' 26' ' ' LEU . 1.8 tp60 -55.14 -61.51 2.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.859 . . . . 0.0 109.262 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.572 HD13 ' HB3' ' A' ' 31' ' ' GLU . 2.6 mm? -44.83 -37.3 3.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.392 -0.818 . . . . 0.0 109.57 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -66.14 -54.79 21.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.439 -0.788 . . . . 0.0 111.182 -179.145 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -86.8 13.02 9.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.216 -0.928 . . . . 0.0 110.249 -178.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -108.35 -2.81 18.86 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.079 -1.013 . . . . 0.0 109.581 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.71 -8.76 76.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.572 ' HB3' HD13 ' A' ' 26' ' ' LEU . 2.4 tp10 -97.7 -152.19 0.39 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.231 -1.158 . . . . 0.0 109.474 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.462 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -177.27 -93.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.165 -0.96 . . . . 0.0 109.411 179.976 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.502 ' CG1' ' O ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -156.5 -168.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.147 -0.971 . . . . 0.0 109.476 179.835 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 35' ' ' SER . . . -63.67 87.14 0.06 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.535 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.455 ' C ' ' O ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER 40.2 43.27 1.35 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.486 -1.008 . . . . 0.0 109.788 179.772 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.417 ' O ' ' C ' ' A' ' 37' ' ' SER . 2.2 m120 -122.63 -25.25 4.74 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.103 -0.998 . . . . 0.0 109.726 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 36' ' ' ASN . 0.9 OUTLIER 45.27 76.82 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.16 -0.962 . . . . 0.0 109.211 -179.762 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.717 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -98.93 -23.37 0.22 Allowed Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -179.068 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.717 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 37.5 Cg_endo -80.28 100.87 1.29 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 C-N-CA 121.476 1.451 . . . . 0.0 113.577 -178.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.604 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -127.53 -176.51 3.77 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.12 -0.987 . . . . 0.0 108.722 176.897 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.1 OUTLIER -100.18 144.36 29.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.097 -1.002 . . . . 0.0 109.455 179.94 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.541 ' CE2' ' HA ' ' A' ' 44' ' ' ASN . 4.4 t80 -110.52 135.94 50.42 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.201 -0.937 . . . . 0.0 109.535 -179.655 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.553 ' OD1' ' CD2' ' A' ' 45' ' ' TYR . 2.7 p30 -92.16 3.67 54.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.899 . . . . 0.0 109.893 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.541 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 7.1 p-10 42.22 104.79 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.651 0.738 . . . . 0.0 111.2 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.553 ' CD2' ' OD1' ' A' ' 43' ' ' ASN . 0.9 OUTLIER -131.88 -33.23 1.39 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.071 -1.018 . . . . 0.0 109.823 179.206 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.485 ' OE1' ' CZ ' ' A' ' 48' ' ' PHE . 0.1 OUTLIER -38.17 -53.2 1.44 Allowed 'General case' 0 C--N 1.309 -1.176 0 O-C-N 121.481 -0.762 . . . . 0.0 110.159 -179.556 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.87 48.53 0.04 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.485 ' CZ ' ' OE1' ' A' ' 46' ' ' GLU . 24.8 m-85 -104.61 144.83 31.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -1.141 . . . . 0.0 109.337 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 50' ' ' PHE . 1.1 m-20 -119.07 49.58 1.31 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.292 -0.88 . . . . 0.0 109.433 179.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.462 ' O ' ' O ' ' A' ' 49' ' ' ASP . 21.7 m-85 -50.36 -178.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.385 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.1 p -133.93 18.26 3.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -0.859 . . . . 0.0 109.003 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 66.6 t -85.74 -82.0 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.372 -0.83 . . . . 0.0 109.532 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.31 177.98 10.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.004 -1.06 . . . . 0.0 110.147 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.555 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -79.5 -52.54 1.12 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.473 -0.767 . . . . 0.0 110.884 -179.889 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 54' ' ' SER . 33.1 Cg_endo -73.07 95.11 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.016 1.81 . . . . 0.0 109.844 -177.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.461 ' CE1' ' CB ' ' A' ' 87' ' ' ALA . 5.7 m-85 -95.94 -179.28 4.64 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.63 0.728 . . . . 0.0 110.276 -178.913 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.577 ' CD2' ' O ' ' A' ' 81' ' ' ASN . 96.5 m-85 -152.73 131.61 12.49 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.392 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.464 ' CG ' ' CD2' ' A' ' 40' ' ' HIS . 0.5 OUTLIER -91.91 142.19 27.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 110.815 -178.837 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.63 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 24.1 t-105 -160.26 137.74 6.99 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.63 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.6 Cg_endo -69.78 149.52 66.89 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.175 1.917 . . . . 0.0 111.423 -179.042 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.596 HD11 ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -120.5 129.13 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.607 -0.683 . . . . 0.0 109.349 -179.672 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.503 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -118.84 172.29 7.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.287 179.514 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.81 27.79 6.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.117 -0.99 . . . . 0.0 108.847 179.688 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.91 -12.46 17.5 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.564 -0.71 . . . . 0.0 109.318 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.66 -10.22 68.72 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 2.9 m-20 -97.55 172.95 7.41 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.216 -1.167 . . . . 0.0 110.022 -179.542 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.453 HG11 ' CZ2' ' A' ' 59' ' ' TRP . 93.7 t -90.09 150.08 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.525 ' C ' ' CD1' ' A' ' 68' ' ' TYR . 13.6 t80 -47.31 118.75 2.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.955 -1.091 . . . . 0.0 109.69 -179.479 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.455 ' O ' ' OG ' ' A' ' 69' ' ' SER . 1.7 t -135.38 13.88 3.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.489 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 132.57 140.59 4.48 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 137.86 -128.24 4.18 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.8 p -69.55 120.98 80.77 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.225 -1.162 . . . . 0.0 109.334 179.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.69 -57.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.279 1.986 . . . . 0.0 110.443 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.48 ' HA2' ' NE ' ' A' ' 77' ' ' ARG . . . -97.34 -113.02 3.05 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 91' ' ' THR . . . 60.23 -85.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.352 -1.087 . . . . 0.0 110.561 179.521 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.406 ' C ' ' HD2' ' A' ' 77' ' ' ARG . 36.6 m-20 -122.95 131.5 53.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.848 -1.158 . . . . 0.0 110.39 -179.173 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.48 ' NE ' ' HA2' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -151.88 106.66 3.24 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.331 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 89' ' ' VAL . 7.3 p -78.81 137.98 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 110.454 -178.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.572 HG11 ' N ' ' A' ' 80' ' ' PHE . 39.8 t -97.55 166.67 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.01 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.59 ' CG ' ' OE1' ' A' ' 20' ' ' GLN . 5.7 p90 -163.46 -174.33 3.7 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 118.822 -1.151 . . . . 0.0 110.281 -178.002 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.577 ' O ' ' CD2' ' A' ' 57' ' ' TYR . 3.2 t-20 -109.11 -80.13 0.58 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.28 -0.888 . . . . 0.0 109.766 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.583 ' O ' ' CE1' ' A' ' 24' ' ' TYR . 10.8 pt-20 -161.9 23.36 0.11 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 109.448 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.453 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 4.0 t-20 -151.7 51.38 0.81 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.552 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.453 ' CG ' ' O ' ' A' ' 83' ' ' ASN . 16.6 p30 44.86 26.95 0.23 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.446 ' OE1' ' HB3' ' A' ' 81' ' ' ASN . 14.0 mt-30 -64.4 -163.18 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.206 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.444 ' C ' ' CD1' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -144.48 104.37 4.06 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.787 -1.196 . . . . 0.0 110.573 179.913 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.462 ' O ' ' CG ' ' A' ' 50' ' ' PHE . . . -81.68 -36.85 28.28 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 150.91 138.34 2.82 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.542 ' HB ' ' CD1' ' A' ' 4' ' ' TYR . 36.9 t -83.04 100.0 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.181 -1.188 . . . . 0.0 109.67 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.502 ' HB ' ' HB3' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -87.01 159.83 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.4 -0.813 . . . . 0.0 108.845 179.481 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 75' ' ' ALA . 15.1 t -122.16 159.79 26.47 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.941 -1.099 . . . . 0.0 110.886 -178.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.577 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 0.1 OUTLIER -115.5 71.9 0.78 Allowed 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.434 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.445 ' OG1' ' C ' ' A' ' 92' ' ' HIS . 0.2 OUTLIER -176.61 133.13 0.21 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.416 -0.802 . . . . 0.0 109.294 -179.812 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 94.98 -6.97 69.74 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -120.54 147.29 45.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.157 -1.202 . . . . 0.0 109.727 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 95' ' ' ALA . 49.2 m -44.03 118.09 1.38 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.28 -0.887 . . . . 0.0 108.901 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.486 ' O ' ' C ' ' A' ' 98' ' ' ASN . . . 64.36 43.7 96.47 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.219 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.577 ' O ' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 32.92 40.75 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.987 -0.714 . . . . 0.0 110.446 179.711 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 97' ' ' GLY . 3.0 t-20 -54.69 167.55 0.35 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.141 -0.975 . . . . 0.0 109.279 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.502 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -74.83 150.38 39.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.132 -0.98 . . . . 0.0 109.344 179.993 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -161.02 122.54 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.417 -0.802 . . . . 0.0 109.086 179.687 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 101' ' ' VAL . 3.6 pt-20 -41.8 131.48 3.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.387 -0.821 . . . . 0.0 109.861 -179.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.421 ' SG ' ' HB ' ' A' ' 91' ' ' THR . 0.7 OUTLIER -92.81 121.41 34.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.37 -0.831 . . . . 0.0 109.253 -179.981 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.8 p . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.623 -1.18 . . . . 0.0 109.445 179.955 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.495 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.6 p 166.49 138.06 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.169 -0.957 . . . . 0.0 110.141 179.705 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -115.4 -20.05 10.44 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.381 -0.824 . . . . 0.0 109.069 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.576 ' CG ' HG21 ' A' ' 89' ' ' VAL . 13.7 m-85 -95.65 109.71 21.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.313 -0.867 . . . . 0.0 109.371 179.839 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 9' ' ' ASN . 1.2 p -144.25 143.79 31.2 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.966 . . . . 0.0 109.642 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.61 8.16 4.92 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.148 0.975 . . . . 0.0 109.904 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.28 55.2 0.2 Allowed Glycine 0 C--N 1.278 -2.69 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m 55.15 19.06 2.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.45 -1.029 . . . . 0.0 109.134 -179.524 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.402 ' O ' HG23 ' A' ' 5' ' ' THR . 0.6 OUTLIER -75.07 -156.88 0.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.434 -0.791 . . . . 0.0 109.091 179.929 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.4 t -155.49 58.14 0.63 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.117 -0.99 . . . . 0.0 109.766 -180.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 63' ' ' SER . 3.3 m-85 -84.51 115.3 22.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.341 -0.849 . . . . 0.0 108.925 179.527 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.554 ' O ' HG21 ' A' ' 16' ' ' VAL . 30.2 t -81.71 136.17 35.48 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.252 -0.905 . . . . 0.0 110.222 -179.259 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.1 p -49.05 -31.41 7.7 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.497 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.2 t -70.64 -40.99 72.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.532 -0.73 . . . . 0.0 109.278 179.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -66.42 -30.25 70.57 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.172 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.554 HG21 ' O ' ' A' ' 12' ' ' SER . 3.2 t -68.35 -32.9 57.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 119.519 -0.872 . . . . 0.0 108.823 179.315 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.8 -46.68 77.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.481 -0.762 . . . . 0.0 109.584 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.63 -55.66 28.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.2 -0.937 . . . . 0.0 109.251 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.566 ' CB ' ' CD1' ' A' ' 61' ' ' ILE . . . -72.05 -3.51 23.4 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.388 -0.82 . . . . 0.0 109.37 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.627 ' NE2' ' CD1' ' A' ' 80' ' ' PHE . 6.3 tp60 -100.96 -15.96 17.33 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 179.333 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.452 ' HA ' ' OD1' ' A' ' 84' ' ' ASN . . . -93.12 -15.1 26.4 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.0 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.05 -47.67 23.82 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.402 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -60.89 -24.91 63.23 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 179.351 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.435 ' CD2' ' OD1' ' A' ' 84' ' ' ASN . 19.9 t80 -83.21 -36.05 24.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.521 -0.987 . . . . 0.0 109.26 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -49.89 72.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.304 -0.872 . . . . 0.0 108.838 179.492 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.61 -40.57 95.28 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.313 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.51 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 2.2 t60 -62.52 -20.9 65.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.389 -0.819 . . . . 0.0 109.42 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.79 -30.85 16.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.948 . . . . 0.0 109.806 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.77 9.91 33.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.127 -0.983 . . . . 0.0 109.46 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 46.8 24.12 1.75 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.1 -137.59 0.09 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.211 -1.17 . . . . 0.0 109.016 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.531 HG21 ' HG ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -173.59 170.34 4.1 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.899 -1.126 . . . . 0.0 109.45 -179.938 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.417 ' HB ' ' HA ' ' A' ' 69' ' ' SER . 33.2 m -83.26 -138.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.316 -0.865 . . . . 0.0 109.276 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -46.88 -49.35 17.43 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.75 -32.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.487 -1.007 . . . . 0.0 109.188 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -69.47 -8.82 50.21 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.386 -0.821 . . . . 0.0 109.79 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.531 ' HG ' HG21 ' A' ' 32' ' ' THR . 0.8 OUTLIER 67.66 -172.69 0.19 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.096 -1.002 . . . . 0.0 108.908 -179.64 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.561 ' CD1' ' HD3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER 167.53 -45.05 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.186 -0.946 . . . . 0.0 112.435 179.114 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 32.3 Cg_endo -74.71 100.37 1.33 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 121.416 1.41 . . . . 0.0 112.538 -178.512 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.549 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -142.53 -174.04 4.03 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.674 -0.641 . . . . 0.0 109.535 178.463 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.606 ' HB2' ' CE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -94.66 124.16 38.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.346 -0.846 . . . . 0.0 109.903 -179.398 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.47 ' CE1' ' CZ ' ' A' ' 100' ' ' PHE . 10.5 t80 -105.8 143.59 33.74 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.118 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.577 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 74.0 m-20 -78.47 -106.61 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.905 -1.122 . . . . 0.0 109.287 -179.674 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.577 ' CB ' ' O ' ' A' ' 43' ' ' ASN . 5.9 p30 154.42 95.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.478 -0.764 . . . . 0.0 109.188 179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 1.4 p90 -124.6 -28.15 3.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -0.981 . . . . 0.0 109.632 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 45' ' ' TYR . 1.9 tm-20 -40.62 -65.7 0.39 Allowed 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.383 -0.823 . . . . 0.0 109.909 -179.647 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.92 59.75 0.01 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.413 ' CE1' ' HA ' ' A' ' 101' ' ' VAL . 84.8 m-85 -98.63 154.76 17.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.31 -1.112 . . . . 0.0 109.3 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.58 45.16 2.51 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.266 -0.897 . . . . 0.0 109.273 179.589 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.538 ' CG ' ' O ' ' A' ' 87' ' ' ALA . 14.4 m-85 -61.37 -167.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 109.869 -179.716 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.07 27.75 0.85 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.523 -0.736 . . . . 0.0 109.213 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.578 ' CG1' ' ND2' ' A' ' 81' ' ' ASN . 93.7 t -101.05 -80.08 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.191 -0.943 . . . . 0.0 109.741 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.412 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 86.6 p -158.39 178.01 10.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.169 -0.957 . . . . 0.0 110.189 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.601 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -83.3 -46.94 0.81 Allowed Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.592 -0.692 . . . . 0.0 111.536 -179.558 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 54' ' ' SER . 32.0 Cg_endo -73.03 83.93 1.37 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.899 1.733 . . . . 0.0 110.409 -178.004 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.583 ' CE1' ' CB ' ' A' ' 87' ' ' ALA . 10.1 m-85 -86.23 -175.22 5.42 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.826 0.822 . . . . 0.0 110.769 -179.156 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.606 ' CE2' ' HB2' ' A' ' 41' ' ' LYS . 47.8 m-85 -151.96 126.09 9.22 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -88.1 138.42 31.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.921 -1.112 . . . . 0.0 110.627 -178.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.615 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 21.1 t-105 -160.62 138.55 7.18 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 179.407 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.615 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.6 Cg_endo -69.54 154.47 68.56 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.33 2.02 . . . . 0.0 111.496 -178.817 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.566 ' CD1' ' CB ' ' A' ' 19' ' ' ALA . 0.2 OUTLIER -129.12 129.07 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.594 -0.691 . . . . 0.0 109.823 -179.17 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.496 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -123.15 167.65 13.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.243 -0.911 . . . . 0.0 108.776 179.191 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . 84.1 p -127.92 65.97 1.36 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.101 -0.999 . . . . 0.0 109.355 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.23 25.34 0.11 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.391 -0.818 . . . . 0.0 109.57 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 51.1 45.26 51.58 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -121.89 -27.73 4.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.316 -1.108 . . . . 0.0 109.669 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 t 62.37 174.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.14 -0.975 . . . . 0.0 109.153 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.531 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 29.0 t80 -96.4 106.0 18.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.078 -1.014 . . . . 0.0 109.682 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.417 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 0.8 OUTLIER -151.89 21.27 0.69 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.353 -0.842 . . . . 0.0 109.366 -179.977 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.17 -91.06 1.44 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.82 57.21 0.04 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.46 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -140.58 63.04 20.16 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.236 -1.155 . . . . 0.0 109.224 179.894 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.526 ' CB ' ' OH ' ' A' ' 38' ' ' TYR . 34.8 Cg_endo -78.62 163.46 26.66 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.856 2.371 . . . . 0.0 111.051 -179.607 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 75' ' ' ALA . . . 131.47 133.34 3.47 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.969 -1.11 . . . . 0.0 110.544 179.236 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.535 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . 70.41 -150.57 0.1 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.431 -1.041 . . . . 0.0 110.971 178.779 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.535 ' C ' ' O ' ' A' ' 75' ' ' ALA . 96.2 m-20 -7.08 126.46 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 CA-C-O 121.686 0.755 . . . . 0.0 112.837 -179.317 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.5 ' O ' HG12 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -161.89 80.71 0.56 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.962 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.456 HG23 HG23 ' A' ' 89' ' ' VAL . 7.5 p -62.47 145.54 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.87 -1.144 . . . . 0.0 109.303 -179.587 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.536 HG13 ' N ' ' A' ' 80' ' ' PHE . 68.2 t -113.06 165.78 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.346 -0.847 . . . . 0.0 109.843 -179.463 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.627 ' CD1' ' NE2' ' A' ' 20' ' ' GLN . 2.1 p90 -156.25 -174.98 5.19 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.56 -178.483 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.578 ' ND2' ' CG1' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -116.22 -82.07 0.62 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.061 -1.025 . . . . 0.0 109.967 -179.576 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -153.08 10.64 0.46 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.358 -0.839 . . . . 0.0 110.401 -179.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.448 ' O ' ' CB ' ' A' ' 84' ' ' ASN . 45.3 t-20 -135.06 7.32 3.42 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.175 -0.953 . . . . 0.0 108.835 179.309 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 85' ' ' GLN . 6.2 m-80 72.28 9.36 5.88 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.373 -0.829 . . . . 0.0 109.451 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 1.8 mm100 -49.38 -92.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.555 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.543 ' O ' ' CG2' ' A' ' 52' ' ' VAL . 0.1 OUTLIER 170.72 106.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 0.0 110.716 178.681 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.583 ' CB ' ' CE1' ' A' ' 56' ' ' TYR . . . -82.72 -30.86 28.81 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.292 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 146.9 -165.96 28.43 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.576 HG21 ' CG ' ' A' ' 4' ' ' TYR . 73.3 t -134.1 102.24 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.312 -1.111 . . . . 0.0 109.203 179.748 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.523 ' CD1' ' CG2' ' A' ' 79' ' ' VAL . 0.4 OUTLIER -104.5 153.99 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 109.273 -179.731 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 100' ' ' PHE . 10.2 t -122.65 137.33 54.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.095 -1.003 . . . . 0.0 110.275 -179.455 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.438 ' CE1' ' CD2' ' A' ' 100' ' ' PHE . 1.8 m-70 -80.6 75.33 7.49 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.428 -0.795 . . . . 0.0 108.908 179.175 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.5 t -173.97 158.41 3.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.544 -0.723 . . . . 0.0 109.393 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 87.04 -14.58 56.91 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.491 ' CB ' ' HB2' ' A' ' 99' ' ' ASN . . . -131.67 114.78 15.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -1.137 . . . . 0.0 109.22 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.468 ' O ' ' C ' ' A' ' 97' ' ' GLY . 7.4 p 46.09 -160.5 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.008 -1.058 . . . . 0.0 108.963 -179.762 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 96' ' ' SER . . . -40.38 -45.12 3.25 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.468 ' O ' ' O ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -155.68 -74.89 0.1 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.213 -1.169 . . . . 0.0 109.506 179.517 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.491 ' HB2' ' CB ' ' A' ' 95' ' ' ALA . 1.3 m-80 62.34 132.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.153 -0.967 . . . . 0.0 108.62 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.482 ' CB ' HG13 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -92.75 141.52 28.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.921 -1.112 . . . . 0.0 109.851 -179.79 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 102' ' ' GLU . 4.2 m -152.12 148.94 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.793 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 101' ' ' VAL . 0.6 OUTLIER -43.44 141.1 1.46 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.09 -1.006 . . . . 0.0 109.64 -179.675 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -55.04 144.18 24.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.399 -0.813 . . . . 0.0 109.597 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.488 1.472 0 O-C-N 121.245 -0.909 . . . . 0.0 109.514 179.891 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.321 0.581 . . . . 0.0 109.666 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 28.9 p 178.18 105.87 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.378 -0.826 . . . . 0.0 109.606 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -68.31 -52.39 34.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.97 -1.081 . . . . 0.0 109.147 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.48 ' CG ' ' CG2' ' A' ' 89' ' ' VAL . 60.3 m-85 -92.95 105.92 17.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.411 -0.806 . . . . 0.0 109.347 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 9' ' ' ASN . 2.3 t -134.26 128.66 34.29 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.945 -1.097 . . . . 0.0 109.836 -179.866 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.484 ' SG ' ' OG1' ' A' ' 91' ' ' THR . 2.0 t -96.34 -164.79 1.19 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.357 -0.84 . . . . 0.0 109.036 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.404 ' O ' ' CB ' ' A' ' 8' ' ' SER . . . -54.26 96.26 0.03 OUTLIER Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -179.126 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.52 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 0.8 OUTLIER 70.07 54.01 0.35 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.361 -1.082 . . . . 0.0 109.837 179.272 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 8' ' ' SER . 2.1 m120 -155.69 89.42 1.17 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.398 -0.813 . . . . 0.0 109.182 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.423 ' C ' ' CB ' ' A' ' 2' ' ' CYS . 0.4 OUTLIER -74.51 79.63 1.95 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.385 -0.822 . . . . 0.0 109.181 -179.599 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.466 ' O ' ' O ' ' A' ' 4' ' ' TYR . 3.2 m-85 -94.46 126.09 39.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.043 -1.036 . . . . 0.0 109.131 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.565 ' O ' HG21 ' A' ' 16' ' ' VAL . 18.6 t -89.35 130.28 35.75 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 110.118 -179.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 12' ' ' SER . 4.2 t -46.22 -25.84 0.68 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.505 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.7 t -69.09 -47.4 65.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.4 -0.812 . . . . 0.0 109.314 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -26.49 65.53 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.129 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.565 HG21 ' O ' ' A' ' 12' ' ' SER . 13.5 t -69.09 -36.03 71.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.263 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.2 t -56.64 -47.04 80.59 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.452 -0.78 . . . . 0.0 109.668 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.08 -54.03 51.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.025 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.519 ' CB ' HD11 ' A' ' 61' ' ' ILE . . . -68.22 -12.24 60.64 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.454 -0.779 . . . . 0.0 109.061 179.545 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.502 ' OE1' ' CG ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -83.56 -27.82 29.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 0.0 108.647 179.605 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.84 -14.16 54.82 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.428 -0.795 . . . . 0.0 108.881 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.76 -56.01 5.09 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.416 -0.802 . . . . 0.0 109.355 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.551 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -66.82 -28.13 73.64 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.578 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.437 ' CE1' ' O ' ' A' ' 82' ' ' GLU . 7.0 t80 -71.89 -40.06 69.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.538 -0.977 . . . . 0.0 109.614 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.88 -51.95 54.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.049 -1.032 . . . . 0.0 109.389 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.48 ' HB3' ' CG ' ' A' ' 39' ' ' PRO . 0.8 OUTLIER -52.18 -44.02 64.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.298 -0.876 . . . . 0.0 109.404 179.768 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.624 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 3.1 t60 -53.01 -53.73 45.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.414 -0.804 . . . . 0.0 110.14 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -82.73 -1.58 51.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.331 -0.856 . . . . 0.0 109.802 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.466 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -92.67 -1.5 56.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.719 -179.836 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 51.06 37.6 37.24 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -128.67 -152.46 0.52 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.34 -1.094 . . . . 0.0 109.367 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.564 HG22 ' CB ' ' A' ' 37' ' ' SER . 0.6 OUTLIER -159.28 -175.91 5.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.337 -0.852 . . . . 0.0 109.197 179.901 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 35' ' ' SER . 16.6 m -130.72 160.56 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.033 -1.042 . . . . 0.0 109.803 -179.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 53.28 -89.2 0.01 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 33' ' ' VAL . 2.1 p -177.29 25.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.324 -1.103 . . . . 0.0 109.99 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.433 ' O ' ' OG ' ' A' ' 37' ' ' SER . 3.6 m-20 -147.84 13.16 1.02 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.056 -1.027 . . . . 0.0 109.514 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.564 ' CB ' HG22 ' A' ' 32' ' ' THR . 3.3 p 64.4 -170.25 0.19 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -0.879 . . . . 0.0 109.542 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.584 ' C ' ' CE1' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 170.33 -44.99 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.419 -0.801 . . . . 0.0 111.66 178.621 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 34.2 Cg_endo -77.36 101.08 1.46 Allowed 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 121.314 1.342 . . . . 0.0 111.858 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.584 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -138.56 -175.27 4.07 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.396 -0.815 . . . . 0.0 109.546 178.65 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -78.55 141.97 37.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.366 -0.834 . . . . 0.0 109.73 -179.563 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.594 ' OH ' ' CD1' ' A' ' 100' ' ' PHE . 13.7 t80 -100.61 128.86 46.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.412 -0.805 . . . . 0.0 109.284 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 44' ' ' ASN . 1.7 t30 -93.4 -4.75 50.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.192 -0.942 . . . . 0.0 109.636 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.557 ' HA ' ' CZ ' ' A' ' 42' ' ' TYR . 0.5 OUTLIER 40.06 93.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.486 -0.759 . . . . 0.0 109.951 179.952 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.464 ' O ' ' C ' ' A' ' 46' ' ' GLU . 75.4 m-85 -86.77 -38.43 16.9 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.35 -0.844 . . . . 0.0 109.842 -179.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.501 ' OE1' ' CE1' ' A' ' 48' ' ' PHE . 0.9 OUTLIER -38.7 -46.53 1.25 Allowed 'General case' 0 C--N 1.309 -1.193 0 O-C-N 121.413 -0.804 . . . . 0.0 110.039 -179.593 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.5 62.44 0.57 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 -179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.501 ' CE1' ' OE1' ' A' ' 46' ' ' GLU . 51.7 m-85 -97.32 179.9 4.73 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.28 -1.13 . . . . 0.0 108.987 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -117.12 -41.98 2.96 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.221 -0.924 . . . . 0.0 108.89 179.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.579 ' CD2' ' O ' ' A' ' 87' ' ' ALA . 4.4 m-85 47.33 -170.92 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.481 -0.762 . . . . 0.0 109.777 179.549 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -146.55 20.22 1.33 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.477 -0.764 . . . . 0.0 108.961 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.478 ' HB ' ' CE1' ' A' ' 56' ' ' TYR . 46.9 t -92.91 -83.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.366 -0.834 . . . . 0.0 109.569 -179.783 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 52' ' ' VAL . 69.9 m -166.87 -175.66 3.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.129 -0.982 . . . . 0.0 109.985 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.572 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -79.07 -51.19 1.32 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.51 -0.743 . . . . 0.0 111.007 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 54' ' ' SER . 33.3 Cg_endo -73.44 89.1 0.96 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.911 1.741 . . . . 0.0 109.768 -177.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.524 ' O ' ' CD2' ' A' ' 57' ' ' TYR . 5.9 m-85 -90.04 -168.63 2.18 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.581 0.705 . . . . 0.0 110.144 -178.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.624 ' CE1' ' NE2' ' A' ' 27' ' ' HIS . 72.9 m-85 -158.66 120.29 3.48 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.176 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -88.68 137.9 31.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 110.838 -178.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.628 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 41.0 t-105 -161.03 137.8 6.45 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.416 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.628 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 33.1 Cg_endo -71.66 148.43 53.07 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.242 1.961 . . . . 0.0 111.446 -178.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.519 HD11 ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -111.53 125.48 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.855 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.485 HD21 ' C ' ' A' ' 61' ' ' ILE . 1.5 mt -121.06 165.53 15.18 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.11 -0.994 . . . . 0.0 109.537 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 11' ' ' TYR . 22.9 t -129.16 48.0 2.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.469 -0.769 . . . . 0.0 109.252 179.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.35 21.8 3.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.406 -0.809 . . . . 0.0 109.396 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 54.74 44.2 80.31 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.57 116.28 5.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -1.132 . . . . 0.0 109.534 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.513 HG13 ' CZ2' ' A' ' 59' ' ' TRP . 54.3 t -54.51 148.48 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.209 -0.932 . . . . 0.0 109.43 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.492 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 58.5 t80 -56.91 154.13 9.95 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.226 -0.921 . . . . 0.0 109.572 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.414 ' N ' ' CG ' ' A' ' 68' ' ' TYR . 1.2 t -158.68 -53.2 0.06 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.361 -0.837 . . . . 0.0 109.383 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -166.31 79.49 0.12 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 72' ' ' SER . . . 162.06 142.56 3.43 Favored Glycine 0 N--CA 1.49 2.279 0 O-C-N 121.113 -1.228 . . . . 0.0 110.055 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.485 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 1.7 m 42.99 61.65 9.39 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.429 -1.042 . . . . 0.0 110.033 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.485 ' HD3' ' N ' ' A' ' 72' ' ' SER . 36.3 Cg_endo -78.89 -48.21 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.627 2.218 . . . . 0.0 110.551 179.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.495 ' CA ' ' CB ' ' A' ' 92' ' ' HIS . . . -82.06 -135.66 2.13 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.493 ' O ' ' OG1' ' A' ' 91' ' ' THR . . . 64.76 -83.78 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.448 -1.031 . . . . 0.0 110.552 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.435 ' OD1' ' HB2' ' A' ' 6' ' ' CYS . 6.1 m-20 -119.02 139.99 50.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.757 -1.214 . . . . 0.0 109.956 -179.357 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.451 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 69.0 mtt180 -152.09 134.19 15.03 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.596 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.0 p -114.36 138.98 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.062 -1.024 . . . . 0.0 109.288 179.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.565 ' CG1' ' N ' ' A' ' 80' ' ' PHE . 43.1 t -104.51 167.46 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.36 -0.838 . . . . 0.0 109.654 -179.618 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.597 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 4.4 p90 -163.95 -172.82 2.95 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.398 -178.169 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 82' ' ' GLU . 46.7 t-20 -122.06 -46.52 2.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.018 -1.051 . . . . 0.0 109.653 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 81' ' ' ASN . 5.2 pt-20 166.85 -27.3 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.46 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 1.4 m-20 -100.37 27.54 5.65 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.074 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 83' ' ' ASN . 2.5 p-10 46.24 27.52 0.57 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.358 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.568 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 1.2 mt-30 -54.65 -32.02 58.47 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.568 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 85.94 105.25 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.587 0.708 . . . . 0.0 110.532 179.075 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.579 ' O ' ' CD2' ' A' ' 50' ' ' PHE . . . -80.49 -43.44 20.82 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 156.19 159.04 9.15 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.48 ' CG2' ' CG ' ' A' ' 4' ' ' TYR . 58.1 t -96.39 92.37 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.185 -1.185 . . . . 0.0 109.706 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.533 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 0.4 OUTLIER -78.83 173.65 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.576 -0.703 . . . . 0.0 109.33 179.736 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' A' ' 75' ' ' ALA . 5.6 t -132.25 146.04 51.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.04 -1.038 . . . . 0.0 111.013 -179.035 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.569 ' CD2' ' HB2' ' A' ' 98' ' ' ASN . 0.1 OUTLIER -93.39 62.72 3.44 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.363 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.488 ' N ' ' HA ' ' A' ' 98' ' ' ASN . 2.6 t 178.92 24.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.806 -179.29 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -131.44 27.22 3.78 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.47 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -158.92 97.28 1.4 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.222 -1.164 . . . . 0.0 110.533 -179.65 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.47 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER 36.33 54.32 1.03 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.802 -0.561 . . . . 0.0 110.331 179.316 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 93' ' ' THR . . . 122.92 -87.72 0.4 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.569 ' HB2' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -138.16 -69.52 0.44 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.181 -1.188 . . . . 0.0 109.828 179.949 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.503 ' O ' ' HA ' ' A' ' 92' ' ' HIS . 1.1 t30 44.82 -167.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 0.0 108.774 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.64 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -130.12 114.83 16.22 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.838 -1.164 . . . . 0.0 110.805 179.916 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' A' ' 102' ' ' GLU . 1.6 m -130.27 128.03 63.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.375 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 101' ' ' VAL . 4.0 mt-10 -42.98 105.66 0.05 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.331 -0.856 . . . . 0.0 109.879 -179.416 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.7 107.27 3.4 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.299 -0.876 . . . . 0.0 109.562 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 109.402 179.982 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.223 0.535 . . . . 0.0 109.767 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.7 p 164.96 99.62 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.259 -0.9 . . . . 0.0 110.06 179.559 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -78.78 -2.9 41.73 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.394 -0.816 . . . . 0.0 108.992 179.472 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.48 ' CD2' HG21 ' A' ' 89' ' ' VAL . 8.0 m-85 -118.9 107.04 13.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.949 . . . . 0.0 109.681 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.0 m -142.38 143.04 32.52 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.429 ' SG ' ' OD1' ' A' ' 76' ' ' ASP . 80.8 m -123.51 15.31 9.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.048 -1.033 . . . . 0.0 110.339 -179.499 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.29 -88.56 0.1 OUTLIER Glycine 0 C--N 1.28 -2.554 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.78 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.43 26.67 7.24 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.351 -1.087 . . . . 0.0 109.504 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -106.58 131.63 53.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.706 -179.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 1' ' ' ALA . 43.3 t -104.28 75.95 1.29 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.53 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 3.5 m-85 -83.48 126.48 32.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.852 . . . . 0.0 110.253 -179.139 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 0.7 OUTLIER -81.92 125.83 31.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.645 -0.659 . . . . 0.0 109.65 179.851 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.49 -22.93 0.82 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.16 -0.963 . . . . 0.0 109.194 179.659 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.97 -39.43 26.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.94 . . . . 0.0 110.097 -179.704 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.34 -35.1 75.58 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.556 HG11 HG12 ' A' ' 61' ' ' ILE . 2.9 t -58.81 -26.41 32.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.057 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.7 t -63.09 -43.98 97.02 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -34.47 77.97 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.083 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.602 ' CB ' HD13 ' A' ' 61' ' ' ILE . . . -84.8 -10.04 57.58 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.059 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.512 ' NE2' ' O ' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -91.88 -21.49 20.58 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.272 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -88.32 -8.84 54.49 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 26' ' ' LEU . . . -81.04 -56.16 4.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.12 -0.988 . . . . 0.0 108.835 179.679 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.4 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -61.8 -20.46 59.74 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 179.384 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.515 ' CE1' ' HA ' ' A' ' 82' ' ' GLU . 34.0 t80 -87.28 -69.84 0.66 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.375 -1.073 . . . . 0.0 109.565 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -42.54 -52.7 4.66 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.257 -0.902 . . . . 0.0 109.398 179.9 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.51 HD13 ' CB ' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -56.92 -42.63 80.3 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.427 -0.796 . . . . 0.0 109.155 179.837 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.525 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 5.3 t60 -53.65 -52.67 59.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.352 -0.843 . . . . 0.0 110.102 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 39.5 tp10 -84.38 -2.53 57.28 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.138 -0.976 . . . . 0.0 109.575 -179.56 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.422 ' HB3' ' HA ' ' A' ' 26' ' ' LEU . 38.0 t70 -94.93 -7.81 38.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.175 -0.953 . . . . 0.0 109.365 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.26 -40.12 3.04 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.517 ' O ' ' CG2' ' A' ' 32' ' ' THR . 1.1 mp0 -65.64 -173.9 0.18 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -1.138 . . . . 0.0 109.277 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.517 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 7.2 p -161.53 -94.75 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.181 -0.95 . . . . 0.0 109.503 179.595 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.5 m -135.62 -114.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.982 -1.074 . . . . 0.0 109.785 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.516 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -97.42 44.75 1.83 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.5 OUTLIER 76.19 24.33 1.14 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.446 -1.032 . . . . 0.0 109.547 179.886 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -119.73 7.54 11.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -0.903 . . . . 0.0 109.677 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.431 ' HA ' HG22 ' A' ' 32' ' ' THR . 52.1 p 45.32 88.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.252 -0.905 . . . . 0.0 109.88 179.94 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.623 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -91.61 -40.2 0.38 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.314 -0.866 . . . . 0.0 111.736 -179.686 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 33.7 Cg_endo -76.08 109.76 2.94 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 120.986 1.124 . . . . 0.0 110.086 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.578 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -128.27 -173.23 2.89 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.203 -179.396 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -103.37 141.95 35.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.093 -1.004 . . . . 0.0 110.059 -179.622 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.452 ' HB2' ' HG2' ' A' ' 58' ' ' GLU . 68.3 t80 -107.05 160.09 15.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.205 -0.934 . . . . 0.0 109.228 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.564 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 0.4 OUTLIER -109.95 -84.98 0.55 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.095 -1.003 . . . . 0.0 109.776 -179.91 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.581 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 6.1 p30 155.99 135.07 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.581 ' CD1' ' O ' ' A' ' 44' ' ' ASN . 19.6 m-85 -152.41 -64.88 0.17 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.068 -1.02 . . . . 0.0 109.414 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -40.64 -53.87 2.68 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.374 -0.829 . . . . 0.0 109.529 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 48' ' ' PHE . . . 140.52 -73.66 0.38 Allowed Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.613 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.54 ' HB3' ' CE2' ' A' ' 50' ' ' PHE . 70.7 m-85 66.91 157.09 0.11 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.406 -1.055 . . . . 0.0 108.389 -179.873 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -108.71 27.78 9.08 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.715 -1.194 . . . . 0.0 110.381 -178.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.54 ' CE2' ' HB3' ' A' ' 48' ' ' PHE . 8.1 p90 -125.22 -174.32 3.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.984 -1.073 . . . . 0.0 109.697 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -170.08 54.81 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.268 -0.895 . . . . 0.0 109.304 -179.679 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.475 ' HB ' ' CE1' ' A' ' 56' ' ' TYR . 29.9 t -43.45 -66.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.198 -0.939 . . . . 0.0 109.524 -179.82 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.463 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -164.18 -172.89 2.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.135 -0.978 . . . . 0.0 109.767 -179.816 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.506 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -79.6 -54.97 0.9 Allowed Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.266 -0.896 . . . . 0.0 111.223 -179.255 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 54' ' ' SER . 34.4 Cg_endo -72.42 87.02 0.95 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.877 1.718 . . . . 0.0 109.979 -178.114 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.538 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 9.3 m-85 -87.13 178.1 7.0 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.233 0.54 . . . . 0.0 109.639 -179.38 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.538 ' CD1' ' C ' ' A' ' 56' ' ' TYR . 94.0 m-85 -156.71 129.56 7.77 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.364 -0.835 . . . . 0.0 109.576 179.62 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.479 ' HG3' ' ND1' ' A' ' 40' ' ' HIS . 0.2 OUTLIER -99.86 138.18 37.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -0.94 . . . . 0.0 109.663 -179.933 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.605 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 21.1 t-105 -155.69 136.64 9.1 Favored Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.605 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.8 Cg_endo -71.5 137.29 30.24 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 C-N-CA 122.168 1.912 . . . . 0.0 111.801 -178.224 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.602 HD13 ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -110.93 133.51 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.96 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.52 ' N ' ' CD1' ' A' ' 61' ' ' ILE . 0.3 OUTLIER -131.93 158.69 40.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -0.9 . . . . 0.0 109.158 179.921 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 98.1 p -122.83 27.4 7.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.911 . . . . 0.0 108.88 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -153.87 -39.08 0.1 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.454 -0.779 . . . . 0.0 109.356 -179.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 66' ' ' ASP . . . -88.98 -9.99 67.1 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.494 ' O ' ' CB ' ' A' ' 67' ' ' VAL . 67.8 t0 48.09 96.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -1.124 . . . . 0.0 109.56 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.494 ' CB ' ' O ' ' A' ' 66' ' ' ASP . 2.9 t 75.62 135.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.545 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.492 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 45.9 t80 -81.39 150.34 28.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.903 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.451 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 4.8 t -165.47 -42.3 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.422 -0.799 . . . . 0.0 109.285 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -158.09 124.49 1.4 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.89 -145.29 12.65 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.85 107.77 60.9 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.285 -1.126 . . . . 0.0 109.636 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.477 ' CB ' ' OH ' ' A' ' 38' ' ' TYR . 35.7 Cg_endo -77.12 -175.63 2.76 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.534 2.156 . . . . 0.0 110.534 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.457 ' O ' ' CB ' ' A' ' 75' ' ' ALA . . . 93.35 -175.64 36.3 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 74' ' ' GLY . . . 71.52 -144.91 0.06 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.141 -1.211 . . . . 0.0 110.108 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.429 ' OD1' ' SG ' ' A' ' 6' ' ' CYS . 5.7 m-20 -44.11 151.54 0.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.354 -0.841 . . . . 0.0 110.986 -179.135 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.525 ' NH2' ' CE1' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -164.95 111.84 0.99 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.104 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.494 HG23 HD21 ' A' ' 86' ' ' LEU . 13.9 p -92.56 129.25 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.821 -1.175 . . . . 0.0 110.312 -178.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.535 ' CG1' ' N ' ' A' ' 80' ' ' PHE . 55.2 t -98.39 167.36 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.467 -0.771 . . . . 0.0 109.145 179.569 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.567 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 4.7 p90 -168.48 -170.76 1.3 Allowed 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.662 -178.082 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.456 ' ND2' ' CB ' ' A' ' 53' ' ' SER . 1.0 OUTLIER -129.71 -42.4 1.29 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.172 -0.955 . . . . 0.0 110.056 -179.341 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.515 ' HA ' ' CE1' ' A' ' 24' ' ' TYR . 7.6 pt-20 166.26 -27.31 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.737 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.46 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -100.84 26.08 7.27 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.489 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.469 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 8.5 p30 48.7 25.27 0.95 Allowed 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.45 0.643 . . . . 0.0 109.636 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.535 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 3.0 mt-30 -55.35 -36.16 66.01 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.535 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER 83.59 104.11 0.05 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.557 0.694 . . . . 0.0 110.694 179.142 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.492 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . . . -76.81 -34.0 57.96 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.783 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 150.34 151.52 5.56 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.48 HG21 ' CD2' ' A' ' 4' ' ' TYR . 85.9 t -89.34 88.07 2.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.268 -1.136 . . . . 0.0 109.696 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 77' ' ' ARG . 0.8 OUTLIER -78.97 158.26 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.276 -0.89 . . . . 0.0 108.789 179.681 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 100' ' ' PHE . 9.5 t -119.22 168.48 10.84 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.043 -1.036 . . . . 0.0 110.642 -179.1 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.622 ' NE2' ' CE2' ' A' ' 100' ' ' PHE . 0.3 OUTLIER -120.98 68.98 0.88 Allowed 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 3.1 m -175.75 -30.37 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.401 -0.812 . . . . 0.0 110.183 -179.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.42 17.17 40.41 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.161 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.476 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -153.98 121.2 5.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -1.164 . . . . 0.0 109.482 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.476 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.9 OUTLIER 39.28 -156.38 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.367 -0.833 . . . . 0.0 109.49 179.68 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 96' ' ' SER . . . -41.39 -59.99 2.49 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 179.341 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.58 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -167.43 32.65 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.243 -1.151 . . . . 0.0 109.27 179.251 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.436 ' O ' ' O ' ' A' ' 98' ' ' ASN . 1.4 t30 -48.14 173.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.99 -1.068 . . . . 0.0 109.251 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.622 ' CE2' ' NE2' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -100.13 144.13 29.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.1 -1.0 . . . . 0.0 109.528 -179.94 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 100' ' ' PHE . 10.3 m -158.02 137.19 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.377 -0.827 . . . . 0.0 108.899 179.624 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.87 96.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.098 -1.001 . . . . 0.0 109.554 -179.59 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.453 ' N ' ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -48.41 126.77 11.97 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.298 -0.876 . . . . 0.0 109.464 179.832 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.837 -1.078 . . . . 0.0 109.483 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.471 ' O ' ' SG ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.541 0.686 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 31.4 p 38.93 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.912 0.863 . . . . 0.0 110.264 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -102.5 -1.44 30.53 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.361 -0.837 . . . . 0.0 109.307 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.695 ' CG ' HG21 ' A' ' 89' ' ' VAL . 23.0 m-85 -115.07 65.73 0.68 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.9 . . . . 0.0 109.225 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.797 HG23 ' O ' ' A' ' 5' ' ' THR . 11.5 t -86.78 92.46 8.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.94 . . . . 0.0 109.741 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.9 m -104.24 155.75 18.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.119 -0.988 . . . . 0.0 109.236 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 8' ' ' SER . . . 47.43 29.3 5.29 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.436 ' O ' ' OD1' ' A' ' 9' ' ' ASN . 5.0 m 70.44 43.84 0.76 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -1.14 . . . . 0.0 109.422 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.487 ' O ' ' HA ' ' A' ' 5' ' ' THR . 83.0 m-20 -136.97 86.33 2.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.136 -0.978 . . . . 0.0 109.547 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.472 ' HA ' ' HB ' ' A' ' 5' ' ' THR . 0.5 OUTLIER -54.9 88.26 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.498 -0.751 . . . . 0.0 109.395 179.868 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 63' ' ' SER . 1.9 m-85 -79.68 144.51 33.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.311 -0.868 . . . . 0.0 108.924 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.81 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -78.58 122.48 25.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.376 -0.827 . . . . 0.0 109.568 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.6 p -59.03 -26.62 64.72 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 83.4 p -78.93 -28.55 43.84 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 0.5 OUTLIER -79.74 -27.4 40.55 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.081 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 12' ' ' SER . 13.5 t -66.6 -29.9 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.499 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 1.9 t -64.4 -46.21 84.26 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.93 -51.81 67.69 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.821 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -66.41 -18.81 65.58 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.726 ' NE2' ' CD1' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -71.11 -36.65 72.23 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -82.0 -1.72 49.19 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.54 -54.82 5.33 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.353 -0.842 . . . . 0.0 108.914 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.574 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -72.89 -18.5 79.01 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.44 ' O ' ' C ' ' A' ' 25' ' ' GLN . 14.6 t80 -80.22 -60.52 2.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.557 -0.966 . . . . 0.0 109.348 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.7 OUTLIER -41.64 -35.38 0.74 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.319 -0.863 . . . . 0.0 109.614 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.518 ' HA ' HD22 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -75.23 -47.13 29.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 0.0 109.65 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.583 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 11.5 t60 -56.25 -37.44 69.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.368 -0.833 . . . . 0.0 110.941 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -85.41 -31.47 22.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.027 -1.046 . . . . 0.0 109.48 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 0.5 OUTLIER -68.09 -20.51 64.95 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.274 -0.891 . . . . 0.0 109.366 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.23 -19.02 25.08 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.506 ' HB3' HD11 ' A' ' 26' ' ' LEU . 1.7 tp10 -63.01 -154.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.234 -1.156 . . . . 0.0 109.492 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.778 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -162.69 174.47 12.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.336 -0.852 . . . . 0.0 109.408 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.496 ' CG2' ' HB2' ' A' ' 38' ' ' TYR . 18.0 m -130.4 158.1 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.276 -0.89 . . . . 0.0 109.383 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.403 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . 55.63 -89.21 0.01 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER 171.04 32.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.327 -1.102 . . . . 0.0 109.725 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 37' ' ' SER . 1.6 m120 -152.64 25.29 0.58 Allowed 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.106 -0.996 . . . . 0.0 109.666 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.778 ' HA ' HG22 ' A' ' 32' ' ' THR . 1.0 OUTLIER 47.95 92.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.018 -1.051 . . . . 0.0 108.887 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.68 ' CD2' ' CE2' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -79.34 -47.29 1.58 Allowed Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.261 -0.9 . . . . 0.0 110.765 -179.367 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 38' ' ' TYR . 32.6 Cg_endo -74.71 108.04 2.61 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 120.95 1.1 . . . . 0.0 109.349 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.62 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -125.74 -174.8 3.17 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.459 -179.11 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -104.6 131.28 52.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.346 -0.846 . . . . 0.0 109.42 -179.526 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.596 ' CZ ' ' HA ' ' A' ' 44' ' ' ASN . 11.9 t80 -97.33 137.83 35.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.272 -0.893 . . . . 0.0 109.259 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.523 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -89.85 -32.49 16.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.144 -0.973 . . . . 0.0 109.776 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.626 ' ND2' ' CD1' ' A' ' 48' ' ' PHE . 4.7 t-20 77.2 135.59 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.591 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.445 ' O ' ' C ' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -159.5 -38.11 0.06 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.307 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.6 OUTLIER -38.72 -73.02 0.05 Allowed 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.623 -0.673 . . . . 0.0 110.069 -179.582 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 155.41 61.72 0.01 OUTLIER Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.626 ' CD1' ' ND2' ' A' ' 44' ' ' ASN . 48.6 m-85 -90.74 -168.01 1.97 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.299 -1.118 . . . . 0.0 109.332 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 50' ' ' PHE . 5.0 p30 -145.05 26.59 1.34 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.52 ' CB ' ' OH ' ' A' ' 56' ' ' TYR . 20.9 m-30 -45.6 173.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.503 -0.748 . . . . 0.0 109.769 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.4 m -146.53 30.3 1.01 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.357 -0.839 . . . . 0.0 109.088 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.835 HG11 ' OD1' ' A' ' 81' ' ' ASN . 97.2 t -96.28 -92.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.338 -0.851 . . . . 0.0 109.545 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.497 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 66.9 m -142.63 -172.93 3.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.074 -1.016 . . . . 0.0 109.962 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.592 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -85.49 -49.25 0.56 Allowed Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.364 -0.835 . . . . 0.0 111.61 -179.175 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 54' ' ' SER . 33.5 Cg_endo -74.09 83.41 1.64 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 121.863 1.708 . . . . 0.0 110.396 -177.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.546 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 7.1 m-85 -79.38 -177.96 6.01 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.645 0.736 . . . . 0.0 110.022 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.583 ' CE2' ' NE2' ' A' ' 27' ' ' HIS . 97.6 m-85 -157.95 152.33 24.63 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.599 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 19.2 mt-10 -119.63 143.17 47.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.991 -1.068 . . . . 0.0 111.124 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.653 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 21.3 t-105 -160.75 138.81 7.21 Favored Pre-proline 0 N--CA 1.49 1.57 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.653 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.2 Cg_endo -69.22 142.59 50.74 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.338 2.025 . . . . 0.0 111.861 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.978 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -119.57 131.64 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.978 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.9 OUTLIER -123.13 167.49 13.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.191 -0.943 . . . . 0.0 109.576 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -135.72 17.47 3.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.368 -0.833 . . . . 0.0 109.25 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.25 -54.2 0.2 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.284 -0.885 . . . . 0.0 109.423 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . -67.42 -98.16 0.03 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.716 ' O ' HD12 ' A' ' 62' ' ' LEU . 3.0 t0 175.49 -162.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -1.161 . . . . 0.0 109.538 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.41 ' H ' HG23 ' A' ' 67' ' ' VAL . 8.5 t -52.55 136.47 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.304 -0.873 . . . . 0.0 109.568 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.68 ' CE2' ' CD2' ' A' ' 38' ' ' TYR . 28.9 t80 -52.92 117.84 3.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.2 -0.937 . . . . 0.0 109.254 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -177.19 74.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.404 -0.81 . . . . 0.0 109.662 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.52 62.12 0.31 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.31 -136.29 3.91 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.2 m -166.29 101.63 0.7 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.309 -1.112 . . . . 0.0 109.186 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.57 ' HG3' ' CD1' ' A' ' 68' ' ' TYR . 35.8 Cg_endo -77.82 -81.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.435 2.09 . . . . 0.0 110.685 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.39 -176.89 4.86 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . 56.47 -122.03 1.65 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.101 -1.235 . . . . 0.0 109.555 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 75' ' ' ALA . 87.2 m-20 -41.4 146.85 0.19 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.848 -1.158 . . . . 0.0 110.167 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.491 ' O ' HG12 ' A' ' 90' ' ' ILE . 2.6 tpp180 -176.37 90.12 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.455 -0.778 . . . . 0.0 109.219 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.752 HG21 HD21 ' A' ' 86' ' ' LEU . 7.5 p -65.04 144.63 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.097 -1.002 . . . . 0.0 109.547 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.605 HG23 HD13 ' A' ' 90' ' ' ILE . 24.7 t -104.84 167.48 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.345 -0.847 . . . . 0.0 109.642 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.726 ' CD1' ' NE2' ' A' ' 20' ' ' GLN . 13.8 p90 -164.53 -173.39 3.03 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.409 -178.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.835 ' OD1' HG11 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -124.07 -81.15 0.63 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.066 -1.022 . . . . 0.0 110.267 -179.395 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -158.74 21.55 0.22 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.312 -0.867 . . . . 0.0 109.484 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.453 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 4.4 m120 -140.39 23.89 2.31 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.597 ' ND2' ' O ' ' A' ' 84' ' ' ASN . 0.3 OUTLIER 52.83 19.92 1.45 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 -179.321 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.503 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 51.8 mm-40 -60.62 -111.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.752 HD21 HG21 ' A' ' 78' ' ' VAL . 0.2 OUTLIER 172.84 110.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 110.693 178.825 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.588 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . . . -79.62 -38.92 32.75 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 148.69 156.71 7.24 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.695 HG21 ' CG ' ' A' ' 4' ' ' TYR . 94.8 t -87.14 113.48 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -1.155 . . . . 0.0 109.411 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.605 HD13 HG23 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -109.27 154.54 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.421 -0.8 . . . . 0.0 109.142 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 100' ' ' PHE . 4.6 t -107.79 146.82 31.67 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.033 -1.042 . . . . 0.0 110.418 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.615 ' CD2' ' HB2' ' A' ' 98' ' ' ASN . 16.1 t60 -116.76 66.05 0.72 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.451 ' HA ' ' HB3' ' A' ' 98' ' ' ASN . 1.9 m 178.42 -29.65 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.746 -0.596 . . . . 0.0 109.717 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.88 10.79 44.92 Favored Glycine 0 N--CA 1.494 2.504 0 O-C-N 120.993 -1.067 . . . . 0.0 110.638 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -141.15 147.06 37.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.016 -1.285 . . . . 0.0 109.669 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 95' ' ' ALA . 1.2 p -43.03 133.3 3.8 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 98' ' ' ASN . . . 62.84 35.03 91.42 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 107.949 -2.061 . . . . 0.0 107.949 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.615 ' HB2' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 34.71 41.66 0.06 Allowed 'General case' 0 C--N 1.309 -1.177 0 O-C-N 122.105 -0.644 . . . . 0.0 110.349 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -56.93 166.55 0.98 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.123 -0.986 . . . . 0.0 108.623 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.639 ' O ' HG13 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -91.44 147.51 22.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.933 -1.104 . . . . 0.0 109.839 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.639 HG13 ' O ' ' A' ' 100' ' ' PHE . 17.4 m -161.38 133.97 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 101' ' ' VAL . 35.8 mt-10 -43.26 135.17 3.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.964 . . . . 0.0 109.448 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 1.5 m -60.73 121.3 11.92 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.246 -0.908 . . . . 0.0 109.325 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.556 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 7.1 p 173.27 137.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.37 -0.832 . . . . 0.0 109.906 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -115.72 -29.57 6.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 0.0 109.505 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.716 ' CD2' HG21 ' A' ' 89' ' ' VAL . 13.0 m-85 -87.11 93.66 9.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.955 . . . . 0.0 109.233 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.3 m -126.76 141.08 51.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.144 -0.972 . . . . 0.0 109.869 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -143.98 14.98 1.71 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.122 0.963 . . . . 0.0 109.785 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 177.88 50.0 0.07 OUTLIER Glycine 0 C--N 1.281 -2.526 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 8' ' ' SER . 3.3 t 55.0 20.47 3.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.47 -1.018 . . . . 0.0 109.201 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.572 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 25.8 m-80 -74.5 -34.41 63.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 0.0 109.627 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 9' ' ' ASN . 46.5 t 61.52 52.03 3.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.116 -0.99 . . . . 0.0 109.621 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.572 ' CE1' ' HB3' ' A' ' 9' ' ' ASN . 7.6 m-30 -80.61 129.97 34.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.303 -0.873 . . . . 0.0 109.073 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.701 ' O ' HG23 ' A' ' 16' ' ' VAL . 3.9 m -88.57 137.96 31.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.167 -0.958 . . . . 0.0 110.11 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 p -53.55 -23.33 10.33 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.0 t -77.33 -38.16 51.0 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.357 -0.839 . . . . 0.0 108.94 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -70.86 -28.86 64.89 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 12' ' ' SER . 7.5 t -70.28 -31.2 46.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 C-N-CA 119.602 -0.839 . . . . 0.0 108.777 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.09 -45.62 92.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.598 -0.689 . . . . 0.0 109.433 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.62 -48.92 79.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 108.806 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.688 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -72.32 -12.22 61.04 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.554 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -83.9 -28.36 27.97 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.348 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -82.22 -14.55 55.36 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.438 -0.789 . . . . 0.0 109.099 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 26' ' ' LEU . . . -76.9 -52.94 8.55 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.279 -0.888 . . . . 0.0 109.062 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.556 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -66.16 -30.56 77.08 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.869 -1.693 . . . . 0.0 108.869 179.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.585 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 5.2 t80 -72.11 -70.65 0.32 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.415 -1.05 . . . . 0.0 108.982 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -40.71 -57.85 1.79 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.444 -0.785 . . . . 0.0 109.656 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -46.55 -46.44 19.35 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.048 -1.032 . . . . 0.0 109.262 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -58.81 -48.69 80.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.454 -0.779 . . . . 0.0 110.86 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -86.7 12.04 11.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.134 -0.979 . . . . 0.0 109.939 -179.151 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 55.1 t0 -104.48 -11.82 16.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.076 -1.015 . . . . 0.0 109.364 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.51 -5.12 61.53 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.44 ' HB2' HD13 ' A' ' 26' ' ' LEU . 5.5 mm-40 -87.81 -176.82 5.64 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.298 -1.119 . . . . 0.0 109.367 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.839 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -145.15 178.5 8.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -0.966 . . . . 0.0 109.677 179.741 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.55 HG23 ' N ' ' A' ' 34' ' ' GLY . 27.4 m -100.3 -126.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.322 -0.861 . . . . 0.0 109.441 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.55 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -43.5 -47.55 7.14 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER 163.99 -34.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -1.106 . . . . 0.0 109.638 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.428 ' O ' ' CB ' ' A' ' 37' ' ' SER . 0.6 OUTLIER -75.96 -11.84 60.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 0.0 110.008 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.839 ' HA ' HG22 ' A' ' 32' ' ' THR . 1.1 p 69.29 121.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.026 -1.047 . . . . 0.0 108.916 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.735 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -98.3 -19.24 0.21 Allowed Pre-proline 0 N--CA 1.495 1.808 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -179.102 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.735 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 37.4 Cg_endo -79.82 102.03 1.43 Allowed 'Trans proline' 0 C--N 1.318 -1.056 0 C-N-CA 121.275 1.316 . . . . 0.0 113.426 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.481 ' HB2' ' OE2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -128.77 137.43 51.54 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.072 -1.017 . . . . 0.0 109.748 177.184 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 2.5 ptmt -51.14 143.51 10.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 110.292 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.647 ' HD2' HG21 ' A' ' 79' ' ' VAL . 4.4 t80 -114.45 102.01 9.68 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 44' ' ' ASN . 4.0 p30 -74.77 21.66 0.11 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.901 -1.124 . . . . 0.0 111.582 -178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.558 ' HA ' ' CZ ' ' A' ' 42' ' ' TYR . 1.2 m-20 60.42 148.63 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.66 -1.275 . . . . 0.0 109.612 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.483 ' CD2' ' O ' ' A' ' 44' ' ' ASN . 0.2 OUTLIER -174.39 -57.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.933 . . . . 0.0 109.614 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.661 ' OE2' HG12 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -37.44 -55.99 1.03 Allowed 'General case' 0 C--N 1.308 -1.204 0 O-C-N 121.616 -0.677 . . . . 0.0 110.293 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.21 51.69 0.08 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.528 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 11.3 m-85 -91.43 -170.1 2.52 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.301 -1.117 . . . . 0.0 108.629 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -150.49 44.9 0.87 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.095 -1.003 . . . . 0.0 110.308 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.52 -179.5 5.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.954 -1.091 . . . . 0.0 109.236 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.4 m -153.22 56.68 0.77 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.237 -0.914 . . . . 0.0 109.466 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.688 HG21 ' O ' ' A' ' 86' ' ' LEU . 37.4 t -94.62 -27.0 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.258 -0.901 . . . . 0.0 109.647 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.532 ' HB3' ' CB ' ' A' ' 81' ' ' ASN . 4.1 t 167.55 162.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.028 -1.045 . . . . 0.0 109.57 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.591 ' CB ' ' HD3' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -75.82 -59.71 1.14 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.094 -1.004 . . . . 0.0 110.646 -179.27 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.591 ' HD3' ' CB ' ' A' ' 54' ' ' SER . 36.0 Cg_endo -71.34 84.37 0.94 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 121.959 1.773 . . . . 0.0 110.623 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.605 ' CE1' ' HB2' ' A' ' 87' ' ' ALA . 38.3 m-85 -79.62 -171.04 2.62 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.648 0.737 . . . . 0.0 109.904 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.584 ' CD2' ' O ' ' A' ' 56' ' ' TYR . 76.9 m-85 -160.82 151.04 17.79 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.481 ' OE2' ' HB2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -120.79 140.39 51.78 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.901 -1.124 . . . . 0.0 110.543 -178.828 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.684 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 3.7 t-105 -155.99 146.34 15.97 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.684 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.8 Cg_endo -68.32 130.58 21.48 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.098 1.866 . . . . 0.0 111.43 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.979 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -97.84 132.54 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.979 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.9 OUTLIER -123.81 165.01 18.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 0.0 109.342 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.55 ' HB2' ' CZ ' ' A' ' 11' ' ' TYR . 27.1 t -120.26 37.42 4.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 108.97 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.39 -172.91 3.07 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.404 -0.81 . . . . 0.0 109.638 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -96.28 50.48 1.66 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -150.04 147.34 27.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.09 -1.241 . . . . 0.0 109.432 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.477 HG13 ' HZ2' ' A' ' 59' ' ' TRP . 81.0 t -92.18 152.27 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.89 . . . . 0.0 109.252 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.603 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 44.4 t80 -59.79 132.17 53.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.201 -0.937 . . . . 0.0 109.573 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.1 t -155.91 20.36 0.38 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.303 -0.873 . . . . 0.0 109.246 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.5 89.75 1.41 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -162.65 -39.52 0.02 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.435 ' O ' ' OG ' ' A' ' 72' ' ' SER . 28.1 p -158.17 102.14 1.73 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.16 -1.2 . . . . 0.0 109.326 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -75.15 114.14 3.94 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.336 2.024 . . . . 0.0 110.158 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.462 ' HA2' ' CD2' ' A' ' 92' ' ' HIS . . . 109.83 -125.08 7.44 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.559 ' N ' ' HB2' ' A' ' 92' ' ' HIS . . . 51.01 -174.06 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.201 -1.176 . . . . 0.0 109.638 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.491 ' CB ' HG23 ' A' ' 61' ' ' ILE . 65.8 m-20 -37.89 143.16 0.12 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.649 0.738 . . . . 0.0 110.681 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.495 ' CA ' HG22 ' A' ' 61' ' ' ILE . 2.0 ttt180 -153.95 133.65 12.96 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.804 ' CG2' HD11 ' A' ' 86' ' ' LEU . 10.8 p -119.24 130.08 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.928 -1.107 . . . . 0.0 110.461 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.647 HG21 ' HD2' ' A' ' 42' ' ' TYR . 12.9 t -89.5 163.25 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 CA-C-O 122.298 1.047 . . . . 0.0 109.857 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.559 ' N ' ' CG1' ' A' ' 79' ' ' VAL . 34.4 p90 -159.74 -168.47 2.27 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.539 ' OD1' ' HG2' ' A' ' 82' ' ' GLU . 1.2 p30 -122.07 -44.79 2.27 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.866 -1.134 . . . . 0.0 111.004 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.585 ' O ' ' CZ ' ' A' ' 24' ' ' TYR . 2.1 pt-20 161.21 -21.54 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.419 ' C ' ' CG ' ' A' ' 84' ' ' ASN . 1.8 m-20 -92.16 20.27 6.11 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.581 ' OD1' ' CE2' ' A' ' 24' ' ' TYR . 0.0 OUTLIER 63.62 8.08 3.46 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.7 -0.625 . . . . 0.0 109.686 -179.474 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.41 ' O ' ' O ' ' A' ' 84' ' ' ASN . 13.6 mt-30 -60.66 -160.32 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.804 HD11 ' CG2' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -137.84 117.42 12.99 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.488 -1.382 . . . . 0.0 110.755 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.605 ' HB2' ' CE1' ' A' ' 56' ' ' TYR . . . -83.92 -43.23 15.47 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 170.48 163.69 24.94 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.716 HG21 ' CD2' ' A' ' 4' ' ' TYR . 75.1 t -115.93 99.22 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.021 -1.282 . . . . 0.0 109.388 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.588 HD13 ' H ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -88.37 -173.39 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.398 -0.814 . . . . 0.0 109.401 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.589 ' O ' HG23 ' A' ' 91' ' ' THR . 5.9 t -148.9 121.43 8.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.986 -1.071 . . . . 0.0 110.213 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.559 ' HB2' ' N ' ' A' ' 75' ' ' ALA . 2.4 m-70 -78.99 79.13 5.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.549 -0.719 . . . . 0.0 109.291 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 98' ' ' ASN . 0.6 OUTLIER 177.36 -28.56 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.171 -0.956 . . . . 0.0 110.095 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.8 -16.31 16.69 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 1.064 ' HB3' ' CB ' ' A' ' 99' ' ' ASN . . . -122.52 178.15 5.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.104 -1.233 . . . . 0.0 109.412 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 98' ' ' ASN . 1.0 OUTLIER -40.95 157.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.449 -0.782 . . . . 0.0 109.31 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 96' ' ' SER . . . 43.97 -95.18 0.01 OUTLIER Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -127.28 -73.91 0.6 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.346 -1.091 . . . . 0.0 109.347 179.339 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 1.064 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . 0.9 OUTLIER 59.33 120.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.044 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.562 ' CD2' ' O ' ' A' ' 100' ' ' PHE . 38.3 p90 -98.76 117.53 33.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.843 -1.161 . . . . 0.0 110.705 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.661 HG12 ' OE2' ' A' ' 46' ' ' GLU . 18.0 m -128.91 158.2 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.513 ' N ' HG22 ' A' ' 90' ' ' ILE . 4.3 pt-20 -43.42 138.81 2.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 109.37 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.1 OUTLIER -75.73 176.8 7.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.63 -179.645 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.081 -0.962 . . . . 0.0 109.523 -179.9 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.482 ' O ' ' SG ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.414 0.626 . . . . 0.0 109.724 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 21.6 p 36.78 91.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.603 0.716 . . . . 0.0 110.224 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -97.86 1.63 48.38 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.46 ' CD2' HG21 ' A' ' 89' ' ' VAL . 16.1 m-85 -104.28 78.1 1.47 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.482 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 9' ' ' ASN . 28.1 m -84.31 93.98 8.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.427 ' O ' ' C ' ' A' ' 7' ' ' GLY . 2.8 m -120.65 155.03 34.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 109.474 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 6' ' ' CYS . . . 43.8 27.21 0.91 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 1.4 m 68.94 50.59 0.59 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.292 -1.122 . . . . 0.0 109.582 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 5' ' ' THR . 25.1 m120 -144.55 126.53 15.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.171 -0.956 . . . . 0.0 109.598 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.465 ' C ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -82.99 84.07 7.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -0.831 . . . . 0.0 109.02 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 4.2 m-30 -79.82 138.68 37.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.41 -0.806 . . . . 0.0 109.661 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.876 ' O ' HG23 ' A' ' 16' ' ' VAL . 2.0 t -80.73 123.28 28.07 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.696 -0.627 . . . . 0.0 109.92 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.18 -24.37 0.45 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 109.221 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.6 t -81.53 -41.1 22.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.983 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -67.62 -28.32 67.64 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 12' ' ' SER . 1.9 t -68.39 -29.64 44.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.575 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 21.5 t -62.63 -46.13 89.66 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -59.43 5.02 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.841 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -61.83 -16.42 50.04 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.904 ' OE1' HG11 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -73.56 -33.81 64.85 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.296 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.62 1.65 53.08 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.0 -62.28 1.73 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.249 -0.907 . . . . 0.0 109.04 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.507 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -60.89 -16.49 47.17 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -82.42 -64.91 1.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.342 -1.093 . . . . 0.0 109.248 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -47.42 -52.43 16.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.353 -0.842 . . . . 0.0 109.745 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.847 ' O ' HD12 ' A' ' 26' ' ' LEU . 2.7 tp -59.72 -38.46 81.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.292 -0.88 . . . . 0.0 109.397 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.649 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 66.1 t60 -68.7 -20.13 64.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.006 -1.059 . . . . 0.0 110.29 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 5.4 tp10 -87.19 -21.97 25.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.057 -1.027 . . . . 0.0 109.507 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 9.9 t70 -89.05 -12.26 41.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.267 -0.896 . . . . 0.0 109.502 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.35 0.84 59.01 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.533 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 5.6 tp10 -67.95 -144.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -1.175 . . . . 0.0 109.517 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.846 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -167.26 -174.6 2.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.058 -1.026 . . . . 0.0 109.619 -179.73 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.465 HG23 ' H ' ' A' ' 34' ' ' GLY . 2.5 m -105.03 -104.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 109.631 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -77.13 -38.19 30.49 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 2.2 t 162.83 -36.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.437 -1.037 . . . . 0.0 109.385 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.418 ' O ' ' O ' ' A' ' 37' ' ' SER . 5.4 m120 -68.82 -16.5 63.8 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.327 -0.858 . . . . 0.0 109.262 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.846 ' HA ' HG22 ' A' ' 32' ' ' THR . 8.1 t 63.09 126.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.271 -0.893 . . . . 0.0 109.431 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.651 ' H ' ' CD ' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -117.99 -27.41 0.08 OUTLIER Pre-proline 0 N--CA 1.499 2.001 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -178.56 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.651 ' CD ' ' H ' ' A' ' 38' ' ' TYR . 37.0 Cg_endo -79.34 100.72 1.35 Allowed 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 121.062 1.175 . . . . 0.0 112.724 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.487 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -135.92 160.61 38.07 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.115 -0.991 . . . . 0.0 108.747 177.439 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -62.72 139.83 58.69 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.128 -0.982 . . . . 0.0 110.232 -179.272 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.578 ' CD2' ' OD1' ' A' ' 44' ' ' ASN . 9.2 t80 -101.41 150.26 23.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.365 -0.834 . . . . 0.0 108.784 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 1.1 m-20 -107.51 -15.55 14.58 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.014 -1.054 . . . . 0.0 110.357 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.578 ' OD1' ' CD2' ' A' ' 42' ' ' TYR . 22.8 m-80 60.26 92.17 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.026 -1.046 . . . . 0.0 109.215 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -122.83 28.19 7.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.194 -0.941 . . . . 0.0 109.626 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.711 ' OE2' HG12 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -101.42 -65.67 0.96 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.46 ' N ' ' CG ' ' A' ' 46' ' ' GLU . . . 144.34 35.38 0.07 OUTLIER Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.558 ' CE1' ' OE2' ' A' ' 46' ' ' GLU . 15.9 m-85 -61.71 -171.07 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.92 6.75 4.66 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 118.102 -1.439 . . . . 0.0 110.292 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.534 ' CZ ' ' CD2' ' A' ' 48' ' ' PHE . 1.8 p90 -96.32 -169.98 2.01 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.996 -1.065 . . . . 0.0 109.347 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 50' ' ' PHE . 6.5 t 167.95 45.21 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.272 -0.893 . . . . 0.0 109.527 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -44.54 -27.73 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 109.252 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.542 ' O ' ' CE1' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -170.99 165.98 7.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.391 -0.818 . . . . 0.0 109.66 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.614 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -78.04 -51.2 1.72 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.323 -0.86 . . . . 0.0 111.044 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 54' ' ' SER . 32.9 Cg_endo -72.77 92.41 0.79 Allowed 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.856 1.704 . . . . 0.0 109.5 -177.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.822 ' CE2' ' HB1' ' A' ' 87' ' ' ALA . 2.2 m-30 -91.85 -170.96 2.72 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.961 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.649 ' CE1' ' NE2' ' A' ' 27' ' ' HIS . 61.1 m-85 -164.29 105.55 0.88 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -74.76 139.4 43.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 109.384 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.726 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 14.6 t-105 -159.84 141.03 9.24 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.726 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.4 Cg_endo -68.16 131.21 23.06 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 C-N-CA 122.156 1.904 . . . . 0.0 111.433 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.973 HD12 ' N ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -106.44 128.2 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.705 -0.622 . . . . 0.0 109.42 -179.614 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.973 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.2 mt -125.03 164.28 20.52 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.306 -0.872 . . . . 0.0 109.352 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.434 ' O ' ' OG ' ' A' ' 63' ' ' SER . 2.2 t -118.51 16.55 13.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.145 -0.972 . . . . 0.0 109.077 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.45 -156.9 0.57 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.597 -0.689 . . . . 0.0 109.487 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -116.0 54.81 0.57 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -163.32 107.17 1.03 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -1.184 . . . . 0.0 109.709 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.431 HG13 ' HZ2' ' A' ' 59' ' ' TRP . 43.5 t -47.76 160.01 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.216 -0.927 . . . . 0.0 109.099 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.617 ' HB2' ' HG2' ' A' ' 60' ' ' PRO . 6.5 t80 -49.1 119.24 3.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.915 -1.116 . . . . 0.0 109.388 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -168.08 39.41 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.432 -0.793 . . . . 0.0 109.127 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.71 -0.97 6.86 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -83.95 -153.66 17.06 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.47 131.51 74.45 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.235 -1.156 . . . . 0.0 109.408 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.413 ' O ' ' O ' ' A' ' 74' ' ' GLY . 36.4 Cg_endo -79.85 -89.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.547 2.164 . . . . 0.0 110.753 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 76' ' ' ASP . . . -59.06 -112.55 0.01 OUTLIER Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.417 ' N ' ' HB3' ' A' ' 92' ' ' HIS . . . 50.9 -87.23 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.383 -1.069 . . . . 0.0 110.415 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 74' ' ' GLY . 1.0 OUTLIER -117.32 116.37 27.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.928 -1.108 . . . . 0.0 109.988 -179.582 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.562 ' NH1' ' CE1' ' A' ' 38' ' ' TYR . 2.3 mtm-85 -128.78 138.14 51.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.139 -0.976 . . . . 0.0 109.138 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.904 HG11 ' OE1' ' A' ' 20' ' ' GLN . 9.8 p -123.62 142.85 38.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.676 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 23.4 t -110.59 165.88 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 122.188 0.994 . . . . 0.0 111.02 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.59 ' CE1' ' HB2' ' A' ' 57' ' ' TYR . 22.7 p90 -161.95 -170.48 2.54 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.258 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.45 ' O ' ' CD2' ' A' ' 57' ' ' TYR . 20.0 t30 -124.35 -82.15 0.64 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.006 -1.059 . . . . 0.0 109.929 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -158.08 18.68 0.24 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.409 -0.807 . . . . 0.0 109.6 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.487 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 2.7 m-20 -153.5 26.11 0.51 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 84' ' ' ASN . 0.4 OUTLIER 53.4 19.65 1.7 Allowed 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.362 0.601 . . . . 0.0 109.557 -179.649 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.595 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -46.83 -35.32 6.19 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.093 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.636 HD21 ' NE2' ' A' ' 20' ' ' GLN . 0.0 OUTLIER 92.43 110.09 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.549 0.69 . . . . 0.0 111.152 179.044 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.822 ' HB1' ' CE2' ' A' ' 56' ' ' TYR . . . -87.42 -42.22 12.99 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 151.21 146.01 4.24 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.46 HG21 ' CD2' ' A' ' 4' ' ' TYR . 61.1 t -86.8 88.81 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.029 -1.277 . . . . 0.0 109.462 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.537 ' HB ' ' HB3' ' A' ' 100' ' ' PHE . 1.1 pt -79.39 170.24 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.315 -0.866 . . . . 0.0 108.785 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.1 t -135.97 141.26 44.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.075 -1.016 . . . . 0.0 110.274 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.601 ' CD2' ' HB2' ' A' ' 98' ' ' ASN . 2.9 t60 -92.77 76.02 4.91 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 1.2 m 171.76 148.38 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.17 -20.69 46.29 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -126.43 151.9 47.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.122 -1.222 . . . . 0.0 109.665 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 95' ' ' ALA . 20.3 m -41.57 125.78 2.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.47 -0.769 . . . . 0.0 109.321 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.487 ' O ' ' C ' ' A' ' 98' ' ' ASN . . . 65.33 40.5 96.53 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.601 ' HB2' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 32.9 52.4 0.31 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 122.053 -0.675 . . . . 0.0 110.209 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -57.27 167.39 0.93 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.214 -0.929 . . . . 0.0 109.222 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.537 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -88.78 122.05 31.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.143 -0.973 . . . . 0.0 109.664 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.711 HG12 ' OE2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -136.06 152.85 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.267 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.4 OUTLIER -56.92 131.28 49.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.14 -0.975 . . . . 0.0 109.491 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 89.8 m -54.18 148.05 11.93 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.26 -0.9 . . . . 0.0 109.627 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 109.573 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.511 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.6 p 165.3 126.86 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.26 -0.9 . . . . 0.0 110.291 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -96.21 -29.68 13.9 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.616 ' CG ' HG21 ' A' ' 89' ' ' VAL . 18.0 m-85 -91.81 103.69 16.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.479 -0.763 . . . . 0.0 109.11 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.571 HG22 ' H ' ' A' ' 7' ' ' GLY . 40.4 m -125.83 123.92 39.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.096 -1.003 . . . . 0.0 109.89 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.8 m -103.57 16.91 25.28 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.093 0.949 . . . . 0.0 109.61 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.571 ' H ' HG22 ' A' ' 5' ' ' THR . . . 152.82 -88.46 0.13 Allowed Glycine 0 C--N 1.284 -2.355 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.3 m -138.4 42.14 2.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -1.146 . . . . 0.0 109.684 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.487 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 1.0 OUTLIER -103.73 -26.33 12.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.183 -0.948 . . . . 0.0 109.38 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.1 t 60.18 57.78 2.85 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.38 -0.825 . . . . 0.0 109.675 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.527 ' CE1' ' HB3' ' A' ' 63' ' ' SER . 6.2 m-30 -87.88 114.02 24.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.39 -0.819 . . . . 0.0 108.874 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -85.99 138.35 32.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.062 -1.023 . . . . 0.0 109.98 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 p -48.82 -23.13 0.97 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.369 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.8 m -77.81 -41.33 37.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.113 -0.992 . . . . 0.0 109.543 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -71.68 -28.76 63.94 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 12' ' ' SER . 41.4 t -65.32 -24.93 35.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.42 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 3.4 t -66.97 -44.59 80.08 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.72 -38.46 85.16 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.759 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -81.31 -13.99 57.81 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.723 ' NE2' ' CG ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -82.13 -27.91 32.5 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.394 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -83.32 -13.21 55.59 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.13 -50.78 20.83 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.441 -0.787 . . . . 0.0 109.266 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.574 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -77.29 -29.02 57.01 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.579 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 3.2 t80 -71.37 -27.84 63.63 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.436 -1.038 . . . . 0.0 109.114 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 1.9 tt0 -74.16 -63.04 1.31 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.112 -0.992 . . . . 0.0 108.951 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 26' ' ' LEU . 1.6 tp -46.47 -34.74 5.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.349 -0.845 . . . . 0.0 108.972 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.576 ' NE2' ' CZ ' ' A' ' 57' ' ' TYR . 2.0 t60 -65.52 -59.23 4.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.477 -0.765 . . . . 0.0 110.093 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -83.02 10.22 8.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.246 -0.909 . . . . 0.0 109.759 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 45.7 t0 -95.84 -23.76 16.76 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.956 . . . . 0.0 109.61 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.97 -0.66 84.41 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.4 ' C ' ' OG1' ' A' ' 32' ' ' THR . 1.0 OUTLIER -97.56 -146.33 0.31 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.191 -1.182 . . . . 0.0 109.367 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.536 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -168.99 -177.17 2.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -0.938 . . . . 0.0 109.523 -179.903 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.556 HG21 ' HB2' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -92.54 -100.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 109.057 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.505 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -94.19 30.87 7.16 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 1.0 OUTLIER 78.21 1.39 2.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.525 -0.986 . . . . 0.0 109.334 -179.482 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.53 ' O ' ' CB ' ' A' ' 37' ' ' SER . 0.5 OUTLIER -93.18 -19.36 21.53 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.334 -0.853 . . . . 0.0 109.743 -179.651 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.536 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.8 OUTLIER 76.45 93.34 0.07 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 109.294 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.605 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -85.77 -43.53 0.62 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 111.238 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 32.9 Cg_endo -75.46 108.41 2.69 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 120.927 1.085 . . . . 0.0 110.045 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.616 ' CE1' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -123.79 124.68 43.23 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.3 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.539 ' HA ' ' CD1' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -49.63 125.06 10.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.387 -0.821 . . . . 0.0 110.72 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 2.1 t80 -88.83 159.45 17.71 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.433 ' O ' ' CZ ' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -169.6 35.61 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 4.2 m-20 -90.21 -171.48 3.13 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.681 0.753 . . . . 0.0 110.233 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.558 ' CG ' ' C ' ' A' ' 44' ' ' ASN . 0.2 OUTLIER -158.68 24.32 0.22 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.585 ' OE1' HG12 ' A' ' 101' ' ' VAL . 0.4 OUTLIER -36.37 -67.24 0.18 Allowed 'General case' 0 C--N 1.31 -1.144 0 O-C-N 121.784 -0.573 . . . . 0.0 110.176 -179.235 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.446 ' O ' ' OE2' ' A' ' 102' ' ' GLU . . . -167.01 41.86 0.25 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.614 ' CE1' HG22 ' A' ' 90' ' ' ILE . 65.7 m-85 -100.88 158.15 16.2 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.276 -1.132 . . . . 0.0 109.254 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -125.5 11.0 7.95 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.229 -0.92 . . . . 0.0 109.59 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.61 ' CE2' ' HB3' ' A' ' 48' ' ' PHE . 2.3 p90 -78.19 165.0 24.45 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.142 -0.973 . . . . 0.0 109.363 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 52' ' ' VAL . 33.3 t -144.39 34.76 1.19 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.214 -0.929 . . . . 0.0 109.594 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.608 HG12 ' HB3' ' A' ' 81' ' ' ASN . 59.8 t -44.41 -45.98 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.264 -0.898 . . . . 0.0 109.058 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.404 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 0.1 OUTLIER 172.5 157.0 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.765 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.6 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -59.28 -51.25 82.86 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.408 -0.807 . . . . 0.0 110.623 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 54' ' ' SER . 35.6 Cg_endo -75.6 83.15 1.96 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.046 1.83 . . . . 0.0 110.27 -178.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.608 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 48.7 m-85 -79.35 -172.02 3.0 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.322 0.582 . . . . 0.0 110.148 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.608 ' CG ' ' O ' ' A' ' 56' ' ' TYR . 34.3 m-85 -165.02 118.39 1.24 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.616 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -95.53 146.03 24.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 0.0 110.17 -179.36 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.652 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 8.8 t-105 -160.36 142.97 9.76 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.652 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.2 Cg_endo -67.79 138.67 45.52 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.067 1.844 . . . . 0.0 111.309 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.978 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -110.35 133.0 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.465 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.978 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.3 OUTLIER -125.89 169.48 12.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.312 -0.867 . . . . 0.0 109.29 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.527 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 2.2 p -122.94 28.45 7.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.309 -0.869 . . . . 0.0 109.056 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.77 -12.28 8.47 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.468 -0.77 . . . . 0.0 109.446 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.82 29.46 59.2 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 67' ' ' VAL . 5.8 t0 -102.56 -3.67 26.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -1.157 . . . . 0.0 109.758 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' A' ' 66' ' ' ASP . 3.4 t 55.55 166.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.947 . . . . 0.0 109.42 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.61 ' CD1' HD11 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -115.18 120.96 41.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.903 . . . . 0.0 109.565 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.484 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -140.01 78.57 1.67 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.874 . . . . 0.0 109.527 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 71' ' ' GLY . . . 161.34 37.42 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 70' ' ' GLY . . . 41.95 -145.52 0.74 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.8 t 64.42 74.19 0.42 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.177 -1.19 . . . . 0.0 109.533 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.5 -177.27 3.72 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.596 2.197 . . . . 0.0 110.321 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.552 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 173.84 76.19 0.05 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.597 ' HA ' ' N ' ' A' ' 92' ' ' HIS . . . 67.39 -143.12 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.205 -1.174 . . . . 0.0 109.813 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.527 ' O ' ' O ' ' A' ' 75' ' ' ALA . 49.8 m-20 14.29 113.54 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.532 ' O ' HG12 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -162.86 128.95 3.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.129 -0.982 . . . . 0.0 109.264 178.592 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.805 HG21 HD21 ' A' ' 86' ' ' LEU . 4.6 p -116.49 140.01 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.749 -1.219 . . . . 0.0 109.227 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -105.0 -175.36 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 122.371 1.081 . . . . 0.0 110.628 -179.235 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.723 ' CG ' ' NE2' ' A' ' 20' ' ' GLN . 26.1 p90 179.81 -169.15 0.12 Allowed 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.65 ' ND2' ' CG ' ' A' ' 82' ' ' GLU . 3.9 p-10 -123.09 -39.73 2.46 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.998 -1.064 . . . . 0.0 110.231 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.65 ' CG ' ' ND2' ' A' ' 81' ' ' ASN . 4.4 pt-20 159.51 -26.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.474 ' O ' ' CB ' ' A' ' 84' ' ' ASN . 0.5 OUTLIER -86.33 -5.24 59.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.338 -0.851 . . . . 0.0 109.089 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 83' ' ' ASN . 7.7 t-20 74.7 30.32 1.02 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.37 -0.831 . . . . 0.0 109.702 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.525 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -74.07 -25.74 60.0 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.218 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.805 HD21 HG21 ' A' ' 78' ' ' VAL . 0.2 OUTLIER 81.81 110.76 0.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.389 0.614 . . . . 0.0 110.195 179.306 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.556 ' N ' HD13 ' A' ' 86' ' ' LEU . . . -78.94 -39.49 34.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.389 -0.82 . . . . 0.0 109.048 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.524 ' O ' HG23 ' A' ' 78' ' ' VAL . . . 162.49 169.53 25.99 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.616 HG21 ' CG ' ' A' ' 4' ' ' TYR . 47.5 t -100.09 87.77 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.265 -1.138 . . . . 0.0 109.559 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.614 HG22 ' CE1' ' A' ' 48' ' ' PHE . 4.4 pt -90.15 146.28 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -0.864 . . . . 0.0 109.411 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.564 ' OG1' ' HB1' ' A' ' 75' ' ' ALA . 9.9 t -123.17 135.19 54.21 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.625 -1.297 . . . . 0.0 110.489 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.597 ' N ' ' HA ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -86.39 75.66 9.76 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.368 -0.833 . . . . 0.0 109.187 179.241 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.3 m -179.66 -31.87 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.335 -0.853 . . . . 0.0 109.233 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -68.43 -6.99 51.5 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.911 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -139.53 123.14 17.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.136 -1.214 . . . . 0.0 109.547 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.454 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.3 OUTLIER 47.69 -165.64 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.159 -0.963 . . . . 0.0 109.156 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 96' ' ' SER . . . -40.62 -66.29 0.88 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.584 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -153.58 89.5 1.34 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.27 -1.135 . . . . 0.0 109.08 179.445 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.911 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.9 OUTLIER -112.25 141.1 46.36 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.442 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.568 ' O ' HG13 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -75.08 138.05 41.85 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.994 -1.066 . . . . 0.0 109.558 -179.755 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.585 HG12 ' OE1' ' A' ' 46' ' ' GLU . 30.3 m -160.17 145.57 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.344 -0.848 . . . . 0.0 109.005 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.567 ' HG3' ' CD1' ' A' ' 48' ' ' PHE . 1.4 mp0 -45.46 124.26 4.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.545 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.47 130.78 40.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 109.613 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 67.6 p . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.334 -0.854 . . . . 0.0 109.514 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.495 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.8 p 164.83 124.52 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.28 -0.887 . . . . 0.0 110.06 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -104.03 -7.24 20.44 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.46 -0.775 . . . . 0.0 109.067 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.583 ' HD2' HG21 ' A' ' 16' ' ' VAL . 17.2 m-85 -104.71 110.09 22.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.936 . . . . 0.0 109.382 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 9' ' ' ASN . 82.8 p -142.31 118.4 10.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.285 -0.885 . . . . 0.0 109.804 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -124.44 11.6 8.66 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 122.317 1.056 . . . . 0.0 109.436 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 8' ' ' SER . . . -160.94 32.74 0.38 Allowed Glycine 0 C--N 1.282 -2.454 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 3.9 t 70.95 9.32 6.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.316 -1.108 . . . . 0.0 109.315 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.541 ' O ' HG22 ' A' ' 5' ' ' THR . 14.6 m-80 -78.1 178.06 7.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 109.556 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 51.8 t -127.74 70.22 1.33 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.341 -0.849 . . . . 0.0 109.084 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' A' ' 4' ' ' TYR . 3.5 m-85 -79.63 118.68 21.68 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.262 -0.899 . . . . 0.0 109.543 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.57 ' O ' HG23 ' A' ' 16' ' ' VAL . 48.8 m -80.21 133.76 36.05 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.491 -0.756 . . . . 0.0 109.958 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.95 -30.32 10.11 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 t -73.43 -38.99 65.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.362 -0.836 . . . . 0.0 109.076 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -67.95 -26.04 65.75 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.583 HG21 ' HD2' ' A' ' 4' ' ' TYR . 19.4 t -77.15 -29.08 16.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.481 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 0.2 OUTLIER -67.66 -37.84 82.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.422 -0.799 . . . . 0.0 109.382 179.688 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -47.05 86.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.133 -0.98 . . . . 0.0 108.433 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.835 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -73.25 -17.98 61.28 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.573 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -76.45 -32.13 58.25 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.438 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -79.12 -8.31 58.88 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.628 ' HB1' HG13 ' A' ' 67' ' ' VAL . . . -83.29 -55.92 4.06 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.352 -0.843 . . . . 0.0 108.843 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.627 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -68.22 -20.86 73.56 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.577 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 1.0 OUTLIER -81.84 -58.08 3.15 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.586 -0.949 . . . . 0.0 109.521 -179.635 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.509 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -49.15 -36.45 19.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.13 -0.981 . . . . 0.0 109.486 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.945 HD13 ' HB2' ' A' ' 31' ' ' GLU . 1.2 mm? -72.61 -40.24 66.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.351 -0.843 . . . . 0.0 109.278 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.664 ' CE1' ' CE1' ' A' ' 57' ' ' TYR . 2.6 t60 -61.38 -32.78 72.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.438 -0.789 . . . . 0.0 110.433 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.509 ' OE1' ' CZ ' ' A' ' 24' ' ' TYR . 4.2 pt-20 -86.69 -26.23 24.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.951 -1.093 . . . . 0.0 109.812 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -84.86 -6.54 59.35 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.1 -1.0 . . . . 0.0 109.547 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.79 -28.31 6.59 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.945 ' HB2' HD13 ' A' ' 26' ' ' LEU . 3.1 mm-40 -58.61 -166.94 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.172 -1.193 . . . . 0.0 109.454 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.551 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -155.83 -93.61 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.886 . . . . 0.0 109.524 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -134.67 -167.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.129 -0.982 . . . . 0.0 109.318 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -40.73 -37.41 1.3 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 t -176.37 -51.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -1.186 . . . . 0.0 109.814 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.548 ' O ' ' CB ' ' A' ' 37' ' ' SER . 35.3 m120 -51.39 -86.0 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.156 -0.965 . . . . 0.0 109.645 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.588 ' CA ' ' CG2' ' A' ' 33' ' ' VAL . 0.3 OUTLIER 160.33 -178.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.729 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER 175.46 -49.38 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.917 -1.114 . . . . 0.0 112.302 178.8 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.531 ' HD2' ' H ' ' A' ' 38' ' ' TYR . 31.4 Cg_endo -75.3 100.55 1.38 Allowed 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 121.215 1.276 . . . . 0.0 112.094 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.729 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -140.72 137.12 33.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.693 -0.629 . . . . 0.0 109.356 178.66 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -42.77 133.84 3.42 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.396 -0.815 . . . . 0.0 110.318 -179.059 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.586 ' OH ' ' CD1' ' A' ' 100' ' ' PHE . 30.2 t80 -94.09 159.43 15.16 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.385 -0.822 . . . . 0.0 109.031 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.566 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 7.9 m-80 -106.63 -39.98 5.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.073 -1.017 . . . . 0.0 110.11 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.605 ' ND2' ' O ' ' A' ' 44' ' ' ASN . 0.0 OUTLIER 62.92 127.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.11 -0.993 . . . . 0.0 108.764 -179.49 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.482 ' O ' ' C ' ' A' ' 46' ' ' GLU . 1.4 m-85 -161.68 -36.25 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.093 -1.004 . . . . 0.0 110.052 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.482 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -34.75 -72.83 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.671 -0.643 . . . . 0.0 110.412 -179.322 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 171.2 56.46 0.04 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.535 ' CE2' HG22 ' A' ' 90' ' ' ILE . 90.6 m-85 -86.66 177.97 7.19 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.204 -1.174 . . . . 0.0 108.407 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.424 ' OD1' ' C ' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -131.19 11.25 4.99 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.986 -1.071 . . . . 0.0 110.095 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 87' ' ' ALA . 0.7 OUTLIER -88.61 -174.95 4.76 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.036 -1.04 . . . . 0.0 109.201 179.542 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.0 m -173.86 40.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.212 -0.93 . . . . 0.0 109.521 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.0 t -52.24 -39.42 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.296 -0.878 . . . . 0.0 109.284 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.5 ' OG ' ' CB ' ' A' ' 81' ' ' ASN . 32.9 p -177.86 151.37 0.69 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 109.671 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.596 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -59.2 -52.74 72.39 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.333 -0.854 . . . . 0.0 110.08 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 54' ' ' SER . 35.9 Cg_endo -75.48 86.54 1.46 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.989 1.792 . . . . 0.0 109.511 -178.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.604 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 10.6 m-85 -78.84 -169.15 1.66 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.664 ' CE1' ' CE1' ' A' ' 27' ' ' HIS . 66.0 m-85 -162.72 106.73 1.11 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 40' ' ' HIS . 4.1 pt-20 -78.87 137.22 37.57 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.743 0.782 . . . . 0.0 110.726 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.666 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 26.6 t-105 -160.82 139.82 7.71 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.666 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.8 Cg_endo -70.35 158.95 54.61 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.273 1.982 . . . . 0.0 111.749 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 1.006 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -132.41 136.6 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.525 -0.734 . . . . 0.0 109.225 -179.547 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.006 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.5 OUTLIER -121.31 174.96 6.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.106 -0.996 . . . . 0.0 109.775 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.67 31.6 4.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.911 . . . . 0.0 109.189 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.94 -58.72 2.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.376 -0.828 . . . . 0.0 109.399 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.31 52.37 0.03 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -156.67 150.55 24.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -1.175 . . . . 0.0 109.548 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.628 HG13 ' HB1' ' A' ' 22' ' ' ALA . 45.3 t -83.66 133.25 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.351 -0.843 . . . . 0.0 109.351 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.879 ' HD2' HD21 ' A' ' 62' ' ' LEU . 0.7 OUTLIER -56.06 135.67 52.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -0.954 . . . . 0.0 109.508 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.481 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -151.58 52.35 0.83 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.264 -0.897 . . . . 0.0 109.265 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.38 158.21 33.28 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.74 79.18 0.63 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.3 m 53.77 87.4 0.14 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.238 -1.154 . . . . 0.0 109.767 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.6 170.47 19.16 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.653 2.235 . . . . 0.0 110.261 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.586 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 109.14 -164.25 12.49 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 69.38 -162.08 0.18 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.29 -1.123 . . . . 0.0 110.488 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 91' ' ' THR . 38.9 m-20 -46.98 165.86 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.678 0.751 . . . . 0.0 110.787 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.514 ' O ' HG12 ' A' ' 90' ' ' ILE . 36.1 ttm180 -172.82 104.68 0.14 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.001 ' CG2' HD11 ' A' ' 86' ' ' LEU . 4.2 p -79.68 152.22 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.895 -1.128 . . . . 0.0 110.154 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.595 HG12 ' N ' ' A' ' 80' ' ' PHE . 44.7 t -120.32 165.13 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.879 0.847 . . . . 0.0 109.83 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.595 ' N ' HG12 ' A' ' 79' ' ' VAL . 8.4 p90 -165.63 -169.49 1.57 Allowed 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.746 -0.781 . . . . 0.0 109.426 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.571 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 1.9 p30 -122.28 -46.47 2.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.009 -1.057 . . . . 0.0 110.48 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.577 ' O ' ' CZ ' ' A' ' 24' ' ' TYR . 0.7 OUTLIER 163.31 -23.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -179.674 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.484 ' HB3' ' OE1' ' A' ' 85' ' ' GLN . 1.9 m-20 -86.95 14.29 7.63 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.469 ' O ' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 71.93 6.3 5.57 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.442 -0.787 . . . . 0.0 109.048 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.5 ' HB2' ' ND2' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -58.38 -162.34 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 178.766 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.001 HD11 ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -143.55 107.72 4.75 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.663 -1.273 . . . . 0.0 110.567 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.564 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . . . -69.27 -36.73 77.41 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 149.46 162.77 10.6 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.565 ' HB ' ' CD1' ' A' ' 4' ' ' TYR . 41.8 t -101.07 87.95 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -1.149 . . . . 0.0 109.547 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.557 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 0.5 OUTLIER -82.6 154.0 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.561 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.573 HG22 HG23 ' A' ' 101' ' ' VAL . 9.5 t -110.73 162.47 14.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.979 -1.075 . . . . 0.0 110.808 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.651 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 2.0 t60 -119.66 53.88 1.03 Allowed 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 40.7 m -172.55 125.82 0.5 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.497 -0.752 . . . . 0.0 109.229 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 119.72 -14.93 10.56 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 98' ' ' ASN . . . -117.74 86.41 2.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.18 -1.188 . . . . 0.0 109.546 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER 42.11 74.13 0.12 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.545 -0.722 . . . . 0.0 109.119 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.55 -76.9 0.73 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.761 -1.735 . . . . 0.0 108.761 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.651 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -150.17 -84.08 0.09 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.258 -1.142 . . . . 0.0 109.43 179.717 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.535 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 1.6 t30 63.57 152.11 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.348 -0.845 . . . . 0.0 109.124 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.592 ' O ' HG13 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -96.53 143.78 27.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 109.776 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 100' ' ' PHE . 3.7 m -158.03 131.41 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.475 -0.766 . . . . 0.0 109.159 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -45.45 126.15 6.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.34 -0.85 . . . . 0.0 109.559 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 1.3 m -49.05 165.85 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.259 -0.901 . . . . 0.0 109.645 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.489 1.482 0 O-C-N 121.27 -0.893 . . . . 0.0 109.508 -179.864 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 32.1 p -173.74 115.19 0.23 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.191 -0.943 . . . . 0.0 110.07 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -78.11 -45.38 23.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 0.0 109.212 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.583 ' CE1' ' HB ' ' A' ' 89' ' ' VAL . 28.1 m-85 -74.07 95.82 2.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.0 109.029 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -108.56 67.64 0.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 110.008 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.436 ' HB2' ' OD1' ' A' ' 76' ' ' ASP . 4.1 m -84.16 156.64 21.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 109.071 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 6' ' ' CYS . . . 44.6 -107.8 0.16 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.5 p -142.5 41.25 1.6 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.172 -1.193 . . . . 0.0 109.459 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -118.89 140.59 49.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 0.0 109.566 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -89.86 66.88 7.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -78.76 114.82 18.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 0.0 108.855 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . 1.068 ' O ' HG23 ' A' ' 16' ' ' VAL . 1.0 OUTLIER -88.73 148.78 23.8 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.321 -0.862 . . . . 0.0 110.505 -179.181 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -13.39 18.38 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.85 -36.49 12.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.26 -0.9 . . . . 0.0 109.75 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.15 -30.55 62.32 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.987 -1.071 . . . . 0.0 108.117 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 1.068 HG23 ' O ' ' A' ' 12' ' ' SER . 3.8 t -62.38 -31.1 50.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.11 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 t -58.57 -45.24 89.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.282 -0.886 . . . . 0.0 109.866 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.9 m -65.73 -52.02 54.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.578 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.932 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -74.36 -6.6 49.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.287 -0.883 . . . . 0.0 109.579 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.793 ' OE1' HG22 ' A' ' 78' ' ' VAL . 4.3 tp60 -99.69 -15.85 18.38 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.39 -17.72 29.9 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.12 -57.82 3.65 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.432 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -48.42 -28.33 6.41 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.594 ' CE1' ' HA ' ' A' ' 82' ' ' GLU . 24.7 t80 -77.35 -48.4 17.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.602 -0.94 . . . . 0.0 109.596 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.403 ' O ' ' HB2' ' A' ' 29' ' ' ASP . 0.1 OUTLIER -54.09 -40.97 67.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.126 -0.984 . . . . 0.0 108.858 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.88 HD11 ' O ' ' A' ' 31' ' ' GLU . 1.9 tm? -65.84 -43.61 87.99 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.613 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 19.5 t60 -67.55 -17.9 64.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.368 -0.833 . . . . 0.0 109.765 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.95 11.19 31.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 109.579 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 1.8 t0 -122.63 -0.22 9.21 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.346 -0.846 . . . . 0.0 109.451 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.85 21.03 58.07 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.88 ' O ' HD11 ' A' ' 26' ' ' LEU . 3.4 mt-10 -102.35 -166.99 1.34 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.366 -1.079 . . . . 0.0 109.36 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.892 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -147.26 173.66 12.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.242 -0.911 . . . . 0.0 109.513 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 34' ' ' GLY . 33.8 m -89.02 -138.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.41 -0.806 . . . . 0.0 108.968 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.472 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -98.5 33.49 5.99 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.6 p -161.43 -154.3 0.34 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -1.152 . . . . 0.0 109.955 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.748 ' O ' HG21 ' A' ' 32' ' ' THR . 2.2 m120 -53.32 -60.98 2.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 110.101 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.892 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.6 OUTLIER 168.76 108.34 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.404 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.724 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.4 OUTLIER -82.51 -34.31 0.65 Allowed Pre-proline 0 C--O 1.2 -1.507 0 O-C-N 121.01 -1.056 . . . . 0.0 112.221 -178.804 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.763 ' HG2' HD12 ' A' ' 26' ' ' LEU . 35.9 Cg_endo -79.13 109.05 2.47 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 N-CA-C 109.874 -0.856 . . . . 0.0 109.874 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.724 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -133.58 177.53 7.63 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.601 ' HB2' ' CE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -97.51 129.73 44.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.058 -1.027 . . . . 0.0 110.456 -178.626 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.566 ' HB2' ' HG3' ' A' ' 58' ' ' GLU . 10.6 t80 -94.38 168.84 10.63 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.48 ' OD1' ' CE1' ' A' ' 45' ' ' TYR . 0.9 OUTLIER -145.33 18.41 1.54 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.019 -1.051 . . . . 0.0 110.129 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 43' ' ' ASN . 10.9 m120 62.03 108.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.069 -1.019 . . . . 0.0 109.738 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.48 ' CE1' ' OD1' ' A' ' 43' ' ' ASN . 3.3 m-30 -114.91 -4.9 12.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.331 -0.855 . . . . 0.0 109.44 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.552 ' CD ' ' CE1' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -110.88 -33.86 6.4 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.115 -0.991 . . . . 0.0 108.787 -179.431 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.01 28.65 2.81 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.552 ' CE1' ' CD ' ' A' ' 46' ' ' GLU . 48.3 m-85 -61.66 -168.18 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 4.8 m-20 -139.1 -44.15 0.46 Allowed 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 118.557 -1.257 . . . . 0.0 109.771 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 49' ' ' ASP . 20.0 m-85 64.17 177.58 0.18 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.323 -0.86 . . . . 0.0 109.478 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.9 -18.58 17.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.232 -0.917 . . . . 0.0 109.07 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.582 HG23 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -98.0 -176.49 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.338 -0.851 . . . . 0.0 108.896 179.609 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.477 ' HA ' ' OH ' ' A' ' 56' ' ' TYR . 12.6 t -151.37 86.42 1.35 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.108 -0.995 . . . . 0.0 109.52 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.668 ' CB ' ' HD2' ' A' ' 55' ' ' PRO . 0.3 OUTLIER -172.58 -176.56 0.34 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.072 -1.018 . . . . 0.0 109.53 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.668 ' HD2' ' CB ' ' A' ' 54' ' ' SER . 29.4 Cg_endo -71.79 96.36 0.76 Allowed 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 121.489 1.459 . . . . 0.0 108.55 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.559 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 24.0 m-85 -75.95 -170.94 1.5 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.777 0.798 . . . . 0.0 110.694 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.613 ' CE2' ' NE2' ' A' ' 27' ' ' HIS . 49.4 m-85 -150.72 147.18 27.03 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.664 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 1.2 mp0 -96.96 146.29 25.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.872 -1.142 . . . . 0.0 110.365 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.657 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 46.3 t-105 -159.45 135.7 6.36 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.657 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 31.9 Cg_endo -72.75 148.68 47.04 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 121.922 1.748 . . . . 0.0 111.115 -178.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.986 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -122.53 142.19 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.986 HD23 ' C ' ' A' ' 61' ' ' ILE . 1.4 mt -122.51 -170.67 2.12 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.249 -0.907 . . . . 0.0 109.383 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.57 54.8 0.93 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 108.928 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -157.75 -43.8 0.06 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.391 -0.818 . . . . 0.0 109.464 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.98 39.45 3.56 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.475 ' C ' HG23 ' A' ' 67' ' ' VAL . 0.5 OUTLIER -114.3 18.22 17.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -1.146 . . . . 0.0 109.464 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.475 HG23 ' C ' ' A' ' 66' ' ' ASP . 2.0 t 62.3 167.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.902 . . . . 0.0 109.693 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.631 ' HD1' HD11 ' A' ' 62' ' ' LEU . 6.1 t80 -106.86 139.13 41.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.343 -0.848 . . . . 0.0 109.591 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.8 m -122.46 -20.21 6.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.243 -0.911 . . . . 0.0 109.636 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 163.73 148.27 5.35 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 144.3 -142.95 11.51 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.445 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 20.3 m -51.89 118.15 11.26 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.217 -1.166 . . . . 0.0 109.323 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.518 ' O ' ' NH1' ' A' ' 77' ' ' ARG . 35.7 Cg_endo -77.72 -75.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.452 2.101 . . . . 0.0 110.571 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.553 ' CA ' ' HB2' ' A' ' 92' ' ' HIS . . . -59.13 -117.83 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.545 ' N ' ' HB2' ' A' ' 92' ' ' HIS . . . 49.54 -167.18 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.278 -1.131 . . . . 0.0 109.704 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.436 ' OD1' ' HB2' ' A' ' 6' ' ' CYS . 1.1 m-20 -42.04 147.82 0.21 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.276 -0.89 . . . . 0.0 109.864 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.518 ' NH1' ' O ' ' A' ' 73' ' ' PRO . 2.2 ttm180 -164.82 70.84 0.17 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.421 -0.799 . . . . 0.0 109.372 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.793 HG22 ' OE1' ' A' ' 20' ' ' GLN . 10.9 p -44.72 149.75 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 109.284 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 1.083 ' CG1' ' HB3' ' A' ' 87' ' ' ALA . 0.4 OUTLIER -121.0 171.92 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.02 -1.05 . . . . 0.0 110.338 -179.484 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.601 ' CD1' ' NE2' ' A' ' 20' ' ' GLN . 19.2 p90 -172.04 -167.52 0.49 Allowed 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.102 -178.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.522 ' N ' ' OD1' ' A' ' 81' ' ' ASN . 0.2 OUTLIER -132.54 -78.47 0.5 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.829 -1.17 . . . . 0.0 109.837 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.594 ' HA ' ' CE1' ' A' ' 24' ' ' TYR . 10.3 pt-20 -160.76 24.58 0.14 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.37 -0.831 . . . . 0.0 109.176 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.47 ' HB2' ' CG ' ' A' ' 85' ' ' GLN . 37.8 m-20 -146.03 17.55 1.4 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.456 -0.777 . . . . 0.0 109.241 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.593 ' ND2' ' O ' ' A' ' 84' ' ' ASN . 0.7 OUTLIER 47.45 25.68 0.65 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.42 -0.8 . . . . 0.0 109.216 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.568 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -70.29 -27.6 64.53 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.609 HD22 ' HG2' ' A' ' 20' ' ' GLN . 0.1 OUTLIER 85.87 115.87 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.58 0.705 . . . . 0.0 110.739 179.044 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 1.083 ' HB3' ' CG1' ' A' ' 79' ' ' VAL . . . -96.3 -30.72 13.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.507 -0.746 . . . . 0.0 108.999 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.416 ' N ' ' CD1' ' A' ' 86' ' ' LEU . . . 158.08 -153.77 24.92 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.583 ' HB ' ' CE1' ' A' ' 4' ' ' TYR . 42.8 t -147.09 127.72 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.025 -1.279 . . . . 0.0 109.795 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.557 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -114.34 144.91 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.553 -0.717 . . . . 0.0 109.142 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.521 ' O ' HG23 ' A' ' 91' ' ' THR . 6.2 t -133.43 123.93 26.19 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.091 -1.006 . . . . 0.0 109.933 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.606 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -79.37 84.05 5.33 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.541 -0.724 . . . . 0.0 109.477 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 176.1 127.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.423 -0.798 . . . . 0.0 109.251 179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.98 -18.3 28.93 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.608 ' HB3' ' CB ' ' A' ' 99' ' ' ASN . . . -115.46 90.78 3.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.364 -1.08 . . . . 0.0 109.413 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.4 OUTLIER 43.95 78.95 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 109.346 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.91 -88.91 1.59 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.606 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -125.56 -90.55 0.55 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.213 -1.169 . . . . 0.0 109.376 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.608 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . 0.7 OUTLIER 61.08 136.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -0.961 . . . . 0.0 109.059 -179.584 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.557 ' CD1' ' HB ' ' A' ' 90' ' ' ILE . 21.8 m-85 -79.66 155.28 28.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.834 -1.166 . . . . 0.0 110.195 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -160.7 133.85 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.141 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -54.5 126.15 22.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.336 -0.853 . . . . 0.0 109.611 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 1.3 m -68.48 109.29 3.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.408 -0.808 . . . . 0.0 109.819 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.944 . . . . 0.0 109.477 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.507 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.8 p 167.14 130.33 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.218 -0.926 . . . . 0.0 110.065 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -103.87 -9.83 18.66 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.443 -0.786 . . . . 0.0 109.344 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.622 ' CD2' HG23 ' A' ' 89' ' ' VAL . 19.4 m-85 -109.54 132.16 54.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.308 -0.87 . . . . 0.0 109.247 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.448 HG23 ' H ' ' A' ' 10' ' ' CYS . 5.2 m -155.82 113.37 3.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.134 -0.979 . . . . 0.0 109.611 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.4 m -94.27 17.35 12.93 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 122.112 0.958 . . . . 0.0 109.691 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.91 -71.44 0.2 Allowed Glycine 0 C--N 1.283 -2.378 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.7 m -162.62 49.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.314 -1.11 . . . . 0.0 109.239 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.557 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . 6.9 m120 -103.12 -28.88 11.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.308 -0.87 . . . . 0.0 109.771 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.448 ' H ' HG23 ' A' ' 5' ' ' THR . 44.4 t 59.42 63.07 1.63 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.132 -0.98 . . . . 0.0 109.102 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.574 ' CE1' ' HB3' ' A' ' 63' ' ' SER . 40.8 m-85 -79.13 122.41 26.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.445 -0.784 . . . . 0.0 109.144 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.748 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -79.59 133.23 36.43 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.422 -0.799 . . . . 0.0 109.61 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.5 t -52.48 -19.93 2.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.202 -0.936 . . . . 0.0 109.063 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.54 -36.8 18.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 110.015 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -74.59 -27.13 60.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.009 -1.057 . . . . 0.0 108.194 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 12' ' ' SER . 19.3 t -69.5 -33.18 55.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -34.91 78.62 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -38.01 82.48 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.754 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -84.91 -7.67 59.07 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.571 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -90.73 -28.12 18.5 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.276 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -79.5 -11.83 59.89 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.729 ' HB1' HG13 ' A' ' 67' ' ' VAL . . . -80.22 -39.1 29.77 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.607 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -85.52 -15.46 66.06 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -88.7 -58.51 2.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.392 -1.064 . . . . 0.0 109.13 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.49 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -53.56 -35.2 60.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 109.298 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.418 ' HA ' HD22 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -68.17 -46.96 69.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.328 -0.858 . . . . 0.0 109.222 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -49.85 -42.27 47.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.413 -0.804 . . . . 0.0 110.229 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.39 -20.67 27.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.128 -0.983 . . . . 0.0 110.037 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.463 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 28.2 t0 -74.99 -20.23 59.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.128 -0.982 . . . . 0.0 109.54 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.92 19.7 78.54 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 29' ' ' ASP . 0.8 OUTLIER -103.91 -169.3 1.61 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.346 -1.09 . . . . 0.0 109.472 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.864 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -135.67 -170.69 2.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.322 -0.861 . . . . 0.0 109.288 179.71 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.596 ' H ' HG22 ' A' ' 32' ' ' THR . 64.2 t -89.86 -98.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.304 -0.873 . . . . 0.0 109.321 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -124.52 -8.64 5.77 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER 163.72 -46.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.281 -1.129 . . . . 0.0 109.315 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 37' ' ' SER . 1.6 m-80 -82.19 5.37 20.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.608 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.864 ' HA ' HG22 ' A' ' 32' ' ' THR . 81.6 p 45.29 -162.15 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.931 . . . . 0.0 108.876 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.715 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER 167.01 -44.31 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.142 -0.974 . . . . 0.0 111.911 179.243 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 31.1 Cg_endo -74.42 99.75 1.24 Allowed 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.466 1.444 . . . . 0.0 112.274 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.715 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -144.76 -173.89 4.19 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.284 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.575 ' HB2' ' CE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -96.45 126.04 41.37 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.041 -1.037 . . . . 0.0 109.966 -179.167 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.608 ' CE2' ' HA ' ' A' ' 44' ' ' ASN . 8.2 t80 -105.22 139.45 39.86 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.505 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 9.5 m120 -70.41 -46.71 63.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.171 -0.956 . . . . 0.0 110.098 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.608 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 0.5 OUTLIER 76.47 55.85 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.269 -0.894 . . . . 0.0 109.008 -179.403 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -106.09 46.84 0.9 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.269 -0.895 . . . . 0.0 109.483 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.529 ' OE2' ' CG1' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -101.12 -28.76 12.51 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.659 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.33 19.98 3.07 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.609 ' CD2' ' CZ ' ' A' ' 50' ' ' PHE . 59.7 m-85 -63.41 -169.15 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -154.43 36.54 0.42 Allowed 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 118.565 -1.254 . . . . 0.0 109.918 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.609 ' CZ ' ' CD2' ' A' ' 48' ' ' PHE . 6.7 m-85 -62.16 -175.14 0.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.038 -1.039 . . . . 0.0 109.41 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 p -144.72 35.38 1.15 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.384 -0.822 . . . . 0.0 109.038 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.543 HG13 ' HB2' ' A' ' 85' ' ' GLN . 68.8 t -92.9 -71.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.334 -0.853 . . . . 0.0 109.826 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 t -161.68 178.15 9.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.796 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.576 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -79.24 -51.45 1.26 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.349 -0.844 . . . . 0.0 110.654 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 54' ' ' SER . 34.6 Cg_endo -76.06 85.62 1.63 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 121.992 1.795 . . . . 0.0 110.352 -177.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.585 ' O ' ' CD1' ' A' ' 57' ' ' TYR . 48.2 m-85 -79.12 -178.37 6.11 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.394 0.616 . . . . 0.0 109.862 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.585 ' CD1' ' O ' ' A' ' 56' ' ' TYR . 48.3 m-85 -150.88 145.01 25.37 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -104.21 138.52 40.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.234 -0.916 . . . . 0.0 110.6 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.69 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 22.6 t-105 -160.8 138.93 7.23 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.69 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.9 Cg_endo -67.53 142.22 58.35 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.119 1.88 . . . . 0.0 111.274 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.911 HD12 ' N ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -118.63 131.67 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.729 -0.607 . . . . 0.0 109.417 -179.263 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.911 ' N ' HD12 ' A' ' 61' ' ' ILE . 2.9 mt -120.89 165.51 15.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.225 -0.922 . . . . 0.0 109.756 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.574 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 92.9 p -111.11 -1.88 16.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.086 -1.009 . . . . 0.0 108.816 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.58 -37.93 62.8 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.606 -0.683 . . . . 0.0 109.507 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.25 46.15 1.1 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.15 146.44 27.67 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.312 -1.11 . . . . 0.0 109.36 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.729 HG13 ' HB1' ' A' ' 22' ' ' ALA . 73.8 t -66.35 136.44 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.156 -0.965 . . . . 0.0 109.343 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.597 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 20.1 t80 -47.91 147.4 2.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.894 . . . . 0.0 109.638 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.574 ' HA ' HG12 ' A' ' 33' ' ' VAL . 5.4 t -174.82 54.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.529 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.2 119.45 4.62 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.1 -133.19 2.8 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.1 114.55 63.5 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.26 -1.141 . . . . 0.0 109.451 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.02 121.05 5.99 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.336 2.024 . . . . 0.0 110.362 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.516 ' O ' ' NH1' ' A' ' 77' ' ' ARG . . . 110.61 -138.48 14.95 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.558 ' N ' ' HB2' ' A' ' 92' ' ' HIS . . . 64.04 -86.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -1.116 . . . . 0.0 110.222 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.479 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 7.4 m-20 -132.52 110.48 10.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.939 -1.1 . . . . 0.0 110.157 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 60' ' ' PRO . 3.7 mpt_? -116.58 146.12 42.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.448 -0.782 . . . . 0.0 109.024 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.6 p -113.95 134.8 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.053 -1.029 . . . . 0.0 109.33 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.616 HG12 ' N ' ' A' ' 80' ' ' PHE . 58.4 t -97.4 166.04 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-O 121.95 0.881 . . . . 0.0 110.472 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.616 ' N ' HG12 ' A' ' 79' ' ' VAL . 7.1 p90 -164.83 -171.44 2.28 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -126.23 -83.47 0.62 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.842 -1.161 . . . . 0.0 109.977 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -151.43 8.59 0.53 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.418 -0.801 . . . . 0.0 110.37 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.401 ' HB3' ' HG2' ' A' ' 85' ' ' GLN . 4.8 t-20 -138.34 15.07 2.79 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.907 -1.121 . . . . 0.0 108.562 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 84' ' ' ASN . 38.4 t30 59.04 30.97 20.92 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.42 -0.8 . . . . 0.0 109.063 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.561 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -63.84 -26.4 68.6 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.067 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.561 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER 85.81 109.0 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.488 0.661 . . . . 0.0 110.652 179.05 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.582 ' HB1' ' CD2' ' A' ' 50' ' ' PHE . . . -83.04 -37.79 23.43 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 153.01 168.25 16.69 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.622 HG23 ' CD2' ' A' ' 4' ' ' TYR . 44.9 t -104.46 102.36 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.158 -1.201 . . . . 0.0 109.343 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.556 HG22 ' CE2' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -93.31 168.44 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.428 -0.795 . . . . 0.0 109.889 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.725 HG22 HG23 ' A' ' 101' ' ' VAL . 5.4 t -106.48 -173.41 2.29 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.456 -0.778 . . . . 0.0 110.387 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.558 ' HB2' ' N ' ' A' ' 75' ' ' ALA . 0.5 OUTLIER -148.82 62.95 1.06 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 1.2 m 172.79 -28.61 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.758 -0.589 . . . . 0.0 109.883 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.9 -9.2 52.37 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 120.033 -1.079 . . . . 0.0 110.654 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -120.1 176.7 5.31 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.932 -1.334 . . . . 0.0 109.805 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.2 OUTLIER -41.53 124.37 2.43 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.676 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.18 -88.69 0.12 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 107.962 -2.055 . . . . 0.0 107.962 -178.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.554 ' HB3' ' O ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -165.56 38.24 0.06 Allowed 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.088 -1.243 . . . . 0.0 109.444 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 98' ' ' ASN . 12.3 t-20 -50.72 179.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.077 -1.015 . . . . 0.0 108.762 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -106.1 146.84 29.66 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.857 -1.152 . . . . 0.0 109.197 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.725 HG23 HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -160.27 140.88 3.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.458 ' OE2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -39.42 138.67 0.64 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.549 -0.719 . . . . 0.0 110.132 -179.119 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.454 ' SG ' ' HB ' ' A' ' 91' ' ' THR . 4.2 m -94.48 97.82 10.42 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.355 -0.841 . . . . 0.0 109.568 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 109.28 179.902 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.229 0.538 . . . . 0.0 109.654 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 32.0 p 178.2 133.02 0.07 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.356 -0.84 . . . . 0.0 109.843 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -94.96 -35.57 11.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 0.0 108.987 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.837 ' CD2' HG21 ' A' ' 89' ' ' VAL . 66.8 m-85 -92.34 81.87 4.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.36 -0.837 . . . . 0.0 109.017 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.754 HG23 ' O ' ' A' ' 5' ' ' THR . 9.8 t -93.98 89.56 6.11 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.321 -0.862 . . . . 0.0 110.149 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.436 ' CB ' ' OD1' ' A' ' 76' ' ' ASP . 0.1 OUTLIER -89.57 -165.05 1.25 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.904 . . . . 0.0 109.0 179.369 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.441 ' O ' ' OG ' ' A' ' 8' ' ' SER . . . -59.13 95.56 0.07 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.454 ' O ' ' OG ' ' A' ' 8' ' ' SER . 4.5 p 65.7 49.2 1.78 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -1.159 . . . . 0.0 109.648 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.432 ' ND2' ' OD2' ' A' ' 76' ' ' ASP . 0.2 OUTLIER -123.8 -71.85 0.7 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.358 -0.839 . . . . 0.0 109.283 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.46 ' C ' ' CB ' ' A' ' 2' ' ' CYS . 50.6 t 53.01 51.69 15.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 109.654 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.57 ' CD1' ' HB3' ' A' ' 63' ' ' SER . 4.3 m-85 -93.43 144.59 25.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.411 -0.805 . . . . 0.0 108.951 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.856 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -83.64 134.4 34.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 110.095 -179.726 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.2 p -50.85 -25.4 4.47 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.43 -42.63 61.78 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.316 -0.865 . . . . 0.0 108.944 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.31 -19.42 61.04 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 12' ' ' SER . 12.2 t -78.81 -29.02 14.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.454 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 0.6 OUTLIER -65.44 -34.39 78.18 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.228 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -53.7 27.54 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.731 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -62.08 -18.28 60.21 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.693 ' NE2' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -76.13 -37.48 57.97 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.289 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -74.64 -3.27 30.2 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.07 -63.21 1.39 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.378 -0.826 . . . . 0.0 108.776 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.631 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -62.38 -16.88 55.49 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.413 ' CD1' ' C ' ' A' ' 24' ' ' TYR . 1.1 t80 -83.34 -62.65 1.53 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.562 -0.963 . . . . 0.0 109.014 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 2.8 tt0 -48.38 -34.38 10.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.169 -0.957 . . . . 0.0 108.88 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.526 HD11 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -69.46 -44.57 70.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.506 -0.747 . . . . 0.0 109.51 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -59.27 -38.11 79.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.47 -0.769 . . . . 0.0 110.297 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -89.6 -14.79 34.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.105 -0.997 . . . . 0.0 110.352 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -83.48 -10.71 58.18 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.102 -0.999 . . . . 0.0 109.214 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 63.2 11.44 39.4 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -88.02 -144.66 0.13 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.403 -1.057 . . . . 0.0 109.057 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.526 ' N ' HD11 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -167.67 175.22 7.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.002 -1.061 . . . . 0.0 109.688 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.475 HG23 ' H ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -102.17 -94.68 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.235 -0.915 . . . . 0.0 109.87 -179.72 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.475 ' H ' HG23 ' A' ' 33' ' ' VAL . . . -88.77 32.83 4.4 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 1.2 m 67.61 8.59 6.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.195 -1.179 . . . . 0.0 109.332 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.4 ' O ' ' CB ' ' A' ' 37' ' ' SER . 2.4 m120 -102.03 -14.42 17.15 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.198 -0.939 . . . . 0.0 109.503 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.501 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.9 OUTLIER 68.28 105.15 0.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.866 . . . . 0.0 109.255 -179.763 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.64 ' H ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -116.66 -33.16 0.08 OUTLIER Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 114.274 1.212 . . . . 0.0 114.274 -178.443 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.64 ' CD ' ' H ' ' A' ' 38' ' ' TYR . 36.4 Cg_endo -80.62 101.88 1.35 Allowed 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.291 1.327 . . . . 0.0 112.734 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.483 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -135.11 -167.3 1.97 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.104 -0.997 . . . . 0.0 109.259 177.798 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 8.8 ptmm? -76.33 179.03 6.06 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.496 -0.753 . . . . 0.0 109.654 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.794 ' CD2' HG21 ' A' ' 79' ' ' VAL . 7.0 t80 -139.21 98.02 3.42 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.322 -0.861 . . . . 0.0 108.894 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.528 ' O ' ' CE1' ' A' ' 45' ' ' TYR . 8.1 m120 -61.29 -20.2 62.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.423 -0.798 . . . . 0.0 109.772 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.613 ' O ' ' CB ' ' A' ' 45' ' ' TYR . 10.2 p-10 40.24 -144.0 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.534 -0.729 . . . . 0.0 109.901 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.613 ' CB ' ' O ' ' A' ' 44' ' ' ASN . 18.4 m-30 107.11 -20.76 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.603 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 2.2 tm-20 -40.4 -33.46 0.26 Allowed 'General case' 0 C--N 1.309 -1.189 0 O-C-N 121.06 -1.025 . . . . 0.0 110.343 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.73 -15.74 0.72 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.603 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -104.02 159.91 15.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.104 -1.233 . . . . 0.0 108.815 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.491 ' C ' ' CG ' ' A' ' 50' ' ' PHE . 1.4 t0 -143.88 -36.3 0.35 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.199 -0.938 . . . . 0.0 109.837 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.491 ' CG ' ' C ' ' A' ' 49' ' ' ASP . 5.5 m-85 74.82 177.63 0.22 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.137 -0.977 . . . . 0.0 109.457 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.98 41.2 3.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.177 -0.952 . . . . 0.0 109.535 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.538 HG12 ' N ' ' A' ' 53' ' ' SER . 3.3 t -100.97 -72.19 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.334 -0.854 . . . . 0.0 109.337 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.538 ' N ' HG12 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -159.09 167.91 27.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.093 -1.004 . . . . 0.0 110.174 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.571 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -75.99 -52.32 2.62 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.462 -0.774 . . . . 0.0 110.364 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 54' ' ' SER . 35.5 Cg_endo -76.42 83.6 2.01 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.055 1.837 . . . . 0.0 109.72 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.633 ' CE1' ' CB ' ' A' ' 87' ' ' ALA . 31.1 m-85 -79.51 176.2 9.91 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.549 0.69 . . . . 0.0 110.05 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.574 ' CD1' ' O ' ' A' ' 81' ' ' ASN . 89.9 m-85 -142.56 129.03 20.14 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 0.3 OUTLIER -89.11 136.57 32.94 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.906 0.86 . . . . 0.0 111.063 -178.242 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.688 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 39.3 t-105 -160.39 135.79 5.83 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.688 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.6 Cg_endo -70.21 147.1 59.26 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.055 1.837 . . . . 0.0 111.272 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 1.065 HD12 ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -110.0 130.05 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.565 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.065 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.1 mt -138.61 119.3 14.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.347 -0.845 . . . . 0.0 108.953 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.57 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.3 t -126.34 73.67 1.39 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.685 -0.634 . . . . 0.0 109.429 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 173.43 -31.57 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.152 -0.967 . . . . 0.0 109.371 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.18 -74.81 0.83 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.05 -150.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -1.145 . . . . 0.0 109.529 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.429 ' O ' ' N ' ' A' ' 69' ' ' SER . 13.6 t -96.51 145.1 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.336 -0.853 . . . . 0.0 109.492 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.547 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 82.3 t80 -50.28 97.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.0 109.467 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 67' ' ' VAL . 1.2 p -132.66 26.88 4.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 109.437 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.19 79.69 0.42 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -156.25 -123.12 0.78 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.8 t -127.22 102.07 24.47 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.256 -1.143 . . . . 0.0 109.246 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.516 ' HB2' ' OH ' ' A' ' 38' ' ' TYR . 34.2 Cg_endo -76.55 -159.07 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.323 2.016 . . . . 0.0 110.551 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.483 ' O ' ' N ' ' A' ' 76' ' ' ASP . . . 66.09 -145.87 48.36 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.466 ' N ' ' HB3' ' A' ' 92' ' ' HIS . . . 48.11 -95.18 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.08 -1.247 . . . . 0.0 109.768 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 91' ' ' THR . 59.7 m-20 -111.05 139.91 46.03 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.861 -1.149 . . . . 0.0 110.208 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.732 ' HA ' HG22 ' A' ' 61' ' ' ILE . 57.8 mtp180 -156.91 159.32 38.02 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.583 HG13 HE21 ' A' ' 20' ' ' GLN . 13.1 p -134.74 145.1 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.804 -1.185 . . . . 0.0 110.03 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.89 HG23 ' CD1' ' A' ' 90' ' ' ILE . 3.0 t -106.24 165.05 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 122.106 0.955 . . . . 0.0 109.861 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.693 ' CD1' ' NE2' ' A' ' 20' ' ' GLN . 4.0 p90 -156.09 -169.02 2.93 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.753 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.574 ' O ' ' CD1' ' A' ' 57' ' ' TYR . 10.6 t30 -107.41 -80.05 0.57 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.007 -1.058 . . . . 0.0 110.179 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.502 ' HG3' ' ND2' ' A' ' 81' ' ' ASN . 1.3 pp20? -167.85 23.62 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.428 -0.795 . . . . 0.0 109.546 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.597 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 1.2 m120 -149.49 21.72 0.93 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 109.072 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.597 ' ND2' ' O ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER 80.72 8.11 1.27 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.55 -0.719 . . . . 0.0 109.438 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.504 ' OE1' ' HB2' ' A' ' 83' ' ' ASN . 6.3 mp0 -56.91 -165.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -0.985 . . . . 0.0 108.943 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.424 ' O ' HG21 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -139.56 107.6 5.72 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.957 -1.089 . . . . 0.0 110.098 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.633 ' CB ' ' CE1' ' A' ' 56' ' ' TYR . . . -80.87 -43.01 20.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.427 -0.796 . . . . 0.0 108.925 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 162.26 142.47 3.4 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.837 HG21 ' CD2' ' A' ' 4' ' ' TYR . 60.1 t -81.95 97.26 3.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.116 -1.226 . . . . 0.0 109.976 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.89 ' CD1' HG23 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -78.6 179.85 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.105 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . 1.098 HG22 ' O ' ' A' ' 101' ' ' VAL . 12.4 t -135.81 -131.98 0.15 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.916 -1.115 . . . . 0.0 108.457 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.817 ' CD2' ' HB2' ' A' ' 95' ' ' ALA . 0.2 OUTLIER 163.57 42.32 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 -179.657 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.4 m -77.55 97.27 4.99 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.695 0.759 . . . . 0.0 109.713 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.502 ' O ' ' C ' ' A' ' 95' ' ' ALA . . . 93.55 -29.91 7.91 Favored Glycine 0 C--N 1.297 -1.592 0 N-CA-C 107.753 -2.139 . . . . 0.0 107.753 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.817 ' HB2' ' CD2' ' A' ' 92' ' ' HIS . . . 34.45 -154.97 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.3 -0.529 . . . . 0.0 109.873 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.455 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.6 OUTLIER 46.01 47.53 12.67 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -179.034 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.98 -25.64 2.65 Favored Glycine 0 N--CA 1.483 1.828 0 N-CA-C 106.026 -2.83 . . . . 0.0 106.026 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 1.001 ' O ' HG13 ' A' ' 101' ' ' VAL . 7.8 m120 -105.65 -29.77 9.9 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.531 ' OD1' ' HG3' ' A' ' 46' ' ' GLU . 11.5 p-10 37.21 -146.1 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.706 ' CD1' ' CE1' ' A' ' 42' ' ' TYR . 5.3 m-85 -75.78 77.15 2.73 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 1.098 ' O ' HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -85.36 131.82 33.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.392 -0.818 . . . . 0.0 108.969 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -43.71 151.51 0.19 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.527 -1.358 . . . . 0.0 109.717 -179.049 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 1.2 m -75.71 92.25 2.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.924 . . . . 0.0 109.37 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.869 . . . . 0.0 109.437 -179.934 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.51 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.8 p 163.37 121.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.355 -0.841 . . . . 0.0 109.67 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -105.4 3.52 29.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.91 . . . . 0.0 109.431 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.588 ' CD1' HG21 ' A' ' 89' ' ' VAL . 11.4 m-85 -119.69 104.63 10.42 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.119 -0.988 . . . . 0.0 109.625 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.715 HG22 ' H ' ' A' ' 7' ' ' GLY . 98.5 m -143.85 123.34 13.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.093 -1.004 . . . . 0.0 109.421 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -91.97 9.81 31.56 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.163 -0.961 . . . . 0.0 109.945 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.715 ' H ' HG22 ' A' ' 5' ' ' THR . . . -177.39 -62.64 0.06 OUTLIER Glycine 0 C--N 1.282 -2.43 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.434 ' HA ' HG21 ' A' ' 5' ' ' THR . 3.6 m -174.46 30.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -1.129 . . . . 0.0 109.51 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.608 ' H ' HG23 ' A' ' 5' ' ' THR . 8.4 m-80 -80.02 -24.49 40.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.923 . . . . 0.0 109.371 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 9' ' ' ASN . 37.8 t 58.87 68.49 0.81 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.37 -0.832 . . . . 0.0 109.574 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.558 ' CE1' ' HB3' ' A' ' 9' ' ' ASN . 11.0 m-85 -89.47 132.94 34.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.131 -0.98 . . . . 0.0 109.259 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.588 ' O ' HG23 ' A' ' 16' ' ' VAL . 15.3 t -83.07 130.5 35.13 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.368 -0.832 . . . . 0.0 109.859 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 p -56.36 -17.57 8.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.304 -0.872 . . . . 0.0 109.287 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.7 -32.55 21.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.89 . . . . 0.0 109.575 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.435 ' O ' ' OG1' ' A' ' 18' ' ' THR . 0.5 OUTLIER -77.13 -37.33 54.26 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.305 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 12' ' ' SER . 28.8 t -51.9 -37.44 21.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.99 -43.29 99.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.576 -0.702 . . . . 0.0 109.339 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -59.17 -47.4 85.44 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.519 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.72 ' CB ' HD13 ' A' ' 61' ' ' ILE . . . -70.82 -15.2 62.63 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.715 ' NE2' HG13 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -89.65 -12.77 38.65 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.533 -0.729 . . . . 0.0 109.096 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -94.1 -20.92 19.46 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.08 -61.24 2.05 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.59 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -55.93 -24.94 43.99 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -73.83 -46.4 45.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.623 -0.928 . . . . 0.0 109.256 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -66.16 -63.63 1.04 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.373 -0.829 . . . . 0.0 108.906 179.757 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.859 HD21 ' C ' ' A' ' 32' ' ' THR . 3.3 tp -44.2 -33.93 1.7 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.302 -0.874 . . . . 0.0 109.068 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.618 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -63.86 -59.77 4.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.323 -0.861 . . . . 0.0 109.254 179.772 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.5 11.84 7.98 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.511 -0.743 . . . . 0.0 109.542 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -100.53 -24.01 14.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -0.919 . . . . 0.0 109.448 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.0 -16.76 45.57 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.43 -148.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.247 -1.149 . . . . 0.0 109.277 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.988 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.1 OUTLIER -170.61 -176.09 2.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.397 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.498 HG23 ' H ' ' A' ' 35' ' ' SER . 19.0 m -89.74 -126.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.143 -0.973 . . . . 0.0 109.606 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.403 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -130.34 -4.04 4.58 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.085 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.498 ' H ' HG23 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -109.86 -93.09 0.43 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.023 -1.281 . . . . 0.0 109.128 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -130.62 58.78 1.68 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.321 -0.862 . . . . 0.0 108.969 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.988 ' HA ' HG22 ' A' ' 32' ' ' THR . 4.2 t 57.71 -158.75 0.27 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.309 -0.87 . . . . 0.0 109.019 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.676 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER 166.84 -43.96 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 112.168 179.284 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 32.0 Cg_endo -75.2 100.66 1.39 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.353 1.368 . . . . 0.0 112.367 -178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.676 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -143.93 175.12 10.26 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.143 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -72.25 157.76 37.1 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.044 -1.035 . . . . 0.0 110.044 -179.391 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.506 ' OH ' ' CD1' ' A' ' 100' ' ' PHE . 87.3 t80 -145.93 89.6 1.91 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.438 -0.789 . . . . 0.0 109.19 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.522 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 32.3 m120 -52.29 -88.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.171 -0.956 . . . . 0.0 110.169 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.524 ' N ' ' OD1' ' A' ' 44' ' ' ASN . 2.4 p30 161.97 135.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.175 -0.953 . . . . 0.0 109.276 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -131.05 -0.91 4.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.077 -1.014 . . . . 0.0 109.862 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -100.73 -19.35 16.07 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.191 -0.943 . . . . 0.0 108.62 -179.789 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.26 23.88 7.1 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.581 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 18.4 m-85 -63.85 87.16 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 50' ' ' PHE . 5.7 t70 -54.57 -32.25 58.2 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.839 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.902 ' CD2' ' HB1' ' A' ' 87' ' ' ALA . 9.8 m-30 44.93 -170.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.357 -0.84 . . . . 0.0 109.607 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -151.55 32.28 0.57 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -0.951 . . . . 0.0 109.454 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.5 t -113.48 -86.62 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.833 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.576 ' O ' ' CZ ' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -152.76 164.89 36.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.103 -0.998 . . . . 0.0 109.762 -179.77 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.59 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -62.22 -51.96 70.26 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.386 -0.821 . . . . 0.0 110.395 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 54' ' ' SER . 36.3 Cg_endo -76.18 80.77 2.6 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.072 1.848 . . . . 0.0 110.716 -178.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.576 ' CZ ' ' O ' ' A' ' 53' ' ' SER . 93.3 m-85 -78.85 -164.63 0.62 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.618 ' CE1' ' NE2' ' A' ' 27' ' ' HIS . 60.4 m-85 -156.1 113.94 3.31 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.519 -0.738 . . . . 0.0 109.266 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -82.91 137.59 34.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.254 -0.904 . . . . 0.0 110.447 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.67 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 10.0 t-105 -160.7 140.65 8.27 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.67 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.5 Cg_endo -69.75 130.52 19.5 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.202 1.935 . . . . 0.0 111.45 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.945 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -111.56 130.25 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.945 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.3 OUTLIER -120.7 168.71 11.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.157 -0.964 . . . . 0.0 109.595 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.484 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 12.3 t -121.38 26.92 8.59 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.7 -55.74 0.05 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.601 -0.687 . . . . 0.0 109.309 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 66' ' ' ASP . . . -72.95 -4.34 62.28 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.417 ' OD1' ' C ' ' A' ' 66' ' ' ASP . 49.5 t0 60.51 -99.88 0.1 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -1.161 . . . . 0.0 109.731 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.9 t -81.26 151.97 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.957 -1.089 . . . . 0.0 109.473 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.585 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 31.5 t80 -82.68 124.23 30.01 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.131 -0.98 . . . . 0.0 109.833 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 99.8 p -119.97 -3.19 10.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.464 -0.773 . . . . 0.0 109.266 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.49 130.64 3.49 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 154.39 86.47 0.06 OUTLIER Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.0 t 51.73 93.03 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.181 -1.188 . . . . 0.0 109.767 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.57 -169.4 0.77 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.708 2.272 . . . . 0.0 110.818 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.647 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 77.64 -170.17 54.93 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 71.63 -162.21 0.13 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.149 -1.206 . . . . 0.0 110.765 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.503 ' N ' ' OG1' ' A' ' 91' ' ' THR . 14.9 m-20 -36.51 154.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.547 0.689 . . . . 0.0 111.106 -178.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.603 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 10.0 ttm105 -177.92 70.4 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.484 -0.76 . . . . 0.0 109.019 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.715 HG13 ' NE2' ' A' ' 20' ' ' GLN . 1.4 p -53.72 166.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.813 -1.179 . . . . 0.0 109.741 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.731 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -126.84 176.88 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.275 -0.89 . . . . 0.0 109.838 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.684 ' HD1' HE21 ' A' ' 20' ' ' GLN . 8.7 p90 -164.51 -171.69 2.43 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.125 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.442 ' C ' ' HG2' ' A' ' 82' ' ' GLU . 7.6 t-20 -129.4 -80.08 0.56 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.038 -1.039 . . . . 0.0 110.06 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.442 ' HG2' ' C ' ' A' ' 81' ' ' ASN . 65.3 mm-40 -149.2 11.12 0.8 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.374 -0.829 . . . . 0.0 110.235 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.619 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 3.6 t-20 -147.74 15.64 1.1 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.026 -1.046 . . . . 0.0 109.567 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.619 ' ND2' ' O ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER 68.16 12.42 8.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.307 -0.871 . . . . 0.0 109.363 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.547 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 1.8 mt-30 -45.95 -31.87 2.43 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.662 HD11 ' CG2' ' A' ' 78' ' ' VAL . 0.1 OUTLIER 85.13 104.1 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.479 0.657 . . . . 0.0 109.952 179.569 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.902 ' HB1' ' CD2' ' A' ' 50' ' ' PHE . . . -77.34 -33.62 55.41 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.372 -0.83 . . . . 0.0 109.14 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 149.55 160.87 9.43 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.588 HG21 ' CD1' ' A' ' 4' ' ' TYR . 4.9 t -85.97 106.06 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.203 -1.174 . . . . 0.0 110.127 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.603 ' CG1' ' O ' ' A' ' 77' ' ' ARG . 14.6 pt -108.38 138.71 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.702 HG22 HG23 ' A' ' 101' ' ' VAL . 4.4 t -120.88 175.06 6.23 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.959 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.597 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -115.36 68.62 0.71 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.407 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.535 ' HB ' ' O ' ' A' ' 92' ' ' HIS . 13.7 t 172.5 158.93 0.11 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 98.48 -21.4 46.19 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.772 -1.204 . . . . 0.0 110.403 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.753 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -125.32 -171.92 2.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.056 -1.261 . . . . 0.0 109.423 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 95' ' ' ALA . 20.4 m -42.02 111.18 0.21 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -0.842 . . . . 0.0 108.905 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 63.76 -105.68 1.16 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.597 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -132.14 35.35 3.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.241 -1.152 . . . . 0.0 108.771 178.942 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.753 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 4.4 t-20 -45.58 170.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.306 -0.871 . . . . 0.0 109.436 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.542 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 13.1 m-85 -92.4 149.19 21.56 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.212 -0.93 . . . . 0.0 109.534 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.702 HG23 HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -156.12 148.56 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 1.0 OUTLIER -82.38 122.08 27.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.431 -0.793 . . . . 0.0 109.857 -179.584 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.559 ' O ' HG23 ' A' ' 104' ' ' THR . 80.5 m -43.51 121.23 2.21 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.325 -0.859 . . . . 0.0 109.538 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 103' ' ' CYS . 13.7 p . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.124 -0.985 . . . . 0.0 109.535 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.432 ' C ' ' SG ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.293 0.568 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 0.8 OUTLIER 174.0 124.56 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.306 -0.871 . . . . 0.0 110.152 179.685 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -87.53 -36.39 17.62 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.356 -0.84 . . . . 0.0 109.051 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.818 ' CG ' HG21 ' A' ' 89' ' ' VAL . 41.5 m-85 -82.35 115.66 21.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.355 -0.84 . . . . 0.0 109.394 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.493 HG22 ' O ' ' A' ' 9' ' ' ASN . 1.1 p -150.18 122.88 8.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.403 -0.811 . . . . 0.0 109.643 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -112.08 10.28 20.36 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.241 1.02 . . . . 0.0 109.641 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 172.73 -96.23 0.11 Allowed Glycine 0 C--N 1.282 -2.445 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -123.2 23.4 9.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -1.109 . . . . 0.0 109.231 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.493 ' O ' HG22 ' A' ' 5' ' ' THR . 6.6 m120 -96.76 106.57 18.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.895 . . . . 0.0 109.819 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 47.8 t -78.33 78.47 4.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.346 -0.846 . . . . 0.0 109.417 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.411 ' CE2' ' HB3' ' A' ' 9' ' ' ASN . 14.6 m-85 -98.31 110.15 22.78 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.432 -0.792 . . . . 0.0 109.003 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.584 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -84.66 128.95 34.86 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.174 -0.954 . . . . 0.0 109.956 -179.619 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 12' ' ' SER . 1.1 p -41.17 -27.6 0.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 12' ' ' SER . 5.3 t -69.74 -50.43 43.54 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.349 -0.844 . . . . 0.0 109.623 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.34 -22.74 65.58 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 12' ' ' SER . 17.8 t -78.0 -29.47 15.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.404 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 46.7 t -61.39 -46.44 90.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.568 -0.708 . . . . 0.0 109.412 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.2 -53.26 60.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.923 . . . . 0.0 108.606 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.548 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -66.97 -15.49 63.74 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.716 ' NE2' ' CD1' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -74.89 -37.99 61.99 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.531 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.8 -6.05 52.82 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.91 -62.13 1.8 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.375 -0.828 . . . . 0.0 109.075 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.565 ' HA3' ' CD2' ' A' ' 59' ' ' TRP . . . -58.33 -25.15 57.17 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.484 ' CE2' ' O ' ' A' ' 82' ' ' GLU . 2.8 t80 -73.15 -44.49 59.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.408 -1.054 . . . . 0.0 109.44 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' A' ' 26' ' ' LEU . 0.7 OUTLIER -55.7 -69.68 0.13 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.487 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.486 HD11 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -42.38 -45.19 4.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.415 -0.803 . . . . 0.0 109.971 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -52.7 -54.6 31.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.299 -0.875 . . . . 0.0 110.518 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.66 -3.07 49.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.099 -1.001 . . . . 0.0 109.9 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -87.2 8.01 25.81 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.108 -0.995 . . . . 0.0 109.618 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 48.86 27.53 6.53 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.475 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -125.67 -158.21 0.83 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.458 -1.025 . . . . 0.0 109.405 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.695 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -147.62 -174.64 4.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.915 . . . . 0.0 109.256 179.727 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' A' ' 34' ' ' GLY . 33.8 m -103.71 171.68 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.065 -1.022 . . . . 0.0 109.831 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -45.04 -38.39 6.05 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 36' ' ' ASN . 0.6 OUTLIER -78.51 175.55 10.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -1.098 . . . . 0.0 109.474 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' A' ' 37' ' ' SER . 20.2 m-20 -43.86 -48.19 8.33 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.261 -0.899 . . . . 0.0 109.115 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.695 ' HA ' HG22 ' A' ' 32' ' ' THR . 5.8 t 176.04 -164.12 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.715 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.2 OUTLIER 170.19 -45.12 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.083 -1.01 . . . . 0.0 112.213 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.58 ' HD2' ' H ' ' A' ' 38' ' ' TYR . 31.7 Cg_endo -75.41 97.0 1.06 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 121.002 1.134 . . . . 0.0 111.656 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.715 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -139.61 -179.52 5.96 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.557 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.559 ' HA ' ' CD1' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -69.6 162.12 28.24 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.333 -0.854 . . . . 0.0 110.038 -179.32 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.616 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 18.1 t80 -127.61 152.85 47.13 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.525 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 3.3 p-10 -165.59 95.48 0.63 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.977 -1.077 . . . . 0.0 109.829 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.616 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 0.6 OUTLIER -135.71 -41.12 0.69 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.335 -0.853 . . . . 0.0 109.433 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER 42.65 26.47 0.07 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.402 -0.811 . . . . 0.0 110.018 179.696 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -39.95 -27.63 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 O-C-N 121.319 -0.863 . . . . 0.0 109.984 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 45' ' ' TYR . . . 167.69 -23.82 0.11 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.558 ' CZ ' ' HA ' ' A' ' 101' ' ' VAL . 0.1 OUTLIER -92.46 49.94 1.55 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.447 -1.031 . . . . 0.0 109.211 179.591 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.53 103.14 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -0.879 . . . . 0.0 109.454 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 1.053 ' CD2' ' HB1' ' A' ' 87' ' ' ALA . 12.7 m-85 -65.87 164.09 15.6 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.259 -0.901 . . . . 0.0 109.306 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.3 t -108.63 23.45 14.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 0.0 109.868 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.515 ' CG1' ' HB3' ' A' ' 81' ' ' ASN . 14.2 t -80.53 -58.48 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.091 -1.006 . . . . 0.0 109.377 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -175.38 172.12 2.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 109.682 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.595 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -69.57 -53.41 12.57 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.357 -0.839 . . . . 0.0 110.155 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 54' ' ' SER . 35.8 Cg_endo -74.82 90.39 1.07 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.972 1.781 . . . . 0.0 110.034 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.534 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 30.3 m-85 -78.61 -170.34 2.06 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.559 ' CD1' ' HA ' ' A' ' 41' ' ' LYS . 57.9 m-85 -157.7 111.92 2.61 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -82.52 139.82 33.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.454 -0.779 . . . . 0.0 110.388 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.704 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 35.7 t-105 -160.86 139.36 7.42 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.704 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 32.0 Cg_endo -71.02 145.26 49.41 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.215 1.943 . . . . 0.0 111.434 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.977 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -108.38 138.15 36.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.977 HD23 ' C ' ' A' ' 61' ' ' ILE . 1.1 mt -124.91 168.69 12.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.044 -1.035 . . . . 0.0 109.965 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.16 0.17 9.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.035 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.69 -166.54 1.42 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.383 -0.823 . . . . 0.0 109.197 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.27 59.2 0.48 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.673 ' O ' HD12 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -158.9 106.18 1.82 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.173 -1.193 . . . . 0.0 109.799 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.527 HG13 ' HZ2' ' A' ' 59' ' ' TRP . 77.5 t -52.4 143.41 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -0.893 . . . . 0.0 108.931 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.659 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 42.9 t80 -45.95 120.85 2.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.875 -1.141 . . . . 0.0 109.43 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.6 p -165.95 29.9 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.464 -0.773 . . . . 0.0 109.291 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -116.03 -67.08 0.4 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.434 ' C ' ' OG ' ' A' ' 72' ' ' SER . . . 148.47 151.44 5.46 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.434 ' OG ' ' C ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER 51.11 92.62 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.37 -1.077 . . . . 0.0 110.085 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.534 ' CD ' ' OH ' ' A' ' 38' ' ' TYR . 35.0 Cg_endo -79.11 -72.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.897 2.398 . . . . 0.0 109.642 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 101.68 98.1 2.35 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.614 ' HB2' ' HB ' ' A' ' 93' ' ' THR . . . 61.69 -149.88 0.39 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.292 -1.122 . . . . 0.0 110.262 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.542 ' O ' ' O ' ' A' ' 75' ' ' ALA . 2.4 m-20 28.29 108.62 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 121.524 0.678 . . . . 0.0 112.584 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.497 ' O ' HG12 ' A' ' 90' ' ' ILE . 2.0 ttm-85 -154.0 111.28 3.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.014 -1.053 . . . . 0.0 109.003 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 89' ' ' VAL . 7.7 p -91.34 154.99 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.059 -1.026 . . . . 0.0 109.495 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.932 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 52.6 t -120.35 166.98 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.275 -0.891 . . . . 0.0 109.923 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.716 ' CD1' ' NE2' ' A' ' 20' ' ' GLN . 10.8 p90 -169.6 -177.32 2.69 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.755 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.543 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -124.25 -38.79 2.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.433 -0.792 . . . . 0.0 109.529 -179.728 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.543 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 4.0 mt-10 162.44 -27.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.442 -0.786 . . . . 0.0 108.936 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.545 ' HB3' ' HG2' ' A' ' 85' ' ' GLN . 1.1 t-20 -98.58 19.76 14.05 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.516 -0.74 . . . . 0.0 109.135 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.614 ' ND2' ' O ' ' A' ' 84' ' ' ASN . 0.3 OUTLIER 52.42 23.29 2.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.827 -0.545 . . . . 0.0 110.028 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.545 ' HG2' ' HB3' ' A' ' 83' ' ' ASN . 4.1 mt-30 -55.2 -31.82 61.73 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.547 HD22 ' HG3' ' A' ' 20' ' ' GLN . 0.1 OUTLIER 84.79 104.54 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.406 0.622 . . . . 0.0 110.912 179.135 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 1.053 ' HB1' ' CD2' ' A' ' 50' ' ' PHE . . . -73.26 -44.58 59.07 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.413 ' O ' HG23 ' A' ' 78' ' ' VAL . . . 166.43 -154.38 24.84 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.924 -1.671 . . . . 0.0 108.924 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.818 HG21 ' CG ' ' A' ' 4' ' ' TYR . 34.9 t -138.1 81.19 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.093 -1.239 . . . . 0.0 109.532 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.586 HD13 ' CG2' ' A' ' 79' ' ' VAL . 0.7 OUTLIER -80.06 152.14 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.333 -0.854 . . . . 0.0 108.802 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.421 ' CG2' HG23 ' A' ' 101' ' ' VAL . 0.8 OUTLIER -116.38 138.96 50.92 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.108 -0.995 . . . . 0.0 111.378 -178.256 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.617 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.1 OUTLIER -86.62 59.3 5.56 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.543 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.614 ' HB ' ' HB2' ' A' ' 75' ' ' ALA . 3.5 m -176.32 -31.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.208 -0.932 . . . . 0.0 109.692 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.72 -17.23 13.78 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.639 ' HB3' ' CB ' ' A' ' 99' ' ' ASN . . . -121.81 174.17 7.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -1.167 . . . . 0.0 109.747 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 95' ' ' ALA . 2.7 t -39.86 128.18 2.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.575 -0.703 . . . . 0.0 109.317 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 63.38 -88.59 0.06 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.617 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -139.44 -64.24 0.5 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -1.182 . . . . 0.0 109.552 179.685 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.639 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . 1.0 OUTLIER 47.35 -172.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.138 -0.977 . . . . 0.0 109.189 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -131.38 131.89 44.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.154 -0.966 . . . . 0.0 109.708 179.595 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.558 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 0.7 OUTLIER -147.25 131.66 10.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.353 -0.842 . . . . 0.0 108.856 179.385 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -51.97 133.79 32.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.901 . . . . 0.0 109.817 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 8.0 m -65.48 148.52 51.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.321 -0.862 . . . . 0.0 109.569 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 31.2 p . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 116.719 -1.61 . . . . 0.0 109.408 179.906 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.533 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 1.8 p 163.52 142.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.355 -0.84 . . . . 0.0 109.545 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' A' ' 3' ' ' ASP . 41.7 t0 -104.51 -41.66 5.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 109.559 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.715 ' CG ' HG21 ' A' ' 89' ' ' VAL . 34.6 m-85 -83.36 128.76 34.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.924 . . . . 0.0 109.54 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -137.19 110.38 7.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.303 -0.873 . . . . 0.0 109.274 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.3 m -106.51 13.79 27.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.12 -0.987 . . . . 0.0 109.95 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 128.73 92.59 0.71 Allowed Glycine 0 C--N 1.283 -2.369 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 54.18 27.74 8.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.368 -1.078 . . . . 0.0 109.532 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -93.59 -43.74 8.54 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.303 -0.873 . . . . 0.0 109.496 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 10' ' ' CYS . 47.8 t 49.98 49.28 20.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 109.219 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.575 ' CE1' ' OG ' ' A' ' 63' ' ' SER . 6.4 m-30 -87.38 120.6 28.84 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.433 -0.792 . . . . 0.0 109.38 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.655 ' O ' HG23 ' A' ' 16' ' ' VAL . 17.8 t -85.18 118.34 24.67 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.267 -0.895 . . . . 0.0 109.235 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.477 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 3.7 p -41.52 -26.16 0.06 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.557 -0.715 . . . . 0.0 109.614 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -61.67 -54.92 36.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.147 -0.971 . . . . 0.0 109.185 179.407 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -69.8 -25.91 64.0 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 12' ' ' SER . 18.9 t -68.24 -25.07 30.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.55 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 0.1 OUTLIER -65.45 -44.5 87.05 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.3 m -59.2 -51.16 71.18 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.467 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -65.94 -16.42 63.85 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.952 ' HA ' HE21 ' A' ' 20' ' ' GLN . 0.0 OUTLIER -82.26 -25.14 34.35 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.611 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.37 -7.83 58.15 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.298 -0.876 . . . . 0.0 108.664 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.7 -63.72 1.28 Allowed 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.603 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -50.9 -30.17 21.64 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.484 ' O ' ' HB3' ' A' ' 27' ' ' HIS . 3.1 t80 -74.14 -56.31 5.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.386 -1.067 . . . . 0.0 108.816 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.472 ' HG2' ' OD1' ' A' ' 29' ' ' ASP . 5.0 tt0 -53.05 -67.64 0.24 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.422 -0.799 . . . . 0.0 109.126 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 26' ' ' LEU . 4.8 tp -42.96 -37.21 1.8 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.301 -0.875 . . . . 0.0 109.598 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.63 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 3.2 t60 -61.51 -53.18 59.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.174 -0.954 . . . . 0.0 110.134 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -86.93 6.9 29.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.352 -0.843 . . . . 0.0 110.122 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.472 ' OD1' ' HG2' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -98.04 -16.85 19.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.022 -1.049 . . . . 0.0 109.579 -179.79 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.16 -11.15 58.77 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.594 ' HG3' ' N ' ' A' ' 32' ' ' THR . 31.9 tp10 -84.96 164.86 18.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -1.134 . . . . 0.0 109.201 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.711 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -129.85 171.44 12.72 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.498 -0.751 . . . . 0.0 109.798 -179.746 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.455 ' HB ' ' HA ' ' A' ' 69' ' ' SER . 33.0 m -81.27 166.8 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.437 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.87 -29.32 42.16 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.413 ' HB2' ' HA2' ' A' ' 70' ' ' GLY . 0.6 OUTLIER -73.92 -144.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -1.141 . . . . 0.0 109.204 179.79 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 37' ' ' SER . 2.9 m120 -102.11 60.49 0.85 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.961 -1.087 . . . . 0.0 109.803 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.711 ' HA ' HG22 ' A' ' 32' ' ' THR . 6.2 t 70.97 -168.97 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.553 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.634 ' CZ ' ' CB ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER 165.07 -41.96 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.33 -0.856 . . . . 0.0 112.206 178.895 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.59 ' HD2' ' H ' ' A' ' 38' ' ' TYR . 31.4 Cg_endo -75.35 100.07 1.33 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.096 1.197 . . . . 0.0 111.977 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.542 ' CD2' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -145.35 176.92 9.21 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.577 -0.702 . . . . 0.0 109.252 178.691 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.563 ' HA ' ' CD1' ' A' ' 57' ' ' TYR . 0.7 OUTLIER -59.27 161.63 5.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.32 -0.863 . . . . 0.0 109.968 -179.497 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.626 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 44.9 t80 -134.29 68.19 1.49 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.45 -0.781 . . . . 0.0 109.023 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.453 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 1.3 m-20 -86.55 61.88 7.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.18 -0.95 . . . . 0.0 109.151 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.664 ' ND2' ' CZ ' ' A' ' 100' ' ' PHE . 6.4 m-80 -89.74 -78.26 0.37 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.557 -0.714 . . . . 0.0 110.515 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.527 ' CB ' ' O ' ' A' ' 44' ' ' ASN . 3.1 m-85 79.49 29.19 0.33 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.47 -0.769 . . . . 0.0 108.953 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -36.24 -71.21 0.08 Allowed 'General case' 0 C--N 1.308 -1.198 0 O-C-N 121.749 -0.594 . . . . 0.0 110.23 -179.603 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.19 44.2 0.55 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.07 169.17 18.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -1.137 . . . . 0.0 109.545 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -112.51 -31.86 6.66 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.534 ' CB ' ' OH ' ' A' ' 56' ' ' TYR . 8.3 m-30 55.41 178.13 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.408 -0.808 . . . . 0.0 109.567 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.48 37.57 1.01 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.312 -0.867 . . . . 0.0 109.092 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.558 HG21 ' HA ' ' A' ' 87' ' ' ALA . 41.1 t -110.12 -82.61 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.394 -0.816 . . . . 0.0 109.708 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.528 ' N ' HG12 ' A' ' 52' ' ' VAL . 4.7 t -163.15 154.08 16.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.164 -0.96 . . . . 0.0 109.855 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.597 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -55.9 -50.66 85.94 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.398 -0.814 . . . . 0.0 110.442 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 54' ' ' SER . 35.8 Cg_endo -75.82 84.44 1.78 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.018 1.812 . . . . 0.0 110.156 -178.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.556 ' CE1' ' HB2' ' A' ' 87' ' ' ALA . 49.2 m-85 -81.81 -169.52 2.39 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.821 0.82 . . . . 0.0 109.879 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.63 ' CE1' ' NE2' ' A' ' 27' ' ' HIS . 70.2 m-85 -156.75 109.05 2.5 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.48 ' N ' ' HB2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -76.2 138.51 40.7 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.844 0.83 . . . . 0.0 110.911 -178.048 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.668 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 34.8 t-105 -160.58 137.26 6.49 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.668 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.5 Cg_endo -67.67 151.84 78.66 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.986 1.791 . . . . 0.0 110.592 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.985 ' C ' HD23 ' A' ' 62' ' ' LEU . 1.3 tp -122.13 138.7 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.421 -0.8 . . . . 0.0 110.023 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.985 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.7 OUTLIER -124.34 -175.54 3.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.385 -0.822 . . . . 0.0 108.896 179.476 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.575 ' OG ' ' CE1' ' A' ' 11' ' ' TYR . 16.6 p -146.72 55.1 1.12 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.01 -1.056 . . . . 0.0 109.636 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.31 30.94 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.464 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 47.31 90.0 0.01 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.478 ' O ' ' HB ' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -161.16 -36.33 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.256 -1.143 . . . . 0.0 110.025 -179.681 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.478 ' HB ' ' O ' ' A' ' 66' ' ' ASP . 4.4 t 71.81 140.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.119 -0.988 . . . . 0.0 108.958 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.584 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 71.9 t80 -65.45 107.03 1.54 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.113 -0.992 . . . . 0.0 110.109 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.455 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 1.2 m -123.11 30.39 6.38 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.413 ' HA2' ' HB2' ' A' ' 35' ' ' SER . . . 107.77 77.93 1.07 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -159.31 -96.69 0.12 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.3 p -123.43 94.82 46.09 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.22 -1.164 . . . . 0.0 109.858 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.634 ' CB ' ' CZ ' ' A' ' 38' ' ' TYR . 36.2 Cg_endo -79.48 -61.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.585 2.19 . . . . 0.0 110.359 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . -60.21 -146.43 0.01 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 65.03 -84.98 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.37 -1.077 . . . . 0.0 109.939 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -124.59 100.33 6.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.163 -0.96 . . . . 0.0 109.574 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.526 ' O ' HG12 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -117.68 152.47 35.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 108.893 179.685 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.842 HG11 ' NE2' ' A' ' 20' ' ' GLN . 1.4 p -117.2 -173.88 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.053 -1.03 . . . . 0.0 109.496 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.712 ' H ' HG22 ' A' ' 78' ' ' VAL . 6.8 t -147.21 166.8 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.167 -0.958 . . . . 0.0 110.009 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.61 ' CE1' ' HB2' ' A' ' 57' ' ' TYR . 3.8 p90 -166.61 -176.26 3.47 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.522 ' O ' ' CD2' ' A' ' 57' ' ' TYR . 11.5 t30 -118.68 -80.16 0.61 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.927 -1.108 . . . . 0.0 109.754 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -158.55 20.59 0.22 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.462 -0.774 . . . . 0.0 109.419 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.652 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 0.3 OUTLIER -150.84 18.37 0.79 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.292 -0.88 . . . . 0.0 108.842 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.652 ' ND2' ' O ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER 67.34 14.16 9.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.594 -0.692 . . . . 0.0 109.349 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.504 ' O ' ' HB3' ' A' ' 86' ' ' LEU . 1.8 mt-30 -51.72 -26.85 10.23 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.504 ' HB3' ' O ' ' A' ' 85' ' ' GLN . 0.7 OUTLIER 66.49 116.31 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.539 0.685 . . . . 0.0 110.041 179.745 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.558 ' HA ' HG21 ' A' ' 52' ' ' VAL . . . -79.05 -34.43 43.77 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.458 ' HA2' ' OH ' ' A' ' 4' ' ' TYR . . . 146.13 176.64 20.16 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.715 HG21 ' CG ' ' A' ' 4' ' ' TYR . 54.7 t -100.52 147.29 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.996 -1.296 . . . . 0.0 110.055 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.544 ' HB ' ' CB ' ' A' ' 100' ' ' PHE . 0.9 OUTLIER -141.09 162.5 22.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.537 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 75' ' ' ALA . 5.8 t -129.59 127.17 40.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.711 -1.243 . . . . 0.0 111.545 -178.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.62 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -79.01 75.35 5.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.532 -0.73 . . . . 0.0 109.177 179.055 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 1.1 m 173.44 -28.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.204 -0.935 . . . . 0.0 109.263 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.53 -11.17 33.69 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.738 ' HB3' ' CB ' ' A' ' 99' ' ' ASN . . . -125.48 176.86 6.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.097 -1.237 . . . . 0.0 109.725 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER -42.99 131.7 4.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.411 -0.806 . . . . 0.0 109.109 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.51 -89.03 0.05 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.62 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -136.22 -79.7 0.41 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -1.118 . . . . 0.0 109.106 179.319 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.738 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . 0.3 OUTLIER 58.51 152.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.231 -0.918 . . . . 0.0 109.054 -179.812 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.664 ' CZ ' ' ND2' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -109.02 126.99 53.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.741 -1.224 . . . . 0.0 110.58 -179.412 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -129.55 140.45 49.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.987 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.469 ' OE2' ' CE1' ' A' ' 50' ' ' PHE . 5.8 mm-40 -52.47 122.56 9.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.384 -0.823 . . . . 0.0 109.703 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 1.7 m -70.55 129.92 40.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.352 -0.842 . . . . 0.0 109.462 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 40.1 p . . . . . 0 N--CA 1.488 1.467 0 O-C-N 121.187 -0.946 . . . . 0.0 109.367 179.912 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.426 ' C ' ' SG ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.392 0.615 . . . . 0.0 109.651 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 0.8 OUTLIER 173.54 126.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.319 -0.863 . . . . 0.0 109.838 179.788 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -121.43 -3.87 9.38 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.417 -0.802 . . . . 0.0 109.29 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.677 ' CG ' HG21 ' A' ' 89' ' ' VAL . 57.4 m-85 -103.52 85.98 2.56 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.913 . . . . 0.0 109.192 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.635 HG23 ' H ' ' A' ' 10' ' ' CYS . 33.9 m -117.52 129.53 55.86 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.269 -0.894 . . . . 0.0 110.255 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.1 m -133.07 12.21 4.26 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.191 0.996 . . . . 0.0 109.156 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 8' ' ' SER . . . -176.53 35.77 0.09 OUTLIER Glycine 0 C--N 1.282 -2.454 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 7' ' ' GLY . 0.6 OUTLIER 67.6 25.0 8.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.308 -1.113 . . . . 0.0 109.16 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.474 ' O ' ' C ' ' A' ' 10' ' ' CYS . 5.6 m-20 -89.43 -17.63 28.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.412 -0.805 . . . . 0.0 109.746 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.635 ' H ' HG23 ' A' ' 5' ' ' THR . 0.8 OUTLIER 40.03 79.09 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 O-C-N 121.543 -0.723 . . . . 0.0 109.315 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.482 ' HB2' ' HB2' ' A' ' 4' ' ' TYR . 11.6 m-85 -78.91 134.3 36.89 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.883 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -78.58 129.57 34.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.567 -0.708 . . . . 0.0 109.804 -179.316 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -17.75 5.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.336 -0.852 . . . . 0.0 109.312 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.94 -30.69 15.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 0.0 109.571 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.47 -31.51 62.26 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 12' ' ' SER . 3.5 t -65.09 -25.44 37.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.493 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 0.1 OUTLIER -72.27 -40.15 67.84 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.537 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.77 -53.08 62.11 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.674 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -63.22 -25.42 68.32 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.574 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -70.09 -30.37 67.57 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.137 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -81.02 -12.68 59.31 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.632 ' HB1' HG13 ' A' ' 67' ' ' VAL . . . -81.19 -47.22 13.72 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.614 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -74.69 -28.62 62.78 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -75.65 -39.41 57.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.504 -0.998 . . . . 0.0 109.198 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.501 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 7.4 tt0 -69.73 -57.71 4.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.171 -0.955 . . . . 0.0 108.509 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.576 HD11 ' HB3' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -49.74 -36.23 24.98 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.297 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -67.37 -39.4 85.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.426 -0.796 . . . . 0.0 109.512 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.65 -2.77 47.98 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.317 -0.864 . . . . 0.0 109.057 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -101.8 0.5 35.84 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.266 -0.896 . . . . 0.0 109.509 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 54.21 26.07 34.77 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.576 ' HB3' HD11 ' A' ' 26' ' ' LEU . 1.7 mm-40 -106.06 -164.11 0.99 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.252 -1.146 . . . . 0.0 109.605 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.93 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -142.3 175.97 9.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.357 -0.839 . . . . 0.0 109.337 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.668 HG22 ' CA ' ' A' ' 37' ' ' SER . 22.3 m -87.99 -156.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.212 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -40.07 -35.9 0.77 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER 167.15 -27.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.119 -1.224 . . . . 0.0 109.549 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 37' ' ' SER . 11.1 m-80 -81.73 8.89 8.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.171 -0.956 . . . . 0.0 109.533 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.93 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.8 OUTLIER 46.2 -169.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.226 -0.921 . . . . 0.0 108.968 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.726 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER 169.42 -47.18 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.428 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.951 179.247 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 38' ' ' TYR . 30.7 Cg_endo -73.48 99.38 1.13 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.525 1.483 . . . . 0.0 112.453 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.726 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -144.7 175.16 10.37 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.944 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -63.04 157.66 21.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.959 -1.088 . . . . 0.0 110.213 -179.214 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.884 ' CG ' HG11 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -129.09 132.31 47.39 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.478 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.424 ' O ' ' C ' ' A' ' 44' ' ' ASN . 1.4 p-10 -123.15 -22.63 5.11 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.814 -1.179 . . . . 0.0 109.635 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.75 ' ND2' ' CD1' ' A' ' 100' ' ' PHE . 0.3 OUTLIER 45.28 -160.23 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.284 -0.885 . . . . 0.0 108.919 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.631 ' CG ' ' O ' ' A' ' 44' ' ' ASN . 0.9 OUTLIER 171.43 -26.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.536 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.3 OUTLIER -32.09 -59.85 0.28 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 121.307 0.575 . . . . 0.0 110.42 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.04 54.68 0.01 OUTLIER Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.525 ' CZ ' ' HA ' ' A' ' 101' ' ' VAL . 62.8 m-85 -108.64 142.78 38.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -1.128 . . . . 0.0 109.611 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -108.89 76.31 1.0 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -0.903 . . . . 0.0 109.615 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.478 ' HB3' ' OH ' ' A' ' 56' ' ' TYR . 18.8 m-30 -66.63 -178.53 0.72 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.188 -0.945 . . . . 0.0 109.003 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.5 t -140.41 17.38 2.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.865 . . . . 0.0 108.976 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.577 ' HB ' ' CE1' ' A' ' 56' ' ' TYR . 57.4 t -88.1 -82.67 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.44 -0.788 . . . . 0.0 109.617 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.583 ' O ' ' CE2' ' A' ' 56' ' ' TYR . 61.1 m -160.21 -174.22 4.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -0.925 . . . . 0.0 109.902 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.574 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -81.66 -52.45 0.78 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.316 -0.865 . . . . 0.0 110.717 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 54' ' ' SER . 35.2 Cg_endo -75.49 88.14 1.31 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.07 1.847 . . . . 0.0 110.201 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.791 ' CE1' ' HB2' ' A' ' 87' ' ' ALA . 21.9 m-85 -89.17 -167.89 2.01 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.587 ' CG ' ' O ' ' A' ' 56' ' ' TYR . 84.0 m-85 -160.88 114.91 2.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.507 -0.746 . . . . 0.0 109.328 179.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.451 ' CD ' ' NH1' ' A' ' 77' ' ' ARG . 3.0 pt-20 -80.0 142.41 35.03 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.292 -0.88 . . . . 0.0 110.909 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.667 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 22.1 t-105 -160.77 138.63 7.1 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.667 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 31.8 Cg_endo -70.15 161.36 46.27 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.059 1.839 . . . . 0.0 111.429 -178.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.939 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -133.34 135.74 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.679 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.939 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.3 OUTLIER -118.72 161.49 20.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -0.913 . . . . 0.0 109.608 -179.864 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.1 26.05 5.2 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.463 -0.773 . . . . 0.0 109.287 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.22 -62.72 0.78 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.359 -0.838 . . . . 0.0 109.45 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -93.15 -108.52 1.87 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 67' ' ' VAL . 8.9 t70 -179.45 134.12 0.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -1.159 . . . . 0.0 109.521 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.632 HG13 ' HB1' ' A' ' 22' ' ' ALA . 2.8 t 62.79 133.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -0.902 . . . . 0.0 109.804 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.595 ' HA ' HD11 ' A' ' 62' ' ' LEU . 43.3 t80 -75.51 105.75 6.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.015 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.1 m -112.87 16.57 19.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.131 -0.981 . . . . 0.0 109.812 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.54 52.72 0.23 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -110.95 -112.3 3.35 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.82 108.94 43.78 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.193 -1.18 . . . . 0.0 109.421 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.65 -161.81 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.467 2.112 . . . . 0.0 110.483 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 53.71 -175.76 0.32 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 91' ' ' THR . . . 61.85 -150.05 0.38 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -1.136 . . . . 0.0 110.198 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' ' 75' ' ' ALA . 12.0 m-20 -32.27 148.73 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.56 0.695 . . . . 0.0 111.435 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.577 ' NH2' ' CE2' ' A' ' 100' ' ' PHE . 8.3 ttp180 -176.38 86.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.731 ' CG2' HD11 ' A' ' 86' ' ' LEU . 8.8 p -72.38 143.16 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.894 . . . . 0.0 109.688 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.884 HG11 ' CG ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -109.19 177.63 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.105 -0.997 . . . . 0.0 109.679 179.864 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.575 ' CE1' ' O ' ' A' ' 57' ' ' TYR . 14.0 p90 -174.76 -169.19 0.4 Allowed 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.0 -178.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -128.88 -80.99 0.57 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.374 -0.829 . . . . 0.0 109.728 -179.497 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.45 ' CG ' ' C ' ' A' ' 81' ' ' ASN . 0.3 OUTLIER -158.6 19.69 0.22 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.457 -0.777 . . . . 0.0 109.412 -179.804 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.456 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 0.8 OUTLIER -150.34 28.85 0.72 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.619 ' ND2' ' O ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER 51.7 20.8 1.19 Allowed 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.28 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.542 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 2.4 mt-30 -47.53 -38.38 14.0 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.731 HD11 ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER 82.19 104.16 0.06 Allowed 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.469 0.652 . . . . 0.0 110.565 179.135 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.835 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . . . -76.24 -31.92 58.62 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 140.23 163.81 9.66 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.677 HG21 ' CG ' ' A' ' 4' ' ' TYR . 58.9 t -94.73 124.47 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.068 -1.254 . . . . 0.0 109.491 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' A' ' 100' ' ' PHE . 1.0 OUTLIER -118.14 176.31 3.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.268 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 75' ' ' ALA . 8.3 t -144.16 147.34 33.55 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.045 -1.034 . . . . 0.0 110.419 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.642 ' NE2' ' CE2' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -96.88 76.71 2.75 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.535 -0.728 . . . . 0.0 109.134 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.431 ' OG1' ' C ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 176.17 123.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 0.0 109.809 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 116.33 -0.6 20.65 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.677 ' HB3' ' CB ' ' A' ' 99' ' ' ASN . . . -139.51 93.42 2.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.13 -1.218 . . . . 0.0 109.776 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER 41.65 85.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.427 -0.796 . . . . 0.0 109.743 179.642 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.17 -77.54 2.07 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.622 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -144.54 -77.02 0.22 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.161 -1.199 . . . . 0.0 109.892 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.677 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . 0.3 OUTLIER 59.43 155.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 108.535 -179.097 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.75 ' CD1' ' ND2' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -103.69 136.98 42.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.949 -1.095 . . . . 0.0 110.267 -179.521 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 0.9 OUTLIER -146.13 157.98 11.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.167 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 103' ' ' CYS . 12.4 pt-20 -60.5 130.72 48.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.149 -0.969 . . . . 0.0 109.737 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.422 ' C ' ' O ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -42.35 114.53 0.58 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.452 -0.78 . . . . 0.0 109.635 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.136 -0.935 . . . . 0.0 109.405 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.431 ' O ' ' SG ' ' A' ' 10' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.266 0.555 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.501 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.9 OUTLIER 169.72 115.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -0.862 . . . . 0.0 109.862 179.839 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -78.72 -31.65 46.51 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.338 -0.851 . . . . 0.0 108.981 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.617 ' CG ' HG21 ' A' ' 89' ' ' VAL . 18.3 m-85 -98.96 96.28 7.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.38 -0.825 . . . . 0.0 108.908 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.56 HG22 ' O ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -116.61 105.69 12.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.186 -0.947 . . . . 0.0 109.873 -179.705 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.583 ' O ' ' C ' ' A' ' 7' ' ' GLY . 87.4 m -82.85 -173.87 4.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.287 -0.883 . . . . 0.0 108.867 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.583 ' C ' ' O ' ' A' ' 6' ' ' CYS . . . 7.69 -77.26 0.0 OUTLIER Glycine 0 N--CA 1.507 3.372 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 6' ' ' CYS . 3.7 p -161.08 55.36 0.29 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.228 -1.16 . . . . 0.0 109.468 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.56 ' O ' HG22 ' A' ' 5' ' ' THR . 1.5 m-20 -117.28 -144.65 0.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.353 -0.842 . . . . 0.0 109.741 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.507 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 46.5 t -162.44 60.46 0.22 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.132 -0.98 . . . . 0.0 109.152 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 63' ' ' SER . 6.1 m-85 -86.78 113.2 22.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.5 -0.75 . . . . 0.0 109.333 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.535 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -87.94 131.41 34.61 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.255 -0.903 . . . . 0.0 109.835 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 12' ' ' SER . 1.8 p -45.33 -37.17 4.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.607 -0.683 . . . . 0.0 109.445 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.4 -47.26 84.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.376 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.16 -23.94 61.36 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.689 HG11 HG21 ' A' ' 78' ' ' VAL . 63.0 t -65.19 -31.97 56.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.6 t -61.66 -45.65 93.12 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.668 -0.645 . . . . 0.0 109.449 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.07 -49.53 77.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.121 -0.987 . . . . 0.0 108.608 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.709 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -71.08 -12.85 61.73 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.587 ' OE1' ' CG ' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -80.6 -34.07 35.44 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.506 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.98 -13.65 59.94 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.884 ' HB1' HG13 ' A' ' 67' ' ' VAL . . . -72.61 -41.13 65.92 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.609 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -81.72 -32.7 29.42 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.201 -1.559 . . . . 0.0 109.201 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.493 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 9.9 t80 -67.61 -40.8 84.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.426 -1.043 . . . . 0.0 109.758 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.406 ' O ' ' C ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -60.97 -66.53 0.52 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.912 . . . . 0.0 108.966 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.554 ' CD1' ' HB3' ' A' ' 31' ' ' GLU . 0.9 OUTLIER -43.85 -44.56 6.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.458 -0.776 . . . . 0.0 109.0 179.242 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.446 ' HB3' ' O ' ' A' ' 24' ' ' TYR . 2.0 t60 -49.75 -68.06 0.21 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.738 -0.601 . . . . 0.0 110.678 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -76.68 2.23 14.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.252 -0.905 . . . . 0.0 110.004 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.464 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 1.1 m-20 -82.93 -28.89 29.58 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.195 -0.941 . . . . 0.0 109.775 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.73 -15.33 63.32 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.554 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 3.2 tp10 -83.43 -149.0 0.09 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -1.154 . . . . 0.0 109.249 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.929 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.3 OUTLIER -159.19 -172.34 3.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.133 -0.979 . . . . 0.0 109.386 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.627 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -82.94 -95.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.924 . . . . 0.0 109.496 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.469 ' H ' HG23 ' A' ' 33' ' ' VAL . . . -115.2 -20.31 5.61 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.6 OUTLIER 167.21 -42.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.157 -1.202 . . . . 0.0 109.728 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 37' ' ' SER . 95.1 m-20 -77.25 -10.3 59.33 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.216 -0.928 . . . . 0.0 109.523 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.929 ' HA ' HG22 ' A' ' 32' ' ' THR . 4.0 p 62.08 135.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 109.183 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.674 ' H ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -121.44 -33.71 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.077 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -178.748 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.674 ' CD ' ' H ' ' A' ' 38' ' ' TYR . 36.3 Cg_endo -80.31 101.5 1.34 Allowed 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 121.304 1.336 . . . . 0.0 112.611 -178.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.491 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -138.78 134.95 34.13 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.244 -0.91 . . . . 0.0 109.801 177.931 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.609 ' HB2' ' CE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -51.02 131.02 26.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.166 -0.959 . . . . 0.0 109.384 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.537 ' CZ ' ' HA ' ' A' ' 44' ' ' ASN . 4.1 t80 -113.51 140.84 47.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.282 -0.886 . . . . 0.0 109.172 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.598 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 3.7 m-80 -85.87 -90.63 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.191 -0.943 . . . . 0.0 109.739 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.598 ' ND2' ' O ' ' A' ' 43' ' ' ASN . 0.5 OUTLIER 174.49 148.05 0.07 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 109.39 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.412 ' O ' ' C ' ' A' ' 46' ' ' GLU . 11.2 m-85 -139.69 -72.61 0.38 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.239 -0.913 . . . . 0.0 109.331 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.595 ' CB ' ' CZ ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -40.34 -37.83 0.72 Allowed 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.512 -0.743 . . . . 0.0 109.853 -179.604 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.86 62.22 0.75 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.595 ' CZ ' ' CB ' ' A' ' 46' ' ' GLU . 23.9 m-85 -90.78 -168.01 1.97 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.246 -1.149 . . . . 0.0 108.885 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.34 -39.36 2.2 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.152 -0.968 . . . . 0.0 109.538 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.527 ' CB ' ' OH ' ' A' ' 56' ' ' TYR . 18.3 m-85 47.26 -168.55 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.21 -0.931 . . . . 0.0 109.393 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.83 31.76 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 109.502 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.0 t -108.52 -66.61 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.927 . . . . 0.0 109.513 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.51 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 70.7 m -165.31 -179.9 5.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.088 -1.008 . . . . 0.0 110.049 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.576 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -79.51 -50.32 1.31 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.534 -0.728 . . . . 0.0 110.761 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 54' ' ' SER . 35.4 Cg_endo -75.79 81.36 2.39 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.986 1.791 . . . . 0.0 110.374 -178.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.594 ' O ' ' CD1' ' A' ' 57' ' ' TYR . 36.5 m-85 -79.27 -171.62 2.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.696 -0.628 . . . . 0.0 109.832 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.609 ' CE2' ' HB2' ' A' ' 41' ' ' LYS . 68.0 m-85 -155.4 158.44 38.64 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.509 ' HB2' ' CZ ' ' A' ' 77' ' ' ARG . 2.6 pt-20 -117.86 139.17 51.49 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.938 -1.102 . . . . 0.0 110.303 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.654 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 26.8 t-105 -159.9 138.64 7.8 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.654 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.5 Cg_endo -69.71 141.37 45.25 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.224 1.949 . . . . 0.0 111.469 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.958 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -109.31 140.3 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.958 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.9 OUTLIER -126.23 163.26 23.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.951 . . . . 0.0 109.764 -179.619 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . 9.3 t -132.99 25.91 4.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.358 -0.839 . . . . 0.0 109.351 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.69 -46.62 0.12 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.354 -0.841 . . . . 0.0 109.314 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . -78.52 -101.21 0.21 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 1.6 t0 175.61 -62.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -1.132 . . . . 0.0 109.569 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.884 HG13 ' HB1' ' A' ' 22' ' ' ALA . 11.7 t -127.84 126.18 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 109.756 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.605 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 6.2 t80 -63.44 136.31 57.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.158 -0.964 . . . . 0.0 109.304 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 p -161.44 53.31 0.26 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.55 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.498 ' O ' ' CE1' ' A' ' 68' ' ' TYR . . . 126.24 -165.96 19.21 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.74 -157.51 41.86 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.9 t -120.01 120.14 30.48 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.331 -1.099 . . . . 0.0 109.44 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.457 ' HB2' ' OH ' ' A' ' 38' ' ' TYR . 34.7 Cg_endo -77.73 172.91 14.93 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.295 1.996 . . . . 0.0 110.669 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.0 134.58 2.13 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.542 ' HA ' ' N ' ' A' ' 92' ' ' HIS . . . 55.88 -153.18 0.35 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -1.151 . . . . 0.0 109.479 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.498 ' O ' ' O ' ' A' ' 75' ' ' ALA . 45.6 m-20 20.75 106.74 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.509 ' CZ ' ' HB2' ' A' ' 58' ' ' GLU . 6.9 mtp-105 -160.06 135.38 8.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.154 -0.966 . . . . 0.0 108.584 178.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.689 HG21 HG11 ' A' ' 16' ' ' VAL . 3.9 p -123.99 135.1 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.739 -1.225 . . . . 0.0 109.638 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.626 HG23 ' CD1' ' A' ' 90' ' ' ILE . 29.9 t -92.39 166.13 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.973 0.892 . . . . 0.0 109.808 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.587 ' CG ' ' OE1' ' A' ' 20' ' ' GLN . 3.2 p90 -161.53 -178.92 6.92 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.189 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.491 ' ND2' ' HG2' ' A' ' 82' ' ' GLU . 11.8 t30 -112.48 -81.75 0.59 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 109.692 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.493 ' O ' ' CZ ' ' A' ' 24' ' ' TYR . 2.5 pt-20 -162.64 21.78 0.09 Allowed 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.464 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 2.4 m-20 -140.61 29.5 1.93 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.464 ' CG ' ' O ' ' A' ' 83' ' ' ASN . 1.7 p-10 46.95 24.5 0.37 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.502 0.668 . . . . 0.0 109.22 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 26.7 mm-40 -63.61 -106.73 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 174.42 114.55 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.739 179.081 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.541 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . . . -89.79 -42.24 11.4 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 161.28 155.0 7.67 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.617 HG21 ' CG ' ' A' ' 4' ' ' TYR . 32.0 t -92.05 88.72 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.334 -1.098 . . . . 0.0 109.285 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.626 ' CD1' HG23 ' A' ' 79' ' ' VAL . 1.2 pt -90.88 156.2 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.432 -0.793 . . . . 0.0 109.527 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.579 HG22 HG23 ' A' ' 101' ' ' VAL . 13.0 t -122.2 137.01 54.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.859 -1.151 . . . . 0.0 110.245 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.642 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -81.56 67.58 7.58 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.294 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 177.54 164.02 0.58 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.045 -1.034 . . . . 0.0 109.668 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.84 22.11 75.21 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.574 ' HB3' ' CB ' ' A' ' 99' ' ' ASN . . . -155.81 51.84 0.56 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -1.149 . . . . 0.0 109.353 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.7 m 68.07 93.66 0.07 Allowed 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.53 -83.9 1.1 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.642 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -139.07 -83.18 0.28 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -1.181 . . . . 0.0 109.177 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.574 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . 1.1 m-20 61.23 137.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.329 -0.857 . . . . 0.0 109.292 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.658 ' O ' HG13 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -85.85 151.63 23.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.117 -0.989 . . . . 0.0 109.385 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.658 HG13 ' O ' ' A' ' 100' ' ' PHE . 3.2 m -160.63 136.93 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.409 -0.807 . . . . 0.0 109.073 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -53.21 123.75 12.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.243 -0.911 . . . . 0.0 109.588 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -76.04 83.0 2.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.295 -0.878 . . . . 0.0 109.688 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.127 -0.983 . . . . 0.0 109.42 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.572 ' SG ' HG22 ' A' ' 5' ' ' THR . 6.0 t 62.38 91.93 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.881 . . . . 0.0 109.836 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -105.84 2.66 27.92 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.449 -0.782 . . . . 0.0 109.032 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.553 ' CG ' HG21 ' A' ' 89' ' ' VAL . 28.8 m-85 -121.14 67.89 0.88 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.267 -0.896 . . . . 0.0 109.402 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.572 HG22 ' SG ' ' A' ' 2' ' ' CYS . 11.6 p -79.74 124.62 28.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.905 . . . . 0.0 109.192 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.1 m -113.31 17.14 18.77 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.011 0.91 . . . . 0.0 110.069 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 136.02 -93.25 0.23 Allowed Glycine 0 C--N 1.282 -2.459 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.9 m -119.82 28.66 7.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -1.102 . . . . 0.0 109.29 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.453 ' O ' ' C ' ' A' ' 10' ' ' CYS . 1.7 m120 -111.53 -36.64 5.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 109.619 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' ASN . 1.7 t 41.33 80.4 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.413 -0.804 . . . . 0.0 109.469 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.633 ' CE2' ' CB ' ' A' ' 63' ' ' SER . 2.7 m-85 -86.6 148.34 25.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -0.833 . . . . 0.0 110.148 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.833 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -80.05 128.11 33.09 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.639 -0.663 . . . . 0.0 109.839 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.3 p -56.96 -18.52 13.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.921 . . . . 0.0 108.969 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.05 -30.33 15.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.264 -0.897 . . . . 0.0 109.592 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -73.55 -30.97 63.39 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 12' ' ' SER . 3.9 t -60.82 -32.07 51.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.03 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.3 t -60.38 -46.83 88.58 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.486 -0.759 . . . . 0.0 110.031 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -42.67 93.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.103 -0.998 . . . . 0.0 108.967 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.857 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -78.2 -11.63 59.94 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.511 -0.743 . . . . 0.0 109.16 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.593 ' NE2' ' CG ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -86.67 -26.6 24.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.367 -0.833 . . . . 0.0 108.984 179.617 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -83.98 -10.19 58.11 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.382 -0.824 . . . . 0.0 109.181 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.61 -47.43 17.15 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.35 -0.844 . . . . 0.0 109.276 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.608 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -75.29 -16.86 80.37 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.481 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 6.2 t80 -87.0 -63.4 1.31 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.444 -1.033 . . . . 0.0 109.544 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 29' ' ' ASP . 0.9 OUTLIER -46.95 -58.59 3.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.272 -0.893 . . . . 0.0 109.766 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.473 ' CD1' ' HB3' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -51.73 -47.08 64.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.295 -0.878 . . . . 0.0 109.773 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.628 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 2.9 t60 -52.9 -62.19 1.81 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.389 -0.82 . . . . 0.0 110.918 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -72.28 -7.23 48.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 109.735 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 13.7 t70 -78.46 -14.23 59.47 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.196 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.94 0.28 59.79 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.473 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 2.6 tp10 -94.43 -145.27 0.25 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.3 -1.118 . . . . 0.0 109.4 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.913 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -163.62 179.51 7.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 109.573 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.484 HG23 ' N ' ' A' ' 34' ' ' GLY . 17.1 m -89.41 -120.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 109.305 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.484 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -65.57 -42.35 95.64 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER 169.72 -38.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.311 -1.111 . . . . 0.0 109.549 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 37' ' ' SER . 5.4 m120 -65.46 -11.79 46.37 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.23 -0.919 . . . . 0.0 109.674 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.913 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.7 OUTLIER 59.66 114.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 0.0 109.129 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.668 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -107.65 -27.39 0.18 Allowed Pre-proline 0 N--CA 1.498 1.966 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -178.69 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.668 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 36.5 Cg_endo -79.4 102.51 1.51 Allowed 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 121.318 1.345 . . . . 0.0 113.167 -178.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.49 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -131.2 165.31 23.62 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.16 -0.962 . . . . 0.0 109.179 177.263 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.635 ' HB2' ' CE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -73.79 132.28 42.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 109.31 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.598 ' CZ ' ' HA ' ' A' ' 44' ' ' ASN . 26.9 t80 -100.97 134.26 44.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.367 -0.833 . . . . 0.0 109.351 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -103.24 -8.64 20.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.185 -0.947 . . . . 0.0 109.728 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.598 ' HA ' ' CZ ' ' A' ' 42' ' ' TYR . 2.2 m120 62.16 175.0 0.13 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.692 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.458 ' O ' ' C ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -179.15 -45.25 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.388 -0.82 . . . . 0.0 108.986 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.576 ' OE1' ' CZ ' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -38.52 -44.4 0.95 Allowed 'General case' 0 C--N 1.307 -1.242 0 O-C-N 121.696 -0.627 . . . . 0.0 109.945 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.55 47.12 0.09 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.576 ' CZ ' ' OE1' ' A' ' 46' ' ' GLU . 16.0 m-85 -106.58 139.76 40.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -1.184 . . . . 0.0 109.379 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.64 -30.85 11.53 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.285 -0.884 . . . . 0.0 109.262 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.552 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 30.1 m-85 50.93 -170.52 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.42 -0.8 . . . . 0.0 109.743 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.21 44.42 0.48 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.362 -0.836 . . . . 0.0 109.364 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.529 HG12 ' OD1' ' A' ' 81' ' ' ASN . 54.8 t -121.53 -45.34 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.263 -0.898 . . . . 0.0 109.636 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.579 ' O ' ' CE1' ' A' ' 56' ' ' TYR . 0.6 OUTLIER 167.72 -176.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.111 -0.993 . . . . 0.0 109.936 -179.64 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.558 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -86.4 -54.41 0.4 Allowed Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.373 -0.829 . . . . 0.0 111.646 -179.051 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 54' ' ' SER . 33.7 Cg_endo -73.1 86.02 1.16 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.045 1.83 . . . . 0.0 110.607 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.65 ' CE2' ' HB1' ' A' ' 87' ' ' ALA . 3.7 m-30 -87.21 -173.5 4.44 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.461 0.648 . . . . 0.0 110.054 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.635 ' CE2' ' HB2' ' A' ' 41' ' ' LYS . 75.7 m-85 -156.63 116.67 3.57 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -77.54 140.74 39.78 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.83 0.824 . . . . 0.0 110.968 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.653 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 20.9 t-105 -160.64 137.53 6.59 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.653 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.7 Cg_endo -68.94 147.05 67.26 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.138 1.892 . . . . 0.0 111.424 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.994 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -121.09 126.0 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.536 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.994 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.3 OUTLIER -122.72 166.1 15.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.278 -0.889 . . . . 0.0 109.284 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.633 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -130.91 7.42 4.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.289 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.97 -69.85 0.54 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.259 -0.901 . . . . 0.0 109.338 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 158.31 60.61 0.01 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -175.58 139.29 0.42 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -1.17 . . . . 0.0 109.461 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.476 HG13 ' HZ2' ' A' ' 59' ' ' TRP . 91.5 t -77.3 147.6 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.0 109.441 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.547 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 0.7 OUTLIER -65.38 166.61 9.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 109.749 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.41 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 5.7 m -169.2 49.87 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.434 -0.791 . . . . 0.0 109.14 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.45 114.91 0.92 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 72' ' ' SER . . . -178.64 39.4 0.08 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 1.4 p 75.14 109.7 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.248 -1.148 . . . . 0.0 109.584 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.531 ' HA ' ' NH2' ' A' ' 77' ' ' ARG . 36.2 Cg_endo -79.41 119.68 4.23 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.49 2.127 . . . . 0.0 110.555 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.505 ' HA2' ' HB2' ' A' ' 92' ' ' HIS . . . 170.0 -168.9 41.77 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . 47.74 -154.77 0.07 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -1.166 . . . . 0.0 110.506 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 51.8 m-20 -39.53 129.26 1.9 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.549 0.69 . . . . 0.0 109.619 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.544 ' CZ ' ' HB3' ' A' ' 60' ' ' PRO . 23.4 mmt-85 -158.43 122.25 3.99 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.723 HG21 ' CG1' ' A' ' 16' ' ' VAL . 0.9 OUTLIER -105.25 148.61 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.263 -0.898 . . . . 0.0 109.812 -178.941 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.643 HG12 ' H ' ' A' ' 80' ' ' PHE . 2.0 t -121.52 174.55 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.962 0.886 . . . . 0.0 109.673 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.643 ' H ' HG12 ' A' ' 79' ' ' VAL . 4.4 p90 -173.92 -167.87 0.38 Allowed 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.354 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.558 ' OD1' ' CE1' ' A' ' 56' ' ' TYR . 3.1 m120 -120.49 -80.57 0.62 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.266 -0.897 . . . . 0.0 109.794 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.412 ' OE1' ' O ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -163.43 23.98 0.08 Allowed 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.471 ' O ' ' HB3' ' A' ' 84' ' ' ASN . 14.5 m120 -148.91 16.28 0.96 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.483 -0.761 . . . . 0.0 109.056 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 83' ' ' ASN . 21.4 t30 62.32 13.89 6.35 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.366 -0.834 . . . . 0.0 109.348 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.562 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -46.89 -32.08 3.54 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.67 -1.234 . . . . 0.0 107.67 179.315 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.562 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.2 OUTLIER 84.95 110.58 0.05 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.534 0.683 . . . . 0.0 110.528 179.211 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.65 ' HB1' ' CE2' ' A' ' 56' ' ' TYR . . . -82.63 -43.48 16.93 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.561 ' O ' HG22 ' A' ' 78' ' ' VAL . . . 158.93 -161.14 31.71 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.553 HG21 ' CG ' ' A' ' 4' ' ' TYR . 39.1 t -134.96 92.46 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -1.179 . . . . 0.0 109.252 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.573 ' HB ' ' HB3' ' A' ' 100' ' ' PHE . 0.6 OUTLIER -94.41 151.45 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.4 -0.812 . . . . 0.0 109.858 -179.668 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.2 t -125.85 134.58 51.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 109.731 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.695 ' CD2' ' CD1' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -82.61 74.64 9.57 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.323 -0.86 . . . . 0.0 108.99 179.733 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 7.9 m -169.68 135.37 1.49 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.492 -0.755 . . . . 0.0 109.466 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 93.42 24.11 22.36 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.725 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . . . -156.51 91.5 1.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.132 -1.217 . . . . 0.0 109.682 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 95' ' ' ALA . 1.7 t 43.78 79.35 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.304 -0.873 . . . . 0.0 109.314 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.62 -70.5 3.16 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.62 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -148.76 -82.15 0.12 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -1.1 . . . . 0.0 109.318 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.725 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 4.3 m-20 60.73 138.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.372 -0.83 . . . . 0.0 109.315 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.695 ' CD1' ' CD2' ' A' ' 92' ' ' HIS . 0.6 OUTLIER -79.12 148.86 32.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.058 -1.026 . . . . 0.0 109.85 -179.588 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -151.94 114.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.411 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 1.7 pt-20 -43.71 131.26 5.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.326 -0.859 . . . . 0.0 109.575 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.518 ' HB3' ' O ' ' A' ' 5' ' ' THR . 84.0 m -72.31 106.26 4.39 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.324 -0.86 . . . . 0.0 109.401 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.826 -1.083 . . . . 0.0 109.54 -179.833 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 15.3 p 176.45 98.12 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.108 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -67.66 -19.41 65.19 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.319 -0.863 . . . . 0.0 108.895 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.682 ' CG ' HG21 ' A' ' 89' ' ' VAL . 39.4 m-85 -103.46 81.55 1.93 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.654 ' O ' HG22 ' A' ' 5' ' ' THR . 46.8 m -101.1 69.44 1.3 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.397 -0.814 . . . . 0.0 110.473 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.518 ' O ' ' N ' ' A' ' 8' ' ' SER . 3.9 m -80.6 154.58 27.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.036 -1.04 . . . . 0.0 108.505 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 6' ' ' CYS . . . 44.06 -94.98 0.01 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 6' ' ' CYS . 2.4 t -159.28 40.85 0.21 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -1.114 . . . . 0.0 109.1 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.442 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 2.8 m-80 -94.88 -35.88 11.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.919 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.431 ' C ' ' CB ' ' A' ' 2' ' ' CYS . 42.3 t 56.46 59.98 3.35 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.065 -1.022 . . . . 0.0 108.637 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.587 ' CE2' ' HB2' ' A' ' 63' ' ' SER . 2.9 m-30 -89.49 144.27 26.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.432 -0.792 . . . . 0.0 110.177 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.843 ' O ' HG23 ' A' ' 16' ' ' VAL . 4.0 m -82.85 133.81 35.12 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.578 -0.701 . . . . 0.0 109.966 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.1 p -62.56 -23.39 66.97 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.0 t -79.47 -33.1 42.61 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.457 ' HB2' ' HB2' ' A' ' 12' ' ' SER . 5.4 m-20 -77.38 -27.27 52.46 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 12' ' ' SER . 25.6 t -63.58 -24.27 35.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.429 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 15.0 t -66.52 -42.83 86.67 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.7 -42.27 99.55 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.834 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -74.33 -14.44 60.89 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.539 ' OE1' ' CB ' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -82.27 -30.6 30.55 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.498 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.62 -13.69 59.7 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.474 ' HB1' HG11 ' A' ' 67' ' ' VAL . . . -73.31 -58.53 3.24 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.563 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -61.64 -22.46 61.78 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.458 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 16.8 t80 -75.84 -37.32 59.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.555 -0.967 . . . . 0.0 109.127 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -69.74 -46.34 66.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.836 . . . . 0.0 108.849 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.984 HD22 HG13 ' A' ' 33' ' ' VAL . 9.5 tp -71.54 -18.06 62.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.392 -0.817 . . . . 0.0 108.87 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.621 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 55.1 t60 -89.66 -20.5 23.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.516 -0.74 . . . . 0.0 109.397 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.17 -23.26 24.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 109.338 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -97.78 -10.09 25.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.355 -0.84 . . . . 0.0 109.508 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.75 18.74 70.62 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.564 ' CG ' ' N ' ' A' ' 32' ' ' THR . 34.1 tt0 -88.8 167.08 13.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -1.171 . . . . 0.0 109.646 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.882 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -104.01 166.68 10.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.504 -0.747 . . . . 0.0 109.412 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.984 HG13 HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -102.56 -79.06 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.062 -1.024 . . . . 0.0 109.685 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -72.62 -44.05 41.5 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.5 OUTLIER 163.32 -33.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.326 -1.102 . . . . 0.0 109.327 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 37' ' ' SER . 58.6 m-20 -76.77 -77.2 0.15 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.255 -0.903 . . . . 0.0 109.184 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.882 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.1 OUTLIER 158.1 128.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.617 ' H ' ' CD ' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -120.43 -37.31 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.838 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -178.593 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.617 ' CD ' ' H ' ' A' ' 38' ' ' TYR . 35.1 Cg_endo -80.42 101.93 1.37 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 120.975 1.117 . . . . 0.0 112.485 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.543 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -132.12 -172.05 2.79 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.365 -0.835 . . . . 0.0 109.267 178.121 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -81.74 158.22 24.26 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.824 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 1.2 t80 -121.38 124.1 43.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.102 -0.998 . . . . 0.0 109.747 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -110.24 -75.22 0.63 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 108.543 179.295 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 0.4 OUTLIER 77.15 -76.03 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.363 -0.836 . . . . 0.0 110.458 179.002 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 56.66 45.69 21.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.925 -1.109 . . . . 0.0 109.115 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.581 ' HG2' ' CE2' ' A' ' 48' ' ' PHE . 0.8 OUTLIER -94.2 -28.42 15.64 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.249 -0.907 . . . . 0.0 109.306 -179.668 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 159.84 -23.61 0.29 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.581 ' CE2' ' HG2' ' A' ' 46' ' ' GLU . 3.5 p90 -111.87 139.74 47.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.431 -1.041 . . . . 0.0 109.225 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 50' ' ' PHE . 2.4 m-20 -122.8 -23.79 4.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.682 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.517 ' CB ' ' O ' ' A' ' 49' ' ' ASP . 3.1 m-85 80.54 173.82 0.13 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.363 -0.835 . . . . 0.0 109.382 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.9 p -120.74 39.48 3.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.219 -0.925 . . . . 0.0 109.625 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.496 HG21 ' HA ' ' A' ' 87' ' ' ALA . 15.0 t -98.58 -67.14 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.157 -0.964 . . . . 0.0 109.505 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.444 ' O ' ' CE2' ' A' ' 56' ' ' TYR . 0.2 OUTLIER -165.55 174.98 9.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.097 -1.002 . . . . 0.0 109.996 -179.702 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.584 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -79.22 -51.04 1.3 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.46 -0.775 . . . . 0.0 110.61 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 54' ' ' SER . 36.2 Cg_endo -76.25 82.85 2.12 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.94 1.76 . . . . 0.0 110.208 -178.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.541 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 49.0 m-85 -79.35 -178.15 6.09 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.561 0.696 . . . . 0.0 109.712 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.621 ' CE1' ' NE2' ' A' ' 27' ' ' HIS . 97.1 m-85 -158.13 135.63 10.32 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.474 ' OE2' ' O ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -96.03 140.5 30.68 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.094 -1.003 . . . . 0.0 111.589 -178.115 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.716 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 27.5 t-105 -160.81 139.29 7.42 Favored Pre-proline 0 N--CA 1.495 1.799 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.716 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 31.6 Cg_endo -70.09 143.15 48.39 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.161 1.907 . . . . 0.0 111.321 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 1.031 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -107.02 116.29 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.56 -0.712 . . . . 0.0 109.512 -179.638 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.031 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.7 OUTLIER -116.94 164.04 15.3 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.296 -0.878 . . . . 0.0 108.985 179.494 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.587 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -172.48 56.32 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.55 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 177.14 36.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.271 -0.893 . . . . 0.0 109.118 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.04 -70.31 0.08 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -173.74 167.75 4.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.202 -1.175 . . . . 0.0 109.77 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.474 HG11 ' HB1' ' A' ' 22' ' ' ALA . 39.8 t -62.59 150.1 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.331 -0.856 . . . . 0.0 109.298 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.596 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 17.1 t80 -52.0 138.86 24.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.966 -1.084 . . . . 0.0 109.533 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.458 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 5.0 t -159.9 21.9 0.17 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.393 -0.817 . . . . 0.0 109.69 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 130.98 154.7 7.98 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.91 -133.5 6.8 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.97 131.07 21.98 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.145 -1.209 . . . . 0.0 109.175 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.475 ' HA ' ' OH ' ' A' ' 38' ' ' TYR . 36.2 Cg_endo -79.48 -172.57 1.57 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.406 2.071 . . . . 0.0 111.012 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.704 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 74.52 -167.74 54.68 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.704 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 77.6 -152.02 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.246 -1.149 . . . . 0.0 110.459 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.24 162.65 9.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.391 -0.818 . . . . 0.0 109.811 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.573 ' O ' HG12 ' A' ' 90' ' ' ILE . 0.9 OUTLIER 175.1 96.59 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.176 -0.952 . . . . 0.0 109.149 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.032 HG21 HD21 ' A' ' 86' ' ' LEU . 2.6 p -77.02 140.12 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.884 -1.135 . . . . 0.0 110.579 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.577 ' CG1' ' N ' ' A' ' 80' ' ' PHE . 16.7 t -92.53 169.44 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.577 ' CE1' ' O ' ' A' ' 57' ' ' TYR . 4.6 p90 -162.84 -173.31 3.43 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.629 -0.829 . . . . 0.0 109.502 -178.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.483 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 6.4 t30 -124.0 -81.77 0.64 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.17 -0.956 . . . . 0.0 109.405 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 81' ' ' ASN . 65.9 mt-10 -156.4 12.82 0.29 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.459 -0.776 . . . . 0.0 110.317 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.638 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 0.1 OUTLIER -137.9 6.01 2.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.023 -1.048 . . . . 0.0 109.489 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.638 ' ND2' ' O ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER 70.91 16.14 6.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.448 -0.783 . . . . 0.0 109.441 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.586 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -53.72 -31.29 47.69 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.383 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.032 HD21 HG21 ' A' ' 78' ' ' VAL . 0.6 OUTLIER 89.21 103.28 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.686 0.755 . . . . 0.0 110.599 179.226 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.496 ' HA ' HG21 ' A' ' 52' ' ' VAL . . . -70.97 -52.59 18.85 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.25 171.29 34.79 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.682 HG21 ' CG ' ' A' ' 4' ' ' TYR . 64.3 t -102.91 124.69 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.937 -1.331 . . . . 0.0 109.906 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.588 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 0.5 OUTLIER -125.59 153.22 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.331 -0.856 . . . . 0.0 108.696 179.553 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 99' ' ' ASN . 6.3 t -117.07 165.49 13.32 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.026 -1.046 . . . . 0.0 110.019 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.62 ' NE2' ' CD2' ' A' ' 100' ' ' PHE . 0.4 OUTLIER -121.11 67.27 0.87 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.437 -0.789 . . . . 0.0 109.28 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 7.4 m -168.81 126.22 1.01 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.462 -0.773 . . . . 0.0 109.292 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 107.96 -20.57 31.03 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 98' ' ' ASN . . . -105.83 93.94 4.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.211 -1.17 . . . . 0.0 109.681 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 95' ' ' ALA . 51.7 m 41.59 52.58 3.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.511 -0.743 . . . . 0.0 109.477 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.1 -73.29 0.21 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.602 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -144.38 -81.96 0.16 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.259 -1.142 . . . . 0.0 109.472 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 92' ' ' HIS . 0.8 OUTLIER 57.06 159.29 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.317 -0.864 . . . . 0.0 109.15 -179.519 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.62 ' CD2' ' NE2' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -96.61 145.17 25.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.902 -1.124 . . . . 0.0 110.04 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.443 ' O ' ' C ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -155.97 130.55 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.293 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 101' ' ' VAL . 2.3 pt-20 -39.98 136.83 1.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.468 -0.77 . . . . 0.0 110.124 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.99 123.83 29.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.395 -0.816 . . . . 0.0 109.382 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.1 p . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.171 -0.955 . . . . 0.0 109.38 179.844 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.443 ' O ' ' SG ' ' A' ' 10' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.598 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 0.8 OUTLIER 173.94 106.91 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.279 -0.888 . . . . 0.0 110.398 179.558 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -79.66 -14.74 58.57 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.722 ' CG ' HG21 ' A' ' 89' ' ' VAL . 16.2 m-85 -112.8 126.94 55.97 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.337 -0.852 . . . . 0.0 109.051 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 7' ' ' GLY . 1.2 m -152.83 109.32 3.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.235 -0.916 . . . . 0.0 109.744 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 103' ' ' CYS . 29.9 m -95.44 16.81 15.96 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.066 0.936 . . . . 0.0 109.557 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.468 ' O ' HG22 ' A' ' 5' ' ' THR . . . -177.65 -146.47 6.31 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 p -88.17 15.11 7.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.208 -1.172 . . . . 0.0 109.304 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -79.67 -168.18 1.49 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.322 -0.861 . . . . 0.0 109.664 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 1' ' ' ALA . 45.6 t -149.55 74.3 1.22 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.5 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 4.2 m-85 -80.44 124.6 29.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.393 -0.817 . . . . 0.0 110.041 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.772 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -83.79 124.79 31.28 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.502 -0.749 . . . . 0.0 109.63 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 12' ' ' SER . 28.3 t -46.39 -25.67 0.69 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.239 -0.913 . . . . 0.0 108.754 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.3 t -76.91 -43.36 35.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 109.285 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.41 -26.09 67.07 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.886 HG13 HG12 ' A' ' 61' ' ' ILE . 3.0 t -72.87 -32.99 42.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.91 -42.31 97.83 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -47.32 86.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 108.628 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 1.088 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -75.9 -10.59 59.55 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.635 ' NE2' ' CG ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -83.17 -30.61 27.68 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.922 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.425 ' HA ' ' HB3' ' A' ' 24' ' ' TYR . . . -80.25 -16.73 54.07 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.38 -47.27 61.7 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.557 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -73.14 -31.21 61.88 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.684 -1.766 . . . . 0.0 108.684 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.425 ' HB3' ' HA ' ' A' ' 21' ' ' ALA . 11.2 t80 -68.23 -32.15 72.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.46 -1.024 . . . . 0.0 109.171 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -73.36 -47.9 38.57 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.732 HD21 ' C ' ' A' ' 32' ' ' THR . 5.6 tp -65.25 -21.2 66.71 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.088 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -85.65 -24.76 26.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.526 -0.734 . . . . 0.0 109.516 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -88.12 -11.55 46.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.319 -0.863 . . . . 0.0 109.403 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -107.88 -11.57 15.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.374 -0.829 . . . . 0.0 109.721 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.64 14.89 77.71 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.426 ' O ' HG23 ' A' ' 32' ' ' THR . 0.3 OUTLIER -81.27 -157.17 0.16 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -1.207 . . . . 0.0 109.379 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.826 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -158.19 166.79 31.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.322 -0.861 . . . . 0.0 109.254 179.801 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.607 HG13 HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -110.33 -70.44 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.144 -0.973 . . . . 0.0 109.585 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 35' ' ' SER . . . -85.93 16.45 42.15 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 0.5 OUTLIER 66.36 19.73 10.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.132 -1.217 . . . . 0.0 109.114 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -120.92 5.58 10.42 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.402 -0.811 . . . . 0.0 109.293 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.826 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.3 OUTLIER 68.3 73.51 0.29 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.224 -0.922 . . . . 0.0 108.653 -179.179 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.654 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -71.67 -45.33 12.63 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.117 -0.99 . . . . 0.0 110.938 -179.367 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 35.3 Cg_endo -77.15 106.61 2.27 Favored 'Trans proline' 0 C--N 1.3 -1.993 0 C-N-CA 120.855 1.037 . . . . 0.0 109.873 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.654 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -127.09 -175.37 3.41 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -107.13 143.34 35.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.943 -1.098 . . . . 0.0 110.367 -179.454 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.54 ' HB3' ' CB ' ' A' ' 56' ' ' TYR . 12.0 t80 -104.11 161.59 13.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.503 -0.748 . . . . 0.0 109.245 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 44' ' ' ASN . 0.5 OUTLIER -123.83 -16.22 6.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.124 -0.985 . . . . 0.0 109.567 179.615 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.543 ' O ' ' CD2' ' A' ' 45' ' ' TYR . 0.7 OUTLIER 62.1 130.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.556 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.543 ' CD2' ' O ' ' A' ' 44' ' ' ASN . 5.6 m-85 -161.44 -38.54 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.399 -0.813 . . . . 0.0 109.126 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.818 ' OE2' HG12 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -37.93 -68.36 0.16 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.469 0.652 . . . . 0.0 110.131 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.56 61.14 0.01 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -89.62 -174.75 4.44 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.358 -1.084 . . . . 0.0 108.61 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -117.09 -20.4 9.32 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.897 -1.127 . . . . 0.0 110.043 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.511 ' CD1' ' C ' ' A' ' 50' ' ' PHE . 10.1 p90 -80.74 179.97 7.54 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.129 -0.982 . . . . 0.0 109.438 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.475 ' HA ' ' OH ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -177.4 57.08 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.259 -0.9 . . . . 0.0 109.254 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.711 HG11 ' HB2' ' A' ' 85' ' ' GLN . 42.3 t -45.03 -63.13 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.165 -0.959 . . . . 0.0 109.023 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.408 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -154.75 -178.97 7.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.312 -0.868 . . . . 0.0 109.95 179.972 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.588 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -79.7 -50.09 1.29 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.405 -0.809 . . . . 0.0 110.81 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 54' ' ' SER . 34.5 Cg_endo -75.28 83.62 1.83 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.991 1.794 . . . . 0.0 109.764 -178.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.621 ' CE1' ' HB2' ' A' ' 87' ' ' ALA . 10.1 m-85 -81.68 179.82 7.68 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.745 0.783 . . . . 0.0 110.804 -178.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.577 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 64.4 m-85 -157.26 117.12 3.43 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.624 ' HG2' HD11 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -96.66 147.66 23.66 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.266 -0.896 . . . . 0.0 110.489 -178.584 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.696 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 4.1 t-105 -160.75 143.93 9.83 Favored Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.696 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 28.4 Cg_endo -66.35 133.03 31.17 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.336 2.024 . . . . 0.0 112.091 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 1.088 HD13 ' HB3' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -118.31 115.66 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.704 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.023 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -118.58 163.75 16.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.107 -0.996 . . . . 0.0 109.13 179.761 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.1 t -131.53 36.17 3.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.484 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.73 6.8 12.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.18 -0.95 . . . . 0.0 109.618 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.71 -32.7 7.26 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.991 ' O ' HD12 ' A' ' 62' ' ' LEU . 11.9 m-20 -98.97 91.39 5.01 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.23 -1.159 . . . . 0.0 109.375 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.584 ' O ' ' CD1' ' A' ' 68' ' ' TYR . 43.4 t -65.02 156.75 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 109.857 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.589 ' HB3' ' CZ2' ' A' ' 59' ' ' TRP . 48.6 p90 39.17 -162.69 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.598 0.713 . . . . 0.0 110.023 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.492 ' N ' ' CD2' ' A' ' 68' ' ' TYR . 29.0 t 53.11 173.22 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.342 -0.849 . . . . 0.0 109.427 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.63 -160.45 15.99 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.66 41.32 2.25 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 t -161.26 85.95 1.72 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.221 -1.164 . . . . 0.0 109.306 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.557 ' HA ' ' OH ' ' A' ' 38' ' ' TYR . 35.5 Cg_endo -79.95 44.05 1.64 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.789 2.326 . . . . 0.0 111.022 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.631 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . -173.03 -167.52 33.05 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 72.28 -141.89 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.117 -1.225 . . . . 0.0 110.162 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.465 ' C ' ' O ' ' A' ' 75' ' ' ALA . 1.2 m-20 -34.2 131.14 0.31 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.444 -0.785 . . . . 0.0 111.21 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.519 ' O ' HG12 ' A' ' 90' ' ' ILE . 6.5 ttm-85 -167.24 110.11 0.68 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.469 -0.769 . . . . 0.0 108.989 179.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.797 HG23 HD11 ' A' ' 86' ' ' LEU . 4.3 p -71.95 164.62 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.069 -1.019 . . . . 0.0 109.67 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 1.021 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 4.0 t -130.52 171.36 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.973 0.892 . . . . 0.0 109.961 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.638 ' H ' HG12 ' A' ' 79' ' ' VAL . 24.0 p90 -174.02 -172.46 0.72 Allowed 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.418 ' CG ' ' N ' ' A' ' 82' ' ' GLU . 2.9 t30 -125.33 -84.9 0.64 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.962 -1.087 . . . . 0.0 109.794 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.418 ' N ' ' CG ' ' A' ' 81' ' ' ASN . 6.9 mt-10 -142.16 0.55 1.36 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.494 -0.753 . . . . 0.0 109.919 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 84' ' ' ASN . 8.7 m-20 -131.4 4.81 4.35 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 108.895 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.515 ' OD1' ' HB3' ' A' ' 20' ' ' GLN . 5.5 t30 75.1 32.43 0.77 Allowed 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.334 -0.854 . . . . 0.0 109.192 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.711 ' HB2' HG11 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -62.16 -33.16 73.98 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.46 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.797 HD11 HG23 ' A' ' 78' ' ' VAL . 0.1 OUTLIER 84.99 103.95 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.488 0.661 . . . . 0.0 110.994 178.937 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 1.021 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . . . -74.54 -27.8 60.68 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.42 ' H ' ' CD1' ' A' ' 86' ' ' LEU . . . 148.14 -149.03 21.04 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.722 HG21 ' CG ' ' A' ' 4' ' ' TYR . 72.5 t -129.85 87.71 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.254 -1.145 . . . . 0.0 109.639 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.624 HD11 ' HG2' ' A' ' 58' ' ' GLU . 12.2 pt -79.4 136.24 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.514 -0.741 . . . . 0.0 109.221 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.631 ' O ' HG23 ' A' ' 91' ' ' THR . 13.1 t -130.5 118.54 21.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.91 . . . . 0.0 110.296 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.813 ' CE1' ' CE2' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -84.01 76.42 10.06 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.368 -0.832 . . . . 0.0 108.848 179.279 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 1.4 m 178.96 -30.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.553 -0.717 . . . . 0.0 109.404 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -59.04 -15.01 27.23 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.887 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . . . -117.96 163.68 16.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.186 -1.185 . . . . 0.0 109.553 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 95' ' ' ALA . 3.7 m -42.92 120.33 1.75 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 109.008 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.97 -82.84 1.64 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.654 -1.779 . . . . 0.0 108.654 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.632 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -151.9 -86.81 0.07 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.318 -1.107 . . . . 0.0 109.287 179.419 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.887 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 4.0 m-80 61.04 129.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 108.937 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.813 ' CE2' ' CE1' ' A' ' 92' ' ' HIS . 57.0 m-85 -85.33 125.58 33.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.891 -1.131 . . . . 0.0 110.292 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.818 HG12 ' OE2' ' A' ' 46' ' ' GLU . 1.2 m -142.69 137.51 27.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.497 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 24.0 pt-20 -61.52 123.61 18.35 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.164 -0.96 . . . . 0.0 109.221 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.448 ' HB3' ' HA ' ' A' ' 6' ' ' CYS . 84.7 m -56.93 161.01 3.17 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.151 -0.968 . . . . 0.0 109.398 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.479 0 O-C-N 121.22 -0.925 . . . . 0.0 109.492 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 27.2 p -178.77 88.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.145 -0.972 . . . . 0.0 109.956 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -89.9 2.72 54.71 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.296 -0.878 . . . . 0.0 109.285 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -126.57 105.74 8.94 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.112 -0.992 . . . . 0.0 109.637 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.644 HG23 ' O ' ' A' ' 5' ' ' THR . 6.0 t -136.43 106.79 6.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.892 . . . . 0.0 109.318 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.47 ' SG ' ' HB ' ' A' ' 91' ' ' THR . 57.3 m -93.47 17.14 11.99 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.17 0.986 . . . . 0.0 109.63 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.48 -111.77 0.32 Allowed Glycine 0 C--N 1.282 -2.432 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.14 3.93 12.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.15 -1.206 . . . . 0.0 109.271 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.562 ' O ' ' N ' ' A' ' 11' ' ' TYR . 3.9 m120 -92.51 68.12 4.79 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.246 -0.909 . . . . 0.0 109.411 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -49.74 89.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.567 ' CZ ' ' OG ' ' A' ' 63' ' ' SER . 4.0 m-30 -83.17 144.6 29.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.456 -0.778 . . . . 0.0 110.173 -178.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.601 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 0.1 OUTLIER -79.18 127.84 32.54 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.818 -0.551 . . . . 0.0 110.042 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.35 -43.19 61.74 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.9 m -62.68 -34.52 77.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.378 -0.826 . . . . 0.0 108.958 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -69.22 -31.1 69.45 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 12' ' ' SER . 6.7 t -58.82 -25.43 29.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.469 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 20.3 t -74.4 -40.6 61.93 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -40.44 80.36 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.74 ' CB ' HD13 ' A' ' 61' ' ' ILE . . . -77.06 -26.43 53.56 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.782 ' NE2' HG13 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -75.03 -16.62 60.59 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.056 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -92.62 -11.71 33.54 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.95 -56.2 3.95 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.581 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -69.16 -24.13 76.02 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.565 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 11.0 t80 -77.99 -53.33 7.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.501 -1.0 . . . . 0.0 109.048 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 1.1 tm0? -45.64 -47.15 14.89 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.559 ' CD1' ' N ' ' A' ' 32' ' ' THR . 1.0 OUTLIER -59.79 -48.87 79.93 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.389 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.465 ' NE2' ' CZ ' ' A' ' 57' ' ' TYR . 9.1 t60 -59.06 -14.51 9.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.264 -0.898 . . . . 0.0 110.367 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -96.0 -28.18 14.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.89 -1.131 . . . . 0.0 109.957 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.39 8.0 45.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.115 -0.99 . . . . 0.0 109.432 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 48.62 34.07 13.62 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.536 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -102.17 -147.72 0.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -1.169 . . . . 0.0 109.429 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.99 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.3 OUTLIER -157.87 -178.19 7.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.064 -1.022 . . . . 0.0 110.016 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.521 HG23 ' N ' ' A' ' 34' ' ' GLY . 25.8 m -98.81 -139.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.878 . . . . 0.0 109.515 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.521 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -42.27 -51.41 5.32 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 173.62 -31.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.263 -1.14 . . . . 0.0 109.635 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.445 ' O ' ' CB ' ' A' ' 37' ' ' SER . 5.8 m120 -74.82 -7.38 53.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.25 -0.906 . . . . 0.0 109.573 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.99 ' HA ' HG22 ' A' ' 32' ' ' THR . 2.4 p 71.84 -165.33 0.13 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -0.922 . . . . 0.0 109.481 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.723 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.2 OUTLIER 167.64 -45.03 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.482 -0.761 . . . . 0.0 111.269 179.435 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 31.8 Cg_endo -76.59 100.68 1.42 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 121.482 1.455 . . . . 0.0 112.025 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.723 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -140.33 163.44 32.77 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.591 -0.693 . . . . 0.0 109.513 178.735 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -58.06 154.13 13.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.795 -1.19 . . . . 0.0 108.664 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.631 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -136.74 155.22 50.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.124 -0.985 . . . . 0.0 110.044 -178.562 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.612 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . 0.7 OUTLIER -137.82 -71.99 0.42 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.537 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.631 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 8.4 t30 80.18 -69.66 0.1 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.593 -0.692 . . . . 0.0 111.411 178.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.612 ' CE2' ' HB3' ' A' ' 43' ' ' ASN . 86.6 m-85 67.41 9.12 6.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 108.846 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.605 ' HB2' ' ND2' ' A' ' 44' ' ' ASN . 0.4 OUTLIER -39.33 -50.72 2.05 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 121.557 -0.715 . . . . 0.0 109.809 -179.725 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 159.37 36.71 0.02 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.509 ' CE2' ' HB3' ' A' ' 46' ' ' GLU . 7.5 m-85 -115.64 -179.91 3.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.243 -1.151 . . . . 0.0 109.346 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -128.73 -34.68 1.96 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.464 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.528 ' CB ' ' OH ' ' A' ' 56' ' ' TYR . 16.8 m-30 55.21 179.12 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 109.916 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.6 p -139.76 21.04 2.5 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.573 HG12 ' N ' ' A' ' 53' ' ' SER . 77.1 t -95.42 -92.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.544 -0.722 . . . . 0.0 109.843 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.573 ' N ' HG12 ' A' ' 52' ' ' VAL . 60.7 m -166.27 -168.84 1.29 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.976 . . . . 0.0 110.047 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.607 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -77.78 -50.74 1.89 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.614 -0.679 . . . . 0.0 111.056 -179.816 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 54' ' ' SER . 32.5 Cg_endo -73.01 92.38 0.81 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 121.897 1.731 . . . . 0.0 110.168 -177.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.607 ' CE1' ' HB2' ' A' ' 87' ' ' ALA . 17.4 m-85 -94.66 -169.15 1.96 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.589 ' O ' ' CE1' ' A' ' 80' ' ' PHE . 70.4 m-85 -161.66 106.94 1.3 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 0.3 OUTLIER -78.1 140.24 39.05 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.836 0.827 . . . . 0.0 110.921 -178.613 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.678 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 31.3 t-105 -160.35 137.02 6.52 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.678 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.9 Cg_endo -69.08 145.89 62.59 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.092 1.862 . . . . 0.0 111.484 -178.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.983 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -110.88 128.49 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.56 -0.713 . . . . 0.0 109.527 -179.339 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.983 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -124.82 161.33 26.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.153 -0.967 . . . . 0.0 109.261 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.567 ' OG ' ' CZ ' ' A' ' 11' ' ' TYR . 53.8 m -133.42 5.73 3.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.303 -0.873 . . . . 0.0 109.398 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.37 -71.48 0.73 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.917 . . . . 0.0 109.202 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . -74.32 -92.83 0.14 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 53.4 t0 179.87 -36.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.289 -1.124 . . . . 0.0 109.758 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.04 155.48 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.162 -0.961 . . . . 0.0 109.89 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.567 ' HB2' ' HG2' ' A' ' 60' ' ' PRO . 54.1 t80 -71.57 115.06 10.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.908 . . . . 0.0 109.397 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.6 t -152.74 -43.43 0.1 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.38 -0.825 . . . . 0.0 109.278 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.31 -27.44 57.9 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.419 ' O ' ' OG ' ' A' ' 72' ' ' SER . . . 101.14 -163.97 18.2 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.554 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 18.2 p 55.82 60.81 8.5 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.305 -1.115 . . . . 0.0 109.846 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 72' ' ' SER . 36.8 Cg_endo -79.59 -159.05 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.651 2.234 . . . . 0.0 110.436 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.566 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 92.2 -171.65 34.15 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 70.86 -80.85 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.482 -1.011 . . . . 0.0 110.377 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.602 ' HB3' HG23 ' A' ' 61' ' ' ILE . 54.6 m-20 -113.66 135.17 54.22 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.015 -1.053 . . . . 0.0 109.698 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.557 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 4.6 mtt180 -155.99 84.82 1.01 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.313 -0.867 . . . . 0.0 109.073 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.782 HG13 ' NE2' ' A' ' 20' ' ' GLN . 14.6 p -77.93 150.44 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.975 -1.078 . . . . 0.0 109.484 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.652 HG12 ' H ' ' A' ' 80' ' ' PHE . 3.0 t -111.62 173.35 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.364 -0.835 . . . . 0.0 109.418 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.652 ' H ' HG12 ' A' ' 79' ' ' VAL . 4.4 p90 -164.24 -171.47 2.41 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.221 -178.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.556 ' HB2' HG11 ' A' ' 52' ' ' VAL . 26.3 t-20 -121.08 -83.08 0.66 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.026 -1.046 . . . . 0.0 109.99 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.565 ' O ' ' CZ ' ' A' ' 24' ' ' TYR . 42.0 mt-10 -141.91 -9.44 0.91 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.402 -0.811 . . . . 0.0 110.862 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -131.77 25.06 4.69 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.907 -1.121 . . . . 0.0 108.882 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.455 ' O ' ' C ' ' A' ' 85' ' ' GLN . 3.1 m120 62.37 21.73 12.75 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.495 -0.753 . . . . 0.0 109.506 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.568 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 1.4 mt-30 -44.11 -30.23 0.73 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.568 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER 85.18 103.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.553 0.692 . . . . 0.0 110.904 178.91 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.607 ' HB2' ' CE1' ' A' ' 56' ' ' TYR . . . -79.41 -33.21 42.85 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 139.73 145.3 4.67 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.507 HG22 ' HB ' ' A' ' 78' ' ' VAL . 61.2 t -80.57 118.88 29.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.144 -1.209 . . . . 0.0 109.282 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.674 HD12 ' HB2' ' A' ' 100' ' ' PHE . 0.4 OUTLIER -104.45 179.12 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.925 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.484 ' O ' ' O ' ' A' ' 99' ' ' ASN . 1.5 t -138.0 135.3 35.82 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.354 -1.338 . . . . 0.0 111.916 -178.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.465 ' HB2' ' N ' ' A' ' 75' ' ' ALA . 0.2 OUTLIER -86.19 62.34 7.38 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.553 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 93' ' ' THR . 6.8 t -176.2 25.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.385 -0.822 . . . . 0.0 110.314 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.19 10.56 17.48 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 1.026 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . . . -153.29 -174.42 4.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -1.152 . . . . 0.0 109.554 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 95' ' ' ALA . 1.9 t -42.71 113.98 0.53 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.343 -0.848 . . . . 0.0 109.718 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.46 -81.84 0.82 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.475 ' O ' ' O ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -138.36 -76.32 0.38 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -1.138 . . . . 0.0 109.722 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 1.026 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 3.8 m-20 59.94 154.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.674 ' HB2' HD12 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -114.36 118.75 34.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.711 -1.243 . . . . 0.0 110.961 -179.233 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.443 ' O ' ' C ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -125.51 139.83 50.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 107.85 -1.166 . . . . 0.0 107.85 178.357 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -41.82 140.01 1.11 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.137 -0.977 . . . . 0.0 110.347 -178.672 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.442 ' O ' ' OE1' ' A' ' 102' ' ' GLU . 0.5 OUTLIER -56.36 109.03 0.54 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.419 -0.801 . . . . 0.0 109.478 179.716 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 109.538 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 8.5 p 173.96 99.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.931 . . . . 0.0 109.862 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -101.51 -9.42 21.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.349 -0.844 . . . . 0.0 109.311 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.989 ' CG ' HG21 ' A' ' 89' ' ' VAL . 18.8 m-85 -106.14 82.15 1.72 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.115 -0.991 . . . . 0.0 109.163 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.694 HG22 ' HA ' ' A' ' 10' ' ' CYS . 76.3 p -89.83 131.51 35.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -0.852 . . . . 0.0 109.719 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.516 ' CB ' ' OD1' ' A' ' 76' ' ' ASP . 4.0 m -143.55 157.76 44.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.348 -0.845 . . . . 0.0 109.138 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 8' ' ' SER . . . 44.95 32.94 3.4 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 7' ' ' GLY . 0.6 OUTLIER 68.53 49.18 0.77 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.323 -1.104 . . . . 0.0 109.573 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.464 ' O ' ' HB ' ' A' ' 5' ' ' THR . 25.2 m120 -136.3 172.91 12.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.185 -0.947 . . . . 0.0 110.032 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.694 ' HA ' HG22 ' A' ' 5' ' ' THR . 0.4 OUTLIER -127.48 81.87 2.05 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.663 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.536 ' CE2' ' HB2' ' A' ' 63' ' ' SER . 2.9 m-85 -79.0 138.28 37.96 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.476 -0.765 . . . . 0.0 109.826 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.662 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.8 OUTLIER -79.62 124.74 28.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.607 -0.683 . . . . 0.0 109.767 -179.709 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.64 -21.94 3.01 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.559 -0.856 . . . . 0.0 108.975 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 t -82.28 -36.64 26.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.384 -0.822 . . . . 0.0 109.328 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -69.48 -33.79 73.39 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 12' ' ' SER . 5.0 t -58.66 -38.4 71.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.48 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 0.9 OUTLIER -63.71 -31.63 72.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.616 -0.677 . . . . 0.0 109.487 179.547 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -56.78 9.13 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.795 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -63.62 -17.25 62.69 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.733 ' NE2' ' CG ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -77.43 -36.0 53.53 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -74.13 -6.31 46.94 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.717 ' HB1' HG22 ' A' ' 67' ' ' VAL . . . -84.19 -53.6 5.39 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.607 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -68.33 -27.77 73.59 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.484 ' C ' ' CD1' ' A' ' 24' ' ' TYR . 1.3 t80 -76.31 -60.02 2.51 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.502 -0.999 . . . . 0.0 109.599 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 14.6 mt-30 -57.58 -31.67 66.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.032 -1.042 . . . . 0.0 109.137 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.658 HD23 ' HG3' ' A' ' 39' ' ' PRO . 9.2 tp -74.01 -28.89 61.67 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 108.54 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 39' ' ' PRO . 14.0 t60 -79.5 -21.91 44.68 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.422 -0.799 . . . . 0.0 109.448 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -89.31 -31.93 17.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.322 -0.861 . . . . 0.0 109.464 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -80.93 -13.77 58.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.94 . . . . 0.0 109.579 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.24 36.34 27.61 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.859 ' O ' HG23 ' A' ' 32' ' ' THR . 0.3 OUTLIER -105.49 -158.78 0.68 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.252 -1.146 . . . . 0.0 109.791 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.859 HG23 ' O ' ' A' ' 31' ' ' GLU . 1.1 p -168.22 -172.18 1.69 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.573 HG11 ' O ' ' A' ' 68' ' ' TYR . 33.7 m -125.38 152.35 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.08 -1.012 . . . . 0.0 110.377 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 48.79 -88.54 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.541 ' N ' ' O ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -175.09 28.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.417 -1.049 . . . . 0.0 109.346 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.447 ' O ' ' OG ' ' A' ' 37' ' ' SER . 5.2 m-20 -138.0 23.64 2.82 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.339 -0.85 . . . . 0.0 109.159 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.591 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 75.8 p 48.98 -165.98 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.416 -0.803 . . . . 0.0 109.692 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.729 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 168.7 -44.88 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.549 -0.719 . . . . 0.0 111.541 179.212 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.658 ' HG3' HD23 ' A' ' 26' ' ' LEU . 33.2 Cg_endo -76.77 100.75 1.43 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 121.377 1.385 . . . . 0.0 111.986 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.729 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -140.4 -170.15 2.93 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.682 -0.636 . . . . 0.0 109.349 178.642 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 11.5 ptmt -75.51 163.84 26.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.406 -0.809 . . . . 0.0 110.395 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.588 ' CE2' ' HA ' ' A' ' 44' ' ' ASN . 85.7 t80 -142.83 93.88 2.57 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 44' ' ' ASN . 0.5 OUTLIER -81.79 37.91 0.49 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.12 -0.987 . . . . 0.0 110.752 -179.053 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.588 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER 39.92 -160.99 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.216 -0.927 . . . . 0.0 109.948 179.394 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.457 ' CB ' ' O ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER 167.25 -67.31 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.4 -0.813 . . . . 0.0 109.217 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -38.96 -52.63 1.78 Allowed 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.519 -0.738 . . . . 0.0 110.016 -179.784 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.07 51.18 0.05 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.548 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 21.0 m-85 -101.09 115.09 29.66 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.178 -1.189 . . . . 0.0 109.523 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.04 88.94 7.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.411 -0.806 . . . . 0.0 109.18 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.548 ' CZ ' ' HB2' ' A' ' 48' ' ' PHE . 60.6 m-85 -78.87 -172.46 3.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.358 -0.839 . . . . 0.0 109.657 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 84.2 p -153.48 42.25 0.56 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 109.3 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.83 HG21 ' O ' ' A' ' 86' ' ' LEU . 38.3 t -114.65 -41.63 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.32 -0.862 . . . . 0.0 109.518 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.492 ' HB3' ' OD1' ' A' ' 81' ' ' ASN . 0.6 OUTLIER 176.7 -174.47 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.147 -0.971 . . . . 0.0 109.75 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.567 ' CB ' ' HD3' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -91.97 -56.24 0.25 Allowed Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.247 -0.908 . . . . 0.0 111.518 -179.231 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.567 ' HD3' ' CB ' ' A' ' 54' ' ' SER . 35.4 Cg_endo -75.17 89.3 1.18 Allowed 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.913 1.742 . . . . 0.0 110.082 -177.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 1.025 ' CE2' ' HB1' ' A' ' 87' ' ' ALA . 4.0 m-30 -84.82 -179.52 7.11 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.433 0.635 . . . . 0.0 109.982 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.583 ' O ' ' CE1' ' A' ' 80' ' ' PHE . 87.2 m-85 -151.86 130.38 12.21 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.477 -0.765 . . . . 0.0 109.098 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.513 ' OE1' ' NH2' ' A' ' 77' ' ' ARG . 12.7 pt-20 -89.11 133.7 34.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 0.0 110.917 -178.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.684 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 20.0 t-105 -160.25 139.52 8.02 Favored Pre-proline 0 N--CA 1.491 1.6 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.684 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 32.8 Cg_endo -72.11 152.88 57.06 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.482 2.121 . . . . 0.0 111.897 -178.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 1.053 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -115.48 122.3 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.053 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -117.58 169.81 9.25 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.098 -1.001 . . . . 0.0 109.429 179.611 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.536 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 6.6 t -121.26 39.06 3.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 108.799 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.64 -31.13 5.28 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.569 -0.707 . . . . 0.0 109.356 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.23 12.56 59.84 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 67' ' ' VAL . 0.6 OUTLIER -106.16 9.89 32.1 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.212 -1.169 . . . . 0.0 109.595 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.717 HG22 ' HB1' ' A' ' 22' ' ' ALA . 91.9 t 60.8 143.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.169 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.779 ' HA ' HD11 ' A' ' 62' ' ' LEU . 16.7 t80 -55.53 108.79 0.47 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.124 -0.985 . . . . 0.0 109.402 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.68 48.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.408 -0.808 . . . . 0.0 109.325 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -149.38 -52.72 0.02 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 167.78 -167.61 40.15 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.411 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 0.3 OUTLIER 60.68 68.05 1.4 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.296 -1.12 . . . . 0.0 109.324 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 72' ' ' SER . 36.3 Cg_endo -78.72 155.74 27.4 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.742 2.295 . . . . 0.0 110.944 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.713 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 74.99 -149.84 40.06 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 80.17 -77.95 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.503 -0.998 . . . . 0.0 109.989 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.516 ' OD1' ' CB ' ' A' ' 6' ' ' CYS . 41.8 m-20 -131.28 134.91 46.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.019 -1.05 . . . . 0.0 110.333 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.629 ' NH1' ' CE2' ' A' ' 38' ' ' TYR . 1.6 mtt180 -138.42 123.92 19.56 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 78' ' ' VAL . 4.7 p -112.52 120.84 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.958 -1.089 . . . . 0.0 108.896 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.814 ' CG2' HD11 ' A' ' 90' ' ' ILE . 14.8 t -79.05 170.61 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 122.083 0.944 . . . . 0.0 110.266 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.733 ' CG ' ' NE2' ' A' ' 20' ' ' GLN . 3.2 p90 -164.19 -171.36 2.38 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.492 ' OD1' ' HB3' ' A' ' 53' ' ' SER . 7.3 t30 -123.95 -81.41 0.64 Allowed 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.229 -0.989 . . . . 0.0 109.949 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.457 ' OE2' ' O ' ' A' ' 81' ' ' ASN . 66.7 mm-40 -159.24 18.08 0.18 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.288 -0.882 . . . . 0.0 109.645 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.465 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 3.8 m-20 -136.79 24.25 3.09 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.584 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 0.2 OUTLIER 48.02 23.32 0.48 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.463 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.633 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -67.68 -90.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.444 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.83 ' O ' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER 165.39 106.8 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.132 -0.98 . . . . 0.0 110.36 178.674 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 1.025 ' HB1' ' CE2' ' A' ' 56' ' ' TYR . . . -74.97 -42.09 58.29 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 162.74 154.13 7.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.989 HG21 ' CG ' ' A' ' 4' ' ' TYR . 40.2 t -93.3 105.33 16.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 120.843 -1.387 . . . . 0.0 110.164 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.814 HD11 ' CG2' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -99.43 172.64 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.214 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.469 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 2.8 t -145.02 141.07 28.59 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.668 -1.27 . . . . 0.0 111.261 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.528 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.3 OUTLIER -88.68 55.95 3.58 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.306 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 93' ' ' THR . 5.8 t -168.4 23.09 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.157 -0.964 . . . . 0.0 110.309 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -125.81 23.99 5.83 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.849 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -177.89 117.93 0.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.407 -1.054 . . . . 0.0 109.506 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.459 ' O ' ' C ' ' A' ' 97' ' ' GLY . 2.5 m 46.06 -159.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.114 -0.991 . . . . 0.0 109.21 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 96' ' ' SER . . . -39.02 -50.64 2.68 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.528 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -152.12 -76.02 0.13 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.107 -1.231 . . . . 0.0 109.605 179.74 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.849 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.2 OUTLIER 60.91 146.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.135 -0.978 . . . . 0.0 108.772 -179.476 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.549 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -93.5 125.78 38.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.857 -1.152 . . . . 0.0 110.451 -179.51 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.543 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -145.22 137.68 21.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.512 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.45 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.0 OUTLIER -44.36 129.83 6.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.229 -0.919 . . . . 0.0 109.477 -179.598 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.469 ' SG ' ' HB ' ' A' ' 91' ' ' THR . 12.6 m -54.13 98.36 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.196 -0.94 . . . . 0.0 109.425 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 109.478 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.496 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 25.6 p 174.29 156.64 0.14 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.346 -0.846 . . . . 0.0 109.776 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.72 -40.75 2.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.344 -0.847 . . . . 0.0 109.105 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.641 ' CE1' ' CG2' ' A' ' 89' ' ' VAL . 15.1 m-85 -82.24 127.17 32.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.348 -0.845 . . . . 0.0 109.656 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.46 ' O ' ' SG ' ' A' ' 103' ' ' CYS . 0.2 OUTLIER -133.44 129.6 37.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.375 -0.828 . . . . 0.0 109.194 179.727 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 98.3 m -139.38 16.56 2.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.118 -0.989 . . . . 0.0 110.079 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.14 42.9 0.07 OUTLIER Glycine 0 C--N 1.284 -2.348 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.09 12.34 4.93 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.281 -1.129 . . . . 0.0 109.29 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.409 ' O ' HG23 ' A' ' 5' ' ' THR . 13.3 m120 -84.22 -171.97 3.91 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.216 -0.928 . . . . 0.0 109.13 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.432 ' C ' ' CB ' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -131.47 67.09 1.53 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.248 -0.908 . . . . 0.0 109.047 -179.902 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.5 ' CZ ' ' HB3' ' A' ' 63' ' ' SER . 36.2 m-85 -79.3 120.32 23.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.0 108.802 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.904 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -91.84 137.2 32.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.911 . . . . 0.0 110.407 -179.164 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.7 p -51.75 -21.9 3.14 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.9 t -84.45 -35.86 22.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.307 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.3 -23.5 60.29 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.904 HG23 ' O ' ' A' ' 12' ' ' SER . 2.7 t -74.58 -31.5 27.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -45.15 95.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -0.777 . . . . 0.0 109.034 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.1 m -60.09 -42.64 95.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.218 -0.926 . . . . 0.0 108.801 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.821 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -76.43 -13.28 60.12 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.475 ' NE2' ' O ' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -87.31 -21.99 25.4 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.1 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -85.59 -12.49 51.38 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.34 -56.04 4.32 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.349 -0.845 . . . . 0.0 109.261 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.591 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -66.56 -21.12 70.53 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.491 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 0.9 OUTLIER -81.38 -62.4 1.66 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.459 -1.024 . . . . 0.0 109.158 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 1.6 tt0 -44.3 -43.36 7.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.149 -0.97 . . . . 0.0 109.247 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.46 ' HA ' HD22 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -64.15 -43.84 93.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.252 -0.905 . . . . 0.0 109.12 179.726 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.621 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 28.3 t60 -68.07 -14.54 63.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.841 . . . . 0.0 110.102 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -95.65 -26.31 15.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.012 -1.055 . . . . 0.0 110.01 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 26.3 t0 -88.15 -10.48 49.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.161 -0.962 . . . . 0.0 109.73 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.09 0.78 66.46 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.414 ' C ' HD11 ' A' ' 26' ' ' LEU . 2.5 mm-40 -79.34 -169.29 1.82 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.159 -1.201 . . . . 0.0 109.281 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.995 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -127.37 178.21 6.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.774 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.567 ' CG2' ' HD3' ' A' ' 39' ' ' PRO . 60.1 t -82.31 -98.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.401 -0.812 . . . . 0.0 110.277 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.528 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -122.01 57.64 0.61 Allowed Glycine 0 N--CA 1.488 2.114 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.186 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER 78.96 -10.63 1.32 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.51 -0.994 . . . . 0.0 110.512 179.416 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -112.1 -6.8 14.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.894 -1.129 . . . . 0.0 109.515 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.995 ' HA ' HG22 ' A' ' 32' ' ' THR . 8.0 t 58.13 -175.06 0.08 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.238 -0.914 . . . . 0.0 109.316 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.735 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER 168.27 -44.94 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 111.495 179.324 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 31.8 Cg_endo -75.58 100.65 1.39 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.409 1.406 . . . . 0.0 111.976 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.735 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -144.39 -178.28 5.9 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.584 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.602 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -74.85 154.02 38.44 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.404 ' N ' ' HG2' ' A' ' 41' ' ' LYS . 19.2 t80 -125.62 145.72 50.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.992 -1.067 . . . . 0.0 110.249 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.444 ' O ' ' C ' ' A' ' 44' ' ' ASN . 41.1 t-20 -117.49 66.02 0.74 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 43' ' ' ASN . 0.6 OUTLIER -40.0 147.72 0.09 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.501 -0.749 . . . . 0.0 110.146 -179.369 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.459 ' O ' ' C ' ' A' ' 46' ' ' GLU . 98.2 m-85 -118.57 -44.73 2.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.403 -0.811 . . . . 0.0 108.999 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -38.63 -47.93 1.39 Allowed 'General case' 0 C--N 1.309 -1.18 0 O-C-N 121.599 -0.688 . . . . 0.0 109.915 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.16 48.38 0.06 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 86.7 m-85 -96.17 90.82 5.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.244 -1.151 . . . . 0.0 108.964 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.59 82.51 1.77 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.925 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.975 ' CD2' ' HB1' ' A' ' 87' ' ' ALA . 4.8 m-85 -78.33 -169.22 1.57 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.369 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.1 m -109.6 17.12 21.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.305 -0.872 . . . . 0.0 109.419 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.436 HG21 ' HA ' ' A' ' 87' ' ' ALA . 64.1 t -77.06 -60.13 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.356 -0.84 . . . . 0.0 109.48 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.42 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -172.11 161.77 5.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.105 -0.997 . . . . 0.0 109.715 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.585 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -72.18 -51.99 7.6 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.477 -0.764 . . . . 0.0 110.227 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 54' ' ' SER . 36.4 Cg_endo -76.24 87.0 1.47 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 121.939 1.759 . . . . 0.0 109.858 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.563 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 38.1 m-85 -79.04 -174.44 4.07 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.698 -0.627 . . . . 0.0 109.67 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.621 ' CE2' ' NE2' ' A' ' 27' ' ' HIS . 83.2 m-85 -154.93 134.63 12.77 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.405 ' HB2' ' NH2' ' A' ' 77' ' ' ARG . 3.9 pt-20 -96.75 144.3 26.88 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 122.053 0.93 . . . . 0.0 111.845 -177.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.698 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 32.2 t-105 -161.19 136.04 5.46 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.698 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.4 Cg_endo -69.57 147.2 63.59 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 121.864 1.709 . . . . 0.0 111.479 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.936 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -119.02 137.4 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.779 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.936 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.8 OUTLIER -120.27 172.79 7.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.128 -0.983 . . . . 0.0 109.701 -179.301 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.5 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . 5.4 p -119.45 29.64 7.51 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.187 -0.946 . . . . 0.0 108.768 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.96 -148.99 0.39 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.48 -0.762 . . . . 0.0 109.541 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -121.75 72.14 0.38 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -170.99 155.42 4.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -1.12 . . . . 0.0 109.769 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.567 HG13 ' HZ2' ' A' ' 59' ' ' TRP . 23.6 t -93.81 154.91 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.852 . . . . 0.0 109.291 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.516 ' O ' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -72.79 84.46 1.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.95 -1.094 . . . . 0.0 110.025 -179.506 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.436 ' HA ' HG12 ' A' ' 33' ' ' VAL . 14.5 t -81.0 -5.4 57.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.306 -0.871 . . . . 0.0 109.125 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -174.82 -144.14 4.78 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.17 -157.15 31.62 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.499 ' OG ' ' HD2' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -127.25 156.52 74.6 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.199 -1.177 . . . . 0.0 109.502 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.499 ' HD2' ' OG ' ' A' ' 72' ' ' SER . 35.5 Cg_endo -77.88 -175.15 2.55 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.643 2.229 . . . . 0.0 110.379 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 88.01 -167.1 35.95 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.573 ' N ' ' HB2' ' A' ' 92' ' ' HIS . . . 66.33 -83.94 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.706 -0.879 . . . . 0.0 109.987 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -137.12 157.28 47.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.044 -1.035 . . . . 0.0 109.753 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.487 ' O ' HG12 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -170.35 114.75 0.48 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.246 -0.909 . . . . 0.0 109.338 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 88' ' ' GLY . 14.1 p -90.77 134.09 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.07 -1.019 . . . . 0.0 109.173 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.842 HG23 ' CD1' ' A' ' 90' ' ' ILE . 20.1 t -98.88 165.32 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 122.174 0.988 . . . . 0.0 110.313 -179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.572 ' N ' ' CG1' ' A' ' 79' ' ' VAL . 20.1 p90 -163.16 -168.46 1.74 Allowed 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -178.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.52 ' O ' ' CB ' ' A' ' 82' ' ' GLU . 2.1 p-10 -128.73 -44.38 1.34 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.791 -1.193 . . . . 0.0 110.387 -179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 0.2 OUTLIER 163.1 -25.89 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.379 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.503 ' HB3' ' HG2' ' A' ' 85' ' ' GLN . 1.2 t-20 -90.9 0.5 57.48 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.488 ' HB3' ' O ' ' A' ' 83' ' ' ASN . 37.6 t30 64.84 28.32 12.81 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.541 -0.724 . . . . 0.0 109.56 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.557 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -70.06 -27.56 64.74 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.98 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.565 HD21 HG21 ' A' ' 78' ' ' VAL . 0.3 OUTLIER 88.06 114.18 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.603 0.716 . . . . 0.0 110.197 179.42 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.975 ' HB1' ' CD2' ' A' ' 50' ' ' PHE . . . -87.38 -44.87 11.05 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.676 ' O ' HG23 ' A' ' 78' ' ' VAL . . . 166.1 -158.99 32.14 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.641 ' CG2' ' CE1' ' A' ' 4' ' ' TYR . 23.5 t -140.44 99.39 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.088 -1.243 . . . . 0.0 110.076 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.842 ' CD1' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -80.94 145.27 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.177 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.611 HG22 ' O ' ' A' ' 101' ' ' VAL . 9.7 t -130.53 132.05 45.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.867 -1.146 . . . . 0.0 110.884 -179.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.578 ' ND1' ' O ' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -91.76 79.24 5.38 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.646 -0.658 . . . . 0.0 109.534 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.0 m -175.07 118.23 0.18 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.183 -0.948 . . . . 0.0 109.603 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 113.86 2.89 23.69 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.411 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -144.87 146.53 32.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.135 -1.215 . . . . 0.0 109.731 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 95' ' ' ALA . 34.5 m -44.5 143.02 1.42 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.346 -0.846 . . . . 0.0 109.055 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.461 ' O ' ' C ' ' A' ' 98' ' ' ASN . . . 50.54 38.6 35.62 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.578 ' O ' ' ND1' ' A' ' 92' ' ' HIS . 0.2 OUTLIER 36.02 44.18 0.24 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.947 -0.737 . . . . 0.0 110.041 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -47.52 132.8 13.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.983 -1.073 . . . . 0.0 109.167 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.614 ' CD1' ' HB ' ' A' ' 90' ' ' ILE . 19.3 m-85 -60.03 134.57 57.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.034 -1.041 . . . . 0.0 109.924 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.611 ' O ' HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -137.61 130.84 42.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.865 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.477 ' CG ' ' O ' ' A' ' 102' ' ' GLU . 1.5 pt-20 -55.15 111.22 0.81 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.281 -0.887 . . . . 0.0 109.268 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 5' ' ' THR . 0.5 OUTLIER -55.33 146.38 19.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.342 -0.849 . . . . 0.0 109.917 -179.484 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 74.6 p . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.36 -0.838 . . . . 0.0 109.489 -179.993 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.439 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.258 0.551 . . . . 0.0 109.618 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.4 p 168.75 145.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.259 -0.901 . . . . 0.0 110.183 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -120.2 -27.67 5.23 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.542 -0.724 . . . . 0.0 109.086 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.621 ' CG ' HG21 ' A' ' 89' ' ' VAL . 19.4 m-85 -88.61 112.16 22.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 109.312 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.644 HG23 ' N ' ' A' ' 9' ' ' ASN . 80.1 m -140.32 120.2 13.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.341 -0.849 . . . . 0.0 109.337 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 69.3 m -118.05 16.71 14.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 122.171 0.986 . . . . 0.0 109.682 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 169.09 60.88 0.03 OUTLIER Glycine 0 C--N 1.282 -2.421 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.07 15.72 7.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.322 -1.105 . . . . 0.0 109.147 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.644 ' N ' HG23 ' A' ' 5' ' ' THR . 11.8 m120 -81.19 131.74 35.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.415 -0.803 . . . . 0.0 109.723 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.3 t -97.83 58.89 1.42 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.836 . . . . 0.0 109.007 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.574 ' CE1' ' HB2' ' A' ' 63' ' ' SER . 7.5 m-30 -79.92 127.73 32.6 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.753 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -85.03 138.76 32.24 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.183 -0.948 . . . . 0.0 110.188 -179.223 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.46 -18.76 7.68 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.1 t -89.4 -31.24 17.84 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.521 -0.737 . . . . 0.0 109.153 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.31 -34.83 68.39 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 12' ' ' SER . 2.6 t -57.56 -35.18 49.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.04 -40.95 77.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.558 -0.714 . . . . 0.0 109.258 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.17 -55.98 13.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.332 -0.855 . . . . 0.0 109.137 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.533 ' HB3' ' CD1' ' A' ' 61' ' ' ILE . . . -71.41 -4.15 24.76 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.485 -0.759 . . . . 0.0 109.264 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.805 ' OE1' HG22 ' A' ' 78' ' ' VAL . 5.6 tp60 -101.57 -8.49 21.83 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.64 -9.14 19.41 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.333 -0.854 . . . . 0.0 109.248 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.6 -36.97 28.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 109.133 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 27' ' ' HIS . . . -72.03 -9.66 71.82 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.511 ' CE1' ' O ' ' A' ' 82' ' ' GLU . 18.4 t80 -101.36 -49.59 4.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.442 -1.034 . . . . 0.0 109.347 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -52.18 -38.58 58.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.876 . . . . 0.0 109.339 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.572 HD11 ' CB ' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -79.89 -45.11 19.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.473 -0.767 . . . . 0.0 109.138 179.754 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.575 ' ND1' ' N ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -45.41 -39.06 6.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.584 -0.697 . . . . 0.0 110.326 -179.713 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.575 ' N ' ' ND1' ' A' ' 27' ' ' HIS . 3.4 tp10 -94.29 -40.28 10.06 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.257 -0.902 . . . . 0.0 109.128 -178.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 28' ' ' GLU . 19.9 t0 -47.81 -23.76 0.82 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.434 ' N ' ' C ' ' A' ' 28' ' ' GLU . . . 80.5 14.16 80.49 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.572 ' CB ' HD11 ' A' ' 26' ' ' LEU . 0.9 OUTLIER -103.17 -170.11 1.74 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.232 -1.158 . . . . 0.0 109.176 179.789 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.983 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -137.41 174.41 10.63 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.204 -0.935 . . . . 0.0 109.648 -179.868 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.468 ' O ' ' C ' ' A' ' 34' ' ' GLY . 14.1 m -81.13 -162.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.876 . . . . 0.0 109.252 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -34.92 -57.6 0.79 Allowed Glycine 0 N--CA 1.498 2.779 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.73 30.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.321 -1.105 . . . . 0.0 109.724 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 37' ' ' SER . 1.2 m120 -134.16 6.45 3.61 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.214 -0.929 . . . . 0.0 109.356 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.983 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.2 OUTLIER 47.39 -173.64 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.234 -0.916 . . . . 0.0 109.357 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.73 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER 164.45 -44.15 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.641 -0.662 . . . . 0.0 111.415 179.522 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 38' ' ' TYR . 30.7 Cg_endo -73.83 99.62 1.18 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 121.295 1.33 . . . . 0.0 112.294 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.73 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -141.36 179.36 6.83 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.078 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -69.36 149.67 48.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.971 -1.081 . . . . 0.0 109.797 -179.336 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.615 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 1.5 t80 -115.3 146.57 41.38 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -156.94 91.3 1.19 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.997 -1.065 . . . . 0.0 109.711 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.615 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 2.2 t-20 -113.88 -51.56 2.78 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.351 -0.843 . . . . 0.0 109.599 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.453 ' O ' ' C ' ' A' ' 46' ' ' GLU . 40.7 m-85 50.44 22.65 1.07 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.133 -0.98 . . . . 0.0 109.055 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 48' ' ' PHE . 1.1 tm-20 -38.7 -61.31 0.73 Allowed 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.64 -0.662 . . . . 0.0 109.992 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.42 ' C ' ' CD1' ' A' ' 48' ' ' PHE . . . -177.09 45.18 0.1 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.507 ' CZ ' ' HB3' ' A' ' 46' ' ' GLU . 0.7 OUTLIER -124.89 168.05 13.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -1.134 . . . . 0.0 109.479 -179.908 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 50' ' ' PHE . 11.1 t70 -124.42 68.7 1.08 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.345 -0.847 . . . . 0.0 109.156 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.541 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 17.4 m-85 -52.52 -171.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.445 -0.785 . . . . 0.0 109.859 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 99.6 p -158.12 37.29 0.25 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.387 -0.821 . . . . 0.0 109.323 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.591 HG21 ' O ' ' A' ' 86' ' ' LEU . 97.4 t -108.97 -73.79 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.227 -0.92 . . . . 0.0 109.738 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.2 177.74 8.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.173 -0.955 . . . . 0.0 110.211 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.62 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -78.99 -50.92 1.36 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.658 -0.651 . . . . 0.0 111.13 -179.88 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 54' ' ' SER . 32.4 Cg_endo -72.56 93.57 0.76 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.861 1.707 . . . . 0.0 109.881 -177.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.59 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 4.5 m-85 -87.06 -176.82 5.86 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.509 0.671 . . . . 0.0 110.009 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.59 ' CG ' ' O ' ' A' ' 56' ' ' TYR . 81.7 m-85 -160.65 118.58 2.49 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.456 ' HB3' ' HB2' ' A' ' 42' ' ' TYR . 0.7 OUTLIER -83.77 142.05 30.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.142 -0.974 . . . . 0.0 111.125 -178.554 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.689 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 26.0 t-105 -161.16 139.31 7.14 Favored Pre-proline 0 N--CA 1.494 1.746 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.689 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.8 Cg_endo -68.35 144.61 62.64 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.003 1.802 . . . . 0.0 111.362 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 1.005 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -109.59 136.66 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.645 -0.659 . . . . 0.0 109.326 -179.501 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.005 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.3 OUTLIER -125.89 -177.7 4.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.297 -0.877 . . . . 0.0 109.417 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.574 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -117.57 -14.09 10.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.075 -1.016 . . . . 0.0 108.815 179.676 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.32 -58.53 3.23 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.584 -0.698 . . . . 0.0 109.189 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 114.21 10.59 13.39 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.451 ' O ' ' HB ' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -89.51 13.81 12.95 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.212 -1.169 . . . . 0.0 109.488 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.581 HG13 ' CZ2' ' A' ' 59' ' ' TRP . 99.6 t 61.77 131.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.274 -0.891 . . . . 0.0 109.527 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.569 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 34.6 t80 -46.81 107.32 0.1 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.235 -0.916 . . . . 0.0 109.469 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.3 16.07 6.09 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.175 -0.953 . . . . 0.0 109.468 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.6 65.18 0.02 OUTLIER Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.09 147.53 19.21 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.85 124.57 8.06 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.266 -1.138 . . . . 0.0 109.326 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.436 ' HB3' ' OH ' ' A' ' 38' ' ' TYR . 36.3 Cg_endo -78.02 150.56 26.59 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.452 2.101 . . . . 0.0 110.732 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.716 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 106.2 -175.03 21.0 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 79.84 -70.54 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.431 -1.04 . . . . 0.0 110.546 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.421 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 1.4 m-20 -134.95 152.22 51.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.741 -1.225 . . . . 0.0 110.107 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.545 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 7.4 mtt180 -163.47 105.68 0.98 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.42 -0.8 . . . . 0.0 108.981 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.805 HG22 ' OE1' ' A' ' 20' ' ' GLN . 8.1 p -89.45 144.59 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.986 -1.071 . . . . 0.0 109.479 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.582 HG12 ' N ' ' A' ' 80' ' ' PHE . 35.5 t -112.52 166.08 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.35 -0.844 . . . . 0.0 109.771 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 80' ' ' PHE . 1.5 p90 -151.71 -178.2 6.57 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.585 ' HB3' HG12 ' A' ' 52' ' ' VAL . 16.9 p-10 -109.79 -47.16 3.39 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.019 -1.05 . . . . 0.0 109.857 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.535 ' HG2' ' ND2' ' A' ' 81' ' ' ASN . 0.6 OUTLIER 167.15 -25.07 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.502 ' HB3' ' HG2' ' A' ' 85' ' ' GLN . 1.1 t30 -92.49 8.86 36.88 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.47 -0.769 . . . . 0.0 108.967 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 83' ' ' ASN . 19.2 t30 63.33 13.42 7.01 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.42 -0.8 . . . . 0.0 110.137 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.566 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 3.7 mt-30 -57.13 -82.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.852 -1.155 . . . . 0.0 107.968 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.591 ' O ' HG21 ' A' ' 52' ' ' VAL . 0.1 OUTLIER 165.28 108.87 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.398 -0.814 . . . . 0.0 110.684 178.466 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.541 ' O ' ' CD1' ' A' ' 50' ' ' PHE . . . -74.97 -44.09 50.27 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 146.55 149.18 4.92 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.689 -1.765 . . . . 0.0 108.689 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.621 HG21 ' CG ' ' A' ' 4' ' ' TYR . 38.9 t -88.64 131.44 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.161 -1.199 . . . . 0.0 109.744 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.805 HD12 ' CB ' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -123.85 178.01 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.608 HG22 HG23 ' A' ' 101' ' ' VAL . 2.7 t -138.48 145.85 41.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.813 -1.179 . . . . 0.0 111.195 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.632 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.1 OUTLIER -93.25 76.94 4.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.621 -0.674 . . . . 0.0 109.557 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 92' ' ' HIS . 7.1 t 176.52 -27.25 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.411 -0.806 . . . . 0.0 110.434 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.531 ' HA3' HG21 ' A' ' 101' ' ' VAL . . . -65.14 -7.01 29.19 Favored Glycine 0 N--CA 1.493 2.434 0 O-C-N 121.125 -0.984 . . . . 0.0 110.673 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.994 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . . . -133.71 164.86 26.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.884 -1.362 . . . . 0.0 110.056 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 95' ' ' ALA . 11.1 p -41.7 120.95 1.61 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.58 -0.7 . . . . 0.0 109.26 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.8 -78.0 2.05 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.846 -1.701 . . . . 0.0 108.846 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.632 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -160.52 -68.07 0.07 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.268 -1.137 . . . . 0.0 109.551 179.751 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.994 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 0.3 OUTLIER 57.05 -173.36 0.08 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.135 -0.978 . . . . 0.0 109.142 -179.711 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.805 ' CB ' HD12 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -132.87 113.81 13.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.021 -1.049 . . . . 0.0 110.103 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.608 HG23 HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -123.64 136.74 59.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.334 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.485 ' OE2' ' HB3' ' A' ' 48' ' ' PHE . 2.2 mt-10 -56.11 120.47 7.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.286 -0.884 . . . . 0.0 109.728 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.2 176.33 0.34 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.898 . . . . 0.0 109.462 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 19.0 p . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.972 -1.014 . . . . 0.0 109.588 -179.901 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.465 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.8 p 167.17 115.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.924 . . . . 0.0 109.8 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 14.9 t70 -108.72 4.71 24.06 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.398 -0.814 . . . . 0.0 109.363 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.582 ' CD1' ' HB ' ' A' ' 89' ' ' VAL . 5.4 m-85 -104.99 71.35 0.95 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.548 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 5' ' ' THR . 8.8 t -86.84 124.44 33.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.179 -0.95 . . . . 0.0 109.388 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 92.5 m -122.24 16.66 10.67 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 122.096 0.951 . . . . 0.0 109.684 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 152.73 -62.09 0.39 Allowed Glycine 0 C--N 1.283 -2.383 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.6 m -166.98 36.03 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.347 -1.09 . . . . 0.0 109.065 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.461 ' O ' ' C ' ' A' ' 10' ' ' CYS . 3.7 m120 -111.44 -27.74 8.49 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.356 -0.84 . . . . 0.0 109.803 -179.565 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.493 ' C ' ' HB2' ' A' ' 2' ' ' CYS . 1.1 t 40.4 76.44 0.07 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.365 -0.834 . . . . 0.0 109.311 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.424 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 2.8 m-85 -79.57 150.34 31.11 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.417 -0.802 . . . . 0.0 109.297 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.992 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -80.47 132.1 35.66 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.432 -0.793 . . . . 0.0 109.62 -179.874 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.2 p -63.33 -13.96 44.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.127 -0.983 . . . . 0.0 109.04 179.61 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.81 -27.05 13.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.31 -0.869 . . . . 0.0 109.028 179.695 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.525 ' HB2' ' HB2' ' A' ' 12' ' ' SER . 17.8 t0 -74.91 -34.2 62.11 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.278 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.992 HG23 ' O ' ' A' ' 12' ' ' SER . 2.8 t -56.47 -36.67 48.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.13 -41.11 87.46 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.37 -45.66 92.15 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.157 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.814 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -75.97 -8.29 56.6 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.075 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.59 ' OE1' ' CG ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -90.58 -25.96 19.92 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.383 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.96 -13.13 59.17 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.071 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.31 -57.0 3.56 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.33 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.605 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -62.11 -25.69 66.62 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 178.959 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.583 ' CE1' ' O ' ' A' ' 82' ' ' GLU . 10.2 t80 -75.72 -59.87 2.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.477 -1.013 . . . . 0.0 109.451 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 29' ' ' ASP . 1.8 tp60 -55.14 -61.51 2.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.859 . . . . 0.0 109.262 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.804 HD13 ' HB3' ' A' ' 31' ' ' GLU . 2.6 mm? -44.83 -37.3 3.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.392 -0.818 . . . . 0.0 109.57 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.408 ' HB3' ' O ' ' A' ' 24' ' ' TYR . 3.5 t60 -66.14 -54.79 21.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.439 -0.788 . . . . 0.0 111.182 -179.145 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -86.8 13.02 9.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.216 -0.928 . . . . 0.0 110.249 -178.541 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 8.0 t0 -108.35 -2.81 18.86 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.079 -1.013 . . . . 0.0 109.581 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.71 -8.76 76.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.807 ' O ' HG23 ' A' ' 32' ' ' THR . 2.4 tp10 -97.7 -152.19 0.39 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.231 -1.158 . . . . 0.0 109.474 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.821 HG22 ' CG ' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -177.27 -93.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.165 -0.96 . . . . 0.0 109.411 179.976 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -156.5 -168.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.147 -0.971 . . . . 0.0 109.476 179.835 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 35' ' ' SER . . . -63.67 87.14 0.06 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.535 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.455 ' C ' ' O ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER 40.2 43.27 1.35 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.486 -1.008 . . . . 0.0 109.788 179.772 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.417 ' O ' ' C ' ' A' ' 37' ' ' SER . 4.9 m-80 -122.63 -25.25 4.74 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.103 -0.998 . . . . 0.0 109.726 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 36' ' ' ASN . 0.9 OUTLIER 45.27 76.82 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.16 -0.962 . . . . 0.0 109.211 -179.762 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.717 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -98.93 -23.37 0.22 Allowed Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -179.068 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.821 ' CG ' HG22 ' A' ' 32' ' ' THR . 37.5 Cg_endo -80.28 100.87 1.29 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 C-N-CA 121.476 1.451 . . . . 0.0 113.577 -178.732 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.545 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -127.53 -176.51 3.77 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.12 -0.987 . . . . 0.0 108.722 176.897 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.1 OUTLIER -100.18 144.36 29.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.097 -1.002 . . . . 0.0 109.455 179.94 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.579 ' CE2' ' HA ' ' A' ' 44' ' ' ASN . 4.4 t80 -110.52 135.94 50.42 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.201 -0.937 . . . . 0.0 109.535 -179.655 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.553 ' OD1' ' CD2' ' A' ' 45' ' ' TYR . 2.7 p30 -92.16 3.67 54.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.899 . . . . 0.0 109.893 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.579 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 7.1 p-10 42.22 104.79 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.651 0.738 . . . . 0.0 111.2 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.553 ' CD2' ' OD1' ' A' ' 43' ' ' ASN . 0.9 OUTLIER -131.88 -33.23 1.39 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.071 -1.018 . . . . 0.0 109.823 179.206 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.485 ' OE1' ' CZ ' ' A' ' 48' ' ' PHE . 0.1 OUTLIER -38.17 -53.2 1.44 Allowed 'General case' 0 C--N 1.309 -1.176 0 O-C-N 121.481 -0.762 . . . . 0.0 110.159 -179.556 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.87 48.53 0.04 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.485 ' CZ ' ' OE1' ' A' ' 46' ' ' GLU . 24.8 m-85 -104.61 144.83 31.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -1.141 . . . . 0.0 109.337 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 50' ' ' PHE . 1.1 m-20 -119.07 49.58 1.31 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.292 -0.88 . . . . 0.0 109.433 179.697 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.502 ' HB2' ' OH ' ' A' ' 56' ' ' TYR . 21.7 m-85 -50.36 -178.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.385 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.1 p -133.93 18.26 3.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -0.859 . . . . 0.0 109.003 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.496 HG21 ' O ' ' A' ' 86' ' ' LEU . 66.6 t -85.74 -82.0 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.372 -0.83 . . . . 0.0 109.532 -179.857 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.31 177.98 10.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.004 -1.06 . . . . 0.0 110.147 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.602 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -79.5 -52.54 1.12 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.473 -0.767 . . . . 0.0 110.884 -179.889 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 54' ' ' SER . 33.1 Cg_endo -73.07 95.11 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.016 1.81 . . . . 0.0 109.844 -177.86 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.595 ' CE1' ' HB2' ' A' ' 87' ' ' ALA . 5.7 m-85 -95.94 -179.28 4.64 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.63 0.728 . . . . 0.0 110.276 -178.913 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.577 ' CD2' ' O ' ' A' ' 81' ' ' ASN . 96.5 m-85 -152.73 131.61 12.49 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.392 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.91 142.19 27.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 110.815 -178.837 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.681 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 24.1 t-105 -160.26 137.74 6.99 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.697 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.681 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.6 Cg_endo -69.78 149.52 66.89 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.175 1.917 . . . . 0.0 111.423 -179.042 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.975 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -120.5 129.13 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.607 -0.683 . . . . 0.0 109.349 -179.672 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.975 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.4 OUTLIER -118.84 172.29 7.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.287 179.514 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.81 27.79 6.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.117 -0.99 . . . . 0.0 108.847 179.688 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.91 -12.46 17.5 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.564 -0.71 . . . . 0.0 109.318 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.66 -10.22 68.72 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.703 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 2.9 m-20 -97.55 172.95 7.41 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.216 -1.167 . . . . 0.0 110.022 -179.542 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.509 HG13 ' CZ2' ' A' ' 59' ' ' TRP . 93.7 t -90.09 150.08 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.679 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.918 ' HA ' HD11 ' A' ' 62' ' ' LEU . 13.6 t80 -47.31 118.75 2.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.955 -1.091 . . . . 0.0 109.69 -179.479 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.455 ' O ' ' OG ' ' A' ' 69' ' ' SER . 1.7 t -135.38 13.88 3.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.489 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 132.57 140.59 4.48 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 137.86 -128.24 4.18 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.8 p -69.55 120.98 80.77 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.225 -1.162 . . . . 0.0 109.334 179.852 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.69 -57.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.279 1.986 . . . . 0.0 110.443 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.537 ' HA3' ' CB ' ' A' ' 92' ' ' HIS . . . -97.34 -113.02 3.05 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 91' ' ' THR . . . 60.23 -85.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.352 -1.087 . . . . 0.0 110.561 179.521 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.436 ' C ' ' HD2' ' A' ' 77' ' ' ARG . 36.6 m-20 -122.95 131.5 53.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.848 -1.158 . . . . 0.0 110.39 -179.173 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.523 ' NE ' ' HA2' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -151.88 106.66 3.24 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.331 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 89' ' ' VAL . 7.3 p -78.81 137.98 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 110.454 -178.969 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.601 HG23 HD13 ' A' ' 90' ' ' ILE . 39.8 t -97.55 166.67 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.01 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.59 ' CG ' ' OE1' ' A' ' 20' ' ' GLN . 5.7 p90 -163.46 -174.33 3.7 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 118.822 -1.151 . . . . 0.0 110.281 -178.002 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.577 ' O ' ' CD2' ' A' ' 57' ' ' TYR . 3.2 t-20 -109.11 -80.13 0.58 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.28 -0.888 . . . . 0.0 109.766 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.583 ' O ' ' CE1' ' A' ' 24' ' ' TYR . 10.8 pt-20 -161.9 23.36 0.11 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 109.448 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.453 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 4.0 t-20 -151.7 51.38 0.81 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.552 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.487 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 0.4 OUTLIER 44.86 26.95 0.23 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.568 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.477 ' OE1' ' HB3' ' A' ' 81' ' ' ASN . 14.0 mt-30 -64.4 -163.18 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.206 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.496 ' O ' HG21 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -144.48 104.37 4.06 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.787 -1.196 . . . . 0.0 110.573 179.913 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.595 ' HB2' ' CE1' ' A' ' 56' ' ' TYR . . . -81.68 -36.85 28.28 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.854 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 150.91 138.34 2.82 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.582 ' HB ' ' CD1' ' A' ' 4' ' ' TYR . 36.9 t -83.04 100.0 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.181 -1.188 . . . . 0.0 109.67 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.627 ' HB ' ' HB3' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -87.01 159.83 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.4 -0.813 . . . . 0.0 108.845 179.481 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.666 HG22 HG23 ' A' ' 101' ' ' VAL . 15.1 t -122.16 159.79 26.47 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.941 -1.099 . . . . 0.0 110.886 -178.982 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.69 ' CD2' ' O ' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -115.5 71.9 0.78 Allowed 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.434 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.445 ' OG1' ' C ' ' A' ' 92' ' ' HIS . 0.2 OUTLIER -176.61 133.13 0.21 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.416 -0.802 . . . . 0.0 109.294 -179.812 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 94.98 -6.97 69.74 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.774 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -120.54 147.29 45.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.157 -1.202 . . . . 0.0 109.727 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 95' ' ' ALA . 49.2 m -44.03 118.09 1.38 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.28 -0.887 . . . . 0.0 108.901 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.486 ' O ' ' C ' ' A' ' 98' ' ' ASN . . . 64.36 43.7 96.47 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.219 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.69 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 32.92 40.75 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.987 -0.714 . . . . 0.0 110.446 179.711 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 97' ' ' GLY . 3.0 t-20 -54.69 167.55 0.35 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.141 -0.975 . . . . 0.0 109.279 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.627 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -74.83 150.38 39.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.132 -0.98 . . . . 0.0 109.344 179.993 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.666 HG23 HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -161.02 122.54 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.417 -0.802 . . . . 0.0 109.086 179.687 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 3.6 pt-20 -41.8 131.48 3.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.387 -0.821 . . . . 0.0 109.861 -179.696 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.457 ' SG ' ' HB ' ' A' ' 91' ' ' THR . 0.7 OUTLIER -92.81 121.41 34.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.37 -0.831 . . . . 0.0 109.253 -179.981 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.8 p . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.623 -1.18 . . . . 0.0 109.445 179.955 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.495 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.6 p 166.49 138.06 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.169 -0.957 . . . . 0.0 110.141 179.705 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -115.4 -20.05 10.44 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.381 -0.824 . . . . 0.0 109.069 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.659 ' CG ' HG21 ' A' ' 89' ' ' VAL . 13.7 m-85 -95.65 109.71 21.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.313 -0.867 . . . . 0.0 109.371 179.839 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.475 HG22 ' C ' ' A' ' 9' ' ' ASN . 1.2 p -144.25 143.79 31.2 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.966 . . . . 0.0 109.642 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.61 8.16 4.92 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.148 0.975 . . . . 0.0 109.904 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.28 55.2 0.2 Allowed Glycine 0 C--N 1.278 -2.69 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m 55.15 19.06 2.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.45 -1.029 . . . . 0.0 109.134 -179.524 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.475 ' C ' HG22 ' A' ' 5' ' ' THR . 0.6 OUTLIER -75.07 -156.88 0.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.434 -0.791 . . . . 0.0 109.091 179.929 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.4 t -155.49 58.14 0.63 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.117 -0.99 . . . . 0.0 109.766 -180.0 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.494 ' CZ ' ' HB3' ' A' ' 63' ' ' SER . 3.3 m-85 -84.51 115.3 22.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.341 -0.849 . . . . 0.0 108.925 179.527 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.699 ' O ' HG23 ' A' ' 16' ' ' VAL . 30.2 t -81.71 136.17 35.48 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.252 -0.905 . . . . 0.0 110.222 -179.259 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.1 p -49.05 -31.41 7.7 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.497 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.2 t -70.64 -40.99 72.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.532 -0.73 . . . . 0.0 109.278 179.734 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -66.42 -30.25 70.57 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.172 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 12' ' ' SER . 3.2 t -68.35 -32.9 57.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 119.519 -0.872 . . . . 0.0 108.823 179.315 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.8 -46.68 77.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.481 -0.762 . . . . 0.0 109.584 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.63 -55.66 28.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.2 -0.937 . . . . 0.0 109.251 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.932 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -72.05 -3.51 23.4 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.388 -0.82 . . . . 0.0 109.37 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.65 ' OE1' HG22 ' A' ' 78' ' ' VAL . 6.3 tp60 -100.96 -15.96 17.33 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 179.333 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.474 ' HA ' ' OD1' ' A' ' 84' ' ' ASN . . . -93.12 -15.1 26.4 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.0 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.05 -47.67 23.82 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.444 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -60.89 -24.91 63.23 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 179.351 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.435 ' CD2' ' OD1' ' A' ' 84' ' ' ASN . 19.9 t80 -83.21 -36.05 24.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.521 -0.987 . . . . 0.0 109.26 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -49.89 72.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.304 -0.872 . . . . 0.0 108.838 179.492 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 26' ' ' LEU . 0.5 OUTLIER -61.61 -40.57 95.28 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.313 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.51 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 2.2 t60 -62.52 -20.9 65.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.389 -0.819 . . . . 0.0 109.42 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.79 -30.85 16.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.948 . . . . 0.0 109.806 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.77 9.91 33.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.127 -0.983 . . . . 0.0 109.46 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 46.8 24.12 1.75 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.1 -137.59 0.09 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.211 -1.17 . . . . 0.0 109.016 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.888 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -173.59 170.34 4.1 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.899 -1.126 . . . . 0.0 109.45 -179.938 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.489 HG21 ' CE1' ' A' ' 68' ' ' TYR . 33.2 m -83.26 -138.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.316 -0.865 . . . . 0.0 109.276 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.446 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -46.88 -49.35 17.43 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.75 -32.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.487 -1.007 . . . . 0.0 109.188 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -69.47 -8.82 50.21 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.386 -0.821 . . . . 0.0 109.79 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.888 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.8 OUTLIER 67.66 -172.69 0.19 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.096 -1.002 . . . . 0.0 108.908 -179.64 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.585 ' CD1' ' HD3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER 167.53 -45.05 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.186 -0.946 . . . . 0.0 112.435 179.114 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.567 ' HD2' ' H ' ' A' ' 38' ' ' TYR . 32.3 Cg_endo -74.71 100.37 1.33 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 121.416 1.41 . . . . 0.0 112.538 -178.512 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.549 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -142.53 -174.04 4.03 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.674 -0.641 . . . . 0.0 109.535 178.463 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.635 ' HB2' ' CE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -94.66 124.16 38.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.346 -0.846 . . . . 0.0 109.903 -179.398 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.47 ' CE1' ' CZ ' ' A' ' 100' ' ' PHE . 10.5 t80 -105.8 143.59 33.74 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.118 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.577 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 74.0 m-20 -78.47 -106.61 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.905 -1.122 . . . . 0.0 109.287 -179.674 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.577 ' CB ' ' O ' ' A' ' 43' ' ' ASN . 5.9 p30 154.42 95.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.478 -0.764 . . . . 0.0 109.188 179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 1.4 p90 -124.6 -28.15 3.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -0.981 . . . . 0.0 109.632 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.493 ' OE1' HG12 ' A' ' 101' ' ' VAL . 1.9 tm-20 -40.62 -65.7 0.39 Allowed 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.383 -0.823 . . . . 0.0 109.909 -179.647 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.92 59.75 0.01 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.43 ' CE1' ' HA ' ' A' ' 101' ' ' VAL . 84.8 m-85 -98.63 154.76 17.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.31 -1.112 . . . . 0.0 109.3 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.58 45.16 2.51 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.266 -0.897 . . . . 0.0 109.273 179.589 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.538 ' CG ' ' O ' ' A' ' 87' ' ' ALA . 14.4 m-85 -61.37 -167.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 109.869 -179.716 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.07 27.75 0.85 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.523 -0.736 . . . . 0.0 109.213 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.972 HG11 ' ND2' ' A' ' 81' ' ' ASN . 93.7 t -101.05 -80.08 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.191 -0.943 . . . . 0.0 109.741 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.463 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 86.6 p -158.39 178.01 10.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.169 -0.957 . . . . 0.0 110.189 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.62 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -83.3 -46.94 0.81 Allowed Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.592 -0.692 . . . . 0.0 111.536 -179.558 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 54' ' ' SER . 32.0 Cg_endo -73.03 83.93 1.37 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.899 1.733 . . . . 0.0 110.409 -178.004 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.583 ' CE1' ' CB ' ' A' ' 87' ' ' ALA . 10.1 m-85 -86.23 -175.22 5.42 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.826 0.822 . . . . 0.0 110.769 -179.156 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.635 ' CE2' ' HB2' ' A' ' 41' ' ' LYS . 47.8 m-85 -151.96 126.09 9.22 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.941 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -88.1 138.42 31.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.921 -1.112 . . . . 0.0 110.627 -178.985 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.665 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 21.1 t-105 -160.62 138.55 7.18 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 179.407 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.665 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.6 Cg_endo -69.54 154.47 68.56 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.33 2.02 . . . . 0.0 111.496 -178.817 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 1.008 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -129.12 129.07 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.594 -0.691 . . . . 0.0 109.823 -179.17 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.008 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -123.15 167.65 13.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.243 -0.911 . . . . 0.0 108.776 179.191 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . 84.1 p -127.92 65.97 1.36 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.101 -0.999 . . . . 0.0 109.355 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.23 25.34 0.11 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.391 -0.818 . . . . 0.0 109.57 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 51.1 45.26 51.58 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -121.89 -27.73 4.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.316 -1.108 . . . . 0.0 109.669 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.582 HG12 ' H ' ' A' ' 68' ' ' TYR . 2.5 t 62.37 174.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.14 -0.975 . . . . 0.0 109.153 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.6 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 29.0 t80 -96.4 106.0 18.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.078 -1.014 . . . . 0.0 109.682 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.48 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 0.8 OUTLIER -151.89 21.27 0.69 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.353 -0.842 . . . . 0.0 109.366 -179.977 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.17 -91.06 1.44 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.844 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.82 57.21 0.04 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.521 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -140.58 63.04 20.16 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.236 -1.155 . . . . 0.0 109.224 179.894 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.566 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 34.8 Cg_endo -78.62 163.46 26.66 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.856 2.371 . . . . 0.0 111.051 -179.607 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.564 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 131.47 133.34 3.47 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.969 -1.11 . . . . 0.0 110.544 179.236 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 70.41 -150.57 0.1 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.431 -1.041 . . . . 0.0 110.971 178.779 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.535 ' C ' ' O ' ' A' ' 75' ' ' ALA . 96.2 m-20 -7.08 126.46 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 CA-C-O 121.686 0.755 . . . . 0.0 112.837 -179.317 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.508 ' O ' HG12 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -161.89 80.71 0.56 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.962 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.694 HG21 ' CG1' ' A' ' 16' ' ' VAL . 7.5 p -62.47 145.54 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.87 -1.144 . . . . 0.0 109.303 -179.587 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.613 HG12 ' N ' ' A' ' 80' ' ' PHE . 68.2 t -113.06 165.78 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.346 -0.847 . . . . 0.0 109.843 -179.463 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.627 ' CD1' ' NE2' ' A' ' 20' ' ' GLN . 2.1 p90 -156.25 -174.98 5.19 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.56 -178.483 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.972 ' ND2' HG11 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -116.22 -82.07 0.62 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.061 -1.025 . . . . 0.0 109.967 -179.576 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -153.08 10.64 0.46 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.358 -0.839 . . . . 0.0 110.401 -179.417 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.456 ' HB3' ' HG2' ' A' ' 85' ' ' GLN . 45.3 t-20 -135.06 7.32 3.42 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.175 -0.953 . . . . 0.0 108.835 179.309 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.474 ' OD1' ' HA ' ' A' ' 21' ' ' ALA . 6.2 m-80 72.28 9.36 5.88 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.373 -0.829 . . . . 0.0 109.451 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.524 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 1.8 mm100 -49.38 -92.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.555 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.753 ' O ' HG21 ' A' ' 52' ' ' VAL . 0.1 OUTLIER 170.72 106.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 0.0 110.716 178.681 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.583 ' CB ' ' CE1' ' A' ' 56' ' ' TYR . . . -82.72 -30.86 28.81 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.292 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.503 ' O ' HG23 ' A' ' 78' ' ' VAL . . . 146.9 -165.96 28.43 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.659 HG21 ' CG ' ' A' ' 4' ' ' TYR . 73.3 t -134.1 102.24 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.312 -1.111 . . . . 0.0 109.203 179.748 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.534 ' HB ' ' HB2' ' A' ' 100' ' ' PHE . 0.4 OUTLIER -104.5 153.99 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 109.273 -179.731 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 100' ' ' PHE . 10.2 t -122.65 137.33 54.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.095 -1.003 . . . . 0.0 110.275 -179.455 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.438 ' CE1' ' CD2' ' A' ' 100' ' ' PHE . 1.8 m-70 -80.6 75.33 7.49 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.428 -0.795 . . . . 0.0 108.908 179.175 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.5 t -173.97 158.41 3.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.544 -0.723 . . . . 0.0 109.393 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 87.04 -14.58 56.91 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.802 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . . . -131.67 114.78 15.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -1.137 . . . . 0.0 109.22 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.468 ' O ' ' C ' ' A' ' 97' ' ' GLY . 7.4 p 46.09 -160.5 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.008 -1.058 . . . . 0.0 108.963 -179.762 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 96' ' ' SER . . . -40.38 -45.12 3.25 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.468 ' O ' ' O ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -155.68 -74.89 0.1 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.213 -1.169 . . . . 0.0 109.506 179.517 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.802 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 1.9 m120 62.34 132.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.153 -0.967 . . . . 0.0 108.62 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.534 ' HB2' ' HB ' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -92.75 141.52 28.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.921 -1.112 . . . . 0.0 109.851 -179.79 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.493 HG12 ' OE1' ' A' ' 46' ' ' GLU . 4.2 m -152.12 148.94 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.793 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 101' ' ' VAL . 0.6 OUTLIER -43.44 141.1 1.46 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.09 -1.006 . . . . 0.0 109.64 -179.675 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -55.04 144.18 24.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.399 -0.813 . . . . 0.0 109.597 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.488 1.472 0 O-C-N 121.245 -0.909 . . . . 0.0 109.514 179.891 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.321 0.581 . . . . 0.0 109.666 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 28.9 p 178.18 105.87 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.378 -0.826 . . . . 0.0 109.606 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -68.31 -52.39 34.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.97 -1.081 . . . . 0.0 109.147 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.595 ' CB ' HG21 ' A' ' 89' ' ' VAL . 60.3 m-85 -92.95 105.92 17.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.411 -0.806 . . . . 0.0 109.347 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 9' ' ' ASN . 2.3 t -134.26 128.66 34.29 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.945 -1.097 . . . . 0.0 109.836 -179.866 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.484 ' SG ' ' OG1' ' A' ' 91' ' ' THR . 2.0 t -96.34 -164.79 1.19 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.357 -0.84 . . . . 0.0 109.036 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.404 ' O ' ' CB ' ' A' ' 8' ' ' SER . . . -54.26 96.26 0.03 OUTLIER Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -179.126 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.52 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 0.8 OUTLIER 70.07 54.01 0.35 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.361 -1.082 . . . . 0.0 109.837 179.272 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 8' ' ' SER . 2.1 m120 -155.69 89.42 1.17 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.398 -0.813 . . . . 0.0 109.182 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.423 ' C ' ' CB ' ' A' ' 2' ' ' CYS . 0.4 OUTLIER -74.51 79.63 1.95 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.385 -0.822 . . . . 0.0 109.181 -179.599 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.524 ' CZ ' ' HB2' ' A' ' 63' ' ' SER . 3.2 m-85 -94.46 126.09 39.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.043 -1.036 . . . . 0.0 109.131 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.635 ' O ' HG23 ' A' ' 16' ' ' VAL . 18.6 t -89.35 130.28 35.75 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 110.118 -179.466 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.523 ' HG ' ' HE2' ' A' ' 4' ' ' TYR . 4.2 t -46.22 -25.84 0.68 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.505 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.7 t -69.09 -47.4 65.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.4 -0.812 . . . . 0.0 109.314 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -26.49 65.53 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.129 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 12' ' ' SER . 13.5 t -69.09 -36.03 71.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.263 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.2 t -56.64 -47.04 80.59 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.452 -0.78 . . . . 0.0 109.668 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.08 -54.03 51.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.025 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.566 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -68.22 -12.24 60.64 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.454 -0.779 . . . . 0.0 109.061 179.545 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.652 ' NE2' ' CG ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -83.56 -27.82 29.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 0.0 108.647 179.605 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.84 -14.16 54.82 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.428 -0.795 . . . . 0.0 108.881 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.76 -56.01 5.09 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.416 -0.802 . . . . 0.0 109.355 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.612 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -66.82 -28.13 73.64 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.578 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.437 ' CE1' ' O ' ' A' ' 82' ' ' GLU . 7.0 t80 -71.89 -40.06 69.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.538 -0.977 . . . . 0.0 109.614 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.88 -51.95 54.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.049 -1.032 . . . . 0.0 109.389 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.537 ' HB3' ' CG ' ' A' ' 39' ' ' PRO . 0.8 OUTLIER -52.18 -44.02 64.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.298 -0.876 . . . . 0.0 109.404 179.768 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.624 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 3.1 t60 -53.01 -53.73 45.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.414 -0.804 . . . . 0.0 110.14 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -82.73 -1.58 51.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.331 -0.856 . . . . 0.0 109.802 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -92.67 -1.5 56.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.719 -179.836 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 51.06 37.6 37.24 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.507 ' O ' HG23 ' A' ' 32' ' ' THR . 3.1 tp10 -128.67 -152.46 0.52 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.34 -1.094 . . . . 0.0 109.367 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.751 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.6 OUTLIER -159.28 -175.91 5.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.337 -0.852 . . . . 0.0 109.197 179.901 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 35' ' ' SER . 16.6 m -130.72 160.56 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.033 -1.042 . . . . 0.0 109.803 -179.828 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 53.28 -89.2 0.01 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 33' ' ' VAL . 2.1 p -177.29 25.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.324 -1.103 . . . . 0.0 109.99 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -147.84 13.16 1.02 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.056 -1.027 . . . . 0.0 109.514 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.751 ' HA ' HG22 ' A' ' 32' ' ' THR . 3.3 p 64.4 -170.25 0.19 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -0.879 . . . . 0.0 109.542 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.71 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 170.33 -44.99 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.419 -0.801 . . . . 0.0 111.66 178.621 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.585 ' HD2' ' H ' ' A' ' 38' ' ' TYR . 34.2 Cg_endo -77.36 101.08 1.46 Allowed 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 121.314 1.342 . . . . 0.0 111.858 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.71 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -138.56 -175.27 4.07 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.396 -0.815 . . . . 0.0 109.546 178.65 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -78.55 141.97 37.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.366 -0.834 . . . . 0.0 109.73 -179.563 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.599 ' CZ ' ' HA ' ' A' ' 44' ' ' ASN . 13.7 t80 -100.61 128.86 46.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.412 -0.805 . . . . 0.0 109.284 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 44' ' ' ASN . 1.7 t30 -93.4 -4.75 50.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.192 -0.942 . . . . 0.0 109.636 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.599 ' HA ' ' CZ ' ' A' ' 42' ' ' TYR . 0.8 OUTLIER 40.06 93.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.486 -0.759 . . . . 0.0 109.951 179.952 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.464 ' O ' ' C ' ' A' ' 46' ' ' GLU . 75.4 m-85 -86.77 -38.43 16.9 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.35 -0.844 . . . . 0.0 109.842 -179.872 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.501 ' OE1' ' CE1' ' A' ' 48' ' ' PHE . 0.9 OUTLIER -38.7 -46.53 1.25 Allowed 'General case' 0 C--N 1.309 -1.193 0 O-C-N 121.413 -0.804 . . . . 0.0 110.039 -179.593 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.5 62.44 0.57 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 -179.969 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.501 ' CE1' ' OE1' ' A' ' 46' ' ' GLU . 51.7 m-85 -97.32 179.9 4.73 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.28 -1.13 . . . . 0.0 108.987 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -117.12 -41.98 2.96 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.221 -0.924 . . . . 0.0 108.89 179.501 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.581 ' CD2' ' HB1' ' A' ' 87' ' ' ALA . 4.4 m-85 47.33 -170.92 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.481 -0.762 . . . . 0.0 109.777 179.549 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -146.55 20.22 1.33 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.477 -0.764 . . . . 0.0 108.961 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.529 ' HB ' ' CE1' ' A' ' 56' ' ' TYR . 46.9 t -92.91 -83.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.366 -0.834 . . . . 0.0 109.569 -179.783 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.519 ' N ' HG12 ' A' ' 52' ' ' VAL . 69.9 m -166.87 -175.66 3.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.129 -0.982 . . . . 0.0 109.985 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.601 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -79.07 -51.19 1.32 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.51 -0.743 . . . . 0.0 111.007 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 54' ' ' SER . 33.3 Cg_endo -73.44 89.1 0.96 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.911 1.741 . . . . 0.0 109.768 -177.953 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.639 ' CE1' ' HB2' ' A' ' 87' ' ' ALA . 5.9 m-85 -90.04 -168.63 2.18 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.581 0.705 . . . . 0.0 110.144 -178.943 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.624 ' CE1' ' NE2' ' A' ' 27' ' ' HIS . 72.9 m-85 -158.66 120.29 3.48 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.176 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -88.68 137.9 31.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 110.838 -178.721 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.677 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 41.0 t-105 -161.03 137.8 6.45 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.416 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.677 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 33.1 Cg_endo -71.66 148.43 53.07 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.242 1.961 . . . . 0.0 111.446 -178.893 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.955 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -111.53 125.48 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.855 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.955 HD23 ' C ' ' A' ' 61' ' ' ILE . 1.5 mt -121.06 165.53 15.18 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.11 -0.994 . . . . 0.0 109.537 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.524 ' HB2' ' CZ ' ' A' ' 11' ' ' TYR . 22.9 t -129.16 48.0 2.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.469 -0.769 . . . . 0.0 109.252 179.857 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.35 21.8 3.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.406 -0.809 . . . . 0.0 109.396 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 54.74 44.2 80.31 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.57 116.28 5.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -1.132 . . . . 0.0 109.534 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.598 HG13 ' CZ2' ' A' ' 59' ' ' TRP . 54.3 t -54.51 148.48 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.209 -0.932 . . . . 0.0 109.43 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.574 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 58.5 t80 -56.91 154.13 9.95 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.226 -0.921 . . . . 0.0 109.572 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.414 ' N ' ' CG ' ' A' ' 68' ' ' TYR . 1.2 t -158.68 -53.2 0.06 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.361 -0.837 . . . . 0.0 109.383 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -166.31 79.49 0.12 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 72' ' ' SER . . . 162.06 142.56 3.43 Favored Glycine 0 N--CA 1.49 2.279 0 O-C-N 121.113 -1.228 . . . . 0.0 110.055 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.536 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 1.7 m 42.99 61.65 9.39 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.429 -1.042 . . . . 0.0 110.033 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.536 ' HD3' ' N ' ' A' ' 72' ' ' SER . 36.3 Cg_endo -78.89 -48.21 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.627 2.218 . . . . 0.0 110.551 179.816 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.495 ' CA ' ' CB ' ' A' ' 92' ' ' HIS . . . -82.06 -135.66 2.13 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.544 ' N ' ' HB2' ' A' ' 92' ' ' HIS . . . 64.76 -83.78 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.448 -1.031 . . . . 0.0 110.552 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.476 ' OD1' ' HB2' ' A' ' 6' ' ' CYS . 6.1 m-20 -119.02 139.99 50.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.757 -1.214 . . . . 0.0 109.956 -179.357 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.659 ' HD2' ' CD2' ' A' ' 92' ' ' HIS . 69.0 mtt180 -152.09 134.19 15.03 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.596 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.0 p -114.36 138.98 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.062 -1.024 . . . . 0.0 109.288 179.771 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.606 HG12 ' N ' ' A' ' 80' ' ' PHE . 43.1 t -104.51 167.46 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.36 -0.838 . . . . 0.0 109.654 -179.618 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.652 ' CG ' ' NE2' ' A' ' 20' ' ' GLN . 4.4 p90 -163.95 -172.82 2.95 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.398 -178.169 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.462 ' O ' ' HB3' ' A' ' 82' ' ' GLU . 46.7 t-20 -122.06 -46.52 2.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.018 -1.051 . . . . 0.0 109.653 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 81' ' ' ASN . 5.2 pt-20 166.85 -27.3 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.46 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 1.4 m-20 -100.37 27.54 5.65 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.074 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 83' ' ' ASN . 2.5 p-10 46.24 27.52 0.57 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.358 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.568 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 1.2 mt-30 -54.65 -32.02 58.47 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.947 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.568 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 85.94 105.25 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.587 0.708 . . . . 0.0 110.532 179.075 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.639 ' HB2' ' CE1' ' A' ' 56' ' ' TYR . . . -80.49 -43.44 20.82 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.868 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 156.19 159.04 9.15 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.595 HG21 ' CB ' ' A' ' 4' ' ' TYR . 58.1 t -96.39 92.37 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.185 -1.185 . . . . 0.0 109.706 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.645 HD12 ' CB ' ' A' ' 100' ' ' PHE . 0.4 OUTLIER -78.83 173.65 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.576 -0.703 . . . . 0.0 109.33 179.736 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.504 HG22 HG23 ' A' ' 101' ' ' VAL . 5.6 t -132.25 146.04 51.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.04 -1.038 . . . . 0.0 111.013 -179.035 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.659 ' CD2' ' HD2' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -93.39 62.72 3.44 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.363 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 93' ' ' THR . 2.6 t 178.92 24.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.806 -179.29 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -131.44 27.22 3.78 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.729 ' HB3' ' CB ' ' A' ' 99' ' ' ASN . . . -158.92 97.28 1.4 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.222 -1.164 . . . . 0.0 110.533 -179.65 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.47 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER 36.33 54.32 1.03 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.802 -0.561 . . . . 0.0 110.331 179.316 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 93' ' ' THR . . . 122.92 -87.72 0.4 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.526 ' HA ' ' N ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -138.16 -69.52 0.44 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.181 -1.188 . . . . 0.0 109.828 179.949 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.729 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . 1.1 t30 44.82 -167.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 0.0 108.774 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.645 ' CB ' HD12 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -130.12 114.83 16.22 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.838 -1.164 . . . . 0.0 110.805 179.916 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.504 HG23 HG22 ' A' ' 91' ' ' THR . 1.6 m -130.27 128.03 63.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.375 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 101' ' ' VAL . 4.0 mt-10 -42.98 105.66 0.05 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.331 -0.856 . . . . 0.0 109.879 -179.416 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.7 107.27 3.4 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.299 -0.876 . . . . 0.0 109.562 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 109.402 179.982 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.223 0.535 . . . . 0.0 109.767 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.7 p 164.96 99.62 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.259 -0.9 . . . . 0.0 110.06 179.559 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -78.78 -2.9 41.73 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.394 -0.816 . . . . 0.0 108.992 179.472 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.597 ' CD2' HG21 ' A' ' 89' ' ' VAL . 8.0 m-85 -118.9 107.04 13.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.949 . . . . 0.0 109.681 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.607 HG23 ' O ' ' A' ' 9' ' ' ASN . 56.0 m -142.38 143.04 32.52 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.429 ' SG ' ' OD1' ' A' ' 76' ' ' ASP . 80.8 m -123.51 15.31 9.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.048 -1.033 . . . . 0.0 110.339 -179.499 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.555 ' H ' HG22 ' A' ' 5' ' ' THR . . . 167.29 -88.56 0.1 OUTLIER Glycine 0 C--N 1.28 -2.554 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.78 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.43 26.67 7.24 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.351 -1.087 . . . . 0.0 109.504 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.607 ' O ' HG23 ' A' ' 5' ' ' THR . 2.5 m-80 -106.58 131.63 53.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.706 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 1' ' ' ALA . 43.3 t -104.28 75.95 1.29 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.53 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 3.5 m-85 -83.48 126.48 32.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.852 . . . . 0.0 110.253 -179.139 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.747 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.7 OUTLIER -81.92 125.83 31.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.645 -0.659 . . . . 0.0 109.65 179.851 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.49 -22.93 0.82 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.16 -0.963 . . . . 0.0 109.194 179.659 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.97 -39.43 26.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.94 . . . . 0.0 110.097 -179.704 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.34 -35.1 75.58 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 12' ' ' SER . 2.9 t -58.81 -26.41 32.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.057 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.7 t -63.09 -43.98 97.02 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.519 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -34.47 77.97 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.083 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.888 ' CB ' HD13 ' A' ' 61' ' ' ILE . . . -84.8 -10.04 57.58 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.059 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.512 ' NE2' ' O ' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -91.88 -21.49 20.58 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.272 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.514 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -88.32 -8.84 54.49 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 26' ' ' LEU . . . -81.04 -56.16 4.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.12 -0.988 . . . . 0.0 108.835 179.679 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.439 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -61.8 -20.46 59.74 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 179.384 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.578 ' CE1' ' HA ' ' A' ' 82' ' ' GLU . 34.0 t80 -87.28 -69.84 0.66 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.375 -1.073 . . . . 0.0 109.565 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.514 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -42.54 -52.7 4.66 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.257 -0.902 . . . . 0.0 109.398 179.9 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.636 HD13 ' CB ' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -56.92 -42.63 80.3 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.427 -0.796 . . . . 0.0 109.155 179.837 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.525 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 5.3 t60 -53.65 -52.67 59.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.352 -0.843 . . . . 0.0 110.102 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 28' ' ' GLU . 39.5 tp10 -84.38 -2.53 57.28 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.138 -0.976 . . . . 0.0 109.575 -179.56 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.435 ' HB3' ' HA ' ' A' ' 26' ' ' LEU . 38.0 t70 -94.93 -7.81 38.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.175 -0.953 . . . . 0.0 109.365 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.26 -40.12 3.04 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.746 ' O ' HG23 ' A' ' 32' ' ' THR . 1.1 mp0 -65.64 -173.9 0.18 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -1.138 . . . . 0.0 109.277 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 31' ' ' GLU . 7.2 p -161.53 -94.75 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.181 -0.95 . . . . 0.0 109.503 179.595 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.409 ' CG1' ' HB2' ' A' ' 38' ' ' TYR . 3.5 m -135.62 -114.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.982 -1.074 . . . . 0.0 109.785 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.516 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -97.42 44.75 1.83 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.5 OUTLIER 76.19 24.33 1.14 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.446 -1.032 . . . . 0.0 109.547 179.886 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -119.73 7.54 11.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -0.903 . . . . 0.0 109.677 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.453 ' HA ' ' CB ' ' A' ' 32' ' ' THR . 52.1 p 45.32 88.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.252 -0.905 . . . . 0.0 109.88 179.94 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.623 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -91.61 -40.2 0.38 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.314 -0.866 . . . . 0.0 111.736 -179.686 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 33.7 Cg_endo -76.08 109.76 2.94 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 120.986 1.124 . . . . 0.0 110.086 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.578 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -128.27 -173.23 2.89 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.203 -179.396 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -103.37 141.95 35.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.093 -1.004 . . . . 0.0 110.059 -179.622 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.485 ' CE2' ' HA ' ' A' ' 44' ' ' ASN . 68.3 t80 -107.05 160.09 15.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.205 -0.934 . . . . 0.0 109.228 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.564 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 0.5 OUTLIER -109.95 -84.98 0.55 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.095 -1.003 . . . . 0.0 109.776 -179.91 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.581 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 0.4 OUTLIER 155.99 135.07 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.729 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.581 ' CD1' ' O ' ' A' ' 44' ' ' ASN . 19.6 m-85 -152.41 -64.88 0.17 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.068 -1.02 . . . . 0.0 109.414 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -40.64 -53.87 2.68 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.374 -0.829 . . . . 0.0 109.529 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 48' ' ' PHE . . . 140.52 -73.66 0.38 Allowed Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.613 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.584 ' HB3' ' CE2' ' A' ' 50' ' ' PHE . 70.7 m-85 66.91 157.09 0.11 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.406 -1.055 . . . . 0.0 108.389 -179.873 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -108.71 27.78 9.08 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.715 -1.194 . . . . 0.0 110.381 -178.884 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.584 ' CE2' ' HB3' ' A' ' 48' ' ' PHE . 8.1 p90 -125.22 -174.32 3.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.984 -1.073 . . . . 0.0 109.697 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -170.08 54.81 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.268 -0.895 . . . . 0.0 109.304 -179.679 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.513 ' HB ' ' CE1' ' A' ' 56' ' ' TYR . 29.9 t -43.45 -66.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.198 -0.939 . . . . 0.0 109.524 -179.82 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.486 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -164.18 -172.89 2.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.135 -0.978 . . . . 0.0 109.767 -179.816 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.571 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -79.6 -54.97 0.9 Allowed Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.266 -0.896 . . . . 0.0 111.223 -179.255 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 54' ' ' SER . 34.4 Cg_endo -72.42 87.02 0.95 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.877 1.718 . . . . 0.0 109.979 -178.114 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.676 ' HE1' ' HB2' ' A' ' 87' ' ' ALA . 9.3 m-85 -87.13 178.1 7.0 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.233 0.54 . . . . 0.0 109.639 -179.38 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 41' ' ' LYS . 94.0 m-85 -156.71 129.56 7.77 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.364 -0.835 . . . . 0.0 109.576 179.62 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.517 ' HG3' ' ND1' ' A' ' 40' ' ' HIS . 0.2 OUTLIER -99.86 138.18 37.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -0.94 . . . . 0.0 109.663 -179.933 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.655 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 21.1 t-105 -155.69 136.64 9.1 Favored Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.655 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.8 Cg_endo -71.5 137.29 30.24 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 C-N-CA 122.168 1.912 . . . . 0.0 111.801 -178.224 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 1.013 HD12 ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -110.93 133.51 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.96 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.013 ' N ' HD12 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -131.93 158.69 40.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -0.9 . . . . 0.0 109.158 179.921 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 98.1 p -122.83 27.4 7.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.911 . . . . 0.0 108.88 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -153.87 -39.08 0.1 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.454 -0.779 . . . . 0.0 109.356 -179.604 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 66' ' ' ASP . . . -88.98 -9.99 67.1 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.839 ' OD1' HG23 ' A' ' 67' ' ' VAL . 67.8 t0 48.09 96.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -1.124 . . . . 0.0 109.56 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.839 HG23 ' OD1' ' A' ' 66' ' ' ASP . 2.9 t 75.62 135.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.545 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.568 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 45.9 t80 -81.39 150.34 28.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.903 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.451 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 4.8 t -165.47 -42.3 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.422 -0.799 . . . . 0.0 109.285 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -158.09 124.49 1.4 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.89 -145.29 12.65 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.85 107.77 60.9 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.285 -1.126 . . . . 0.0 109.636 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.477 ' CB ' ' OH ' ' A' ' 38' ' ' TYR . 35.7 Cg_endo -77.12 -175.63 2.76 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.534 2.156 . . . . 0.0 110.534 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.64 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 93.35 -175.64 36.3 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 71.52 -144.91 0.06 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.141 -1.211 . . . . 0.0 110.108 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.429 ' OD1' ' SG ' ' A' ' 6' ' ' CYS . 5.7 m-20 -44.11 151.54 0.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.354 -0.841 . . . . 0.0 110.986 -179.135 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.525 ' NH2' ' CE1' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -164.95 111.84 0.99 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.104 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.815 HG21 HD21 ' A' ' 86' ' ' LEU . 13.9 p -92.56 129.25 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.821 -1.175 . . . . 0.0 110.312 -178.974 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.622 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 55.2 t -98.39 167.36 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.467 -0.771 . . . . 0.0 109.145 179.569 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.616 ' N ' HG12 ' A' ' 79' ' ' VAL . 4.7 p90 -168.48 -170.76 1.3 Allowed 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.662 -178.082 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.456 ' ND2' ' CB ' ' A' ' 53' ' ' SER . 1.0 OUTLIER -129.71 -42.4 1.29 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.172 -0.955 . . . . 0.0 110.056 -179.341 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.578 ' HA ' ' CE1' ' A' ' 24' ' ' TYR . 7.6 pt-20 166.26 -27.31 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.737 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.46 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -100.84 26.08 7.27 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.489 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 84' ' ' ASN . 8.5 p30 48.7 25.27 0.95 Allowed 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.45 0.643 . . . . 0.0 109.636 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.535 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 3.0 mt-30 -55.35 -36.16 66.01 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.967 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.815 HD21 HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER 83.59 104.11 0.05 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.557 0.694 . . . . 0.0 110.694 179.142 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.676 ' HB2' ' HE1' ' A' ' 56' ' ' TYR . . . -76.81 -34.0 57.96 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.783 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 150.34 151.52 5.56 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.597 HG21 ' CD2' ' A' ' 4' ' ' TYR . 85.9 t -89.34 88.07 2.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.268 -1.136 . . . . 0.0 109.696 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.555 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 0.8 OUTLIER -78.97 158.26 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.276 -0.89 . . . . 0.0 108.789 179.681 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.467 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 9.5 t -119.22 168.48 10.84 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.043 -1.036 . . . . 0.0 110.642 -179.1 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.58 ' CD2' ' O ' ' A' ' 98' ' ' ASN . 0.3 OUTLIER -120.98 68.98 0.88 Allowed 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 3.1 m -175.75 -30.37 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.401 -0.812 . . . . 0.0 110.183 -179.717 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.42 17.17 40.41 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.161 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.653 ' HB2' HG11 ' A' ' 101' ' ' VAL . . . -153.98 121.2 5.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -1.164 . . . . 0.0 109.482 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.476 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.9 OUTLIER 39.28 -156.38 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.367 -0.833 . . . . 0.0 109.49 179.68 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 96' ' ' SER . . . -41.39 -59.99 2.49 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 179.341 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.58 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -167.43 32.65 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.243 -1.151 . . . . 0.0 109.27 179.251 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.436 ' O ' ' O ' ' A' ' 98' ' ' ASN . 1.4 t30 -48.14 173.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.99 -1.068 . . . . 0.0 109.251 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.555 ' HB3' ' CG1' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -100.13 144.13 29.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.1 -1.0 . . . . 0.0 109.528 -179.94 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.653 HG11 ' HB2' ' A' ' 95' ' ' ALA . 10.3 m -158.02 137.19 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.377 -0.827 . . . . 0.0 108.899 179.624 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.87 96.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.098 -1.001 . . . . 0.0 109.554 -179.59 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.467 ' SG ' ' HB ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -48.41 126.77 11.97 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.298 -0.876 . . . . 0.0 109.464 179.832 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.837 -1.078 . . . . 0.0 109.483 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.471 ' O ' ' SG ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.541 0.686 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 31.4 p 38.93 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.912 0.863 . . . . 0.0 110.264 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -102.5 -1.44 30.53 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.361 -0.837 . . . . 0.0 109.307 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.695 ' CG ' HG21 ' A' ' 89' ' ' VAL . 23.0 m-85 -115.07 65.73 0.68 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.9 . . . . 0.0 109.225 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.797 HG23 ' O ' ' A' ' 5' ' ' THR . 11.5 t -86.78 92.46 8.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.94 . . . . 0.0 109.741 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.9 m -104.24 155.75 18.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.119 -0.988 . . . . 0.0 109.236 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 8' ' ' SER . . . 47.43 29.3 5.29 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.436 ' O ' ' OD1' ' A' ' 9' ' ' ASN . 5.0 m 70.44 43.84 0.76 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -1.14 . . . . 0.0 109.422 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.487 ' O ' ' HA ' ' A' ' 5' ' ' THR . 83.0 m-20 -136.97 86.33 2.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.136 -0.978 . . . . 0.0 109.547 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.472 ' HA ' ' HB ' ' A' ' 5' ' ' THR . 0.5 OUTLIER -54.9 88.26 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.498 -0.751 . . . . 0.0 109.395 179.868 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 63' ' ' SER . 1.9 m-85 -79.68 144.51 33.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.311 -0.868 . . . . 0.0 108.924 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.81 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -78.58 122.48 25.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.376 -0.827 . . . . 0.0 109.568 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.6 p -59.03 -26.62 64.72 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 83.4 p -78.93 -28.55 43.84 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 0.5 OUTLIER -79.74 -27.4 40.55 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.081 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 12' ' ' SER . 13.5 t -66.6 -29.9 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.499 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 1.9 t -64.4 -46.21 84.26 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.93 -51.81 67.69 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.821 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -66.41 -18.81 65.58 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.726 ' NE2' ' CD1' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -71.11 -36.65 72.23 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -82.0 -1.72 49.19 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.54 -54.82 5.33 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.353 -0.842 . . . . 0.0 108.914 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.574 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -72.89 -18.5 79.01 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.44 ' O ' ' C ' ' A' ' 25' ' ' GLN . 14.6 t80 -80.22 -60.52 2.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.557 -0.966 . . . . 0.0 109.348 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.7 OUTLIER -41.64 -35.38 0.74 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.319 -0.863 . . . . 0.0 109.614 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.518 ' HA ' HD22 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -75.23 -47.13 29.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 0.0 109.65 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.583 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 11.5 t60 -56.25 -37.44 69.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.368 -0.833 . . . . 0.0 110.941 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -85.41 -31.47 22.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.027 -1.046 . . . . 0.0 109.48 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 0.5 OUTLIER -68.09 -20.51 64.95 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.274 -0.891 . . . . 0.0 109.366 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.23 -19.02 25.08 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.506 ' HB3' HD11 ' A' ' 26' ' ' LEU . 1.7 tp10 -63.01 -154.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.234 -1.156 . . . . 0.0 109.492 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.778 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -162.69 174.47 12.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.336 -0.852 . . . . 0.0 109.408 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.496 ' CG2' ' HB2' ' A' ' 38' ' ' TYR . 18.0 m -130.4 158.1 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.276 -0.89 . . . . 0.0 109.383 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.403 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . 55.63 -89.21 0.01 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER 171.04 32.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.327 -1.102 . . . . 0.0 109.725 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 37' ' ' SER . 1.6 m120 -152.64 25.29 0.58 Allowed 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.106 -0.996 . . . . 0.0 109.666 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.778 ' HA ' HG22 ' A' ' 32' ' ' THR . 1.0 OUTLIER 47.95 92.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.018 -1.051 . . . . 0.0 108.887 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.68 ' CD2' ' CE2' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -79.34 -47.29 1.58 Allowed Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.261 -0.9 . . . . 0.0 110.765 -179.367 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 38' ' ' TYR . 32.6 Cg_endo -74.71 108.04 2.61 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 120.95 1.1 . . . . 0.0 109.349 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.62 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -125.74 -174.8 3.17 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.459 -179.11 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -104.6 131.28 52.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.346 -0.846 . . . . 0.0 109.42 -179.526 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.596 ' CZ ' ' HA ' ' A' ' 44' ' ' ASN . 11.9 t80 -97.33 137.83 35.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.272 -0.893 . . . . 0.0 109.259 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.523 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -89.85 -32.49 16.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.144 -0.973 . . . . 0.0 109.776 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.626 ' ND2' ' CD1' ' A' ' 48' ' ' PHE . 4.7 t-20 77.2 135.59 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.591 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.445 ' O ' ' C ' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -159.5 -38.11 0.06 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.307 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.6 OUTLIER -38.72 -73.02 0.05 Allowed 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.623 -0.673 . . . . 0.0 110.069 -179.582 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 155.41 61.72 0.01 OUTLIER Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.626 ' CD1' ' ND2' ' A' ' 44' ' ' ASN . 48.6 m-85 -90.74 -168.01 1.97 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.299 -1.118 . . . . 0.0 109.332 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 50' ' ' PHE . 5.0 p30 -145.05 26.59 1.34 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.52 ' CB ' ' OH ' ' A' ' 56' ' ' TYR . 20.9 m-30 -45.6 173.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.503 -0.748 . . . . 0.0 109.769 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.4 m -146.53 30.3 1.01 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.357 -0.839 . . . . 0.0 109.088 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.835 HG11 ' OD1' ' A' ' 81' ' ' ASN . 97.2 t -96.28 -92.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.338 -0.851 . . . . 0.0 109.545 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.497 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 66.9 m -142.63 -172.93 3.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.074 -1.016 . . . . 0.0 109.962 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.592 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -85.49 -49.25 0.56 Allowed Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.364 -0.835 . . . . 0.0 111.61 -179.175 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 54' ' ' SER . 33.5 Cg_endo -74.09 83.41 1.64 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 121.863 1.708 . . . . 0.0 110.396 -177.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.546 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 7.1 m-85 -79.38 -177.96 6.01 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.645 0.736 . . . . 0.0 110.022 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.583 ' CE2' ' NE2' ' A' ' 27' ' ' HIS . 97.6 m-85 -157.95 152.33 24.63 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.599 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 19.2 mt-10 -119.63 143.17 47.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.991 -1.068 . . . . 0.0 111.124 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.653 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 21.3 t-105 -160.75 138.81 7.21 Favored Pre-proline 0 N--CA 1.49 1.57 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.653 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.2 Cg_endo -69.22 142.59 50.74 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.338 2.025 . . . . 0.0 111.861 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.978 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -119.57 131.64 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.978 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.9 OUTLIER -123.13 167.49 13.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.191 -0.943 . . . . 0.0 109.576 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -135.72 17.47 3.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.368 -0.833 . . . . 0.0 109.25 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.25 -54.2 0.2 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.284 -0.885 . . . . 0.0 109.423 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . -67.42 -98.16 0.03 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.716 ' O ' HD12 ' A' ' 62' ' ' LEU . 3.0 t0 175.49 -162.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -1.161 . . . . 0.0 109.538 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.41 ' H ' HG23 ' A' ' 67' ' ' VAL . 8.5 t -52.55 136.47 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.304 -0.873 . . . . 0.0 109.568 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.68 ' CE2' ' CD2' ' A' ' 38' ' ' TYR . 28.9 t80 -52.92 117.84 3.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.2 -0.937 . . . . 0.0 109.254 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -177.19 74.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.404 -0.81 . . . . 0.0 109.662 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.52 62.12 0.31 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.31 -136.29 3.91 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.2 m -166.29 101.63 0.7 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.309 -1.112 . . . . 0.0 109.186 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.57 ' HG3' ' CD1' ' A' ' 68' ' ' TYR . 35.8 Cg_endo -77.82 -81.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.435 2.09 . . . . 0.0 110.685 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.39 -176.89 4.86 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . 56.47 -122.03 1.65 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.101 -1.235 . . . . 0.0 109.555 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 75' ' ' ALA . 87.2 m-20 -41.4 146.85 0.19 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.848 -1.158 . . . . 0.0 110.167 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.491 ' O ' HG12 ' A' ' 90' ' ' ILE . 2.6 tpp180 -176.37 90.12 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.455 -0.778 . . . . 0.0 109.219 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.752 HG21 HD21 ' A' ' 86' ' ' LEU . 7.5 p -65.04 144.63 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.097 -1.002 . . . . 0.0 109.547 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.605 HG23 HD13 ' A' ' 90' ' ' ILE . 24.7 t -104.84 167.48 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.345 -0.847 . . . . 0.0 109.642 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.726 ' CD1' ' NE2' ' A' ' 20' ' ' GLN . 13.8 p90 -164.53 -173.39 3.03 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.409 -178.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.835 ' OD1' HG11 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -124.07 -81.15 0.63 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.066 -1.022 . . . . 0.0 110.267 -179.395 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -158.74 21.55 0.22 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.312 -0.867 . . . . 0.0 109.484 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.453 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 4.4 m120 -140.39 23.89 2.31 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.597 ' ND2' ' O ' ' A' ' 84' ' ' ASN . 0.3 OUTLIER 52.83 19.92 1.45 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 -179.321 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.503 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 51.8 mm-40 -60.62 -111.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.752 HD21 HG21 ' A' ' 78' ' ' VAL . 0.2 OUTLIER 172.84 110.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 110.693 178.825 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.588 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . . . -79.62 -38.92 32.75 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 148.69 156.71 7.24 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.695 HG21 ' CG ' ' A' ' 4' ' ' TYR . 94.8 t -87.14 113.48 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -1.155 . . . . 0.0 109.411 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.605 HD13 HG23 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -109.27 154.54 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.421 -0.8 . . . . 0.0 109.142 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 100' ' ' PHE . 4.6 t -107.79 146.82 31.67 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.033 -1.042 . . . . 0.0 110.418 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.615 ' CD2' ' HB2' ' A' ' 98' ' ' ASN . 16.1 t60 -116.76 66.05 0.72 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.451 ' HA ' ' HB3' ' A' ' 98' ' ' ASN . 1.9 m 178.42 -29.65 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.746 -0.596 . . . . 0.0 109.717 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.88 10.79 44.92 Favored Glycine 0 N--CA 1.494 2.504 0 O-C-N 120.993 -1.067 . . . . 0.0 110.638 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -141.15 147.06 37.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.016 -1.285 . . . . 0.0 109.669 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 95' ' ' ALA . 1.2 p -43.03 133.3 3.8 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 98' ' ' ASN . . . 62.84 35.03 91.42 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 107.949 -2.061 . . . . 0.0 107.949 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.615 ' HB2' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 34.71 41.66 0.06 Allowed 'General case' 0 C--N 1.309 -1.177 0 O-C-N 122.105 -0.644 . . . . 0.0 110.349 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -56.93 166.55 0.98 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.123 -0.986 . . . . 0.0 108.623 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.639 ' O ' HG13 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -91.44 147.51 22.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.933 -1.104 . . . . 0.0 109.839 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.639 HG13 ' O ' ' A' ' 100' ' ' PHE . 17.4 m -161.38 133.97 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 101' ' ' VAL . 35.8 mt-10 -43.26 135.17 3.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.964 . . . . 0.0 109.448 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 1.5 m -60.73 121.3 11.92 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.246 -0.908 . . . . 0.0 109.325 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.556 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 7.1 p 173.27 137.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.37 -0.832 . . . . 0.0 109.906 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -115.72 -29.57 6.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 0.0 109.505 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.716 ' CD2' HG21 ' A' ' 89' ' ' VAL . 13.0 m-85 -87.11 93.66 9.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.955 . . . . 0.0 109.233 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.3 m -126.76 141.08 51.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.144 -0.972 . . . . 0.0 109.869 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -143.98 14.98 1.71 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.122 0.963 . . . . 0.0 109.785 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 177.88 50.0 0.07 OUTLIER Glycine 0 C--N 1.281 -2.526 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 8' ' ' SER . 3.3 t 55.0 20.47 3.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.47 -1.018 . . . . 0.0 109.201 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.572 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 25.8 m-80 -74.5 -34.41 63.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 0.0 109.627 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 9' ' ' ASN . 46.5 t 61.52 52.03 3.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.116 -0.99 . . . . 0.0 109.621 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.572 ' CE1' ' HB3' ' A' ' 9' ' ' ASN . 7.6 m-30 -80.61 129.97 34.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.303 -0.873 . . . . 0.0 109.073 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.701 ' O ' HG23 ' A' ' 16' ' ' VAL . 3.9 m -88.57 137.96 31.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.167 -0.958 . . . . 0.0 110.11 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 p -53.55 -23.33 10.33 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.0 t -77.33 -38.16 51.0 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.357 -0.839 . . . . 0.0 108.94 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -70.86 -28.86 64.89 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 12' ' ' SER . 7.5 t -70.28 -31.2 46.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 C-N-CA 119.602 -0.839 . . . . 0.0 108.777 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.09 -45.62 92.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.598 -0.689 . . . . 0.0 109.433 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.62 -48.92 79.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 108.806 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.688 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -72.32 -12.22 61.04 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.554 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -83.9 -28.36 27.97 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.348 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -82.22 -14.55 55.36 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.438 -0.789 . . . . 0.0 109.099 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 26' ' ' LEU . . . -76.9 -52.94 8.55 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.279 -0.888 . . . . 0.0 109.062 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.556 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -66.16 -30.56 77.08 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.869 -1.693 . . . . 0.0 108.869 179.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.585 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 5.2 t80 -72.11 -70.65 0.32 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.415 -1.05 . . . . 0.0 108.982 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -40.71 -57.85 1.79 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.444 -0.785 . . . . 0.0 109.656 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -46.55 -46.44 19.35 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.048 -1.032 . . . . 0.0 109.262 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -58.81 -48.69 80.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.454 -0.779 . . . . 0.0 110.86 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -86.7 12.04 11.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.134 -0.979 . . . . 0.0 109.939 -179.151 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 55.1 t0 -104.48 -11.82 16.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.076 -1.015 . . . . 0.0 109.364 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.51 -5.12 61.53 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.44 ' HB2' HD13 ' A' ' 26' ' ' LEU . 5.5 mm-40 -87.81 -176.82 5.64 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.298 -1.119 . . . . 0.0 109.367 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.839 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -145.15 178.5 8.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -0.966 . . . . 0.0 109.677 179.741 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.55 HG23 ' N ' ' A' ' 34' ' ' GLY . 27.4 m -100.3 -126.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.322 -0.861 . . . . 0.0 109.441 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.55 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -43.5 -47.55 7.14 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER 163.99 -34.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -1.106 . . . . 0.0 109.638 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.428 ' O ' ' CB ' ' A' ' 37' ' ' SER . 0.6 OUTLIER -75.96 -11.84 60.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 0.0 110.008 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.839 ' HA ' HG22 ' A' ' 32' ' ' THR . 1.1 p 69.29 121.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.026 -1.047 . . . . 0.0 108.916 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.735 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -98.3 -19.24 0.21 Allowed Pre-proline 0 N--CA 1.495 1.808 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -179.102 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.735 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 37.4 Cg_endo -79.82 102.03 1.43 Allowed 'Trans proline' 0 C--N 1.318 -1.056 0 C-N-CA 121.275 1.316 . . . . 0.0 113.426 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.481 ' HB2' ' OE2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -128.77 137.43 51.54 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.072 -1.017 . . . . 0.0 109.748 177.184 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 2.5 ptmt -51.14 143.51 10.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 110.292 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.647 ' HD2' HG21 ' A' ' 79' ' ' VAL . 4.4 t80 -114.45 102.01 9.68 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 44' ' ' ASN . 4.0 p30 -74.77 21.66 0.11 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.901 -1.124 . . . . 0.0 111.582 -178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.558 ' HA ' ' CZ ' ' A' ' 42' ' ' TYR . 1.2 m-20 60.42 148.63 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.66 -1.275 . . . . 0.0 109.612 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.483 ' CD2' ' O ' ' A' ' 44' ' ' ASN . 0.2 OUTLIER -174.39 -57.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.933 . . . . 0.0 109.614 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.661 ' OE2' HG12 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -37.44 -55.99 1.03 Allowed 'General case' 0 C--N 1.308 -1.204 0 O-C-N 121.616 -0.677 . . . . 0.0 110.293 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.21 51.69 0.08 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.528 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 11.3 m-85 -91.43 -170.1 2.52 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.301 -1.117 . . . . 0.0 108.629 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -150.49 44.9 0.87 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.095 -1.003 . . . . 0.0 110.308 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.52 -179.5 5.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.954 -1.091 . . . . 0.0 109.236 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.4 m -153.22 56.68 0.77 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.237 -0.914 . . . . 0.0 109.466 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.688 HG21 ' O ' ' A' ' 86' ' ' LEU . 37.4 t -94.62 -27.0 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.258 -0.901 . . . . 0.0 109.647 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.532 ' HB3' ' CB ' ' A' ' 81' ' ' ASN . 4.1 t 167.55 162.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.028 -1.045 . . . . 0.0 109.57 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.591 ' CB ' ' HD3' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -75.82 -59.71 1.14 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.094 -1.004 . . . . 0.0 110.646 -179.27 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.591 ' HD3' ' CB ' ' A' ' 54' ' ' SER . 36.0 Cg_endo -71.34 84.37 0.94 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 121.959 1.773 . . . . 0.0 110.623 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.605 ' CE1' ' HB2' ' A' ' 87' ' ' ALA . 38.3 m-85 -79.62 -171.04 2.62 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.648 0.737 . . . . 0.0 109.904 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.584 ' CD2' ' O ' ' A' ' 56' ' ' TYR . 76.9 m-85 -160.82 151.04 17.79 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.481 ' OE2' ' HB2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -120.79 140.39 51.78 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.901 -1.124 . . . . 0.0 110.543 -178.828 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.684 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 3.7 t-105 -155.99 146.34 15.97 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.684 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.8 Cg_endo -68.32 130.58 21.48 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.098 1.866 . . . . 0.0 111.43 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.979 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -97.84 132.54 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.979 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.9 OUTLIER -123.81 165.01 18.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 0.0 109.342 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.55 ' HB2' ' CZ ' ' A' ' 11' ' ' TYR . 27.1 t -120.26 37.42 4.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 108.97 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.39 -172.91 3.07 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.404 -0.81 . . . . 0.0 109.638 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -96.28 50.48 1.66 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -150.04 147.34 27.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.09 -1.241 . . . . 0.0 109.432 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.477 HG13 ' HZ2' ' A' ' 59' ' ' TRP . 81.0 t -92.18 152.27 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.89 . . . . 0.0 109.252 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.603 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 44.4 t80 -59.79 132.17 53.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.201 -0.937 . . . . 0.0 109.573 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.1 t -155.91 20.36 0.38 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.303 -0.873 . . . . 0.0 109.246 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.5 89.75 1.41 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -162.65 -39.52 0.02 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.435 ' O ' ' OG ' ' A' ' 72' ' ' SER . 28.1 p -158.17 102.14 1.73 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.16 -1.2 . . . . 0.0 109.326 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -75.15 114.14 3.94 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.336 2.024 . . . . 0.0 110.158 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.462 ' HA2' ' CD2' ' A' ' 92' ' ' HIS . . . 109.83 -125.08 7.44 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.559 ' N ' ' HB2' ' A' ' 92' ' ' HIS . . . 51.01 -174.06 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.201 -1.176 . . . . 0.0 109.638 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.491 ' CB ' HG23 ' A' ' 61' ' ' ILE . 65.8 m-20 -37.89 143.16 0.12 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.649 0.738 . . . . 0.0 110.681 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.495 ' CA ' HG22 ' A' ' 61' ' ' ILE . 2.0 ttt180 -153.95 133.65 12.96 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.804 ' CG2' HD11 ' A' ' 86' ' ' LEU . 10.8 p -119.24 130.08 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.928 -1.107 . . . . 0.0 110.461 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.647 HG21 ' HD2' ' A' ' 42' ' ' TYR . 12.9 t -89.5 163.25 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 CA-C-O 122.298 1.047 . . . . 0.0 109.857 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.559 ' N ' ' CG1' ' A' ' 79' ' ' VAL . 34.4 p90 -159.74 -168.47 2.27 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.539 ' OD1' ' HG2' ' A' ' 82' ' ' GLU . 1.2 p30 -122.07 -44.79 2.27 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.866 -1.134 . . . . 0.0 111.004 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.585 ' O ' ' CZ ' ' A' ' 24' ' ' TYR . 2.1 pt-20 161.21 -21.54 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.419 ' C ' ' CG ' ' A' ' 84' ' ' ASN . 1.8 m-20 -92.16 20.27 6.11 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.581 ' OD1' ' CE2' ' A' ' 24' ' ' TYR . 0.0 OUTLIER 63.62 8.08 3.46 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.7 -0.625 . . . . 0.0 109.686 -179.474 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.41 ' O ' ' O ' ' A' ' 84' ' ' ASN . 13.6 mt-30 -60.66 -160.32 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.804 HD11 ' CG2' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -137.84 117.42 12.99 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.488 -1.382 . . . . 0.0 110.755 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.605 ' HB2' ' CE1' ' A' ' 56' ' ' TYR . . . -83.92 -43.23 15.47 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 170.48 163.69 24.94 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.716 HG21 ' CD2' ' A' ' 4' ' ' TYR . 75.1 t -115.93 99.22 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.021 -1.282 . . . . 0.0 109.388 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.588 HD13 ' H ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -88.37 -173.39 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.398 -0.814 . . . . 0.0 109.401 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.589 ' O ' HG23 ' A' ' 91' ' ' THR . 5.9 t -148.9 121.43 8.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.986 -1.071 . . . . 0.0 110.213 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.559 ' HB2' ' N ' ' A' ' 75' ' ' ALA . 2.4 m-70 -78.99 79.13 5.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.549 -0.719 . . . . 0.0 109.291 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 98' ' ' ASN . 0.6 OUTLIER 177.36 -28.56 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.171 -0.956 . . . . 0.0 110.095 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.8 -16.31 16.69 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 1.064 ' HB3' ' CB ' ' A' ' 99' ' ' ASN . . . -122.52 178.15 5.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.104 -1.233 . . . . 0.0 109.412 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 98' ' ' ASN . 1.0 OUTLIER -40.95 157.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.449 -0.782 . . . . 0.0 109.31 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 96' ' ' SER . . . 43.97 -95.18 0.01 OUTLIER Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -127.28 -73.91 0.6 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.346 -1.091 . . . . 0.0 109.347 179.339 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 1.064 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . 0.9 OUTLIER 59.33 120.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.044 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.562 ' CD2' ' O ' ' A' ' 100' ' ' PHE . 38.3 p90 -98.76 117.53 33.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.843 -1.161 . . . . 0.0 110.705 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.661 HG12 ' OE2' ' A' ' 46' ' ' GLU . 18.0 m -128.91 158.2 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.513 ' N ' HG22 ' A' ' 90' ' ' ILE . 4.3 pt-20 -43.42 138.81 2.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 109.37 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.1 OUTLIER -75.73 176.8 7.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.63 -179.645 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.081 -0.962 . . . . 0.0 109.523 -179.9 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.482 ' O ' ' SG ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.414 0.626 . . . . 0.0 109.724 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 21.6 p 36.78 91.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.603 0.716 . . . . 0.0 110.224 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -97.86 1.63 48.38 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.46 ' CD2' HG21 ' A' ' 89' ' ' VAL . 16.1 m-85 -104.28 78.1 1.47 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.482 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 9' ' ' ASN . 28.1 m -84.31 93.98 8.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.427 ' O ' ' C ' ' A' ' 7' ' ' GLY . 2.8 m -120.65 155.03 34.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 109.474 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 6' ' ' CYS . . . 43.8 27.21 0.91 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 1.4 m 68.94 50.59 0.59 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.292 -1.122 . . . . 0.0 109.582 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 5' ' ' THR . 25.1 m120 -144.55 126.53 15.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.171 -0.956 . . . . 0.0 109.598 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.465 ' C ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -82.99 84.07 7.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -0.831 . . . . 0.0 109.02 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 4.2 m-30 -79.82 138.68 37.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.41 -0.806 . . . . 0.0 109.661 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.876 ' O ' HG23 ' A' ' 16' ' ' VAL . 2.0 t -80.73 123.28 28.07 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.696 -0.627 . . . . 0.0 109.92 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.18 -24.37 0.45 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 109.221 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.6 t -81.53 -41.1 22.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.983 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -67.62 -28.32 67.64 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 12' ' ' SER . 1.9 t -68.39 -29.64 44.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.575 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 21.5 t -62.63 -46.13 89.66 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -59.43 5.02 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.841 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -61.83 -16.42 50.04 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.904 ' OE1' HG11 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -73.56 -33.81 64.85 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.296 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.62 1.65 53.08 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.0 -62.28 1.73 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.249 -0.907 . . . . 0.0 109.04 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.507 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -60.89 -16.49 47.17 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -82.42 -64.91 1.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.342 -1.093 . . . . 0.0 109.248 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -47.42 -52.43 16.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.353 -0.842 . . . . 0.0 109.745 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.847 ' O ' HD12 ' A' ' 26' ' ' LEU . 2.7 tp -59.72 -38.46 81.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.292 -0.88 . . . . 0.0 109.397 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.649 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 66.1 t60 -68.7 -20.13 64.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.006 -1.059 . . . . 0.0 110.29 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 5.4 tp10 -87.19 -21.97 25.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.057 -1.027 . . . . 0.0 109.507 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 9.9 t70 -89.05 -12.26 41.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.267 -0.896 . . . . 0.0 109.502 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.35 0.84 59.01 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.533 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 5.6 tp10 -67.95 -144.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -1.175 . . . . 0.0 109.517 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.846 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -167.26 -174.6 2.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.058 -1.026 . . . . 0.0 109.619 -179.73 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.465 HG23 ' H ' ' A' ' 34' ' ' GLY . 2.5 m -105.03 -104.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 109.631 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -77.13 -38.19 30.49 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 2.2 t 162.83 -36.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.437 -1.037 . . . . 0.0 109.385 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.418 ' O ' ' O ' ' A' ' 37' ' ' SER . 5.4 m120 -68.82 -16.5 63.8 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.327 -0.858 . . . . 0.0 109.262 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.846 ' HA ' HG22 ' A' ' 32' ' ' THR . 8.1 t 63.09 126.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.271 -0.893 . . . . 0.0 109.431 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.651 ' H ' ' CD ' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -117.99 -27.41 0.08 OUTLIER Pre-proline 0 N--CA 1.499 2.001 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -178.56 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.651 ' CD ' ' H ' ' A' ' 38' ' ' TYR . 37.0 Cg_endo -79.34 100.72 1.35 Allowed 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 121.062 1.175 . . . . 0.0 112.724 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.487 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -135.92 160.61 38.07 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.115 -0.991 . . . . 0.0 108.747 177.439 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -62.72 139.83 58.69 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.128 -0.982 . . . . 0.0 110.232 -179.272 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.578 ' CD2' ' OD1' ' A' ' 44' ' ' ASN . 9.2 t80 -101.41 150.26 23.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.365 -0.834 . . . . 0.0 108.784 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 1.1 m-20 -107.51 -15.55 14.58 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.014 -1.054 . . . . 0.0 110.357 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.578 ' OD1' ' CD2' ' A' ' 42' ' ' TYR . 22.8 m-80 60.26 92.17 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.026 -1.046 . . . . 0.0 109.215 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -122.83 28.19 7.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.194 -0.941 . . . . 0.0 109.626 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.711 ' OE2' HG12 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -101.42 -65.67 0.96 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.46 ' N ' ' CG ' ' A' ' 46' ' ' GLU . . . 144.34 35.38 0.07 OUTLIER Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.558 ' CE1' ' OE2' ' A' ' 46' ' ' GLU . 15.9 m-85 -61.71 -171.07 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.92 6.75 4.66 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 118.102 -1.439 . . . . 0.0 110.292 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.534 ' CZ ' ' CD2' ' A' ' 48' ' ' PHE . 1.8 p90 -96.32 -169.98 2.01 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.996 -1.065 . . . . 0.0 109.347 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 50' ' ' PHE . 6.5 t 167.95 45.21 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.272 -0.893 . . . . 0.0 109.527 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -44.54 -27.73 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 109.252 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.542 ' O ' ' CE1' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -170.99 165.98 7.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.391 -0.818 . . . . 0.0 109.66 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.614 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -78.04 -51.2 1.72 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.323 -0.86 . . . . 0.0 111.044 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 54' ' ' SER . 32.9 Cg_endo -72.77 92.41 0.79 Allowed 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.856 1.704 . . . . 0.0 109.5 -177.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.822 ' CE2' ' HB1' ' A' ' 87' ' ' ALA . 2.2 m-30 -91.85 -170.96 2.72 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.961 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.649 ' CE1' ' NE2' ' A' ' 27' ' ' HIS . 61.1 m-85 -164.29 105.55 0.88 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -74.76 139.4 43.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 109.384 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.726 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 14.6 t-105 -159.84 141.03 9.24 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.726 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.4 Cg_endo -68.16 131.21 23.06 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 C-N-CA 122.156 1.904 . . . . 0.0 111.433 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.973 HD12 ' N ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -106.44 128.2 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.705 -0.622 . . . . 0.0 109.42 -179.614 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.973 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.2 mt -125.03 164.28 20.52 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.306 -0.872 . . . . 0.0 109.352 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.434 ' O ' ' OG ' ' A' ' 63' ' ' SER . 2.2 t -118.51 16.55 13.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.145 -0.972 . . . . 0.0 109.077 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.45 -156.9 0.57 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.597 -0.689 . . . . 0.0 109.487 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -116.0 54.81 0.57 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -163.32 107.17 1.03 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -1.184 . . . . 0.0 109.709 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.431 HG13 ' HZ2' ' A' ' 59' ' ' TRP . 43.5 t -47.76 160.01 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.216 -0.927 . . . . 0.0 109.099 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.617 ' HB2' ' HG2' ' A' ' 60' ' ' PRO . 6.5 t80 -49.1 119.24 3.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.915 -1.116 . . . . 0.0 109.388 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -168.08 39.41 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.432 -0.793 . . . . 0.0 109.127 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.71 -0.97 6.86 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -83.95 -153.66 17.06 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.47 131.51 74.45 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.235 -1.156 . . . . 0.0 109.408 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.413 ' O ' ' O ' ' A' ' 74' ' ' GLY . 36.4 Cg_endo -79.85 -89.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.547 2.164 . . . . 0.0 110.753 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 76' ' ' ASP . . . -59.06 -112.55 0.01 OUTLIER Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.417 ' N ' ' HB3' ' A' ' 92' ' ' HIS . . . 50.9 -87.23 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.383 -1.069 . . . . 0.0 110.415 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 74' ' ' GLY . 1.0 OUTLIER -117.32 116.37 27.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.928 -1.108 . . . . 0.0 109.988 -179.582 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.562 ' NH1' ' CE1' ' A' ' 38' ' ' TYR . 2.3 mtm-85 -128.78 138.14 51.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.139 -0.976 . . . . 0.0 109.138 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.904 HG11 ' OE1' ' A' ' 20' ' ' GLN . 9.8 p -123.62 142.85 38.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.676 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 23.4 t -110.59 165.88 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 122.188 0.994 . . . . 0.0 111.02 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.59 ' CE1' ' HB2' ' A' ' 57' ' ' TYR . 22.7 p90 -161.95 -170.48 2.54 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.258 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.45 ' O ' ' CD2' ' A' ' 57' ' ' TYR . 20.0 t30 -124.35 -82.15 0.64 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.006 -1.059 . . . . 0.0 109.929 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -158.08 18.68 0.24 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.409 -0.807 . . . . 0.0 109.6 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.487 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 2.7 m-20 -153.5 26.11 0.51 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 84' ' ' ASN . 0.4 OUTLIER 53.4 19.65 1.7 Allowed 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.362 0.601 . . . . 0.0 109.557 -179.649 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.595 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -46.83 -35.32 6.19 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.093 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.636 HD21 ' NE2' ' A' ' 20' ' ' GLN . 0.0 OUTLIER 92.43 110.09 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.549 0.69 . . . . 0.0 111.152 179.044 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.822 ' HB1' ' CE2' ' A' ' 56' ' ' TYR . . . -87.42 -42.22 12.99 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 151.21 146.01 4.24 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.46 HG21 ' CD2' ' A' ' 4' ' ' TYR . 61.1 t -86.8 88.81 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.029 -1.277 . . . . 0.0 109.462 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.537 ' HB ' ' HB3' ' A' ' 100' ' ' PHE . 1.1 pt -79.39 170.24 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.315 -0.866 . . . . 0.0 108.785 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.1 t -135.97 141.26 44.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.075 -1.016 . . . . 0.0 110.274 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.601 ' CD2' ' HB2' ' A' ' 98' ' ' ASN . 2.9 t60 -92.77 76.02 4.91 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 1.2 m 171.76 148.38 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.17 -20.69 46.29 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -126.43 151.9 47.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.122 -1.222 . . . . 0.0 109.665 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 95' ' ' ALA . 20.3 m -41.57 125.78 2.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.47 -0.769 . . . . 0.0 109.321 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.487 ' O ' ' C ' ' A' ' 98' ' ' ASN . . . 65.33 40.5 96.53 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.601 ' HB2' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 32.9 52.4 0.31 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 122.053 -0.675 . . . . 0.0 110.209 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -57.27 167.39 0.93 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.214 -0.929 . . . . 0.0 109.222 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.537 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -88.78 122.05 31.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.143 -0.973 . . . . 0.0 109.664 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.711 HG12 ' OE2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -136.06 152.85 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.267 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.4 OUTLIER -56.92 131.28 49.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.14 -0.975 . . . . 0.0 109.491 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 89.8 m -54.18 148.05 11.93 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.26 -0.9 . . . . 0.0 109.627 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 109.573 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.511 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.6 p 165.3 126.86 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.26 -0.9 . . . . 0.0 110.291 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -96.21 -29.68 13.9 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.616 ' CG ' HG21 ' A' ' 89' ' ' VAL . 18.0 m-85 -91.81 103.69 16.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.479 -0.763 . . . . 0.0 109.11 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.571 HG22 ' H ' ' A' ' 7' ' ' GLY . 40.4 m -125.83 123.92 39.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.096 -1.003 . . . . 0.0 109.89 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.8 m -103.57 16.91 25.28 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.093 0.949 . . . . 0.0 109.61 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.571 ' H ' HG22 ' A' ' 5' ' ' THR . . . 152.82 -88.46 0.13 Allowed Glycine 0 C--N 1.284 -2.355 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.3 m -138.4 42.14 2.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -1.146 . . . . 0.0 109.684 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.487 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 1.0 OUTLIER -103.73 -26.33 12.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.183 -0.948 . . . . 0.0 109.38 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.1 t 60.18 57.78 2.85 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.38 -0.825 . . . . 0.0 109.675 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.527 ' CE1' ' HB3' ' A' ' 63' ' ' SER . 6.2 m-30 -87.88 114.02 24.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.39 -0.819 . . . . 0.0 108.874 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -85.99 138.35 32.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.062 -1.023 . . . . 0.0 109.98 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 p -48.82 -23.13 0.97 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.369 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.8 m -77.81 -41.33 37.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.113 -0.992 . . . . 0.0 109.543 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -71.68 -28.76 63.94 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 12' ' ' SER . 41.4 t -65.32 -24.93 35.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.42 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 3.4 t -66.97 -44.59 80.08 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.72 -38.46 85.16 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.759 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -81.31 -13.99 57.81 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.723 ' NE2' ' CG ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -82.13 -27.91 32.5 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.394 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -83.32 -13.21 55.59 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.13 -50.78 20.83 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.441 -0.787 . . . . 0.0 109.266 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.574 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -77.29 -29.02 57.01 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.579 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 3.2 t80 -71.37 -27.84 63.63 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.436 -1.038 . . . . 0.0 109.114 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 1.9 tt0 -74.16 -63.04 1.31 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.112 -0.992 . . . . 0.0 108.951 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 26' ' ' LEU . 1.6 tp -46.47 -34.74 5.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.349 -0.845 . . . . 0.0 108.972 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.576 ' NE2' ' CZ ' ' A' ' 57' ' ' TYR . 2.0 t60 -65.52 -59.23 4.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.477 -0.765 . . . . 0.0 110.093 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -83.02 10.22 8.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.246 -0.909 . . . . 0.0 109.759 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 45.7 t0 -95.84 -23.76 16.76 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.956 . . . . 0.0 109.61 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.97 -0.66 84.41 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.4 ' C ' ' OG1' ' A' ' 32' ' ' THR . 1.0 OUTLIER -97.56 -146.33 0.31 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.191 -1.182 . . . . 0.0 109.367 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.536 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -168.99 -177.17 2.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -0.938 . . . . 0.0 109.523 -179.903 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.556 HG21 ' HB2' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -92.54 -100.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 109.057 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.505 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -94.19 30.87 7.16 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 1.0 OUTLIER 78.21 1.39 2.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.525 -0.986 . . . . 0.0 109.334 -179.482 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.53 ' O ' ' CB ' ' A' ' 37' ' ' SER . 0.5 OUTLIER -93.18 -19.36 21.53 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.334 -0.853 . . . . 0.0 109.743 -179.651 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.536 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.8 OUTLIER 76.45 93.34 0.07 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 109.294 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.605 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -85.77 -43.53 0.62 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 111.238 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 32.9 Cg_endo -75.46 108.41 2.69 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 120.927 1.085 . . . . 0.0 110.045 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.616 ' CE1' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -123.79 124.68 43.23 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.3 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.539 ' HA ' ' CD1' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -49.63 125.06 10.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.387 -0.821 . . . . 0.0 110.72 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 2.1 t80 -88.83 159.45 17.71 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.433 ' O ' ' CZ ' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -169.6 35.61 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 4.2 m-20 -90.21 -171.48 3.13 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.681 0.753 . . . . 0.0 110.233 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.558 ' CG ' ' C ' ' A' ' 44' ' ' ASN . 0.2 OUTLIER -158.68 24.32 0.22 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.585 ' OE1' HG12 ' A' ' 101' ' ' VAL . 0.4 OUTLIER -36.37 -67.24 0.18 Allowed 'General case' 0 C--N 1.31 -1.144 0 O-C-N 121.784 -0.573 . . . . 0.0 110.176 -179.235 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.446 ' O ' ' OE2' ' A' ' 102' ' ' GLU . . . -167.01 41.86 0.25 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.614 ' CE1' HG22 ' A' ' 90' ' ' ILE . 65.7 m-85 -100.88 158.15 16.2 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.276 -1.132 . . . . 0.0 109.254 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -125.5 11.0 7.95 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.229 -0.92 . . . . 0.0 109.59 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.61 ' CE2' ' HB3' ' A' ' 48' ' ' PHE . 2.3 p90 -78.19 165.0 24.45 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.142 -0.973 . . . . 0.0 109.363 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 52' ' ' VAL . 33.3 t -144.39 34.76 1.19 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.214 -0.929 . . . . 0.0 109.594 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.608 HG12 ' HB3' ' A' ' 81' ' ' ASN . 59.8 t -44.41 -45.98 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.264 -0.898 . . . . 0.0 109.058 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.404 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 0.1 OUTLIER 172.5 157.0 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.765 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.6 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -59.28 -51.25 82.86 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.408 -0.807 . . . . 0.0 110.623 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 54' ' ' SER . 35.6 Cg_endo -75.6 83.15 1.96 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.046 1.83 . . . . 0.0 110.27 -178.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.608 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 48.7 m-85 -79.35 -172.02 3.0 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.322 0.582 . . . . 0.0 110.148 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.608 ' CG ' ' O ' ' A' ' 56' ' ' TYR . 34.3 m-85 -165.02 118.39 1.24 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.616 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -95.53 146.03 24.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 0.0 110.17 -179.36 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.652 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 8.8 t-105 -160.36 142.97 9.76 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.652 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.2 Cg_endo -67.79 138.67 45.52 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.067 1.844 . . . . 0.0 111.309 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.978 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -110.35 133.0 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.465 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.978 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.3 OUTLIER -125.89 169.48 12.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.312 -0.867 . . . . 0.0 109.29 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.527 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 2.2 p -122.94 28.45 7.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.309 -0.869 . . . . 0.0 109.056 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.77 -12.28 8.47 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.468 -0.77 . . . . 0.0 109.446 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.82 29.46 59.2 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 67' ' ' VAL . 5.8 t0 -102.56 -3.67 26.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -1.157 . . . . 0.0 109.758 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' A' ' 66' ' ' ASP . 3.4 t 55.55 166.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.947 . . . . 0.0 109.42 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.61 ' CD1' HD11 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -115.18 120.96 41.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.903 . . . . 0.0 109.565 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.484 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -140.01 78.57 1.67 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.874 . . . . 0.0 109.527 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 71' ' ' GLY . . . 161.34 37.42 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 70' ' ' GLY . . . 41.95 -145.52 0.74 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.8 t 64.42 74.19 0.42 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.177 -1.19 . . . . 0.0 109.533 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.5 -177.27 3.72 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.596 2.197 . . . . 0.0 110.321 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.552 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 173.84 76.19 0.05 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.597 ' HA ' ' N ' ' A' ' 92' ' ' HIS . . . 67.39 -143.12 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.205 -1.174 . . . . 0.0 109.813 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.527 ' O ' ' O ' ' A' ' 75' ' ' ALA . 49.8 m-20 14.29 113.54 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.532 ' O ' HG12 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -162.86 128.95 3.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.129 -0.982 . . . . 0.0 109.264 178.592 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.805 HG21 HD21 ' A' ' 86' ' ' LEU . 4.6 p -116.49 140.01 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.749 -1.219 . . . . 0.0 109.227 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -105.0 -175.36 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 122.371 1.081 . . . . 0.0 110.628 -179.235 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.723 ' CG ' ' NE2' ' A' ' 20' ' ' GLN . 26.1 p90 179.81 -169.15 0.12 Allowed 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.65 ' ND2' ' CG ' ' A' ' 82' ' ' GLU . 3.9 p-10 -123.09 -39.73 2.46 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.998 -1.064 . . . . 0.0 110.231 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.65 ' CG ' ' ND2' ' A' ' 81' ' ' ASN . 4.4 pt-20 159.51 -26.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.474 ' O ' ' CB ' ' A' ' 84' ' ' ASN . 0.5 OUTLIER -86.33 -5.24 59.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.338 -0.851 . . . . 0.0 109.089 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 83' ' ' ASN . 7.7 t-20 74.7 30.32 1.02 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.37 -0.831 . . . . 0.0 109.702 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.525 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -74.07 -25.74 60.0 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.218 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.805 HD21 HG21 ' A' ' 78' ' ' VAL . 0.2 OUTLIER 81.81 110.76 0.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.389 0.614 . . . . 0.0 110.195 179.306 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.556 ' N ' HD13 ' A' ' 86' ' ' LEU . . . -78.94 -39.49 34.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.389 -0.82 . . . . 0.0 109.048 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.524 ' O ' HG23 ' A' ' 78' ' ' VAL . . . 162.49 169.53 25.99 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.616 HG21 ' CG ' ' A' ' 4' ' ' TYR . 47.5 t -100.09 87.77 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.265 -1.138 . . . . 0.0 109.559 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.614 HG22 ' CE1' ' A' ' 48' ' ' PHE . 4.4 pt -90.15 146.28 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -0.864 . . . . 0.0 109.411 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.564 ' OG1' ' HB1' ' A' ' 75' ' ' ALA . 9.9 t -123.17 135.19 54.21 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.625 -1.297 . . . . 0.0 110.489 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.597 ' N ' ' HA ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -86.39 75.66 9.76 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.368 -0.833 . . . . 0.0 109.187 179.241 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.3 m -179.66 -31.87 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.335 -0.853 . . . . 0.0 109.233 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -68.43 -6.99 51.5 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.911 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -139.53 123.14 17.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.136 -1.214 . . . . 0.0 109.547 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.454 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.3 OUTLIER 47.69 -165.64 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.159 -0.963 . . . . 0.0 109.156 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 96' ' ' SER . . . -40.62 -66.29 0.88 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.584 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -153.58 89.5 1.34 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.27 -1.135 . . . . 0.0 109.08 179.445 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.911 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.9 OUTLIER -112.25 141.1 46.36 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.442 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.568 ' O ' HG13 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -75.08 138.05 41.85 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.994 -1.066 . . . . 0.0 109.558 -179.755 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.585 HG12 ' OE1' ' A' ' 46' ' ' GLU . 30.3 m -160.17 145.57 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.344 -0.848 . . . . 0.0 109.005 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.567 ' HG3' ' CD1' ' A' ' 48' ' ' PHE . 1.4 mp0 -45.46 124.26 4.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.545 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.47 130.78 40.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 109.613 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 67.6 p . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.334 -0.854 . . . . 0.0 109.514 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.495 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.8 p 164.83 124.52 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.28 -0.887 . . . . 0.0 110.06 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -104.03 -7.24 20.44 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.46 -0.775 . . . . 0.0 109.067 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.583 ' HD2' HG21 ' A' ' 16' ' ' VAL . 17.2 m-85 -104.71 110.09 22.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.936 . . . . 0.0 109.382 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 9' ' ' ASN . 82.8 p -142.31 118.4 10.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.285 -0.885 . . . . 0.0 109.804 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -124.44 11.6 8.66 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 122.317 1.056 . . . . 0.0 109.436 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 8' ' ' SER . . . -160.94 32.74 0.38 Allowed Glycine 0 C--N 1.282 -2.454 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 3.9 t 70.95 9.32 6.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.316 -1.108 . . . . 0.0 109.315 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.541 ' O ' HG22 ' A' ' 5' ' ' THR . 14.6 m-80 -78.1 178.06 7.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 109.556 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 51.8 t -127.74 70.22 1.33 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.341 -0.849 . . . . 0.0 109.084 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' A' ' 4' ' ' TYR . 3.5 m-85 -79.63 118.68 21.68 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.262 -0.899 . . . . 0.0 109.543 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.57 ' O ' HG23 ' A' ' 16' ' ' VAL . 48.8 m -80.21 133.76 36.05 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.491 -0.756 . . . . 0.0 109.958 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.95 -30.32 10.11 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 t -73.43 -38.99 65.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.362 -0.836 . . . . 0.0 109.076 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -67.95 -26.04 65.75 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.583 HG21 ' HD2' ' A' ' 4' ' ' TYR . 19.4 t -77.15 -29.08 16.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.481 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 0.2 OUTLIER -67.66 -37.84 82.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.422 -0.799 . . . . 0.0 109.382 179.688 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -47.05 86.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.133 -0.98 . . . . 0.0 108.433 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.835 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -73.25 -17.98 61.28 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.573 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -76.45 -32.13 58.25 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.438 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -79.12 -8.31 58.88 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.628 ' HB1' HG13 ' A' ' 67' ' ' VAL . . . -83.29 -55.92 4.06 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.352 -0.843 . . . . 0.0 108.843 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.627 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -68.22 -20.86 73.56 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.577 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 1.0 OUTLIER -81.84 -58.08 3.15 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.586 -0.949 . . . . 0.0 109.521 -179.635 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.509 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -49.15 -36.45 19.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.13 -0.981 . . . . 0.0 109.486 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.945 HD13 ' HB2' ' A' ' 31' ' ' GLU . 1.2 mm? -72.61 -40.24 66.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.351 -0.843 . . . . 0.0 109.278 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.664 ' CE1' ' CE1' ' A' ' 57' ' ' TYR . 2.6 t60 -61.38 -32.78 72.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.438 -0.789 . . . . 0.0 110.433 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.509 ' OE1' ' CZ ' ' A' ' 24' ' ' TYR . 4.2 pt-20 -86.69 -26.23 24.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.951 -1.093 . . . . 0.0 109.812 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -84.86 -6.54 59.35 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.1 -1.0 . . . . 0.0 109.547 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.79 -28.31 6.59 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.945 ' HB2' HD13 ' A' ' 26' ' ' LEU . 3.1 mm-40 -58.61 -166.94 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.172 -1.193 . . . . 0.0 109.454 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.551 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -155.83 -93.61 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.886 . . . . 0.0 109.524 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -134.67 -167.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.129 -0.982 . . . . 0.0 109.318 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -40.73 -37.41 1.3 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 t -176.37 -51.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -1.186 . . . . 0.0 109.814 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.548 ' O ' ' CB ' ' A' ' 37' ' ' SER . 35.3 m120 -51.39 -86.0 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.156 -0.965 . . . . 0.0 109.645 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.588 ' CA ' ' CG2' ' A' ' 33' ' ' VAL . 0.3 OUTLIER 160.33 -178.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.729 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER 175.46 -49.38 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.917 -1.114 . . . . 0.0 112.302 178.8 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.531 ' HD2' ' H ' ' A' ' 38' ' ' TYR . 31.4 Cg_endo -75.3 100.55 1.38 Allowed 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 121.215 1.276 . . . . 0.0 112.094 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.729 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -140.72 137.12 33.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.693 -0.629 . . . . 0.0 109.356 178.66 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -42.77 133.84 3.42 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.396 -0.815 . . . . 0.0 110.318 -179.059 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.586 ' OH ' ' CD1' ' A' ' 100' ' ' PHE . 30.2 t80 -94.09 159.43 15.16 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.385 -0.822 . . . . 0.0 109.031 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.566 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 7.9 m-80 -106.63 -39.98 5.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.073 -1.017 . . . . 0.0 110.11 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.605 ' ND2' ' O ' ' A' ' 44' ' ' ASN . 0.0 OUTLIER 62.92 127.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.11 -0.993 . . . . 0.0 108.764 -179.49 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.482 ' O ' ' C ' ' A' ' 46' ' ' GLU . 1.4 m-85 -161.68 -36.25 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.093 -1.004 . . . . 0.0 110.052 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.482 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -34.75 -72.83 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.671 -0.643 . . . . 0.0 110.412 -179.322 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 171.2 56.46 0.04 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.535 ' CE2' HG22 ' A' ' 90' ' ' ILE . 90.6 m-85 -86.66 177.97 7.19 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.204 -1.174 . . . . 0.0 108.407 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.424 ' OD1' ' C ' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -131.19 11.25 4.99 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.986 -1.071 . . . . 0.0 110.095 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 87' ' ' ALA . 0.7 OUTLIER -88.61 -174.95 4.76 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.036 -1.04 . . . . 0.0 109.201 179.542 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.0 m -173.86 40.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.212 -0.93 . . . . 0.0 109.521 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.0 t -52.24 -39.42 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.296 -0.878 . . . . 0.0 109.284 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.5 ' OG ' ' CB ' ' A' ' 81' ' ' ASN . 32.9 p -177.86 151.37 0.69 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 109.671 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.596 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -59.2 -52.74 72.39 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.333 -0.854 . . . . 0.0 110.08 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 54' ' ' SER . 35.9 Cg_endo -75.48 86.54 1.46 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.989 1.792 . . . . 0.0 109.511 -178.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.604 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 10.6 m-85 -78.84 -169.15 1.66 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.664 ' CE1' ' CE1' ' A' ' 27' ' ' HIS . 66.0 m-85 -162.72 106.73 1.11 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 40' ' ' HIS . 4.1 pt-20 -78.87 137.22 37.57 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.743 0.782 . . . . 0.0 110.726 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.666 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 26.6 t-105 -160.82 139.82 7.71 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.666 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.8 Cg_endo -70.35 158.95 54.61 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.273 1.982 . . . . 0.0 111.749 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 1.006 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -132.41 136.6 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.525 -0.734 . . . . 0.0 109.225 -179.547 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.006 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.5 OUTLIER -121.31 174.96 6.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.106 -0.996 . . . . 0.0 109.775 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.67 31.6 4.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.911 . . . . 0.0 109.189 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.94 -58.72 2.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.376 -0.828 . . . . 0.0 109.399 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.31 52.37 0.03 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -156.67 150.55 24.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -1.175 . . . . 0.0 109.548 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.628 HG13 ' HB1' ' A' ' 22' ' ' ALA . 45.3 t -83.66 133.25 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.351 -0.843 . . . . 0.0 109.351 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.879 ' HD2' HD21 ' A' ' 62' ' ' LEU . 0.7 OUTLIER -56.06 135.67 52.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -0.954 . . . . 0.0 109.508 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.481 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -151.58 52.35 0.83 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.264 -0.897 . . . . 0.0 109.265 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.38 158.21 33.28 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.74 79.18 0.63 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.3 m 53.77 87.4 0.14 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.238 -1.154 . . . . 0.0 109.767 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.6 170.47 19.16 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.653 2.235 . . . . 0.0 110.261 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.586 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 109.14 -164.25 12.49 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 69.38 -162.08 0.18 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.29 -1.123 . . . . 0.0 110.488 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 91' ' ' THR . 38.9 m-20 -46.98 165.86 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.678 0.751 . . . . 0.0 110.787 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.514 ' O ' HG12 ' A' ' 90' ' ' ILE . 36.1 ttm180 -172.82 104.68 0.14 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.001 ' CG2' HD11 ' A' ' 86' ' ' LEU . 4.2 p -79.68 152.22 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.895 -1.128 . . . . 0.0 110.154 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.595 HG12 ' N ' ' A' ' 80' ' ' PHE . 44.7 t -120.32 165.13 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.879 0.847 . . . . 0.0 109.83 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.595 ' N ' HG12 ' A' ' 79' ' ' VAL . 8.4 p90 -165.63 -169.49 1.57 Allowed 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.746 -0.781 . . . . 0.0 109.426 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.571 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 1.9 p30 -122.28 -46.47 2.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.009 -1.057 . . . . 0.0 110.48 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.577 ' O ' ' CZ ' ' A' ' 24' ' ' TYR . 0.7 OUTLIER 163.31 -23.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -179.674 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.484 ' HB3' ' OE1' ' A' ' 85' ' ' GLN . 1.9 m-20 -86.95 14.29 7.63 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.469 ' O ' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 71.93 6.3 5.57 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.442 -0.787 . . . . 0.0 109.048 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.5 ' HB2' ' ND2' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -58.38 -162.34 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 178.766 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.001 HD11 ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -143.55 107.72 4.75 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.663 -1.273 . . . . 0.0 110.567 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.564 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . . . -69.27 -36.73 77.41 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 149.46 162.77 10.6 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.565 ' HB ' ' CD1' ' A' ' 4' ' ' TYR . 41.8 t -101.07 87.95 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -1.149 . . . . 0.0 109.547 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.557 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 0.5 OUTLIER -82.6 154.0 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.561 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.573 HG22 HG23 ' A' ' 101' ' ' VAL . 9.5 t -110.73 162.47 14.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.979 -1.075 . . . . 0.0 110.808 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.651 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 2.0 t60 -119.66 53.88 1.03 Allowed 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 40.7 m -172.55 125.82 0.5 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.497 -0.752 . . . . 0.0 109.229 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 119.72 -14.93 10.56 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 98' ' ' ASN . . . -117.74 86.41 2.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.18 -1.188 . . . . 0.0 109.546 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER 42.11 74.13 0.12 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.545 -0.722 . . . . 0.0 109.119 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.55 -76.9 0.73 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.761 -1.735 . . . . 0.0 108.761 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.651 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -150.17 -84.08 0.09 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.258 -1.142 . . . . 0.0 109.43 179.717 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.535 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 1.6 t30 63.57 152.11 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.348 -0.845 . . . . 0.0 109.124 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.592 ' O ' HG13 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -96.53 143.78 27.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 109.776 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 100' ' ' PHE . 3.7 m -158.03 131.41 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.475 -0.766 . . . . 0.0 109.159 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -45.45 126.15 6.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.34 -0.85 . . . . 0.0 109.559 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 1.3 m -49.05 165.85 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.259 -0.901 . . . . 0.0 109.645 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.489 1.482 0 O-C-N 121.27 -0.893 . . . . 0.0 109.508 -179.864 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 32.1 p -173.74 115.19 0.23 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.191 -0.943 . . . . 0.0 110.07 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -78.11 -45.38 23.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 0.0 109.212 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.583 ' CE1' ' HB ' ' A' ' 89' ' ' VAL . 28.1 m-85 -74.07 95.82 2.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.0 109.029 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -108.56 67.64 0.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 110.008 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.436 ' HB2' ' OD1' ' A' ' 76' ' ' ASP . 4.1 m -84.16 156.64 21.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 109.071 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 6' ' ' CYS . . . 44.6 -107.8 0.16 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.5 p -142.5 41.25 1.6 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.172 -1.193 . . . . 0.0 109.459 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -118.89 140.59 49.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 0.0 109.566 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -89.86 66.88 7.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -78.76 114.82 18.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 0.0 108.855 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . 1.068 ' O ' HG23 ' A' ' 16' ' ' VAL . 1.0 OUTLIER -88.73 148.78 23.8 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.321 -0.862 . . . . 0.0 110.505 -179.181 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -13.39 18.38 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.85 -36.49 12.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.26 -0.9 . . . . 0.0 109.75 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.15 -30.55 62.32 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.987 -1.071 . . . . 0.0 108.117 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 1.068 HG23 ' O ' ' A' ' 12' ' ' SER . 3.8 t -62.38 -31.1 50.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.11 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 t -58.57 -45.24 89.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.282 -0.886 . . . . 0.0 109.866 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.9 m -65.73 -52.02 54.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.578 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.932 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -74.36 -6.6 49.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.287 -0.883 . . . . 0.0 109.579 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.793 ' OE1' HG22 ' A' ' 78' ' ' VAL . 4.3 tp60 -99.69 -15.85 18.38 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.39 -17.72 29.9 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.12 -57.82 3.65 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.432 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -48.42 -28.33 6.41 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.594 ' CE1' ' HA ' ' A' ' 82' ' ' GLU . 24.7 t80 -77.35 -48.4 17.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.602 -0.94 . . . . 0.0 109.596 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.403 ' O ' ' HB2' ' A' ' 29' ' ' ASP . 0.1 OUTLIER -54.09 -40.97 67.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.126 -0.984 . . . . 0.0 108.858 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.88 HD11 ' O ' ' A' ' 31' ' ' GLU . 1.9 tm? -65.84 -43.61 87.99 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.613 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 19.5 t60 -67.55 -17.9 64.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.368 -0.833 . . . . 0.0 109.765 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.95 11.19 31.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 109.579 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 1.8 t0 -122.63 -0.22 9.21 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.346 -0.846 . . . . 0.0 109.451 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.85 21.03 58.07 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.88 ' O ' HD11 ' A' ' 26' ' ' LEU . 3.4 mt-10 -102.35 -166.99 1.34 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.366 -1.079 . . . . 0.0 109.36 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.892 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -147.26 173.66 12.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.242 -0.911 . . . . 0.0 109.513 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 34' ' ' GLY . 33.8 m -89.02 -138.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.41 -0.806 . . . . 0.0 108.968 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.472 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -98.5 33.49 5.99 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.6 p -161.43 -154.3 0.34 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -1.152 . . . . 0.0 109.955 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.748 ' O ' HG21 ' A' ' 32' ' ' THR . 2.2 m120 -53.32 -60.98 2.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 110.101 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.892 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.6 OUTLIER 168.76 108.34 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.404 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.724 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.4 OUTLIER -82.51 -34.31 0.65 Allowed Pre-proline 0 C--O 1.2 -1.507 0 O-C-N 121.01 -1.056 . . . . 0.0 112.221 -178.804 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.763 ' HG2' HD12 ' A' ' 26' ' ' LEU . 35.9 Cg_endo -79.13 109.05 2.47 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 N-CA-C 109.874 -0.856 . . . . 0.0 109.874 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.724 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -133.58 177.53 7.63 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.601 ' HB2' ' CE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -97.51 129.73 44.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.058 -1.027 . . . . 0.0 110.456 -178.626 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.566 ' HB2' ' HG3' ' A' ' 58' ' ' GLU . 10.6 t80 -94.38 168.84 10.63 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.48 ' OD1' ' CE1' ' A' ' 45' ' ' TYR . 0.9 OUTLIER -145.33 18.41 1.54 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.019 -1.051 . . . . 0.0 110.129 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 43' ' ' ASN . 10.9 m120 62.03 108.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.069 -1.019 . . . . 0.0 109.738 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.48 ' CE1' ' OD1' ' A' ' 43' ' ' ASN . 3.3 m-30 -114.91 -4.9 12.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.331 -0.855 . . . . 0.0 109.44 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.552 ' CD ' ' CE1' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -110.88 -33.86 6.4 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.115 -0.991 . . . . 0.0 108.787 -179.431 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.01 28.65 2.81 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.552 ' CE1' ' CD ' ' A' ' 46' ' ' GLU . 48.3 m-85 -61.66 -168.18 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 4.8 m-20 -139.1 -44.15 0.46 Allowed 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 118.557 -1.257 . . . . 0.0 109.771 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 49' ' ' ASP . 20.0 m-85 64.17 177.58 0.18 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.323 -0.86 . . . . 0.0 109.478 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.9 -18.58 17.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.232 -0.917 . . . . 0.0 109.07 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.582 HG23 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -98.0 -176.49 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.338 -0.851 . . . . 0.0 108.896 179.609 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.477 ' HA ' ' OH ' ' A' ' 56' ' ' TYR . 12.6 t -151.37 86.42 1.35 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.108 -0.995 . . . . 0.0 109.52 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.668 ' CB ' ' HD2' ' A' ' 55' ' ' PRO . 0.3 OUTLIER -172.58 -176.56 0.34 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.072 -1.018 . . . . 0.0 109.53 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.668 ' HD2' ' CB ' ' A' ' 54' ' ' SER . 29.4 Cg_endo -71.79 96.36 0.76 Allowed 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 121.489 1.459 . . . . 0.0 108.55 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.559 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 24.0 m-85 -75.95 -170.94 1.5 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.777 0.798 . . . . 0.0 110.694 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.613 ' CE2' ' NE2' ' A' ' 27' ' ' HIS . 49.4 m-85 -150.72 147.18 27.03 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.664 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 1.2 mp0 -96.96 146.29 25.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.872 -1.142 . . . . 0.0 110.365 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.657 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 46.3 t-105 -159.45 135.7 6.36 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.657 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 31.9 Cg_endo -72.75 148.68 47.04 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 121.922 1.748 . . . . 0.0 111.115 -178.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.986 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -122.53 142.19 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.986 HD23 ' C ' ' A' ' 61' ' ' ILE . 1.4 mt -122.51 -170.67 2.12 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.249 -0.907 . . . . 0.0 109.383 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.57 54.8 0.93 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 108.928 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -157.75 -43.8 0.06 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.391 -0.818 . . . . 0.0 109.464 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.98 39.45 3.56 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.475 ' C ' HG23 ' A' ' 67' ' ' VAL . 0.5 OUTLIER -114.3 18.22 17.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -1.146 . . . . 0.0 109.464 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.475 HG23 ' C ' ' A' ' 66' ' ' ASP . 2.0 t 62.3 167.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.902 . . . . 0.0 109.693 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.631 ' HD1' HD11 ' A' ' 62' ' ' LEU . 6.1 t80 -106.86 139.13 41.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.343 -0.848 . . . . 0.0 109.591 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.8 m -122.46 -20.21 6.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.243 -0.911 . . . . 0.0 109.636 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 163.73 148.27 5.35 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 144.3 -142.95 11.51 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.445 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 20.3 m -51.89 118.15 11.26 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.217 -1.166 . . . . 0.0 109.323 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.518 ' O ' ' NH1' ' A' ' 77' ' ' ARG . 35.7 Cg_endo -77.72 -75.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.452 2.101 . . . . 0.0 110.571 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.553 ' CA ' ' HB2' ' A' ' 92' ' ' HIS . . . -59.13 -117.83 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.545 ' N ' ' HB2' ' A' ' 92' ' ' HIS . . . 49.54 -167.18 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.278 -1.131 . . . . 0.0 109.704 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.436 ' OD1' ' HB2' ' A' ' 6' ' ' CYS . 1.1 m-20 -42.04 147.82 0.21 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.276 -0.89 . . . . 0.0 109.864 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.518 ' NH1' ' O ' ' A' ' 73' ' ' PRO . 2.2 ttm180 -164.82 70.84 0.17 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.421 -0.799 . . . . 0.0 109.372 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.793 HG22 ' OE1' ' A' ' 20' ' ' GLN . 10.9 p -44.72 149.75 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 109.284 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 1.083 ' CG1' ' HB3' ' A' ' 87' ' ' ALA . 0.4 OUTLIER -121.0 171.92 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.02 -1.05 . . . . 0.0 110.338 -179.484 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.601 ' CD1' ' NE2' ' A' ' 20' ' ' GLN . 19.2 p90 -172.04 -167.52 0.49 Allowed 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.102 -178.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.522 ' N ' ' OD1' ' A' ' 81' ' ' ASN . 0.2 OUTLIER -132.54 -78.47 0.5 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.829 -1.17 . . . . 0.0 109.837 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.594 ' HA ' ' CE1' ' A' ' 24' ' ' TYR . 10.3 pt-20 -160.76 24.58 0.14 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.37 -0.831 . . . . 0.0 109.176 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.47 ' HB2' ' CG ' ' A' ' 85' ' ' GLN . 37.8 m-20 -146.03 17.55 1.4 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.456 -0.777 . . . . 0.0 109.241 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.593 ' ND2' ' O ' ' A' ' 84' ' ' ASN . 0.7 OUTLIER 47.45 25.68 0.65 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.42 -0.8 . . . . 0.0 109.216 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.568 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -70.29 -27.6 64.53 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.609 HD22 ' HG2' ' A' ' 20' ' ' GLN . 0.1 OUTLIER 85.87 115.87 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.58 0.705 . . . . 0.0 110.739 179.044 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 1.083 ' HB3' ' CG1' ' A' ' 79' ' ' VAL . . . -96.3 -30.72 13.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.507 -0.746 . . . . 0.0 108.999 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.416 ' N ' ' CD1' ' A' ' 86' ' ' LEU . . . 158.08 -153.77 24.92 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.583 ' HB ' ' CE1' ' A' ' 4' ' ' TYR . 42.8 t -147.09 127.72 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.025 -1.279 . . . . 0.0 109.795 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.557 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -114.34 144.91 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.553 -0.717 . . . . 0.0 109.142 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.521 ' O ' HG23 ' A' ' 91' ' ' THR . 6.2 t -133.43 123.93 26.19 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.091 -1.006 . . . . 0.0 109.933 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.606 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -79.37 84.05 5.33 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.541 -0.724 . . . . 0.0 109.477 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 176.1 127.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.423 -0.798 . . . . 0.0 109.251 179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.98 -18.3 28.93 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.608 ' HB3' ' CB ' ' A' ' 99' ' ' ASN . . . -115.46 90.78 3.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.364 -1.08 . . . . 0.0 109.413 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.4 OUTLIER 43.95 78.95 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 109.346 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.91 -88.91 1.59 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.606 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -125.56 -90.55 0.55 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.213 -1.169 . . . . 0.0 109.376 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.608 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . 0.7 OUTLIER 61.08 136.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -0.961 . . . . 0.0 109.059 -179.584 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.557 ' CD1' ' HB ' ' A' ' 90' ' ' ILE . 21.8 m-85 -79.66 155.28 28.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.834 -1.166 . . . . 0.0 110.195 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -160.7 133.85 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.141 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -54.5 126.15 22.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.336 -0.853 . . . . 0.0 109.611 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 1.3 m -68.48 109.29 3.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.408 -0.808 . . . . 0.0 109.819 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.944 . . . . 0.0 109.477 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.507 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.8 p 167.14 130.33 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.218 -0.926 . . . . 0.0 110.065 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -103.87 -9.83 18.66 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.443 -0.786 . . . . 0.0 109.344 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.622 ' CD2' HG23 ' A' ' 89' ' ' VAL . 19.4 m-85 -109.54 132.16 54.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.308 -0.87 . . . . 0.0 109.247 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.448 HG23 ' H ' ' A' ' 10' ' ' CYS . 5.2 m -155.82 113.37 3.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.134 -0.979 . . . . 0.0 109.611 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.4 m -94.27 17.35 12.93 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 122.112 0.958 . . . . 0.0 109.691 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.91 -71.44 0.2 Allowed Glycine 0 C--N 1.283 -2.378 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.7 m -162.62 49.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.314 -1.11 . . . . 0.0 109.239 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.557 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . 6.9 m120 -103.12 -28.88 11.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.308 -0.87 . . . . 0.0 109.771 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.448 ' H ' HG23 ' A' ' 5' ' ' THR . 44.4 t 59.42 63.07 1.63 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.132 -0.98 . . . . 0.0 109.102 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.574 ' CE1' ' HB3' ' A' ' 63' ' ' SER . 40.8 m-85 -79.13 122.41 26.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.445 -0.784 . . . . 0.0 109.144 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.748 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -79.59 133.23 36.43 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.422 -0.799 . . . . 0.0 109.61 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.5 t -52.48 -19.93 2.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.202 -0.936 . . . . 0.0 109.063 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.54 -36.8 18.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 110.015 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -74.59 -27.13 60.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.009 -1.057 . . . . 0.0 108.194 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 12' ' ' SER . 19.3 t -69.5 -33.18 55.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -34.91 78.62 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -38.01 82.48 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.754 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -84.91 -7.67 59.07 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.571 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -90.73 -28.12 18.5 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.276 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -79.5 -11.83 59.89 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.729 ' HB1' HG13 ' A' ' 67' ' ' VAL . . . -80.22 -39.1 29.77 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.607 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -85.52 -15.46 66.06 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -88.7 -58.51 2.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.392 -1.064 . . . . 0.0 109.13 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.49 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -53.56 -35.2 60.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 109.298 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.418 ' HA ' HD22 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -68.17 -46.96 69.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.328 -0.858 . . . . 0.0 109.222 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -49.85 -42.27 47.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.413 -0.804 . . . . 0.0 110.229 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.39 -20.67 27.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.128 -0.983 . . . . 0.0 110.037 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.463 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 28.2 t0 -74.99 -20.23 59.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.128 -0.982 . . . . 0.0 109.54 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.92 19.7 78.54 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 29' ' ' ASP . 0.8 OUTLIER -103.91 -169.3 1.61 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.346 -1.09 . . . . 0.0 109.472 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.864 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -135.67 -170.69 2.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.322 -0.861 . . . . 0.0 109.288 179.71 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.596 ' H ' HG22 ' A' ' 32' ' ' THR . 64.2 t -89.86 -98.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.304 -0.873 . . . . 0.0 109.321 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -124.52 -8.64 5.77 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER 163.72 -46.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.281 -1.129 . . . . 0.0 109.315 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 37' ' ' SER . 1.6 m-80 -82.19 5.37 20.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.608 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.864 ' HA ' HG22 ' A' ' 32' ' ' THR . 81.6 p 45.29 -162.15 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.931 . . . . 0.0 108.876 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.715 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER 167.01 -44.31 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.142 -0.974 . . . . 0.0 111.911 179.243 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 31.1 Cg_endo -74.42 99.75 1.24 Allowed 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.466 1.444 . . . . 0.0 112.274 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.715 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -144.76 -173.89 4.19 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.284 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.575 ' HB2' ' CE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -96.45 126.04 41.37 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.041 -1.037 . . . . 0.0 109.966 -179.167 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.608 ' CE2' ' HA ' ' A' ' 44' ' ' ASN . 8.2 t80 -105.22 139.45 39.86 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.505 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 9.5 m120 -70.41 -46.71 63.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.171 -0.956 . . . . 0.0 110.098 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.608 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 0.5 OUTLIER 76.47 55.85 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.269 -0.894 . . . . 0.0 109.008 -179.403 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -106.09 46.84 0.9 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.269 -0.895 . . . . 0.0 109.483 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.529 ' OE2' ' CG1' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -101.12 -28.76 12.51 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.659 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.33 19.98 3.07 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.609 ' CD2' ' CZ ' ' A' ' 50' ' ' PHE . 59.7 m-85 -63.41 -169.15 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -154.43 36.54 0.42 Allowed 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 118.565 -1.254 . . . . 0.0 109.918 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.609 ' CZ ' ' CD2' ' A' ' 48' ' ' PHE . 6.7 m-85 -62.16 -175.14 0.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.038 -1.039 . . . . 0.0 109.41 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 p -144.72 35.38 1.15 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.384 -0.822 . . . . 0.0 109.038 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.543 HG13 ' HB2' ' A' ' 85' ' ' GLN . 68.8 t -92.9 -71.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.334 -0.853 . . . . 0.0 109.826 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 t -161.68 178.15 9.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.796 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.576 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -79.24 -51.45 1.26 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.349 -0.844 . . . . 0.0 110.654 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 54' ' ' SER . 34.6 Cg_endo -76.06 85.62 1.63 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 121.992 1.795 . . . . 0.0 110.352 -177.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.585 ' O ' ' CD1' ' A' ' 57' ' ' TYR . 48.2 m-85 -79.12 -178.37 6.11 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.394 0.616 . . . . 0.0 109.862 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.585 ' CD1' ' O ' ' A' ' 56' ' ' TYR . 48.3 m-85 -150.88 145.01 25.37 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -104.21 138.52 40.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.234 -0.916 . . . . 0.0 110.6 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.69 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 22.6 t-105 -160.8 138.93 7.23 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.69 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.9 Cg_endo -67.53 142.22 58.35 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.119 1.88 . . . . 0.0 111.274 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.911 HD12 ' N ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -118.63 131.67 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.729 -0.607 . . . . 0.0 109.417 -179.263 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.911 ' N ' HD12 ' A' ' 61' ' ' ILE . 2.9 mt -120.89 165.51 15.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.225 -0.922 . . . . 0.0 109.756 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.574 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 92.9 p -111.11 -1.88 16.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.086 -1.009 . . . . 0.0 108.816 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.58 -37.93 62.8 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.606 -0.683 . . . . 0.0 109.507 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.25 46.15 1.1 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.15 146.44 27.67 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.312 -1.11 . . . . 0.0 109.36 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.729 HG13 ' HB1' ' A' ' 22' ' ' ALA . 73.8 t -66.35 136.44 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.156 -0.965 . . . . 0.0 109.343 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.597 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 20.1 t80 -47.91 147.4 2.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.894 . . . . 0.0 109.638 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.574 ' HA ' HG12 ' A' ' 33' ' ' VAL . 5.4 t -174.82 54.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.529 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.2 119.45 4.62 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.1 -133.19 2.8 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.1 114.55 63.5 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.26 -1.141 . . . . 0.0 109.451 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.02 121.05 5.99 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.336 2.024 . . . . 0.0 110.362 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.516 ' O ' ' NH1' ' A' ' 77' ' ' ARG . . . 110.61 -138.48 14.95 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.558 ' N ' ' HB2' ' A' ' 92' ' ' HIS . . . 64.04 -86.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -1.116 . . . . 0.0 110.222 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.479 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 7.4 m-20 -132.52 110.48 10.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.939 -1.1 . . . . 0.0 110.157 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 60' ' ' PRO . 3.7 mpt_? -116.58 146.12 42.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.448 -0.782 . . . . 0.0 109.024 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.6 p -113.95 134.8 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.053 -1.029 . . . . 0.0 109.33 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.616 HG12 ' N ' ' A' ' 80' ' ' PHE . 58.4 t -97.4 166.04 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-O 121.95 0.881 . . . . 0.0 110.472 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.616 ' N ' HG12 ' A' ' 79' ' ' VAL . 7.1 p90 -164.83 -171.44 2.28 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -126.23 -83.47 0.62 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.842 -1.161 . . . . 0.0 109.977 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -151.43 8.59 0.53 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.418 -0.801 . . . . 0.0 110.37 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.401 ' HB3' ' HG2' ' A' ' 85' ' ' GLN . 4.8 t-20 -138.34 15.07 2.79 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.907 -1.121 . . . . 0.0 108.562 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 84' ' ' ASN . 38.4 t30 59.04 30.97 20.92 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.42 -0.8 . . . . 0.0 109.063 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.561 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -63.84 -26.4 68.6 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.067 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.561 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER 85.81 109.0 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.488 0.661 . . . . 0.0 110.652 179.05 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.582 ' HB1' ' CD2' ' A' ' 50' ' ' PHE . . . -83.04 -37.79 23.43 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 153.01 168.25 16.69 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.622 HG23 ' CD2' ' A' ' 4' ' ' TYR . 44.9 t -104.46 102.36 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.158 -1.201 . . . . 0.0 109.343 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.556 HG22 ' CE2' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -93.31 168.44 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.428 -0.795 . . . . 0.0 109.889 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.725 HG22 HG23 ' A' ' 101' ' ' VAL . 5.4 t -106.48 -173.41 2.29 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.456 -0.778 . . . . 0.0 110.387 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.558 ' HB2' ' N ' ' A' ' 75' ' ' ALA . 0.5 OUTLIER -148.82 62.95 1.06 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 1.2 m 172.79 -28.61 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.758 -0.589 . . . . 0.0 109.883 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.9 -9.2 52.37 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 120.033 -1.079 . . . . 0.0 110.654 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -120.1 176.7 5.31 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.932 -1.334 . . . . 0.0 109.805 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.2 OUTLIER -41.53 124.37 2.43 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.676 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.18 -88.69 0.12 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 107.962 -2.055 . . . . 0.0 107.962 -178.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.554 ' HB3' ' O ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -165.56 38.24 0.06 Allowed 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.088 -1.243 . . . . 0.0 109.444 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 98' ' ' ASN . 12.3 t-20 -50.72 179.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.077 -1.015 . . . . 0.0 108.762 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -106.1 146.84 29.66 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.857 -1.152 . . . . 0.0 109.197 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.725 HG23 HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -160.27 140.88 3.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.458 ' OE2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -39.42 138.67 0.64 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.549 -0.719 . . . . 0.0 110.132 -179.119 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.454 ' SG ' ' HB ' ' A' ' 91' ' ' THR . 4.2 m -94.48 97.82 10.42 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.355 -0.841 . . . . 0.0 109.568 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 109.28 179.902 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.229 0.538 . . . . 0.0 109.654 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 32.0 p 178.2 133.02 0.07 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.356 -0.84 . . . . 0.0 109.843 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -94.96 -35.57 11.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 0.0 108.987 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.837 ' CD2' HG21 ' A' ' 89' ' ' VAL . 66.8 m-85 -92.34 81.87 4.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.36 -0.837 . . . . 0.0 109.017 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.754 HG23 ' O ' ' A' ' 5' ' ' THR . 9.8 t -93.98 89.56 6.11 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.321 -0.862 . . . . 0.0 110.149 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.436 ' CB ' ' OD1' ' A' ' 76' ' ' ASP . 0.1 OUTLIER -89.57 -165.05 1.25 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.904 . . . . 0.0 109.0 179.369 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.441 ' O ' ' OG ' ' A' ' 8' ' ' SER . . . -59.13 95.56 0.07 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.454 ' O ' ' OG ' ' A' ' 8' ' ' SER . 4.5 p 65.7 49.2 1.78 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -1.159 . . . . 0.0 109.648 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.432 ' ND2' ' OD2' ' A' ' 76' ' ' ASP . 0.2 OUTLIER -123.8 -71.85 0.7 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.358 -0.839 . . . . 0.0 109.283 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.46 ' C ' ' CB ' ' A' ' 2' ' ' CYS . 50.6 t 53.01 51.69 15.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 109.654 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.57 ' CD1' ' HB3' ' A' ' 63' ' ' SER . 4.3 m-85 -93.43 144.59 25.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.411 -0.805 . . . . 0.0 108.951 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.856 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -83.64 134.4 34.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 110.095 -179.726 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.2 p -50.85 -25.4 4.47 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.43 -42.63 61.78 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.316 -0.865 . . . . 0.0 108.944 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.31 -19.42 61.04 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 12' ' ' SER . 12.2 t -78.81 -29.02 14.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.454 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 0.6 OUTLIER -65.44 -34.39 78.18 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.228 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -53.7 27.54 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.731 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -62.08 -18.28 60.21 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.693 ' NE2' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -76.13 -37.48 57.97 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.289 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -74.64 -3.27 30.2 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.07 -63.21 1.39 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.378 -0.826 . . . . 0.0 108.776 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.631 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -62.38 -16.88 55.49 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.413 ' CD1' ' C ' ' A' ' 24' ' ' TYR . 1.1 t80 -83.34 -62.65 1.53 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.562 -0.963 . . . . 0.0 109.014 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 2.8 tt0 -48.38 -34.38 10.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.169 -0.957 . . . . 0.0 108.88 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.526 HD11 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -69.46 -44.57 70.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.506 -0.747 . . . . 0.0 109.51 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -59.27 -38.11 79.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.47 -0.769 . . . . 0.0 110.297 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -89.6 -14.79 34.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.105 -0.997 . . . . 0.0 110.352 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -83.48 -10.71 58.18 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.102 -0.999 . . . . 0.0 109.214 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 63.2 11.44 39.4 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -88.02 -144.66 0.13 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.403 -1.057 . . . . 0.0 109.057 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.526 ' N ' HD11 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -167.67 175.22 7.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.002 -1.061 . . . . 0.0 109.688 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.475 HG23 ' H ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -102.17 -94.68 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.235 -0.915 . . . . 0.0 109.87 -179.72 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.475 ' H ' HG23 ' A' ' 33' ' ' VAL . . . -88.77 32.83 4.4 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 1.2 m 67.61 8.59 6.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.195 -1.179 . . . . 0.0 109.332 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.4 ' O ' ' CB ' ' A' ' 37' ' ' SER . 2.4 m120 -102.03 -14.42 17.15 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.198 -0.939 . . . . 0.0 109.503 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.501 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.9 OUTLIER 68.28 105.15 0.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.866 . . . . 0.0 109.255 -179.763 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.64 ' H ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -116.66 -33.16 0.08 OUTLIER Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 114.274 1.212 . . . . 0.0 114.274 -178.443 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.64 ' CD ' ' H ' ' A' ' 38' ' ' TYR . 36.4 Cg_endo -80.62 101.88 1.35 Allowed 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.291 1.327 . . . . 0.0 112.734 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.483 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -135.11 -167.3 1.97 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.104 -0.997 . . . . 0.0 109.259 177.798 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 8.8 ptmm? -76.33 179.03 6.06 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.496 -0.753 . . . . 0.0 109.654 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.794 ' CD2' HG21 ' A' ' 79' ' ' VAL . 7.0 t80 -139.21 98.02 3.42 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.322 -0.861 . . . . 0.0 108.894 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.528 ' O ' ' CE1' ' A' ' 45' ' ' TYR . 8.1 m120 -61.29 -20.2 62.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.423 -0.798 . . . . 0.0 109.772 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.613 ' O ' ' CB ' ' A' ' 45' ' ' TYR . 10.2 p-10 40.24 -144.0 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.534 -0.729 . . . . 0.0 109.901 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.613 ' CB ' ' O ' ' A' ' 44' ' ' ASN . 18.4 m-30 107.11 -20.76 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.603 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 2.2 tm-20 -40.4 -33.46 0.26 Allowed 'General case' 0 C--N 1.309 -1.189 0 O-C-N 121.06 -1.025 . . . . 0.0 110.343 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.73 -15.74 0.72 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.603 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -104.02 159.91 15.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.104 -1.233 . . . . 0.0 108.815 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.491 ' C ' ' CG ' ' A' ' 50' ' ' PHE . 1.4 t0 -143.88 -36.3 0.35 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.199 -0.938 . . . . 0.0 109.837 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.491 ' CG ' ' C ' ' A' ' 49' ' ' ASP . 5.5 m-85 74.82 177.63 0.22 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.137 -0.977 . . . . 0.0 109.457 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.98 41.2 3.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.177 -0.952 . . . . 0.0 109.535 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.538 HG12 ' N ' ' A' ' 53' ' ' SER . 3.3 t -100.97 -72.19 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.334 -0.854 . . . . 0.0 109.337 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.538 ' N ' HG12 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -159.09 167.91 27.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.093 -1.004 . . . . 0.0 110.174 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.571 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -75.99 -52.32 2.62 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.462 -0.774 . . . . 0.0 110.364 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 54' ' ' SER . 35.5 Cg_endo -76.42 83.6 2.01 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.055 1.837 . . . . 0.0 109.72 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.633 ' CE1' ' CB ' ' A' ' 87' ' ' ALA . 31.1 m-85 -79.51 176.2 9.91 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.549 0.69 . . . . 0.0 110.05 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.574 ' CD1' ' O ' ' A' ' 81' ' ' ASN . 89.9 m-85 -142.56 129.03 20.14 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 0.3 OUTLIER -89.11 136.57 32.94 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.906 0.86 . . . . 0.0 111.063 -178.242 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.688 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 39.3 t-105 -160.39 135.79 5.83 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.688 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.6 Cg_endo -70.21 147.1 59.26 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.055 1.837 . . . . 0.0 111.272 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 1.065 HD12 ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -110.0 130.05 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.565 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.065 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.1 mt -138.61 119.3 14.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.347 -0.845 . . . . 0.0 108.953 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.57 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.3 t -126.34 73.67 1.39 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.685 -0.634 . . . . 0.0 109.429 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 173.43 -31.57 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.152 -0.967 . . . . 0.0 109.371 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.18 -74.81 0.83 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.05 -150.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -1.145 . . . . 0.0 109.529 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.429 ' O ' ' N ' ' A' ' 69' ' ' SER . 13.6 t -96.51 145.1 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.336 -0.853 . . . . 0.0 109.492 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.547 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 82.3 t80 -50.28 97.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.0 109.467 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 67' ' ' VAL . 1.2 p -132.66 26.88 4.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 109.437 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.19 79.69 0.42 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -156.25 -123.12 0.78 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.8 t -127.22 102.07 24.47 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.256 -1.143 . . . . 0.0 109.246 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.516 ' HB2' ' OH ' ' A' ' 38' ' ' TYR . 34.2 Cg_endo -76.55 -159.07 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.323 2.016 . . . . 0.0 110.551 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.483 ' O ' ' N ' ' A' ' 76' ' ' ASP . . . 66.09 -145.87 48.36 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.466 ' N ' ' HB3' ' A' ' 92' ' ' HIS . . . 48.11 -95.18 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.08 -1.247 . . . . 0.0 109.768 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 91' ' ' THR . 59.7 m-20 -111.05 139.91 46.03 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.861 -1.149 . . . . 0.0 110.208 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.732 ' HA ' HG22 ' A' ' 61' ' ' ILE . 57.8 mtp180 -156.91 159.32 38.02 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.583 HG13 HE21 ' A' ' 20' ' ' GLN . 13.1 p -134.74 145.1 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.804 -1.185 . . . . 0.0 110.03 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.89 HG23 ' CD1' ' A' ' 90' ' ' ILE . 3.0 t -106.24 165.05 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 122.106 0.955 . . . . 0.0 109.861 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.693 ' CD1' ' NE2' ' A' ' 20' ' ' GLN . 4.0 p90 -156.09 -169.02 2.93 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.753 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.574 ' O ' ' CD1' ' A' ' 57' ' ' TYR . 10.6 t30 -107.41 -80.05 0.57 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.007 -1.058 . . . . 0.0 110.179 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.502 ' HG3' ' ND2' ' A' ' 81' ' ' ASN . 1.3 pp20? -167.85 23.62 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.428 -0.795 . . . . 0.0 109.546 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.597 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 1.2 m120 -149.49 21.72 0.93 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 109.072 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.597 ' ND2' ' O ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER 80.72 8.11 1.27 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.55 -0.719 . . . . 0.0 109.438 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.504 ' OE1' ' HB2' ' A' ' 83' ' ' ASN . 6.3 mp0 -56.91 -165.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -0.985 . . . . 0.0 108.943 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.424 ' O ' HG21 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -139.56 107.6 5.72 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.957 -1.089 . . . . 0.0 110.098 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.633 ' CB ' ' CE1' ' A' ' 56' ' ' TYR . . . -80.87 -43.01 20.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.427 -0.796 . . . . 0.0 108.925 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 162.26 142.47 3.4 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.837 HG21 ' CD2' ' A' ' 4' ' ' TYR . 60.1 t -81.95 97.26 3.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.116 -1.226 . . . . 0.0 109.976 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.89 ' CD1' HG23 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -78.6 179.85 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.105 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . 1.098 HG22 ' O ' ' A' ' 101' ' ' VAL . 12.4 t -135.81 -131.98 0.15 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.916 -1.115 . . . . 0.0 108.457 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.817 ' CD2' ' HB2' ' A' ' 95' ' ' ALA . 0.2 OUTLIER 163.57 42.32 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 -179.657 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.4 m -77.55 97.27 4.99 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.695 0.759 . . . . 0.0 109.713 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.502 ' O ' ' C ' ' A' ' 95' ' ' ALA . . . 93.55 -29.91 7.91 Favored Glycine 0 C--N 1.297 -1.592 0 N-CA-C 107.753 -2.139 . . . . 0.0 107.753 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.817 ' HB2' ' CD2' ' A' ' 92' ' ' HIS . . . 34.45 -154.97 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.3 -0.529 . . . . 0.0 109.873 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.455 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.6 OUTLIER 46.01 47.53 12.67 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -179.034 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.98 -25.64 2.65 Favored Glycine 0 N--CA 1.483 1.828 0 N-CA-C 106.026 -2.83 . . . . 0.0 106.026 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 1.001 ' O ' HG13 ' A' ' 101' ' ' VAL . 7.8 m120 -105.65 -29.77 9.9 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.531 ' OD1' ' HG3' ' A' ' 46' ' ' GLU . 11.5 p-10 37.21 -146.1 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.706 ' CD1' ' CE1' ' A' ' 42' ' ' TYR . 5.3 m-85 -75.78 77.15 2.73 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 1.098 ' O ' HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -85.36 131.82 33.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.392 -0.818 . . . . 0.0 108.969 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -43.71 151.51 0.19 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.527 -1.358 . . . . 0.0 109.717 -179.049 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 1.2 m -75.71 92.25 2.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.924 . . . . 0.0 109.37 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.869 . . . . 0.0 109.437 -179.934 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.51 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.8 p 163.37 121.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.355 -0.841 . . . . 0.0 109.67 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -105.4 3.52 29.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.91 . . . . 0.0 109.431 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.588 ' CD1' HG21 ' A' ' 89' ' ' VAL . 11.4 m-85 -119.69 104.63 10.42 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.119 -0.988 . . . . 0.0 109.625 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.715 HG22 ' H ' ' A' ' 7' ' ' GLY . 98.5 m -143.85 123.34 13.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.093 -1.004 . . . . 0.0 109.421 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -91.97 9.81 31.56 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.163 -0.961 . . . . 0.0 109.945 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.715 ' H ' HG22 ' A' ' 5' ' ' THR . . . -177.39 -62.64 0.06 OUTLIER Glycine 0 C--N 1.282 -2.43 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.434 ' HA ' HG21 ' A' ' 5' ' ' THR . 3.6 m -174.46 30.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -1.129 . . . . 0.0 109.51 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.608 ' H ' HG23 ' A' ' 5' ' ' THR . 8.4 m-80 -80.02 -24.49 40.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.923 . . . . 0.0 109.371 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 9' ' ' ASN . 37.8 t 58.87 68.49 0.81 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.37 -0.832 . . . . 0.0 109.574 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.558 ' CE1' ' HB3' ' A' ' 9' ' ' ASN . 11.0 m-85 -89.47 132.94 34.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.131 -0.98 . . . . 0.0 109.259 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.588 ' O ' HG23 ' A' ' 16' ' ' VAL . 15.3 t -83.07 130.5 35.13 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.368 -0.832 . . . . 0.0 109.859 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 p -56.36 -17.57 8.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.304 -0.872 . . . . 0.0 109.287 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.7 -32.55 21.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.89 . . . . 0.0 109.575 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.435 ' O ' ' OG1' ' A' ' 18' ' ' THR . 0.5 OUTLIER -77.13 -37.33 54.26 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.305 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 12' ' ' SER . 28.8 t -51.9 -37.44 21.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.99 -43.29 99.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.576 -0.702 . . . . 0.0 109.339 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -59.17 -47.4 85.44 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.519 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.72 ' CB ' HD13 ' A' ' 61' ' ' ILE . . . -70.82 -15.2 62.63 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.715 ' NE2' HG13 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -89.65 -12.77 38.65 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.533 -0.729 . . . . 0.0 109.096 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -94.1 -20.92 19.46 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.08 -61.24 2.05 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.59 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -55.93 -24.94 43.99 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -73.83 -46.4 45.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.623 -0.928 . . . . 0.0 109.256 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -66.16 -63.63 1.04 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.373 -0.829 . . . . 0.0 108.906 179.757 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.859 HD21 ' C ' ' A' ' 32' ' ' THR . 3.3 tp -44.2 -33.93 1.7 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.302 -0.874 . . . . 0.0 109.068 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.618 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -63.86 -59.77 4.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.323 -0.861 . . . . 0.0 109.254 179.772 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.5 11.84 7.98 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.511 -0.743 . . . . 0.0 109.542 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -100.53 -24.01 14.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -0.919 . . . . 0.0 109.448 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.0 -16.76 45.57 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.43 -148.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.247 -1.149 . . . . 0.0 109.277 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.988 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.1 OUTLIER -170.61 -176.09 2.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.397 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.498 HG23 ' H ' ' A' ' 35' ' ' SER . 19.0 m -89.74 -126.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.143 -0.973 . . . . 0.0 109.606 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.403 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -130.34 -4.04 4.58 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.085 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.498 ' H ' HG23 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -109.86 -93.09 0.43 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.023 -1.281 . . . . 0.0 109.128 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -130.62 58.78 1.68 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.321 -0.862 . . . . 0.0 108.969 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.988 ' HA ' HG22 ' A' ' 32' ' ' THR . 4.2 t 57.71 -158.75 0.27 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.309 -0.87 . . . . 0.0 109.019 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.676 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER 166.84 -43.96 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 112.168 179.284 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 32.0 Cg_endo -75.2 100.66 1.39 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.353 1.368 . . . . 0.0 112.367 -178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.676 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -143.93 175.12 10.26 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.143 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -72.25 157.76 37.1 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.044 -1.035 . . . . 0.0 110.044 -179.391 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.506 ' OH ' ' CD1' ' A' ' 100' ' ' PHE . 87.3 t80 -145.93 89.6 1.91 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.438 -0.789 . . . . 0.0 109.19 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.522 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 32.3 m120 -52.29 -88.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.171 -0.956 . . . . 0.0 110.169 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.524 ' N ' ' OD1' ' A' ' 44' ' ' ASN . 2.4 p30 161.97 135.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.175 -0.953 . . . . 0.0 109.276 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -131.05 -0.91 4.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.077 -1.014 . . . . 0.0 109.862 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -100.73 -19.35 16.07 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.191 -0.943 . . . . 0.0 108.62 -179.789 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.26 23.88 7.1 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.581 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 18.4 m-85 -63.85 87.16 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 50' ' ' PHE . 5.7 t70 -54.57 -32.25 58.2 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.839 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.902 ' CD2' ' HB1' ' A' ' 87' ' ' ALA . 9.8 m-30 44.93 -170.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.357 -0.84 . . . . 0.0 109.607 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -151.55 32.28 0.57 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -0.951 . . . . 0.0 109.454 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.5 t -113.48 -86.62 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.833 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.576 ' O ' ' CZ ' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -152.76 164.89 36.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.103 -0.998 . . . . 0.0 109.762 -179.77 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.59 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -62.22 -51.96 70.26 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.386 -0.821 . . . . 0.0 110.395 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 54' ' ' SER . 36.3 Cg_endo -76.18 80.77 2.6 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.072 1.848 . . . . 0.0 110.716 -178.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.576 ' CZ ' ' O ' ' A' ' 53' ' ' SER . 93.3 m-85 -78.85 -164.63 0.62 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.618 ' CE1' ' NE2' ' A' ' 27' ' ' HIS . 60.4 m-85 -156.1 113.94 3.31 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.519 -0.738 . . . . 0.0 109.266 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -82.91 137.59 34.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.254 -0.904 . . . . 0.0 110.447 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.67 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 10.0 t-105 -160.7 140.65 8.27 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.67 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.5 Cg_endo -69.75 130.52 19.5 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.202 1.935 . . . . 0.0 111.45 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.945 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -111.56 130.25 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.945 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.3 OUTLIER -120.7 168.71 11.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.157 -0.964 . . . . 0.0 109.595 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.484 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 12.3 t -121.38 26.92 8.59 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.7 -55.74 0.05 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.601 -0.687 . . . . 0.0 109.309 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 66' ' ' ASP . . . -72.95 -4.34 62.28 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.417 ' OD1' ' C ' ' A' ' 66' ' ' ASP . 49.5 t0 60.51 -99.88 0.1 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -1.161 . . . . 0.0 109.731 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.9 t -81.26 151.97 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.957 -1.089 . . . . 0.0 109.473 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.585 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 31.5 t80 -82.68 124.23 30.01 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.131 -0.98 . . . . 0.0 109.833 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 99.8 p -119.97 -3.19 10.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.464 -0.773 . . . . 0.0 109.266 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.49 130.64 3.49 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 154.39 86.47 0.06 OUTLIER Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.0 t 51.73 93.03 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.181 -1.188 . . . . 0.0 109.767 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.57 -169.4 0.77 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.708 2.272 . . . . 0.0 110.818 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.647 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 77.64 -170.17 54.93 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 71.63 -162.21 0.13 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.149 -1.206 . . . . 0.0 110.765 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.503 ' N ' ' OG1' ' A' ' 91' ' ' THR . 14.9 m-20 -36.51 154.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.547 0.689 . . . . 0.0 111.106 -178.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.603 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 10.0 ttm105 -177.92 70.4 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.484 -0.76 . . . . 0.0 109.019 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.715 HG13 ' NE2' ' A' ' 20' ' ' GLN . 1.4 p -53.72 166.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.813 -1.179 . . . . 0.0 109.741 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.731 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -126.84 176.88 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.275 -0.89 . . . . 0.0 109.838 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.684 ' HD1' HE21 ' A' ' 20' ' ' GLN . 8.7 p90 -164.51 -171.69 2.43 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.125 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.442 ' C ' ' HG2' ' A' ' 82' ' ' GLU . 7.6 t-20 -129.4 -80.08 0.56 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.038 -1.039 . . . . 0.0 110.06 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.442 ' HG2' ' C ' ' A' ' 81' ' ' ASN . 65.3 mm-40 -149.2 11.12 0.8 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.374 -0.829 . . . . 0.0 110.235 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.619 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 3.6 t-20 -147.74 15.64 1.1 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.026 -1.046 . . . . 0.0 109.567 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.619 ' ND2' ' O ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER 68.16 12.42 8.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.307 -0.871 . . . . 0.0 109.363 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.547 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 1.8 mt-30 -45.95 -31.87 2.43 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.662 HD11 ' CG2' ' A' ' 78' ' ' VAL . 0.1 OUTLIER 85.13 104.1 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.479 0.657 . . . . 0.0 109.952 179.569 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.902 ' HB1' ' CD2' ' A' ' 50' ' ' PHE . . . -77.34 -33.62 55.41 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.372 -0.83 . . . . 0.0 109.14 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 149.55 160.87 9.43 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.588 HG21 ' CD1' ' A' ' 4' ' ' TYR . 4.9 t -85.97 106.06 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.203 -1.174 . . . . 0.0 110.127 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.603 ' CG1' ' O ' ' A' ' 77' ' ' ARG . 14.6 pt -108.38 138.71 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.702 HG22 HG23 ' A' ' 101' ' ' VAL . 4.4 t -120.88 175.06 6.23 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.959 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.597 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -115.36 68.62 0.71 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.407 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.535 ' HB ' ' O ' ' A' ' 92' ' ' HIS . 13.7 t 172.5 158.93 0.11 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 98.48 -21.4 46.19 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.772 -1.204 . . . . 0.0 110.403 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.753 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -125.32 -171.92 2.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.056 -1.261 . . . . 0.0 109.423 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 95' ' ' ALA . 20.4 m -42.02 111.18 0.21 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -0.842 . . . . 0.0 108.905 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 63.76 -105.68 1.16 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.597 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -132.14 35.35 3.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.241 -1.152 . . . . 0.0 108.771 178.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.753 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 4.4 t-20 -45.58 170.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.306 -0.871 . . . . 0.0 109.436 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.542 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 13.1 m-85 -92.4 149.19 21.56 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.212 -0.93 . . . . 0.0 109.534 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.702 HG23 HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -156.12 148.56 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 1.0 OUTLIER -82.38 122.08 27.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.431 -0.793 . . . . 0.0 109.857 -179.584 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.559 ' O ' HG23 ' A' ' 104' ' ' THR . 80.5 m -43.51 121.23 2.21 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.325 -0.859 . . . . 0.0 109.538 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 103' ' ' CYS . 13.7 p . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.124 -0.985 . . . . 0.0 109.535 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.432 ' C ' ' SG ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.293 0.568 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 0.8 OUTLIER 174.0 124.56 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.306 -0.871 . . . . 0.0 110.152 179.685 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -87.53 -36.39 17.62 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.356 -0.84 . . . . 0.0 109.051 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.818 ' CG ' HG21 ' A' ' 89' ' ' VAL . 41.5 m-85 -82.35 115.66 21.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.355 -0.84 . . . . 0.0 109.394 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.493 HG22 ' O ' ' A' ' 9' ' ' ASN . 1.1 p -150.18 122.88 8.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.403 -0.811 . . . . 0.0 109.643 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -112.08 10.28 20.36 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.241 1.02 . . . . 0.0 109.641 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 172.73 -96.23 0.11 Allowed Glycine 0 C--N 1.282 -2.445 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -123.2 23.4 9.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -1.109 . . . . 0.0 109.231 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.493 ' O ' HG22 ' A' ' 5' ' ' THR . 6.6 m120 -96.76 106.57 18.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.895 . . . . 0.0 109.819 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 47.8 t -78.33 78.47 4.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.346 -0.846 . . . . 0.0 109.417 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.411 ' CE2' ' HB3' ' A' ' 9' ' ' ASN . 14.6 m-85 -98.31 110.15 22.78 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.432 -0.792 . . . . 0.0 109.003 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.584 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -84.66 128.95 34.86 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.174 -0.954 . . . . 0.0 109.956 -179.619 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 12' ' ' SER . 1.1 p -41.17 -27.6 0.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 12' ' ' SER . 5.3 t -69.74 -50.43 43.54 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.349 -0.844 . . . . 0.0 109.623 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.34 -22.74 65.58 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 12' ' ' SER . 17.8 t -78.0 -29.47 15.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.404 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 46.7 t -61.39 -46.44 90.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.568 -0.708 . . . . 0.0 109.412 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.2 -53.26 60.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.923 . . . . 0.0 108.606 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.548 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -66.97 -15.49 63.74 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.716 ' NE2' ' CD1' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -74.89 -37.99 61.99 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.531 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.8 -6.05 52.82 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.91 -62.13 1.8 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.375 -0.828 . . . . 0.0 109.075 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.565 ' HA3' ' CD2' ' A' ' 59' ' ' TRP . . . -58.33 -25.15 57.17 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.484 ' CE2' ' O ' ' A' ' 82' ' ' GLU . 2.8 t80 -73.15 -44.49 59.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.408 -1.054 . . . . 0.0 109.44 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' A' ' 26' ' ' LEU . 0.7 OUTLIER -55.7 -69.68 0.13 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.487 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.486 HD11 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -42.38 -45.19 4.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.415 -0.803 . . . . 0.0 109.971 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -52.7 -54.6 31.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.299 -0.875 . . . . 0.0 110.518 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.66 -3.07 49.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.099 -1.001 . . . . 0.0 109.9 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -87.2 8.01 25.81 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.108 -0.995 . . . . 0.0 109.618 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 48.86 27.53 6.53 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.475 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -125.67 -158.21 0.83 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.458 -1.025 . . . . 0.0 109.405 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.695 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -147.62 -174.64 4.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.915 . . . . 0.0 109.256 179.727 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' A' ' 34' ' ' GLY . 33.8 m -103.71 171.68 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.065 -1.022 . . . . 0.0 109.831 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -45.04 -38.39 6.05 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 36' ' ' ASN . 0.6 OUTLIER -78.51 175.55 10.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -1.098 . . . . 0.0 109.474 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' A' ' 37' ' ' SER . 20.2 m-20 -43.86 -48.19 8.33 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.261 -0.899 . . . . 0.0 109.115 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.695 ' HA ' HG22 ' A' ' 32' ' ' THR . 5.8 t 176.04 -164.12 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.715 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.2 OUTLIER 170.19 -45.12 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.083 -1.01 . . . . 0.0 112.213 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.58 ' HD2' ' H ' ' A' ' 38' ' ' TYR . 31.7 Cg_endo -75.41 97.0 1.06 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 121.002 1.134 . . . . 0.0 111.656 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.715 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -139.61 -179.52 5.96 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.557 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.559 ' HA ' ' CD1' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -69.6 162.12 28.24 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.333 -0.854 . . . . 0.0 110.038 -179.32 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.616 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 18.1 t80 -127.61 152.85 47.13 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.525 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 3.3 p-10 -165.59 95.48 0.63 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.977 -1.077 . . . . 0.0 109.829 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.616 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 0.6 OUTLIER -135.71 -41.12 0.69 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.335 -0.853 . . . . 0.0 109.433 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER 42.65 26.47 0.07 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.402 -0.811 . . . . 0.0 110.018 179.696 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -39.95 -27.63 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 O-C-N 121.319 -0.863 . . . . 0.0 109.984 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 45' ' ' TYR . . . 167.69 -23.82 0.11 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.558 ' CZ ' ' HA ' ' A' ' 101' ' ' VAL . 0.1 OUTLIER -92.46 49.94 1.55 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.447 -1.031 . . . . 0.0 109.211 179.591 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.53 103.14 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -0.879 . . . . 0.0 109.454 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 1.053 ' CD2' ' HB1' ' A' ' 87' ' ' ALA . 12.7 m-85 -65.87 164.09 15.6 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.259 -0.901 . . . . 0.0 109.306 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.3 t -108.63 23.45 14.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 0.0 109.868 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.515 ' CG1' ' HB3' ' A' ' 81' ' ' ASN . 14.2 t -80.53 -58.48 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.091 -1.006 . . . . 0.0 109.377 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -175.38 172.12 2.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 109.682 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.595 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -69.57 -53.41 12.57 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.357 -0.839 . . . . 0.0 110.155 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 54' ' ' SER . 35.8 Cg_endo -74.82 90.39 1.07 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.972 1.781 . . . . 0.0 110.034 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.534 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 30.3 m-85 -78.61 -170.34 2.06 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.559 ' CD1' ' HA ' ' A' ' 41' ' ' LYS . 57.9 m-85 -157.7 111.92 2.61 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -82.52 139.82 33.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.454 -0.779 . . . . 0.0 110.388 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.704 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 35.7 t-105 -160.86 139.36 7.42 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.704 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 32.0 Cg_endo -71.02 145.26 49.41 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.215 1.943 . . . . 0.0 111.434 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.977 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -108.38 138.15 36.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.977 HD23 ' C ' ' A' ' 61' ' ' ILE . 1.1 mt -124.91 168.69 12.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.044 -1.035 . . . . 0.0 109.965 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.16 0.17 9.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.035 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.69 -166.54 1.42 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.383 -0.823 . . . . 0.0 109.197 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.27 59.2 0.48 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.673 ' O ' HD12 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -158.9 106.18 1.82 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.173 -1.193 . . . . 0.0 109.799 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.527 HG13 ' HZ2' ' A' ' 59' ' ' TRP . 77.5 t -52.4 143.41 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -0.893 . . . . 0.0 108.931 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.659 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 42.9 t80 -45.95 120.85 2.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.875 -1.141 . . . . 0.0 109.43 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.6 p -165.95 29.9 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.464 -0.773 . . . . 0.0 109.291 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -116.03 -67.08 0.4 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.434 ' C ' ' OG ' ' A' ' 72' ' ' SER . . . 148.47 151.44 5.46 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.434 ' OG ' ' C ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER 51.11 92.62 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.37 -1.077 . . . . 0.0 110.085 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.534 ' CD ' ' OH ' ' A' ' 38' ' ' TYR . 35.0 Cg_endo -79.11 -72.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.897 2.398 . . . . 0.0 109.642 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 101.68 98.1 2.35 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.614 ' HB2' ' HB ' ' A' ' 93' ' ' THR . . . 61.69 -149.88 0.39 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.292 -1.122 . . . . 0.0 110.262 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.542 ' O ' ' O ' ' A' ' 75' ' ' ALA . 2.4 m-20 28.29 108.62 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 121.524 0.678 . . . . 0.0 112.584 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.497 ' O ' HG12 ' A' ' 90' ' ' ILE . 2.0 ttm-85 -154.0 111.28 3.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.014 -1.053 . . . . 0.0 109.003 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 89' ' ' VAL . 7.7 p -91.34 154.99 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.059 -1.026 . . . . 0.0 109.495 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.932 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 52.6 t -120.35 166.98 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.275 -0.891 . . . . 0.0 109.923 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.716 ' CD1' ' NE2' ' A' ' 20' ' ' GLN . 10.8 p90 -169.6 -177.32 2.69 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.755 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.543 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -124.25 -38.79 2.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.433 -0.792 . . . . 0.0 109.529 -179.728 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.543 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 4.0 mt-10 162.44 -27.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.442 -0.786 . . . . 0.0 108.936 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.545 ' HB3' ' HG2' ' A' ' 85' ' ' GLN . 1.1 t-20 -98.58 19.76 14.05 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.516 -0.74 . . . . 0.0 109.135 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.614 ' ND2' ' O ' ' A' ' 84' ' ' ASN . 0.3 OUTLIER 52.42 23.29 2.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.827 -0.545 . . . . 0.0 110.028 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.545 ' HG2' ' HB3' ' A' ' 83' ' ' ASN . 4.1 mt-30 -55.2 -31.82 61.73 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.547 HD22 ' HG3' ' A' ' 20' ' ' GLN . 0.1 OUTLIER 84.79 104.54 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.406 0.622 . . . . 0.0 110.912 179.135 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 1.053 ' HB1' ' CD2' ' A' ' 50' ' ' PHE . . . -73.26 -44.58 59.07 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.413 ' O ' HG23 ' A' ' 78' ' ' VAL . . . 166.43 -154.38 24.84 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.924 -1.671 . . . . 0.0 108.924 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.818 HG21 ' CG ' ' A' ' 4' ' ' TYR . 34.9 t -138.1 81.19 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.093 -1.239 . . . . 0.0 109.532 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.586 HD13 ' CG2' ' A' ' 79' ' ' VAL . 0.7 OUTLIER -80.06 152.14 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.333 -0.854 . . . . 0.0 108.802 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.421 ' CG2' HG23 ' A' ' 101' ' ' VAL . 0.8 OUTLIER -116.38 138.96 50.92 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.108 -0.995 . . . . 0.0 111.378 -178.256 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.617 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.1 OUTLIER -86.62 59.3 5.56 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.543 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.614 ' HB ' ' HB2' ' A' ' 75' ' ' ALA . 3.5 m -176.32 -31.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.208 -0.932 . . . . 0.0 109.692 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.72 -17.23 13.78 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.639 ' HB3' ' CB ' ' A' ' 99' ' ' ASN . . . -121.81 174.17 7.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -1.167 . . . . 0.0 109.747 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 95' ' ' ALA . 2.7 t -39.86 128.18 2.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.575 -0.703 . . . . 0.0 109.317 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 63.38 -88.59 0.06 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.617 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -139.44 -64.24 0.5 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -1.182 . . . . 0.0 109.552 179.685 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.639 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . 1.0 OUTLIER 47.35 -172.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.138 -0.977 . . . . 0.0 109.189 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -131.38 131.89 44.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.154 -0.966 . . . . 0.0 109.708 179.595 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.558 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 0.7 OUTLIER -147.25 131.66 10.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.353 -0.842 . . . . 0.0 108.856 179.385 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -51.97 133.79 32.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.901 . . . . 0.0 109.817 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 8.0 m -65.48 148.52 51.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.321 -0.862 . . . . 0.0 109.569 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 31.2 p . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 116.719 -1.61 . . . . 0.0 109.408 179.906 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.533 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 1.8 p 163.52 142.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.355 -0.84 . . . . 0.0 109.545 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' A' ' 3' ' ' ASP . 41.7 t0 -104.51 -41.66 5.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 109.559 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.715 ' CG ' HG21 ' A' ' 89' ' ' VAL . 34.6 m-85 -83.36 128.76 34.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.924 . . . . 0.0 109.54 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -137.19 110.38 7.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.303 -0.873 . . . . 0.0 109.274 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.3 m -106.51 13.79 27.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.12 -0.987 . . . . 0.0 109.95 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 128.73 92.59 0.71 Allowed Glycine 0 C--N 1.283 -2.369 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 54.18 27.74 8.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.368 -1.078 . . . . 0.0 109.532 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -93.59 -43.74 8.54 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.303 -0.873 . . . . 0.0 109.496 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 10' ' ' CYS . 47.8 t 49.98 49.28 20.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 109.219 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.575 ' CE1' ' OG ' ' A' ' 63' ' ' SER . 6.4 m-30 -87.38 120.6 28.84 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.433 -0.792 . . . . 0.0 109.38 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.655 ' O ' HG23 ' A' ' 16' ' ' VAL . 17.8 t -85.18 118.34 24.67 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.267 -0.895 . . . . 0.0 109.235 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.477 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 3.7 p -41.52 -26.16 0.06 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.557 -0.715 . . . . 0.0 109.614 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -61.67 -54.92 36.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.147 -0.971 . . . . 0.0 109.185 179.407 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -69.8 -25.91 64.0 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 12' ' ' SER . 18.9 t -68.24 -25.07 30.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.55 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 0.1 OUTLIER -65.45 -44.5 87.05 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.3 m -59.2 -51.16 71.18 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.467 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -65.94 -16.42 63.85 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.952 ' HA ' HE21 ' A' ' 20' ' ' GLN . 0.0 OUTLIER -82.26 -25.14 34.35 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.611 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.37 -7.83 58.15 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.298 -0.876 . . . . 0.0 108.664 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.7 -63.72 1.28 Allowed 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.603 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -50.9 -30.17 21.64 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.484 ' O ' ' HB3' ' A' ' 27' ' ' HIS . 3.1 t80 -74.14 -56.31 5.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.386 -1.067 . . . . 0.0 108.816 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.472 ' HG2' ' OD1' ' A' ' 29' ' ' ASP . 5.0 tt0 -53.05 -67.64 0.24 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.422 -0.799 . . . . 0.0 109.126 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 26' ' ' LEU . 4.8 tp -42.96 -37.21 1.8 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.301 -0.875 . . . . 0.0 109.598 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.63 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 3.2 t60 -61.51 -53.18 59.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.174 -0.954 . . . . 0.0 110.134 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -86.93 6.9 29.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.352 -0.843 . . . . 0.0 110.122 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.472 ' OD1' ' HG2' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -98.04 -16.85 19.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.022 -1.049 . . . . 0.0 109.579 -179.79 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.16 -11.15 58.77 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.594 ' HG3' ' N ' ' A' ' 32' ' ' THR . 31.9 tp10 -84.96 164.86 18.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -1.134 . . . . 0.0 109.201 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.711 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -129.85 171.44 12.72 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.498 -0.751 . . . . 0.0 109.798 -179.746 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.455 ' HB ' ' HA ' ' A' ' 69' ' ' SER . 33.0 m -81.27 166.8 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.437 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.87 -29.32 42.16 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.413 ' HB2' ' HA2' ' A' ' 70' ' ' GLY . 0.6 OUTLIER -73.92 -144.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -1.141 . . . . 0.0 109.204 179.79 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 37' ' ' SER . 2.9 m120 -102.11 60.49 0.85 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.961 -1.087 . . . . 0.0 109.803 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.711 ' HA ' HG22 ' A' ' 32' ' ' THR . 6.2 t 70.97 -168.97 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.553 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.634 ' CZ ' ' CB ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER 165.07 -41.96 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.33 -0.856 . . . . 0.0 112.206 178.895 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.59 ' HD2' ' H ' ' A' ' 38' ' ' TYR . 31.4 Cg_endo -75.35 100.07 1.33 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.096 1.197 . . . . 0.0 111.977 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.542 ' CD2' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -145.35 176.92 9.21 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.577 -0.702 . . . . 0.0 109.252 178.691 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.563 ' HA ' ' CD1' ' A' ' 57' ' ' TYR . 0.7 OUTLIER -59.27 161.63 5.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.32 -0.863 . . . . 0.0 109.968 -179.497 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.626 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 44.9 t80 -134.29 68.19 1.49 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.45 -0.781 . . . . 0.0 109.023 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.453 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 1.3 m-20 -86.55 61.88 7.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.18 -0.95 . . . . 0.0 109.151 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.664 ' ND2' ' CZ ' ' A' ' 100' ' ' PHE . 6.4 m-80 -89.74 -78.26 0.37 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.557 -0.714 . . . . 0.0 110.515 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.527 ' CB ' ' O ' ' A' ' 44' ' ' ASN . 3.1 m-85 79.49 29.19 0.33 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.47 -0.769 . . . . 0.0 108.953 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -36.24 -71.21 0.08 Allowed 'General case' 0 C--N 1.308 -1.198 0 O-C-N 121.749 -0.594 . . . . 0.0 110.23 -179.603 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.19 44.2 0.55 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.07 169.17 18.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -1.137 . . . . 0.0 109.545 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -112.51 -31.86 6.66 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.534 ' CB ' ' OH ' ' A' ' 56' ' ' TYR . 8.3 m-30 55.41 178.13 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.408 -0.808 . . . . 0.0 109.567 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.48 37.57 1.01 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.312 -0.867 . . . . 0.0 109.092 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.558 HG21 ' HA ' ' A' ' 87' ' ' ALA . 41.1 t -110.12 -82.61 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.394 -0.816 . . . . 0.0 109.708 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.528 ' N ' HG12 ' A' ' 52' ' ' VAL . 4.7 t -163.15 154.08 16.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.164 -0.96 . . . . 0.0 109.855 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.597 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -55.9 -50.66 85.94 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.398 -0.814 . . . . 0.0 110.442 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 54' ' ' SER . 35.8 Cg_endo -75.82 84.44 1.78 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.018 1.812 . . . . 0.0 110.156 -178.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.556 ' CE1' ' HB2' ' A' ' 87' ' ' ALA . 49.2 m-85 -81.81 -169.52 2.39 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.821 0.82 . . . . 0.0 109.879 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.63 ' CE1' ' NE2' ' A' ' 27' ' ' HIS . 70.2 m-85 -156.75 109.05 2.5 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.48 ' N ' ' HB2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -76.2 138.51 40.7 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.844 0.83 . . . . 0.0 110.911 -178.048 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.668 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 34.8 t-105 -160.58 137.26 6.49 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.668 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.5 Cg_endo -67.67 151.84 78.66 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.986 1.791 . . . . 0.0 110.592 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.985 ' C ' HD23 ' A' ' 62' ' ' LEU . 1.3 tp -122.13 138.7 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.421 -0.8 . . . . 0.0 110.023 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.985 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.7 OUTLIER -124.34 -175.54 3.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.385 -0.822 . . . . 0.0 108.896 179.476 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.575 ' OG ' ' CE1' ' A' ' 11' ' ' TYR . 16.6 p -146.72 55.1 1.12 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.01 -1.056 . . . . 0.0 109.636 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.31 30.94 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.464 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 47.31 90.0 0.01 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.478 ' O ' ' HB ' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -161.16 -36.33 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.256 -1.143 . . . . 0.0 110.025 -179.681 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.478 ' HB ' ' O ' ' A' ' 66' ' ' ASP . 4.4 t 71.81 140.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.119 -0.988 . . . . 0.0 108.958 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.584 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 71.9 t80 -65.45 107.03 1.54 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.113 -0.992 . . . . 0.0 110.109 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.455 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 1.2 m -123.11 30.39 6.38 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.413 ' HA2' ' HB2' ' A' ' 35' ' ' SER . . . 107.77 77.93 1.07 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -159.31 -96.69 0.12 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.3 p -123.43 94.82 46.09 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.22 -1.164 . . . . 0.0 109.858 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.634 ' CB ' ' CZ ' ' A' ' 38' ' ' TYR . 36.2 Cg_endo -79.48 -61.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.585 2.19 . . . . 0.0 110.359 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . -60.21 -146.43 0.01 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 65.03 -84.98 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.37 -1.077 . . . . 0.0 109.939 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -124.59 100.33 6.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.163 -0.96 . . . . 0.0 109.574 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.526 ' O ' HG12 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -117.68 152.47 35.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 108.893 179.685 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.842 HG11 ' NE2' ' A' ' 20' ' ' GLN . 1.4 p -117.2 -173.88 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.053 -1.03 . . . . 0.0 109.496 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.712 ' H ' HG22 ' A' ' 78' ' ' VAL . 6.8 t -147.21 166.8 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.167 -0.958 . . . . 0.0 110.009 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.61 ' CE1' ' HB2' ' A' ' 57' ' ' TYR . 3.8 p90 -166.61 -176.26 3.47 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.522 ' O ' ' CD2' ' A' ' 57' ' ' TYR . 11.5 t30 -118.68 -80.16 0.61 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.927 -1.108 . . . . 0.0 109.754 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -158.55 20.59 0.22 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.462 -0.774 . . . . 0.0 109.419 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.652 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 0.3 OUTLIER -150.84 18.37 0.79 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.292 -0.88 . . . . 0.0 108.842 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.652 ' ND2' ' O ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER 67.34 14.16 9.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.594 -0.692 . . . . 0.0 109.349 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.504 ' O ' ' HB3' ' A' ' 86' ' ' LEU . 1.8 mt-30 -51.72 -26.85 10.23 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.504 ' HB3' ' O ' ' A' ' 85' ' ' GLN . 0.7 OUTLIER 66.49 116.31 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.539 0.685 . . . . 0.0 110.041 179.745 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.558 ' HA ' HG21 ' A' ' 52' ' ' VAL . . . -79.05 -34.43 43.77 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.458 ' HA2' ' OH ' ' A' ' 4' ' ' TYR . . . 146.13 176.64 20.16 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.715 HG21 ' CG ' ' A' ' 4' ' ' TYR . 54.7 t -100.52 147.29 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.996 -1.296 . . . . 0.0 110.055 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.544 ' HB ' ' CB ' ' A' ' 100' ' ' PHE . 0.9 OUTLIER -141.09 162.5 22.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.537 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 75' ' ' ALA . 5.8 t -129.59 127.17 40.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.711 -1.243 . . . . 0.0 111.545 -178.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.62 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -79.01 75.35 5.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.532 -0.73 . . . . 0.0 109.177 179.055 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 1.1 m 173.44 -28.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.204 -0.935 . . . . 0.0 109.263 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.53 -11.17 33.69 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.738 ' HB3' ' CB ' ' A' ' 99' ' ' ASN . . . -125.48 176.86 6.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.097 -1.237 . . . . 0.0 109.725 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER -42.99 131.7 4.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.411 -0.806 . . . . 0.0 109.109 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.51 -89.03 0.05 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.62 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -136.22 -79.7 0.41 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -1.118 . . . . 0.0 109.106 179.319 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.738 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . 0.3 OUTLIER 58.51 152.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.231 -0.918 . . . . 0.0 109.054 -179.812 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.664 ' CZ ' ' ND2' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -109.02 126.99 53.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.741 -1.224 . . . . 0.0 110.58 -179.412 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -129.55 140.45 49.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.469 ' OE2' ' CE1' ' A' ' 50' ' ' PHE . 5.8 mm-40 -52.47 122.56 9.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.384 -0.823 . . . . 0.0 109.703 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 1.7 m -70.55 129.92 40.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.352 -0.842 . . . . 0.0 109.462 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 40.1 p . . . . . 0 N--CA 1.488 1.467 0 O-C-N 121.187 -0.946 . . . . 0.0 109.367 179.912 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.426 ' C ' ' SG ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.392 0.615 . . . . 0.0 109.651 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 0.8 OUTLIER 173.54 126.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.319 -0.863 . . . . 0.0 109.838 179.788 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -121.43 -3.87 9.38 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.417 -0.802 . . . . 0.0 109.29 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.677 ' CG ' HG21 ' A' ' 89' ' ' VAL . 57.4 m-85 -103.52 85.98 2.56 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.913 . . . . 0.0 109.192 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.635 HG23 ' H ' ' A' ' 10' ' ' CYS . 33.9 m -117.52 129.53 55.86 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.269 -0.894 . . . . 0.0 110.255 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.1 m -133.07 12.21 4.26 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.191 0.996 . . . . 0.0 109.156 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 8' ' ' SER . . . -176.53 35.77 0.09 OUTLIER Glycine 0 C--N 1.282 -2.454 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 7' ' ' GLY . 0.6 OUTLIER 67.6 25.0 8.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.308 -1.113 . . . . 0.0 109.16 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.474 ' O ' ' C ' ' A' ' 10' ' ' CYS . 5.6 m-20 -89.43 -17.63 28.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.412 -0.805 . . . . 0.0 109.746 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.635 ' H ' HG23 ' A' ' 5' ' ' THR . 0.8 OUTLIER 40.03 79.09 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 O-C-N 121.543 -0.723 . . . . 0.0 109.315 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.482 ' HB2' ' HB2' ' A' ' 4' ' ' TYR . 11.6 m-85 -78.91 134.3 36.89 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.883 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -78.58 129.57 34.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.567 -0.708 . . . . 0.0 109.804 -179.316 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -17.75 5.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.336 -0.852 . . . . 0.0 109.312 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.94 -30.69 15.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 0.0 109.571 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.47 -31.51 62.26 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 12' ' ' SER . 3.5 t -65.09 -25.44 37.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.493 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 0.1 OUTLIER -72.27 -40.15 67.84 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.537 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.77 -53.08 62.11 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.674 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -63.22 -25.42 68.32 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.574 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -70.09 -30.37 67.57 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.137 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -81.02 -12.68 59.31 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.632 ' HB1' HG13 ' A' ' 67' ' ' VAL . . . -81.19 -47.22 13.72 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.614 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -74.69 -28.62 62.78 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -75.65 -39.41 57.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.504 -0.998 . . . . 0.0 109.198 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.501 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 7.4 tt0 -69.73 -57.71 4.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.171 -0.955 . . . . 0.0 108.509 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.576 HD11 ' HB3' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -49.74 -36.23 24.98 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.297 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -67.37 -39.4 85.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.426 -0.796 . . . . 0.0 109.512 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.65 -2.77 47.98 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.317 -0.864 . . . . 0.0 109.057 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -101.8 0.5 35.84 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.266 -0.896 . . . . 0.0 109.509 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 54.21 26.07 34.77 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.576 ' HB3' HD11 ' A' ' 26' ' ' LEU . 1.7 mm-40 -106.06 -164.11 0.99 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.252 -1.146 . . . . 0.0 109.605 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.93 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -142.3 175.97 9.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.357 -0.839 . . . . 0.0 109.337 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.668 HG22 ' CA ' ' A' ' 37' ' ' SER . 22.3 m -87.99 -156.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.212 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -40.07 -35.9 0.77 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER 167.15 -27.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.119 -1.224 . . . . 0.0 109.549 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 37' ' ' SER . 11.1 m-80 -81.73 8.89 8.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.171 -0.956 . . . . 0.0 109.533 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.93 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.8 OUTLIER 46.2 -169.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.226 -0.921 . . . . 0.0 108.968 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.726 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER 169.42 -47.18 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.428 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.951 179.247 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 38' ' ' TYR . 30.7 Cg_endo -73.48 99.38 1.13 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.525 1.483 . . . . 0.0 112.453 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.726 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -144.7 175.16 10.37 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.944 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -63.04 157.66 21.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.959 -1.088 . . . . 0.0 110.213 -179.214 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.884 ' CG ' HG11 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -129.09 132.31 47.39 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.478 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.424 ' O ' ' C ' ' A' ' 44' ' ' ASN . 1.4 p-10 -123.15 -22.63 5.11 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.814 -1.179 . . . . 0.0 109.635 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.75 ' ND2' ' CD1' ' A' ' 100' ' ' PHE . 0.3 OUTLIER 45.28 -160.23 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.284 -0.885 . . . . 0.0 108.919 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.631 ' CG ' ' O ' ' A' ' 44' ' ' ASN . 0.9 OUTLIER 171.43 -26.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.536 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.3 OUTLIER -32.09 -59.85 0.28 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 121.307 0.575 . . . . 0.0 110.42 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.04 54.68 0.01 OUTLIER Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.525 ' CZ ' ' HA ' ' A' ' 101' ' ' VAL . 62.8 m-85 -108.64 142.78 38.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -1.128 . . . . 0.0 109.611 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -108.89 76.31 1.0 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -0.903 . . . . 0.0 109.615 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.478 ' HB3' ' OH ' ' A' ' 56' ' ' TYR . 18.8 m-30 -66.63 -178.53 0.72 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.188 -0.945 . . . . 0.0 109.003 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.5 t -140.41 17.38 2.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.865 . . . . 0.0 108.976 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.577 ' HB ' ' CE1' ' A' ' 56' ' ' TYR . 57.4 t -88.1 -82.67 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.44 -0.788 . . . . 0.0 109.617 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.583 ' O ' ' CE2' ' A' ' 56' ' ' TYR . 61.1 m -160.21 -174.22 4.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -0.925 . . . . 0.0 109.902 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.574 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -81.66 -52.45 0.78 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.316 -0.865 . . . . 0.0 110.717 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 54' ' ' SER . 35.2 Cg_endo -75.49 88.14 1.31 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.07 1.847 . . . . 0.0 110.201 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.791 ' CE1' ' HB2' ' A' ' 87' ' ' ALA . 21.9 m-85 -89.17 -167.89 2.01 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.587 ' CG ' ' O ' ' A' ' 56' ' ' TYR . 84.0 m-85 -160.88 114.91 2.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.507 -0.746 . . . . 0.0 109.328 179.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.451 ' CD ' ' NH1' ' A' ' 77' ' ' ARG . 3.0 pt-20 -80.0 142.41 35.03 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.292 -0.88 . . . . 0.0 110.909 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.667 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 22.1 t-105 -160.77 138.63 7.1 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.667 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 31.8 Cg_endo -70.15 161.36 46.27 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.059 1.839 . . . . 0.0 111.429 -178.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.939 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -133.34 135.74 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.679 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.939 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.3 OUTLIER -118.72 161.49 20.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -0.913 . . . . 0.0 109.608 -179.864 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.1 26.05 5.2 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.463 -0.773 . . . . 0.0 109.287 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.22 -62.72 0.78 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.359 -0.838 . . . . 0.0 109.45 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -93.15 -108.52 1.87 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 67' ' ' VAL . 8.9 t70 -179.45 134.12 0.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -1.159 . . . . 0.0 109.521 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.632 HG13 ' HB1' ' A' ' 22' ' ' ALA . 2.8 t 62.79 133.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -0.902 . . . . 0.0 109.804 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.595 ' HA ' HD11 ' A' ' 62' ' ' LEU . 43.3 t80 -75.51 105.75 6.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.015 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.1 m -112.87 16.57 19.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.131 -0.981 . . . . 0.0 109.812 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.54 52.72 0.23 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -110.95 -112.3 3.35 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.82 108.94 43.78 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.193 -1.18 . . . . 0.0 109.421 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.65 -161.81 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.467 2.112 . . . . 0.0 110.483 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 53.71 -175.76 0.32 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 91' ' ' THR . . . 61.85 -150.05 0.38 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -1.136 . . . . 0.0 110.198 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' ' 75' ' ' ALA . 12.0 m-20 -32.27 148.73 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.56 0.695 . . . . 0.0 111.435 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.577 ' NH2' ' CE2' ' A' ' 100' ' ' PHE . 8.3 ttp180 -176.38 86.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.731 ' CG2' HD11 ' A' ' 86' ' ' LEU . 8.8 p -72.38 143.16 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.894 . . . . 0.0 109.688 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.884 HG11 ' CG ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -109.19 177.63 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.105 -0.997 . . . . 0.0 109.679 179.864 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.575 ' CE1' ' O ' ' A' ' 57' ' ' TYR . 14.0 p90 -174.76 -169.19 0.4 Allowed 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.0 -178.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -128.88 -80.99 0.57 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.374 -0.829 . . . . 0.0 109.728 -179.497 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.45 ' CG ' ' C ' ' A' ' 81' ' ' ASN . 0.3 OUTLIER -158.6 19.69 0.22 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.457 -0.777 . . . . 0.0 109.412 -179.804 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.456 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 0.8 OUTLIER -150.34 28.85 0.72 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.619 ' ND2' ' O ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER 51.7 20.8 1.19 Allowed 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.28 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.542 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 2.4 mt-30 -47.53 -38.38 14.0 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.731 HD11 ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER 82.19 104.16 0.06 Allowed 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.469 0.652 . . . . 0.0 110.565 179.135 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.835 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . . . -76.24 -31.92 58.62 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 140.23 163.81 9.66 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.677 HG21 ' CG ' ' A' ' 4' ' ' TYR . 58.9 t -94.73 124.47 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.068 -1.254 . . . . 0.0 109.491 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' A' ' 100' ' ' PHE . 1.0 OUTLIER -118.14 176.31 3.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.268 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 75' ' ' ALA . 8.3 t -144.16 147.34 33.55 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.045 -1.034 . . . . 0.0 110.419 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.642 ' NE2' ' CE2' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -96.88 76.71 2.75 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.535 -0.728 . . . . 0.0 109.134 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.431 ' OG1' ' C ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 176.17 123.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 0.0 109.809 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 116.33 -0.6 20.65 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.677 ' HB3' ' CB ' ' A' ' 99' ' ' ASN . . . -139.51 93.42 2.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.13 -1.218 . . . . 0.0 109.776 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER 41.65 85.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.427 -0.796 . . . . 0.0 109.743 179.642 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.17 -77.54 2.07 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.622 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -144.54 -77.02 0.22 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.161 -1.199 . . . . 0.0 109.892 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.677 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . 0.3 OUTLIER 59.43 155.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 108.535 -179.097 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.75 ' CD1' ' ND2' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -103.69 136.98 42.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.949 -1.095 . . . . 0.0 110.267 -179.521 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 0.9 OUTLIER -146.13 157.98 11.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.167 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 103' ' ' CYS . 12.4 pt-20 -60.5 130.72 48.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.149 -0.969 . . . . 0.0 109.737 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.422 ' C ' ' O ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -42.35 114.53 0.58 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.452 -0.78 . . . . 0.0 109.635 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.136 -0.935 . . . . 0.0 109.405 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.431 ' O ' ' SG ' ' A' ' 10' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.266 0.555 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.501 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.9 OUTLIER 169.72 115.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -0.862 . . . . 0.0 109.862 179.839 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -78.72 -31.65 46.51 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.338 -0.851 . . . . 0.0 108.981 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.617 ' CG ' HG21 ' A' ' 89' ' ' VAL . 18.3 m-85 -98.96 96.28 7.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.38 -0.825 . . . . 0.0 108.908 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.56 HG22 ' O ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -116.61 105.69 12.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.186 -0.947 . . . . 0.0 109.873 -179.705 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.583 ' O ' ' C ' ' A' ' 7' ' ' GLY . 87.4 m -82.85 -173.87 4.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.287 -0.883 . . . . 0.0 108.867 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.583 ' C ' ' O ' ' A' ' 6' ' ' CYS . . . 7.69 -77.26 0.0 OUTLIER Glycine 0 N--CA 1.507 3.372 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 6' ' ' CYS . 3.7 p -161.08 55.36 0.29 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.228 -1.16 . . . . 0.0 109.468 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.56 ' O ' HG22 ' A' ' 5' ' ' THR . 1.5 m-20 -117.28 -144.65 0.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.353 -0.842 . . . . 0.0 109.741 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.507 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 46.5 t -162.44 60.46 0.22 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.132 -0.98 . . . . 0.0 109.152 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 63' ' ' SER . 6.1 m-85 -86.78 113.2 22.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.5 -0.75 . . . . 0.0 109.333 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.535 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -87.94 131.41 34.61 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.255 -0.903 . . . . 0.0 109.835 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 12' ' ' SER . 1.8 p -45.33 -37.17 4.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.607 -0.683 . . . . 0.0 109.445 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.4 -47.26 84.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.376 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.16 -23.94 61.36 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.689 HG11 HG21 ' A' ' 78' ' ' VAL . 63.0 t -65.19 -31.97 56.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.6 t -61.66 -45.65 93.12 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.668 -0.645 . . . . 0.0 109.449 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.07 -49.53 77.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.121 -0.987 . . . . 0.0 108.608 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.709 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -71.08 -12.85 61.73 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.587 ' OE1' ' CG ' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -80.6 -34.07 35.44 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.506 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.98 -13.65 59.94 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.884 ' HB1' HG13 ' A' ' 67' ' ' VAL . . . -72.61 -41.13 65.92 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.609 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -81.72 -32.7 29.42 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.201 -1.559 . . . . 0.0 109.201 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.493 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 9.9 t80 -67.61 -40.8 84.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.426 -1.043 . . . . 0.0 109.758 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.406 ' O ' ' C ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -60.97 -66.53 0.52 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.912 . . . . 0.0 108.966 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.554 ' CD1' ' HB3' ' A' ' 31' ' ' GLU . 0.9 OUTLIER -43.85 -44.56 6.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.458 -0.776 . . . . 0.0 109.0 179.242 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.446 ' HB3' ' O ' ' A' ' 24' ' ' TYR . 2.0 t60 -49.75 -68.06 0.21 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.738 -0.601 . . . . 0.0 110.678 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -76.68 2.23 14.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.252 -0.905 . . . . 0.0 110.004 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.464 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 1.1 m-20 -82.93 -28.89 29.58 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.195 -0.941 . . . . 0.0 109.775 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.73 -15.33 63.32 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.554 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 3.2 tp10 -83.43 -149.0 0.09 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -1.154 . . . . 0.0 109.249 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.929 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.3 OUTLIER -159.19 -172.34 3.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.133 -0.979 . . . . 0.0 109.386 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.627 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -82.94 -95.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.924 . . . . 0.0 109.496 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.469 ' H ' HG23 ' A' ' 33' ' ' VAL . . . -115.2 -20.31 5.61 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.6 OUTLIER 167.21 -42.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.157 -1.202 . . . . 0.0 109.728 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 37' ' ' SER . 95.1 m-20 -77.25 -10.3 59.33 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.216 -0.928 . . . . 0.0 109.523 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.929 ' HA ' HG22 ' A' ' 32' ' ' THR . 4.0 p 62.08 135.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 109.183 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.674 ' H ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -121.44 -33.71 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.077 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -178.748 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.674 ' CD ' ' H ' ' A' ' 38' ' ' TYR . 36.3 Cg_endo -80.31 101.5 1.34 Allowed 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 121.304 1.336 . . . . 0.0 112.611 -178.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.491 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -138.78 134.95 34.13 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.244 -0.91 . . . . 0.0 109.801 177.931 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.609 ' HB2' ' CE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -51.02 131.02 26.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.166 -0.959 . . . . 0.0 109.384 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.537 ' CZ ' ' HA ' ' A' ' 44' ' ' ASN . 4.1 t80 -113.51 140.84 47.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.282 -0.886 . . . . 0.0 109.172 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.598 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 3.7 m-80 -85.87 -90.63 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.191 -0.943 . . . . 0.0 109.739 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.598 ' ND2' ' O ' ' A' ' 43' ' ' ASN . 0.5 OUTLIER 174.49 148.05 0.07 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 109.39 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.412 ' O ' ' C ' ' A' ' 46' ' ' GLU . 11.2 m-85 -139.69 -72.61 0.38 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.239 -0.913 . . . . 0.0 109.331 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.595 ' CB ' ' CZ ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -40.34 -37.83 0.72 Allowed 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.512 -0.743 . . . . 0.0 109.853 -179.604 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.86 62.22 0.75 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.595 ' CZ ' ' CB ' ' A' ' 46' ' ' GLU . 23.9 m-85 -90.78 -168.01 1.97 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.246 -1.149 . . . . 0.0 108.885 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.34 -39.36 2.2 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.152 -0.968 . . . . 0.0 109.538 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.527 ' CB ' ' OH ' ' A' ' 56' ' ' TYR . 18.3 m-85 47.26 -168.55 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.21 -0.931 . . . . 0.0 109.393 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.83 31.76 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 109.502 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.0 t -108.52 -66.61 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.927 . . . . 0.0 109.513 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.51 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 70.7 m -165.31 -179.9 5.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.088 -1.008 . . . . 0.0 110.049 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.576 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -79.51 -50.32 1.31 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.534 -0.728 . . . . 0.0 110.761 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 54' ' ' SER . 35.4 Cg_endo -75.79 81.36 2.39 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.986 1.791 . . . . 0.0 110.374 -178.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.594 ' O ' ' CD1' ' A' ' 57' ' ' TYR . 36.5 m-85 -79.27 -171.62 2.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.696 -0.628 . . . . 0.0 109.832 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.609 ' CE2' ' HB2' ' A' ' 41' ' ' LYS . 68.0 m-85 -155.4 158.44 38.64 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.509 ' HB2' ' CZ ' ' A' ' 77' ' ' ARG . 2.6 pt-20 -117.86 139.17 51.49 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.938 -1.102 . . . . 0.0 110.303 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.654 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 26.8 t-105 -159.9 138.64 7.8 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.654 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.5 Cg_endo -69.71 141.37 45.25 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.224 1.949 . . . . 0.0 111.469 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.958 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -109.31 140.3 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.958 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.9 OUTLIER -126.23 163.26 23.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.951 . . . . 0.0 109.764 -179.619 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . 9.3 t -132.99 25.91 4.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.358 -0.839 . . . . 0.0 109.351 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.69 -46.62 0.12 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.354 -0.841 . . . . 0.0 109.314 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . -78.52 -101.21 0.21 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 1.6 t0 175.61 -62.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -1.132 . . . . 0.0 109.569 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.884 HG13 ' HB1' ' A' ' 22' ' ' ALA . 11.7 t -127.84 126.18 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 109.756 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.605 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 6.2 t80 -63.44 136.31 57.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.158 -0.964 . . . . 0.0 109.304 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 p -161.44 53.31 0.26 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.55 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.498 ' O ' ' CE1' ' A' ' 68' ' ' TYR . . . 126.24 -165.96 19.21 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.74 -157.51 41.86 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.9 t -120.01 120.14 30.48 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.331 -1.099 . . . . 0.0 109.44 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.457 ' HB2' ' OH ' ' A' ' 38' ' ' TYR . 34.7 Cg_endo -77.73 172.91 14.93 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.295 1.996 . . . . 0.0 110.669 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.0 134.58 2.13 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.542 ' HA ' ' N ' ' A' ' 92' ' ' HIS . . . 55.88 -153.18 0.35 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -1.151 . . . . 0.0 109.479 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.498 ' O ' ' O ' ' A' ' 75' ' ' ALA . 45.6 m-20 20.75 106.74 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.509 ' CZ ' ' HB2' ' A' ' 58' ' ' GLU . 6.9 mtp-105 -160.06 135.38 8.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.154 -0.966 . . . . 0.0 108.584 178.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.689 HG21 HG11 ' A' ' 16' ' ' VAL . 3.9 p -123.99 135.1 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.739 -1.225 . . . . 0.0 109.638 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.626 HG23 ' CD1' ' A' ' 90' ' ' ILE . 29.9 t -92.39 166.13 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.973 0.892 . . . . 0.0 109.808 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.587 ' CG ' ' OE1' ' A' ' 20' ' ' GLN . 3.2 p90 -161.53 -178.92 6.92 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.189 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.491 ' ND2' ' HG2' ' A' ' 82' ' ' GLU . 11.8 t30 -112.48 -81.75 0.59 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 109.692 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.493 ' O ' ' CZ ' ' A' ' 24' ' ' TYR . 2.5 pt-20 -162.64 21.78 0.09 Allowed 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.464 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 2.4 m-20 -140.61 29.5 1.93 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.464 ' CG ' ' O ' ' A' ' 83' ' ' ASN . 1.7 p-10 46.95 24.5 0.37 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.502 0.668 . . . . 0.0 109.22 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 26.7 mm-40 -63.61 -106.73 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 174.42 114.55 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.739 179.081 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.541 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . . . -89.79 -42.24 11.4 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 161.28 155.0 7.67 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.617 HG21 ' CG ' ' A' ' 4' ' ' TYR . 32.0 t -92.05 88.72 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.334 -1.098 . . . . 0.0 109.285 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.626 ' CD1' HG23 ' A' ' 79' ' ' VAL . 1.2 pt -90.88 156.2 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.432 -0.793 . . . . 0.0 109.527 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.579 HG22 HG23 ' A' ' 101' ' ' VAL . 13.0 t -122.2 137.01 54.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.859 -1.151 . . . . 0.0 110.245 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.642 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -81.56 67.58 7.58 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.294 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 177.54 164.02 0.58 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.045 -1.034 . . . . 0.0 109.668 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.84 22.11 75.21 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.574 ' HB3' ' CB ' ' A' ' 99' ' ' ASN . . . -155.81 51.84 0.56 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -1.149 . . . . 0.0 109.353 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.7 m 68.07 93.66 0.07 Allowed 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.53 -83.9 1.1 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.642 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -139.07 -83.18 0.28 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -1.181 . . . . 0.0 109.177 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.574 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . 1.1 m-20 61.23 137.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.329 -0.857 . . . . 0.0 109.292 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.658 ' O ' HG13 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -85.85 151.63 23.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.117 -0.989 . . . . 0.0 109.385 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.658 HG13 ' O ' ' A' ' 100' ' ' PHE . 3.2 m -160.63 136.93 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.409 -0.807 . . . . 0.0 109.073 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -53.21 123.75 12.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.243 -0.911 . . . . 0.0 109.588 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -76.04 83.0 2.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.295 -0.878 . . . . 0.0 109.688 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.127 -0.983 . . . . 0.0 109.42 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.572 ' SG ' HG22 ' A' ' 5' ' ' THR . 6.0 t 62.38 91.93 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.881 . . . . 0.0 109.836 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -105.84 2.66 27.92 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.449 -0.782 . . . . 0.0 109.032 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.553 ' CG ' HG21 ' A' ' 89' ' ' VAL . 28.8 m-85 -121.14 67.89 0.88 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.267 -0.896 . . . . 0.0 109.402 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.572 HG22 ' SG ' ' A' ' 2' ' ' CYS . 11.6 p -79.74 124.62 28.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.905 . . . . 0.0 109.192 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.1 m -113.31 17.14 18.77 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.011 0.91 . . . . 0.0 110.069 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 136.02 -93.25 0.23 Allowed Glycine 0 C--N 1.282 -2.459 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.9 m -119.82 28.66 7.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -1.102 . . . . 0.0 109.29 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.453 ' O ' ' C ' ' A' ' 10' ' ' CYS . 1.7 m120 -111.53 -36.64 5.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 109.619 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' ASN . 1.7 t 41.33 80.4 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.413 -0.804 . . . . 0.0 109.469 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.633 ' CE2' ' CB ' ' A' ' 63' ' ' SER . 2.7 m-85 -86.6 148.34 25.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -0.833 . . . . 0.0 110.148 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.833 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -80.05 128.11 33.09 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.639 -0.663 . . . . 0.0 109.839 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.3 p -56.96 -18.52 13.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.921 . . . . 0.0 108.969 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.05 -30.33 15.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.264 -0.897 . . . . 0.0 109.592 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -73.55 -30.97 63.39 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 12' ' ' SER . 3.9 t -60.82 -32.07 51.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.03 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.3 t -60.38 -46.83 88.58 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.486 -0.759 . . . . 0.0 110.031 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -42.67 93.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.103 -0.998 . . . . 0.0 108.967 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.857 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -78.2 -11.63 59.94 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.511 -0.743 . . . . 0.0 109.16 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.593 ' NE2' ' CG ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -86.67 -26.6 24.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.367 -0.833 . . . . 0.0 108.984 179.617 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -83.98 -10.19 58.11 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.382 -0.824 . . . . 0.0 109.181 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.61 -47.43 17.15 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.35 -0.844 . . . . 0.0 109.276 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.608 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -75.29 -16.86 80.37 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.481 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 6.2 t80 -87.0 -63.4 1.31 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.444 -1.033 . . . . 0.0 109.544 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 29' ' ' ASP . 0.9 OUTLIER -46.95 -58.59 3.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.272 -0.893 . . . . 0.0 109.766 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.473 ' CD1' ' HB3' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -51.73 -47.08 64.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.295 -0.878 . . . . 0.0 109.773 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.628 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 2.9 t60 -52.9 -62.19 1.81 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.389 -0.82 . . . . 0.0 110.918 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -72.28 -7.23 48.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 109.735 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 13.7 t70 -78.46 -14.23 59.47 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.196 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.94 0.28 59.79 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.473 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 2.6 tp10 -94.43 -145.27 0.25 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.3 -1.118 . . . . 0.0 109.4 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.913 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -163.62 179.51 7.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 109.573 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.484 HG23 ' N ' ' A' ' 34' ' ' GLY . 17.1 m -89.41 -120.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 109.305 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.484 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -65.57 -42.35 95.64 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER 169.72 -38.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.311 -1.111 . . . . 0.0 109.549 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 37' ' ' SER . 5.4 m120 -65.46 -11.79 46.37 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.23 -0.919 . . . . 0.0 109.674 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.913 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.7 OUTLIER 59.66 114.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 0.0 109.129 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.668 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -107.65 -27.39 0.18 Allowed Pre-proline 0 N--CA 1.498 1.966 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -178.69 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.668 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 36.5 Cg_endo -79.4 102.51 1.51 Allowed 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 121.318 1.345 . . . . 0.0 113.167 -178.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.49 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -131.2 165.31 23.62 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.16 -0.962 . . . . 0.0 109.179 177.263 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.635 ' HB2' ' CE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -73.79 132.28 42.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 109.31 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.598 ' CZ ' ' HA ' ' A' ' 44' ' ' ASN . 26.9 t80 -100.97 134.26 44.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.367 -0.833 . . . . 0.0 109.351 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -103.24 -8.64 20.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.185 -0.947 . . . . 0.0 109.728 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.598 ' HA ' ' CZ ' ' A' ' 42' ' ' TYR . 2.2 m120 62.16 175.0 0.13 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.692 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.458 ' O ' ' C ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -179.15 -45.25 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.388 -0.82 . . . . 0.0 108.986 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.576 ' OE1' ' CZ ' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -38.52 -44.4 0.95 Allowed 'General case' 0 C--N 1.307 -1.242 0 O-C-N 121.696 -0.627 . . . . 0.0 109.945 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.55 47.12 0.09 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.576 ' CZ ' ' OE1' ' A' ' 46' ' ' GLU . 16.0 m-85 -106.58 139.76 40.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -1.184 . . . . 0.0 109.379 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.64 -30.85 11.53 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.285 -0.884 . . . . 0.0 109.262 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.552 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 30.1 m-85 50.93 -170.52 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.42 -0.8 . . . . 0.0 109.743 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.21 44.42 0.48 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.362 -0.836 . . . . 0.0 109.364 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.529 HG12 ' OD1' ' A' ' 81' ' ' ASN . 54.8 t -121.53 -45.34 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.263 -0.898 . . . . 0.0 109.636 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.579 ' O ' ' CE1' ' A' ' 56' ' ' TYR . 0.6 OUTLIER 167.72 -176.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.111 -0.993 . . . . 0.0 109.936 -179.64 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.558 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -86.4 -54.41 0.4 Allowed Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.373 -0.829 . . . . 0.0 111.646 -179.051 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 54' ' ' SER . 33.7 Cg_endo -73.1 86.02 1.16 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.045 1.83 . . . . 0.0 110.607 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.65 ' CE2' ' HB1' ' A' ' 87' ' ' ALA . 3.7 m-30 -87.21 -173.5 4.44 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.461 0.648 . . . . 0.0 110.054 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.635 ' CE2' ' HB2' ' A' ' 41' ' ' LYS . 75.7 m-85 -156.63 116.67 3.57 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -77.54 140.74 39.78 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.83 0.824 . . . . 0.0 110.968 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.653 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 20.9 t-105 -160.64 137.53 6.59 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.653 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.7 Cg_endo -68.94 147.05 67.26 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.138 1.892 . . . . 0.0 111.424 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.994 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -121.09 126.0 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.536 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.994 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.3 OUTLIER -122.72 166.1 15.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.278 -0.889 . . . . 0.0 109.284 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.633 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -130.91 7.42 4.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.289 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.97 -69.85 0.54 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.259 -0.901 . . . . 0.0 109.338 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 158.31 60.61 0.01 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -175.58 139.29 0.42 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -1.17 . . . . 0.0 109.461 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.476 HG13 ' HZ2' ' A' ' 59' ' ' TRP . 91.5 t -77.3 147.6 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.0 109.441 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.547 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 0.7 OUTLIER -65.38 166.61 9.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 109.749 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.41 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 5.7 m -169.2 49.87 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.434 -0.791 . . . . 0.0 109.14 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.45 114.91 0.92 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 72' ' ' SER . . . -178.64 39.4 0.08 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 1.4 p 75.14 109.7 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.248 -1.148 . . . . 0.0 109.584 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.531 ' HA ' ' NH2' ' A' ' 77' ' ' ARG . 36.2 Cg_endo -79.41 119.68 4.23 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.49 2.127 . . . . 0.0 110.555 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.505 ' HA2' ' HB2' ' A' ' 92' ' ' HIS . . . 170.0 -168.9 41.77 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . 47.74 -154.77 0.07 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -1.166 . . . . 0.0 110.506 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 51.8 m-20 -39.53 129.26 1.9 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.549 0.69 . . . . 0.0 109.619 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.544 ' CZ ' ' HB3' ' A' ' 60' ' ' PRO . 23.4 mmt-85 -158.43 122.25 3.99 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.723 HG21 ' CG1' ' A' ' 16' ' ' VAL . 0.9 OUTLIER -105.25 148.61 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.263 -0.898 . . . . 0.0 109.812 -178.941 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.643 HG12 ' H ' ' A' ' 80' ' ' PHE . 2.0 t -121.52 174.55 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.962 0.886 . . . . 0.0 109.673 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.643 ' H ' HG12 ' A' ' 79' ' ' VAL . 4.4 p90 -173.92 -167.87 0.38 Allowed 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.354 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.558 ' OD1' ' CE1' ' A' ' 56' ' ' TYR . 3.1 m120 -120.49 -80.57 0.62 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.266 -0.897 . . . . 0.0 109.794 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.412 ' OE1' ' O ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -163.43 23.98 0.08 Allowed 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.471 ' O ' ' HB3' ' A' ' 84' ' ' ASN . 14.5 m120 -148.91 16.28 0.96 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.483 -0.761 . . . . 0.0 109.056 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 83' ' ' ASN . 21.4 t30 62.32 13.89 6.35 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.366 -0.834 . . . . 0.0 109.348 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.562 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -46.89 -32.08 3.54 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.67 -1.234 . . . . 0.0 107.67 179.315 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.562 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.2 OUTLIER 84.95 110.58 0.05 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.534 0.683 . . . . 0.0 110.528 179.211 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.65 ' HB1' ' CE2' ' A' ' 56' ' ' TYR . . . -82.63 -43.48 16.93 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.561 ' O ' HG22 ' A' ' 78' ' ' VAL . . . 158.93 -161.14 31.71 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.553 HG21 ' CG ' ' A' ' 4' ' ' TYR . 39.1 t -134.96 92.46 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -1.179 . . . . 0.0 109.252 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.573 ' HB ' ' HB3' ' A' ' 100' ' ' PHE . 0.6 OUTLIER -94.41 151.45 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.4 -0.812 . . . . 0.0 109.858 -179.668 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.2 t -125.85 134.58 51.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 109.731 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.695 ' CD2' ' CD1' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -82.61 74.64 9.57 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.323 -0.86 . . . . 0.0 108.99 179.733 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 7.9 m -169.68 135.37 1.49 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.492 -0.755 . . . . 0.0 109.466 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 93.42 24.11 22.36 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.725 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . . . -156.51 91.5 1.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.132 -1.217 . . . . 0.0 109.682 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 95' ' ' ALA . 1.7 t 43.78 79.35 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.304 -0.873 . . . . 0.0 109.314 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.62 -70.5 3.16 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.62 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -148.76 -82.15 0.12 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -1.1 . . . . 0.0 109.318 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.725 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 4.3 m-20 60.73 138.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.372 -0.83 . . . . 0.0 109.315 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.695 ' CD1' ' CD2' ' A' ' 92' ' ' HIS . 0.6 OUTLIER -79.12 148.86 32.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.058 -1.026 . . . . 0.0 109.85 -179.588 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -151.94 114.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.411 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 1.7 pt-20 -43.71 131.26 5.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.326 -0.859 . . . . 0.0 109.575 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.518 ' HB3' ' O ' ' A' ' 5' ' ' THR . 84.0 m -72.31 106.26 4.39 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.324 -0.86 . . . . 0.0 109.401 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.826 -1.083 . . . . 0.0 109.54 -179.833 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 15.3 p 176.45 98.12 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.108 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -67.66 -19.41 65.19 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.319 -0.863 . . . . 0.0 108.895 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.682 ' CG ' HG21 ' A' ' 89' ' ' VAL . 39.4 m-85 -103.46 81.55 1.93 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.654 ' O ' HG22 ' A' ' 5' ' ' THR . 46.8 m -101.1 69.44 1.3 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.397 -0.814 . . . . 0.0 110.473 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.518 ' O ' ' N ' ' A' ' 8' ' ' SER . 3.9 m -80.6 154.58 27.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.036 -1.04 . . . . 0.0 108.505 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 6' ' ' CYS . . . 44.06 -94.98 0.01 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 6' ' ' CYS . 2.4 t -159.28 40.85 0.21 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -1.114 . . . . 0.0 109.1 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.442 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 2.8 m-80 -94.88 -35.88 11.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.919 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.431 ' C ' ' CB ' ' A' ' 2' ' ' CYS . 42.3 t 56.46 59.98 3.35 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.065 -1.022 . . . . 0.0 108.637 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.587 ' CE2' ' HB2' ' A' ' 63' ' ' SER . 2.9 m-30 -89.49 144.27 26.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.432 -0.792 . . . . 0.0 110.177 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.843 ' O ' HG23 ' A' ' 16' ' ' VAL . 4.0 m -82.85 133.81 35.12 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.578 -0.701 . . . . 0.0 109.966 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.1 p -62.56 -23.39 66.97 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.0 t -79.47 -33.1 42.61 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.457 ' HB2' ' HB2' ' A' ' 12' ' ' SER . 5.4 m-20 -77.38 -27.27 52.46 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 12' ' ' SER . 25.6 t -63.58 -24.27 35.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.429 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 15.0 t -66.52 -42.83 86.67 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.7 -42.27 99.55 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.834 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -74.33 -14.44 60.89 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.539 ' OE1' ' CB ' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -82.27 -30.6 30.55 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.498 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.62 -13.69 59.7 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.474 ' HB1' HG11 ' A' ' 67' ' ' VAL . . . -73.31 -58.53 3.24 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.563 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -61.64 -22.46 61.78 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.458 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 16.8 t80 -75.84 -37.32 59.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.555 -0.967 . . . . 0.0 109.127 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -69.74 -46.34 66.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.836 . . . . 0.0 108.849 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.984 HD22 HG13 ' A' ' 33' ' ' VAL . 9.5 tp -71.54 -18.06 62.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.392 -0.817 . . . . 0.0 108.87 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.621 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 55.1 t60 -89.66 -20.5 23.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.516 -0.74 . . . . 0.0 109.397 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.17 -23.26 24.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 109.338 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -97.78 -10.09 25.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.355 -0.84 . . . . 0.0 109.508 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.75 18.74 70.62 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.564 ' CG ' ' N ' ' A' ' 32' ' ' THR . 34.1 tt0 -88.8 167.08 13.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -1.171 . . . . 0.0 109.646 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.882 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -104.01 166.68 10.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.504 -0.747 . . . . 0.0 109.412 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.984 HG13 HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -102.56 -79.06 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.062 -1.024 . . . . 0.0 109.685 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -72.62 -44.05 41.5 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.5 OUTLIER 163.32 -33.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.326 -1.102 . . . . 0.0 109.327 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 37' ' ' SER . 58.6 m-20 -76.77 -77.2 0.15 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.255 -0.903 . . . . 0.0 109.184 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.882 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.1 OUTLIER 158.1 128.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.617 ' H ' ' CD ' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -120.43 -37.31 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.838 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -178.593 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.617 ' CD ' ' H ' ' A' ' 38' ' ' TYR . 35.1 Cg_endo -80.42 101.93 1.37 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 120.975 1.117 . . . . 0.0 112.485 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.543 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -132.12 -172.05 2.79 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.365 -0.835 . . . . 0.0 109.267 178.121 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -81.74 158.22 24.26 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.824 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 1.2 t80 -121.38 124.1 43.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.102 -0.998 . . . . 0.0 109.747 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -110.24 -75.22 0.63 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 108.543 179.295 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 0.4 OUTLIER 77.15 -76.03 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.363 -0.836 . . . . 0.0 110.458 179.002 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 56.66 45.69 21.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.925 -1.109 . . . . 0.0 109.115 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.581 ' HG2' ' CE2' ' A' ' 48' ' ' PHE . 0.8 OUTLIER -94.2 -28.42 15.64 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.249 -0.907 . . . . 0.0 109.306 -179.668 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 159.84 -23.61 0.29 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.581 ' CE2' ' HG2' ' A' ' 46' ' ' GLU . 3.5 p90 -111.87 139.74 47.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.431 -1.041 . . . . 0.0 109.225 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 50' ' ' PHE . 2.4 m-20 -122.8 -23.79 4.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.682 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.517 ' CB ' ' O ' ' A' ' 49' ' ' ASP . 3.1 m-85 80.54 173.82 0.13 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.363 -0.835 . . . . 0.0 109.382 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.9 p -120.74 39.48 3.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.219 -0.925 . . . . 0.0 109.625 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.496 HG21 ' HA ' ' A' ' 87' ' ' ALA . 15.0 t -98.58 -67.14 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.157 -0.964 . . . . 0.0 109.505 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.444 ' O ' ' CE2' ' A' ' 56' ' ' TYR . 0.2 OUTLIER -165.55 174.98 9.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.097 -1.002 . . . . 0.0 109.996 -179.702 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.584 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -79.22 -51.04 1.3 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.46 -0.775 . . . . 0.0 110.61 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 54' ' ' SER . 36.2 Cg_endo -76.25 82.85 2.12 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.94 1.76 . . . . 0.0 110.208 -178.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.541 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 49.0 m-85 -79.35 -178.15 6.09 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.561 0.696 . . . . 0.0 109.712 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.621 ' CE1' ' NE2' ' A' ' 27' ' ' HIS . 97.1 m-85 -158.13 135.63 10.32 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.474 ' OE2' ' O ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -96.03 140.5 30.68 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.094 -1.003 . . . . 0.0 111.589 -178.115 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.716 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 27.5 t-105 -160.81 139.29 7.42 Favored Pre-proline 0 N--CA 1.495 1.799 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.716 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 31.6 Cg_endo -70.09 143.15 48.39 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.161 1.907 . . . . 0.0 111.321 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 1.031 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -107.02 116.29 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.56 -0.712 . . . . 0.0 109.512 -179.638 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.031 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.7 OUTLIER -116.94 164.04 15.3 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.296 -0.878 . . . . 0.0 108.985 179.494 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.587 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -172.48 56.32 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.55 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 177.14 36.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.271 -0.893 . . . . 0.0 109.118 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.04 -70.31 0.08 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -173.74 167.75 4.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.202 -1.175 . . . . 0.0 109.77 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.474 HG11 ' HB1' ' A' ' 22' ' ' ALA . 39.8 t -62.59 150.1 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.331 -0.856 . . . . 0.0 109.298 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.596 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 17.1 t80 -52.0 138.86 24.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.966 -1.084 . . . . 0.0 109.533 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.458 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 5.0 t -159.9 21.9 0.17 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.393 -0.817 . . . . 0.0 109.69 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 130.98 154.7 7.98 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.91 -133.5 6.8 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.97 131.07 21.98 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.145 -1.209 . . . . 0.0 109.175 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.475 ' HA ' ' OH ' ' A' ' 38' ' ' TYR . 36.2 Cg_endo -79.48 -172.57 1.57 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.406 2.071 . . . . 0.0 111.012 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.704 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 74.52 -167.74 54.68 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.704 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 77.6 -152.02 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.246 -1.149 . . . . 0.0 110.459 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.24 162.65 9.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.391 -0.818 . . . . 0.0 109.811 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.573 ' O ' HG12 ' A' ' 90' ' ' ILE . 0.9 OUTLIER 175.1 96.59 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.176 -0.952 . . . . 0.0 109.149 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.032 HG21 HD21 ' A' ' 86' ' ' LEU . 2.6 p -77.02 140.12 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.884 -1.135 . . . . 0.0 110.579 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.577 ' CG1' ' N ' ' A' ' 80' ' ' PHE . 16.7 t -92.53 169.44 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.577 ' CE1' ' O ' ' A' ' 57' ' ' TYR . 4.6 p90 -162.84 -173.31 3.43 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.629 -0.829 . . . . 0.0 109.502 -178.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.483 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 6.4 t30 -124.0 -81.77 0.64 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.17 -0.956 . . . . 0.0 109.405 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 81' ' ' ASN . 65.9 mt-10 -156.4 12.82 0.29 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.459 -0.776 . . . . 0.0 110.317 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.638 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 0.1 OUTLIER -137.9 6.01 2.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.023 -1.048 . . . . 0.0 109.489 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.638 ' ND2' ' O ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER 70.91 16.14 6.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.448 -0.783 . . . . 0.0 109.441 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.586 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -53.72 -31.29 47.69 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.383 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.032 HD21 HG21 ' A' ' 78' ' ' VAL . 0.6 OUTLIER 89.21 103.28 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.686 0.755 . . . . 0.0 110.599 179.226 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.496 ' HA ' HG21 ' A' ' 52' ' ' VAL . . . -70.97 -52.59 18.85 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.25 171.29 34.79 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.682 HG21 ' CG ' ' A' ' 4' ' ' TYR . 64.3 t -102.91 124.69 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.937 -1.331 . . . . 0.0 109.906 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.588 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 0.5 OUTLIER -125.59 153.22 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.331 -0.856 . . . . 0.0 108.696 179.553 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 99' ' ' ASN . 6.3 t -117.07 165.49 13.32 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.026 -1.046 . . . . 0.0 110.019 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.62 ' NE2' ' CD2' ' A' ' 100' ' ' PHE . 0.4 OUTLIER -121.11 67.27 0.87 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.437 -0.789 . . . . 0.0 109.28 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 7.4 m -168.81 126.22 1.01 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.462 -0.773 . . . . 0.0 109.292 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 107.96 -20.57 31.03 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 98' ' ' ASN . . . -105.83 93.94 4.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.211 -1.17 . . . . 0.0 109.681 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 95' ' ' ALA . 51.7 m 41.59 52.58 3.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.511 -0.743 . . . . 0.0 109.477 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.1 -73.29 0.21 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.602 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -144.38 -81.96 0.16 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.259 -1.142 . . . . 0.0 109.472 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 92' ' ' HIS . 0.8 OUTLIER 57.06 159.29 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.317 -0.864 . . . . 0.0 109.15 -179.519 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.62 ' CD2' ' NE2' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -96.61 145.17 25.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.902 -1.124 . . . . 0.0 110.04 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.443 ' O ' ' C ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -155.97 130.55 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.293 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 101' ' ' VAL . 2.3 pt-20 -39.98 136.83 1.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.468 -0.77 . . . . 0.0 110.124 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.99 123.83 29.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.395 -0.816 . . . . 0.0 109.382 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.1 p . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.171 -0.955 . . . . 0.0 109.38 179.844 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.443 ' O ' ' SG ' ' A' ' 10' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.598 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 0.8 OUTLIER 173.94 106.91 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.279 -0.888 . . . . 0.0 110.398 179.558 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -79.66 -14.74 58.57 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.722 ' CG ' HG21 ' A' ' 89' ' ' VAL . 16.2 m-85 -112.8 126.94 55.97 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.337 -0.852 . . . . 0.0 109.051 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 7' ' ' GLY . 1.2 m -152.83 109.32 3.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.235 -0.916 . . . . 0.0 109.744 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 103' ' ' CYS . 29.9 m -95.44 16.81 15.96 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.066 0.936 . . . . 0.0 109.557 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.468 ' O ' HG22 ' A' ' 5' ' ' THR . . . -177.65 -146.47 6.31 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 p -88.17 15.11 7.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.208 -1.172 . . . . 0.0 109.304 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -79.67 -168.18 1.49 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.322 -0.861 . . . . 0.0 109.664 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 1' ' ' ALA . 45.6 t -149.55 74.3 1.22 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.5 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 4.2 m-85 -80.44 124.6 29.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.393 -0.817 . . . . 0.0 110.041 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.772 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -83.79 124.79 31.28 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.502 -0.749 . . . . 0.0 109.63 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 12' ' ' SER . 28.3 t -46.39 -25.67 0.69 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.239 -0.913 . . . . 0.0 108.754 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.3 t -76.91 -43.36 35.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 109.285 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.41 -26.09 67.07 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.886 HG13 HG12 ' A' ' 61' ' ' ILE . 3.0 t -72.87 -32.99 42.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.91 -42.31 97.83 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -47.32 86.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 108.628 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 1.088 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -75.9 -10.59 59.55 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.635 ' NE2' ' CG ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -83.17 -30.61 27.68 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.922 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.425 ' HA ' ' HB3' ' A' ' 24' ' ' TYR . . . -80.25 -16.73 54.07 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.38 -47.27 61.7 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.557 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -73.14 -31.21 61.88 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.684 -1.766 . . . . 0.0 108.684 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.425 ' HB3' ' HA ' ' A' ' 21' ' ' ALA . 11.2 t80 -68.23 -32.15 72.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.46 -1.024 . . . . 0.0 109.171 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -73.36 -47.9 38.57 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.732 HD21 ' C ' ' A' ' 32' ' ' THR . 5.6 tp -65.25 -21.2 66.71 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.088 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -85.65 -24.76 26.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.526 -0.734 . . . . 0.0 109.516 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -88.12 -11.55 46.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.319 -0.863 . . . . 0.0 109.403 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -107.88 -11.57 15.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.374 -0.829 . . . . 0.0 109.721 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.64 14.89 77.71 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.426 ' O ' HG23 ' A' ' 32' ' ' THR . 0.3 OUTLIER -81.27 -157.17 0.16 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -1.207 . . . . 0.0 109.379 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.826 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -158.19 166.79 31.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.322 -0.861 . . . . 0.0 109.254 179.801 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.607 HG13 HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -110.33 -70.44 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.144 -0.973 . . . . 0.0 109.585 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 35' ' ' SER . . . -85.93 16.45 42.15 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 0.5 OUTLIER 66.36 19.73 10.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.132 -1.217 . . . . 0.0 109.114 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -120.92 5.58 10.42 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.402 -0.811 . . . . 0.0 109.293 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.826 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.3 OUTLIER 68.3 73.51 0.29 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.224 -0.922 . . . . 0.0 108.653 -179.179 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.654 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -71.67 -45.33 12.63 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.117 -0.99 . . . . 0.0 110.938 -179.367 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 35.3 Cg_endo -77.15 106.61 2.27 Favored 'Trans proline' 0 C--N 1.3 -1.993 0 C-N-CA 120.855 1.037 . . . . 0.0 109.873 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.654 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -127.09 -175.37 3.41 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -107.13 143.34 35.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.943 -1.098 . . . . 0.0 110.367 -179.454 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.54 ' HB3' ' CB ' ' A' ' 56' ' ' TYR . 12.0 t80 -104.11 161.59 13.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.503 -0.748 . . . . 0.0 109.245 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 44' ' ' ASN . 0.5 OUTLIER -123.83 -16.22 6.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.124 -0.985 . . . . 0.0 109.567 179.615 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.543 ' O ' ' CD2' ' A' ' 45' ' ' TYR . 0.7 OUTLIER 62.1 130.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.556 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.543 ' CD2' ' O ' ' A' ' 44' ' ' ASN . 5.6 m-85 -161.44 -38.54 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.399 -0.813 . . . . 0.0 109.126 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.818 ' OE2' HG12 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -37.93 -68.36 0.16 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.469 0.652 . . . . 0.0 110.131 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.56 61.14 0.01 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -89.62 -174.75 4.44 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.358 -1.084 . . . . 0.0 108.61 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -117.09 -20.4 9.32 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.897 -1.127 . . . . 0.0 110.043 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.511 ' CD1' ' C ' ' A' ' 50' ' ' PHE . 10.1 p90 -80.74 179.97 7.54 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.129 -0.982 . . . . 0.0 109.438 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.475 ' HA ' ' OH ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -177.4 57.08 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.259 -0.9 . . . . 0.0 109.254 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.711 HG11 ' HB2' ' A' ' 85' ' ' GLN . 42.3 t -45.03 -63.13 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.165 -0.959 . . . . 0.0 109.023 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.408 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -154.75 -178.97 7.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.312 -0.868 . . . . 0.0 109.95 179.972 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.588 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -79.7 -50.09 1.29 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.405 -0.809 . . . . 0.0 110.81 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 54' ' ' SER . 34.5 Cg_endo -75.28 83.62 1.83 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.991 1.794 . . . . 0.0 109.764 -178.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.621 ' CE1' ' HB2' ' A' ' 87' ' ' ALA . 10.1 m-85 -81.68 179.82 7.68 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.745 0.783 . . . . 0.0 110.804 -178.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.577 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 64.4 m-85 -157.26 117.12 3.43 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.624 ' HG2' HD11 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -96.66 147.66 23.66 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.266 -0.896 . . . . 0.0 110.489 -178.584 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.696 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 4.1 t-105 -160.75 143.93 9.83 Favored Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.696 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 28.4 Cg_endo -66.35 133.03 31.17 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.336 2.024 . . . . 0.0 112.091 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 1.088 HD13 ' HB3' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -118.31 115.66 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.704 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.023 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -118.58 163.75 16.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.107 -0.996 . . . . 0.0 109.13 179.761 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.1 t -131.53 36.17 3.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.484 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.73 6.8 12.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.18 -0.95 . . . . 0.0 109.618 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.71 -32.7 7.26 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.991 ' O ' HD12 ' A' ' 62' ' ' LEU . 11.9 m-20 -98.97 91.39 5.01 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.23 -1.159 . . . . 0.0 109.375 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.584 ' O ' ' CD1' ' A' ' 68' ' ' TYR . 43.4 t -65.02 156.75 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 109.857 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.589 ' HB3' ' CZ2' ' A' ' 59' ' ' TRP . 48.6 p90 39.17 -162.69 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.598 0.713 . . . . 0.0 110.023 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.492 ' N ' ' CD2' ' A' ' 68' ' ' TYR . 29.0 t 53.11 173.22 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.342 -0.849 . . . . 0.0 109.427 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.63 -160.45 15.99 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.66 41.32 2.25 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 t -161.26 85.95 1.72 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.221 -1.164 . . . . 0.0 109.306 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.557 ' HA ' ' OH ' ' A' ' 38' ' ' TYR . 35.5 Cg_endo -79.95 44.05 1.64 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.789 2.326 . . . . 0.0 111.022 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.631 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . -173.03 -167.52 33.05 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 72.28 -141.89 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.117 -1.225 . . . . 0.0 110.162 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.465 ' C ' ' O ' ' A' ' 75' ' ' ALA . 1.2 m-20 -34.2 131.14 0.31 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.444 -0.785 . . . . 0.0 111.21 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.519 ' O ' HG12 ' A' ' 90' ' ' ILE . 6.5 ttm-85 -167.24 110.11 0.68 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.469 -0.769 . . . . 0.0 108.989 179.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.797 HG23 HD11 ' A' ' 86' ' ' LEU . 4.3 p -71.95 164.62 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.069 -1.019 . . . . 0.0 109.67 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 1.021 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 4.0 t -130.52 171.36 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.973 0.892 . . . . 0.0 109.961 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.638 ' H ' HG12 ' A' ' 79' ' ' VAL . 24.0 p90 -174.02 -172.46 0.72 Allowed 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.418 ' CG ' ' N ' ' A' ' 82' ' ' GLU . 2.9 t30 -125.33 -84.9 0.64 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.962 -1.087 . . . . 0.0 109.794 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.418 ' N ' ' CG ' ' A' ' 81' ' ' ASN . 6.9 mt-10 -142.16 0.55 1.36 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.494 -0.753 . . . . 0.0 109.919 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 84' ' ' ASN . 8.7 m-20 -131.4 4.81 4.35 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 108.895 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.515 ' OD1' ' HB3' ' A' ' 20' ' ' GLN . 5.5 t30 75.1 32.43 0.77 Allowed 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.334 -0.854 . . . . 0.0 109.192 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.711 ' HB2' HG11 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -62.16 -33.16 73.98 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.46 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.797 HD11 HG23 ' A' ' 78' ' ' VAL . 0.1 OUTLIER 84.99 103.95 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.488 0.661 . . . . 0.0 110.994 178.937 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 1.021 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . . . -74.54 -27.8 60.68 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.42 ' H ' ' CD1' ' A' ' 86' ' ' LEU . . . 148.14 -149.03 21.04 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.722 HG21 ' CG ' ' A' ' 4' ' ' TYR . 72.5 t -129.85 87.71 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.254 -1.145 . . . . 0.0 109.639 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.624 HD11 ' HG2' ' A' ' 58' ' ' GLU . 12.2 pt -79.4 136.24 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.514 -0.741 . . . . 0.0 109.221 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.631 ' O ' HG23 ' A' ' 91' ' ' THR . 13.1 t -130.5 118.54 21.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.91 . . . . 0.0 110.296 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.813 ' CE1' ' CE2' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -84.01 76.42 10.06 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.368 -0.832 . . . . 0.0 108.848 179.279 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 1.4 m 178.96 -30.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.553 -0.717 . . . . 0.0 109.404 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -59.04 -15.01 27.23 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.887 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . . . -117.96 163.68 16.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.186 -1.185 . . . . 0.0 109.553 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 95' ' ' ALA . 3.7 m -42.92 120.33 1.75 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 109.008 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.97 -82.84 1.64 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.654 -1.779 . . . . 0.0 108.654 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.632 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -151.9 -86.81 0.07 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.318 -1.107 . . . . 0.0 109.287 179.419 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.887 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 4.0 m-80 61.04 129.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 108.937 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.813 ' CE2' ' CE1' ' A' ' 92' ' ' HIS . 57.0 m-85 -85.33 125.58 33.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.891 -1.131 . . . . 0.0 110.292 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.818 HG12 ' OE2' ' A' ' 46' ' ' GLU . 1.2 m -142.69 137.51 27.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.497 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 24.0 pt-20 -61.52 123.61 18.35 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.164 -0.96 . . . . 0.0 109.221 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.448 ' HB3' ' HA ' ' A' ' 6' ' ' CYS . 84.7 m -56.93 161.01 3.17 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.151 -0.968 . . . . 0.0 109.398 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.479 0 O-C-N 121.22 -0.925 . . . . 0.0 109.492 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 27.2 p -178.77 88.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.145 -0.972 . . . . 0.0 109.956 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -89.9 2.72 54.71 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.296 -0.878 . . . . 0.0 109.285 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -126.57 105.74 8.94 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.112 -0.992 . . . . 0.0 109.637 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.644 HG23 ' O ' ' A' ' 5' ' ' THR . 6.0 t -136.43 106.79 6.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.892 . . . . 0.0 109.318 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.47 ' SG ' ' HB ' ' A' ' 91' ' ' THR . 57.3 m -93.47 17.14 11.99 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.17 0.986 . . . . 0.0 109.63 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.48 -111.77 0.32 Allowed Glycine 0 C--N 1.282 -2.432 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.14 3.93 12.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.15 -1.206 . . . . 0.0 109.271 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.562 ' O ' ' N ' ' A' ' 11' ' ' TYR . 3.9 m120 -92.51 68.12 4.79 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.246 -0.909 . . . . 0.0 109.411 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -49.74 89.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.567 ' CZ ' ' OG ' ' A' ' 63' ' ' SER . 4.0 m-30 -83.17 144.6 29.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.456 -0.778 . . . . 0.0 110.173 -178.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.601 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 0.1 OUTLIER -79.18 127.84 32.54 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.818 -0.551 . . . . 0.0 110.042 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.35 -43.19 61.74 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.9 m -62.68 -34.52 77.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.378 -0.826 . . . . 0.0 108.958 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -69.22 -31.1 69.45 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 12' ' ' SER . 6.7 t -58.82 -25.43 29.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.469 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 20.3 t -74.4 -40.6 61.93 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -40.44 80.36 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.74 ' CB ' HD13 ' A' ' 61' ' ' ILE . . . -77.06 -26.43 53.56 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.782 ' NE2' HG13 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -75.03 -16.62 60.59 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.056 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -92.62 -11.71 33.54 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.95 -56.2 3.95 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.581 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -69.16 -24.13 76.02 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.565 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 11.0 t80 -77.99 -53.33 7.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.501 -1.0 . . . . 0.0 109.048 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 1.1 tm0? -45.64 -47.15 14.89 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.559 ' CD1' ' N ' ' A' ' 32' ' ' THR . 1.0 OUTLIER -59.79 -48.87 79.93 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.389 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.465 ' NE2' ' CZ ' ' A' ' 57' ' ' TYR . 9.1 t60 -59.06 -14.51 9.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.264 -0.898 . . . . 0.0 110.367 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -96.0 -28.18 14.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.89 -1.131 . . . . 0.0 109.957 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.39 8.0 45.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.115 -0.99 . . . . 0.0 109.432 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 48.62 34.07 13.62 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.536 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -102.17 -147.72 0.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -1.169 . . . . 0.0 109.429 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.99 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.3 OUTLIER -157.87 -178.19 7.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.064 -1.022 . . . . 0.0 110.016 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.521 HG23 ' N ' ' A' ' 34' ' ' GLY . 25.8 m -98.81 -139.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.878 . . . . 0.0 109.515 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.521 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -42.27 -51.41 5.32 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 173.62 -31.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.263 -1.14 . . . . 0.0 109.635 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.445 ' O ' ' CB ' ' A' ' 37' ' ' SER . 5.8 m120 -74.82 -7.38 53.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.25 -0.906 . . . . 0.0 109.573 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.99 ' HA ' HG22 ' A' ' 32' ' ' THR . 2.4 p 71.84 -165.33 0.13 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -0.922 . . . . 0.0 109.481 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.723 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.2 OUTLIER 167.64 -45.03 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.482 -0.761 . . . . 0.0 111.269 179.435 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 31.8 Cg_endo -76.59 100.68 1.42 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 121.482 1.455 . . . . 0.0 112.025 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.723 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -140.33 163.44 32.77 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.591 -0.693 . . . . 0.0 109.513 178.735 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -58.06 154.13 13.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.795 -1.19 . . . . 0.0 108.664 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.631 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -136.74 155.22 50.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.124 -0.985 . . . . 0.0 110.044 -178.562 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.612 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . 0.7 OUTLIER -137.82 -71.99 0.42 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.537 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.631 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 8.4 t30 80.18 -69.66 0.1 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.593 -0.692 . . . . 0.0 111.411 178.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.612 ' CE2' ' HB3' ' A' ' 43' ' ' ASN . 86.6 m-85 67.41 9.12 6.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 108.846 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.605 ' HB2' ' ND2' ' A' ' 44' ' ' ASN . 0.4 OUTLIER -39.33 -50.72 2.05 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 121.557 -0.715 . . . . 0.0 109.809 -179.725 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 159.37 36.71 0.02 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.509 ' CE2' ' HB3' ' A' ' 46' ' ' GLU . 7.5 m-85 -115.64 -179.91 3.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.243 -1.151 . . . . 0.0 109.346 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -128.73 -34.68 1.96 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.464 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.528 ' CB ' ' OH ' ' A' ' 56' ' ' TYR . 16.8 m-30 55.21 179.12 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 109.916 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.6 p -139.76 21.04 2.5 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.573 HG12 ' N ' ' A' ' 53' ' ' SER . 77.1 t -95.42 -92.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.544 -0.722 . . . . 0.0 109.843 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.573 ' N ' HG12 ' A' ' 52' ' ' VAL . 60.7 m -166.27 -168.84 1.29 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.976 . . . . 0.0 110.047 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.607 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -77.78 -50.74 1.89 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.614 -0.679 . . . . 0.0 111.056 -179.816 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 54' ' ' SER . 32.5 Cg_endo -73.01 92.38 0.81 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 121.897 1.731 . . . . 0.0 110.168 -177.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.607 ' CE1' ' HB2' ' A' ' 87' ' ' ALA . 17.4 m-85 -94.66 -169.15 1.96 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.589 ' O ' ' CE1' ' A' ' 80' ' ' PHE . 70.4 m-85 -161.66 106.94 1.3 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 0.3 OUTLIER -78.1 140.24 39.05 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.836 0.827 . . . . 0.0 110.921 -178.613 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.678 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 31.3 t-105 -160.35 137.02 6.52 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.678 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.9 Cg_endo -69.08 145.89 62.59 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.092 1.862 . . . . 0.0 111.484 -178.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.983 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -110.88 128.49 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.56 -0.713 . . . . 0.0 109.527 -179.339 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.983 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -124.82 161.33 26.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.153 -0.967 . . . . 0.0 109.261 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.567 ' OG ' ' CZ ' ' A' ' 11' ' ' TYR . 53.8 m -133.42 5.73 3.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.303 -0.873 . . . . 0.0 109.398 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.37 -71.48 0.73 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.917 . . . . 0.0 109.202 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . -74.32 -92.83 0.14 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 53.4 t0 179.87 -36.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.289 -1.124 . . . . 0.0 109.758 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.04 155.48 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.162 -0.961 . . . . 0.0 109.89 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.567 ' HB2' ' HG2' ' A' ' 60' ' ' PRO . 54.1 t80 -71.57 115.06 10.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.908 . . . . 0.0 109.397 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.6 t -152.74 -43.43 0.1 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.38 -0.825 . . . . 0.0 109.278 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.31 -27.44 57.9 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.419 ' O ' ' OG ' ' A' ' 72' ' ' SER . . . 101.14 -163.97 18.2 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.554 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 18.2 p 55.82 60.81 8.5 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.305 -1.115 . . . . 0.0 109.846 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 72' ' ' SER . 36.8 Cg_endo -79.59 -159.05 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.651 2.234 . . . . 0.0 110.436 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.566 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 92.2 -171.65 34.15 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 70.86 -80.85 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.482 -1.011 . . . . 0.0 110.377 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.602 ' HB3' HG23 ' A' ' 61' ' ' ILE . 54.6 m-20 -113.66 135.17 54.22 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.015 -1.053 . . . . 0.0 109.698 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.557 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 4.6 mtt180 -155.99 84.82 1.01 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.313 -0.867 . . . . 0.0 109.073 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.782 HG13 ' NE2' ' A' ' 20' ' ' GLN . 14.6 p -77.93 150.44 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.975 -1.078 . . . . 0.0 109.484 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.652 HG12 ' H ' ' A' ' 80' ' ' PHE . 3.0 t -111.62 173.35 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.364 -0.835 . . . . 0.0 109.418 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.652 ' H ' HG12 ' A' ' 79' ' ' VAL . 4.4 p90 -164.24 -171.47 2.41 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.221 -178.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.556 ' HB2' HG11 ' A' ' 52' ' ' VAL . 26.3 t-20 -121.08 -83.08 0.66 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.026 -1.046 . . . . 0.0 109.99 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.565 ' O ' ' CZ ' ' A' ' 24' ' ' TYR . 42.0 mt-10 -141.91 -9.44 0.91 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.402 -0.811 . . . . 0.0 110.862 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -131.77 25.06 4.69 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.907 -1.121 . . . . 0.0 108.882 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.455 ' O ' ' C ' ' A' ' 85' ' ' GLN . 3.1 m120 62.37 21.73 12.75 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.495 -0.753 . . . . 0.0 109.506 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.568 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 1.4 mt-30 -44.11 -30.23 0.73 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.568 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER 85.18 103.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.553 0.692 . . . . 0.0 110.904 178.91 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.607 ' HB2' ' CE1' ' A' ' 56' ' ' TYR . . . -79.41 -33.21 42.85 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 139.73 145.3 4.67 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.507 HG22 ' HB ' ' A' ' 78' ' ' VAL . 61.2 t -80.57 118.88 29.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.144 -1.209 . . . . 0.0 109.282 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.674 HD12 ' HB2' ' A' ' 100' ' ' PHE . 0.4 OUTLIER -104.45 179.12 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.925 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.484 ' O ' ' O ' ' A' ' 99' ' ' ASN . 1.5 t -138.0 135.3 35.82 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.354 -1.338 . . . . 0.0 111.916 -178.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.465 ' HB2' ' N ' ' A' ' 75' ' ' ALA . 0.2 OUTLIER -86.19 62.34 7.38 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.553 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 93' ' ' THR . 6.8 t -176.2 25.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.385 -0.822 . . . . 0.0 110.314 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.19 10.56 17.48 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 1.026 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . . . -153.29 -174.42 4.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -1.152 . . . . 0.0 109.554 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 95' ' ' ALA . 1.9 t -42.71 113.98 0.53 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.343 -0.848 . . . . 0.0 109.718 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.46 -81.84 0.82 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.475 ' O ' ' O ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -138.36 -76.32 0.38 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -1.138 . . . . 0.0 109.722 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 1.026 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 3.8 m-20 59.94 154.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.674 ' HB2' HD12 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -114.36 118.75 34.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.711 -1.243 . . . . 0.0 110.961 -179.233 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.443 ' O ' ' C ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -125.51 139.83 50.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 107.85 -1.166 . . . . 0.0 107.85 178.357 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -41.82 140.01 1.11 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.137 -0.977 . . . . 0.0 110.347 -178.672 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.442 ' O ' ' OE1' ' A' ' 102' ' ' GLU . 0.5 OUTLIER -56.36 109.03 0.54 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.419 -0.801 . . . . 0.0 109.478 179.716 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 109.538 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 8.5 p 173.96 99.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.931 . . . . 0.0 109.862 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -101.51 -9.42 21.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.349 -0.844 . . . . 0.0 109.311 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.989 ' CG ' HG21 ' A' ' 89' ' ' VAL . 18.8 m-85 -106.14 82.15 1.72 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.115 -0.991 . . . . 0.0 109.163 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.694 HG22 ' HA ' ' A' ' 10' ' ' CYS . 76.3 p -89.83 131.51 35.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -0.852 . . . . 0.0 109.719 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.516 ' CB ' ' OD1' ' A' ' 76' ' ' ASP . 4.0 m -143.55 157.76 44.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.348 -0.845 . . . . 0.0 109.138 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 8' ' ' SER . . . 44.95 32.94 3.4 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 7' ' ' GLY . 0.6 OUTLIER 68.53 49.18 0.77 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.323 -1.104 . . . . 0.0 109.573 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.464 ' O ' ' HB ' ' A' ' 5' ' ' THR . 25.2 m120 -136.3 172.91 12.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.185 -0.947 . . . . 0.0 110.032 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.694 ' HA ' HG22 ' A' ' 5' ' ' THR . 0.4 OUTLIER -127.48 81.87 2.05 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.663 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.536 ' CE2' ' HB2' ' A' ' 63' ' ' SER . 2.9 m-85 -79.0 138.28 37.96 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.476 -0.765 . . . . 0.0 109.826 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.662 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.8 OUTLIER -79.62 124.74 28.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.607 -0.683 . . . . 0.0 109.767 -179.709 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.64 -21.94 3.01 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.559 -0.856 . . . . 0.0 108.975 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 t -82.28 -36.64 26.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.384 -0.822 . . . . 0.0 109.328 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -69.48 -33.79 73.39 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 12' ' ' SER . 5.0 t -58.66 -38.4 71.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.48 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 0.9 OUTLIER -63.71 -31.63 72.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.616 -0.677 . . . . 0.0 109.487 179.547 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -56.78 9.13 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.795 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -63.62 -17.25 62.69 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.733 ' NE2' ' CG ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -77.43 -36.0 53.53 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -74.13 -6.31 46.94 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.717 ' HB1' HG22 ' A' ' 67' ' ' VAL . . . -84.19 -53.6 5.39 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.607 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -68.33 -27.77 73.59 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.484 ' C ' ' CD1' ' A' ' 24' ' ' TYR . 1.3 t80 -76.31 -60.02 2.51 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.502 -0.999 . . . . 0.0 109.599 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 14.6 mt-30 -57.58 -31.67 66.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.032 -1.042 . . . . 0.0 109.137 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.658 HD23 ' HG3' ' A' ' 39' ' ' PRO . 9.2 tp -74.01 -28.89 61.67 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 108.54 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 39' ' ' PRO . 14.0 t60 -79.5 -21.91 44.68 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.422 -0.799 . . . . 0.0 109.448 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -89.31 -31.93 17.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.322 -0.861 . . . . 0.0 109.464 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -80.93 -13.77 58.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.94 . . . . 0.0 109.579 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.24 36.34 27.61 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.859 ' O ' HG23 ' A' ' 32' ' ' THR . 0.3 OUTLIER -105.49 -158.78 0.68 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.252 -1.146 . . . . 0.0 109.791 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.859 HG23 ' O ' ' A' ' 31' ' ' GLU . 1.1 p -168.22 -172.18 1.69 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.573 HG11 ' O ' ' A' ' 68' ' ' TYR . 33.7 m -125.38 152.35 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.08 -1.012 . . . . 0.0 110.377 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 48.79 -88.54 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.541 ' N ' ' O ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -175.09 28.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.417 -1.049 . . . . 0.0 109.346 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.447 ' O ' ' OG ' ' A' ' 37' ' ' SER . 5.2 m-20 -138.0 23.64 2.82 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.339 -0.85 . . . . 0.0 109.159 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.591 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 75.8 p 48.98 -165.98 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.416 -0.803 . . . . 0.0 109.692 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.729 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 168.7 -44.88 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.549 -0.719 . . . . 0.0 111.541 179.212 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.658 ' HG3' HD23 ' A' ' 26' ' ' LEU . 33.2 Cg_endo -76.77 100.75 1.43 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 121.377 1.385 . . . . 0.0 111.986 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.729 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -140.4 -170.15 2.93 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.682 -0.636 . . . . 0.0 109.349 178.642 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 11.5 ptmt -75.51 163.84 26.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.406 -0.809 . . . . 0.0 110.395 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.588 ' CE2' ' HA ' ' A' ' 44' ' ' ASN . 85.7 t80 -142.83 93.88 2.57 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 44' ' ' ASN . 0.5 OUTLIER -81.79 37.91 0.49 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.12 -0.987 . . . . 0.0 110.752 -179.053 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.588 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER 39.92 -160.99 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.216 -0.927 . . . . 0.0 109.948 179.394 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.457 ' CB ' ' O ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER 167.25 -67.31 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.4 -0.813 . . . . 0.0 109.217 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -38.96 -52.63 1.78 Allowed 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.519 -0.738 . . . . 0.0 110.016 -179.784 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.07 51.18 0.05 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.548 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 21.0 m-85 -101.09 115.09 29.66 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.178 -1.189 . . . . 0.0 109.523 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.04 88.94 7.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.411 -0.806 . . . . 0.0 109.18 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.548 ' CZ ' ' HB2' ' A' ' 48' ' ' PHE . 60.6 m-85 -78.87 -172.46 3.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.358 -0.839 . . . . 0.0 109.657 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 84.2 p -153.48 42.25 0.56 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 109.3 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.83 HG21 ' O ' ' A' ' 86' ' ' LEU . 38.3 t -114.65 -41.63 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.32 -0.862 . . . . 0.0 109.518 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.492 ' HB3' ' OD1' ' A' ' 81' ' ' ASN . 0.6 OUTLIER 176.7 -174.47 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.147 -0.971 . . . . 0.0 109.75 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.567 ' CB ' ' HD3' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -91.97 -56.24 0.25 Allowed Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.247 -0.908 . . . . 0.0 111.518 -179.231 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.567 ' HD3' ' CB ' ' A' ' 54' ' ' SER . 35.4 Cg_endo -75.17 89.3 1.18 Allowed 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.913 1.742 . . . . 0.0 110.082 -177.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 1.025 ' CE2' ' HB1' ' A' ' 87' ' ' ALA . 4.0 m-30 -84.82 -179.52 7.11 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.433 0.635 . . . . 0.0 109.982 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.583 ' O ' ' CE1' ' A' ' 80' ' ' PHE . 87.2 m-85 -151.86 130.38 12.21 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.477 -0.765 . . . . 0.0 109.098 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.513 ' OE1' ' NH2' ' A' ' 77' ' ' ARG . 12.7 pt-20 -89.11 133.7 34.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 0.0 110.917 -178.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.684 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 20.0 t-105 -160.25 139.52 8.02 Favored Pre-proline 0 N--CA 1.491 1.6 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.684 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 32.8 Cg_endo -72.11 152.88 57.06 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.482 2.121 . . . . 0.0 111.897 -178.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 1.053 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -115.48 122.3 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.053 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -117.58 169.81 9.25 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.098 -1.001 . . . . 0.0 109.429 179.611 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.536 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 6.6 t -121.26 39.06 3.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 108.799 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.64 -31.13 5.28 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.569 -0.707 . . . . 0.0 109.356 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.23 12.56 59.84 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 67' ' ' VAL . 0.6 OUTLIER -106.16 9.89 32.1 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.212 -1.169 . . . . 0.0 109.595 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.717 HG22 ' HB1' ' A' ' 22' ' ' ALA . 91.9 t 60.8 143.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.169 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.779 ' HA ' HD11 ' A' ' 62' ' ' LEU . 16.7 t80 -55.53 108.79 0.47 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.124 -0.985 . . . . 0.0 109.402 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.68 48.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.408 -0.808 . . . . 0.0 109.325 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -149.38 -52.72 0.02 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 167.78 -167.61 40.15 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.411 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 0.3 OUTLIER 60.68 68.05 1.4 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.296 -1.12 . . . . 0.0 109.324 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 72' ' ' SER . 36.3 Cg_endo -78.72 155.74 27.4 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.742 2.295 . . . . 0.0 110.944 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.713 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 74.99 -149.84 40.06 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 80.17 -77.95 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.503 -0.998 . . . . 0.0 109.989 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.516 ' OD1' ' CB ' ' A' ' 6' ' ' CYS . 41.8 m-20 -131.28 134.91 46.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.019 -1.05 . . . . 0.0 110.333 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.629 ' NH1' ' CE2' ' A' ' 38' ' ' TYR . 1.6 mtt180 -138.42 123.92 19.56 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 78' ' ' VAL . 4.7 p -112.52 120.84 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.958 -1.089 . . . . 0.0 108.896 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.814 ' CG2' HD11 ' A' ' 90' ' ' ILE . 14.8 t -79.05 170.61 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 122.083 0.944 . . . . 0.0 110.266 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.733 ' CG ' ' NE2' ' A' ' 20' ' ' GLN . 3.2 p90 -164.19 -171.36 2.38 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.492 ' OD1' ' HB3' ' A' ' 53' ' ' SER . 7.3 t30 -123.95 -81.41 0.64 Allowed 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.229 -0.989 . . . . 0.0 109.949 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.457 ' OE2' ' O ' ' A' ' 81' ' ' ASN . 66.7 mm-40 -159.24 18.08 0.18 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.288 -0.882 . . . . 0.0 109.645 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.465 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 3.8 m-20 -136.79 24.25 3.09 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.584 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 0.2 OUTLIER 48.02 23.32 0.48 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.463 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.633 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -67.68 -90.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.444 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.83 ' O ' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER 165.39 106.8 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.132 -0.98 . . . . 0.0 110.36 178.674 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 1.025 ' HB1' ' CE2' ' A' ' 56' ' ' TYR . . . -74.97 -42.09 58.29 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 162.74 154.13 7.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.989 HG21 ' CG ' ' A' ' 4' ' ' TYR . 40.2 t -93.3 105.33 16.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 120.843 -1.387 . . . . 0.0 110.164 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.814 HD11 ' CG2' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -99.43 172.64 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.214 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.469 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 2.8 t -145.02 141.07 28.59 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.668 -1.27 . . . . 0.0 111.261 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.528 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.3 OUTLIER -88.68 55.95 3.58 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.306 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 93' ' ' THR . 5.8 t -168.4 23.09 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.157 -0.964 . . . . 0.0 110.309 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -125.81 23.99 5.83 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.849 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -177.89 117.93 0.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.407 -1.054 . . . . 0.0 109.506 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.459 ' O ' ' C ' ' A' ' 97' ' ' GLY . 2.5 m 46.06 -159.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.114 -0.991 . . . . 0.0 109.21 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 96' ' ' SER . . . -39.02 -50.64 2.68 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.528 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -152.12 -76.02 0.13 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.107 -1.231 . . . . 0.0 109.605 179.74 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.849 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.2 OUTLIER 60.91 146.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.135 -0.978 . . . . 0.0 108.772 -179.476 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.549 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -93.5 125.78 38.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.857 -1.152 . . . . 0.0 110.451 -179.51 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.543 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -145.22 137.68 21.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.512 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.45 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.0 OUTLIER -44.36 129.83 6.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.229 -0.919 . . . . 0.0 109.477 -179.598 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.469 ' SG ' ' HB ' ' A' ' 91' ' ' THR . 12.6 m -54.13 98.36 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.196 -0.94 . . . . 0.0 109.425 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 109.478 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.496 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 25.6 p 174.29 156.64 0.14 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.346 -0.846 . . . . 0.0 109.776 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.72 -40.75 2.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.344 -0.847 . . . . 0.0 109.105 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.641 ' CE1' ' CG2' ' A' ' 89' ' ' VAL . 15.1 m-85 -82.24 127.17 32.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.348 -0.845 . . . . 0.0 109.656 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.46 ' O ' ' SG ' ' A' ' 103' ' ' CYS . 0.2 OUTLIER -133.44 129.6 37.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.375 -0.828 . . . . 0.0 109.194 179.727 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 98.3 m -139.38 16.56 2.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.118 -0.989 . . . . 0.0 110.079 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.14 42.9 0.07 OUTLIER Glycine 0 C--N 1.284 -2.348 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.09 12.34 4.93 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.281 -1.129 . . . . 0.0 109.29 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.409 ' O ' HG23 ' A' ' 5' ' ' THR . 13.3 m120 -84.22 -171.97 3.91 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.216 -0.928 . . . . 0.0 109.13 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.432 ' C ' ' CB ' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -131.47 67.09 1.53 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.248 -0.908 . . . . 0.0 109.047 -179.902 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.5 ' CZ ' ' HB3' ' A' ' 63' ' ' SER . 36.2 m-85 -79.3 120.32 23.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.0 108.802 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.904 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -91.84 137.2 32.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.911 . . . . 0.0 110.407 -179.164 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.7 p -51.75 -21.9 3.14 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.9 t -84.45 -35.86 22.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.307 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.3 -23.5 60.29 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.904 HG23 ' O ' ' A' ' 12' ' ' SER . 2.7 t -74.58 -31.5 27.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -45.15 95.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -0.777 . . . . 0.0 109.034 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.1 m -60.09 -42.64 95.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.218 -0.926 . . . . 0.0 108.801 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.821 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -76.43 -13.28 60.12 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.475 ' NE2' ' O ' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -87.31 -21.99 25.4 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.1 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -85.59 -12.49 51.38 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.34 -56.04 4.32 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.349 -0.845 . . . . 0.0 109.261 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.591 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -66.56 -21.12 70.53 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.491 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 0.9 OUTLIER -81.38 -62.4 1.66 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.459 -1.024 . . . . 0.0 109.158 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 1.6 tt0 -44.3 -43.36 7.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.149 -0.97 . . . . 0.0 109.247 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.46 ' HA ' HD22 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -64.15 -43.84 93.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.252 -0.905 . . . . 0.0 109.12 179.726 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.621 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 28.3 t60 -68.07 -14.54 63.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.841 . . . . 0.0 110.102 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -95.65 -26.31 15.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.012 -1.055 . . . . 0.0 110.01 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 26.3 t0 -88.15 -10.48 49.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.161 -0.962 . . . . 0.0 109.73 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.09 0.78 66.46 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.414 ' C ' HD11 ' A' ' 26' ' ' LEU . 2.5 mm-40 -79.34 -169.29 1.82 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.159 -1.201 . . . . 0.0 109.281 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.995 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -127.37 178.21 6.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.774 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.567 ' CG2' ' HD3' ' A' ' 39' ' ' PRO . 60.1 t -82.31 -98.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.401 -0.812 . . . . 0.0 110.277 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.528 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -122.01 57.64 0.61 Allowed Glycine 0 N--CA 1.488 2.114 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.186 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER 78.96 -10.63 1.32 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.51 -0.994 . . . . 0.0 110.512 179.416 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -112.1 -6.8 14.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.894 -1.129 . . . . 0.0 109.515 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.995 ' HA ' HG22 ' A' ' 32' ' ' THR . 8.0 t 58.13 -175.06 0.08 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.238 -0.914 . . . . 0.0 109.316 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.735 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER 168.27 -44.94 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 111.495 179.324 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 31.8 Cg_endo -75.58 100.65 1.39 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.409 1.406 . . . . 0.0 111.976 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.735 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -144.39 -178.28 5.9 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.584 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.602 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -74.85 154.02 38.44 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.404 ' N ' ' HG2' ' A' ' 41' ' ' LYS . 19.2 t80 -125.62 145.72 50.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.992 -1.067 . . . . 0.0 110.249 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.444 ' O ' ' C ' ' A' ' 44' ' ' ASN . 41.1 t-20 -117.49 66.02 0.74 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 43' ' ' ASN . 0.6 OUTLIER -40.0 147.72 0.09 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.501 -0.749 . . . . 0.0 110.146 -179.369 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.459 ' O ' ' C ' ' A' ' 46' ' ' GLU . 98.2 m-85 -118.57 -44.73 2.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.403 -0.811 . . . . 0.0 108.999 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -38.63 -47.93 1.39 Allowed 'General case' 0 C--N 1.309 -1.18 0 O-C-N 121.599 -0.688 . . . . 0.0 109.915 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.16 48.38 0.06 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 86.7 m-85 -96.17 90.82 5.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.244 -1.151 . . . . 0.0 108.964 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.59 82.51 1.77 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.925 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.975 ' CD2' ' HB1' ' A' ' 87' ' ' ALA . 4.8 m-85 -78.33 -169.22 1.57 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.369 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.1 m -109.6 17.12 21.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.305 -0.872 . . . . 0.0 109.419 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.436 HG21 ' HA ' ' A' ' 87' ' ' ALA . 64.1 t -77.06 -60.13 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.356 -0.84 . . . . 0.0 109.48 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.42 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -172.11 161.77 5.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.105 -0.997 . . . . 0.0 109.715 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.585 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -72.18 -51.99 7.6 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.477 -0.764 . . . . 0.0 110.227 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 54' ' ' SER . 36.4 Cg_endo -76.24 87.0 1.47 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 121.939 1.759 . . . . 0.0 109.858 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.563 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 38.1 m-85 -79.04 -174.44 4.07 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.698 -0.627 . . . . 0.0 109.67 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.621 ' CE2' ' NE2' ' A' ' 27' ' ' HIS . 83.2 m-85 -154.93 134.63 12.77 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.405 ' HB2' ' NH2' ' A' ' 77' ' ' ARG . 3.9 pt-20 -96.75 144.3 26.88 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 122.053 0.93 . . . . 0.0 111.845 -177.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.698 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 32.2 t-105 -161.19 136.04 5.46 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.698 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.4 Cg_endo -69.57 147.2 63.59 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 121.864 1.709 . . . . 0.0 111.479 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.936 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -119.02 137.4 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.779 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.936 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.8 OUTLIER -120.27 172.79 7.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.128 -0.983 . . . . 0.0 109.701 -179.301 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.5 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . 5.4 p -119.45 29.64 7.51 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.187 -0.946 . . . . 0.0 108.768 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.96 -148.99 0.39 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.48 -0.762 . . . . 0.0 109.541 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -121.75 72.14 0.38 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -170.99 155.42 4.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -1.12 . . . . 0.0 109.769 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.567 HG13 ' HZ2' ' A' ' 59' ' ' TRP . 23.6 t -93.81 154.91 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.852 . . . . 0.0 109.291 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.516 ' O ' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -72.79 84.46 1.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.95 -1.094 . . . . 0.0 110.025 -179.506 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.436 ' HA ' HG12 ' A' ' 33' ' ' VAL . 14.5 t -81.0 -5.4 57.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.306 -0.871 . . . . 0.0 109.125 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -174.82 -144.14 4.78 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.17 -157.15 31.62 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.499 ' OG ' ' HD2' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -127.25 156.52 74.6 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.199 -1.177 . . . . 0.0 109.502 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.499 ' HD2' ' OG ' ' A' ' 72' ' ' SER . 35.5 Cg_endo -77.88 -175.15 2.55 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.643 2.229 . . . . 0.0 110.379 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 88.01 -167.1 35.95 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.573 ' N ' ' HB2' ' A' ' 92' ' ' HIS . . . 66.33 -83.94 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.706 -0.879 . . . . 0.0 109.987 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -137.12 157.28 47.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.044 -1.035 . . . . 0.0 109.753 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.487 ' O ' HG12 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -170.35 114.75 0.48 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.246 -0.909 . . . . 0.0 109.338 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 88' ' ' GLY . 14.1 p -90.77 134.09 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.07 -1.019 . . . . 0.0 109.173 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.842 HG23 ' CD1' ' A' ' 90' ' ' ILE . 20.1 t -98.88 165.32 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 122.174 0.988 . . . . 0.0 110.313 -179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.572 ' N ' ' CG1' ' A' ' 79' ' ' VAL . 20.1 p90 -163.16 -168.46 1.74 Allowed 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -178.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.52 ' O ' ' CB ' ' A' ' 82' ' ' GLU . 2.1 p-10 -128.73 -44.38 1.34 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.791 -1.193 . . . . 0.0 110.387 -179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 0.2 OUTLIER 163.1 -25.89 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.379 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.503 ' HB3' ' HG2' ' A' ' 85' ' ' GLN . 1.2 t-20 -90.9 0.5 57.48 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.488 ' HB3' ' O ' ' A' ' 83' ' ' ASN . 37.6 t30 64.84 28.32 12.81 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.541 -0.724 . . . . 0.0 109.56 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.557 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -70.06 -27.56 64.74 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.98 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.565 HD21 HG21 ' A' ' 78' ' ' VAL . 0.3 OUTLIER 88.06 114.18 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.603 0.716 . . . . 0.0 110.197 179.42 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.975 ' HB1' ' CD2' ' A' ' 50' ' ' PHE . . . -87.38 -44.87 11.05 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.676 ' O ' HG23 ' A' ' 78' ' ' VAL . . . 166.1 -158.99 32.14 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.641 ' CG2' ' CE1' ' A' ' 4' ' ' TYR . 23.5 t -140.44 99.39 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.088 -1.243 . . . . 0.0 110.076 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.842 ' CD1' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -80.94 145.27 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.177 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.611 HG22 ' O ' ' A' ' 101' ' ' VAL . 9.7 t -130.53 132.05 45.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.867 -1.146 . . . . 0.0 110.884 -179.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.578 ' ND1' ' O ' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -91.76 79.24 5.38 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.646 -0.658 . . . . 0.0 109.534 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.0 m -175.07 118.23 0.18 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.183 -0.948 . . . . 0.0 109.603 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 113.86 2.89 23.69 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.411 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -144.87 146.53 32.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.135 -1.215 . . . . 0.0 109.731 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 95' ' ' ALA . 34.5 m -44.5 143.02 1.42 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.346 -0.846 . . . . 0.0 109.055 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.461 ' O ' ' C ' ' A' ' 98' ' ' ASN . . . 50.54 38.6 35.62 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.578 ' O ' ' ND1' ' A' ' 92' ' ' HIS . 0.2 OUTLIER 36.02 44.18 0.24 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.947 -0.737 . . . . 0.0 110.041 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -47.52 132.8 13.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.983 -1.073 . . . . 0.0 109.167 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.614 ' CD1' ' HB ' ' A' ' 90' ' ' ILE . 19.3 m-85 -60.03 134.57 57.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.034 -1.041 . . . . 0.0 109.924 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.611 ' O ' HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -137.61 130.84 42.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.865 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.477 ' CG ' ' O ' ' A' ' 102' ' ' GLU . 1.5 pt-20 -55.15 111.22 0.81 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.281 -0.887 . . . . 0.0 109.268 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 5' ' ' THR . 0.5 OUTLIER -55.33 146.38 19.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.342 -0.849 . . . . 0.0 109.917 -179.484 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 74.6 p . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.36 -0.838 . . . . 0.0 109.489 -179.993 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.439 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.258 0.551 . . . . 0.0 109.618 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.4 p 168.75 145.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.259 -0.901 . . . . 0.0 110.183 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -120.2 -27.67 5.23 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.542 -0.724 . . . . 0.0 109.086 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.621 ' CG ' HG21 ' A' ' 89' ' ' VAL . 19.4 m-85 -88.61 112.16 22.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 109.312 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.644 HG23 ' N ' ' A' ' 9' ' ' ASN . 80.1 m -140.32 120.2 13.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.341 -0.849 . . . . 0.0 109.337 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 69.3 m -118.05 16.71 14.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 122.171 0.986 . . . . 0.0 109.682 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 169.09 60.88 0.03 OUTLIER Glycine 0 C--N 1.282 -2.421 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.07 15.72 7.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.322 -1.105 . . . . 0.0 109.147 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.644 ' N ' HG23 ' A' ' 5' ' ' THR . 11.8 m120 -81.19 131.74 35.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.415 -0.803 . . . . 0.0 109.723 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.3 t -97.83 58.89 1.42 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.836 . . . . 0.0 109.007 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.574 ' CE1' ' HB2' ' A' ' 63' ' ' SER . 7.5 m-30 -79.92 127.73 32.6 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.753 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -85.03 138.76 32.24 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.183 -0.948 . . . . 0.0 110.188 -179.223 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.46 -18.76 7.68 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.1 t -89.4 -31.24 17.84 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.521 -0.737 . . . . 0.0 109.153 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.31 -34.83 68.39 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 12' ' ' SER . 2.6 t -57.56 -35.18 49.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.04 -40.95 77.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.558 -0.714 . . . . 0.0 109.258 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.17 -55.98 13.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.332 -0.855 . . . . 0.0 109.137 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.533 ' HB3' ' CD1' ' A' ' 61' ' ' ILE . . . -71.41 -4.15 24.76 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.485 -0.759 . . . . 0.0 109.264 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.805 ' OE1' HG22 ' A' ' 78' ' ' VAL . 5.6 tp60 -101.57 -8.49 21.83 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.64 -9.14 19.41 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.333 -0.854 . . . . 0.0 109.248 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.6 -36.97 28.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 109.133 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 27' ' ' HIS . . . -72.03 -9.66 71.82 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.511 ' CE1' ' O ' ' A' ' 82' ' ' GLU . 18.4 t80 -101.36 -49.59 4.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.442 -1.034 . . . . 0.0 109.347 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -52.18 -38.58 58.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.876 . . . . 0.0 109.339 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.572 HD11 ' CB ' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -79.89 -45.11 19.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.473 -0.767 . . . . 0.0 109.138 179.754 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.575 ' ND1' ' N ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -45.41 -39.06 6.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.584 -0.697 . . . . 0.0 110.326 -179.713 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.575 ' N ' ' ND1' ' A' ' 27' ' ' HIS . 3.4 tp10 -94.29 -40.28 10.06 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.257 -0.902 . . . . 0.0 109.128 -178.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 28' ' ' GLU . 19.9 t0 -47.81 -23.76 0.82 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.434 ' N ' ' C ' ' A' ' 28' ' ' GLU . . . 80.5 14.16 80.49 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.572 ' CB ' HD11 ' A' ' 26' ' ' LEU . 0.9 OUTLIER -103.17 -170.11 1.74 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.232 -1.158 . . . . 0.0 109.176 179.789 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.983 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -137.41 174.41 10.63 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.204 -0.935 . . . . 0.0 109.648 -179.868 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.468 ' O ' ' C ' ' A' ' 34' ' ' GLY . 14.1 m -81.13 -162.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.876 . . . . 0.0 109.252 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -34.92 -57.6 0.79 Allowed Glycine 0 N--CA 1.498 2.779 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.73 30.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.321 -1.105 . . . . 0.0 109.724 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 37' ' ' SER . 1.2 m120 -134.16 6.45 3.61 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.214 -0.929 . . . . 0.0 109.356 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.983 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.2 OUTLIER 47.39 -173.64 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.234 -0.916 . . . . 0.0 109.357 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.73 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER 164.45 -44.15 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.641 -0.662 . . . . 0.0 111.415 179.522 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 38' ' ' TYR . 30.7 Cg_endo -73.83 99.62 1.18 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 121.295 1.33 . . . . 0.0 112.294 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.73 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -141.36 179.36 6.83 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.078 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -69.36 149.67 48.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.971 -1.081 . . . . 0.0 109.797 -179.336 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.615 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 1.5 t80 -115.3 146.57 41.38 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -156.94 91.3 1.19 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.997 -1.065 . . . . 0.0 109.711 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.615 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 2.2 t-20 -113.88 -51.56 2.78 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.351 -0.843 . . . . 0.0 109.599 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.453 ' O ' ' C ' ' A' ' 46' ' ' GLU . 40.7 m-85 50.44 22.65 1.07 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.133 -0.98 . . . . 0.0 109.055 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 48' ' ' PHE . 1.1 tm-20 -38.7 -61.31 0.73 Allowed 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.64 -0.662 . . . . 0.0 109.992 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.42 ' C ' ' CD1' ' A' ' 48' ' ' PHE . . . -177.09 45.18 0.1 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.507 ' CZ ' ' HB3' ' A' ' 46' ' ' GLU . 0.7 OUTLIER -124.89 168.05 13.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -1.134 . . . . 0.0 109.479 -179.908 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 50' ' ' PHE . 11.1 t70 -124.42 68.7 1.08 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.345 -0.847 . . . . 0.0 109.156 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.541 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 17.4 m-85 -52.52 -171.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.445 -0.785 . . . . 0.0 109.859 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 99.6 p -158.12 37.29 0.25 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.387 -0.821 . . . . 0.0 109.323 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.591 HG21 ' O ' ' A' ' 86' ' ' LEU . 97.4 t -108.97 -73.79 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.227 -0.92 . . . . 0.0 109.738 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.2 177.74 8.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.173 -0.955 . . . . 0.0 110.211 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.62 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -78.99 -50.92 1.36 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.658 -0.651 . . . . 0.0 111.13 -179.88 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 54' ' ' SER . 32.4 Cg_endo -72.56 93.57 0.76 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.861 1.707 . . . . 0.0 109.881 -177.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.59 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 4.5 m-85 -87.06 -176.82 5.86 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.509 0.671 . . . . 0.0 110.009 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.59 ' CG ' ' O ' ' A' ' 56' ' ' TYR . 81.7 m-85 -160.65 118.58 2.49 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.456 ' HB3' ' HB2' ' A' ' 42' ' ' TYR . 0.7 OUTLIER -83.77 142.05 30.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.142 -0.974 . . . . 0.0 111.125 -178.554 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.689 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 26.0 t-105 -161.16 139.31 7.14 Favored Pre-proline 0 N--CA 1.494 1.746 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.689 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.8 Cg_endo -68.35 144.61 62.64 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.003 1.802 . . . . 0.0 111.362 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 1.005 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -109.59 136.66 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.645 -0.659 . . . . 0.0 109.326 -179.501 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.005 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.3 OUTLIER -125.89 -177.7 4.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.297 -0.877 . . . . 0.0 109.417 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.574 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -117.57 -14.09 10.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.075 -1.016 . . . . 0.0 108.815 179.676 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.32 -58.53 3.23 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.584 -0.698 . . . . 0.0 109.189 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 114.21 10.59 13.39 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.451 ' O ' ' HB ' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -89.51 13.81 12.95 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.212 -1.169 . . . . 0.0 109.488 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.581 HG13 ' CZ2' ' A' ' 59' ' ' TRP . 99.6 t 61.77 131.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.274 -0.891 . . . . 0.0 109.527 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.569 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 34.6 t80 -46.81 107.32 0.1 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.235 -0.916 . . . . 0.0 109.469 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.3 16.07 6.09 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.175 -0.953 . . . . 0.0 109.468 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.6 65.18 0.02 OUTLIER Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.09 147.53 19.21 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.85 124.57 8.06 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.266 -1.138 . . . . 0.0 109.326 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.436 ' HB3' ' OH ' ' A' ' 38' ' ' TYR . 36.3 Cg_endo -78.02 150.56 26.59 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.452 2.101 . . . . 0.0 110.732 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.716 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 106.2 -175.03 21.0 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 79.84 -70.54 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.431 -1.04 . . . . 0.0 110.546 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.421 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 1.4 m-20 -134.95 152.22 51.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.741 -1.225 . . . . 0.0 110.107 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.545 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 7.4 mtt180 -163.47 105.68 0.98 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.42 -0.8 . . . . 0.0 108.981 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.805 HG22 ' OE1' ' A' ' 20' ' ' GLN . 8.1 p -89.45 144.59 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.986 -1.071 . . . . 0.0 109.479 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.582 HG12 ' N ' ' A' ' 80' ' ' PHE . 35.5 t -112.52 166.08 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.35 -0.844 . . . . 0.0 109.771 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 80' ' ' PHE . 1.5 p90 -151.71 -178.2 6.57 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.585 ' HB3' HG12 ' A' ' 52' ' ' VAL . 16.9 p-10 -109.79 -47.16 3.39 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.019 -1.05 . . . . 0.0 109.857 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.535 ' HG2' ' ND2' ' A' ' 81' ' ' ASN . 0.6 OUTLIER 167.15 -25.07 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.502 ' HB3' ' HG2' ' A' ' 85' ' ' GLN . 1.1 t30 -92.49 8.86 36.88 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.47 -0.769 . . . . 0.0 108.967 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 83' ' ' ASN . 19.2 t30 63.33 13.42 7.01 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.42 -0.8 . . . . 0.0 110.137 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.566 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 3.7 mt-30 -57.13 -82.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.852 -1.155 . . . . 0.0 107.968 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.591 ' O ' HG21 ' A' ' 52' ' ' VAL . 0.1 OUTLIER 165.28 108.87 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.398 -0.814 . . . . 0.0 110.684 178.466 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.541 ' O ' ' CD1' ' A' ' 50' ' ' PHE . . . -74.97 -44.09 50.27 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 146.55 149.18 4.92 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.689 -1.765 . . . . 0.0 108.689 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.621 HG21 ' CG ' ' A' ' 4' ' ' TYR . 38.9 t -88.64 131.44 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.161 -1.199 . . . . 0.0 109.744 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.805 HD12 ' CB ' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -123.85 178.01 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.608 HG22 HG23 ' A' ' 101' ' ' VAL . 2.7 t -138.48 145.85 41.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.813 -1.179 . . . . 0.0 111.195 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.632 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.1 OUTLIER -93.25 76.94 4.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.621 -0.674 . . . . 0.0 109.557 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 92' ' ' HIS . 7.1 t 176.52 -27.25 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.411 -0.806 . . . . 0.0 110.434 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.531 ' HA3' HG21 ' A' ' 101' ' ' VAL . . . -65.14 -7.01 29.19 Favored Glycine 0 N--CA 1.493 2.434 0 O-C-N 121.125 -0.984 . . . . 0.0 110.673 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.994 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . . . -133.71 164.86 26.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.884 -1.362 . . . . 0.0 110.056 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 95' ' ' ALA . 11.1 p -41.7 120.95 1.61 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.58 -0.7 . . . . 0.0 109.26 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.8 -78.0 2.05 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.846 -1.701 . . . . 0.0 108.846 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.632 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -160.52 -68.07 0.07 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.268 -1.137 . . . . 0.0 109.551 179.751 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.994 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 0.3 OUTLIER 57.05 -173.36 0.08 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.135 -0.978 . . . . 0.0 109.142 -179.711 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.805 ' CB ' HD12 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -132.87 113.81 13.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.021 -1.049 . . . . 0.0 110.103 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.608 HG23 HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -123.64 136.74 59.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.334 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.485 ' OE2' ' HB3' ' A' ' 48' ' ' PHE . 2.2 mt-10 -56.11 120.47 7.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.286 -0.884 . . . . 0.0 109.728 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.2 176.33 0.34 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.898 . . . . 0.0 109.462 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 19.0 p . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.972 -1.014 . . . . 0.0 109.588 -179.901 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.465 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.8 p 167.17 115.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.924 . . . . 0.0 109.8 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 14.9 t70 -108.72 4.71 24.06 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.398 -0.814 . . . . 0.0 109.363 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.582 ' CD1' ' HB ' ' A' ' 89' ' ' VAL . 5.4 m-85 -104.99 71.35 0.95 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.548 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 5' ' ' THR . 8.8 t -86.84 124.44 33.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.179 -0.95 . . . . 0.0 109.388 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 92.5 m -122.24 16.66 10.67 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 122.096 0.951 . . . . 0.0 109.684 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 152.73 -62.09 0.39 Allowed Glycine 0 C--N 1.283 -2.383 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.6 m -166.98 36.03 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.347 -1.09 . . . . 0.0 109.065 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.461 ' O ' ' C ' ' A' ' 10' ' ' CYS . 3.7 m120 -111.44 -27.74 8.49 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.356 -0.84 . . . . 0.0 109.803 -179.565 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.493 ' C ' ' HB2' ' A' ' 2' ' ' CYS . 1.1 t 40.4 76.44 0.07 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.365 -0.834 . . . . 0.0 109.311 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.424 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 2.8 m-85 -79.57 150.34 31.11 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.417 -0.802 . . . . 0.0 109.297 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.992 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -80.47 132.1 35.66 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.432 -0.793 . . . . 0.0 109.62 -179.874 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.2 p -63.33 -13.96 44.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.127 -0.983 . . . . 0.0 109.04 179.61 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.81 -27.05 13.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.31 -0.869 . . . . 0.0 109.028 179.695 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.525 ' HB2' ' HB2' ' A' ' 12' ' ' SER . 17.8 t0 -74.91 -34.2 62.11 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.278 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.992 HG23 ' O ' ' A' ' 12' ' ' SER . 2.8 t -56.47 -36.67 48.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.13 -41.11 87.46 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.37 -45.66 92.15 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.157 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.814 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -75.97 -8.29 56.6 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.075 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.59 ' OE1' ' CG ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -90.58 -25.96 19.92 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.383 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.96 -13.13 59.17 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.071 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.31 -57.0 3.56 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.33 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.605 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -62.11 -25.69 66.62 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 178.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.583 ' CE1' ' O ' ' A' ' 82' ' ' GLU . 10.2 t80 -75.72 -59.87 2.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.477 -1.013 . . . . 0.0 109.451 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 29' ' ' ASP . 1.8 tp60 -55.14 -61.51 2.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.859 . . . . 0.0 109.262 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.804 HD13 ' HB3' ' A' ' 31' ' ' GLU . 2.6 mm? -44.83 -37.3 3.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.392 -0.818 . . . . 0.0 109.57 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.408 ' HB3' ' O ' ' A' ' 24' ' ' TYR . 3.5 t60 -66.14 -54.79 21.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.439 -0.788 . . . . 0.0 111.182 -179.145 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -86.8 13.02 9.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.216 -0.928 . . . . 0.0 110.249 -178.541 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 8.0 t0 -108.35 -2.81 18.86 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.079 -1.013 . . . . 0.0 109.581 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.71 -8.76 76.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.807 ' O ' HG23 ' A' ' 32' ' ' THR . 2.4 tp10 -97.7 -152.19 0.39 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.231 -1.158 . . . . 0.0 109.474 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.821 HG22 ' CG ' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -177.27 -93.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.165 -0.96 . . . . 0.0 109.411 179.976 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -156.5 -168.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.147 -0.971 . . . . 0.0 109.476 179.835 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 35' ' ' SER . . . -63.67 87.14 0.06 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.535 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.455 ' C ' ' O ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER 40.2 43.27 1.35 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.486 -1.008 . . . . 0.0 109.788 179.772 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.417 ' O ' ' C ' ' A' ' 37' ' ' SER . 4.9 m-80 -122.63 -25.25 4.74 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.103 -0.998 . . . . 0.0 109.726 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 36' ' ' ASN . 0.9 OUTLIER 45.27 76.82 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.16 -0.962 . . . . 0.0 109.211 -179.762 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.717 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -98.93 -23.37 0.22 Allowed Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -179.068 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.821 ' CG ' HG22 ' A' ' 32' ' ' THR . 37.5 Cg_endo -80.28 100.87 1.29 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 C-N-CA 121.476 1.451 . . . . 0.0 113.577 -178.732 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.545 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -127.53 -176.51 3.77 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.12 -0.987 . . . . 0.0 108.722 176.897 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.1 OUTLIER -100.18 144.36 29.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.097 -1.002 . . . . 0.0 109.455 179.94 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.579 ' CE2' ' HA ' ' A' ' 44' ' ' ASN . 4.4 t80 -110.52 135.94 50.42 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.201 -0.937 . . . . 0.0 109.535 -179.655 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.553 ' OD1' ' CD2' ' A' ' 45' ' ' TYR . 2.7 p30 -92.16 3.67 54.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.899 . . . . 0.0 109.893 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.579 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 7.1 p-10 42.22 104.79 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.651 0.738 . . . . 0.0 111.2 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.553 ' CD2' ' OD1' ' A' ' 43' ' ' ASN . 0.9 OUTLIER -131.88 -33.23 1.39 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.071 -1.018 . . . . 0.0 109.823 179.206 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.485 ' OE1' ' CZ ' ' A' ' 48' ' ' PHE . 0.1 OUTLIER -38.17 -53.2 1.44 Allowed 'General case' 0 C--N 1.309 -1.176 0 O-C-N 121.481 -0.762 . . . . 0.0 110.159 -179.556 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.87 48.53 0.04 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.485 ' CZ ' ' OE1' ' A' ' 46' ' ' GLU . 24.8 m-85 -104.61 144.83 31.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -1.141 . . . . 0.0 109.337 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 50' ' ' PHE . 1.1 m-20 -119.07 49.58 1.31 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.292 -0.88 . . . . 0.0 109.433 179.697 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.502 ' HB2' ' OH ' ' A' ' 56' ' ' TYR . 21.7 m-85 -50.36 -178.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.385 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.1 p -133.93 18.26 3.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -0.859 . . . . 0.0 109.003 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.496 HG21 ' O ' ' A' ' 86' ' ' LEU . 66.6 t -85.74 -82.0 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.372 -0.83 . . . . 0.0 109.532 -179.857 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.31 177.98 10.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.004 -1.06 . . . . 0.0 110.147 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.602 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -79.5 -52.54 1.12 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.473 -0.767 . . . . 0.0 110.884 -179.889 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 54' ' ' SER . 33.1 Cg_endo -73.07 95.11 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.016 1.81 . . . . 0.0 109.844 -177.86 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.595 ' CE1' ' HB2' ' A' ' 87' ' ' ALA . 5.7 m-85 -95.94 -179.28 4.64 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.63 0.728 . . . . 0.0 110.276 -178.913 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.577 ' CD2' ' O ' ' A' ' 81' ' ' ASN . 96.5 m-85 -152.73 131.61 12.49 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.392 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.91 142.19 27.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 110.815 -178.837 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.681 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 24.1 t-105 -160.26 137.74 6.99 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.697 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.681 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.6 Cg_endo -69.78 149.52 66.89 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.175 1.917 . . . . 0.0 111.423 -179.042 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.975 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -120.5 129.13 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.607 -0.683 . . . . 0.0 109.349 -179.672 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.975 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.4 OUTLIER -118.84 172.29 7.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.287 179.514 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.81 27.79 6.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.117 -0.99 . . . . 0.0 108.847 179.688 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.91 -12.46 17.5 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.564 -0.71 . . . . 0.0 109.318 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.66 -10.22 68.72 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.703 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 2.9 m-20 -97.55 172.95 7.41 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.216 -1.167 . . . . 0.0 110.022 -179.542 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.509 HG13 ' CZ2' ' A' ' 59' ' ' TRP . 93.7 t -90.09 150.08 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.679 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.918 ' HA ' HD11 ' A' ' 62' ' ' LEU . 13.6 t80 -47.31 118.75 2.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.955 -1.091 . . . . 0.0 109.69 -179.479 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.455 ' O ' ' OG ' ' A' ' 69' ' ' SER . 1.7 t -135.38 13.88 3.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.489 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 132.57 140.59 4.48 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 137.86 -128.24 4.18 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.8 p -69.55 120.98 80.77 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.225 -1.162 . . . . 0.0 109.334 179.852 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.69 -57.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.279 1.986 . . . . 0.0 110.443 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.537 ' HA3' ' CB ' ' A' ' 92' ' ' HIS . . . -97.34 -113.02 3.05 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 91' ' ' THR . . . 60.23 -85.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.352 -1.087 . . . . 0.0 110.561 179.521 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.436 ' C ' ' HD2' ' A' ' 77' ' ' ARG . 36.6 m-20 -122.95 131.5 53.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.848 -1.158 . . . . 0.0 110.39 -179.173 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.523 ' NE ' ' HA2' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -151.88 106.66 3.24 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.331 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 89' ' ' VAL . 7.3 p -78.81 137.98 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 110.454 -178.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.601 HG23 HD13 ' A' ' 90' ' ' ILE . 39.8 t -97.55 166.67 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.01 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.59 ' CG ' ' OE1' ' A' ' 20' ' ' GLN . 5.7 p90 -163.46 -174.33 3.7 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 118.822 -1.151 . . . . 0.0 110.281 -178.002 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.577 ' O ' ' CD2' ' A' ' 57' ' ' TYR . 3.2 t-20 -109.11 -80.13 0.58 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.28 -0.888 . . . . 0.0 109.766 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.583 ' O ' ' CE1' ' A' ' 24' ' ' TYR . 10.8 pt-20 -161.9 23.36 0.11 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 109.448 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.453 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 4.0 t-20 -151.7 51.38 0.81 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.552 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.487 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 0.4 OUTLIER 44.86 26.95 0.23 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.568 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.477 ' OE1' ' HB3' ' A' ' 81' ' ' ASN . 14.0 mt-30 -64.4 -163.18 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.206 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.496 ' O ' HG21 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -144.48 104.37 4.06 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.787 -1.196 . . . . 0.0 110.573 179.913 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.595 ' HB2' ' CE1' ' A' ' 56' ' ' TYR . . . -81.68 -36.85 28.28 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.854 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 150.91 138.34 2.82 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.582 ' HB ' ' CD1' ' A' ' 4' ' ' TYR . 36.9 t -83.04 100.0 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.181 -1.188 . . . . 0.0 109.67 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.627 ' HB ' ' HB3' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -87.01 159.83 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.4 -0.813 . . . . 0.0 108.845 179.481 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.666 HG22 HG23 ' A' ' 101' ' ' VAL . 15.1 t -122.16 159.79 26.47 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.941 -1.099 . . . . 0.0 110.886 -178.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.69 ' CD2' ' O ' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -115.5 71.9 0.78 Allowed 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.434 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.445 ' OG1' ' C ' ' A' ' 92' ' ' HIS . 0.2 OUTLIER -176.61 133.13 0.21 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.416 -0.802 . . . . 0.0 109.294 -179.812 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 94.98 -6.97 69.74 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.774 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -120.54 147.29 45.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.157 -1.202 . . . . 0.0 109.727 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 95' ' ' ALA . 49.2 m -44.03 118.09 1.38 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.28 -0.887 . . . . 0.0 108.901 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.486 ' O ' ' C ' ' A' ' 98' ' ' ASN . . . 64.36 43.7 96.47 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.219 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.69 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 32.92 40.75 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.987 -0.714 . . . . 0.0 110.446 179.711 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 97' ' ' GLY . 3.0 t-20 -54.69 167.55 0.35 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.141 -0.975 . . . . 0.0 109.279 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.627 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -74.83 150.38 39.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.132 -0.98 . . . . 0.0 109.344 179.993 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.666 HG23 HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -161.02 122.54 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.417 -0.802 . . . . 0.0 109.086 179.687 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 3.6 pt-20 -41.8 131.48 3.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.387 -0.821 . . . . 0.0 109.861 -179.696 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.457 ' SG ' ' HB ' ' A' ' 91' ' ' THR . 0.7 OUTLIER -92.81 121.41 34.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.37 -0.831 . . . . 0.0 109.253 -179.981 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.8 p . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.623 -1.18 . . . . 0.0 109.445 179.955 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.495 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.6 p 166.49 138.06 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.169 -0.957 . . . . 0.0 110.141 179.705 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -115.4 -20.05 10.44 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.381 -0.824 . . . . 0.0 109.069 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.659 ' CG ' HG21 ' A' ' 89' ' ' VAL . 13.7 m-85 -95.65 109.71 21.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.313 -0.867 . . . . 0.0 109.371 179.839 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.475 HG22 ' C ' ' A' ' 9' ' ' ASN . 1.2 p -144.25 143.79 31.2 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.966 . . . . 0.0 109.642 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.61 8.16 4.92 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.148 0.975 . . . . 0.0 109.904 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.28 55.2 0.2 Allowed Glycine 0 C--N 1.278 -2.69 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m 55.15 19.06 2.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.45 -1.029 . . . . 0.0 109.134 -179.524 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.475 ' C ' HG22 ' A' ' 5' ' ' THR . 0.6 OUTLIER -75.07 -156.88 0.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.434 -0.791 . . . . 0.0 109.091 179.929 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.4 t -155.49 58.14 0.63 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.117 -0.99 . . . . 0.0 109.766 -180.0 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.494 ' CZ ' ' HB3' ' A' ' 63' ' ' SER . 3.3 m-85 -84.51 115.3 22.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.341 -0.849 . . . . 0.0 108.925 179.527 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.699 ' O ' HG23 ' A' ' 16' ' ' VAL . 30.2 t -81.71 136.17 35.48 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.252 -0.905 . . . . 0.0 110.222 -179.259 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.1 p -49.05 -31.41 7.7 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.497 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.2 t -70.64 -40.99 72.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.532 -0.73 . . . . 0.0 109.278 179.734 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -66.42 -30.25 70.57 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.172 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 12' ' ' SER . 3.2 t -68.35 -32.9 57.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 119.519 -0.872 . . . . 0.0 108.823 179.315 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.8 -46.68 77.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.481 -0.762 . . . . 0.0 109.584 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.63 -55.66 28.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.2 -0.937 . . . . 0.0 109.251 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.932 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -72.05 -3.51 23.4 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.388 -0.82 . . . . 0.0 109.37 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.65 ' OE1' HG22 ' A' ' 78' ' ' VAL . 6.3 tp60 -100.96 -15.96 17.33 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 179.333 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.474 ' HA ' ' OD1' ' A' ' 84' ' ' ASN . . . -93.12 -15.1 26.4 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.0 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.05 -47.67 23.82 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.444 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -60.89 -24.91 63.23 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 179.351 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.435 ' CD2' ' OD1' ' A' ' 84' ' ' ASN . 19.9 t80 -83.21 -36.05 24.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.521 -0.987 . . . . 0.0 109.26 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -49.89 72.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.304 -0.872 . . . . 0.0 108.838 179.492 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 26' ' ' LEU . 0.5 OUTLIER -61.61 -40.57 95.28 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.313 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.51 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 2.2 t60 -62.52 -20.9 65.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.389 -0.819 . . . . 0.0 109.42 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.79 -30.85 16.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.948 . . . . 0.0 109.806 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.77 9.91 33.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.127 -0.983 . . . . 0.0 109.46 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 46.8 24.12 1.75 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.1 -137.59 0.09 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.211 -1.17 . . . . 0.0 109.016 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.888 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -173.59 170.34 4.1 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.899 -1.126 . . . . 0.0 109.45 -179.938 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.489 HG21 ' CE1' ' A' ' 68' ' ' TYR . 33.2 m -83.26 -138.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.316 -0.865 . . . . 0.0 109.276 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.446 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -46.88 -49.35 17.43 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.75 -32.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.487 -1.007 . . . . 0.0 109.188 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -69.47 -8.82 50.21 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.386 -0.821 . . . . 0.0 109.79 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.888 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.8 OUTLIER 67.66 -172.69 0.19 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.096 -1.002 . . . . 0.0 108.908 -179.64 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.585 ' CD1' ' HD3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER 167.53 -45.05 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.186 -0.946 . . . . 0.0 112.435 179.114 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.567 ' HD2' ' H ' ' A' ' 38' ' ' TYR . 32.3 Cg_endo -74.71 100.37 1.33 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 121.416 1.41 . . . . 0.0 112.538 -178.512 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.549 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -142.53 -174.04 4.03 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.674 -0.641 . . . . 0.0 109.535 178.463 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.635 ' HB2' ' CE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -94.66 124.16 38.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.346 -0.846 . . . . 0.0 109.903 -179.398 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.47 ' CE1' ' CZ ' ' A' ' 100' ' ' PHE . 10.5 t80 -105.8 143.59 33.74 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.118 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.577 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 74.0 m-20 -78.47 -106.61 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.905 -1.122 . . . . 0.0 109.287 -179.674 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.577 ' CB ' ' O ' ' A' ' 43' ' ' ASN . 5.9 p30 154.42 95.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.478 -0.764 . . . . 0.0 109.188 179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 1.4 p90 -124.6 -28.15 3.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -0.981 . . . . 0.0 109.632 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.493 ' OE1' HG12 ' A' ' 101' ' ' VAL . 1.9 tm-20 -40.62 -65.7 0.39 Allowed 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.383 -0.823 . . . . 0.0 109.909 -179.647 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.92 59.75 0.01 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.43 ' CE1' ' HA ' ' A' ' 101' ' ' VAL . 84.8 m-85 -98.63 154.76 17.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.31 -1.112 . . . . 0.0 109.3 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.58 45.16 2.51 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.266 -0.897 . . . . 0.0 109.273 179.589 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.538 ' CG ' ' O ' ' A' ' 87' ' ' ALA . 14.4 m-85 -61.37 -167.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 109.869 -179.716 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.07 27.75 0.85 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.523 -0.736 . . . . 0.0 109.213 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.972 HG11 ' ND2' ' A' ' 81' ' ' ASN . 93.7 t -101.05 -80.08 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.191 -0.943 . . . . 0.0 109.741 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.463 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 86.6 p -158.39 178.01 10.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.169 -0.957 . . . . 0.0 110.189 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.62 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -83.3 -46.94 0.81 Allowed Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.592 -0.692 . . . . 0.0 111.536 -179.558 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 54' ' ' SER . 32.0 Cg_endo -73.03 83.93 1.37 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.899 1.733 . . . . 0.0 110.409 -178.004 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.583 ' CE1' ' CB ' ' A' ' 87' ' ' ALA . 10.1 m-85 -86.23 -175.22 5.42 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.826 0.822 . . . . 0.0 110.769 -179.156 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.635 ' CE2' ' HB2' ' A' ' 41' ' ' LYS . 47.8 m-85 -151.96 126.09 9.22 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.941 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -88.1 138.42 31.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.921 -1.112 . . . . 0.0 110.627 -178.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.665 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 21.1 t-105 -160.62 138.55 7.18 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 179.407 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.665 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.6 Cg_endo -69.54 154.47 68.56 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.33 2.02 . . . . 0.0 111.496 -178.817 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 1.008 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -129.12 129.07 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.594 -0.691 . . . . 0.0 109.823 -179.17 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.008 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -123.15 167.65 13.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.243 -0.911 . . . . 0.0 108.776 179.191 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . 84.1 p -127.92 65.97 1.36 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.101 -0.999 . . . . 0.0 109.355 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.23 25.34 0.11 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.391 -0.818 . . . . 0.0 109.57 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 51.1 45.26 51.58 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -121.89 -27.73 4.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.316 -1.108 . . . . 0.0 109.669 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.582 HG12 ' H ' ' A' ' 68' ' ' TYR . 2.5 t 62.37 174.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.14 -0.975 . . . . 0.0 109.153 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.6 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 29.0 t80 -96.4 106.0 18.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.078 -1.014 . . . . 0.0 109.682 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.48 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 0.8 OUTLIER -151.89 21.27 0.69 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.353 -0.842 . . . . 0.0 109.366 -179.977 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.17 -91.06 1.44 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.844 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.82 57.21 0.04 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.521 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -140.58 63.04 20.16 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.236 -1.155 . . . . 0.0 109.224 179.894 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.566 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 34.8 Cg_endo -78.62 163.46 26.66 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.856 2.371 . . . . 0.0 111.051 -179.607 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.564 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 131.47 133.34 3.47 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.969 -1.11 . . . . 0.0 110.544 179.236 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 70.41 -150.57 0.1 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.431 -1.041 . . . . 0.0 110.971 178.779 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.535 ' C ' ' O ' ' A' ' 75' ' ' ALA . 96.2 m-20 -7.08 126.46 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 CA-C-O 121.686 0.755 . . . . 0.0 112.837 -179.317 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.508 ' O ' HG12 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -161.89 80.71 0.56 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.962 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.694 HG21 ' CG1' ' A' ' 16' ' ' VAL . 7.5 p -62.47 145.54 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.87 -1.144 . . . . 0.0 109.303 -179.587 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.613 HG12 ' N ' ' A' ' 80' ' ' PHE . 68.2 t -113.06 165.78 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.346 -0.847 . . . . 0.0 109.843 -179.463 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.627 ' CD1' ' NE2' ' A' ' 20' ' ' GLN . 2.1 p90 -156.25 -174.98 5.19 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.56 -178.483 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.972 ' ND2' HG11 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -116.22 -82.07 0.62 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.061 -1.025 . . . . 0.0 109.967 -179.576 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -153.08 10.64 0.46 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.358 -0.839 . . . . 0.0 110.401 -179.417 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.456 ' HB3' ' HG2' ' A' ' 85' ' ' GLN . 45.3 t-20 -135.06 7.32 3.42 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.175 -0.953 . . . . 0.0 108.835 179.309 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.474 ' OD1' ' HA ' ' A' ' 21' ' ' ALA . 6.2 m-80 72.28 9.36 5.88 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.373 -0.829 . . . . 0.0 109.451 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.524 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 1.8 mm100 -49.38 -92.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.555 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.753 ' O ' HG21 ' A' ' 52' ' ' VAL . 0.1 OUTLIER 170.72 106.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 0.0 110.716 178.681 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.583 ' CB ' ' CE1' ' A' ' 56' ' ' TYR . . . -82.72 -30.86 28.81 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.292 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.503 ' O ' HG23 ' A' ' 78' ' ' VAL . . . 146.9 -165.96 28.43 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.659 HG21 ' CG ' ' A' ' 4' ' ' TYR . 73.3 t -134.1 102.24 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.312 -1.111 . . . . 0.0 109.203 179.748 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.534 ' HB ' ' HB2' ' A' ' 100' ' ' PHE . 0.4 OUTLIER -104.5 153.99 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 109.273 -179.731 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 100' ' ' PHE . 10.2 t -122.65 137.33 54.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.095 -1.003 . . . . 0.0 110.275 -179.455 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.438 ' CE1' ' CD2' ' A' ' 100' ' ' PHE . 1.8 m-70 -80.6 75.33 7.49 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.428 -0.795 . . . . 0.0 108.908 179.175 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.5 t -173.97 158.41 3.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.544 -0.723 . . . . 0.0 109.393 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 87.04 -14.58 56.91 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.802 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . . . -131.67 114.78 15.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -1.137 . . . . 0.0 109.22 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.468 ' O ' ' C ' ' A' ' 97' ' ' GLY . 7.4 p 46.09 -160.5 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.008 -1.058 . . . . 0.0 108.963 -179.762 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 96' ' ' SER . . . -40.38 -45.12 3.25 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.468 ' O ' ' O ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -155.68 -74.89 0.1 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.213 -1.169 . . . . 0.0 109.506 179.517 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.802 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 1.9 m120 62.34 132.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.153 -0.967 . . . . 0.0 108.62 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.534 ' HB2' ' HB ' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -92.75 141.52 28.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.921 -1.112 . . . . 0.0 109.851 -179.79 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.493 HG12 ' OE1' ' A' ' 46' ' ' GLU . 4.2 m -152.12 148.94 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.793 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 101' ' ' VAL . 0.6 OUTLIER -43.44 141.1 1.46 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.09 -1.006 . . . . 0.0 109.64 -179.675 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -55.04 144.18 24.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.399 -0.813 . . . . 0.0 109.597 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.488 1.472 0 O-C-N 121.245 -0.909 . . . . 0.0 109.514 179.891 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.321 0.581 . . . . 0.0 109.666 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 28.9 p 178.18 105.87 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.378 -0.826 . . . . 0.0 109.606 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -68.31 -52.39 34.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.97 -1.081 . . . . 0.0 109.147 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.595 ' CB ' HG21 ' A' ' 89' ' ' VAL . 60.3 m-85 -92.95 105.92 17.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.411 -0.806 . . . . 0.0 109.347 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 9' ' ' ASN . 2.3 t -134.26 128.66 34.29 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.945 -1.097 . . . . 0.0 109.836 -179.866 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.484 ' SG ' ' OG1' ' A' ' 91' ' ' THR . 2.0 t -96.34 -164.79 1.19 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.357 -0.84 . . . . 0.0 109.036 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.404 ' O ' ' CB ' ' A' ' 8' ' ' SER . . . -54.26 96.26 0.03 OUTLIER Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -179.126 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.52 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 0.8 OUTLIER 70.07 54.01 0.35 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.361 -1.082 . . . . 0.0 109.837 179.272 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 8' ' ' SER . 2.1 m120 -155.69 89.42 1.17 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.398 -0.813 . . . . 0.0 109.182 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.423 ' C ' ' CB ' ' A' ' 2' ' ' CYS . 0.4 OUTLIER -74.51 79.63 1.95 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.385 -0.822 . . . . 0.0 109.181 -179.599 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.524 ' CZ ' ' HB2' ' A' ' 63' ' ' SER . 3.2 m-85 -94.46 126.09 39.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.043 -1.036 . . . . 0.0 109.131 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.635 ' O ' HG23 ' A' ' 16' ' ' VAL . 18.6 t -89.35 130.28 35.75 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 110.118 -179.466 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.523 ' HG ' ' HE2' ' A' ' 4' ' ' TYR . 4.2 t -46.22 -25.84 0.68 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.505 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.7 t -69.09 -47.4 65.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.4 -0.812 . . . . 0.0 109.314 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -26.49 65.53 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.129 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 12' ' ' SER . 13.5 t -69.09 -36.03 71.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.263 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.2 t -56.64 -47.04 80.59 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.452 -0.78 . . . . 0.0 109.668 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.08 -54.03 51.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.025 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.566 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -68.22 -12.24 60.64 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.454 -0.779 . . . . 0.0 109.061 179.545 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.652 ' NE2' ' CG ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -83.56 -27.82 29.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 0.0 108.647 179.605 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.84 -14.16 54.82 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.428 -0.795 . . . . 0.0 108.881 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.76 -56.01 5.09 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.416 -0.802 . . . . 0.0 109.355 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.612 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -66.82 -28.13 73.64 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.578 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.437 ' CE1' ' O ' ' A' ' 82' ' ' GLU . 7.0 t80 -71.89 -40.06 69.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.538 -0.977 . . . . 0.0 109.614 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.88 -51.95 54.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.049 -1.032 . . . . 0.0 109.389 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.537 ' HB3' ' CG ' ' A' ' 39' ' ' PRO . 0.8 OUTLIER -52.18 -44.02 64.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.298 -0.876 . . . . 0.0 109.404 179.768 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.624 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 3.1 t60 -53.01 -53.73 45.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.414 -0.804 . . . . 0.0 110.14 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -82.73 -1.58 51.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.331 -0.856 . . . . 0.0 109.802 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -92.67 -1.5 56.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.719 -179.836 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 51.06 37.6 37.24 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.507 ' O ' HG23 ' A' ' 32' ' ' THR . 3.1 tp10 -128.67 -152.46 0.52 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.34 -1.094 . . . . 0.0 109.367 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.751 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.6 OUTLIER -159.28 -175.91 5.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.337 -0.852 . . . . 0.0 109.197 179.901 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 35' ' ' SER . 16.6 m -130.72 160.56 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.033 -1.042 . . . . 0.0 109.803 -179.828 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 53.28 -89.2 0.01 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 33' ' ' VAL . 2.1 p -177.29 25.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.324 -1.103 . . . . 0.0 109.99 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -147.84 13.16 1.02 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.056 -1.027 . . . . 0.0 109.514 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.751 ' HA ' HG22 ' A' ' 32' ' ' THR . 3.3 p 64.4 -170.25 0.19 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -0.879 . . . . 0.0 109.542 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.71 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 170.33 -44.99 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.419 -0.801 . . . . 0.0 111.66 178.621 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.585 ' HD2' ' H ' ' A' ' 38' ' ' TYR . 34.2 Cg_endo -77.36 101.08 1.46 Allowed 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 121.314 1.342 . . . . 0.0 111.858 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.71 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -138.56 -175.27 4.07 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.396 -0.815 . . . . 0.0 109.546 178.65 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -78.55 141.97 37.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.366 -0.834 . . . . 0.0 109.73 -179.563 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.599 ' CZ ' ' HA ' ' A' ' 44' ' ' ASN . 13.7 t80 -100.61 128.86 46.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.412 -0.805 . . . . 0.0 109.284 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 44' ' ' ASN . 1.7 t30 -93.4 -4.75 50.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.192 -0.942 . . . . 0.0 109.636 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.599 ' HA ' ' CZ ' ' A' ' 42' ' ' TYR . 0.8 OUTLIER 40.06 93.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.486 -0.759 . . . . 0.0 109.951 179.952 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.464 ' O ' ' C ' ' A' ' 46' ' ' GLU . 75.4 m-85 -86.77 -38.43 16.9 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.35 -0.844 . . . . 0.0 109.842 -179.872 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.501 ' OE1' ' CE1' ' A' ' 48' ' ' PHE . 0.9 OUTLIER -38.7 -46.53 1.25 Allowed 'General case' 0 C--N 1.309 -1.193 0 O-C-N 121.413 -0.804 . . . . 0.0 110.039 -179.593 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.5 62.44 0.57 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 -179.969 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.501 ' CE1' ' OE1' ' A' ' 46' ' ' GLU . 51.7 m-85 -97.32 179.9 4.73 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.28 -1.13 . . . . 0.0 108.987 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -117.12 -41.98 2.96 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.221 -0.924 . . . . 0.0 108.89 179.501 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.581 ' CD2' ' HB1' ' A' ' 87' ' ' ALA . 4.4 m-85 47.33 -170.92 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.481 -0.762 . . . . 0.0 109.777 179.549 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -146.55 20.22 1.33 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.477 -0.764 . . . . 0.0 108.961 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.529 ' HB ' ' CE1' ' A' ' 56' ' ' TYR . 46.9 t -92.91 -83.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.366 -0.834 . . . . 0.0 109.569 -179.783 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.519 ' N ' HG12 ' A' ' 52' ' ' VAL . 69.9 m -166.87 -175.66 3.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.129 -0.982 . . . . 0.0 109.985 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.601 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -79.07 -51.19 1.32 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.51 -0.743 . . . . 0.0 111.007 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 54' ' ' SER . 33.3 Cg_endo -73.44 89.1 0.96 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.911 1.741 . . . . 0.0 109.768 -177.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.639 ' CE1' ' HB2' ' A' ' 87' ' ' ALA . 5.9 m-85 -90.04 -168.63 2.18 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.581 0.705 . . . . 0.0 110.144 -178.943 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.624 ' CE1' ' NE2' ' A' ' 27' ' ' HIS . 72.9 m-85 -158.66 120.29 3.48 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.176 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -88.68 137.9 31.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 110.838 -178.721 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.677 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 41.0 t-105 -161.03 137.8 6.45 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.416 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.677 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 33.1 Cg_endo -71.66 148.43 53.07 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.242 1.961 . . . . 0.0 111.446 -178.893 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.955 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -111.53 125.48 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.855 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.955 HD23 ' C ' ' A' ' 61' ' ' ILE . 1.5 mt -121.06 165.53 15.18 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.11 -0.994 . . . . 0.0 109.537 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.524 ' HB2' ' CZ ' ' A' ' 11' ' ' TYR . 22.9 t -129.16 48.0 2.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.469 -0.769 . . . . 0.0 109.252 179.857 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.35 21.8 3.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.406 -0.809 . . . . 0.0 109.396 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 54.74 44.2 80.31 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.57 116.28 5.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -1.132 . . . . 0.0 109.534 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.598 HG13 ' CZ2' ' A' ' 59' ' ' TRP . 54.3 t -54.51 148.48 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.209 -0.932 . . . . 0.0 109.43 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.574 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 58.5 t80 -56.91 154.13 9.95 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.226 -0.921 . . . . 0.0 109.572 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.414 ' N ' ' CG ' ' A' ' 68' ' ' TYR . 1.2 t -158.68 -53.2 0.06 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.361 -0.837 . . . . 0.0 109.383 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -166.31 79.49 0.12 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 72' ' ' SER . . . 162.06 142.56 3.43 Favored Glycine 0 N--CA 1.49 2.279 0 O-C-N 121.113 -1.228 . . . . 0.0 110.055 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.536 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 1.7 m 42.99 61.65 9.39 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.429 -1.042 . . . . 0.0 110.033 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.536 ' HD3' ' N ' ' A' ' 72' ' ' SER . 36.3 Cg_endo -78.89 -48.21 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.627 2.218 . . . . 0.0 110.551 179.816 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.495 ' CA ' ' CB ' ' A' ' 92' ' ' HIS . . . -82.06 -135.66 2.13 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.544 ' N ' ' HB2' ' A' ' 92' ' ' HIS . . . 64.76 -83.78 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.448 -1.031 . . . . 0.0 110.552 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.476 ' OD1' ' HB2' ' A' ' 6' ' ' CYS . 6.1 m-20 -119.02 139.99 50.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.757 -1.214 . . . . 0.0 109.956 -179.357 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.659 ' HD2' ' CD2' ' A' ' 92' ' ' HIS . 69.0 mtt180 -152.09 134.19 15.03 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.596 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.0 p -114.36 138.98 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.062 -1.024 . . . . 0.0 109.288 179.771 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.606 HG12 ' N ' ' A' ' 80' ' ' PHE . 43.1 t -104.51 167.46 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.36 -0.838 . . . . 0.0 109.654 -179.618 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.652 ' CG ' ' NE2' ' A' ' 20' ' ' GLN . 4.4 p90 -163.95 -172.82 2.95 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.398 -178.169 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.462 ' O ' ' HB3' ' A' ' 82' ' ' GLU . 46.7 t-20 -122.06 -46.52 2.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.018 -1.051 . . . . 0.0 109.653 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 81' ' ' ASN . 5.2 pt-20 166.85 -27.3 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.46 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 1.4 m-20 -100.37 27.54 5.65 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.074 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 83' ' ' ASN . 2.5 p-10 46.24 27.52 0.57 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.358 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.568 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 1.2 mt-30 -54.65 -32.02 58.47 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.947 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.568 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 85.94 105.25 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.587 0.708 . . . . 0.0 110.532 179.075 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.639 ' HB2' ' CE1' ' A' ' 56' ' ' TYR . . . -80.49 -43.44 20.82 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.868 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 156.19 159.04 9.15 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.595 HG21 ' CB ' ' A' ' 4' ' ' TYR . 58.1 t -96.39 92.37 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.185 -1.185 . . . . 0.0 109.706 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.645 HD12 ' CB ' ' A' ' 100' ' ' PHE . 0.4 OUTLIER -78.83 173.65 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.576 -0.703 . . . . 0.0 109.33 179.736 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.504 HG22 HG23 ' A' ' 101' ' ' VAL . 5.6 t -132.25 146.04 51.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.04 -1.038 . . . . 0.0 111.013 -179.035 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.659 ' CD2' ' HD2' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -93.39 62.72 3.44 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.363 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 93' ' ' THR . 2.6 t 178.92 24.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.806 -179.29 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -131.44 27.22 3.78 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.729 ' HB3' ' CB ' ' A' ' 99' ' ' ASN . . . -158.92 97.28 1.4 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.222 -1.164 . . . . 0.0 110.533 -179.65 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.47 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER 36.33 54.32 1.03 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.802 -0.561 . . . . 0.0 110.331 179.316 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 93' ' ' THR . . . 122.92 -87.72 0.4 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.526 ' HA ' ' N ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -138.16 -69.52 0.44 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.181 -1.188 . . . . 0.0 109.828 179.949 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.729 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . 1.1 t30 44.82 -167.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 0.0 108.774 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.645 ' CB ' HD12 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -130.12 114.83 16.22 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.838 -1.164 . . . . 0.0 110.805 179.916 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.504 HG23 HG22 ' A' ' 91' ' ' THR . 1.6 m -130.27 128.03 63.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.375 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 101' ' ' VAL . 4.0 mt-10 -42.98 105.66 0.05 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.331 -0.856 . . . . 0.0 109.879 -179.416 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.7 107.27 3.4 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.299 -0.876 . . . . 0.0 109.562 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 109.402 179.982 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.223 0.535 . . . . 0.0 109.767 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.7 p 164.96 99.62 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.259 -0.9 . . . . 0.0 110.06 179.559 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -78.78 -2.9 41.73 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.394 -0.816 . . . . 0.0 108.992 179.472 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.597 ' CD2' HG21 ' A' ' 89' ' ' VAL . 8.0 m-85 -118.9 107.04 13.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.949 . . . . 0.0 109.681 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.607 HG23 ' O ' ' A' ' 9' ' ' ASN . 56.0 m -142.38 143.04 32.52 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.429 ' SG ' ' OD1' ' A' ' 76' ' ' ASP . 80.8 m -123.51 15.31 9.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.048 -1.033 . . . . 0.0 110.339 -179.499 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.555 ' H ' HG22 ' A' ' 5' ' ' THR . . . 167.29 -88.56 0.1 OUTLIER Glycine 0 C--N 1.28 -2.554 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.78 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.43 26.67 7.24 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.351 -1.087 . . . . 0.0 109.504 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.607 ' O ' HG23 ' A' ' 5' ' ' THR . 2.5 m-80 -106.58 131.63 53.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.706 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 1' ' ' ALA . 43.3 t -104.28 75.95 1.29 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.53 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 3.5 m-85 -83.48 126.48 32.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.852 . . . . 0.0 110.253 -179.139 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.747 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.7 OUTLIER -81.92 125.83 31.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.645 -0.659 . . . . 0.0 109.65 179.851 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.49 -22.93 0.82 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.16 -0.963 . . . . 0.0 109.194 179.659 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.97 -39.43 26.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.94 . . . . 0.0 110.097 -179.704 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.34 -35.1 75.58 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 12' ' ' SER . 2.9 t -58.81 -26.41 32.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.057 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.7 t -63.09 -43.98 97.02 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.519 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -34.47 77.97 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.083 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.888 ' CB ' HD13 ' A' ' 61' ' ' ILE . . . -84.8 -10.04 57.58 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.059 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.512 ' NE2' ' O ' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -91.88 -21.49 20.58 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.272 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.514 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -88.32 -8.84 54.49 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 26' ' ' LEU . . . -81.04 -56.16 4.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.12 -0.988 . . . . 0.0 108.835 179.679 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.439 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -61.8 -20.46 59.74 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 179.384 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.578 ' CE1' ' HA ' ' A' ' 82' ' ' GLU . 34.0 t80 -87.28 -69.84 0.66 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.375 -1.073 . . . . 0.0 109.565 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.514 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -42.54 -52.7 4.66 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.257 -0.902 . . . . 0.0 109.398 179.9 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.636 HD13 ' CB ' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -56.92 -42.63 80.3 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.427 -0.796 . . . . 0.0 109.155 179.837 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.525 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 5.3 t60 -53.65 -52.67 59.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.352 -0.843 . . . . 0.0 110.102 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 28' ' ' GLU . 39.5 tp10 -84.38 -2.53 57.28 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.138 -0.976 . . . . 0.0 109.575 -179.56 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.435 ' HB3' ' HA ' ' A' ' 26' ' ' LEU . 38.0 t70 -94.93 -7.81 38.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.175 -0.953 . . . . 0.0 109.365 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.26 -40.12 3.04 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.746 ' O ' HG23 ' A' ' 32' ' ' THR . 1.1 mp0 -65.64 -173.9 0.18 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -1.138 . . . . 0.0 109.277 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 31' ' ' GLU . 7.2 p -161.53 -94.75 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.181 -0.95 . . . . 0.0 109.503 179.595 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.409 ' CG1' ' HB2' ' A' ' 38' ' ' TYR . 3.5 m -135.62 -114.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.982 -1.074 . . . . 0.0 109.785 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.516 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -97.42 44.75 1.83 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.5 OUTLIER 76.19 24.33 1.14 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.446 -1.032 . . . . 0.0 109.547 179.886 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -119.73 7.54 11.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -0.903 . . . . 0.0 109.677 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.453 ' HA ' ' CB ' ' A' ' 32' ' ' THR . 52.1 p 45.32 88.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.252 -0.905 . . . . 0.0 109.88 179.94 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.623 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -91.61 -40.2 0.38 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.314 -0.866 . . . . 0.0 111.736 -179.686 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 33.7 Cg_endo -76.08 109.76 2.94 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 120.986 1.124 . . . . 0.0 110.086 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.578 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -128.27 -173.23 2.89 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.203 -179.396 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -103.37 141.95 35.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.093 -1.004 . . . . 0.0 110.059 -179.622 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.485 ' CE2' ' HA ' ' A' ' 44' ' ' ASN . 68.3 t80 -107.05 160.09 15.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.205 -0.934 . . . . 0.0 109.228 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.564 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 0.5 OUTLIER -109.95 -84.98 0.55 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.095 -1.003 . . . . 0.0 109.776 -179.91 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.581 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 0.4 OUTLIER 155.99 135.07 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.729 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.581 ' CD1' ' O ' ' A' ' 44' ' ' ASN . 19.6 m-85 -152.41 -64.88 0.17 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.068 -1.02 . . . . 0.0 109.414 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -40.64 -53.87 2.68 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.374 -0.829 . . . . 0.0 109.529 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 48' ' ' PHE . . . 140.52 -73.66 0.38 Allowed Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.613 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.584 ' HB3' ' CE2' ' A' ' 50' ' ' PHE . 70.7 m-85 66.91 157.09 0.11 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.406 -1.055 . . . . 0.0 108.389 -179.873 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -108.71 27.78 9.08 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.715 -1.194 . . . . 0.0 110.381 -178.884 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.584 ' CE2' ' HB3' ' A' ' 48' ' ' PHE . 8.1 p90 -125.22 -174.32 3.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.984 -1.073 . . . . 0.0 109.697 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -170.08 54.81 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.268 -0.895 . . . . 0.0 109.304 -179.679 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.513 ' HB ' ' CE1' ' A' ' 56' ' ' TYR . 29.9 t -43.45 -66.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.198 -0.939 . . . . 0.0 109.524 -179.82 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.486 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -164.18 -172.89 2.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.135 -0.978 . . . . 0.0 109.767 -179.816 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.571 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -79.6 -54.97 0.9 Allowed Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.266 -0.896 . . . . 0.0 111.223 -179.255 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 54' ' ' SER . 34.4 Cg_endo -72.42 87.02 0.95 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.877 1.718 . . . . 0.0 109.979 -178.114 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.676 ' HE1' ' HB2' ' A' ' 87' ' ' ALA . 9.3 m-85 -87.13 178.1 7.0 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.233 0.54 . . . . 0.0 109.639 -179.38 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 41' ' ' LYS . 94.0 m-85 -156.71 129.56 7.77 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.364 -0.835 . . . . 0.0 109.576 179.62 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.517 ' HG3' ' ND1' ' A' ' 40' ' ' HIS . 0.2 OUTLIER -99.86 138.18 37.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -0.94 . . . . 0.0 109.663 -179.933 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.655 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 21.1 t-105 -155.69 136.64 9.1 Favored Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.655 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.8 Cg_endo -71.5 137.29 30.24 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 C-N-CA 122.168 1.912 . . . . 0.0 111.801 -178.224 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 1.013 HD12 ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -110.93 133.51 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.96 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.013 ' N ' HD12 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -131.93 158.69 40.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -0.9 . . . . 0.0 109.158 179.921 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 98.1 p -122.83 27.4 7.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.911 . . . . 0.0 108.88 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -153.87 -39.08 0.1 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.454 -0.779 . . . . 0.0 109.356 -179.604 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 66' ' ' ASP . . . -88.98 -9.99 67.1 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.839 ' OD1' HG23 ' A' ' 67' ' ' VAL . 67.8 t0 48.09 96.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -1.124 . . . . 0.0 109.56 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.839 HG23 ' OD1' ' A' ' 66' ' ' ASP . 2.9 t 75.62 135.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.545 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.568 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 45.9 t80 -81.39 150.34 28.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.903 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.451 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 4.8 t -165.47 -42.3 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.422 -0.799 . . . . 0.0 109.285 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -158.09 124.49 1.4 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.89 -145.29 12.65 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.85 107.77 60.9 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.285 -1.126 . . . . 0.0 109.636 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.477 ' CB ' ' OH ' ' A' ' 38' ' ' TYR . 35.7 Cg_endo -77.12 -175.63 2.76 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.534 2.156 . . . . 0.0 110.534 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.64 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 93.35 -175.64 36.3 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 71.52 -144.91 0.06 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.141 -1.211 . . . . 0.0 110.108 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.429 ' OD1' ' SG ' ' A' ' 6' ' ' CYS . 5.7 m-20 -44.11 151.54 0.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.354 -0.841 . . . . 0.0 110.986 -179.135 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.525 ' NH2' ' CE1' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -164.95 111.84 0.99 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.104 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.815 HG21 HD21 ' A' ' 86' ' ' LEU . 13.9 p -92.56 129.25 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.821 -1.175 . . . . 0.0 110.312 -178.974 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.622 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 55.2 t -98.39 167.36 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.467 -0.771 . . . . 0.0 109.145 179.569 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.616 ' N ' HG12 ' A' ' 79' ' ' VAL . 4.7 p90 -168.48 -170.76 1.3 Allowed 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.662 -178.082 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.456 ' ND2' ' CB ' ' A' ' 53' ' ' SER . 1.0 OUTLIER -129.71 -42.4 1.29 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.172 -0.955 . . . . 0.0 110.056 -179.341 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.578 ' HA ' ' CE1' ' A' ' 24' ' ' TYR . 7.6 pt-20 166.26 -27.31 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.737 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.46 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -100.84 26.08 7.27 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.489 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 84' ' ' ASN . 8.5 p30 48.7 25.27 0.95 Allowed 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.45 0.643 . . . . 0.0 109.636 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.535 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 3.0 mt-30 -55.35 -36.16 66.01 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.967 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.815 HD21 HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER 83.59 104.11 0.05 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.557 0.694 . . . . 0.0 110.694 179.142 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.676 ' HB2' ' HE1' ' A' ' 56' ' ' TYR . . . -76.81 -34.0 57.96 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.783 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 150.34 151.52 5.56 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.597 HG21 ' CD2' ' A' ' 4' ' ' TYR . 85.9 t -89.34 88.07 2.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.268 -1.136 . . . . 0.0 109.696 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.555 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 0.8 OUTLIER -78.97 158.26 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.276 -0.89 . . . . 0.0 108.789 179.681 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.467 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 9.5 t -119.22 168.48 10.84 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.043 -1.036 . . . . 0.0 110.642 -179.1 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.58 ' CD2' ' O ' ' A' ' 98' ' ' ASN . 0.3 OUTLIER -120.98 68.98 0.88 Allowed 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 3.1 m -175.75 -30.37 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.401 -0.812 . . . . 0.0 110.183 -179.717 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.42 17.17 40.41 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.161 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.653 ' HB2' HG11 ' A' ' 101' ' ' VAL . . . -153.98 121.2 5.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -1.164 . . . . 0.0 109.482 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.476 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.9 OUTLIER 39.28 -156.38 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.367 -0.833 . . . . 0.0 109.49 179.68 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 96' ' ' SER . . . -41.39 -59.99 2.49 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 179.341 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.58 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -167.43 32.65 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.243 -1.151 . . . . 0.0 109.27 179.251 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.436 ' O ' ' O ' ' A' ' 98' ' ' ASN . 1.4 t30 -48.14 173.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.99 -1.068 . . . . 0.0 109.251 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.555 ' HB3' ' CG1' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -100.13 144.13 29.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.1 -1.0 . . . . 0.0 109.528 -179.94 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.653 HG11 ' HB2' ' A' ' 95' ' ' ALA . 10.3 m -158.02 137.19 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.377 -0.827 . . . . 0.0 108.899 179.624 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.87 96.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.098 -1.001 . . . . 0.0 109.554 -179.59 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.467 ' SG ' ' HB ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -48.41 126.77 11.97 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.298 -0.876 . . . . 0.0 109.464 179.832 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.837 -1.078 . . . . 0.0 109.483 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.471 ' O ' ' SG ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.541 0.686 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 31.4 p 38.93 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.912 0.863 . . . . 0.0 110.264 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -102.5 -1.44 30.53 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.361 -0.837 . . . . 0.0 109.307 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.695 ' CG ' HG21 ' A' ' 89' ' ' VAL . 23.0 m-85 -115.07 65.73 0.68 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.9 . . . . 0.0 109.225 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.797 HG23 ' O ' ' A' ' 5' ' ' THR . 11.5 t -86.78 92.46 8.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.94 . . . . 0.0 109.741 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.9 m -104.24 155.75 18.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.119 -0.988 . . . . 0.0 109.236 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 8' ' ' SER . . . 47.43 29.3 5.29 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.436 ' O ' ' OD1' ' A' ' 9' ' ' ASN . 5.0 m 70.44 43.84 0.76 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -1.14 . . . . 0.0 109.422 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.487 ' O ' ' HA ' ' A' ' 5' ' ' THR . 83.0 m-20 -136.97 86.33 2.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.136 -0.978 . . . . 0.0 109.547 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.472 ' HA ' ' HB ' ' A' ' 5' ' ' THR . 0.5 OUTLIER -54.9 88.26 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.498 -0.751 . . . . 0.0 109.395 179.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 63' ' ' SER . 1.9 m-85 -79.68 144.51 33.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.311 -0.868 . . . . 0.0 108.924 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.81 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -78.58 122.48 25.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.376 -0.827 . . . . 0.0 109.568 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.6 p -59.03 -26.62 64.72 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 83.4 p -78.93 -28.55 43.84 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 0.5 OUTLIER -79.74 -27.4 40.55 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.081 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 12' ' ' SER . 13.5 t -66.6 -29.9 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.499 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 1.9 t -64.4 -46.21 84.26 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.93 -51.81 67.69 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.821 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -66.41 -18.81 65.58 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.585 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -71.11 -36.65 72.23 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -82.0 -1.72 49.19 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.54 -54.82 5.33 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.353 -0.842 . . . . 0.0 108.914 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.574 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -72.89 -18.5 79.01 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.44 ' O ' ' C ' ' A' ' 25' ' ' GLN . 14.6 t80 -80.22 -60.52 2.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.557 -0.966 . . . . 0.0 109.348 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.7 OUTLIER -41.64 -35.38 0.74 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.319 -0.863 . . . . 0.0 109.614 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.518 ' HA ' HD22 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -75.23 -47.13 29.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 0.0 109.65 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.583 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 11.5 t60 -56.25 -37.44 69.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.368 -0.833 . . . . 0.0 110.941 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -85.41 -31.47 22.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.027 -1.046 . . . . 0.0 109.48 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 0.5 OUTLIER -68.09 -20.51 64.95 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.274 -0.891 . . . . 0.0 109.366 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.23 -19.02 25.08 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.506 ' HB3' HD11 ' A' ' 26' ' ' LEU . 1.7 tp10 -63.01 -154.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.234 -1.156 . . . . 0.0 109.492 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.778 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -162.69 174.47 12.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.336 -0.852 . . . . 0.0 109.408 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.496 ' CG2' ' HB2' ' A' ' 38' ' ' TYR . 18.0 m -130.4 158.1 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.276 -0.89 . . . . 0.0 109.383 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.403 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . 55.63 -89.21 0.01 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER 171.04 32.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.327 -1.102 . . . . 0.0 109.725 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 37' ' ' SER . 1.6 m-80 -152.64 25.29 0.58 Allowed 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.106 -0.996 . . . . 0.0 109.666 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.778 ' HA ' HG22 ' A' ' 32' ' ' THR . 1.0 OUTLIER 47.95 92.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.018 -1.051 . . . . 0.0 108.887 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.68 ' CD2' ' CE2' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -79.34 -47.29 1.58 Allowed Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.261 -0.9 . . . . 0.0 110.765 -179.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 38' ' ' TYR . 32.6 Cg_endo -74.71 108.04 2.61 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 120.95 1.1 . . . . 0.0 109.349 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.62 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -125.74 -174.8 3.17 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.459 -179.11 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -104.6 131.28 52.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.346 -0.846 . . . . 0.0 109.42 -179.526 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.596 ' CZ ' ' HA ' ' A' ' 44' ' ' ASN . 11.9 t80 -97.33 137.83 35.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.272 -0.893 . . . . 0.0 109.259 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.523 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -89.85 -32.49 16.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.144 -0.973 . . . . 0.0 109.776 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.596 ' HA ' ' CZ ' ' A' ' 42' ' ' TYR . 20.1 t30 77.2 135.59 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.591 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.445 ' O ' ' C ' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -159.5 -38.11 0.06 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.307 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.6 OUTLIER -38.72 -73.02 0.05 Allowed 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.623 -0.673 . . . . 0.0 110.069 -179.582 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 155.41 61.72 0.01 OUTLIER Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.485 ' CD1' ' OD1' ' A' ' 44' ' ' ASN . 48.6 m-85 -90.74 -168.01 1.97 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.299 -1.118 . . . . 0.0 109.332 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 50' ' ' PHE . 5.0 p30 -145.05 26.59 1.34 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.52 ' CB ' ' OH ' ' A' ' 56' ' ' TYR . 20.9 m-30 -45.6 173.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.503 -0.748 . . . . 0.0 109.769 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.4 m -146.53 30.3 1.01 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.357 -0.839 . . . . 0.0 109.088 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.835 HG11 ' OD1' ' A' ' 81' ' ' ASN . 97.2 t -96.28 -92.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.338 -0.851 . . . . 0.0 109.545 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.497 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 66.9 m -142.63 -172.93 3.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.074 -1.016 . . . . 0.0 109.962 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.592 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -85.49 -49.25 0.56 Allowed Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.364 -0.835 . . . . 0.0 111.61 -179.175 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 54' ' ' SER . 33.5 Cg_endo -74.09 83.41 1.64 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 121.863 1.708 . . . . 0.0 110.396 -177.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.546 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 7.1 m-85 -79.38 -177.96 6.01 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.645 0.736 . . . . 0.0 110.022 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.583 ' CE2' ' NE2' ' A' ' 27' ' ' HIS . 97.6 m-85 -157.95 152.33 24.63 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.599 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 19.2 mt-10 -119.63 143.17 47.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.991 -1.068 . . . . 0.0 111.124 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.653 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 21.3 t-105 -160.75 138.81 7.21 Favored Pre-proline 0 N--CA 1.49 1.57 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.653 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.2 Cg_endo -69.22 142.59 50.74 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.338 2.025 . . . . 0.0 111.861 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.978 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -119.57 131.64 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.978 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.9 OUTLIER -123.13 167.49 13.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.191 -0.943 . . . . 0.0 109.576 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -135.72 17.47 3.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.368 -0.833 . . . . 0.0 109.25 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.25 -54.2 0.2 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.284 -0.885 . . . . 0.0 109.423 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . -67.42 -98.16 0.03 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.716 ' O ' HD12 ' A' ' 62' ' ' LEU . 3.0 t0 175.49 -162.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -1.161 . . . . 0.0 109.538 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.41 ' H ' HG23 ' A' ' 67' ' ' VAL . 8.5 t -52.55 136.47 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.304 -0.873 . . . . 0.0 109.568 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.68 ' CE2' ' CD2' ' A' ' 38' ' ' TYR . 28.9 t80 -52.92 117.84 3.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.2 -0.937 . . . . 0.0 109.254 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -177.19 74.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.404 -0.81 . . . . 0.0 109.662 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.52 62.12 0.31 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.31 -136.29 3.91 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.2 m -166.29 101.63 0.7 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.309 -1.112 . . . . 0.0 109.186 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.57 ' HG3' ' CD1' ' A' ' 68' ' ' TYR . 35.8 Cg_endo -77.82 -81.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.435 2.09 . . . . 0.0 110.685 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.39 -176.89 4.86 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . 56.47 -122.03 1.65 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.101 -1.235 . . . . 0.0 109.555 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 75' ' ' ALA . 87.2 m-20 -41.4 146.85 0.19 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.848 -1.158 . . . . 0.0 110.167 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.491 ' O ' HG12 ' A' ' 90' ' ' ILE . 2.6 tpp180 -176.37 90.12 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.455 -0.778 . . . . 0.0 109.219 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.752 HG21 HD21 ' A' ' 86' ' ' LEU . 7.5 p -65.04 144.63 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.097 -1.002 . . . . 0.0 109.547 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.605 HG23 HD13 ' A' ' 90' ' ' ILE . 24.7 t -104.84 167.48 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.345 -0.847 . . . . 0.0 109.642 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.585 ' CD1' ' OE1' ' A' ' 20' ' ' GLN . 13.8 p90 -164.53 -173.39 3.03 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.409 -178.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.835 ' OD1' HG11 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -124.07 -81.15 0.63 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.066 -1.022 . . . . 0.0 110.267 -179.395 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -158.74 21.55 0.22 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.312 -0.867 . . . . 0.0 109.484 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.471 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 4.4 m120 -140.39 23.89 2.31 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 83' ' ' ASN . 5.0 p30 52.83 19.92 1.45 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.503 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 51.8 mm-40 -60.62 -111.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.752 HD21 HG21 ' A' ' 78' ' ' VAL . 0.2 OUTLIER 172.84 110.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 110.693 178.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.588 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . . . -79.62 -38.92 32.75 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 148.69 156.71 7.24 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.695 HG21 ' CG ' ' A' ' 4' ' ' TYR . 94.8 t -87.14 113.48 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -1.155 . . . . 0.0 109.411 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.605 HD13 HG23 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -109.27 154.54 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.421 -0.8 . . . . 0.0 109.142 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 100' ' ' PHE . 4.6 t -107.79 146.82 31.67 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.033 -1.042 . . . . 0.0 110.418 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.615 ' CD2' ' HB2' ' A' ' 98' ' ' ASN . 16.1 t60 -116.76 66.05 0.72 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.451 ' HA ' ' HB3' ' A' ' 98' ' ' ASN . 1.9 m 178.42 -29.65 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.746 -0.596 . . . . 0.0 109.717 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.88 10.79 44.92 Favored Glycine 0 N--CA 1.494 2.504 0 O-C-N 120.993 -1.067 . . . . 0.0 110.638 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -141.15 147.06 37.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.016 -1.285 . . . . 0.0 109.669 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 95' ' ' ALA . 1.2 p -43.03 133.3 3.8 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 98' ' ' ASN . . . 62.84 35.03 91.42 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 107.949 -2.061 . . . . 0.0 107.949 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.615 ' HB2' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 34.71 41.66 0.06 Allowed 'General case' 0 C--N 1.309 -1.177 0 O-C-N 122.105 -0.644 . . . . 0.0 110.349 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -56.93 166.55 0.98 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.123 -0.986 . . . . 0.0 108.623 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.639 ' O ' HG13 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -91.44 147.51 22.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.933 -1.104 . . . . 0.0 109.839 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.639 HG13 ' O ' ' A' ' 100' ' ' PHE . 17.4 m -161.38 133.97 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 101' ' ' VAL . 35.8 mt-10 -43.26 135.17 3.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.964 . . . . 0.0 109.448 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 1.5 m -60.73 121.3 11.92 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.246 -0.908 . . . . 0.0 109.325 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.556 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 7.1 p 173.27 137.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.37 -0.832 . . . . 0.0 109.906 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -115.72 -29.57 6.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 0.0 109.505 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.716 ' CD2' HG21 ' A' ' 89' ' ' VAL . 13.0 m-85 -87.11 93.66 9.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.955 . . . . 0.0 109.233 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.3 m -126.76 141.08 51.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.144 -0.972 . . . . 0.0 109.869 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -143.98 14.98 1.71 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.122 0.963 . . . . 0.0 109.785 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 177.88 50.0 0.07 OUTLIER Glycine 0 C--N 1.281 -2.526 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 8' ' ' SER . 3.3 t 55.0 20.47 3.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.47 -1.018 . . . . 0.0 109.201 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.572 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 25.8 m-80 -74.5 -34.41 63.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 0.0 109.627 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 9' ' ' ASN . 46.5 t 61.52 52.03 3.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.116 -0.99 . . . . 0.0 109.621 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.572 ' CE1' ' HB3' ' A' ' 9' ' ' ASN . 7.6 m-30 -80.61 129.97 34.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.303 -0.873 . . . . 0.0 109.073 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.701 ' O ' HG23 ' A' ' 16' ' ' VAL . 3.9 m -88.57 137.96 31.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.167 -0.958 . . . . 0.0 110.11 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 p -53.55 -23.33 10.33 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.0 t -77.33 -38.16 51.0 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.357 -0.839 . . . . 0.0 108.94 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -70.86 -28.86 64.89 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 12' ' ' SER . 7.5 t -70.28 -31.2 46.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 C-N-CA 119.602 -0.839 . . . . 0.0 108.777 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.09 -45.62 92.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.598 -0.689 . . . . 0.0 109.433 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.62 -48.92 79.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 108.806 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.688 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -72.32 -12.22 61.04 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.554 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -83.9 -28.36 27.97 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.348 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -82.22 -14.55 55.36 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.438 -0.789 . . . . 0.0 109.099 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 26' ' ' LEU . . . -76.9 -52.94 8.55 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.279 -0.888 . . . . 0.0 109.062 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.556 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -66.16 -30.56 77.08 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.869 -1.693 . . . . 0.0 108.869 179.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.585 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 5.2 t80 -72.11 -70.65 0.32 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.415 -1.05 . . . . 0.0 108.982 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -40.71 -57.85 1.79 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.444 -0.785 . . . . 0.0 109.656 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -46.55 -46.44 19.35 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.048 -1.032 . . . . 0.0 109.262 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -58.81 -48.69 80.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.454 -0.779 . . . . 0.0 110.86 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -86.7 12.04 11.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.134 -0.979 . . . . 0.0 109.939 -179.151 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 55.1 t0 -104.48 -11.82 16.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.076 -1.015 . . . . 0.0 109.364 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.51 -5.12 61.53 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.44 ' HB2' HD13 ' A' ' 26' ' ' LEU . 5.5 mm-40 -87.81 -176.82 5.64 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.298 -1.119 . . . . 0.0 109.367 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.839 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -145.15 178.5 8.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -0.966 . . . . 0.0 109.677 179.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.55 HG23 ' N ' ' A' ' 34' ' ' GLY . 27.4 m -100.3 -126.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.322 -0.861 . . . . 0.0 109.441 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.55 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -43.5 -47.55 7.14 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER 163.99 -34.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -1.106 . . . . 0.0 109.638 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.449 ' N ' ' ND2' ' A' ' 36' ' ' ASN . 0.6 OUTLIER -75.96 -11.84 60.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 0.0 110.008 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.839 ' HA ' HG22 ' A' ' 32' ' ' THR . 1.1 p 69.29 121.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.026 -1.047 . . . . 0.0 108.916 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.735 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -98.3 -19.24 0.21 Allowed Pre-proline 0 N--CA 1.495 1.808 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -179.102 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.735 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 37.4 Cg_endo -79.82 102.03 1.43 Allowed 'Trans proline' 0 C--N 1.318 -1.056 0 C-N-CA 121.275 1.316 . . . . 0.0 113.426 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.589 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -128.77 137.43 51.54 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.072 -1.017 . . . . 0.0 109.748 177.184 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 2.5 ptmt -51.14 143.51 10.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 110.292 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.647 ' HD2' HG21 ' A' ' 79' ' ' VAL . 4.4 t80 -114.45 102.01 9.68 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 44' ' ' ASN . 0.3 OUTLIER -74.77 21.66 0.11 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.901 -1.124 . . . . 0.0 111.582 -178.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.558 ' HA ' ' CZ ' ' A' ' 42' ' ' TYR . 1.2 m-20 60.42 148.63 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.66 -1.275 . . . . 0.0 109.612 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.483 ' CD2' ' O ' ' A' ' 44' ' ' ASN . 0.2 OUTLIER -174.39 -57.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.933 . . . . 0.0 109.614 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.661 ' OE2' HG12 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -37.44 -55.99 1.03 Allowed 'General case' 0 C--N 1.308 -1.204 0 O-C-N 121.616 -0.677 . . . . 0.0 110.293 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.21 51.69 0.08 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.528 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 11.3 m-85 -91.43 -170.1 2.52 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.301 -1.117 . . . . 0.0 108.629 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -150.49 44.9 0.87 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.095 -1.003 . . . . 0.0 110.308 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.52 -179.5 5.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.954 -1.091 . . . . 0.0 109.236 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.4 m -153.22 56.68 0.77 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.237 -0.914 . . . . 0.0 109.466 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.688 HG21 ' O ' ' A' ' 86' ' ' LEU . 37.4 t -94.62 -27.0 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.258 -0.901 . . . . 0.0 109.647 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.532 ' HB3' ' CB ' ' A' ' 81' ' ' ASN . 4.1 t 167.55 162.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.028 -1.045 . . . . 0.0 109.57 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.591 ' CB ' ' HD3' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -75.82 -59.71 1.14 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.094 -1.004 . . . . 0.0 110.646 -179.27 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.591 ' HD3' ' CB ' ' A' ' 54' ' ' SER . 36.0 Cg_endo -71.34 84.37 0.94 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 121.959 1.773 . . . . 0.0 110.623 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.605 ' CE1' ' HB2' ' A' ' 87' ' ' ALA . 38.3 m-85 -79.62 -171.04 2.62 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.648 0.737 . . . . 0.0 109.904 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.584 ' CD2' ' O ' ' A' ' 56' ' ' TYR . 76.9 m-85 -160.82 151.04 17.79 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.481 ' OE2' ' HB2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -120.79 140.39 51.78 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.901 -1.124 . . . . 0.0 110.543 -178.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.684 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 3.7 t-105 -155.99 146.34 15.97 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.684 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.8 Cg_endo -68.32 130.58 21.48 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.098 1.866 . . . . 0.0 111.43 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.979 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -97.84 132.54 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.979 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.9 OUTLIER -123.81 165.01 18.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 0.0 109.342 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.55 ' HB2' ' CZ ' ' A' ' 11' ' ' TYR . 27.1 t -120.26 37.42 4.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 108.97 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.39 -172.91 3.07 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.404 -0.81 . . . . 0.0 109.638 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -96.28 50.48 1.66 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -150.04 147.34 27.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.09 -1.241 . . . . 0.0 109.432 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.477 HG13 ' HZ2' ' A' ' 59' ' ' TRP . 81.0 t -92.18 152.27 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.89 . . . . 0.0 109.252 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.603 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 44.4 t80 -59.79 132.17 53.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.201 -0.937 . . . . 0.0 109.573 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.1 t -155.91 20.36 0.38 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.303 -0.873 . . . . 0.0 109.246 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.5 89.75 1.41 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -162.65 -39.52 0.02 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.435 ' O ' ' OG ' ' A' ' 72' ' ' SER . 28.1 p -158.17 102.14 1.73 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.16 -1.2 . . . . 0.0 109.326 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -75.15 114.14 3.94 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.336 2.024 . . . . 0.0 110.158 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.462 ' HA2' ' CD2' ' A' ' 92' ' ' HIS . . . 109.83 -125.08 7.44 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.559 ' N ' ' HB2' ' A' ' 92' ' ' HIS . . . 51.01 -174.06 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.201 -1.176 . . . . 0.0 109.638 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.491 ' CB ' HG23 ' A' ' 61' ' ' ILE . 65.8 m-20 -37.89 143.16 0.12 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.649 0.738 . . . . 0.0 110.681 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.495 ' CA ' HG22 ' A' ' 61' ' ' ILE . 2.0 ttt180 -153.95 133.65 12.96 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.804 ' CG2' HD11 ' A' ' 86' ' ' LEU . 10.8 p -119.24 130.08 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.928 -1.107 . . . . 0.0 110.461 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.647 HG21 ' HD2' ' A' ' 42' ' ' TYR . 12.9 t -89.5 163.25 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 CA-C-O 122.298 1.047 . . . . 0.0 109.857 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.559 ' N ' ' CG1' ' A' ' 79' ' ' VAL . 34.4 p90 -159.74 -168.47 2.27 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.539 ' OD1' ' HG2' ' A' ' 82' ' ' GLU . 1.2 p30 -122.07 -44.79 2.27 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.866 -1.134 . . . . 0.0 111.004 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.585 ' O ' ' CZ ' ' A' ' 24' ' ' TYR . 2.1 pt-20 161.21 -21.54 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.419 ' C ' ' CG ' ' A' ' 84' ' ' ASN . 1.8 m-20 -92.16 20.27 6.11 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.581 ' OD1' ' CE2' ' A' ' 24' ' ' TYR . 0.0 OUTLIER 63.62 8.08 3.46 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.7 -0.625 . . . . 0.0 109.686 -179.474 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.41 ' O ' ' O ' ' A' ' 84' ' ' ASN . 13.6 mt-30 -60.66 -160.32 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.804 HD11 ' CG2' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -137.84 117.42 12.99 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.488 -1.382 . . . . 0.0 110.755 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.605 ' HB2' ' CE1' ' A' ' 56' ' ' TYR . . . -83.92 -43.23 15.47 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 170.48 163.69 24.94 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.716 HG21 ' CD2' ' A' ' 4' ' ' TYR . 75.1 t -115.93 99.22 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.021 -1.282 . . . . 0.0 109.388 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.588 ' H ' HD13 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -88.37 -173.39 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.398 -0.814 . . . . 0.0 109.401 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.589 ' O ' HG23 ' A' ' 91' ' ' THR . 5.9 t -148.9 121.43 8.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.986 -1.071 . . . . 0.0 110.213 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.559 ' HB2' ' N ' ' A' ' 75' ' ' ALA . 2.4 m-70 -78.99 79.13 5.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.549 -0.719 . . . . 0.0 109.291 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 98' ' ' ASN . 0.6 OUTLIER 177.36 -28.56 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.171 -0.956 . . . . 0.0 110.095 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.8 -16.31 16.69 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 1.064 ' HB3' ' CB ' ' A' ' 99' ' ' ASN . . . -122.52 178.15 5.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.104 -1.233 . . . . 0.0 109.412 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 98' ' ' ASN . 1.0 OUTLIER -40.95 157.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.449 -0.782 . . . . 0.0 109.31 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 96' ' ' SER . . . 43.97 -95.18 0.01 OUTLIER Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -127.28 -73.91 0.6 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.346 -1.091 . . . . 0.0 109.347 179.339 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 1.064 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . 0.9 OUTLIER 59.33 120.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.044 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.562 ' CD2' ' O ' ' A' ' 100' ' ' PHE . 38.3 p90 -98.76 117.53 33.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.843 -1.161 . . . . 0.0 110.705 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.661 HG12 ' OE2' ' A' ' 46' ' ' GLU . 18.0 m -128.91 158.2 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.513 ' N ' HG22 ' A' ' 90' ' ' ILE . 4.3 pt-20 -43.42 138.81 2.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 109.37 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.1 OUTLIER -75.73 176.8 7.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.63 -179.645 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.081 -0.962 . . . . 0.0 109.523 -179.9 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.482 ' O ' ' SG ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.414 0.626 . . . . 0.0 109.724 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 21.6 p 36.78 91.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.603 0.716 . . . . 0.0 110.224 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -97.86 1.63 48.38 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.46 ' CD2' HG21 ' A' ' 89' ' ' VAL . 16.1 m-85 -104.28 78.1 1.47 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.482 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 9' ' ' ASN . 28.1 m -84.31 93.98 8.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.427 ' O ' ' C ' ' A' ' 7' ' ' GLY . 2.8 m -120.65 155.03 34.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 109.474 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 6' ' ' CYS . . . 43.8 27.21 0.91 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 1.4 m 68.94 50.59 0.59 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.292 -1.122 . . . . 0.0 109.582 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 5' ' ' THR . 25.1 m120 -144.55 126.53 15.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.171 -0.956 . . . . 0.0 109.598 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.465 ' C ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -82.99 84.07 7.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -0.831 . . . . 0.0 109.02 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 4.2 m-30 -79.82 138.68 37.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.41 -0.806 . . . . 0.0 109.661 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.876 ' O ' HG23 ' A' ' 16' ' ' VAL . 2.0 t -80.73 123.28 28.07 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.696 -0.627 . . . . 0.0 109.92 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.18 -24.37 0.45 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 109.221 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.6 t -81.53 -41.1 22.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.983 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -67.62 -28.32 67.64 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 12' ' ' SER . 1.9 t -68.39 -29.64 44.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.575 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 21.5 t -62.63 -46.13 89.66 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -59.43 5.02 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.841 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -61.83 -16.42 50.04 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.904 ' OE1' HG11 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -73.56 -33.81 64.85 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.296 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.62 1.65 53.08 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.0 -62.28 1.73 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.249 -0.907 . . . . 0.0 109.04 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.507 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -60.89 -16.49 47.17 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -82.42 -64.91 1.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.342 -1.093 . . . . 0.0 109.248 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -47.42 -52.43 16.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.353 -0.842 . . . . 0.0 109.745 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.847 ' O ' HD12 ' A' ' 26' ' ' LEU . 2.7 tp -59.72 -38.46 81.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.292 -0.88 . . . . 0.0 109.397 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.649 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 66.1 t60 -68.7 -20.13 64.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.006 -1.059 . . . . 0.0 110.29 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 5.4 tp10 -87.19 -21.97 25.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.057 -1.027 . . . . 0.0 109.507 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 9.9 t70 -89.05 -12.26 41.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.267 -0.896 . . . . 0.0 109.502 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.35 0.84 59.01 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.533 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 5.6 tp10 -67.95 -144.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -1.175 . . . . 0.0 109.517 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.846 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -167.26 -174.6 2.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.058 -1.026 . . . . 0.0 109.619 -179.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.465 HG23 ' H ' ' A' ' 34' ' ' GLY . 2.5 m -105.03 -104.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 109.631 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -77.13 -38.19 30.49 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 2.2 t 162.83 -36.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.437 -1.037 . . . . 0.0 109.385 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.418 ' O ' ' O ' ' A' ' 37' ' ' SER . 5.4 m120 -68.82 -16.5 63.8 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.327 -0.858 . . . . 0.0 109.262 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.846 ' HA ' HG22 ' A' ' 32' ' ' THR . 8.1 t 63.09 126.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.271 -0.893 . . . . 0.0 109.431 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.651 ' H ' ' CD ' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -117.99 -27.41 0.08 OUTLIER Pre-proline 0 N--CA 1.499 2.001 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -178.56 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.651 ' CD ' ' H ' ' A' ' 38' ' ' TYR . 37.0 Cg_endo -79.34 100.72 1.35 Allowed 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 121.062 1.175 . . . . 0.0 112.724 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.597 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -135.92 160.61 38.07 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.115 -0.991 . . . . 0.0 108.747 177.439 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -62.72 139.83 58.69 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.128 -0.982 . . . . 0.0 110.232 -179.272 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.578 ' CD2' ' OD1' ' A' ' 44' ' ' ASN . 9.2 t80 -101.41 150.26 23.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.365 -0.834 . . . . 0.0 108.784 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 1.1 m-20 -107.51 -15.55 14.58 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.014 -1.054 . . . . 0.0 110.357 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.578 ' OD1' ' CD2' ' A' ' 42' ' ' TYR . 22.8 m-80 60.26 92.17 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.026 -1.046 . . . . 0.0 109.215 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -122.83 28.19 7.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.194 -0.941 . . . . 0.0 109.626 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.711 ' OE2' HG12 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -101.42 -65.67 0.96 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.46 ' N ' ' CG ' ' A' ' 46' ' ' GLU . . . 144.34 35.38 0.07 OUTLIER Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.558 ' CE1' ' OE2' ' A' ' 46' ' ' GLU . 15.9 m-85 -61.71 -171.07 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.92 6.75 4.66 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 118.102 -1.439 . . . . 0.0 110.292 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.534 ' CZ ' ' CD2' ' A' ' 48' ' ' PHE . 1.8 p90 -96.32 -169.98 2.01 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.996 -1.065 . . . . 0.0 109.347 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 50' ' ' PHE . 6.5 t 167.95 45.21 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.272 -0.893 . . . . 0.0 109.527 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -44.54 -27.73 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 109.252 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.542 ' O ' ' CE1' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -170.99 165.98 7.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.391 -0.818 . . . . 0.0 109.66 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.614 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -78.04 -51.2 1.72 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.323 -0.86 . . . . 0.0 111.044 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 54' ' ' SER . 32.9 Cg_endo -72.77 92.41 0.79 Allowed 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.856 1.704 . . . . 0.0 109.5 -177.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.822 ' CE2' ' HB1' ' A' ' 87' ' ' ALA . 2.2 m-30 -91.85 -170.96 2.72 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.961 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.649 ' CE1' ' NE2' ' A' ' 27' ' ' HIS . 61.1 m-85 -164.29 105.55 0.88 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -74.76 139.4 43.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 109.384 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.726 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 14.6 t-105 -159.84 141.03 9.24 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.726 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.4 Cg_endo -68.16 131.21 23.06 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 C-N-CA 122.156 1.904 . . . . 0.0 111.433 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.973 HD12 ' N ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -106.44 128.2 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.705 -0.622 . . . . 0.0 109.42 -179.614 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.973 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.2 mt -125.03 164.28 20.52 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.306 -0.872 . . . . 0.0 109.352 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.434 ' O ' ' OG ' ' A' ' 63' ' ' SER . 2.2 t -118.51 16.55 13.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.145 -0.972 . . . . 0.0 109.077 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.45 -156.9 0.57 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.597 -0.689 . . . . 0.0 109.487 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -116.0 54.81 0.57 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -163.32 107.17 1.03 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -1.184 . . . . 0.0 109.709 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.431 HG13 ' HZ2' ' A' ' 59' ' ' TRP . 43.5 t -47.76 160.01 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.216 -0.927 . . . . 0.0 109.099 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.617 ' HB2' ' HG2' ' A' ' 60' ' ' PRO . 6.5 t80 -49.1 119.24 3.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.915 -1.116 . . . . 0.0 109.388 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -168.08 39.41 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.432 -0.793 . . . . 0.0 109.127 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.71 -0.97 6.86 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -83.95 -153.66 17.06 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.47 131.51 74.45 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.235 -1.156 . . . . 0.0 109.408 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.413 ' O ' ' O ' ' A' ' 74' ' ' GLY . 36.4 Cg_endo -79.85 -89.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.547 2.164 . . . . 0.0 110.753 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 76' ' ' ASP . . . -59.06 -112.55 0.01 OUTLIER Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.417 ' N ' ' HB3' ' A' ' 92' ' ' HIS . . . 50.9 -87.23 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.383 -1.069 . . . . 0.0 110.415 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 74' ' ' GLY . 1.0 OUTLIER -117.32 116.37 27.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.928 -1.108 . . . . 0.0 109.988 -179.582 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.562 ' NH1' ' CE1' ' A' ' 38' ' ' TYR . 2.3 mtm-85 -128.78 138.14 51.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.139 -0.976 . . . . 0.0 109.138 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.904 HG11 ' OE1' ' A' ' 20' ' ' GLN . 9.8 p -123.62 142.85 38.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.676 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 23.4 t -110.59 165.88 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 122.188 0.994 . . . . 0.0 111.02 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.59 ' CE1' ' HB2' ' A' ' 57' ' ' TYR . 22.7 p90 -161.95 -170.48 2.54 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.258 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.45 ' O ' ' CD2' ' A' ' 57' ' ' TYR . 20.0 t30 -124.35 -82.15 0.64 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.006 -1.059 . . . . 0.0 109.929 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -158.08 18.68 0.24 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.409 -0.807 . . . . 0.0 109.6 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.487 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 2.7 m-20 -153.5 26.11 0.51 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.518 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 0.4 OUTLIER 53.4 19.65 1.7 Allowed 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.362 0.601 . . . . 0.0 109.557 -179.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.595 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -46.83 -35.32 6.19 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.093 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.636 HD21 ' NE2' ' A' ' 20' ' ' GLN . 0.0 OUTLIER 92.43 110.09 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.549 0.69 . . . . 0.0 111.152 179.044 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.822 ' HB1' ' CE2' ' A' ' 56' ' ' TYR . . . -87.42 -42.22 12.99 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 151.21 146.01 4.24 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.46 HG21 ' CD2' ' A' ' 4' ' ' TYR . 61.1 t -86.8 88.81 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.029 -1.277 . . . . 0.0 109.462 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.537 ' HB ' ' HB3' ' A' ' 100' ' ' PHE . 1.1 pt -79.39 170.24 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.315 -0.866 . . . . 0.0 108.785 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.1 t -135.97 141.26 44.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.075 -1.016 . . . . 0.0 110.274 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.601 ' CD2' ' HB2' ' A' ' 98' ' ' ASN . 2.9 t60 -92.77 76.02 4.91 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 1.2 m 171.76 148.38 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.17 -20.69 46.29 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -126.43 151.9 47.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.122 -1.222 . . . . 0.0 109.665 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 95' ' ' ALA . 20.3 m -41.57 125.78 2.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.47 -0.769 . . . . 0.0 109.321 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.487 ' O ' ' C ' ' A' ' 98' ' ' ASN . . . 65.33 40.5 96.53 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.601 ' HB2' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 32.9 52.4 0.31 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 122.053 -0.675 . . . . 0.0 110.209 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -57.27 167.39 0.93 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.214 -0.929 . . . . 0.0 109.222 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.537 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -88.78 122.05 31.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.143 -0.973 . . . . 0.0 109.664 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.711 HG12 ' OE2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -136.06 152.85 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.267 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.4 OUTLIER -56.92 131.28 49.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.14 -0.975 . . . . 0.0 109.491 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 89.8 m -54.18 148.05 11.93 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.26 -0.9 . . . . 0.0 109.627 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 109.573 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.511 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.6 p 165.3 126.86 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.26 -0.9 . . . . 0.0 110.291 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -96.21 -29.68 13.9 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.616 ' CG ' HG21 ' A' ' 89' ' ' VAL . 18.0 m-85 -91.81 103.69 16.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.479 -0.763 . . . . 0.0 109.11 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.571 HG22 ' H ' ' A' ' 7' ' ' GLY . 40.4 m -125.83 123.92 39.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.096 -1.003 . . . . 0.0 109.89 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.8 m -103.57 16.91 25.28 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.093 0.949 . . . . 0.0 109.61 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.571 ' H ' HG22 ' A' ' 5' ' ' THR . . . 152.82 -88.46 0.13 Allowed Glycine 0 C--N 1.284 -2.355 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.3 m -138.4 42.14 2.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -1.146 . . . . 0.0 109.684 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.487 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 1.0 OUTLIER -103.73 -26.33 12.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.183 -0.948 . . . . 0.0 109.38 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.1 t 60.18 57.78 2.85 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.38 -0.825 . . . . 0.0 109.675 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.527 ' CE1' ' HB3' ' A' ' 63' ' ' SER . 6.2 m-30 -87.88 114.02 24.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.39 -0.819 . . . . 0.0 108.874 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -85.99 138.35 32.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.062 -1.023 . . . . 0.0 109.98 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 p -48.82 -23.13 0.97 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.369 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.8 m -77.81 -41.33 37.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.113 -0.992 . . . . 0.0 109.543 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -71.68 -28.76 63.94 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 12' ' ' SER . 41.4 t -65.32 -24.93 35.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.42 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 3.4 t -66.97 -44.59 80.08 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.72 -38.46 85.16 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.759 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -81.31 -13.99 57.81 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.573 ' OE1' ' CG ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -82.13 -27.91 32.5 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.394 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -83.32 -13.21 55.59 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.13 -50.78 20.83 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.441 -0.787 . . . . 0.0 109.266 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.574 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -77.29 -29.02 57.01 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.579 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 3.2 t80 -71.37 -27.84 63.63 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.436 -1.038 . . . . 0.0 109.114 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 1.9 tt0 -74.16 -63.04 1.31 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.112 -0.992 . . . . 0.0 108.951 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.482 ' HA ' HD12 ' A' ' 26' ' ' LEU . 1.6 tp -46.47 -34.74 5.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.349 -0.845 . . . . 0.0 108.972 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.576 ' NE2' ' CZ ' ' A' ' 57' ' ' TYR . 2.0 t60 -65.52 -59.23 4.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.477 -0.765 . . . . 0.0 110.093 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -83.02 10.22 8.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.246 -0.909 . . . . 0.0 109.759 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 45.7 t0 -95.84 -23.76 16.76 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.956 . . . . 0.0 109.61 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.97 -0.66 84.41 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.4 ' C ' ' OG1' ' A' ' 32' ' ' THR . 1.0 OUTLIER -97.56 -146.33 0.31 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.191 -1.182 . . . . 0.0 109.367 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.536 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -168.99 -177.17 2.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -0.938 . . . . 0.0 109.523 -179.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.556 HG21 ' HB2' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -92.54 -100.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 109.057 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.505 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -94.19 30.87 7.16 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 1.0 OUTLIER 78.21 1.39 2.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.525 -0.986 . . . . 0.0 109.334 -179.482 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.53 ' O ' ' CB ' ' A' ' 37' ' ' SER . 0.5 OUTLIER -93.18 -19.36 21.53 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.334 -0.853 . . . . 0.0 109.743 -179.651 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.536 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.8 OUTLIER 76.45 93.34 0.07 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 109.294 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.605 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -85.77 -43.53 0.62 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 111.238 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 32.9 Cg_endo -75.46 108.41 2.69 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 120.927 1.085 . . . . 0.0 110.045 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.616 ' CE1' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -123.79 124.68 43.23 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.3 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.539 ' HA ' ' CD1' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -49.63 125.06 10.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.387 -0.821 . . . . 0.0 110.72 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 2.1 t80 -88.83 159.45 17.71 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.433 ' O ' ' CZ ' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -169.6 35.61 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 4.2 m-20 -90.21 -171.48 3.13 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.681 0.753 . . . . 0.0 110.233 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.558 ' CG ' ' C ' ' A' ' 44' ' ' ASN . 0.2 OUTLIER -158.68 24.32 0.22 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.585 ' OE1' HG12 ' A' ' 101' ' ' VAL . 0.4 OUTLIER -36.37 -67.24 0.18 Allowed 'General case' 0 C--N 1.31 -1.144 0 O-C-N 121.784 -0.573 . . . . 0.0 110.176 -179.235 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.446 ' O ' ' OE2' ' A' ' 102' ' ' GLU . . . -167.01 41.86 0.25 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.614 ' CE1' HG22 ' A' ' 90' ' ' ILE . 65.7 m-85 -100.88 158.15 16.2 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.276 -1.132 . . . . 0.0 109.254 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -125.5 11.0 7.95 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.229 -0.92 . . . . 0.0 109.59 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.61 ' CE2' ' HB3' ' A' ' 48' ' ' PHE . 2.3 p90 -78.19 165.0 24.45 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.142 -0.973 . . . . 0.0 109.363 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 52' ' ' VAL . 33.3 t -144.39 34.76 1.19 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.214 -0.929 . . . . 0.0 109.594 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.608 HG12 ' HB3' ' A' ' 81' ' ' ASN . 59.8 t -44.41 -45.98 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.264 -0.898 . . . . 0.0 109.058 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.404 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 0.1 OUTLIER 172.5 157.0 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.765 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.6 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -59.28 -51.25 82.86 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.408 -0.807 . . . . 0.0 110.623 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 54' ' ' SER . 35.6 Cg_endo -75.6 83.15 1.96 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.046 1.83 . . . . 0.0 110.27 -178.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.608 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 48.7 m-85 -79.35 -172.02 3.0 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.322 0.582 . . . . 0.0 110.148 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.608 ' CG ' ' O ' ' A' ' 56' ' ' TYR . 34.3 m-85 -165.02 118.39 1.24 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.616 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -95.53 146.03 24.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 0.0 110.17 -179.36 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.652 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 8.8 t-105 -160.36 142.97 9.76 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.652 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.2 Cg_endo -67.79 138.67 45.52 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.067 1.844 . . . . 0.0 111.309 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.978 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -110.35 133.0 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.465 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.978 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.3 OUTLIER -125.89 169.48 12.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.312 -0.867 . . . . 0.0 109.29 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.527 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 2.2 p -122.94 28.45 7.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.309 -0.869 . . . . 0.0 109.056 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.77 -12.28 8.47 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.468 -0.77 . . . . 0.0 109.446 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.82 29.46 59.2 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 67' ' ' VAL . 5.8 t0 -102.56 -3.67 26.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -1.157 . . . . 0.0 109.758 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' A' ' 66' ' ' ASP . 3.4 t 55.55 166.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.947 . . . . 0.0 109.42 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.61 ' CD1' HD11 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -115.18 120.96 41.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.903 . . . . 0.0 109.565 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.484 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -140.01 78.57 1.67 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.874 . . . . 0.0 109.527 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 71' ' ' GLY . . . 161.34 37.42 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 70' ' ' GLY . . . 41.95 -145.52 0.74 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.8 t 64.42 74.19 0.42 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.177 -1.19 . . . . 0.0 109.533 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.5 -177.27 3.72 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.596 2.197 . . . . 0.0 110.321 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.552 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 173.84 76.19 0.05 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.597 ' HA ' ' N ' ' A' ' 92' ' ' HIS . . . 67.39 -143.12 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.205 -1.174 . . . . 0.0 109.813 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.527 ' O ' ' O ' ' A' ' 75' ' ' ALA . 49.8 m-20 14.29 113.54 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.532 ' O ' HG12 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -162.86 128.95 3.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.129 -0.982 . . . . 0.0 109.264 178.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.805 HG21 HD21 ' A' ' 86' ' ' LEU . 4.6 p -116.49 140.01 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.749 -1.219 . . . . 0.0 109.227 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -105.0 -175.36 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 122.371 1.081 . . . . 0.0 110.628 -179.235 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.573 ' CG ' ' OE1' ' A' ' 20' ' ' GLN . 26.1 p90 179.81 -169.15 0.12 Allowed 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.608 ' HB3' HG12 ' A' ' 52' ' ' VAL . 1.7 p30 -123.09 -39.73 2.46 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.998 -1.064 . . . . 0.0 110.231 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.579 ' O ' ' CZ ' ' A' ' 24' ' ' TYR . 4.4 pt-20 159.51 -26.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.474 ' O ' ' CB ' ' A' ' 84' ' ' ASN . 0.5 OUTLIER -86.33 -5.24 59.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.338 -0.851 . . . . 0.0 109.089 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 83' ' ' ASN . 7.7 t-20 74.7 30.32 1.02 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.37 -0.831 . . . . 0.0 109.702 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.564 ' HG3' ' ND2' ' A' ' 81' ' ' ASN . 0.4 OUTLIER -74.07 -25.74 60.0 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.218 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.805 HD21 HG21 ' A' ' 78' ' ' VAL . 0.2 OUTLIER 81.81 110.76 0.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.389 0.614 . . . . 0.0 110.195 179.306 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.556 ' N ' HD13 ' A' ' 86' ' ' LEU . . . -78.94 -39.49 34.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.389 -0.82 . . . . 0.0 109.048 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.524 ' O ' HG23 ' A' ' 78' ' ' VAL . . . 162.49 169.53 25.99 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.616 HG21 ' CG ' ' A' ' 4' ' ' TYR . 47.5 t -100.09 87.77 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.265 -1.138 . . . . 0.0 109.559 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.614 HG22 ' CE1' ' A' ' 48' ' ' PHE . 4.4 pt -90.15 146.28 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -0.864 . . . . 0.0 109.411 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.564 ' OG1' ' HB1' ' A' ' 75' ' ' ALA . 9.9 t -123.17 135.19 54.21 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.625 -1.297 . . . . 0.0 110.489 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.687 ' CE1' ' CE2' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -86.39 75.66 9.76 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.368 -0.833 . . . . 0.0 109.187 179.241 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.3 m -179.66 -31.87 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.335 -0.853 . . . . 0.0 109.233 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -68.43 -6.99 51.5 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.911 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -139.53 123.14 17.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.136 -1.214 . . . . 0.0 109.547 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.454 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.3 OUTLIER 47.69 -165.64 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.159 -0.963 . . . . 0.0 109.156 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 96' ' ' SER . . . -40.62 -66.29 0.88 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.601 ' O ' ' CE1' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -153.58 89.5 1.34 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.27 -1.135 . . . . 0.0 109.08 179.445 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.911 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.9 OUTLIER -112.25 141.1 46.36 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.687 ' CE2' ' CE1' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -75.08 138.05 41.85 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.994 -1.066 . . . . 0.0 109.558 -179.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.585 HG12 ' OE1' ' A' ' 46' ' ' GLU . 30.3 m -160.17 145.57 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.344 -0.848 . . . . 0.0 109.005 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.567 ' HG3' ' CD1' ' A' ' 48' ' ' PHE . 1.4 mp0 -45.46 124.26 4.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.545 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.47 130.78 40.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 109.613 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 67.6 p . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.334 -0.854 . . . . 0.0 109.514 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.495 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.8 p 164.83 124.52 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.28 -0.887 . . . . 0.0 110.06 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -104.03 -7.24 20.44 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.46 -0.775 . . . . 0.0 109.067 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.583 ' HD2' HG21 ' A' ' 16' ' ' VAL . 17.2 m-85 -104.71 110.09 22.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.936 . . . . 0.0 109.382 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 9' ' ' ASN . 82.8 p -142.31 118.4 10.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.285 -0.885 . . . . 0.0 109.804 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -124.44 11.6 8.66 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 122.317 1.056 . . . . 0.0 109.436 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 8' ' ' SER . . . -160.94 32.74 0.38 Allowed Glycine 0 C--N 1.282 -2.454 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 3.9 t 70.95 9.32 6.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.316 -1.108 . . . . 0.0 109.315 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.541 ' O ' HG22 ' A' ' 5' ' ' THR . 14.6 m-80 -78.1 178.06 7.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 109.556 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 51.8 t -127.74 70.22 1.33 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.341 -0.849 . . . . 0.0 109.084 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' A' ' 4' ' ' TYR . 3.5 m-85 -79.63 118.68 21.68 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.262 -0.899 . . . . 0.0 109.543 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.57 ' O ' HG23 ' A' ' 16' ' ' VAL . 48.8 m -80.21 133.76 36.05 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.491 -0.756 . . . . 0.0 109.958 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.95 -30.32 10.11 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 t -73.43 -38.99 65.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.362 -0.836 . . . . 0.0 109.076 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -67.95 -26.04 65.75 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.583 HG21 ' HD2' ' A' ' 4' ' ' TYR . 19.4 t -77.15 -29.08 16.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.481 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 0.2 OUTLIER -67.66 -37.84 82.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.422 -0.799 . . . . 0.0 109.382 179.688 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -47.05 86.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.133 -0.98 . . . . 0.0 108.433 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.835 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -73.25 -17.98 61.28 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.573 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -76.45 -32.13 58.25 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.438 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -79.12 -8.31 58.88 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.628 ' HB1' HG13 ' A' ' 67' ' ' VAL . . . -83.29 -55.92 4.06 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.352 -0.843 . . . . 0.0 108.843 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.627 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -68.22 -20.86 73.56 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.577 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 1.0 OUTLIER -81.84 -58.08 3.15 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.586 -0.949 . . . . 0.0 109.521 -179.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.509 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -49.15 -36.45 19.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.13 -0.981 . . . . 0.0 109.486 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.945 HD13 ' HB2' ' A' ' 31' ' ' GLU . 1.2 mm? -72.61 -40.24 66.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.351 -0.843 . . . . 0.0 109.278 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.664 ' CE1' ' CE1' ' A' ' 57' ' ' TYR . 2.6 t60 -61.38 -32.78 72.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.438 -0.789 . . . . 0.0 110.433 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.509 ' OE1' ' CZ ' ' A' ' 24' ' ' TYR . 4.2 pt-20 -86.69 -26.23 24.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.951 -1.093 . . . . 0.0 109.812 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -84.86 -6.54 59.35 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.1 -1.0 . . . . 0.0 109.547 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.79 -28.31 6.59 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.945 ' HB2' HD13 ' A' ' 26' ' ' LEU . 3.1 mm-40 -58.61 -166.94 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.172 -1.193 . . . . 0.0 109.454 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.551 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -155.83 -93.61 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.886 . . . . 0.0 109.524 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -134.67 -167.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.129 -0.982 . . . . 0.0 109.318 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -40.73 -37.41 1.3 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 t -176.37 -51.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -1.186 . . . . 0.0 109.814 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.548 ' O ' ' CB ' ' A' ' 37' ' ' SER . 35.3 m120 -51.39 -86.0 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.156 -0.965 . . . . 0.0 109.645 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.588 ' CA ' ' CG2' ' A' ' 33' ' ' VAL . 0.3 OUTLIER 160.33 -178.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.537 ' C ' ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER 175.46 -49.38 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.917 -1.114 . . . . 0.0 112.302 178.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.531 ' HD2' ' H ' ' A' ' 38' ' ' TYR . 31.4 Cg_endo -75.3 100.55 1.38 Allowed 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 121.215 1.276 . . . . 0.0 112.094 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.537 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -140.72 137.12 33.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.693 -0.629 . . . . 0.0 109.356 178.66 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -42.77 133.84 3.42 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.396 -0.815 . . . . 0.0 110.318 -179.059 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.586 ' OH ' ' CD1' ' A' ' 100' ' ' PHE . 30.2 t80 -94.09 159.43 15.16 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.385 -0.822 . . . . 0.0 109.031 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' A' ' 44' ' ' ASN . 7.9 m-80 -106.63 -39.98 5.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.073 -1.017 . . . . 0.0 110.11 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.514 ' CA ' ' CE2' ' A' ' 42' ' ' TYR . 0.1 OUTLIER 62.92 127.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.11 -0.993 . . . . 0.0 108.764 -179.49 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.482 ' O ' ' C ' ' A' ' 46' ' ' GLU . 1.4 m-85 -161.68 -36.25 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.093 -1.004 . . . . 0.0 110.052 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.482 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -34.75 -72.83 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.671 -0.643 . . . . 0.0 110.412 -179.322 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 171.2 56.46 0.04 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.535 ' CE2' HG22 ' A' ' 90' ' ' ILE . 90.6 m-85 -86.66 177.97 7.19 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.204 -1.174 . . . . 0.0 108.407 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.424 ' OD1' ' C ' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -131.19 11.25 4.99 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.986 -1.071 . . . . 0.0 110.095 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 87' ' ' ALA . 0.7 OUTLIER -88.61 -174.95 4.76 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.036 -1.04 . . . . 0.0 109.201 179.542 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.0 m -173.86 40.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.212 -0.93 . . . . 0.0 109.521 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.0 t -52.24 -39.42 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.296 -0.878 . . . . 0.0 109.284 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.5 ' OG ' ' CB ' ' A' ' 81' ' ' ASN . 32.9 p -177.86 151.37 0.69 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 109.671 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.596 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -59.2 -52.74 72.39 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.333 -0.854 . . . . 0.0 110.08 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 54' ' ' SER . 35.9 Cg_endo -75.48 86.54 1.46 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.989 1.792 . . . . 0.0 109.511 -178.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.604 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 10.6 m-85 -78.84 -169.15 1.66 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.664 ' CE1' ' CE1' ' A' ' 27' ' ' HIS . 66.0 m-85 -162.72 106.73 1.11 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 40' ' ' HIS . 4.1 pt-20 -78.87 137.22 37.57 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.743 0.782 . . . . 0.0 110.726 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.666 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 26.6 t-105 -160.82 139.82 7.71 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.666 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.8 Cg_endo -70.35 158.95 54.61 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.273 1.982 . . . . 0.0 111.749 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 1.006 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -132.41 136.6 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.525 -0.734 . . . . 0.0 109.225 -179.547 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.006 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.5 OUTLIER -121.31 174.96 6.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.106 -0.996 . . . . 0.0 109.775 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.67 31.6 4.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.911 . . . . 0.0 109.189 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.94 -58.72 2.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.376 -0.828 . . . . 0.0 109.399 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.31 52.37 0.03 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -156.67 150.55 24.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -1.175 . . . . 0.0 109.548 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.628 HG13 ' HB1' ' A' ' 22' ' ' ALA . 45.3 t -83.66 133.25 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.351 -0.843 . . . . 0.0 109.351 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.879 ' HD2' HD21 ' A' ' 62' ' ' LEU . 0.7 OUTLIER -56.06 135.67 52.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -0.954 . . . . 0.0 109.508 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.481 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -151.58 52.35 0.83 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.264 -0.897 . . . . 0.0 109.265 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.38 158.21 33.28 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.74 79.18 0.63 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.3 m 53.77 87.4 0.14 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.238 -1.154 . . . . 0.0 109.767 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.6 170.47 19.16 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.653 2.235 . . . . 0.0 110.261 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.586 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 109.14 -164.25 12.49 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 69.38 -162.08 0.18 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.29 -1.123 . . . . 0.0 110.488 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 91' ' ' THR . 38.9 m-20 -46.98 165.86 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.678 0.751 . . . . 0.0 110.787 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.514 ' O ' HG12 ' A' ' 90' ' ' ILE . 36.1 ttm180 -172.82 104.68 0.14 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.001 ' CG2' HD11 ' A' ' 86' ' ' LEU . 4.2 p -79.68 152.22 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.895 -1.128 . . . . 0.0 110.154 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.595 HG12 ' N ' ' A' ' 80' ' ' PHE . 44.7 t -120.32 165.13 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.879 0.847 . . . . 0.0 109.83 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.595 ' N ' HG12 ' A' ' 79' ' ' VAL . 8.4 p90 -165.63 -169.49 1.57 Allowed 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.746 -0.781 . . . . 0.0 109.426 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.571 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 1.9 p30 -122.28 -46.47 2.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.009 -1.057 . . . . 0.0 110.48 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.577 ' O ' ' CZ ' ' A' ' 24' ' ' TYR . 0.7 OUTLIER 163.31 -23.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -179.674 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.484 ' HB3' ' OE1' ' A' ' 85' ' ' GLN . 1.9 m-20 -86.95 14.29 7.63 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.469 ' O ' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER 71.93 6.3 5.57 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.442 -0.787 . . . . 0.0 109.048 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.5 ' HB2' ' ND2' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -58.38 -162.34 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 178.766 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.001 HD11 ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -143.55 107.72 4.75 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.663 -1.273 . . . . 0.0 110.567 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.564 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . . . -69.27 -36.73 77.41 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 149.46 162.77 10.6 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.565 ' HB ' ' CD1' ' A' ' 4' ' ' TYR . 41.8 t -101.07 87.95 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -1.149 . . . . 0.0 109.547 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.557 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 0.5 OUTLIER -82.6 154.0 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.561 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.573 HG22 HG23 ' A' ' 101' ' ' VAL . 9.5 t -110.73 162.47 14.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.979 -1.075 . . . . 0.0 110.808 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.651 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 2.0 t60 -119.66 53.88 1.03 Allowed 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 40.7 m -172.55 125.82 0.5 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.497 -0.752 . . . . 0.0 109.229 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 119.72 -14.93 10.56 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 98' ' ' ASN . . . -117.74 86.41 2.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.18 -1.188 . . . . 0.0 109.546 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER 42.11 74.13 0.12 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.545 -0.722 . . . . 0.0 109.119 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.55 -76.9 0.73 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.761 -1.735 . . . . 0.0 108.761 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.651 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -150.17 -84.08 0.09 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.258 -1.142 . . . . 0.0 109.43 179.717 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.535 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 1.6 t30 63.57 152.11 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.348 -0.845 . . . . 0.0 109.124 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.592 ' O ' HG13 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -96.53 143.78 27.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 109.776 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 100' ' ' PHE . 3.7 m -158.03 131.41 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.475 -0.766 . . . . 0.0 109.159 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -45.45 126.15 6.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.34 -0.85 . . . . 0.0 109.559 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 1.3 m -49.05 165.85 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.259 -0.901 . . . . 0.0 109.645 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.489 1.482 0 O-C-N 121.27 -0.893 . . . . 0.0 109.508 -179.864 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 32.1 p -173.74 115.19 0.23 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.191 -0.943 . . . . 0.0 110.07 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -78.11 -45.38 23.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 0.0 109.212 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.583 ' CE1' ' HB ' ' A' ' 89' ' ' VAL . 28.1 m-85 -74.07 95.82 2.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.0 109.029 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -108.56 67.64 0.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 110.008 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.436 ' HB2' ' OD1' ' A' ' 76' ' ' ASP . 4.1 m -84.16 156.64 21.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 109.071 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 6' ' ' CYS . . . 44.6 -107.8 0.16 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.5 p -142.5 41.25 1.6 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.172 -1.193 . . . . 0.0 109.459 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -118.89 140.59 49.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 0.0 109.566 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -89.86 66.88 7.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -78.76 114.82 18.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 0.0 108.855 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 1.068 ' O ' HG23 ' A' ' 16' ' ' VAL . 1.0 OUTLIER -88.73 148.78 23.8 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.321 -0.862 . . . . 0.0 110.505 -179.181 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -13.39 18.38 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.85 -36.49 12.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.26 -0.9 . . . . 0.0 109.75 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.15 -30.55 62.32 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.987 -1.071 . . . . 0.0 108.117 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 1.068 HG23 ' O ' ' A' ' 12' ' ' SER . 3.8 t -62.38 -31.1 50.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.11 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 t -58.57 -45.24 89.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.282 -0.886 . . . . 0.0 109.866 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.9 m -65.73 -52.02 54.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.578 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.932 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -74.36 -6.6 49.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.287 -0.883 . . . . 0.0 109.579 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.793 ' OE1' HG22 ' A' ' 78' ' ' VAL . 4.3 tp60 -99.69 -15.85 18.38 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.39 -17.72 29.9 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.12 -57.82 3.65 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.432 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -48.42 -28.33 6.41 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.594 ' CE1' ' HA ' ' A' ' 82' ' ' GLU . 24.7 t80 -77.35 -48.4 17.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.602 -0.94 . . . . 0.0 109.596 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.403 ' O ' ' HB2' ' A' ' 29' ' ' ASP . 0.1 OUTLIER -54.09 -40.97 67.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.126 -0.984 . . . . 0.0 108.858 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.88 HD11 ' O ' ' A' ' 31' ' ' GLU . 1.9 tm? -65.84 -43.61 87.99 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.613 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 19.5 t60 -67.55 -17.9 64.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.368 -0.833 . . . . 0.0 109.765 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.95 11.19 31.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 109.579 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 1.8 t0 -122.63 -0.22 9.21 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.346 -0.846 . . . . 0.0 109.451 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.85 21.03 58.07 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.88 ' O ' HD11 ' A' ' 26' ' ' LEU . 3.4 mt-10 -102.35 -166.99 1.34 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.366 -1.079 . . . . 0.0 109.36 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.892 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -147.26 173.66 12.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.242 -0.911 . . . . 0.0 109.513 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 34' ' ' GLY . 33.8 m -89.02 -138.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.41 -0.806 . . . . 0.0 108.968 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.472 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -98.5 33.49 5.99 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.6 p -161.43 -154.3 0.34 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -1.152 . . . . 0.0 109.955 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.748 ' O ' HG21 ' A' ' 32' ' ' THR . 2.2 m120 -53.32 -60.98 2.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 110.101 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.892 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.6 OUTLIER 168.76 108.34 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.404 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.724 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.4 OUTLIER -82.51 -34.31 0.65 Allowed Pre-proline 0 C--O 1.2 -1.507 0 O-C-N 121.01 -1.056 . . . . 0.0 112.221 -178.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.763 ' HG2' HD12 ' A' ' 26' ' ' LEU . 35.9 Cg_endo -79.13 109.05 2.47 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 N-CA-C 109.874 -0.856 . . . . 0.0 109.874 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.724 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -133.58 177.53 7.63 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.601 ' HB2' ' CE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -97.51 129.73 44.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.058 -1.027 . . . . 0.0 110.456 -178.626 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.566 ' HB2' ' HG3' ' A' ' 58' ' ' GLU . 10.6 t80 -94.38 168.84 10.63 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.63 ' ND2' ' CE1' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -145.33 18.41 1.54 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.019 -1.051 . . . . 0.0 110.129 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 43' ' ' ASN . 15.2 m-80 62.03 108.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.069 -1.019 . . . . 0.0 109.738 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.63 ' CE1' ' ND2' ' A' ' 43' ' ' ASN . 3.3 m-30 -114.91 -4.9 12.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.331 -0.855 . . . . 0.0 109.44 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.552 ' CD ' ' CE1' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -110.88 -33.86 6.4 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.115 -0.991 . . . . 0.0 108.787 -179.431 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.01 28.65 2.81 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.552 ' CE1' ' CD ' ' A' ' 46' ' ' GLU . 48.3 m-85 -61.66 -168.18 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 4.8 m-20 -139.1 -44.15 0.46 Allowed 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 118.557 -1.257 . . . . 0.0 109.771 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 49' ' ' ASP . 20.0 m-85 64.17 177.58 0.18 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.323 -0.86 . . . . 0.0 109.478 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.9 -18.58 17.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.232 -0.917 . . . . 0.0 109.07 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.582 HG23 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -98.0 -176.49 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.338 -0.851 . . . . 0.0 108.896 179.609 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.477 ' HA ' ' OH ' ' A' ' 56' ' ' TYR . 12.6 t -151.37 86.42 1.35 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.108 -0.995 . . . . 0.0 109.52 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.668 ' CB ' ' HD2' ' A' ' 55' ' ' PRO . 0.3 OUTLIER -172.58 -176.56 0.34 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.072 -1.018 . . . . 0.0 109.53 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.668 ' HD2' ' CB ' ' A' ' 54' ' ' SER . 29.4 Cg_endo -71.79 96.36 0.76 Allowed 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 121.489 1.459 . . . . 0.0 108.55 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.559 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 24.0 m-85 -75.95 -170.94 1.5 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.777 0.798 . . . . 0.0 110.694 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.613 ' CE2' ' NE2' ' A' ' 27' ' ' HIS . 49.4 m-85 -150.72 147.18 27.03 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.664 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 1.2 mp0 -96.96 146.29 25.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.872 -1.142 . . . . 0.0 110.365 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.657 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 46.3 t-105 -159.45 135.7 6.36 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.657 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 31.9 Cg_endo -72.75 148.68 47.04 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 121.922 1.748 . . . . 0.0 111.115 -178.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.986 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -122.53 142.19 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.986 HD23 ' C ' ' A' ' 61' ' ' ILE . 1.4 mt -122.51 -170.67 2.12 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.249 -0.907 . . . . 0.0 109.383 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.57 54.8 0.93 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 108.928 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -157.75 -43.8 0.06 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.391 -0.818 . . . . 0.0 109.464 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.98 39.45 3.56 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.475 ' C ' HG23 ' A' ' 67' ' ' VAL . 0.5 OUTLIER -114.3 18.22 17.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -1.146 . . . . 0.0 109.464 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.475 HG23 ' C ' ' A' ' 66' ' ' ASP . 2.0 t 62.3 167.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.902 . . . . 0.0 109.693 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.631 ' HD1' HD11 ' A' ' 62' ' ' LEU . 6.1 t80 -106.86 139.13 41.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.343 -0.848 . . . . 0.0 109.591 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.8 m -122.46 -20.21 6.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.243 -0.911 . . . . 0.0 109.636 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 163.73 148.27 5.35 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 144.3 -142.95 11.51 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.445 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 20.3 m -51.89 118.15 11.26 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.217 -1.166 . . . . 0.0 109.323 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.518 ' O ' ' NH1' ' A' ' 77' ' ' ARG . 35.7 Cg_endo -77.72 -75.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.452 2.101 . . . . 0.0 110.571 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.553 ' CA ' ' HB2' ' A' ' 92' ' ' HIS . . . -59.13 -117.83 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.545 ' N ' ' HB2' ' A' ' 92' ' ' HIS . . . 49.54 -167.18 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.278 -1.131 . . . . 0.0 109.704 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.436 ' OD1' ' HB2' ' A' ' 6' ' ' CYS . 1.1 m-20 -42.04 147.82 0.21 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.276 -0.89 . . . . 0.0 109.864 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.518 ' NH1' ' O ' ' A' ' 73' ' ' PRO . 2.2 ttm180 -164.82 70.84 0.17 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.421 -0.799 . . . . 0.0 109.372 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.793 HG22 ' OE1' ' A' ' 20' ' ' GLN . 10.9 p -44.72 149.75 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 109.284 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 1.083 ' CG1' ' HB3' ' A' ' 87' ' ' ALA . 0.4 OUTLIER -121.0 171.92 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.02 -1.05 . . . . 0.0 110.338 -179.484 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.601 ' CD1' ' NE2' ' A' ' 20' ' ' GLN . 19.2 p90 -172.04 -167.52 0.49 Allowed 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.102 -178.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.522 ' N ' ' OD1' ' A' ' 81' ' ' ASN . 0.2 OUTLIER -132.54 -78.47 0.5 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.829 -1.17 . . . . 0.0 109.837 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.594 ' HA ' ' CE1' ' A' ' 24' ' ' TYR . 10.3 pt-20 -160.76 24.58 0.14 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.37 -0.831 . . . . 0.0 109.176 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.47 ' HB2' ' CG ' ' A' ' 85' ' ' GLN . 4.3 m120 -146.03 17.55 1.4 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.456 -0.777 . . . . 0.0 109.241 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.442 ' CG ' ' O ' ' A' ' 83' ' ' ASN . 8.3 p30 47.45 25.68 0.65 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.42 -0.8 . . . . 0.0 109.216 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.568 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -70.29 -27.6 64.53 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.609 HD22 ' HG2' ' A' ' 20' ' ' GLN . 0.1 OUTLIER 85.87 115.87 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.58 0.705 . . . . 0.0 110.739 179.044 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 1.083 ' HB3' ' CG1' ' A' ' 79' ' ' VAL . . . -96.3 -30.72 13.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.507 -0.746 . . . . 0.0 108.999 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.416 ' N ' ' CD1' ' A' ' 86' ' ' LEU . . . 158.08 -153.77 24.92 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.583 ' HB ' ' CE1' ' A' ' 4' ' ' TYR . 42.8 t -147.09 127.72 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.025 -1.279 . . . . 0.0 109.795 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.557 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -114.34 144.91 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.553 -0.717 . . . . 0.0 109.142 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.521 ' O ' HG23 ' A' ' 91' ' ' THR . 6.2 t -133.43 123.93 26.19 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.091 -1.006 . . . . 0.0 109.933 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.606 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -79.37 84.05 5.33 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.541 -0.724 . . . . 0.0 109.477 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 176.1 127.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.423 -0.798 . . . . 0.0 109.251 179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.98 -18.3 28.93 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.608 ' HB3' ' CB ' ' A' ' 99' ' ' ASN . . . -115.46 90.78 3.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.364 -1.08 . . . . 0.0 109.413 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.4 OUTLIER 43.95 78.95 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 109.346 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.91 -88.91 1.59 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.606 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -125.56 -90.55 0.55 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.213 -1.169 . . . . 0.0 109.376 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.608 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . 0.7 OUTLIER 61.08 136.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -0.961 . . . . 0.0 109.059 -179.584 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.557 ' CD1' ' HB ' ' A' ' 90' ' ' ILE . 21.8 m-85 -79.66 155.28 28.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.834 -1.166 . . . . 0.0 110.195 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -160.7 133.85 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.141 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -54.5 126.15 22.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.336 -0.853 . . . . 0.0 109.611 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 1.3 m -68.48 109.29 3.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.408 -0.808 . . . . 0.0 109.819 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.944 . . . . 0.0 109.477 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.507 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.8 p 167.14 130.33 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.218 -0.926 . . . . 0.0 110.065 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -103.87 -9.83 18.66 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.443 -0.786 . . . . 0.0 109.344 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.622 ' CD2' HG23 ' A' ' 89' ' ' VAL . 19.4 m-85 -109.54 132.16 54.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.308 -0.87 . . . . 0.0 109.247 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.448 HG23 ' H ' ' A' ' 10' ' ' CYS . 5.2 m -155.82 113.37 3.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.134 -0.979 . . . . 0.0 109.611 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.4 m -94.27 17.35 12.93 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 122.112 0.958 . . . . 0.0 109.691 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.91 -71.44 0.2 Allowed Glycine 0 C--N 1.283 -2.378 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.7 m -162.62 49.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.314 -1.11 . . . . 0.0 109.239 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.557 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . 6.9 m120 -103.12 -28.88 11.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.308 -0.87 . . . . 0.0 109.771 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.448 ' H ' HG23 ' A' ' 5' ' ' THR . 44.4 t 59.42 63.07 1.63 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.132 -0.98 . . . . 0.0 109.102 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.574 ' CE1' ' HB3' ' A' ' 63' ' ' SER . 40.8 m-85 -79.13 122.41 26.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.445 -0.784 . . . . 0.0 109.144 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.748 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -79.59 133.23 36.43 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.422 -0.799 . . . . 0.0 109.61 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.5 t -52.48 -19.93 2.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.202 -0.936 . . . . 0.0 109.063 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.54 -36.8 18.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 110.015 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -74.59 -27.13 60.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.009 -1.057 . . . . 0.0 108.194 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 12' ' ' SER . 19.3 t -69.5 -33.18 55.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -34.91 78.62 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -38.01 82.48 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.754 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -84.91 -7.67 59.07 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.571 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -90.73 -28.12 18.5 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.276 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -79.5 -11.83 59.89 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.729 ' HB1' HG13 ' A' ' 67' ' ' VAL . . . -80.22 -39.1 29.77 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.607 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -85.52 -15.46 66.06 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -88.7 -58.51 2.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.392 -1.064 . . . . 0.0 109.13 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.49 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -53.56 -35.2 60.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 109.298 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.418 ' HA ' HD22 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -68.17 -46.96 69.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.328 -0.858 . . . . 0.0 109.222 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -49.85 -42.27 47.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.413 -0.804 . . . . 0.0 110.229 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.39 -20.67 27.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.128 -0.983 . . . . 0.0 110.037 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.463 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 28.2 t0 -74.99 -20.23 59.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.128 -0.982 . . . . 0.0 109.54 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.92 19.7 78.54 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 29' ' ' ASP . 0.8 OUTLIER -103.91 -169.3 1.61 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.346 -1.09 . . . . 0.0 109.472 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.864 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -135.67 -170.69 2.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.322 -0.861 . . . . 0.0 109.288 179.71 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.596 ' H ' HG22 ' A' ' 32' ' ' THR . 64.2 t -89.86 -98.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.304 -0.873 . . . . 0.0 109.321 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -124.52 -8.64 5.77 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER 163.72 -46.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.281 -1.129 . . . . 0.0 109.315 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 37' ' ' SER . 1.6 m-80 -82.19 5.37 20.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.608 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.864 ' HA ' HG22 ' A' ' 32' ' ' THR . 81.6 p 45.29 -162.15 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.931 . . . . 0.0 108.876 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.587 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER 167.01 -44.31 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.142 -0.974 . . . . 0.0 111.911 179.243 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 31.1 Cg_endo -74.42 99.75 1.24 Allowed 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.466 1.444 . . . . 0.0 112.274 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.543 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -144.76 -173.89 4.19 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.284 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.575 ' HB2' ' CE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -96.45 126.04 41.37 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.041 -1.037 . . . . 0.0 109.966 -179.167 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.608 ' CE2' ' HA ' ' A' ' 44' ' ' ASN . 8.2 t80 -105.22 139.45 39.86 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.505 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 9.5 m120 -70.41 -46.71 63.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.171 -0.956 . . . . 0.0 110.098 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.608 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 0.2 OUTLIER 76.47 55.85 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.269 -0.894 . . . . 0.0 109.008 -179.403 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -106.09 46.84 0.9 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.269 -0.895 . . . . 0.0 109.483 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.529 ' OE2' ' CG1' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -101.12 -28.76 12.51 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.659 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.33 19.98 3.07 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.609 ' CD2' ' CZ ' ' A' ' 50' ' ' PHE . 59.7 m-85 -63.41 -169.15 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -154.43 36.54 0.42 Allowed 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 118.565 -1.254 . . . . 0.0 109.918 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.609 ' CZ ' ' CD2' ' A' ' 48' ' ' PHE . 6.7 m-85 -62.16 -175.14 0.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.038 -1.039 . . . . 0.0 109.41 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 p -144.72 35.38 1.15 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.384 -0.822 . . . . 0.0 109.038 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.543 HG13 ' HB2' ' A' ' 85' ' ' GLN . 68.8 t -92.9 -71.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.334 -0.853 . . . . 0.0 109.826 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 t -161.68 178.15 9.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.796 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.576 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -79.24 -51.45 1.26 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.349 -0.844 . . . . 0.0 110.654 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 54' ' ' SER . 34.6 Cg_endo -76.06 85.62 1.63 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 121.992 1.795 . . . . 0.0 110.352 -177.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.585 ' O ' ' CD1' ' A' ' 57' ' ' TYR . 48.2 m-85 -79.12 -178.37 6.11 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.394 0.616 . . . . 0.0 109.862 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.585 ' CD1' ' O ' ' A' ' 56' ' ' TYR . 48.3 m-85 -150.88 145.01 25.37 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -104.21 138.52 40.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.234 -0.916 . . . . 0.0 110.6 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.69 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 22.6 t-105 -160.8 138.93 7.23 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.69 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.9 Cg_endo -67.53 142.22 58.35 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.119 1.88 . . . . 0.0 111.274 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.911 HD12 ' N ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -118.63 131.67 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.729 -0.607 . . . . 0.0 109.417 -179.263 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.911 ' N ' HD12 ' A' ' 61' ' ' ILE . 2.9 mt -120.89 165.51 15.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.225 -0.922 . . . . 0.0 109.756 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.574 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 92.9 p -111.11 -1.88 16.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.086 -1.009 . . . . 0.0 108.816 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.58 -37.93 62.8 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.606 -0.683 . . . . 0.0 109.507 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.25 46.15 1.1 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.15 146.44 27.67 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.312 -1.11 . . . . 0.0 109.36 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.729 HG13 ' HB1' ' A' ' 22' ' ' ALA . 73.8 t -66.35 136.44 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.156 -0.965 . . . . 0.0 109.343 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.597 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 20.1 t80 -47.91 147.4 2.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.894 . . . . 0.0 109.638 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.574 ' HA ' HG12 ' A' ' 33' ' ' VAL . 5.4 t -174.82 54.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.529 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.2 119.45 4.62 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.1 -133.19 2.8 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.1 114.55 63.5 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.26 -1.141 . . . . 0.0 109.451 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.02 121.05 5.99 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.336 2.024 . . . . 0.0 110.362 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.516 ' O ' ' NH1' ' A' ' 77' ' ' ARG . . . 110.61 -138.48 14.95 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.558 ' N ' ' HB2' ' A' ' 92' ' ' HIS . . . 64.04 -86.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -1.116 . . . . 0.0 110.222 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.479 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 7.4 m-20 -132.52 110.48 10.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.939 -1.1 . . . . 0.0 110.157 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 60' ' ' PRO . 3.7 mpt_? -116.58 146.12 42.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.448 -0.782 . . . . 0.0 109.024 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.6 p -113.95 134.8 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.053 -1.029 . . . . 0.0 109.33 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.616 HG12 ' N ' ' A' ' 80' ' ' PHE . 58.4 t -97.4 166.04 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-O 121.95 0.881 . . . . 0.0 110.472 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.616 ' N ' HG12 ' A' ' 79' ' ' VAL . 7.1 p90 -164.83 -171.44 2.28 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -126.23 -83.47 0.62 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.842 -1.161 . . . . 0.0 109.977 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -151.43 8.59 0.53 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.418 -0.801 . . . . 0.0 110.37 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.401 ' HB3' ' HG2' ' A' ' 85' ' ' GLN . 4.8 t-20 -138.34 15.07 2.79 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.907 -1.121 . . . . 0.0 108.562 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.459 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 38.4 t30 59.04 30.97 20.92 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.42 -0.8 . . . . 0.0 109.063 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.561 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -63.84 -26.4 68.6 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.067 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.561 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER 85.81 109.0 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.488 0.661 . . . . 0.0 110.652 179.05 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.582 ' HB1' ' CD2' ' A' ' 50' ' ' PHE . . . -83.04 -37.79 23.43 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 153.01 168.25 16.69 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.622 HG23 ' CD2' ' A' ' 4' ' ' TYR . 44.9 t -104.46 102.36 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.158 -1.201 . . . . 0.0 109.343 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.556 HG22 ' CE2' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -93.31 168.44 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.428 -0.795 . . . . 0.0 109.889 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.725 HG22 HG23 ' A' ' 101' ' ' VAL . 5.4 t -106.48 -173.41 2.29 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.456 -0.778 . . . . 0.0 110.387 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.558 ' HB2' ' N ' ' A' ' 75' ' ' ALA . 0.5 OUTLIER -148.82 62.95 1.06 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 1.2 m 172.79 -28.61 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.758 -0.589 . . . . 0.0 109.883 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.9 -9.2 52.37 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 120.033 -1.079 . . . . 0.0 110.654 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -120.1 176.7 5.31 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.932 -1.334 . . . . 0.0 109.805 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.2 OUTLIER -41.53 124.37 2.43 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.676 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.18 -88.69 0.12 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 107.962 -2.055 . . . . 0.0 107.962 -178.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.554 ' HB3' ' O ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -165.56 38.24 0.06 Allowed 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.088 -1.243 . . . . 0.0 109.444 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 98' ' ' ASN . 12.3 t-20 -50.72 179.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.077 -1.015 . . . . 0.0 108.762 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -106.1 146.84 29.66 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.857 -1.152 . . . . 0.0 109.197 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.725 HG23 HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -160.27 140.88 3.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.458 ' OE2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -39.42 138.67 0.64 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.549 -0.719 . . . . 0.0 110.132 -179.119 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.454 ' SG ' ' HB ' ' A' ' 91' ' ' THR . 4.2 m -94.48 97.82 10.42 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.355 -0.841 . . . . 0.0 109.568 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 109.28 179.902 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.229 0.538 . . . . 0.0 109.654 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 32.0 p 178.2 133.02 0.07 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.356 -0.84 . . . . 0.0 109.843 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -94.96 -35.57 11.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 0.0 108.987 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.837 ' CD2' HG21 ' A' ' 89' ' ' VAL . 66.8 m-85 -92.34 81.87 4.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.36 -0.837 . . . . 0.0 109.017 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.754 HG23 ' O ' ' A' ' 5' ' ' THR . 9.8 t -93.98 89.56 6.11 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.321 -0.862 . . . . 0.0 110.149 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.436 ' CB ' ' OD1' ' A' ' 76' ' ' ASP . 0.1 OUTLIER -89.57 -165.05 1.25 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.904 . . . . 0.0 109.0 179.369 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.441 ' O ' ' OG ' ' A' ' 8' ' ' SER . . . -59.13 95.56 0.07 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.454 ' O ' ' OG ' ' A' ' 8' ' ' SER . 4.5 p 65.7 49.2 1.78 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -1.159 . . . . 0.0 109.648 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.432 ' ND2' ' OD2' ' A' ' 76' ' ' ASP . 0.2 OUTLIER -123.8 -71.85 0.7 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.358 -0.839 . . . . 0.0 109.283 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.46 ' C ' ' CB ' ' A' ' 2' ' ' CYS . 50.6 t 53.01 51.69 15.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 109.654 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.57 ' CD1' ' HB3' ' A' ' 63' ' ' SER . 4.3 m-85 -93.43 144.59 25.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.411 -0.805 . . . . 0.0 108.951 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.856 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -83.64 134.4 34.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 110.095 -179.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.2 p -50.85 -25.4 4.47 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.43 -42.63 61.78 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.316 -0.865 . . . . 0.0 108.944 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.31 -19.42 61.04 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 12' ' ' SER . 12.2 t -78.81 -29.02 14.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.454 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 0.6 OUTLIER -65.44 -34.39 78.18 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.228 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -53.7 27.54 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.731 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -62.08 -18.28 60.21 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.543 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -76.13 -37.48 57.97 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.289 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -74.64 -3.27 30.2 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.07 -63.21 1.39 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.378 -0.826 . . . . 0.0 108.776 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.631 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -62.38 -16.88 55.49 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.413 ' CD1' ' C ' ' A' ' 24' ' ' TYR . 1.1 t80 -83.34 -62.65 1.53 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.562 -0.963 . . . . 0.0 109.014 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 2.8 tt0 -48.38 -34.38 10.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.169 -0.957 . . . . 0.0 108.88 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.526 HD11 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -69.46 -44.57 70.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.506 -0.747 . . . . 0.0 109.51 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -59.27 -38.11 79.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.47 -0.769 . . . . 0.0 110.297 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -89.6 -14.79 34.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.105 -0.997 . . . . 0.0 110.352 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -83.48 -10.71 58.18 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.102 -0.999 . . . . 0.0 109.214 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 63.2 11.44 39.4 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -88.02 -144.66 0.13 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.403 -1.057 . . . . 0.0 109.057 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.526 ' N ' HD11 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -167.67 175.22 7.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.002 -1.061 . . . . 0.0 109.688 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.475 HG23 ' H ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -102.17 -94.68 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.235 -0.915 . . . . 0.0 109.87 -179.72 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.475 ' H ' HG23 ' A' ' 33' ' ' VAL . . . -88.77 32.83 4.4 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 1.2 m 67.61 8.59 6.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.195 -1.179 . . . . 0.0 109.332 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.4 ' O ' ' CB ' ' A' ' 37' ' ' SER . 2.4 m120 -102.03 -14.42 17.15 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.198 -0.939 . . . . 0.0 109.503 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.501 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.9 OUTLIER 68.28 105.15 0.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.866 . . . . 0.0 109.255 -179.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.64 ' H ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -116.66 -33.16 0.08 OUTLIER Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 114.274 1.212 . . . . 0.0 114.274 -178.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.64 ' CD ' ' H ' ' A' ' 38' ' ' TYR . 36.4 Cg_endo -80.62 101.88 1.35 Allowed 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.291 1.327 . . . . 0.0 112.734 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.594 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -135.11 -167.3 1.97 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.104 -0.997 . . . . 0.0 109.259 177.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 8.8 ptmm? -76.33 179.03 6.06 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.496 -0.753 . . . . 0.0 109.654 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.794 ' CD2' HG21 ' A' ' 79' ' ' VAL . 7.0 t80 -139.21 98.02 3.42 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.322 -0.861 . . . . 0.0 108.894 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.528 ' O ' ' CE1' ' A' ' 45' ' ' TYR . 8.1 m120 -61.29 -20.2 62.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.423 -0.798 . . . . 0.0 109.772 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.613 ' O ' ' CB ' ' A' ' 45' ' ' TYR . 10.2 p-10 40.24 -144.0 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.534 -0.729 . . . . 0.0 109.901 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.613 ' CB ' ' O ' ' A' ' 44' ' ' ASN . 18.4 m-30 107.11 -20.76 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.603 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 2.2 tm-20 -40.4 -33.46 0.26 Allowed 'General case' 0 C--N 1.309 -1.189 0 O-C-N 121.06 -1.025 . . . . 0.0 110.343 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.73 -15.74 0.72 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.603 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -104.02 159.91 15.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.104 -1.233 . . . . 0.0 108.815 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.491 ' C ' ' CG ' ' A' ' 50' ' ' PHE . 1.4 t0 -143.88 -36.3 0.35 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.199 -0.938 . . . . 0.0 109.837 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.491 ' CG ' ' C ' ' A' ' 49' ' ' ASP . 5.5 m-85 74.82 177.63 0.22 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.137 -0.977 . . . . 0.0 109.457 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.98 41.2 3.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.177 -0.952 . . . . 0.0 109.535 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.538 HG12 ' N ' ' A' ' 53' ' ' SER . 3.3 t -100.97 -72.19 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.334 -0.854 . . . . 0.0 109.337 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.538 ' N ' HG12 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -159.09 167.91 27.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.093 -1.004 . . . . 0.0 110.174 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.571 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -75.99 -52.32 2.62 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.462 -0.774 . . . . 0.0 110.364 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 54' ' ' SER . 35.5 Cg_endo -76.42 83.6 2.01 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.055 1.837 . . . . 0.0 109.72 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.633 ' CE1' ' CB ' ' A' ' 87' ' ' ALA . 31.1 m-85 -79.51 176.2 9.91 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.549 0.69 . . . . 0.0 110.05 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.574 ' CD1' ' O ' ' A' ' 81' ' ' ASN . 89.9 m-85 -142.56 129.03 20.14 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 0.3 OUTLIER -89.11 136.57 32.94 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.906 0.86 . . . . 0.0 111.063 -178.242 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.688 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 39.3 t-105 -160.39 135.79 5.83 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.688 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.6 Cg_endo -70.21 147.1 59.26 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.055 1.837 . . . . 0.0 111.272 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 1.065 HD12 ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -110.0 130.05 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.065 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.1 mt -138.61 119.3 14.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.347 -0.845 . . . . 0.0 108.953 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.57 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.3 t -126.34 73.67 1.39 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.685 -0.634 . . . . 0.0 109.429 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 173.43 -31.57 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.152 -0.967 . . . . 0.0 109.371 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.18 -74.81 0.83 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.05 -150.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -1.145 . . . . 0.0 109.529 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.429 ' O ' ' N ' ' A' ' 69' ' ' SER . 13.6 t -96.51 145.1 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.336 -0.853 . . . . 0.0 109.492 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.547 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 82.3 t80 -50.28 97.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.0 109.467 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 67' ' ' VAL . 1.2 p -132.66 26.88 4.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 109.437 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.19 79.69 0.42 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -156.25 -123.12 0.78 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.8 t -127.22 102.07 24.47 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.256 -1.143 . . . . 0.0 109.246 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.516 ' HB2' ' OH ' ' A' ' 38' ' ' TYR . 34.2 Cg_endo -76.55 -159.07 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.323 2.016 . . . . 0.0 110.551 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.483 ' O ' ' N ' ' A' ' 76' ' ' ASP . . . 66.09 -145.87 48.36 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.466 ' N ' ' HB3' ' A' ' 92' ' ' HIS . . . 48.11 -95.18 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.08 -1.247 . . . . 0.0 109.768 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 91' ' ' THR . 59.7 m-20 -111.05 139.91 46.03 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.861 -1.149 . . . . 0.0 110.208 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.732 ' HA ' HG22 ' A' ' 61' ' ' ILE . 57.8 mtp180 -156.91 159.32 38.02 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.41 HG23 ' HA ' ' A' ' 89' ' ' VAL . 13.1 p -134.74 145.1 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.804 -1.185 . . . . 0.0 110.03 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.89 HG23 ' CD1' ' A' ' 90' ' ' ILE . 3.0 t -106.24 165.05 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 122.106 0.955 . . . . 0.0 109.861 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.615 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 4.0 p90 -156.09 -169.02 2.93 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.753 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.574 ' O ' ' CD1' ' A' ' 57' ' ' TYR . 10.6 t30 -107.41 -80.05 0.57 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.007 -1.058 . . . . 0.0 110.179 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.502 ' HG3' ' ND2' ' A' ' 81' ' ' ASN . 1.3 pp20? -167.85 23.62 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.428 -0.795 . . . . 0.0 109.546 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.515 ' O ' ' CB ' ' A' ' 84' ' ' ASN . 1.2 m120 -149.49 21.72 0.93 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 109.072 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 83' ' ' ASN . 0.1 OUTLIER 80.72 8.11 1.27 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.55 -0.719 . . . . 0.0 109.438 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.504 ' OE1' ' HB2' ' A' ' 83' ' ' ASN . 6.3 mp0 -56.91 -165.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -0.985 . . . . 0.0 108.943 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.424 ' O ' HG21 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -139.56 107.6 5.72 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.957 -1.089 . . . . 0.0 110.098 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.633 ' CB ' ' CE1' ' A' ' 56' ' ' TYR . . . -80.87 -43.01 20.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.427 -0.796 . . . . 0.0 108.925 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 162.26 142.47 3.4 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.837 HG21 ' CD2' ' A' ' 4' ' ' TYR . 60.1 t -81.95 97.26 3.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.116 -1.226 . . . . 0.0 109.976 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.89 ' CD1' HG23 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -78.6 179.85 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.105 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 1.098 HG22 ' O ' ' A' ' 101' ' ' VAL . 12.4 t -135.81 -131.98 0.15 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.916 -1.115 . . . . 0.0 108.457 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.817 ' CD2' ' HB2' ' A' ' 95' ' ' ALA . 0.2 OUTLIER 163.57 42.32 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 -179.657 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.4 m -77.55 97.27 4.99 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.695 0.759 . . . . 0.0 109.713 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.502 ' O ' ' C ' ' A' ' 95' ' ' ALA . . . 93.55 -29.91 7.91 Favored Glycine 0 C--N 1.297 -1.592 0 N-CA-C 107.753 -2.139 . . . . 0.0 107.753 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.817 ' HB2' ' CD2' ' A' ' 92' ' ' HIS . . . 34.45 -154.97 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.3 -0.529 . . . . 0.0 109.873 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.455 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.6 OUTLIER 46.01 47.53 12.67 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -179.034 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.98 -25.64 2.65 Favored Glycine 0 N--CA 1.483 1.828 0 N-CA-C 106.026 -2.83 . . . . 0.0 106.026 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 1.001 ' O ' HG13 ' A' ' 101' ' ' VAL . 7.8 m120 -105.65 -29.77 9.9 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.531 ' OD1' ' HG3' ' A' ' 46' ' ' GLU . 11.5 p-10 37.21 -146.1 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.706 ' CD1' ' CE1' ' A' ' 42' ' ' TYR . 5.3 m-85 -75.78 77.15 2.73 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 1.098 ' O ' HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -85.36 131.82 33.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.392 -0.818 . . . . 0.0 108.969 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -43.71 151.51 0.19 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.527 -1.358 . . . . 0.0 109.717 -179.049 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 1.2 m -75.71 92.25 2.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.924 . . . . 0.0 109.37 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.869 . . . . 0.0 109.437 -179.934 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.51 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.8 p 163.37 121.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.355 -0.841 . . . . 0.0 109.67 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -105.4 3.52 29.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.91 . . . . 0.0 109.431 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.588 ' CD1' HG21 ' A' ' 89' ' ' VAL . 11.4 m-85 -119.69 104.63 10.42 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.119 -0.988 . . . . 0.0 109.625 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.715 HG22 ' H ' ' A' ' 7' ' ' GLY . 98.5 m -143.85 123.34 13.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.093 -1.004 . . . . 0.0 109.421 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -91.97 9.81 31.56 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.163 -0.961 . . . . 0.0 109.945 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.715 ' H ' HG22 ' A' ' 5' ' ' THR . . . -177.39 -62.64 0.06 OUTLIER Glycine 0 C--N 1.282 -2.43 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.434 ' HA ' HG21 ' A' ' 5' ' ' THR . 3.6 m -174.46 30.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -1.129 . . . . 0.0 109.51 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.608 ' H ' HG23 ' A' ' 5' ' ' THR . 8.4 m-80 -80.02 -24.49 40.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.923 . . . . 0.0 109.371 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 9' ' ' ASN . 37.8 t 58.87 68.49 0.81 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.37 -0.832 . . . . 0.0 109.574 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.558 ' CE1' ' HB3' ' A' ' 9' ' ' ASN . 11.0 m-85 -89.47 132.94 34.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.131 -0.98 . . . . 0.0 109.259 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.588 ' O ' HG23 ' A' ' 16' ' ' VAL . 15.3 t -83.07 130.5 35.13 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.368 -0.832 . . . . 0.0 109.859 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 p -56.36 -17.57 8.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.304 -0.872 . . . . 0.0 109.287 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.7 -32.55 21.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.89 . . . . 0.0 109.575 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.435 ' O ' ' OG1' ' A' ' 18' ' ' THR . 0.5 OUTLIER -77.13 -37.33 54.26 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.305 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 12' ' ' SER . 28.8 t -51.9 -37.44 21.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.99 -43.29 99.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.576 -0.702 . . . . 0.0 109.339 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -59.17 -47.4 85.44 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.72 ' CB ' HD13 ' A' ' 61' ' ' ILE . . . -70.82 -15.2 62.63 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.59 ' NE2' ' CG1' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -89.65 -12.77 38.65 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.533 -0.729 . . . . 0.0 109.096 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -94.1 -20.92 19.46 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.08 -61.24 2.05 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.59 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -55.93 -24.94 43.99 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -73.83 -46.4 45.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.623 -0.928 . . . . 0.0 109.256 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -66.16 -63.63 1.04 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.373 -0.829 . . . . 0.0 108.906 179.757 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.859 HD21 ' C ' ' A' ' 32' ' ' THR . 3.3 tp -44.2 -33.93 1.7 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.302 -0.874 . . . . 0.0 109.068 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.618 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -63.86 -59.77 4.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.323 -0.861 . . . . 0.0 109.254 179.772 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.5 11.84 7.98 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.511 -0.743 . . . . 0.0 109.542 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -100.53 -24.01 14.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -0.919 . . . . 0.0 109.448 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.0 -16.76 45.57 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.43 -148.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.247 -1.149 . . . . 0.0 109.277 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.988 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.1 OUTLIER -170.61 -176.09 2.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.397 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.498 HG23 ' H ' ' A' ' 35' ' ' SER . 19.0 m -89.74 -126.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.143 -0.973 . . . . 0.0 109.606 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.403 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -130.34 -4.04 4.58 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.085 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.498 ' H ' HG23 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -109.86 -93.09 0.43 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.023 -1.281 . . . . 0.0 109.128 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -130.62 58.78 1.68 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.321 -0.862 . . . . 0.0 108.969 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.988 ' HA ' HG22 ' A' ' 32' ' ' THR . 4.2 t 57.71 -158.75 0.27 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.309 -0.87 . . . . 0.0 109.019 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.586 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER 166.84 -43.96 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 112.168 179.284 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 32.0 Cg_endo -75.2 100.66 1.39 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.353 1.368 . . . . 0.0 112.367 -178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.553 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -143.93 175.12 10.26 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.143 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -72.25 157.76 37.1 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.044 -1.035 . . . . 0.0 110.044 -179.391 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.506 ' OH ' ' CD1' ' A' ' 100' ' ' PHE . 87.3 t80 -145.93 89.6 1.91 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.438 -0.789 . . . . 0.0 109.19 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.522 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 32.3 m120 -52.29 -88.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.171 -0.956 . . . . 0.0 110.169 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.524 ' N ' ' OD1' ' A' ' 44' ' ' ASN . 2.4 p30 161.97 135.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.175 -0.953 . . . . 0.0 109.276 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -131.05 -0.91 4.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.077 -1.014 . . . . 0.0 109.862 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.497 ' O ' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -100.73 -19.35 16.07 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.191 -0.943 . . . . 0.0 108.62 -179.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.26 23.88 7.1 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.581 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 18.4 m-85 -63.85 87.16 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 50' ' ' PHE . 5.7 t70 -54.57 -32.25 58.2 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.839 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.902 ' CD2' ' HB1' ' A' ' 87' ' ' ALA . 9.8 m-30 44.93 -170.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.357 -0.84 . . . . 0.0 109.607 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -151.55 32.28 0.57 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -0.951 . . . . 0.0 109.454 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.5 t -113.48 -86.62 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.833 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.576 ' O ' ' CZ ' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -152.76 164.89 36.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.103 -0.998 . . . . 0.0 109.762 -179.77 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.59 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -62.22 -51.96 70.26 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.386 -0.821 . . . . 0.0 110.395 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 54' ' ' SER . 36.3 Cg_endo -76.18 80.77 2.6 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.072 1.848 . . . . 0.0 110.716 -178.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.576 ' CZ ' ' O ' ' A' ' 53' ' ' SER . 93.3 m-85 -78.85 -164.63 0.62 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.618 ' CE1' ' NE2' ' A' ' 27' ' ' HIS . 60.4 m-85 -156.1 113.94 3.31 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.519 -0.738 . . . . 0.0 109.266 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -82.91 137.59 34.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.254 -0.904 . . . . 0.0 110.447 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.67 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 10.0 t-105 -160.7 140.65 8.27 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.67 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.5 Cg_endo -69.75 130.52 19.5 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.202 1.935 . . . . 0.0 111.45 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.945 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -111.56 130.25 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.945 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.3 OUTLIER -120.7 168.71 11.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.157 -0.964 . . . . 0.0 109.595 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.484 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 12.3 t -121.38 26.92 8.59 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.7 -55.74 0.05 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.601 -0.687 . . . . 0.0 109.309 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 66' ' ' ASP . . . -72.95 -4.34 62.28 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.417 ' C ' ' OD1' ' A' ' 66' ' ' ASP . 49.5 t0 60.51 -99.88 0.1 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -1.161 . . . . 0.0 109.731 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.9 t -81.26 151.97 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.957 -1.089 . . . . 0.0 109.473 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.585 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 31.5 t80 -82.68 124.23 30.01 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.131 -0.98 . . . . 0.0 109.833 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 99.8 p -119.97 -3.19 10.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.464 -0.773 . . . . 0.0 109.266 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.49 130.64 3.49 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 154.39 86.47 0.06 OUTLIER Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.0 t 51.73 93.03 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.181 -1.188 . . . . 0.0 109.767 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.57 -169.4 0.77 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.708 2.272 . . . . 0.0 110.818 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.647 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 77.64 -170.17 54.93 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 71.63 -162.21 0.13 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.149 -1.206 . . . . 0.0 110.765 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.503 ' N ' ' OG1' ' A' ' 91' ' ' THR . 14.9 m-20 -36.51 154.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.547 0.689 . . . . 0.0 111.106 -178.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.603 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 10.0 ttm105 -177.92 70.4 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.484 -0.76 . . . . 0.0 109.019 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.662 ' CG2' HD11 ' A' ' 86' ' ' LEU . 1.4 p -53.72 166.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.813 -1.179 . . . . 0.0 109.741 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.731 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -126.84 176.88 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.275 -0.89 . . . . 0.0 109.838 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.611 ' CE1' ' O ' ' A' ' 57' ' ' TYR . 8.7 p90 -164.51 -171.69 2.43 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.125 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.442 ' C ' ' HG2' ' A' ' 82' ' ' GLU . 21.8 t30 -129.4 -80.08 0.56 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.038 -1.039 . . . . 0.0 110.06 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.442 ' HG2' ' C ' ' A' ' 81' ' ' ASN . 65.3 mm-40 -149.2 11.12 0.8 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.374 -0.829 . . . . 0.0 110.235 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.49 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 3.6 t-20 -147.74 15.64 1.1 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.026 -1.046 . . . . 0.0 109.567 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.49 ' OD1' ' O ' ' A' ' 83' ' ' ASN . 0.2 OUTLIER 68.16 12.42 8.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.307 -0.871 . . . . 0.0 109.363 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.547 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 1.8 mt-30 -45.95 -31.87 2.43 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.662 HD11 ' CG2' ' A' ' 78' ' ' VAL . 0.1 OUTLIER 85.13 104.1 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.479 0.657 . . . . 0.0 109.952 179.569 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.902 ' HB1' ' CD2' ' A' ' 50' ' ' PHE . . . -77.34 -33.62 55.41 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.372 -0.83 . . . . 0.0 109.14 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 149.55 160.87 9.43 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.588 HG21 ' CD1' ' A' ' 4' ' ' TYR . 4.9 t -85.97 106.06 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.203 -1.174 . . . . 0.0 110.127 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.603 ' CG1' ' O ' ' A' ' 77' ' ' ARG . 14.6 pt -108.38 138.71 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.702 HG22 HG23 ' A' ' 101' ' ' VAL . 4.4 t -120.88 175.06 6.23 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.959 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.597 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -115.36 68.62 0.71 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.407 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.535 ' HB ' ' O ' ' A' ' 92' ' ' HIS . 13.7 t 172.5 158.93 0.11 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 98.48 -21.4 46.19 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.772 -1.204 . . . . 0.0 110.403 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.753 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -125.32 -171.92 2.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.056 -1.261 . . . . 0.0 109.423 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 95' ' ' ALA . 20.4 m -42.02 111.18 0.21 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -0.842 . . . . 0.0 108.905 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 63.76 -105.68 1.16 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.597 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -132.14 35.35 3.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.241 -1.152 . . . . 0.0 108.771 178.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.753 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 4.4 t-20 -45.58 170.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.306 -0.871 . . . . 0.0 109.436 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.542 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 13.1 m-85 -92.4 149.19 21.56 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.212 -0.93 . . . . 0.0 109.534 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.702 HG23 HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -156.12 148.56 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 1.0 OUTLIER -82.38 122.08 27.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.431 -0.793 . . . . 0.0 109.857 -179.584 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.559 ' O ' HG23 ' A' ' 104' ' ' THR . 80.5 m -43.51 121.23 2.21 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.325 -0.859 . . . . 0.0 109.538 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 103' ' ' CYS . 13.7 p . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.124 -0.985 . . . . 0.0 109.535 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.432 ' C ' ' SG ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.293 0.568 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 0.8 OUTLIER 174.0 124.56 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.306 -0.871 . . . . 0.0 110.152 179.685 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -87.53 -36.39 17.62 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.356 -0.84 . . . . 0.0 109.051 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.818 ' CG ' HG21 ' A' ' 89' ' ' VAL . 41.5 m-85 -82.35 115.66 21.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.355 -0.84 . . . . 0.0 109.394 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.493 HG22 ' O ' ' A' ' 9' ' ' ASN . 1.1 p -150.18 122.88 8.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.403 -0.811 . . . . 0.0 109.643 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -112.08 10.28 20.36 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.241 1.02 . . . . 0.0 109.641 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 172.73 -96.23 0.11 Allowed Glycine 0 C--N 1.282 -2.445 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -123.2 23.4 9.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -1.109 . . . . 0.0 109.231 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.493 ' O ' HG22 ' A' ' 5' ' ' THR . 4.5 m-80 -96.76 106.57 18.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.895 . . . . 0.0 109.819 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 47.8 t -78.33 78.47 4.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.346 -0.846 . . . . 0.0 109.417 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.411 ' CE2' ' HB3' ' A' ' 9' ' ' ASN . 14.6 m-85 -98.31 110.15 22.78 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.432 -0.792 . . . . 0.0 109.003 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.584 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -84.66 128.95 34.86 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.174 -0.954 . . . . 0.0 109.956 -179.619 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 12' ' ' SER . 1.1 p -41.17 -27.6 0.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 12' ' ' SER . 5.3 t -69.74 -50.43 43.54 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.349 -0.844 . . . . 0.0 109.623 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.34 -22.74 65.58 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 12' ' ' SER . 17.8 t -78.0 -29.47 15.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.404 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 46.7 t -61.39 -46.44 90.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.568 -0.708 . . . . 0.0 109.412 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.2 -53.26 60.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.923 . . . . 0.0 108.606 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.548 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -66.97 -15.49 63.74 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.581 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -74.89 -37.99 61.99 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.531 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.8 -6.05 52.82 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.91 -62.13 1.8 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.375 -0.828 . . . . 0.0 109.075 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.565 ' HA3' ' CD2' ' A' ' 59' ' ' TRP . . . -58.33 -25.15 57.17 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.484 ' CE2' ' O ' ' A' ' 82' ' ' GLU . 2.8 t80 -73.15 -44.49 59.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.408 -1.054 . . . . 0.0 109.44 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' A' ' 26' ' ' LEU . 0.7 OUTLIER -55.7 -69.68 0.13 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.487 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.486 HD11 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -42.38 -45.19 4.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.415 -0.803 . . . . 0.0 109.971 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -52.7 -54.6 31.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.299 -0.875 . . . . 0.0 110.518 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.66 -3.07 49.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.099 -1.001 . . . . 0.0 109.9 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -87.2 8.01 25.81 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.108 -0.995 . . . . 0.0 109.618 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 48.86 27.53 6.53 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.475 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -125.67 -158.21 0.83 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.458 -1.025 . . . . 0.0 109.405 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.695 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -147.62 -174.64 4.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.915 . . . . 0.0 109.256 179.727 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' A' ' 34' ' ' GLY . 33.8 m -103.71 171.68 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.065 -1.022 . . . . 0.0 109.831 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -45.04 -38.39 6.05 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 36' ' ' ASN . 0.6 OUTLIER -78.51 175.55 10.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -1.098 . . . . 0.0 109.474 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' A' ' 37' ' ' SER . 20.2 m-20 -43.86 -48.19 8.33 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.261 -0.899 . . . . 0.0 109.115 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.695 ' HA ' HG22 ' A' ' 32' ' ' THR . 5.8 t 176.04 -164.12 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.591 ' CA ' ' CE1' ' A' ' 40' ' ' HIS . 0.2 OUTLIER 170.19 -45.12 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.083 -1.01 . . . . 0.0 112.213 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.58 ' HD2' ' H ' ' A' ' 38' ' ' TYR . 31.7 Cg_endo -75.41 97.0 1.06 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 121.002 1.134 . . . . 0.0 111.656 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.591 ' CE1' ' CA ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -139.61 -179.52 5.96 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.559 ' HA ' ' CD1' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -69.6 162.12 28.24 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.333 -0.854 . . . . 0.0 110.038 -179.32 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.616 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 18.1 t80 -127.61 152.85 47.13 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.525 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 3.3 p-10 -165.59 95.48 0.63 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.977 -1.077 . . . . 0.0 109.829 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.616 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 0.6 OUTLIER -135.71 -41.12 0.69 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.335 -0.853 . . . . 0.0 109.433 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.58 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 0.0 OUTLIER 42.65 26.47 0.07 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.402 -0.811 . . . . 0.0 110.018 179.696 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -39.95 -27.63 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 O-C-N 121.319 -0.863 . . . . 0.0 109.984 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 45' ' ' TYR . . . 167.69 -23.82 0.11 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.558 ' CZ ' ' HA ' ' A' ' 101' ' ' VAL . 0.1 OUTLIER -92.46 49.94 1.55 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.447 -1.031 . . . . 0.0 109.211 179.591 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.53 103.14 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -0.879 . . . . 0.0 109.454 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 1.053 ' CD2' ' HB1' ' A' ' 87' ' ' ALA . 12.7 m-85 -65.87 164.09 15.6 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.259 -0.901 . . . . 0.0 109.306 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.3 t -108.63 23.45 14.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 0.0 109.868 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.515 ' CG1' ' HB3' ' A' ' 81' ' ' ASN . 14.2 t -80.53 -58.48 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.091 -1.006 . . . . 0.0 109.377 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -175.38 172.12 2.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 109.682 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.595 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -69.57 -53.41 12.57 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.357 -0.839 . . . . 0.0 110.155 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 54' ' ' SER . 35.8 Cg_endo -74.82 90.39 1.07 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.972 1.781 . . . . 0.0 110.034 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.534 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 30.3 m-85 -78.61 -170.34 2.06 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.559 ' CD1' ' HA ' ' A' ' 41' ' ' LYS . 57.9 m-85 -157.7 111.92 2.61 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -82.52 139.82 33.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.454 -0.779 . . . . 0.0 110.388 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.704 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 35.7 t-105 -160.86 139.36 7.42 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.704 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 32.0 Cg_endo -71.02 145.26 49.41 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.215 1.943 . . . . 0.0 111.434 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.977 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -108.38 138.15 36.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.977 HD23 ' C ' ' A' ' 61' ' ' ILE . 1.1 mt -124.91 168.69 12.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.044 -1.035 . . . . 0.0 109.965 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.16 0.17 9.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.035 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.69 -166.54 1.42 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.383 -0.823 . . . . 0.0 109.197 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.27 59.2 0.48 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.673 ' O ' HD12 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -158.9 106.18 1.82 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.173 -1.193 . . . . 0.0 109.799 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.527 HG13 ' HZ2' ' A' ' 59' ' ' TRP . 77.5 t -52.4 143.41 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -0.893 . . . . 0.0 108.931 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.659 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 42.9 t80 -45.95 120.85 2.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.875 -1.141 . . . . 0.0 109.43 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.6 p -165.95 29.9 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.464 -0.773 . . . . 0.0 109.291 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -116.03 -67.08 0.4 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.434 ' C ' ' OG ' ' A' ' 72' ' ' SER . . . 148.47 151.44 5.46 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.434 ' OG ' ' C ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER 51.11 92.62 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.37 -1.077 . . . . 0.0 110.085 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.534 ' CD ' ' OH ' ' A' ' 38' ' ' TYR . 35.0 Cg_endo -79.11 -72.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.897 2.398 . . . . 0.0 109.642 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 101.68 98.1 2.35 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.614 ' HB2' ' HB ' ' A' ' 93' ' ' THR . . . 61.69 -149.88 0.39 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.292 -1.122 . . . . 0.0 110.262 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.542 ' O ' ' O ' ' A' ' 75' ' ' ALA . 2.4 m-20 28.29 108.62 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 121.524 0.678 . . . . 0.0 112.584 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.497 ' O ' HG12 ' A' ' 90' ' ' ILE . 2.0 ttm-85 -154.0 111.28 3.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.014 -1.053 . . . . 0.0 109.003 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 89' ' ' VAL . 7.7 p -91.34 154.99 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.059 -1.026 . . . . 0.0 109.495 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.932 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 52.6 t -120.35 166.98 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.275 -0.891 . . . . 0.0 109.923 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.615 ' N ' HG12 ' A' ' 79' ' ' VAL . 10.8 p90 -169.6 -177.32 2.69 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.755 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.543 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -124.25 -38.79 2.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.433 -0.792 . . . . 0.0 109.529 -179.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.543 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 4.0 mt-10 162.44 -27.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.442 -0.786 . . . . 0.0 108.936 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.545 ' HB3' ' HG2' ' A' ' 85' ' ' GLN . 1.1 t-20 -98.58 19.76 14.05 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.516 -0.74 . . . . 0.0 109.135 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 6.2 p30 52.42 23.29 2.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.827 -0.545 . . . . 0.0 110.028 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.545 ' HG2' ' HB3' ' A' ' 83' ' ' ASN . 1.6 mt-30 -55.2 -31.82 61.73 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.547 HD22 ' HG3' ' A' ' 20' ' ' GLN . 0.1 OUTLIER 84.79 104.54 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.406 0.622 . . . . 0.0 110.912 179.135 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 1.053 ' HB1' ' CD2' ' A' ' 50' ' ' PHE . . . -73.26 -44.58 59.07 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.413 ' O ' HG23 ' A' ' 78' ' ' VAL . . . 166.43 -154.38 24.84 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.924 -1.671 . . . . 0.0 108.924 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.818 HG21 ' CG ' ' A' ' 4' ' ' TYR . 34.9 t -138.1 81.19 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.093 -1.239 . . . . 0.0 109.532 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.586 HD13 ' CG2' ' A' ' 79' ' ' VAL . 0.7 OUTLIER -80.06 152.14 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.333 -0.854 . . . . 0.0 108.802 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.421 ' CG2' HG23 ' A' ' 101' ' ' VAL . 0.8 OUTLIER -116.38 138.96 50.92 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.108 -0.995 . . . . 0.0 111.378 -178.256 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.617 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.1 OUTLIER -86.62 59.3 5.56 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.543 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.614 ' HB ' ' HB2' ' A' ' 75' ' ' ALA . 3.5 m -176.32 -31.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.208 -0.932 . . . . 0.0 109.692 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.72 -17.23 13.78 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.639 ' HB3' ' CB ' ' A' ' 99' ' ' ASN . . . -121.81 174.17 7.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -1.167 . . . . 0.0 109.747 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 95' ' ' ALA . 2.7 t -39.86 128.18 2.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.575 -0.703 . . . . 0.0 109.317 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 63.38 -88.59 0.06 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.617 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -139.44 -64.24 0.5 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -1.182 . . . . 0.0 109.552 179.685 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.639 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . 1.0 OUTLIER 47.35 -172.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.138 -0.977 . . . . 0.0 109.189 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -131.38 131.89 44.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.154 -0.966 . . . . 0.0 109.708 179.595 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.558 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 0.7 OUTLIER -147.25 131.66 10.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.353 -0.842 . . . . 0.0 108.856 179.385 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -51.97 133.79 32.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.901 . . . . 0.0 109.817 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 8.0 m -65.48 148.52 51.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.321 -0.862 . . . . 0.0 109.569 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 31.2 p . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 116.719 -1.61 . . . . 0.0 109.408 179.906 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.533 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 1.8 p 163.52 142.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.355 -0.84 . . . . 0.0 109.545 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' A' ' 3' ' ' ASP . 41.7 t0 -104.51 -41.66 5.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 109.559 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.715 ' CG ' HG21 ' A' ' 89' ' ' VAL . 34.6 m-85 -83.36 128.76 34.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.924 . . . . 0.0 109.54 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -137.19 110.38 7.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.303 -0.873 . . . . 0.0 109.274 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.3 m -106.51 13.79 27.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.12 -0.987 . . . . 0.0 109.95 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 128.73 92.59 0.71 Allowed Glycine 0 C--N 1.283 -2.369 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 54.18 27.74 8.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.368 -1.078 . . . . 0.0 109.532 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -93.59 -43.74 8.54 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.303 -0.873 . . . . 0.0 109.496 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 10' ' ' CYS . 47.8 t 49.98 49.28 20.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 109.219 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.575 ' CE1' ' OG ' ' A' ' 63' ' ' SER . 6.4 m-30 -87.38 120.6 28.84 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.433 -0.792 . . . . 0.0 109.38 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.655 ' O ' HG23 ' A' ' 16' ' ' VAL . 17.8 t -85.18 118.34 24.67 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.267 -0.895 . . . . 0.0 109.235 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.477 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 3.7 p -41.52 -26.16 0.06 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.557 -0.715 . . . . 0.0 109.614 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -61.67 -54.92 36.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.147 -0.971 . . . . 0.0 109.185 179.407 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -69.8 -25.91 64.0 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.78 HG12 ' NE2' ' A' ' 20' ' ' GLN . 18.9 t -68.24 -25.07 30.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.55 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 0.1 OUTLIER -65.45 -44.5 87.05 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.3 m -59.2 -51.16 71.18 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.467 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -65.94 -16.42 63.85 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.817 ' NE2' HG11 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -82.26 -25.14 34.35 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.611 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.37 -7.83 58.15 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.298 -0.876 . . . . 0.0 108.664 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.7 -63.72 1.28 Allowed 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.603 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -50.9 -30.17 21.64 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.484 ' O ' ' HB3' ' A' ' 27' ' ' HIS . 3.1 t80 -74.14 -56.31 5.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.386 -1.067 . . . . 0.0 108.816 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.472 ' HG2' ' OD1' ' A' ' 29' ' ' ASP . 5.0 tt0 -53.05 -67.64 0.24 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.422 -0.799 . . . . 0.0 109.126 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.482 ' HA ' HD12 ' A' ' 26' ' ' LEU . 4.8 tp -42.96 -37.21 1.8 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.301 -0.875 . . . . 0.0 109.598 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.63 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 3.2 t60 -61.51 -53.18 59.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.174 -0.954 . . . . 0.0 110.134 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -86.93 6.9 29.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.352 -0.843 . . . . 0.0 110.122 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.472 ' OD1' ' HG2' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -98.04 -16.85 19.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.022 -1.049 . . . . 0.0 109.579 -179.79 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.16 -11.15 58.77 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.594 ' HG3' ' N ' ' A' ' 32' ' ' THR . 31.9 tp10 -84.96 164.86 18.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -1.134 . . . . 0.0 109.201 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.711 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -129.85 171.44 12.72 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.498 -0.751 . . . . 0.0 109.798 -179.746 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.455 ' HB ' ' HA ' ' A' ' 69' ' ' SER . 33.0 m -81.27 166.8 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.437 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.87 -29.32 42.16 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.413 ' HB2' ' HA2' ' A' ' 70' ' ' GLY . 0.6 OUTLIER -73.92 -144.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -1.141 . . . . 0.0 109.204 179.79 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.457 ' O ' ' CB ' ' A' ' 37' ' ' SER . 2.9 m120 -102.11 60.49 0.85 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.961 -1.087 . . . . 0.0 109.803 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.711 ' HA ' HG22 ' A' ' 32' ' ' THR . 6.2 t 70.97 -168.97 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.553 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.634 ' CZ ' ' CB ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER 165.07 -41.96 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.33 -0.856 . . . . 0.0 112.206 178.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.59 ' HD2' ' H ' ' A' ' 38' ' ' TYR . 31.4 Cg_endo -75.35 100.07 1.33 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.096 1.197 . . . . 0.0 111.977 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.542 ' CD2' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -145.35 176.92 9.21 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.577 -0.702 . . . . 0.0 109.252 178.691 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.563 ' HA ' ' CD1' ' A' ' 57' ' ' TYR . 0.7 OUTLIER -59.27 161.63 5.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.32 -0.863 . . . . 0.0 109.968 -179.497 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.626 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 44.9 t80 -134.29 68.19 1.49 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.45 -0.781 . . . . 0.0 109.023 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.453 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 1.3 m-20 -86.55 61.88 7.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.18 -0.95 . . . . 0.0 109.151 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 1.8 m120 -89.74 -78.26 0.37 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.557 -0.714 . . . . 0.0 110.515 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.527 ' CB ' ' O ' ' A' ' 44' ' ' ASN . 3.1 m-85 79.49 29.19 0.33 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.47 -0.769 . . . . 0.0 108.953 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -36.24 -71.21 0.08 Allowed 'General case' 0 C--N 1.308 -1.198 0 O-C-N 121.749 -0.594 . . . . 0.0 110.23 -179.603 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.19 44.2 0.55 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.07 169.17 18.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -1.137 . . . . 0.0 109.545 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -112.51 -31.86 6.66 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.534 ' CB ' ' OH ' ' A' ' 56' ' ' TYR . 8.3 m-30 55.41 178.13 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.408 -0.808 . . . . 0.0 109.567 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.48 37.57 1.01 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.312 -0.867 . . . . 0.0 109.092 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.558 HG21 ' HA ' ' A' ' 87' ' ' ALA . 41.1 t -110.12 -82.61 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.394 -0.816 . . . . 0.0 109.708 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.528 ' N ' HG12 ' A' ' 52' ' ' VAL . 4.7 t -163.15 154.08 16.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.164 -0.96 . . . . 0.0 109.855 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.597 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -55.9 -50.66 85.94 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.398 -0.814 . . . . 0.0 110.442 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 54' ' ' SER . 35.8 Cg_endo -75.82 84.44 1.78 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.018 1.812 . . . . 0.0 110.156 -178.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.556 ' CE1' ' HB2' ' A' ' 87' ' ' ALA . 49.2 m-85 -81.81 -169.52 2.39 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.821 0.82 . . . . 0.0 109.879 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.63 ' CE1' ' NE2' ' A' ' 27' ' ' HIS . 70.2 m-85 -156.75 109.05 2.5 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.48 ' N ' ' HB2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -76.2 138.51 40.7 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.844 0.83 . . . . 0.0 110.911 -178.048 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.668 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 34.8 t-105 -160.58 137.26 6.49 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.668 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.5 Cg_endo -67.67 151.84 78.66 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.986 1.791 . . . . 0.0 110.592 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.985 ' C ' HD23 ' A' ' 62' ' ' LEU . 1.3 tp -122.13 138.7 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.421 -0.8 . . . . 0.0 110.023 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.985 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.7 OUTLIER -124.34 -175.54 3.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.385 -0.822 . . . . 0.0 108.896 179.476 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.575 ' OG ' ' CE1' ' A' ' 11' ' ' TYR . 16.6 p -146.72 55.1 1.12 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.01 -1.056 . . . . 0.0 109.636 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.31 30.94 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.464 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 47.31 90.0 0.01 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.478 ' O ' ' HB ' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -161.16 -36.33 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.256 -1.143 . . . . 0.0 110.025 -179.681 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.478 ' HB ' ' O ' ' A' ' 66' ' ' ASP . 4.4 t 71.81 140.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.119 -0.988 . . . . 0.0 108.958 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.584 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 71.9 t80 -65.45 107.03 1.54 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.113 -0.992 . . . . 0.0 110.109 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.455 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 1.2 m -123.11 30.39 6.38 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.413 ' HA2' ' HB2' ' A' ' 35' ' ' SER . . . 107.77 77.93 1.07 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -159.31 -96.69 0.12 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.3 p -123.43 94.82 46.09 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.22 -1.164 . . . . 0.0 109.858 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.634 ' CB ' ' CZ ' ' A' ' 38' ' ' TYR . 36.2 Cg_endo -79.48 -61.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.585 2.19 . . . . 0.0 110.359 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . -60.21 -146.43 0.01 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 65.03 -84.98 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.37 -1.077 . . . . 0.0 109.939 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -124.59 100.33 6.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.163 -0.96 . . . . 0.0 109.574 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.526 ' O ' HG12 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -117.68 152.47 35.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 108.893 179.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.817 HG11 ' NE2' ' A' ' 20' ' ' GLN . 1.4 p -117.2 -173.88 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.053 -1.03 . . . . 0.0 109.496 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.712 ' H ' HG22 ' A' ' 78' ' ' VAL . 6.8 t -147.21 166.8 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.167 -0.958 . . . . 0.0 110.009 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.61 ' CE1' ' HB2' ' A' ' 57' ' ' TYR . 3.8 p90 -166.61 -176.26 3.47 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.522 ' O ' ' CD2' ' A' ' 57' ' ' TYR . 11.5 t30 -118.68 -80.16 0.61 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.927 -1.108 . . . . 0.0 109.754 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -158.55 20.59 0.22 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.462 -0.774 . . . . 0.0 109.419 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.502 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 0.3 OUTLIER -150.84 18.37 0.79 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.292 -0.88 . . . . 0.0 108.842 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.502 ' OD1' ' O ' ' A' ' 83' ' ' ASN . 0.2 OUTLIER 67.34 14.16 9.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.594 -0.692 . . . . 0.0 109.349 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.504 ' O ' ' HB3' ' A' ' 86' ' ' LEU . 1.8 mt-30 -51.72 -26.85 10.23 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.777 HD12 HE21 ' A' ' 20' ' ' GLN . 0.7 OUTLIER 66.49 116.31 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.539 0.685 . . . . 0.0 110.041 179.745 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.558 ' HA ' HG21 ' A' ' 52' ' ' VAL . . . -79.05 -34.43 43.77 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.458 ' HA2' ' OH ' ' A' ' 4' ' ' TYR . . . 146.13 176.64 20.16 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.715 HG21 ' CG ' ' A' ' 4' ' ' TYR . 54.7 t -100.52 147.29 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.996 -1.296 . . . . 0.0 110.055 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.544 ' HB ' ' CB ' ' A' ' 100' ' ' PHE . 0.9 OUTLIER -141.09 162.5 22.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.537 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 75' ' ' ALA . 5.8 t -129.59 127.17 40.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.711 -1.243 . . . . 0.0 111.545 -178.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.62 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.1 OUTLIER -79.01 75.35 5.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.532 -0.73 . . . . 0.0 109.177 179.055 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 1.1 m 173.44 -28.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.204 -0.935 . . . . 0.0 109.263 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.53 -11.17 33.69 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.738 ' HB3' ' CB ' ' A' ' 99' ' ' ASN . . . -125.48 176.86 6.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.097 -1.237 . . . . 0.0 109.725 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER -42.99 131.7 4.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.411 -0.806 . . . . 0.0 109.109 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.51 -89.03 0.05 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.62 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -136.22 -79.7 0.41 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -1.118 . . . . 0.0 109.106 179.319 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.738 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . 0.3 OUTLIER 58.51 152.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.231 -0.918 . . . . 0.0 109.054 -179.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.544 ' CB ' ' HB ' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -109.02 126.99 53.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.741 -1.224 . . . . 0.0 110.58 -179.412 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -129.55 140.45 49.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.469 ' OE2' ' CE1' ' A' ' 50' ' ' PHE . 5.8 mm-40 -52.47 122.56 9.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.384 -0.823 . . . . 0.0 109.703 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 1.7 m -70.55 129.92 40.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.352 -0.842 . . . . 0.0 109.462 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 40.1 p . . . . . 0 N--CA 1.488 1.467 0 O-C-N 121.187 -0.946 . . . . 0.0 109.367 179.912 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.426 ' C ' ' SG ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.392 0.615 . . . . 0.0 109.651 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 0.8 OUTLIER 173.54 126.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.319 -0.863 . . . . 0.0 109.838 179.788 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -121.43 -3.87 9.38 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.417 -0.802 . . . . 0.0 109.29 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.677 ' CG ' HG21 ' A' ' 89' ' ' VAL . 57.4 m-85 -103.52 85.98 2.56 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.913 . . . . 0.0 109.192 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.635 HG23 ' H ' ' A' ' 10' ' ' CYS . 33.9 m -117.52 129.53 55.86 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.269 -0.894 . . . . 0.0 110.255 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.1 m -133.07 12.21 4.26 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.191 0.996 . . . . 0.0 109.156 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 8' ' ' SER . . . -176.53 35.77 0.09 OUTLIER Glycine 0 C--N 1.282 -2.454 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 7' ' ' GLY . 0.6 OUTLIER 67.6 25.0 8.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.308 -1.113 . . . . 0.0 109.16 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.474 ' O ' ' C ' ' A' ' 10' ' ' CYS . 0.9 OUTLIER -89.43 -17.63 28.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.412 -0.805 . . . . 0.0 109.746 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.635 ' H ' HG23 ' A' ' 5' ' ' THR . 0.8 OUTLIER 40.03 79.09 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 O-C-N 121.543 -0.723 . . . . 0.0 109.315 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.482 ' HB2' ' HB2' ' A' ' 4' ' ' TYR . 11.6 m-85 -78.91 134.3 36.89 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.883 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -78.58 129.57 34.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.567 -0.708 . . . . 0.0 109.804 -179.316 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -17.75 5.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.336 -0.852 . . . . 0.0 109.312 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.94 -30.69 15.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 0.0 109.571 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.47 -31.51 62.26 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 12' ' ' SER . 3.5 t -65.09 -25.44 37.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.493 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 0.1 OUTLIER -72.27 -40.15 67.84 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.537 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.77 -53.08 62.11 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.674 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -63.22 -25.42 68.32 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.574 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -70.09 -30.37 67.57 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.137 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -81.02 -12.68 59.31 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.632 ' HB1' HG13 ' A' ' 67' ' ' VAL . . . -81.19 -47.22 13.72 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.614 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -74.69 -28.62 62.78 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -75.65 -39.41 57.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.504 -0.998 . . . . 0.0 109.198 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.501 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 2.1 tt0 -69.73 -57.71 4.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.171 -0.955 . . . . 0.0 108.509 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.576 HD11 ' HB3' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -49.74 -36.23 24.98 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.297 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -67.37 -39.4 85.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.426 -0.796 . . . . 0.0 109.512 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.65 -2.77 47.98 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.317 -0.864 . . . . 0.0 109.057 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -101.8 0.5 35.84 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.266 -0.896 . . . . 0.0 109.509 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 54.21 26.07 34.77 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.576 ' HB3' HD11 ' A' ' 26' ' ' LEU . 1.7 mm-40 -106.06 -164.11 0.99 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.252 -1.146 . . . . 0.0 109.605 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.93 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -142.3 175.97 9.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.357 -0.839 . . . . 0.0 109.337 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.668 HG22 ' CA ' ' A' ' 37' ' ' SER . 22.3 m -87.99 -156.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.212 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -40.07 -35.9 0.77 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER 167.15 -27.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.119 -1.224 . . . . 0.0 109.549 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 37' ' ' SER . 11.1 m-80 -81.73 8.89 8.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.171 -0.956 . . . . 0.0 109.533 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.93 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.8 OUTLIER 46.2 -169.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.226 -0.921 . . . . 0.0 108.968 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.594 ' CD1' ' HD3' ' A' ' 60' ' ' PRO . 0.1 OUTLIER 169.42 -47.18 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.428 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.951 179.247 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 38' ' ' TYR . 30.7 Cg_endo -73.48 99.38 1.13 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.525 1.483 . . . . 0.0 112.453 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.557 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -144.7 175.16 10.37 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -63.04 157.66 21.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.959 -1.088 . . . . 0.0 110.213 -179.214 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.884 ' CG ' HG11 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -129.09 132.31 47.39 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.478 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.424 ' O ' ' C ' ' A' ' 44' ' ' ASN . 1.4 p-10 -123.15 -22.63 5.11 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.814 -1.179 . . . . 0.0 109.635 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.631 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 1.0 OUTLIER 45.28 -160.23 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.284 -0.885 . . . . 0.0 108.919 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.631 ' CG ' ' O ' ' A' ' 44' ' ' ASN . 0.9 OUTLIER 171.43 -26.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.536 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.3 OUTLIER -32.09 -59.85 0.28 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 121.307 0.575 . . . . 0.0 110.42 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.04 54.68 0.01 OUTLIER Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.525 ' CZ ' ' HA ' ' A' ' 101' ' ' VAL . 62.8 m-85 -108.64 142.78 38.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -1.128 . . . . 0.0 109.611 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -108.89 76.31 1.0 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -0.903 . . . . 0.0 109.615 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.478 ' HB3' ' OH ' ' A' ' 56' ' ' TYR . 18.8 m-30 -66.63 -178.53 0.72 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.188 -0.945 . . . . 0.0 109.003 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.5 t -140.41 17.38 2.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.865 . . . . 0.0 108.976 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.577 ' HB ' ' CE1' ' A' ' 56' ' ' TYR . 57.4 t -88.1 -82.67 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.44 -0.788 . . . . 0.0 109.617 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.583 ' O ' ' CE2' ' A' ' 56' ' ' TYR . 61.1 m -160.21 -174.22 4.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -0.925 . . . . 0.0 109.902 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.574 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -81.66 -52.45 0.78 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.316 -0.865 . . . . 0.0 110.717 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 54' ' ' SER . 35.2 Cg_endo -75.49 88.14 1.31 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.07 1.847 . . . . 0.0 110.201 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.791 ' CE1' ' HB2' ' A' ' 87' ' ' ALA . 21.9 m-85 -89.17 -167.89 2.01 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.587 ' CG ' ' O ' ' A' ' 56' ' ' TYR . 84.0 m-85 -160.88 114.91 2.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.507 -0.746 . . . . 0.0 109.328 179.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.451 ' CD ' ' NH1' ' A' ' 77' ' ' ARG . 3.0 pt-20 -80.0 142.41 35.03 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.292 -0.88 . . . . 0.0 110.909 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.667 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 22.1 t-105 -160.77 138.63 7.1 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.667 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 31.8 Cg_endo -70.15 161.36 46.27 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.059 1.839 . . . . 0.0 111.429 -178.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.939 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -133.34 135.74 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.679 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.939 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.3 OUTLIER -118.72 161.49 20.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -0.913 . . . . 0.0 109.608 -179.864 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.1 26.05 5.2 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.463 -0.773 . . . . 0.0 109.287 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.22 -62.72 0.78 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.359 -0.838 . . . . 0.0 109.45 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -93.15 -108.52 1.87 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 67' ' ' VAL . 8.9 t70 -179.45 134.12 0.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -1.159 . . . . 0.0 109.521 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.632 HG13 ' HB1' ' A' ' 22' ' ' ALA . 2.8 t 62.79 133.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -0.902 . . . . 0.0 109.804 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.595 ' HA ' HD11 ' A' ' 62' ' ' LEU . 43.3 t80 -75.51 105.75 6.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.015 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.1 m -112.87 16.57 19.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.131 -0.981 . . . . 0.0 109.812 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.54 52.72 0.23 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -110.95 -112.3 3.35 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.82 108.94 43.78 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.193 -1.18 . . . . 0.0 109.421 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.65 -161.81 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.467 2.112 . . . . 0.0 110.483 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 53.71 -175.76 0.32 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 91' ' ' THR . . . 61.85 -150.05 0.38 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -1.136 . . . . 0.0 110.198 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' ' 75' ' ' ALA . 12.0 m-20 -32.27 148.73 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.56 0.695 . . . . 0.0 111.435 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.577 ' NH2' ' CE2' ' A' ' 100' ' ' PHE . 8.3 ttp180 -176.38 86.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.731 ' CG2' HD11 ' A' ' 86' ' ' LEU . 8.8 p -72.38 143.16 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.894 . . . . 0.0 109.688 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.884 HG11 ' CG ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -109.19 177.63 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.105 -0.997 . . . . 0.0 109.679 179.864 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.575 ' CE1' ' O ' ' A' ' 57' ' ' TYR . 14.0 p90 -174.76 -169.19 0.4 Allowed 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.0 -178.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -128.88 -80.99 0.57 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.374 -0.829 . . . . 0.0 109.728 -179.497 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.45 ' CG ' ' C ' ' A' ' 81' ' ' ASN . 0.3 OUTLIER -158.6 19.69 0.22 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.457 -0.777 . . . . 0.0 109.412 -179.804 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.456 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 0.8 OUTLIER -150.34 28.85 0.72 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.469 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 5.4 p30 51.7 20.8 1.19 Allowed 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.542 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 2.4 mt-30 -47.53 -38.38 14.0 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.731 HD11 ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER 82.19 104.16 0.06 Allowed 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.469 0.652 . . . . 0.0 110.565 179.135 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.835 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . . . -76.24 -31.92 58.62 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 140.23 163.81 9.66 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.677 HG21 ' CG ' ' A' ' 4' ' ' TYR . 58.9 t -94.73 124.47 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.068 -1.254 . . . . 0.0 109.491 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' A' ' 100' ' ' PHE . 1.0 OUTLIER -118.14 176.31 3.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.268 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 75' ' ' ALA . 8.3 t -144.16 147.34 33.55 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.045 -1.034 . . . . 0.0 110.419 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.642 ' NE2' ' CE2' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -96.88 76.71 2.75 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.535 -0.728 . . . . 0.0 109.134 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.431 ' OG1' ' C ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 176.17 123.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 0.0 109.809 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 116.33 -0.6 20.65 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.677 ' HB3' ' CB ' ' A' ' 99' ' ' ASN . . . -139.51 93.42 2.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.13 -1.218 . . . . 0.0 109.776 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER 41.65 85.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.427 -0.796 . . . . 0.0 109.743 179.642 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.17 -77.54 2.07 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.622 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -144.54 -77.02 0.22 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.161 -1.199 . . . . 0.0 109.892 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.677 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . 0.3 OUTLIER 59.43 155.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 108.535 -179.097 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.642 ' CE2' ' NE2' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -103.69 136.98 42.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.949 -1.095 . . . . 0.0 110.267 -179.521 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 0.9 OUTLIER -146.13 157.98 11.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.167 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 103' ' ' CYS . 12.4 pt-20 -60.5 130.72 48.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.149 -0.969 . . . . 0.0 109.737 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.422 ' C ' ' O ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -42.35 114.53 0.58 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.452 -0.78 . . . . 0.0 109.635 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.136 -0.935 . . . . 0.0 109.405 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.431 ' O ' ' SG ' ' A' ' 10' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.266 0.555 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.501 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.9 OUTLIER 169.72 115.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -0.862 . . . . 0.0 109.862 179.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -78.72 -31.65 46.51 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.338 -0.851 . . . . 0.0 108.981 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.617 ' CG ' HG21 ' A' ' 89' ' ' VAL . 18.3 m-85 -98.96 96.28 7.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.38 -0.825 . . . . 0.0 108.908 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.56 HG22 ' O ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -116.61 105.69 12.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.186 -0.947 . . . . 0.0 109.873 -179.705 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.583 ' O ' ' C ' ' A' ' 7' ' ' GLY . 87.4 m -82.85 -173.87 4.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.287 -0.883 . . . . 0.0 108.867 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.583 ' C ' ' O ' ' A' ' 6' ' ' CYS . . . 7.69 -77.26 0.0 OUTLIER Glycine 0 N--CA 1.507 3.372 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 6' ' ' CYS . 3.7 p -161.08 55.36 0.29 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.228 -1.16 . . . . 0.0 109.468 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.56 ' O ' HG22 ' A' ' 5' ' ' THR . 1.5 m-20 -117.28 -144.65 0.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.353 -0.842 . . . . 0.0 109.741 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.507 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 46.5 t -162.44 60.46 0.22 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.132 -0.98 . . . . 0.0 109.152 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 63' ' ' SER . 6.1 m-85 -86.78 113.2 22.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.5 -0.75 . . . . 0.0 109.333 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.535 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -87.94 131.41 34.61 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.255 -0.903 . . . . 0.0 109.835 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 12' ' ' SER . 1.8 p -45.33 -37.17 4.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.607 -0.683 . . . . 0.0 109.445 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.4 -47.26 84.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.376 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.16 -23.94 61.36 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.689 HG11 HG21 ' A' ' 78' ' ' VAL . 63.0 t -65.19 -31.97 56.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.6 t -61.66 -45.65 93.12 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.668 -0.645 . . . . 0.0 109.449 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.07 -49.53 77.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.121 -0.987 . . . . 0.0 108.608 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.709 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -71.08 -12.85 61.73 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.587 ' OE1' ' CG ' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -80.6 -34.07 35.44 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.506 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.98 -13.65 59.94 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.884 ' HB1' HG13 ' A' ' 67' ' ' VAL . . . -72.61 -41.13 65.92 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.609 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -81.72 -32.7 29.42 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.201 -1.559 . . . . 0.0 109.201 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.493 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 9.9 t80 -67.61 -40.8 84.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.426 -1.043 . . . . 0.0 109.758 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.406 ' O ' ' C ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -60.97 -66.53 0.52 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.912 . . . . 0.0 108.966 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.554 ' CD1' ' HB3' ' A' ' 31' ' ' GLU . 0.9 OUTLIER -43.85 -44.56 6.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.458 -0.776 . . . . 0.0 109.0 179.242 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.446 ' HB3' ' O ' ' A' ' 24' ' ' TYR . 2.0 t60 -49.75 -68.06 0.21 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.738 -0.601 . . . . 0.0 110.678 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -76.68 2.23 14.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.252 -0.905 . . . . 0.0 110.004 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.464 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 1.1 m-20 -82.93 -28.89 29.58 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.195 -0.941 . . . . 0.0 109.775 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.73 -15.33 63.32 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.554 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 3.2 tp10 -83.43 -149.0 0.09 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -1.154 . . . . 0.0 109.249 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.929 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.3 OUTLIER -159.19 -172.34 3.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.133 -0.979 . . . . 0.0 109.386 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.627 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -82.94 -95.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.924 . . . . 0.0 109.496 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.469 ' H ' HG23 ' A' ' 33' ' ' VAL . . . -115.2 -20.31 5.61 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.6 OUTLIER 167.21 -42.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.157 -1.202 . . . . 0.0 109.728 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 37' ' ' SER . 95.1 m-20 -77.25 -10.3 59.33 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.216 -0.928 . . . . 0.0 109.523 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.929 ' HA ' HG22 ' A' ' 32' ' ' THR . 4.0 p 62.08 135.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 109.183 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.674 ' H ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -121.44 -33.71 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.077 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -178.748 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.674 ' CD ' ' H ' ' A' ' 38' ' ' TYR . 36.3 Cg_endo -80.31 101.5 1.34 Allowed 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 121.304 1.336 . . . . 0.0 112.611 -178.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.597 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -138.78 134.95 34.13 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.244 -0.91 . . . . 0.0 109.801 177.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.609 ' HB2' ' CE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -51.02 131.02 26.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.166 -0.959 . . . . 0.0 109.384 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.537 ' CZ ' ' HA ' ' A' ' 44' ' ' ASN . 4.1 t80 -113.51 140.84 47.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.282 -0.886 . . . . 0.0 109.172 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.509 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 3.7 m-80 -85.87 -90.63 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.191 -0.943 . . . . 0.0 109.739 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.537 ' HA ' ' CZ ' ' A' ' 42' ' ' TYR . 0.7 OUTLIER 174.49 148.05 0.07 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 109.39 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.412 ' O ' ' C ' ' A' ' 46' ' ' GLU . 11.2 m-85 -139.69 -72.61 0.38 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.239 -0.913 . . . . 0.0 109.331 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.595 ' CB ' ' CZ ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -40.34 -37.83 0.72 Allowed 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.512 -0.743 . . . . 0.0 109.853 -179.604 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.86 62.22 0.75 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.595 ' CZ ' ' CB ' ' A' ' 46' ' ' GLU . 23.9 m-85 -90.78 -168.01 1.97 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.246 -1.149 . . . . 0.0 108.885 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.34 -39.36 2.2 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.152 -0.968 . . . . 0.0 109.538 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.527 ' CB ' ' OH ' ' A' ' 56' ' ' TYR . 18.3 m-85 47.26 -168.55 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.21 -0.931 . . . . 0.0 109.393 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.83 31.76 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 109.502 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.0 t -108.52 -66.61 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.927 . . . . 0.0 109.513 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.51 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 70.7 m -165.31 -179.9 5.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.088 -1.008 . . . . 0.0 110.049 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.576 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -79.51 -50.32 1.31 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.534 -0.728 . . . . 0.0 110.761 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 54' ' ' SER . 35.4 Cg_endo -75.79 81.36 2.39 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.986 1.791 . . . . 0.0 110.374 -178.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.594 ' O ' ' CD1' ' A' ' 57' ' ' TYR . 36.5 m-85 -79.27 -171.62 2.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.696 -0.628 . . . . 0.0 109.832 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.609 ' CE2' ' HB2' ' A' ' 41' ' ' LYS . 68.0 m-85 -155.4 158.44 38.64 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.509 ' HB2' ' CZ ' ' A' ' 77' ' ' ARG . 2.6 pt-20 -117.86 139.17 51.49 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.938 -1.102 . . . . 0.0 110.303 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.654 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 26.8 t-105 -159.9 138.64 7.8 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.654 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.5 Cg_endo -69.71 141.37 45.25 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.224 1.949 . . . . 0.0 111.469 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.958 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -109.31 140.3 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.958 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.9 OUTLIER -126.23 163.26 23.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.951 . . . . 0.0 109.764 -179.619 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . 9.3 t -132.99 25.91 4.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.358 -0.839 . . . . 0.0 109.351 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.69 -46.62 0.12 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.354 -0.841 . . . . 0.0 109.314 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . -78.52 -101.21 0.21 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 1.6 t0 175.61 -62.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -1.132 . . . . 0.0 109.569 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.884 HG13 ' HB1' ' A' ' 22' ' ' ALA . 11.7 t -127.84 126.18 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 109.756 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.605 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 6.2 t80 -63.44 136.31 57.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.158 -0.964 . . . . 0.0 109.304 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 p -161.44 53.31 0.26 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.55 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.498 ' O ' ' CE1' ' A' ' 68' ' ' TYR . . . 126.24 -165.96 19.21 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.74 -157.51 41.86 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.9 t -120.01 120.14 30.48 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.331 -1.099 . . . . 0.0 109.44 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.457 ' HB2' ' OH ' ' A' ' 38' ' ' TYR . 34.7 Cg_endo -77.73 172.91 14.93 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.295 1.996 . . . . 0.0 110.669 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.0 134.58 2.13 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.542 ' HA ' ' N ' ' A' ' 92' ' ' HIS . . . 55.88 -153.18 0.35 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -1.151 . . . . 0.0 109.479 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.498 ' O ' ' O ' ' A' ' 75' ' ' ALA . 45.6 m-20 20.75 106.74 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.509 ' CZ ' ' HB2' ' A' ' 58' ' ' GLU . 6.9 mtp-105 -160.06 135.38 8.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.154 -0.966 . . . . 0.0 108.584 178.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.689 HG21 HG11 ' A' ' 16' ' ' VAL . 3.9 p -123.99 135.1 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.739 -1.225 . . . . 0.0 109.638 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.626 HG23 ' CD1' ' A' ' 90' ' ' ILE . 29.9 t -92.39 166.13 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.973 0.892 . . . . 0.0 109.808 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.587 ' CG ' ' OE1' ' A' ' 20' ' ' GLN . 3.2 p90 -161.53 -178.92 6.92 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.189 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.491 ' ND2' ' HG2' ' A' ' 82' ' ' GLU . 11.8 t30 -112.48 -81.75 0.59 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 109.692 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.493 ' O ' ' CZ ' ' A' ' 24' ' ' TYR . 2.5 pt-20 -162.64 21.78 0.09 Allowed 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.483 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 2.4 m-20 -140.61 29.5 1.93 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 83' ' ' ASN . 10.5 p30 46.95 24.5 0.37 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.502 0.668 . . . . 0.0 109.22 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 26.7 mm-40 -63.61 -106.73 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 174.42 114.55 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.739 179.081 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.541 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . . . -89.79 -42.24 11.4 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 161.28 155.0 7.67 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.617 HG21 ' CG ' ' A' ' 4' ' ' TYR . 32.0 t -92.05 88.72 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.334 -1.098 . . . . 0.0 109.285 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.626 ' CD1' HG23 ' A' ' 79' ' ' VAL . 1.2 pt -90.88 156.2 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.432 -0.793 . . . . 0.0 109.527 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.579 HG22 HG23 ' A' ' 101' ' ' VAL . 13.0 t -122.2 137.01 54.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.859 -1.151 . . . . 0.0 110.245 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.642 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -81.56 67.58 7.58 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.294 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 177.54 164.02 0.58 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.045 -1.034 . . . . 0.0 109.668 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.84 22.11 75.21 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.574 ' HB3' ' CB ' ' A' ' 99' ' ' ASN . . . -155.81 51.84 0.56 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -1.149 . . . . 0.0 109.353 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.7 m 68.07 93.66 0.07 Allowed 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.53 -83.9 1.1 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.642 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -139.07 -83.18 0.28 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -1.181 . . . . 0.0 109.177 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.574 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . 1.1 m-20 61.23 137.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.329 -0.857 . . . . 0.0 109.292 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.658 ' O ' HG13 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -85.85 151.63 23.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.117 -0.989 . . . . 0.0 109.385 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.658 HG13 ' O ' ' A' ' 100' ' ' PHE . 3.2 m -160.63 136.93 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.409 -0.807 . . . . 0.0 109.073 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -53.21 123.75 12.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.243 -0.911 . . . . 0.0 109.588 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -76.04 83.0 2.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.295 -0.878 . . . . 0.0 109.688 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.127 -0.983 . . . . 0.0 109.42 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.572 ' SG ' HG22 ' A' ' 5' ' ' THR . 6.0 t 62.38 91.93 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.881 . . . . 0.0 109.836 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -105.84 2.66 27.92 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.449 -0.782 . . . . 0.0 109.032 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.553 ' CG ' HG21 ' A' ' 89' ' ' VAL . 28.8 m-85 -121.14 67.89 0.88 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.267 -0.896 . . . . 0.0 109.402 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.572 HG22 ' SG ' ' A' ' 2' ' ' CYS . 11.6 p -79.74 124.62 28.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.905 . . . . 0.0 109.192 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.1 m -113.31 17.14 18.77 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.011 0.91 . . . . 0.0 110.069 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 136.02 -93.25 0.23 Allowed Glycine 0 C--N 1.282 -2.459 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.9 m -119.82 28.66 7.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -1.102 . . . . 0.0 109.29 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.453 ' O ' ' C ' ' A' ' 10' ' ' CYS . 1.7 m120 -111.53 -36.64 5.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 109.619 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' ASN . 1.7 t 41.33 80.4 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.413 -0.804 . . . . 0.0 109.469 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.633 ' CE2' ' CB ' ' A' ' 63' ' ' SER . 2.7 m-85 -86.6 148.34 25.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -0.833 . . . . 0.0 110.148 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.833 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -80.05 128.11 33.09 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.639 -0.663 . . . . 0.0 109.839 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.3 p -56.96 -18.52 13.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.921 . . . . 0.0 108.969 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.05 -30.33 15.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.264 -0.897 . . . . 0.0 109.592 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -73.55 -30.97 63.39 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 12' ' ' SER . 3.9 t -60.82 -32.07 51.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.03 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.3 t -60.38 -46.83 88.58 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.486 -0.759 . . . . 0.0 110.031 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -42.67 93.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.103 -0.998 . . . . 0.0 108.967 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.857 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -78.2 -11.63 59.94 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.511 -0.743 . . . . 0.0 109.16 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.507 ' HB2' ' O ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -86.67 -26.6 24.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.367 -0.833 . . . . 0.0 108.984 179.617 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -83.98 -10.19 58.11 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.382 -0.824 . . . . 0.0 109.181 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.61 -47.43 17.15 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.35 -0.844 . . . . 0.0 109.276 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.608 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -75.29 -16.86 80.37 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.481 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 6.2 t80 -87.0 -63.4 1.31 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.444 -1.033 . . . . 0.0 109.544 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 29' ' ' ASP . 0.9 OUTLIER -46.95 -58.59 3.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.272 -0.893 . . . . 0.0 109.766 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.473 ' CD1' ' HB3' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -51.73 -47.08 64.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.295 -0.878 . . . . 0.0 109.773 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.628 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 2.9 t60 -52.9 -62.19 1.81 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.389 -0.82 . . . . 0.0 110.918 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -72.28 -7.23 48.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 109.735 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 13.7 t70 -78.46 -14.23 59.47 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.196 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.94 0.28 59.79 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.473 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 2.6 tp10 -94.43 -145.27 0.25 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.3 -1.118 . . . . 0.0 109.4 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.913 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -163.62 179.51 7.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 109.573 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.484 HG23 ' N ' ' A' ' 34' ' ' GLY . 17.1 m -89.41 -120.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 109.305 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.484 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -65.57 -42.35 95.64 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER 169.72 -38.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.311 -1.111 . . . . 0.0 109.549 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 37' ' ' SER . 5.4 m120 -65.46 -11.79 46.37 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.23 -0.919 . . . . 0.0 109.674 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.913 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.7 OUTLIER 59.66 114.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 0.0 109.129 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.668 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -107.65 -27.39 0.18 Allowed Pre-proline 0 N--CA 1.498 1.966 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -178.69 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.668 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 36.5 Cg_endo -79.4 102.51 1.51 Allowed 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 121.318 1.345 . . . . 0.0 113.167 -178.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.601 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -131.2 165.31 23.62 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.16 -0.962 . . . . 0.0 109.179 177.263 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.635 ' HB2' ' CE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -73.79 132.28 42.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 109.31 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.598 ' CZ ' ' HA ' ' A' ' 44' ' ' ASN . 26.9 t80 -100.97 134.26 44.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.367 -0.833 . . . . 0.0 109.351 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -103.24 -8.64 20.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.185 -0.947 . . . . 0.0 109.728 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.598 ' HA ' ' CZ ' ' A' ' 42' ' ' TYR . 2.2 m120 62.16 175.0 0.13 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.692 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.458 ' O ' ' C ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -179.15 -45.25 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.388 -0.82 . . . . 0.0 108.986 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.576 ' OE1' ' CZ ' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -38.52 -44.4 0.95 Allowed 'General case' 0 C--N 1.307 -1.242 0 O-C-N 121.696 -0.627 . . . . 0.0 109.945 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.55 47.12 0.09 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.576 ' CZ ' ' OE1' ' A' ' 46' ' ' GLU . 16.0 m-85 -106.58 139.76 40.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -1.184 . . . . 0.0 109.379 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.64 -30.85 11.53 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.285 -0.884 . . . . 0.0 109.262 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.552 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 30.1 m-85 50.93 -170.52 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.42 -0.8 . . . . 0.0 109.743 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.21 44.42 0.48 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.362 -0.836 . . . . 0.0 109.364 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.529 HG12 ' OD1' ' A' ' 81' ' ' ASN . 54.8 t -121.53 -45.34 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.263 -0.898 . . . . 0.0 109.636 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.579 ' O ' ' CE1' ' A' ' 56' ' ' TYR . 0.6 OUTLIER 167.72 -176.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.111 -0.993 . . . . 0.0 109.936 -179.64 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.558 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -86.4 -54.41 0.4 Allowed Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.373 -0.829 . . . . 0.0 111.646 -179.051 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 54' ' ' SER . 33.7 Cg_endo -73.1 86.02 1.16 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.045 1.83 . . . . 0.0 110.607 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.65 ' CE2' ' HB1' ' A' ' 87' ' ' ALA . 3.7 m-30 -87.21 -173.5 4.44 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.461 0.648 . . . . 0.0 110.054 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.635 ' CE2' ' HB2' ' A' ' 41' ' ' LYS . 75.7 m-85 -156.63 116.67 3.57 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -77.54 140.74 39.78 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.83 0.824 . . . . 0.0 110.968 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.653 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 20.9 t-105 -160.64 137.53 6.59 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.653 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.7 Cg_endo -68.94 147.05 67.26 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.138 1.892 . . . . 0.0 111.424 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.994 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -121.09 126.0 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.536 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.994 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.3 OUTLIER -122.72 166.1 15.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.278 -0.889 . . . . 0.0 109.284 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.633 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -130.91 7.42 4.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.289 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.97 -69.85 0.54 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.259 -0.901 . . . . 0.0 109.338 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 158.31 60.61 0.01 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -175.58 139.29 0.42 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -1.17 . . . . 0.0 109.461 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.476 HG13 ' HZ2' ' A' ' 59' ' ' TRP . 91.5 t -77.3 147.6 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.0 109.441 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.547 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 0.7 OUTLIER -65.38 166.61 9.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 109.749 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.41 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 5.7 m -169.2 49.87 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.434 -0.791 . . . . 0.0 109.14 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.45 114.91 0.92 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 72' ' ' SER . . . -178.64 39.4 0.08 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 1.4 p 75.14 109.7 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.248 -1.148 . . . . 0.0 109.584 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.531 ' HA ' ' NH2' ' A' ' 77' ' ' ARG . 36.2 Cg_endo -79.41 119.68 4.23 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.49 2.127 . . . . 0.0 110.555 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.505 ' HA2' ' HB2' ' A' ' 92' ' ' HIS . . . 170.0 -168.9 41.77 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . 47.74 -154.77 0.07 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -1.166 . . . . 0.0 110.506 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 51.8 m-20 -39.53 129.26 1.9 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.549 0.69 . . . . 0.0 109.619 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.544 ' CZ ' ' HB3' ' A' ' 60' ' ' PRO . 23.4 mmt-85 -158.43 122.25 3.99 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.723 HG21 ' CG1' ' A' ' 16' ' ' VAL . 0.9 OUTLIER -105.25 148.61 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.263 -0.898 . . . . 0.0 109.812 -178.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.643 HG12 ' H ' ' A' ' 80' ' ' PHE . 2.0 t -121.52 174.55 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.962 0.886 . . . . 0.0 109.673 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.643 ' H ' HG12 ' A' ' 79' ' ' VAL . 4.4 p90 -173.92 -167.87 0.38 Allowed 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.354 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.558 ' OD1' ' CE1' ' A' ' 56' ' ' TYR . 3.1 m120 -120.49 -80.57 0.62 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.266 -0.897 . . . . 0.0 109.794 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.412 ' OE1' ' O ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -163.43 23.98 0.08 Allowed 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.471 ' O ' ' HB3' ' A' ' 84' ' ' ASN . 24.8 m-80 -148.91 16.28 0.96 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.483 -0.761 . . . . 0.0 109.056 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 83' ' ' ASN . 2.9 t-20 62.32 13.89 6.35 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.366 -0.834 . . . . 0.0 109.348 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.562 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -46.89 -32.08 3.54 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.67 -1.234 . . . . 0.0 107.67 179.315 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.562 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.2 OUTLIER 84.95 110.58 0.05 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.534 0.683 . . . . 0.0 110.528 179.211 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.65 ' HB1' ' CE2' ' A' ' 56' ' ' TYR . . . -82.63 -43.48 16.93 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.561 ' O ' HG22 ' A' ' 78' ' ' VAL . . . 158.93 -161.14 31.71 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.553 HG21 ' CG ' ' A' ' 4' ' ' TYR . 39.1 t -134.96 92.46 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -1.179 . . . . 0.0 109.252 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.573 ' HB ' ' HB3' ' A' ' 100' ' ' PHE . 0.6 OUTLIER -94.41 151.45 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.4 -0.812 . . . . 0.0 109.858 -179.668 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.2 t -125.85 134.58 51.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 109.731 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.695 ' CD2' ' CD1' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -82.61 74.64 9.57 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.323 -0.86 . . . . 0.0 108.99 179.733 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 7.9 m -169.68 135.37 1.49 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.492 -0.755 . . . . 0.0 109.466 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 93.42 24.11 22.36 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.725 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . . . -156.51 91.5 1.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.132 -1.217 . . . . 0.0 109.682 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 95' ' ' ALA . 1.7 t 43.78 79.35 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.304 -0.873 . . . . 0.0 109.314 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.62 -70.5 3.16 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.62 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -148.76 -82.15 0.12 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -1.1 . . . . 0.0 109.318 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.725 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 4.3 m-20 60.73 138.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.372 -0.83 . . . . 0.0 109.315 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.695 ' CD1' ' CD2' ' A' ' 92' ' ' HIS . 0.6 OUTLIER -79.12 148.86 32.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.058 -1.026 . . . . 0.0 109.85 -179.588 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -151.94 114.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.411 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 1.7 pt-20 -43.71 131.26 5.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.326 -0.859 . . . . 0.0 109.575 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.518 ' HB3' ' O ' ' A' ' 5' ' ' THR . 84.0 m -72.31 106.26 4.39 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.324 -0.86 . . . . 0.0 109.401 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.826 -1.083 . . . . 0.0 109.54 -179.833 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 15.3 p 176.45 98.12 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.108 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -67.66 -19.41 65.19 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.319 -0.863 . . . . 0.0 108.895 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.682 ' CG ' HG21 ' A' ' 89' ' ' VAL . 39.4 m-85 -103.46 81.55 1.93 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.654 HG22 ' O ' ' A' ' 5' ' ' THR . 46.8 m -101.1 69.44 1.3 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.397 -0.814 . . . . 0.0 110.473 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.518 ' O ' ' N ' ' A' ' 8' ' ' SER . 3.9 m -80.6 154.58 27.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.036 -1.04 . . . . 0.0 108.505 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 6' ' ' CYS . . . 44.06 -94.98 0.01 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 6' ' ' CYS . 2.4 t -159.28 40.85 0.21 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -1.114 . . . . 0.0 109.1 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.442 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 2.8 m-80 -94.88 -35.88 11.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.919 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.431 ' C ' ' CB ' ' A' ' 2' ' ' CYS . 42.3 t 56.46 59.98 3.35 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.065 -1.022 . . . . 0.0 108.637 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.587 ' CE2' ' HB2' ' A' ' 63' ' ' SER . 2.9 m-30 -89.49 144.27 26.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.432 -0.792 . . . . 0.0 110.177 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.843 ' O ' HG23 ' A' ' 16' ' ' VAL . 4.0 m -82.85 133.81 35.12 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.578 -0.701 . . . . 0.0 109.966 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.1 p -62.56 -23.39 66.97 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.0 t -79.47 -33.1 42.61 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.457 ' HB2' ' HB2' ' A' ' 12' ' ' SER . 5.4 m-20 -77.38 -27.27 52.46 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 12' ' ' SER . 25.6 t -63.58 -24.27 35.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.429 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 15.0 t -66.52 -42.83 86.67 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.7 -42.27 99.55 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.834 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -74.33 -14.44 60.89 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.539 ' OE1' ' CB ' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -82.27 -30.6 30.55 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.498 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.62 -13.69 59.7 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.474 ' HB1' HG11 ' A' ' 67' ' ' VAL . . . -73.31 -58.53 3.24 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.563 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -61.64 -22.46 61.78 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.458 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 16.8 t80 -75.84 -37.32 59.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.555 -0.967 . . . . 0.0 109.127 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -69.74 -46.34 66.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.836 . . . . 0.0 108.849 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.984 HD22 HG13 ' A' ' 33' ' ' VAL . 9.5 tp -71.54 -18.06 62.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.392 -0.817 . . . . 0.0 108.87 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.621 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 55.1 t60 -89.66 -20.5 23.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.516 -0.74 . . . . 0.0 109.397 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.17 -23.26 24.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 109.338 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -97.78 -10.09 25.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.355 -0.84 . . . . 0.0 109.508 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.75 18.74 70.62 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.564 ' CG ' ' N ' ' A' ' 32' ' ' THR . 34.1 tt0 -88.8 167.08 13.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -1.171 . . . . 0.0 109.646 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.882 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -104.01 166.68 10.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.504 -0.747 . . . . 0.0 109.412 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.984 HG13 HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -102.56 -79.06 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.062 -1.024 . . . . 0.0 109.685 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -72.62 -44.05 41.5 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.5 OUTLIER 163.32 -33.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.326 -1.102 . . . . 0.0 109.327 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 37' ' ' SER . 58.6 m-20 -76.77 -77.2 0.15 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.255 -0.903 . . . . 0.0 109.184 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.882 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.1 OUTLIER 158.1 128.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.617 ' H ' ' CD ' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -120.43 -37.31 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.838 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -178.593 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.617 ' CD ' ' H ' ' A' ' 38' ' ' TYR . 35.1 Cg_endo -80.42 101.93 1.37 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 120.975 1.117 . . . . 0.0 112.485 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.614 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -132.12 -172.05 2.79 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.365 -0.835 . . . . 0.0 109.267 178.121 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -81.74 158.22 24.26 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.824 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 1.2 t80 -121.38 124.1 43.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.102 -0.998 . . . . 0.0 109.747 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -110.24 -75.22 0.63 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 108.543 179.295 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 0.4 OUTLIER 77.15 -76.03 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.363 -0.836 . . . . 0.0 110.458 179.002 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 56.66 45.69 21.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.925 -1.109 . . . . 0.0 109.115 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.581 ' HG2' ' CE2' ' A' ' 48' ' ' PHE . 0.8 OUTLIER -94.2 -28.42 15.64 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.249 -0.907 . . . . 0.0 109.306 -179.668 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 159.84 -23.61 0.29 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.581 ' CE2' ' HG2' ' A' ' 46' ' ' GLU . 3.5 p90 -111.87 139.74 47.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.431 -1.041 . . . . 0.0 109.225 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 50' ' ' PHE . 2.4 m-20 -122.8 -23.79 4.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.682 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.517 ' CB ' ' O ' ' A' ' 49' ' ' ASP . 3.1 m-85 80.54 173.82 0.13 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.363 -0.835 . . . . 0.0 109.382 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.9 p -120.74 39.48 3.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.219 -0.925 . . . . 0.0 109.625 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.496 HG21 ' HA ' ' A' ' 87' ' ' ALA . 15.0 t -98.58 -67.14 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.157 -0.964 . . . . 0.0 109.505 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.444 ' O ' ' CE2' ' A' ' 56' ' ' TYR . 0.2 OUTLIER -165.55 174.98 9.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.097 -1.002 . . . . 0.0 109.996 -179.702 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.584 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -79.22 -51.04 1.3 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.46 -0.775 . . . . 0.0 110.61 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 54' ' ' SER . 36.2 Cg_endo -76.25 82.85 2.12 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.94 1.76 . . . . 0.0 110.208 -178.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.541 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 49.0 m-85 -79.35 -178.15 6.09 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.561 0.696 . . . . 0.0 109.712 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.621 ' CE1' ' NE2' ' A' ' 27' ' ' HIS . 97.1 m-85 -158.13 135.63 10.32 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.474 ' OE2' ' O ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -96.03 140.5 30.68 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.094 -1.003 . . . . 0.0 111.589 -178.115 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.716 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 27.5 t-105 -160.81 139.29 7.42 Favored Pre-proline 0 N--CA 1.495 1.799 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.716 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 31.6 Cg_endo -70.09 143.15 48.39 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.161 1.907 . . . . 0.0 111.321 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 1.031 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -107.02 116.29 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.56 -0.712 . . . . 0.0 109.512 -179.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.031 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.7 OUTLIER -116.94 164.04 15.3 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.296 -0.878 . . . . 0.0 108.985 179.494 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.587 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -172.48 56.32 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.55 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 177.14 36.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.271 -0.893 . . . . 0.0 109.118 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.04 -70.31 0.08 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -173.74 167.75 4.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.202 -1.175 . . . . 0.0 109.77 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.474 HG11 ' HB1' ' A' ' 22' ' ' ALA . 39.8 t -62.59 150.1 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.331 -0.856 . . . . 0.0 109.298 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.596 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 17.1 t80 -52.0 138.86 24.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.966 -1.084 . . . . 0.0 109.533 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.458 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 5.0 t -159.9 21.9 0.17 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.393 -0.817 . . . . 0.0 109.69 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 130.98 154.7 7.98 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.91 -133.5 6.8 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.97 131.07 21.98 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.145 -1.209 . . . . 0.0 109.175 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.475 ' HA ' ' OH ' ' A' ' 38' ' ' TYR . 36.2 Cg_endo -79.48 -172.57 1.57 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.406 2.071 . . . . 0.0 111.012 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.704 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 74.52 -167.74 54.68 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.704 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 77.6 -152.02 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.246 -1.149 . . . . 0.0 110.459 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.24 162.65 9.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.391 -0.818 . . . . 0.0 109.811 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.573 ' O ' HG12 ' A' ' 90' ' ' ILE . 0.9 OUTLIER 175.1 96.59 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.176 -0.952 . . . . 0.0 109.149 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.032 HG21 HD21 ' A' ' 86' ' ' LEU . 2.6 p -77.02 140.12 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.884 -1.135 . . . . 0.0 110.579 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.577 ' CG1' ' N ' ' A' ' 80' ' ' PHE . 16.7 t -92.53 169.44 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.577 ' CE1' ' O ' ' A' ' 57' ' ' TYR . 4.6 p90 -162.84 -173.31 3.43 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.629 -0.829 . . . . 0.0 109.502 -178.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.483 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 11.0 t-20 -124.0 -81.77 0.64 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.17 -0.956 . . . . 0.0 109.405 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 81' ' ' ASN . 65.9 mt-10 -156.4 12.82 0.29 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.459 -0.776 . . . . 0.0 110.317 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.5 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 0.1 OUTLIER -137.9 6.01 2.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.023 -1.048 . . . . 0.0 109.489 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.5 ' OD1' ' O ' ' A' ' 83' ' ' ASN . 0.3 OUTLIER 70.91 16.14 6.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.448 -0.783 . . . . 0.0 109.441 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.586 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -53.72 -31.29 47.69 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.383 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.032 HD21 HG21 ' A' ' 78' ' ' VAL . 0.6 OUTLIER 89.21 103.28 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.686 0.755 . . . . 0.0 110.599 179.226 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.496 ' HA ' HG21 ' A' ' 52' ' ' VAL . . . -70.97 -52.59 18.85 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.25 171.29 34.79 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.682 HG21 ' CG ' ' A' ' 4' ' ' TYR . 64.3 t -102.91 124.69 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.937 -1.331 . . . . 0.0 109.906 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.588 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 0.5 OUTLIER -125.59 153.22 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.331 -0.856 . . . . 0.0 108.696 179.553 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 99' ' ' ASN . 6.3 t -117.07 165.49 13.32 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.026 -1.046 . . . . 0.0 110.019 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.62 ' NE2' ' CD2' ' A' ' 100' ' ' PHE . 0.4 OUTLIER -121.11 67.27 0.87 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.437 -0.789 . . . . 0.0 109.28 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 7.4 m -168.81 126.22 1.01 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.462 -0.773 . . . . 0.0 109.292 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 107.96 -20.57 31.03 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 98' ' ' ASN . . . -105.83 93.94 4.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.211 -1.17 . . . . 0.0 109.681 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 95' ' ' ALA . 51.7 m 41.59 52.58 3.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.511 -0.743 . . . . 0.0 109.477 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.1 -73.29 0.21 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.602 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -144.38 -81.96 0.16 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.259 -1.142 . . . . 0.0 109.472 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 92' ' ' HIS . 0.8 OUTLIER 57.06 159.29 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.317 -0.864 . . . . 0.0 109.15 -179.519 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.62 ' CD2' ' NE2' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -96.61 145.17 25.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.902 -1.124 . . . . 0.0 110.04 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.443 ' O ' ' C ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -155.97 130.55 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.293 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 101' ' ' VAL . 2.3 pt-20 -39.98 136.83 1.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.468 -0.77 . . . . 0.0 110.124 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.99 123.83 29.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.395 -0.816 . . . . 0.0 109.382 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.1 p . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.171 -0.955 . . . . 0.0 109.38 179.844 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.443 ' O ' ' SG ' ' A' ' 10' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.598 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 0.8 OUTLIER 173.94 106.91 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.279 -0.888 . . . . 0.0 110.398 179.558 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -79.66 -14.74 58.57 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.722 ' CG ' HG21 ' A' ' 89' ' ' VAL . 16.2 m-85 -112.8 126.94 55.97 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.337 -0.852 . . . . 0.0 109.051 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 7' ' ' GLY . 1.2 m -152.83 109.32 3.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.235 -0.916 . . . . 0.0 109.744 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 103' ' ' CYS . 29.9 m -95.44 16.81 15.96 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.066 0.936 . . . . 0.0 109.557 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.468 ' O ' HG22 ' A' ' 5' ' ' THR . . . -177.65 -146.47 6.31 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 p -88.17 15.11 7.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.208 -1.172 . . . . 0.0 109.304 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -79.67 -168.18 1.49 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.322 -0.861 . . . . 0.0 109.664 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 1' ' ' ALA . 45.6 t -149.55 74.3 1.22 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.5 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 4.2 m-85 -80.44 124.6 29.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.393 -0.817 . . . . 0.0 110.041 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.772 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -83.79 124.79 31.28 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.502 -0.749 . . . . 0.0 109.63 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 12' ' ' SER . 28.3 t -46.39 -25.67 0.69 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.239 -0.913 . . . . 0.0 108.754 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.3 t -76.91 -43.36 35.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 109.285 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.41 -26.09 67.07 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.886 HG13 HG12 ' A' ' 61' ' ' ILE . 3.0 t -72.87 -32.99 42.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.91 -42.31 97.83 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -47.32 86.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 108.628 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 1.088 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -75.9 -10.59 59.55 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.635 ' NE2' ' CG ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -83.17 -30.61 27.68 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.922 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.425 ' HA ' ' HB3' ' A' ' 24' ' ' TYR . . . -80.25 -16.73 54.07 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.38 -47.27 61.7 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.557 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -73.14 -31.21 61.88 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.684 -1.766 . . . . 0.0 108.684 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.425 ' HB3' ' HA ' ' A' ' 21' ' ' ALA . 11.2 t80 -68.23 -32.15 72.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.46 -1.024 . . . . 0.0 109.171 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -73.36 -47.9 38.57 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.732 HD21 ' C ' ' A' ' 32' ' ' THR . 5.6 tp -65.25 -21.2 66.71 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -85.65 -24.76 26.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.526 -0.734 . . . . 0.0 109.516 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -88.12 -11.55 46.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.319 -0.863 . . . . 0.0 109.403 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -107.88 -11.57 15.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.374 -0.829 . . . . 0.0 109.721 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.64 14.89 77.71 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.426 ' O ' HG23 ' A' ' 32' ' ' THR . 0.3 OUTLIER -81.27 -157.17 0.16 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -1.207 . . . . 0.0 109.379 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.826 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -158.19 166.79 31.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.322 -0.861 . . . . 0.0 109.254 179.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.607 HG13 HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -110.33 -70.44 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.144 -0.973 . . . . 0.0 109.585 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 35' ' ' SER . . . -85.93 16.45 42.15 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 0.5 OUTLIER 66.36 19.73 10.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.132 -1.217 . . . . 0.0 109.114 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -120.92 5.58 10.42 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.402 -0.811 . . . . 0.0 109.293 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.826 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.3 OUTLIER 68.3 73.51 0.29 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.224 -0.922 . . . . 0.0 108.653 -179.179 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.654 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -71.67 -45.33 12.63 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.117 -0.99 . . . . 0.0 110.938 -179.367 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 35.3 Cg_endo -77.15 106.61 2.27 Favored 'Trans proline' 0 C--N 1.3 -1.993 0 C-N-CA 120.855 1.037 . . . . 0.0 109.873 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.654 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -127.09 -175.37 3.41 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -107.13 143.34 35.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.943 -1.098 . . . . 0.0 110.367 -179.454 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.54 ' HB3' ' CB ' ' A' ' 56' ' ' TYR . 12.0 t80 -104.11 161.59 13.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.503 -0.748 . . . . 0.0 109.245 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 44' ' ' ASN . 0.5 OUTLIER -123.83 -16.22 6.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.124 -0.985 . . . . 0.0 109.567 179.615 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.543 ' O ' ' CD2' ' A' ' 45' ' ' TYR . 0.7 OUTLIER 62.1 130.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.556 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.543 ' CD2' ' O ' ' A' ' 44' ' ' ASN . 5.6 m-85 -161.44 -38.54 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.399 -0.813 . . . . 0.0 109.126 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.818 ' OE2' HG12 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -37.93 -68.36 0.16 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.469 0.652 . . . . 0.0 110.131 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.56 61.14 0.01 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -89.62 -174.75 4.44 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.358 -1.084 . . . . 0.0 108.61 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -117.09 -20.4 9.32 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.897 -1.127 . . . . 0.0 110.043 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.511 ' C ' ' CD1' ' A' ' 50' ' ' PHE . 10.1 p90 -80.74 179.97 7.54 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.129 -0.982 . . . . 0.0 109.438 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.475 ' HA ' ' OH ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -177.4 57.08 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.259 -0.9 . . . . 0.0 109.254 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.711 HG11 ' HB2' ' A' ' 85' ' ' GLN . 42.3 t -45.03 -63.13 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.165 -0.959 . . . . 0.0 109.023 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.408 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -154.75 -178.97 7.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.312 -0.868 . . . . 0.0 109.95 179.972 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.588 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -79.7 -50.09 1.29 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.405 -0.809 . . . . 0.0 110.81 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 54' ' ' SER . 34.5 Cg_endo -75.28 83.62 1.83 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.991 1.794 . . . . 0.0 109.764 -178.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.621 ' CE1' ' HB2' ' A' ' 87' ' ' ALA . 10.1 m-85 -81.68 179.82 7.68 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.745 0.783 . . . . 0.0 110.804 -178.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.577 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 64.4 m-85 -157.26 117.12 3.43 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.624 ' HG2' HD11 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -96.66 147.66 23.66 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.266 -0.896 . . . . 0.0 110.489 -178.584 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.696 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 4.1 t-105 -160.75 143.93 9.83 Favored Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.696 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 28.4 Cg_endo -66.35 133.03 31.17 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.336 2.024 . . . . 0.0 112.091 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 1.088 HD13 ' HB3' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -118.31 115.66 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.704 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.023 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -118.58 163.75 16.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.107 -0.996 . . . . 0.0 109.13 179.761 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.1 t -131.53 36.17 3.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.484 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.73 6.8 12.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.18 -0.95 . . . . 0.0 109.618 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.71 -32.7 7.26 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.991 ' O ' HD12 ' A' ' 62' ' ' LEU . 11.9 m-20 -98.97 91.39 5.01 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.23 -1.159 . . . . 0.0 109.375 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.584 ' O ' ' CD1' ' A' ' 68' ' ' TYR . 43.4 t -65.02 156.75 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 109.857 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.589 ' HB3' ' CZ2' ' A' ' 59' ' ' TRP . 48.6 p90 39.17 -162.69 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.598 0.713 . . . . 0.0 110.023 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.492 ' N ' ' CD2' ' A' ' 68' ' ' TYR . 29.0 t 53.11 173.22 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.342 -0.849 . . . . 0.0 109.427 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.63 -160.45 15.99 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.66 41.32 2.25 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 t -161.26 85.95 1.72 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.221 -1.164 . . . . 0.0 109.306 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.557 ' HA ' ' OH ' ' A' ' 38' ' ' TYR . 35.5 Cg_endo -79.95 44.05 1.64 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.789 2.326 . . . . 0.0 111.022 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.631 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . -173.03 -167.52 33.05 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 72.28 -141.89 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.117 -1.225 . . . . 0.0 110.162 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.465 ' C ' ' O ' ' A' ' 75' ' ' ALA . 1.2 m-20 -34.2 131.14 0.31 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.444 -0.785 . . . . 0.0 111.21 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.519 ' O ' HG12 ' A' ' 90' ' ' ILE . 6.5 ttm-85 -167.24 110.11 0.68 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.469 -0.769 . . . . 0.0 108.989 179.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.797 HG23 HD11 ' A' ' 86' ' ' LEU . 4.3 p -71.95 164.62 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.069 -1.019 . . . . 0.0 109.67 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 1.021 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 4.0 t -130.52 171.36 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.973 0.892 . . . . 0.0 109.961 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.638 ' H ' HG12 ' A' ' 79' ' ' VAL . 24.0 p90 -174.02 -172.46 0.72 Allowed 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.418 ' CG ' ' N ' ' A' ' 82' ' ' GLU . 2.9 t30 -125.33 -84.9 0.64 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.962 -1.087 . . . . 0.0 109.794 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.418 ' N ' ' CG ' ' A' ' 81' ' ' ASN . 6.9 mt-10 -142.16 0.55 1.36 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.494 -0.753 . . . . 0.0 109.919 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 84' ' ' ASN . 8.7 m-20 -131.4 4.81 4.35 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 108.895 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.515 ' OD1' ' HB3' ' A' ' 20' ' ' GLN . 5.5 t30 75.1 32.43 0.77 Allowed 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.334 -0.854 . . . . 0.0 109.192 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.711 ' HB2' HG11 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -62.16 -33.16 73.98 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.46 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.797 HD11 HG23 ' A' ' 78' ' ' VAL . 0.1 OUTLIER 84.99 103.95 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.488 0.661 . . . . 0.0 110.994 178.937 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 1.021 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . . . -74.54 -27.8 60.68 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.42 ' H ' ' CD1' ' A' ' 86' ' ' LEU . . . 148.14 -149.03 21.04 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.722 HG21 ' CG ' ' A' ' 4' ' ' TYR . 72.5 t -129.85 87.71 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.254 -1.145 . . . . 0.0 109.639 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.624 HD11 ' HG2' ' A' ' 58' ' ' GLU . 12.2 pt -79.4 136.24 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.514 -0.741 . . . . 0.0 109.221 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.631 ' O ' HG23 ' A' ' 91' ' ' THR . 13.1 t -130.5 118.54 21.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.91 . . . . 0.0 110.296 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.691 ' CD2' ' CE1' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -84.01 76.42 10.06 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.368 -0.832 . . . . 0.0 108.848 179.279 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 1.4 m 178.96 -30.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.553 -0.717 . . . . 0.0 109.404 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -59.04 -15.01 27.23 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.887 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . . . -117.96 163.68 16.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.186 -1.185 . . . . 0.0 109.553 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 95' ' ' ALA . 3.7 m -42.92 120.33 1.75 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 109.008 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.97 -82.84 1.64 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.654 -1.779 . . . . 0.0 108.654 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.632 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -151.9 -86.81 0.07 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.318 -1.107 . . . . 0.0 109.287 179.419 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.887 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 4.0 m-80 61.04 129.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 108.937 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.691 ' CE1' ' CD2' ' A' ' 92' ' ' HIS . 57.0 m-85 -85.33 125.58 33.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.891 -1.131 . . . . 0.0 110.292 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.818 HG12 ' OE2' ' A' ' 46' ' ' GLU . 1.2 m -142.69 137.51 27.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.497 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 24.0 pt-20 -61.52 123.61 18.35 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.164 -0.96 . . . . 0.0 109.221 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.448 ' HB3' ' HA ' ' A' ' 6' ' ' CYS . 84.7 m -56.93 161.01 3.17 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.151 -0.968 . . . . 0.0 109.398 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.479 0 O-C-N 121.22 -0.925 . . . . 0.0 109.492 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 27.2 p -178.77 88.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.145 -0.972 . . . . 0.0 109.956 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -89.9 2.72 54.71 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.296 -0.878 . . . . 0.0 109.285 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -126.57 105.74 8.94 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.112 -0.992 . . . . 0.0 109.637 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.644 HG23 ' O ' ' A' ' 5' ' ' THR . 6.0 t -136.43 106.79 6.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.892 . . . . 0.0 109.318 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.47 ' SG ' ' HB ' ' A' ' 91' ' ' THR . 57.3 m -93.47 17.14 11.99 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.17 0.986 . . . . 0.0 109.63 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.48 -111.77 0.32 Allowed Glycine 0 C--N 1.282 -2.432 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.14 3.93 12.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.15 -1.206 . . . . 0.0 109.271 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.562 ' O ' ' N ' ' A' ' 11' ' ' TYR . 3.9 m120 -92.51 68.12 4.79 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.246 -0.909 . . . . 0.0 109.411 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -49.74 89.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.567 ' CZ ' ' OG ' ' A' ' 63' ' ' SER . 4.0 m-30 -83.17 144.6 29.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.456 -0.778 . . . . 0.0 110.173 -178.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.601 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 0.1 OUTLIER -79.18 127.84 32.54 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.818 -0.551 . . . . 0.0 110.042 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.35 -43.19 61.74 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.9 m -62.68 -34.52 77.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.378 -0.826 . . . . 0.0 108.958 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -69.22 -31.1 69.45 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 12' ' ' SER . 6.7 t -58.82 -25.43 29.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.469 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 20.3 t -74.4 -40.6 61.93 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -40.44 80.36 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.74 ' CB ' HD13 ' A' ' 61' ' ' ILE . . . -77.06 -26.43 53.56 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.782 ' NE2' HG13 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -75.03 -16.62 60.59 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.056 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -92.62 -11.71 33.54 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.95 -56.2 3.95 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.581 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -69.16 -24.13 76.02 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.565 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 11.0 t80 -77.99 -53.33 7.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.501 -1.0 . . . . 0.0 109.048 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 1.1 tm0? -45.64 -47.15 14.89 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.559 ' CD1' ' N ' ' A' ' 32' ' ' THR . 1.0 OUTLIER -59.79 -48.87 79.93 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.389 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.465 ' NE2' ' CZ ' ' A' ' 57' ' ' TYR . 9.1 t60 -59.06 -14.51 9.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.264 -0.898 . . . . 0.0 110.367 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -96.0 -28.18 14.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.89 -1.131 . . . . 0.0 109.957 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.39 8.0 45.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.115 -0.99 . . . . 0.0 109.432 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 48.62 34.07 13.62 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.536 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -102.17 -147.72 0.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -1.169 . . . . 0.0 109.429 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.99 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.3 OUTLIER -157.87 -178.19 7.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.064 -1.022 . . . . 0.0 110.016 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.521 HG23 ' N ' ' A' ' 34' ' ' GLY . 25.8 m -98.81 -139.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.878 . . . . 0.0 109.515 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.521 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -42.27 -51.41 5.32 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 173.62 -31.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.263 -1.14 . . . . 0.0 109.635 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.445 ' O ' ' CB ' ' A' ' 37' ' ' SER . 5.8 m120 -74.82 -7.38 53.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.25 -0.906 . . . . 0.0 109.573 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.99 ' HA ' HG22 ' A' ' 32' ' ' THR . 2.4 p 71.84 -165.33 0.13 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -0.922 . . . . 0.0 109.481 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.591 ' CD1' ' HD3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER 167.64 -45.03 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.482 -0.761 . . . . 0.0 111.269 179.435 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 31.8 Cg_endo -76.59 100.68 1.42 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 121.482 1.455 . . . . 0.0 112.025 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.587 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -140.33 163.44 32.77 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.591 -0.693 . . . . 0.0 109.513 178.735 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -58.06 154.13 13.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.795 -1.19 . . . . 0.0 108.664 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.631 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -136.74 155.22 50.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.124 -0.985 . . . . 0.0 110.044 -178.562 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.612 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . 0.7 OUTLIER -137.82 -71.99 0.42 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.537 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.631 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 1.0 OUTLIER 80.18 -69.66 0.1 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.593 -0.692 . . . . 0.0 111.411 178.318 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.612 ' CE2' ' HB3' ' A' ' 43' ' ' ASN . 86.6 m-85 67.41 9.12 6.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 108.846 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.509 ' HB3' ' CE2' ' A' ' 48' ' ' PHE . 0.4 OUTLIER -39.33 -50.72 2.05 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 121.557 -0.715 . . . . 0.0 109.809 -179.725 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 159.37 36.71 0.02 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.509 ' CE2' ' HB3' ' A' ' 46' ' ' GLU . 7.5 m-85 -115.64 -179.91 3.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.243 -1.151 . . . . 0.0 109.346 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -128.73 -34.68 1.96 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.464 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.528 ' CB ' ' OH ' ' A' ' 56' ' ' TYR . 16.8 m-30 55.21 179.12 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 109.916 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.6 p -139.76 21.04 2.5 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.573 HG12 ' N ' ' A' ' 53' ' ' SER . 77.1 t -95.42 -92.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.544 -0.722 . . . . 0.0 109.843 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.573 ' N ' HG12 ' A' ' 52' ' ' VAL . 60.7 m -166.27 -168.84 1.29 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.976 . . . . 0.0 110.047 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.607 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -77.78 -50.74 1.89 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.614 -0.679 . . . . 0.0 111.056 -179.816 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 54' ' ' SER . 32.5 Cg_endo -73.01 92.38 0.81 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 121.897 1.731 . . . . 0.0 110.168 -177.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.607 ' CE1' ' HB2' ' A' ' 87' ' ' ALA . 17.4 m-85 -94.66 -169.15 1.96 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.589 ' O ' ' CE1' ' A' ' 80' ' ' PHE . 70.4 m-85 -161.66 106.94 1.3 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 0.3 OUTLIER -78.1 140.24 39.05 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.836 0.827 . . . . 0.0 110.921 -178.613 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.678 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 31.3 t-105 -160.35 137.02 6.52 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.678 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.9 Cg_endo -69.08 145.89 62.59 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.092 1.862 . . . . 0.0 111.484 -178.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.983 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -110.88 128.49 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.56 -0.713 . . . . 0.0 109.527 -179.339 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.983 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -124.82 161.33 26.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.153 -0.967 . . . . 0.0 109.261 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.567 ' OG ' ' CZ ' ' A' ' 11' ' ' TYR . 53.8 m -133.42 5.73 3.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.303 -0.873 . . . . 0.0 109.398 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.37 -71.48 0.73 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.917 . . . . 0.0 109.202 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . -74.32 -92.83 0.14 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 53.4 t0 179.87 -36.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.289 -1.124 . . . . 0.0 109.758 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.04 155.48 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.162 -0.961 . . . . 0.0 109.89 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.567 ' HB2' ' HG2' ' A' ' 60' ' ' PRO . 54.1 t80 -71.57 115.06 10.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.908 . . . . 0.0 109.397 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.6 t -152.74 -43.43 0.1 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.38 -0.825 . . . . 0.0 109.278 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.31 -27.44 57.9 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.419 ' O ' ' OG ' ' A' ' 72' ' ' SER . . . 101.14 -163.97 18.2 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.554 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 18.2 p 55.82 60.81 8.5 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.305 -1.115 . . . . 0.0 109.846 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 72' ' ' SER . 36.8 Cg_endo -79.59 -159.05 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.651 2.234 . . . . 0.0 110.436 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.566 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 92.2 -171.65 34.15 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 70.86 -80.85 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.482 -1.011 . . . . 0.0 110.377 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.602 ' HB3' HG23 ' A' ' 61' ' ' ILE . 54.6 m-20 -113.66 135.17 54.22 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.015 -1.053 . . . . 0.0 109.698 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.557 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 4.6 mtt180 -155.99 84.82 1.01 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.313 -0.867 . . . . 0.0 109.073 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.782 HG13 ' NE2' ' A' ' 20' ' ' GLN . 14.6 p -77.93 150.44 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.975 -1.078 . . . . 0.0 109.484 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.652 HG12 ' H ' ' A' ' 80' ' ' PHE . 3.0 t -111.62 173.35 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.364 -0.835 . . . . 0.0 109.418 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.652 ' H ' HG12 ' A' ' 79' ' ' VAL . 4.4 p90 -164.24 -171.47 2.41 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.221 -178.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.556 ' HB2' HG11 ' A' ' 52' ' ' VAL . 16.8 t30 -121.08 -83.08 0.66 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.026 -1.046 . . . . 0.0 109.99 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.565 ' O ' ' CZ ' ' A' ' 24' ' ' TYR . 42.0 mt-10 -141.91 -9.44 0.91 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.402 -0.811 . . . . 0.0 110.862 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -131.77 25.06 4.69 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.907 -1.121 . . . . 0.0 108.882 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.455 ' O ' ' C ' ' A' ' 85' ' ' GLN . 3.1 m120 62.37 21.73 12.75 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.495 -0.753 . . . . 0.0 109.506 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.568 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -44.11 -30.23 0.73 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.562 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.568 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER 85.18 103.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.553 0.692 . . . . 0.0 110.904 178.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.607 ' HB2' ' CE1' ' A' ' 56' ' ' TYR . . . -79.41 -33.21 42.85 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 139.73 145.3 4.67 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.507 HG22 ' HB ' ' A' ' 78' ' ' VAL . 61.2 t -80.57 118.88 29.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.144 -1.209 . . . . 0.0 109.282 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.674 HD12 ' HB2' ' A' ' 100' ' ' PHE . 0.4 OUTLIER -104.45 179.12 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.925 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.484 ' O ' ' O ' ' A' ' 99' ' ' ASN . 1.5 t -138.0 135.3 35.82 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.354 -1.338 . . . . 0.0 111.916 -178.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.611 ' CE1' ' CD1' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -86.19 62.34 7.38 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.553 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 93' ' ' THR . 6.8 t -176.2 25.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.385 -0.822 . . . . 0.0 110.314 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.19 10.56 17.48 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 1.026 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . . . -153.29 -174.42 4.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -1.152 . . . . 0.0 109.554 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 95' ' ' ALA . 1.9 t -42.71 113.98 0.53 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.343 -0.848 . . . . 0.0 109.718 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.46 -81.84 0.82 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.595 ' HB2' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -138.36 -76.32 0.38 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -1.138 . . . . 0.0 109.722 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 1.026 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 1.0 OUTLIER 59.94 154.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -178.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.674 ' HB2' HD12 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -114.36 118.75 34.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.711 -1.243 . . . . 0.0 110.961 -179.233 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.443 ' O ' ' C ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -125.51 139.83 50.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 107.85 -1.166 . . . . 0.0 107.85 178.357 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -41.82 140.01 1.11 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.137 -0.977 . . . . 0.0 110.347 -178.672 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.442 ' O ' ' OE1' ' A' ' 102' ' ' GLU . 0.5 OUTLIER -56.36 109.03 0.54 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.419 -0.801 . . . . 0.0 109.478 179.716 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 109.538 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 8.5 p 173.96 99.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.931 . . . . 0.0 109.862 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -101.51 -9.42 21.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.349 -0.844 . . . . 0.0 109.311 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.989 ' CG ' HG21 ' A' ' 89' ' ' VAL . 18.8 m-85 -106.14 82.15 1.72 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.115 -0.991 . . . . 0.0 109.163 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.694 HG22 ' HA ' ' A' ' 10' ' ' CYS . 76.3 p -89.83 131.51 35.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -0.852 . . . . 0.0 109.719 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.516 ' CB ' ' OD1' ' A' ' 76' ' ' ASP . 4.0 m -143.55 157.76 44.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.348 -0.845 . . . . 0.0 109.138 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 8' ' ' SER . . . 44.95 32.94 3.4 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 7' ' ' GLY . 0.6 OUTLIER 68.53 49.18 0.77 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.323 -1.104 . . . . 0.0 109.573 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.464 ' O ' ' HB ' ' A' ' 5' ' ' THR . 25.2 m120 -136.3 172.91 12.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.185 -0.947 . . . . 0.0 110.032 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.694 ' HA ' HG22 ' A' ' 5' ' ' THR . 0.4 OUTLIER -127.48 81.87 2.05 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.663 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.536 ' CE2' ' HB2' ' A' ' 63' ' ' SER . 2.9 m-85 -79.0 138.28 37.96 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.476 -0.765 . . . . 0.0 109.826 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.662 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.8 OUTLIER -79.62 124.74 28.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.607 -0.683 . . . . 0.0 109.767 -179.709 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.64 -21.94 3.01 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.559 -0.856 . . . . 0.0 108.975 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 t -82.28 -36.64 26.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.384 -0.822 . . . . 0.0 109.328 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -69.48 -33.79 73.39 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 12' ' ' SER . 5.0 t -58.66 -38.4 71.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.48 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 0.9 OUTLIER -63.71 -31.63 72.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.616 -0.677 . . . . 0.0 109.487 179.547 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -56.78 9.13 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.795 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -63.62 -17.25 62.69 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.57 ' OE1' ' CG ' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -77.43 -36.0 53.53 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -74.13 -6.31 46.94 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.717 ' HB1' HG22 ' A' ' 67' ' ' VAL . . . -84.19 -53.6 5.39 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.607 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -68.33 -27.77 73.59 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.484 ' C ' ' CD1' ' A' ' 24' ' ' TYR . 1.3 t80 -76.31 -60.02 2.51 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.502 -0.999 . . . . 0.0 109.599 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 14.6 mt-30 -57.58 -31.67 66.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.032 -1.042 . . . . 0.0 109.137 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.658 HD23 ' HG3' ' A' ' 39' ' ' PRO . 9.2 tp -74.01 -28.89 61.67 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 108.54 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 39' ' ' PRO . 14.0 t60 -79.5 -21.91 44.68 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.422 -0.799 . . . . 0.0 109.448 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -89.31 -31.93 17.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.322 -0.861 . . . . 0.0 109.464 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -80.93 -13.77 58.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.94 . . . . 0.0 109.579 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.24 36.34 27.61 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.859 ' O ' HG23 ' A' ' 32' ' ' THR . 0.3 OUTLIER -105.49 -158.78 0.68 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.252 -1.146 . . . . 0.0 109.791 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.859 HG23 ' O ' ' A' ' 31' ' ' GLU . 1.1 p -168.22 -172.18 1.69 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.573 HG11 ' O ' ' A' ' 68' ' ' TYR . 33.7 m -125.38 152.35 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.08 -1.012 . . . . 0.0 110.377 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 48.79 -88.54 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.541 ' N ' ' O ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -175.09 28.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.417 -1.049 . . . . 0.0 109.346 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.447 ' O ' ' OG ' ' A' ' 37' ' ' SER . 5.2 m-20 -138.0 23.64 2.82 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.339 -0.85 . . . . 0.0 109.159 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.591 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 75.8 p 48.98 -165.98 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.416 -0.803 . . . . 0.0 109.692 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.629 ' CE2' ' NH1' ' A' ' 77' ' ' ARG . 0.0 OUTLIER 168.7 -44.88 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.549 -0.719 . . . . 0.0 111.541 179.212 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.658 ' HG3' HD23 ' A' ' 26' ' ' LEU . 33.2 Cg_endo -76.77 100.75 1.43 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 121.377 1.385 . . . . 0.0 111.986 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.552 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -140.4 -170.15 2.93 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.682 -0.636 . . . . 0.0 109.349 178.642 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 11.5 ptmt -75.51 163.84 26.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.406 -0.809 . . . . 0.0 110.395 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.588 ' CE2' ' HA ' ' A' ' 44' ' ' ASN . 85.7 t80 -142.83 93.88 2.57 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 44' ' ' ASN . 0.5 OUTLIER -81.79 37.91 0.49 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.12 -0.987 . . . . 0.0 110.752 -179.053 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.588 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER 39.92 -160.99 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.216 -0.927 . . . . 0.0 109.948 179.394 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.457 ' CB ' ' O ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER 167.25 -67.31 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.4 -0.813 . . . . 0.0 109.217 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -38.96 -52.63 1.78 Allowed 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.519 -0.738 . . . . 0.0 110.016 -179.784 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.07 51.18 0.05 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.548 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 21.0 m-85 -101.09 115.09 29.66 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.178 -1.189 . . . . 0.0 109.523 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.04 88.94 7.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.411 -0.806 . . . . 0.0 109.18 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.548 ' CZ ' ' HB2' ' A' ' 48' ' ' PHE . 60.6 m-85 -78.87 -172.46 3.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.358 -0.839 . . . . 0.0 109.657 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 84.2 p -153.48 42.25 0.56 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 109.3 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.83 HG21 ' O ' ' A' ' 86' ' ' LEU . 38.3 t -114.65 -41.63 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.32 -0.862 . . . . 0.0 109.518 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.492 ' HB3' ' OD1' ' A' ' 81' ' ' ASN . 0.6 OUTLIER 176.7 -174.47 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.147 -0.971 . . . . 0.0 109.75 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.567 ' CB ' ' HD3' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -91.97 -56.24 0.25 Allowed Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.247 -0.908 . . . . 0.0 111.518 -179.231 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.567 ' HD3' ' CB ' ' A' ' 54' ' ' SER . 35.4 Cg_endo -75.17 89.3 1.18 Allowed 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.913 1.742 . . . . 0.0 110.082 -177.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 1.025 ' CE2' ' HB1' ' A' ' 87' ' ' ALA . 4.0 m-30 -84.82 -179.52 7.11 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.433 0.635 . . . . 0.0 109.982 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.583 ' O ' ' CE1' ' A' ' 80' ' ' PHE . 87.2 m-85 -151.86 130.38 12.21 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.477 -0.765 . . . . 0.0 109.098 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.513 ' OE1' ' NH2' ' A' ' 77' ' ' ARG . 12.7 pt-20 -89.11 133.7 34.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 0.0 110.917 -178.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.684 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 20.0 t-105 -160.25 139.52 8.02 Favored Pre-proline 0 N--CA 1.491 1.6 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.684 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 32.8 Cg_endo -72.11 152.88 57.06 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.482 2.121 . . . . 0.0 111.897 -178.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 1.053 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -115.48 122.3 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.053 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -117.58 169.81 9.25 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.098 -1.001 . . . . 0.0 109.429 179.611 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.536 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 6.6 t -121.26 39.06 3.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 108.799 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.64 -31.13 5.28 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.569 -0.707 . . . . 0.0 109.356 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.23 12.56 59.84 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 67' ' ' VAL . 0.6 OUTLIER -106.16 9.89 32.1 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.212 -1.169 . . . . 0.0 109.595 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.717 HG22 ' HB1' ' A' ' 22' ' ' ALA . 91.9 t 60.8 143.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.169 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.779 ' HA ' HD11 ' A' ' 62' ' ' LEU . 16.7 t80 -55.53 108.79 0.47 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.124 -0.985 . . . . 0.0 109.402 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.68 48.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.408 -0.808 . . . . 0.0 109.325 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -149.38 -52.72 0.02 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 167.78 -167.61 40.15 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.411 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 0.3 OUTLIER 60.68 68.05 1.4 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.296 -1.12 . . . . 0.0 109.324 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 72' ' ' SER . 36.3 Cg_endo -78.72 155.74 27.4 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.742 2.295 . . . . 0.0 110.944 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.713 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 74.99 -149.84 40.06 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 80.17 -77.95 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.503 -0.998 . . . . 0.0 109.989 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.516 ' OD1' ' CB ' ' A' ' 6' ' ' CYS . 41.8 m-20 -131.28 134.91 46.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.019 -1.05 . . . . 0.0 110.333 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.629 ' NH1' ' CE2' ' A' ' 38' ' ' TYR . 1.6 mtt180 -138.42 123.92 19.56 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 78' ' ' VAL . 4.7 p -112.52 120.84 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.958 -1.089 . . . . 0.0 108.896 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.814 ' CG2' HD11 ' A' ' 90' ' ' ILE . 14.8 t -79.05 170.61 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 122.083 0.944 . . . . 0.0 110.266 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.592 ' N ' HG12 ' A' ' 79' ' ' VAL . 3.2 p90 -164.19 -171.36 2.38 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.492 ' OD1' ' HB3' ' A' ' 53' ' ' SER . 7.3 t30 -123.95 -81.41 0.64 Allowed 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.229 -0.989 . . . . 0.0 109.949 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.457 ' OE2' ' O ' ' A' ' 81' ' ' ASN . 66.7 mm-40 -159.24 18.08 0.18 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.288 -0.882 . . . . 0.0 109.645 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.465 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 3.8 m-20 -136.79 24.25 3.09 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.479 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 8.5 p30 48.02 23.32 0.48 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.633 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -67.68 -90.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.444 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.83 ' O ' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER 165.39 106.8 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.132 -0.98 . . . . 0.0 110.36 178.674 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 1.025 ' HB1' ' CE2' ' A' ' 56' ' ' TYR . . . -74.97 -42.09 58.29 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 162.74 154.13 7.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.989 HG21 ' CG ' ' A' ' 4' ' ' TYR . 40.2 t -93.3 105.33 16.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 120.843 -1.387 . . . . 0.0 110.164 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.814 HD11 ' CG2' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -99.43 172.64 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.214 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.469 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 2.8 t -145.02 141.07 28.59 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.668 -1.27 . . . . 0.0 111.261 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.528 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -88.68 55.95 3.58 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.306 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 93' ' ' THR . 5.8 t -168.4 23.09 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.157 -0.964 . . . . 0.0 110.309 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -125.81 23.99 5.83 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.849 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -177.89 117.93 0.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.407 -1.054 . . . . 0.0 109.506 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.459 ' O ' ' C ' ' A' ' 97' ' ' GLY . 2.5 m 46.06 -159.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.114 -0.991 . . . . 0.0 109.21 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 96' ' ' SER . . . -39.02 -50.64 2.68 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.528 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -152.12 -76.02 0.13 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.107 -1.231 . . . . 0.0 109.605 179.74 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.849 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.2 OUTLIER 60.91 146.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.135 -0.978 . . . . 0.0 108.772 -179.476 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.549 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -93.5 125.78 38.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.857 -1.152 . . . . 0.0 110.451 -179.51 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.543 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -145.22 137.68 21.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.512 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.45 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.0 OUTLIER -44.36 129.83 6.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.229 -0.919 . . . . 0.0 109.477 -179.598 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.469 ' SG ' ' HB ' ' A' ' 91' ' ' THR . 12.6 m -54.13 98.36 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.196 -0.94 . . . . 0.0 109.425 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 109.478 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.496 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 25.6 p 174.29 156.64 0.14 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.346 -0.846 . . . . 0.0 109.776 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.72 -40.75 2.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.344 -0.847 . . . . 0.0 109.105 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.641 ' CE1' ' CG2' ' A' ' 89' ' ' VAL . 15.1 m-85 -82.24 127.17 32.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.348 -0.845 . . . . 0.0 109.656 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.46 ' O ' ' SG ' ' A' ' 103' ' ' CYS . 0.2 OUTLIER -133.44 129.6 37.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.375 -0.828 . . . . 0.0 109.194 179.727 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 98.3 m -139.38 16.56 2.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.118 -0.989 . . . . 0.0 110.079 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.14 42.9 0.07 OUTLIER Glycine 0 C--N 1.284 -2.348 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.09 12.34 4.93 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.281 -1.129 . . . . 0.0 109.29 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.409 ' O ' HG23 ' A' ' 5' ' ' THR . 13.3 m120 -84.22 -171.97 3.91 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.216 -0.928 . . . . 0.0 109.13 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.432 ' C ' ' CB ' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -131.47 67.09 1.53 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.248 -0.908 . . . . 0.0 109.047 -179.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.5 ' CZ ' ' HB3' ' A' ' 63' ' ' SER . 36.2 m-85 -79.3 120.32 23.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.0 108.802 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.904 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -91.84 137.2 32.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.911 . . . . 0.0 110.407 -179.164 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.7 p -51.75 -21.9 3.14 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.9 t -84.45 -35.86 22.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.307 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.3 -23.5 60.29 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.904 HG23 ' O ' ' A' ' 12' ' ' SER . 2.7 t -74.58 -31.5 27.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -45.15 95.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -0.777 . . . . 0.0 109.034 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.1 m -60.09 -42.64 95.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.218 -0.926 . . . . 0.0 108.801 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.821 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -76.43 -13.28 60.12 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.475 ' NE2' ' O ' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -87.31 -21.99 25.4 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.1 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -85.59 -12.49 51.38 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.34 -56.04 4.32 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.349 -0.845 . . . . 0.0 109.261 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.591 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -66.56 -21.12 70.53 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.491 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 0.9 OUTLIER -81.38 -62.4 1.66 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.459 -1.024 . . . . 0.0 109.158 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 1.6 tt0 -44.3 -43.36 7.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.149 -0.97 . . . . 0.0 109.247 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.46 ' HA ' HD22 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -64.15 -43.84 93.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.252 -0.905 . . . . 0.0 109.12 179.726 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.621 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 28.3 t60 -68.07 -14.54 63.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.841 . . . . 0.0 110.102 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -95.65 -26.31 15.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.012 -1.055 . . . . 0.0 110.01 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 26.3 t0 -88.15 -10.48 49.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.161 -0.962 . . . . 0.0 109.73 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.09 0.78 66.46 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.414 ' C ' HD11 ' A' ' 26' ' ' LEU . 2.5 mm-40 -79.34 -169.29 1.82 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.159 -1.201 . . . . 0.0 109.281 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.995 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -127.37 178.21 6.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.774 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.567 ' CG2' ' HD3' ' A' ' 39' ' ' PRO . 60.1 t -82.31 -98.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.401 -0.812 . . . . 0.0 110.277 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.528 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -122.01 57.64 0.61 Allowed Glycine 0 N--CA 1.488 2.114 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.186 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER 78.96 -10.63 1.32 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.51 -0.994 . . . . 0.0 110.512 179.416 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -112.1 -6.8 14.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.894 -1.129 . . . . 0.0 109.515 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.995 ' HA ' HG22 ' A' ' 32' ' ' THR . 8.0 t 58.13 -175.06 0.08 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.238 -0.914 . . . . 0.0 109.316 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.588 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER 168.27 -44.94 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 111.495 179.324 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 31.8 Cg_endo -75.58 100.65 1.39 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.409 1.406 . . . . 0.0 111.976 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.533 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -144.39 -178.28 5.9 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.584 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.602 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -74.85 154.02 38.44 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.404 ' N ' ' HG2' ' A' ' 41' ' ' LYS . 19.2 t80 -125.62 145.72 50.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.992 -1.067 . . . . 0.0 110.249 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.444 ' O ' ' C ' ' A' ' 44' ' ' ASN . 41.1 t-20 -117.49 66.02 0.74 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 43' ' ' ASN . 0.6 OUTLIER -40.0 147.72 0.09 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.501 -0.749 . . . . 0.0 110.146 -179.369 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.459 ' O ' ' C ' ' A' ' 46' ' ' GLU . 98.2 m-85 -118.57 -44.73 2.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.403 -0.811 . . . . 0.0 108.999 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -38.63 -47.93 1.39 Allowed 'General case' 0 C--N 1.309 -1.18 0 O-C-N 121.599 -0.688 . . . . 0.0 109.915 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.16 48.38 0.06 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 86.7 m-85 -96.17 90.82 5.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.244 -1.151 . . . . 0.0 108.964 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.59 82.51 1.77 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.925 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.975 ' CD2' ' HB1' ' A' ' 87' ' ' ALA . 4.8 m-85 -78.33 -169.22 1.57 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.369 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.1 m -109.6 17.12 21.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.305 -0.872 . . . . 0.0 109.419 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.436 HG21 ' HA ' ' A' ' 87' ' ' ALA . 64.1 t -77.06 -60.13 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.356 -0.84 . . . . 0.0 109.48 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.42 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -172.11 161.77 5.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.105 -0.997 . . . . 0.0 109.715 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.585 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -72.18 -51.99 7.6 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.477 -0.764 . . . . 0.0 110.227 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 54' ' ' SER . 36.4 Cg_endo -76.24 87.0 1.47 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 121.939 1.759 . . . . 0.0 109.858 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.563 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 38.1 m-85 -79.04 -174.44 4.07 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.698 -0.627 . . . . 0.0 109.67 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.621 ' CE2' ' NE2' ' A' ' 27' ' ' HIS . 83.2 m-85 -154.93 134.63 12.77 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.405 ' HB2' ' NH2' ' A' ' 77' ' ' ARG . 3.9 pt-20 -96.75 144.3 26.88 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 122.053 0.93 . . . . 0.0 111.845 -177.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.698 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 32.2 t-105 -161.19 136.04 5.46 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.698 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.4 Cg_endo -69.57 147.2 63.59 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 121.864 1.709 . . . . 0.0 111.479 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.936 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -119.02 137.4 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.936 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.8 OUTLIER -120.27 172.79 7.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.128 -0.983 . . . . 0.0 109.701 -179.301 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.5 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . 5.4 p -119.45 29.64 7.51 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.187 -0.946 . . . . 0.0 108.768 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.96 -148.99 0.39 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.48 -0.762 . . . . 0.0 109.541 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -121.75 72.14 0.38 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -170.99 155.42 4.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -1.12 . . . . 0.0 109.769 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.567 HG13 ' HZ2' ' A' ' 59' ' ' TRP . 23.6 t -93.81 154.91 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.852 . . . . 0.0 109.291 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.516 ' O ' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -72.79 84.46 1.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.95 -1.094 . . . . 0.0 110.025 -179.506 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.436 ' HA ' HG12 ' A' ' 33' ' ' VAL . 14.5 t -81.0 -5.4 57.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.306 -0.871 . . . . 0.0 109.125 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -174.82 -144.14 4.78 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.17 -157.15 31.62 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.499 ' OG ' ' HD2' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -127.25 156.52 74.6 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.199 -1.177 . . . . 0.0 109.502 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.499 ' HD2' ' OG ' ' A' ' 72' ' ' SER . 35.5 Cg_endo -77.88 -175.15 2.55 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.643 2.229 . . . . 0.0 110.379 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 88.01 -167.1 35.95 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.573 ' N ' ' HB2' ' A' ' 92' ' ' HIS . . . 66.33 -83.94 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.706 -0.879 . . . . 0.0 109.987 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -137.12 157.28 47.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.044 -1.035 . . . . 0.0 109.753 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.487 ' O ' HG12 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -170.35 114.75 0.48 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.246 -0.909 . . . . 0.0 109.338 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 88' ' ' GLY . 14.1 p -90.77 134.09 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.07 -1.019 . . . . 0.0 109.173 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.842 HG23 ' CD1' ' A' ' 90' ' ' ILE . 20.1 t -98.88 165.32 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 122.174 0.988 . . . . 0.0 110.313 -179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.572 ' N ' ' CG1' ' A' ' 79' ' ' VAL . 20.1 p90 -163.16 -168.46 1.74 Allowed 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -178.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.52 ' O ' ' CB ' ' A' ' 82' ' ' GLU . 3.7 p30 -128.73 -44.38 1.34 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.791 -1.193 . . . . 0.0 110.387 -179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 0.2 OUTLIER 163.1 -25.89 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.379 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.503 ' HB3' ' HG2' ' A' ' 85' ' ' GLN . 1.2 t-20 -90.9 0.5 57.48 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.488 ' HB3' ' O ' ' A' ' 83' ' ' ASN . 37.6 t30 64.84 28.32 12.81 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.541 -0.724 . . . . 0.0 109.56 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.557 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -70.06 -27.56 64.74 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.565 HD21 HG21 ' A' ' 78' ' ' VAL . 0.3 OUTLIER 88.06 114.18 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.603 0.716 . . . . 0.0 110.197 179.42 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.975 ' HB1' ' CD2' ' A' ' 50' ' ' PHE . . . -87.38 -44.87 11.05 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.676 ' O ' HG23 ' A' ' 78' ' ' VAL . . . 166.1 -158.99 32.14 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.641 ' CG2' ' CE1' ' A' ' 4' ' ' TYR . 23.5 t -140.44 99.39 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.088 -1.243 . . . . 0.0 110.076 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.842 ' CD1' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -80.94 145.27 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.177 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.611 HG22 ' O ' ' A' ' 101' ' ' VAL . 9.7 t -130.53 132.05 45.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.867 -1.146 . . . . 0.0 110.884 -179.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.578 ' ND1' ' O ' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -91.76 79.24 5.38 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.646 -0.658 . . . . 0.0 109.534 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.0 m -175.07 118.23 0.18 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.183 -0.948 . . . . 0.0 109.603 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 113.86 2.89 23.69 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.411 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -144.87 146.53 32.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.135 -1.215 . . . . 0.0 109.731 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 95' ' ' ALA . 34.5 m -44.5 143.02 1.42 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.346 -0.846 . . . . 0.0 109.055 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.461 ' O ' ' C ' ' A' ' 98' ' ' ASN . . . 50.54 38.6 35.62 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.578 ' O ' ' ND1' ' A' ' 92' ' ' HIS . 0.2 OUTLIER 36.02 44.18 0.24 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.947 -0.737 . . . . 0.0 110.041 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -47.52 132.8 13.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.983 -1.073 . . . . 0.0 109.167 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.614 ' CD1' ' HB ' ' A' ' 90' ' ' ILE . 19.3 m-85 -60.03 134.57 57.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.034 -1.041 . . . . 0.0 109.924 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.611 ' O ' HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -137.61 130.84 42.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.865 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.477 ' CG ' ' O ' ' A' ' 102' ' ' GLU . 1.5 pt-20 -55.15 111.22 0.81 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.281 -0.887 . . . . 0.0 109.268 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 5' ' ' THR . 0.5 OUTLIER -55.33 146.38 19.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.342 -0.849 . . . . 0.0 109.917 -179.484 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 74.6 p . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.36 -0.838 . . . . 0.0 109.489 -179.993 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.439 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.258 0.551 . . . . 0.0 109.618 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.4 p 168.75 145.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.259 -0.901 . . . . 0.0 110.183 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -120.2 -27.67 5.23 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.542 -0.724 . . . . 0.0 109.086 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.621 ' CG ' HG21 ' A' ' 89' ' ' VAL . 19.4 m-85 -88.61 112.16 22.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 109.312 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.644 HG23 ' N ' ' A' ' 9' ' ' ASN . 80.1 m -140.32 120.2 13.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.341 -0.849 . . . . 0.0 109.337 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 69.3 m -118.05 16.71 14.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 122.171 0.986 . . . . 0.0 109.682 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 169.09 60.88 0.03 OUTLIER Glycine 0 C--N 1.282 -2.421 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.07 15.72 7.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.322 -1.105 . . . . 0.0 109.147 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.644 ' N ' HG23 ' A' ' 5' ' ' THR . 12.0 m-80 -81.19 131.74 35.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.415 -0.803 . . . . 0.0 109.723 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.3 t -97.83 58.89 1.42 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.836 . . . . 0.0 109.007 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.574 ' CE1' ' HB2' ' A' ' 63' ' ' SER . 7.5 m-30 -79.92 127.73 32.6 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.753 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -85.03 138.76 32.24 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.183 -0.948 . . . . 0.0 110.188 -179.223 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.46 -18.76 7.68 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.1 t -89.4 -31.24 17.84 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.521 -0.737 . . . . 0.0 109.153 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.31 -34.83 68.39 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 12' ' ' SER . 2.6 t -57.56 -35.18 49.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.04 -40.95 77.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.558 -0.714 . . . . 0.0 109.258 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.17 -55.98 13.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.332 -0.855 . . . . 0.0 109.137 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.533 ' HB3' ' CD1' ' A' ' 61' ' ' ILE . . . -71.41 -4.15 24.76 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.485 -0.759 . . . . 0.0 109.264 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.805 ' OE1' HG22 ' A' ' 78' ' ' VAL . 5.6 tp60 -101.57 -8.49 21.83 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.531 ' HB2' ' ND2' ' A' ' 84' ' ' ASN . . . -103.64 -9.14 19.41 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.333 -0.854 . . . . 0.0 109.248 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.6 -36.97 28.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 109.133 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 27' ' ' HIS . . . -72.03 -9.66 71.82 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.511 ' CE1' ' O ' ' A' ' 82' ' ' GLU . 18.4 t80 -101.36 -49.59 4.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.442 -1.034 . . . . 0.0 109.347 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -52.18 -38.58 58.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.876 . . . . 0.0 109.339 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.572 HD11 ' CB ' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -79.89 -45.11 19.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.473 -0.767 . . . . 0.0 109.138 179.754 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.575 ' ND1' ' N ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -45.41 -39.06 6.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.584 -0.697 . . . . 0.0 110.326 -179.713 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.575 ' N ' ' ND1' ' A' ' 27' ' ' HIS . 3.4 tp10 -94.29 -40.28 10.06 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.257 -0.902 . . . . 0.0 109.128 -178.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 28' ' ' GLU . 19.9 t0 -47.81 -23.76 0.82 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.434 ' N ' ' C ' ' A' ' 28' ' ' GLU . . . 80.5 14.16 80.49 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.572 ' CB ' HD11 ' A' ' 26' ' ' LEU . 0.9 OUTLIER -103.17 -170.11 1.74 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.232 -1.158 . . . . 0.0 109.176 179.789 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.983 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -137.41 174.41 10.63 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.204 -0.935 . . . . 0.0 109.648 -179.868 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.468 ' O ' ' C ' ' A' ' 34' ' ' GLY . 14.1 m -81.13 -162.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.876 . . . . 0.0 109.252 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -34.92 -57.6 0.79 Allowed Glycine 0 N--CA 1.498 2.779 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.73 30.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.321 -1.105 . . . . 0.0 109.724 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 37' ' ' SER . 1.2 m120 -134.16 6.45 3.61 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.214 -0.929 . . . . 0.0 109.356 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.983 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.2 OUTLIER 47.39 -173.64 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.234 -0.916 . . . . 0.0 109.357 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.602 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER 164.45 -44.15 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.641 -0.662 . . . . 0.0 111.415 179.522 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 38' ' ' TYR . 30.7 Cg_endo -73.83 99.62 1.18 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 121.295 1.33 . . . . 0.0 112.294 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.575 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -141.36 179.36 6.83 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.078 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -69.36 149.67 48.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.971 -1.081 . . . . 0.0 109.797 -179.336 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.615 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 1.5 t80 -115.3 146.57 41.38 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -156.94 91.3 1.19 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.997 -1.065 . . . . 0.0 109.711 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.615 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 2.2 t-20 -113.88 -51.56 2.78 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.351 -0.843 . . . . 0.0 109.599 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.453 ' O ' ' C ' ' A' ' 46' ' ' GLU . 40.7 m-85 50.44 22.65 1.07 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.133 -0.98 . . . . 0.0 109.055 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 48' ' ' PHE . 1.1 tm-20 -38.7 -61.31 0.73 Allowed 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.64 -0.662 . . . . 0.0 109.992 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.42 ' C ' ' CD1' ' A' ' 48' ' ' PHE . . . -177.09 45.18 0.1 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.507 ' CZ ' ' HB3' ' A' ' 46' ' ' GLU . 0.7 OUTLIER -124.89 168.05 13.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -1.134 . . . . 0.0 109.479 -179.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 50' ' ' PHE . 11.1 t70 -124.42 68.7 1.08 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.345 -0.847 . . . . 0.0 109.156 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.541 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 17.4 m-85 -52.52 -171.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.445 -0.785 . . . . 0.0 109.859 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 99.6 p -158.12 37.29 0.25 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.387 -0.821 . . . . 0.0 109.323 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.591 HG21 ' O ' ' A' ' 86' ' ' LEU . 97.4 t -108.97 -73.79 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.227 -0.92 . . . . 0.0 109.738 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.2 177.74 8.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.173 -0.955 . . . . 0.0 110.211 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.62 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -78.99 -50.92 1.36 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.658 -0.651 . . . . 0.0 111.13 -179.88 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 54' ' ' SER . 32.4 Cg_endo -72.56 93.57 0.76 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.861 1.707 . . . . 0.0 109.881 -177.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.59 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 4.5 m-85 -87.06 -176.82 5.86 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.509 0.671 . . . . 0.0 110.009 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.59 ' CG ' ' O ' ' A' ' 56' ' ' TYR . 81.7 m-85 -160.65 118.58 2.49 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.456 ' HB3' ' HB2' ' A' ' 42' ' ' TYR . 0.7 OUTLIER -83.77 142.05 30.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.142 -0.974 . . . . 0.0 111.125 -178.554 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.689 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 26.0 t-105 -161.16 139.31 7.14 Favored Pre-proline 0 N--CA 1.494 1.746 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.689 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.8 Cg_endo -68.35 144.61 62.64 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.003 1.802 . . . . 0.0 111.362 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 1.005 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -109.59 136.66 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.645 -0.659 . . . . 0.0 109.326 -179.501 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.005 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.3 OUTLIER -125.89 -177.7 4.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.297 -0.877 . . . . 0.0 109.417 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.574 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -117.57 -14.09 10.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.075 -1.016 . . . . 0.0 108.815 179.676 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.32 -58.53 3.23 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.584 -0.698 . . . . 0.0 109.189 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 114.21 10.59 13.39 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.451 ' O ' ' HB ' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -89.51 13.81 12.95 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.212 -1.169 . . . . 0.0 109.488 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.581 HG13 ' CZ2' ' A' ' 59' ' ' TRP . 99.6 t 61.77 131.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.274 -0.891 . . . . 0.0 109.527 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.569 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 34.6 t80 -46.81 107.32 0.1 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.235 -0.916 . . . . 0.0 109.469 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.3 16.07 6.09 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.175 -0.953 . . . . 0.0 109.468 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.6 65.18 0.02 OUTLIER Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.09 147.53 19.21 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.85 124.57 8.06 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.266 -1.138 . . . . 0.0 109.326 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.436 ' HB3' ' OH ' ' A' ' 38' ' ' TYR . 36.3 Cg_endo -78.02 150.56 26.59 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.452 2.101 . . . . 0.0 110.732 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.716 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 106.2 -175.03 21.0 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 79.84 -70.54 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.431 -1.04 . . . . 0.0 110.546 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.421 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 1.4 m-20 -134.95 152.22 51.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.741 -1.225 . . . . 0.0 110.107 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.545 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 7.4 mtt180 -163.47 105.68 0.98 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.42 -0.8 . . . . 0.0 108.981 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.805 HG22 ' OE1' ' A' ' 20' ' ' GLN . 8.1 p -89.45 144.59 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.986 -1.071 . . . . 0.0 109.479 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.582 HG12 ' N ' ' A' ' 80' ' ' PHE . 35.5 t -112.52 166.08 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.35 -0.844 . . . . 0.0 109.771 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.628 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 1.5 p90 -151.71 -178.2 6.57 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.585 ' HB3' HG12 ' A' ' 52' ' ' VAL . 16.9 p-10 -109.79 -47.16 3.39 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.019 -1.05 . . . . 0.0 109.857 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.535 ' HG2' ' ND2' ' A' ' 81' ' ' ASN . 0.6 OUTLIER 167.15 -25.07 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.502 ' HB3' ' HG2' ' A' ' 85' ' ' GLN . 1.1 t30 -92.49 8.86 36.88 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.47 -0.769 . . . . 0.0 108.967 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.531 ' ND2' ' HB2' ' A' ' 21' ' ' ALA . 25.8 t-20 63.33 13.42 7.01 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.42 -0.8 . . . . 0.0 110.137 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.566 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 3.7 mt-30 -57.13 -82.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.852 -1.155 . . . . 0.0 107.968 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.591 ' O ' HG21 ' A' ' 52' ' ' VAL . 0.1 OUTLIER 165.28 108.87 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.398 -0.814 . . . . 0.0 110.684 178.466 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.541 ' O ' ' CD1' ' A' ' 50' ' ' PHE . . . -74.97 -44.09 50.27 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 146.55 149.18 4.92 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.689 -1.765 . . . . 0.0 108.689 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.621 HG21 ' CG ' ' A' ' 4' ' ' TYR . 38.9 t -88.64 131.44 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.161 -1.199 . . . . 0.0 109.744 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.805 HD12 ' CB ' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -123.85 178.01 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.608 HG22 HG23 ' A' ' 101' ' ' VAL . 2.7 t -138.48 145.85 41.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.813 -1.179 . . . . 0.0 111.195 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.632 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.1 OUTLIER -93.25 76.94 4.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.621 -0.674 . . . . 0.0 109.557 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 92' ' ' HIS . 7.1 t 176.52 -27.25 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.411 -0.806 . . . . 0.0 110.434 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.531 ' HA3' HG21 ' A' ' 101' ' ' VAL . . . -65.14 -7.01 29.19 Favored Glycine 0 N--CA 1.493 2.434 0 O-C-N 121.125 -0.984 . . . . 0.0 110.673 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.994 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . . . -133.71 164.86 26.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.884 -1.362 . . . . 0.0 110.056 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 95' ' ' ALA . 11.1 p -41.7 120.95 1.61 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.58 -0.7 . . . . 0.0 109.26 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.8 -78.0 2.05 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.846 -1.701 . . . . 0.0 108.846 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.632 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -160.52 -68.07 0.07 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.268 -1.137 . . . . 0.0 109.551 179.751 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.994 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 0.3 OUTLIER 57.05 -173.36 0.08 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.135 -0.978 . . . . 0.0 109.142 -179.711 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.805 ' CB ' HD12 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -132.87 113.81 13.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.021 -1.049 . . . . 0.0 110.103 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.608 HG23 HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -123.64 136.74 59.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.334 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.485 ' OE2' ' HB3' ' A' ' 48' ' ' PHE . 2.2 mt-10 -56.11 120.47 7.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.286 -0.884 . . . . 0.0 109.728 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.2 176.33 0.34 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.898 . . . . 0.0 109.462 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 19.0 p . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.972 -1.014 . . . . 0.0 109.588 -179.901 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.465 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.8 p 167.17 115.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.924 . . . . 0.0 109.8 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 14.9 t70 -108.72 4.71 24.06 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.398 -0.814 . . . . 0.0 109.363 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.582 ' CD1' ' HB ' ' A' ' 89' ' ' VAL . 5.4 m-85 -104.99 71.35 0.95 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.548 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 5' ' ' THR . 8.8 t -86.84 124.44 33.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.179 -0.95 . . . . 0.0 109.388 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 92.5 m -122.24 16.66 10.67 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 122.096 0.951 . . . . 0.0 109.684 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 152.73 -62.09 0.39 Allowed Glycine 0 C--N 1.283 -2.383 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.6 m -166.98 36.03 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.347 -1.09 . . . . 0.0 109.065 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.461 ' O ' ' C ' ' A' ' 10' ' ' CYS . 2.0 m-80 -111.44 -27.74 8.49 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.356 -0.84 . . . . 0.0 109.803 -179.565 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.493 ' C ' ' HB2' ' A' ' 2' ' ' CYS . 1.1 t 40.4 76.44 0.07 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.365 -0.834 . . . . 0.0 109.311 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.424 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 2.8 m-85 -79.57 150.34 31.11 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.417 -0.802 . . . . 0.0 109.297 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.992 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -80.47 132.1 35.66 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.432 -0.793 . . . . 0.0 109.62 -179.874 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.2 p -63.33 -13.96 44.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.127 -0.983 . . . . 0.0 109.04 179.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.81 -27.05 13.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.31 -0.869 . . . . 0.0 109.028 179.695 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.525 ' HB2' ' HB2' ' A' ' 12' ' ' SER . 17.8 t0 -74.91 -34.2 62.11 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.278 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.992 HG23 ' O ' ' A' ' 12' ' ' SER . 2.8 t -56.47 -36.67 48.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.13 -41.11 87.46 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.37 -45.66 92.15 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.157 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.814 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -75.97 -8.29 56.6 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.075 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.59 ' OE1' ' CG ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -90.58 -25.96 19.92 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.383 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.96 -13.13 59.17 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.071 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.31 -57.0 3.56 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.605 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -62.11 -25.69 66.62 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 178.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.583 ' CE1' ' O ' ' A' ' 82' ' ' GLU . 10.2 t80 -75.72 -59.87 2.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.477 -1.013 . . . . 0.0 109.451 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 29' ' ' ASP . 1.8 tp60 -55.14 -61.51 2.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.859 . . . . 0.0 109.262 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.804 HD13 ' HB3' ' A' ' 31' ' ' GLU . 2.6 mm? -44.83 -37.3 3.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.392 -0.818 . . . . 0.0 109.57 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.408 ' HB3' ' O ' ' A' ' 24' ' ' TYR . 3.5 t60 -66.14 -54.79 21.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.439 -0.788 . . . . 0.0 111.182 -179.145 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -86.8 13.02 9.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.216 -0.928 . . . . 0.0 110.249 -178.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 8.0 t0 -108.35 -2.81 18.86 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.079 -1.013 . . . . 0.0 109.581 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.71 -8.76 76.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.807 ' O ' HG23 ' A' ' 32' ' ' THR . 2.4 tp10 -97.7 -152.19 0.39 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.231 -1.158 . . . . 0.0 109.474 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.821 HG22 ' CG ' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -177.27 -93.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.165 -0.96 . . . . 0.0 109.411 179.976 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -156.5 -168.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.147 -0.971 . . . . 0.0 109.476 179.835 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 35' ' ' SER . . . -63.67 87.14 0.06 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.535 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.455 ' C ' ' O ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER 40.2 43.27 1.35 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.486 -1.008 . . . . 0.0 109.788 179.772 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.417 ' O ' ' C ' ' A' ' 37' ' ' SER . 2.2 m120 -122.63 -25.25 4.74 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.103 -0.998 . . . . 0.0 109.726 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 36' ' ' ASN . 0.9 OUTLIER 45.27 76.82 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.16 -0.962 . . . . 0.0 109.211 -179.762 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.717 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -98.93 -23.37 0.22 Allowed Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -179.068 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.821 ' CG ' HG22 ' A' ' 32' ' ' THR . 37.5 Cg_endo -80.28 100.87 1.29 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 C-N-CA 121.476 1.451 . . . . 0.0 113.577 -178.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.604 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -127.53 -176.51 3.77 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.12 -0.987 . . . . 0.0 108.722 176.897 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.1 OUTLIER -100.18 144.36 29.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.097 -1.002 . . . . 0.0 109.455 179.94 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.579 ' CE2' ' HA ' ' A' ' 44' ' ' ASN . 4.4 t80 -110.52 135.94 50.42 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.201 -0.937 . . . . 0.0 109.535 -179.655 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.553 ' OD1' ' CD2' ' A' ' 45' ' ' TYR . 2.7 p30 -92.16 3.67 54.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.899 . . . . 0.0 109.893 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.579 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 7.1 p-10 42.22 104.79 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.651 0.738 . . . . 0.0 111.2 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.553 ' CD2' ' OD1' ' A' ' 43' ' ' ASN . 0.9 OUTLIER -131.88 -33.23 1.39 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.071 -1.018 . . . . 0.0 109.823 179.206 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.485 ' OE1' ' CZ ' ' A' ' 48' ' ' PHE . 0.1 OUTLIER -38.17 -53.2 1.44 Allowed 'General case' 0 C--N 1.309 -1.176 0 O-C-N 121.481 -0.762 . . . . 0.0 110.159 -179.556 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.87 48.53 0.04 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.485 ' CZ ' ' OE1' ' A' ' 46' ' ' GLU . 24.8 m-85 -104.61 144.83 31.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -1.141 . . . . 0.0 109.337 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 50' ' ' PHE . 1.1 m-20 -119.07 49.58 1.31 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.292 -0.88 . . . . 0.0 109.433 179.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.502 ' HB2' ' OH ' ' A' ' 56' ' ' TYR . 21.7 m-85 -50.36 -178.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.385 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.1 p -133.93 18.26 3.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -0.859 . . . . 0.0 109.003 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.496 HG21 ' O ' ' A' ' 86' ' ' LEU . 66.6 t -85.74 -82.0 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.372 -0.83 . . . . 0.0 109.532 -179.857 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.31 177.98 10.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.004 -1.06 . . . . 0.0 110.147 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.602 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -79.5 -52.54 1.12 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.473 -0.767 . . . . 0.0 110.884 -179.889 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 54' ' ' SER . 33.1 Cg_endo -73.07 95.11 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.016 1.81 . . . . 0.0 109.844 -177.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.595 ' CE1' ' HB2' ' A' ' 87' ' ' ALA . 5.7 m-85 -95.94 -179.28 4.64 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.63 0.728 . . . . 0.0 110.276 -178.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.577 ' CD2' ' O ' ' A' ' 81' ' ' ASN . 96.5 m-85 -152.73 131.61 12.49 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.392 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.494 ' HG3' ' CD2' ' A' ' 40' ' ' HIS . 0.5 OUTLIER -91.91 142.19 27.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 110.815 -178.837 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.681 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 24.1 t-105 -160.26 137.74 6.99 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.681 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.6 Cg_endo -69.78 149.52 66.89 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.175 1.917 . . . . 0.0 111.423 -179.042 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.975 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -120.5 129.13 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.607 -0.683 . . . . 0.0 109.349 -179.672 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.975 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.4 OUTLIER -118.84 172.29 7.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.287 179.514 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.81 27.79 6.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.117 -0.99 . . . . 0.0 108.847 179.688 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.91 -12.46 17.5 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.564 -0.71 . . . . 0.0 109.318 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.66 -10.22 68.72 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.703 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 2.9 m-20 -97.55 172.95 7.41 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.216 -1.167 . . . . 0.0 110.022 -179.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.509 HG13 ' CZ2' ' A' ' 59' ' ' TRP . 93.7 t -90.09 150.08 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.918 ' HA ' HD11 ' A' ' 62' ' ' LEU . 13.6 t80 -47.31 118.75 2.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.955 -1.091 . . . . 0.0 109.69 -179.479 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.455 ' O ' ' OG ' ' A' ' 69' ' ' SER . 1.7 t -135.38 13.88 3.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.489 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 132.57 140.59 4.48 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 137.86 -128.24 4.18 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.8 p -69.55 120.98 80.77 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.225 -1.162 . . . . 0.0 109.334 179.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.69 -57.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.279 1.986 . . . . 0.0 110.443 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.537 ' HA3' ' CB ' ' A' ' 92' ' ' HIS . . . -97.34 -113.02 3.05 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 91' ' ' THR . . . 60.23 -85.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.352 -1.087 . . . . 0.0 110.561 179.521 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.436 ' C ' ' HD2' ' A' ' 77' ' ' ARG . 36.6 m-20 -122.95 131.5 53.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.848 -1.158 . . . . 0.0 110.39 -179.173 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.523 ' NE ' ' HA2' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -151.88 106.66 3.24 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.331 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 89' ' ' VAL . 7.3 p -78.81 137.98 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 110.454 -178.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.601 HG23 HD13 ' A' ' 90' ' ' ILE . 39.8 t -97.55 166.67 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.01 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.59 ' CG ' ' OE1' ' A' ' 20' ' ' GLN . 5.7 p90 -163.46 -174.33 3.7 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 118.822 -1.151 . . . . 0.0 110.281 -178.002 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.577 ' O ' ' CD2' ' A' ' 57' ' ' TYR . 3.2 t-20 -109.11 -80.13 0.58 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.28 -0.888 . . . . 0.0 109.766 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.583 ' O ' ' CE1' ' A' ' 24' ' ' TYR . 10.8 pt-20 -161.9 23.36 0.11 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 109.448 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.453 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 4.0 t-20 -151.7 51.38 0.81 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.552 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.453 ' CG ' ' O ' ' A' ' 83' ' ' ASN . 16.6 p30 44.86 26.95 0.23 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.477 ' OE1' ' HB3' ' A' ' 81' ' ' ASN . 14.0 mt-30 -64.4 -163.18 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.206 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.496 ' O ' HG21 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -144.48 104.37 4.06 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.787 -1.196 . . . . 0.0 110.573 179.913 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.595 ' HB2' ' CE1' ' A' ' 56' ' ' TYR . . . -81.68 -36.85 28.28 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 150.91 138.34 2.82 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.582 ' HB ' ' CD1' ' A' ' 4' ' ' TYR . 36.9 t -83.04 100.0 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.181 -1.188 . . . . 0.0 109.67 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.627 ' HB ' ' HB3' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -87.01 159.83 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.4 -0.813 . . . . 0.0 108.845 179.481 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.666 HG22 HG23 ' A' ' 101' ' ' VAL . 15.1 t -122.16 159.79 26.47 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.941 -1.099 . . . . 0.0 110.886 -178.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.577 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 0.1 OUTLIER -115.5 71.9 0.78 Allowed 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.434 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.445 ' OG1' ' C ' ' A' ' 92' ' ' HIS . 0.2 OUTLIER -176.61 133.13 0.21 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.416 -0.802 . . . . 0.0 109.294 -179.812 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 94.98 -6.97 69.74 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -120.54 147.29 45.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.157 -1.202 . . . . 0.0 109.727 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 95' ' ' ALA . 49.2 m -44.03 118.09 1.38 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.28 -0.887 . . . . 0.0 108.901 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.486 ' O ' ' C ' ' A' ' 98' ' ' ASN . . . 64.36 43.7 96.47 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.219 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.577 ' O ' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 32.92 40.75 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.987 -0.714 . . . . 0.0 110.446 179.711 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 97' ' ' GLY . 3.0 t-20 -54.69 167.55 0.35 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.141 -0.975 . . . . 0.0 109.279 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.627 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -74.83 150.38 39.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.132 -0.98 . . . . 0.0 109.344 179.993 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.666 HG23 HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -161.02 122.54 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.417 -0.802 . . . . 0.0 109.086 179.687 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 3.6 pt-20 -41.8 131.48 3.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.387 -0.821 . . . . 0.0 109.861 -179.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.457 ' SG ' ' HB ' ' A' ' 91' ' ' THR . 0.7 OUTLIER -92.81 121.41 34.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.37 -0.831 . . . . 0.0 109.253 -179.981 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.8 p . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.623 -1.18 . . . . 0.0 109.445 179.955 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.495 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.6 p 166.49 138.06 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.169 -0.957 . . . . 0.0 110.141 179.705 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -115.4 -20.05 10.44 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.381 -0.824 . . . . 0.0 109.069 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.659 ' CG ' HG21 ' A' ' 89' ' ' VAL . 13.7 m-85 -95.65 109.71 21.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.313 -0.867 . . . . 0.0 109.371 179.839 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.475 HG22 ' C ' ' A' ' 9' ' ' ASN . 1.2 p -144.25 143.79 31.2 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.966 . . . . 0.0 109.642 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.61 8.16 4.92 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.148 0.975 . . . . 0.0 109.904 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.28 55.2 0.2 Allowed Glycine 0 C--N 1.278 -2.69 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m 55.15 19.06 2.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.45 -1.029 . . . . 0.0 109.134 -179.524 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.475 ' C ' HG22 ' A' ' 5' ' ' THR . 0.6 OUTLIER -75.07 -156.88 0.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.434 -0.791 . . . . 0.0 109.091 179.929 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.4 t -155.49 58.14 0.63 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.117 -0.99 . . . . 0.0 109.766 -180.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.494 ' CZ ' ' HB3' ' A' ' 63' ' ' SER . 3.3 m-85 -84.51 115.3 22.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.341 -0.849 . . . . 0.0 108.925 179.527 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.699 ' O ' HG23 ' A' ' 16' ' ' VAL . 30.2 t -81.71 136.17 35.48 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.252 -0.905 . . . . 0.0 110.222 -179.259 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.1 p -49.05 -31.41 7.7 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.497 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.2 t -70.64 -40.99 72.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.532 -0.73 . . . . 0.0 109.278 179.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -66.42 -30.25 70.57 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.172 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 12' ' ' SER . 3.2 t -68.35 -32.9 57.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 119.519 -0.872 . . . . 0.0 108.823 179.315 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.8 -46.68 77.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.481 -0.762 . . . . 0.0 109.584 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.63 -55.66 28.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.2 -0.937 . . . . 0.0 109.251 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.932 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -72.05 -3.51 23.4 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.388 -0.82 . . . . 0.0 109.37 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.65 ' OE1' HG22 ' A' ' 78' ' ' VAL . 6.3 tp60 -100.96 -15.96 17.33 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 179.333 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.474 ' HA ' ' OD1' ' A' ' 84' ' ' ASN . . . -93.12 -15.1 26.4 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.05 -47.67 23.82 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.444 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -60.89 -24.91 63.23 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 179.351 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.435 ' CD2' ' OD1' ' A' ' 84' ' ' ASN . 19.9 t80 -83.21 -36.05 24.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.521 -0.987 . . . . 0.0 109.26 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -49.89 72.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.304 -0.872 . . . . 0.0 108.838 179.492 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.465 ' HA ' HD12 ' A' ' 26' ' ' LEU . 0.5 OUTLIER -61.61 -40.57 95.28 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.313 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.51 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 2.2 t60 -62.52 -20.9 65.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.389 -0.819 . . . . 0.0 109.42 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.79 -30.85 16.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.948 . . . . 0.0 109.806 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.77 9.91 33.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.127 -0.983 . . . . 0.0 109.46 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 46.8 24.12 1.75 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.1 -137.59 0.09 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.211 -1.17 . . . . 0.0 109.016 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.888 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -173.59 170.34 4.1 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.899 -1.126 . . . . 0.0 109.45 -179.938 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.489 HG21 ' CE1' ' A' ' 68' ' ' TYR . 33.2 m -83.26 -138.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.316 -0.865 . . . . 0.0 109.276 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.446 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -46.88 -49.35 17.43 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.75 -32.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.487 -1.007 . . . . 0.0 109.188 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -69.47 -8.82 50.21 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.386 -0.821 . . . . 0.0 109.79 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.888 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.8 OUTLIER 67.66 -172.69 0.19 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.096 -1.002 . . . . 0.0 108.908 -179.64 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.585 ' CD1' ' HD3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER 167.53 -45.05 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.186 -0.946 . . . . 0.0 112.435 179.114 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.567 ' HD2' ' H ' ' A' ' 38' ' ' TYR . 32.3 Cg_endo -74.71 100.37 1.33 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 121.416 1.41 . . . . 0.0 112.538 -178.512 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.549 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -142.53 -174.04 4.03 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.674 -0.641 . . . . 0.0 109.535 178.463 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.635 ' HB2' ' CE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -94.66 124.16 38.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.346 -0.846 . . . . 0.0 109.903 -179.398 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.47 ' CE1' ' CZ ' ' A' ' 100' ' ' PHE . 10.5 t80 -105.8 143.59 33.74 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.118 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.577 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 74.0 m-20 -78.47 -106.61 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.905 -1.122 . . . . 0.0 109.287 -179.674 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.577 ' CB ' ' O ' ' A' ' 43' ' ' ASN . 5.9 p30 154.42 95.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.478 -0.764 . . . . 0.0 109.188 179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 1.4 p90 -124.6 -28.15 3.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -0.981 . . . . 0.0 109.632 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.493 ' OE1' HG12 ' A' ' 101' ' ' VAL . 1.9 tm-20 -40.62 -65.7 0.39 Allowed 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.383 -0.823 . . . . 0.0 109.909 -179.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.92 59.75 0.01 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.43 ' CE1' ' HA ' ' A' ' 101' ' ' VAL . 84.8 m-85 -98.63 154.76 17.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.31 -1.112 . . . . 0.0 109.3 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.58 45.16 2.51 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.266 -0.897 . . . . 0.0 109.273 179.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.538 ' CG ' ' O ' ' A' ' 87' ' ' ALA . 14.4 m-85 -61.37 -167.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 109.869 -179.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.07 27.75 0.85 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.523 -0.736 . . . . 0.0 109.213 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.972 HG11 ' ND2' ' A' ' 81' ' ' ASN . 93.7 t -101.05 -80.08 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.191 -0.943 . . . . 0.0 109.741 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.463 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 86.6 p -158.39 178.01 10.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.169 -0.957 . . . . 0.0 110.189 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.62 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -83.3 -46.94 0.81 Allowed Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.592 -0.692 . . . . 0.0 111.536 -179.558 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 54' ' ' SER . 32.0 Cg_endo -73.03 83.93 1.37 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.899 1.733 . . . . 0.0 110.409 -178.004 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.583 ' CE1' ' CB ' ' A' ' 87' ' ' ALA . 10.1 m-85 -86.23 -175.22 5.42 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.826 0.822 . . . . 0.0 110.769 -179.156 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.635 ' CE2' ' HB2' ' A' ' 41' ' ' LYS . 47.8 m-85 -151.96 126.09 9.22 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -88.1 138.42 31.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.921 -1.112 . . . . 0.0 110.627 -178.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.665 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 21.1 t-105 -160.62 138.55 7.18 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 179.407 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.665 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.6 Cg_endo -69.54 154.47 68.56 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.33 2.02 . . . . 0.0 111.496 -178.817 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 1.008 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -129.12 129.07 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.594 -0.691 . . . . 0.0 109.823 -179.17 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.008 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -123.15 167.65 13.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.243 -0.911 . . . . 0.0 108.776 179.191 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . 84.1 p -127.92 65.97 1.36 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.101 -0.999 . . . . 0.0 109.355 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.23 25.34 0.11 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.391 -0.818 . . . . 0.0 109.57 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 51.1 45.26 51.58 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -121.89 -27.73 4.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.316 -1.108 . . . . 0.0 109.669 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.582 HG12 ' H ' ' A' ' 68' ' ' TYR . 2.5 t 62.37 174.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.14 -0.975 . . . . 0.0 109.153 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.6 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 29.0 t80 -96.4 106.0 18.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.078 -1.014 . . . . 0.0 109.682 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.48 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 0.8 OUTLIER -151.89 21.27 0.69 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.353 -0.842 . . . . 0.0 109.366 -179.977 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.17 -91.06 1.44 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.82 57.21 0.04 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.521 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -140.58 63.04 20.16 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.236 -1.155 . . . . 0.0 109.224 179.894 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.566 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 34.8 Cg_endo -78.62 163.46 26.66 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.856 2.371 . . . . 0.0 111.051 -179.607 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.564 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 131.47 133.34 3.47 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.969 -1.11 . . . . 0.0 110.544 179.236 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 70.41 -150.57 0.1 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.431 -1.041 . . . . 0.0 110.971 178.779 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.535 ' C ' ' O ' ' A' ' 75' ' ' ALA . 96.2 m-20 -7.08 126.46 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 CA-C-O 121.686 0.755 . . . . 0.0 112.837 -179.317 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.508 ' O ' HG12 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -161.89 80.71 0.56 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.962 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.694 HG21 ' CG1' ' A' ' 16' ' ' VAL . 7.5 p -62.47 145.54 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.87 -1.144 . . . . 0.0 109.303 -179.587 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.613 HG12 ' N ' ' A' ' 80' ' ' PHE . 68.2 t -113.06 165.78 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.346 -0.847 . . . . 0.0 109.843 -179.463 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.627 ' CD1' ' NE2' ' A' ' 20' ' ' GLN . 2.1 p90 -156.25 -174.98 5.19 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.56 -178.483 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.972 ' ND2' HG11 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -116.22 -82.07 0.62 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.061 -1.025 . . . . 0.0 109.967 -179.576 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -153.08 10.64 0.46 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.358 -0.839 . . . . 0.0 110.401 -179.417 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.456 ' HB3' ' HG2' ' A' ' 85' ' ' GLN . 45.3 t-20 -135.06 7.32 3.42 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.175 -0.953 . . . . 0.0 108.835 179.309 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.474 ' OD1' ' HA ' ' A' ' 21' ' ' ALA . 6.2 m-80 72.28 9.36 5.88 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.373 -0.829 . . . . 0.0 109.451 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.524 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 1.8 mm100 -49.38 -92.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.555 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.753 ' O ' HG21 ' A' ' 52' ' ' VAL . 0.1 OUTLIER 170.72 106.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 0.0 110.716 178.681 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.583 ' CB ' ' CE1' ' A' ' 56' ' ' TYR . . . -82.72 -30.86 28.81 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.292 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.503 ' O ' HG23 ' A' ' 78' ' ' VAL . . . 146.9 -165.96 28.43 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.659 HG21 ' CG ' ' A' ' 4' ' ' TYR . 73.3 t -134.1 102.24 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.312 -1.111 . . . . 0.0 109.203 179.748 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.534 ' HB ' ' HB2' ' A' ' 100' ' ' PHE . 0.4 OUTLIER -104.5 153.99 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 109.273 -179.731 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 100' ' ' PHE . 10.2 t -122.65 137.33 54.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.095 -1.003 . . . . 0.0 110.275 -179.455 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.438 ' CE1' ' CD2' ' A' ' 100' ' ' PHE . 1.8 m-70 -80.6 75.33 7.49 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.428 -0.795 . . . . 0.0 108.908 179.175 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.5 t -173.97 158.41 3.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.544 -0.723 . . . . 0.0 109.393 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 87.04 -14.58 56.91 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.802 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . . . -131.67 114.78 15.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -1.137 . . . . 0.0 109.22 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.468 ' O ' ' C ' ' A' ' 97' ' ' GLY . 7.4 p 46.09 -160.5 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.008 -1.058 . . . . 0.0 108.963 -179.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 96' ' ' SER . . . -40.38 -45.12 3.25 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.468 ' O ' ' O ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -155.68 -74.89 0.1 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.213 -1.169 . . . . 0.0 109.506 179.517 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.802 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 1.3 m-80 62.34 132.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.153 -0.967 . . . . 0.0 108.62 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.534 ' HB2' ' HB ' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -92.75 141.52 28.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.921 -1.112 . . . . 0.0 109.851 -179.79 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.493 HG12 ' OE1' ' A' ' 46' ' ' GLU . 4.2 m -152.12 148.94 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.793 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 101' ' ' VAL . 0.6 OUTLIER -43.44 141.1 1.46 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.09 -1.006 . . . . 0.0 109.64 -179.675 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -55.04 144.18 24.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.399 -0.813 . . . . 0.0 109.597 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.488 1.472 0 O-C-N 121.245 -0.909 . . . . 0.0 109.514 179.891 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.321 0.581 . . . . 0.0 109.666 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 28.9 p 178.18 105.87 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.378 -0.826 . . . . 0.0 109.606 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -68.31 -52.39 34.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.97 -1.081 . . . . 0.0 109.147 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.595 ' CB ' HG21 ' A' ' 89' ' ' VAL . 60.3 m-85 -92.95 105.92 17.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.411 -0.806 . . . . 0.0 109.347 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 9' ' ' ASN . 2.3 t -134.26 128.66 34.29 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.945 -1.097 . . . . 0.0 109.836 -179.866 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.484 ' SG ' ' OG1' ' A' ' 91' ' ' THR . 2.0 t -96.34 -164.79 1.19 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.357 -0.84 . . . . 0.0 109.036 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.404 ' O ' ' CB ' ' A' ' 8' ' ' SER . . . -54.26 96.26 0.03 OUTLIER Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -179.126 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.52 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 0.8 OUTLIER 70.07 54.01 0.35 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.361 -1.082 . . . . 0.0 109.837 179.272 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 8' ' ' SER . 2.1 m120 -155.69 89.42 1.17 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.398 -0.813 . . . . 0.0 109.182 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.423 ' C ' ' CB ' ' A' ' 2' ' ' CYS . 0.4 OUTLIER -74.51 79.63 1.95 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.385 -0.822 . . . . 0.0 109.181 -179.599 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.524 ' CZ ' ' HB2' ' A' ' 63' ' ' SER . 3.2 m-85 -94.46 126.09 39.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.043 -1.036 . . . . 0.0 109.131 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.635 ' O ' HG23 ' A' ' 16' ' ' VAL . 18.6 t -89.35 130.28 35.75 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 110.118 -179.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.523 ' HG ' ' HE2' ' A' ' 4' ' ' TYR . 4.2 t -46.22 -25.84 0.68 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.505 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.7 t -69.09 -47.4 65.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.4 -0.812 . . . . 0.0 109.314 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -26.49 65.53 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.129 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 12' ' ' SER . 13.5 t -69.09 -36.03 71.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.263 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.2 t -56.64 -47.04 80.59 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.452 -0.78 . . . . 0.0 109.668 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.08 -54.03 51.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.025 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.566 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -68.22 -12.24 60.64 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.454 -0.779 . . . . 0.0 109.061 179.545 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.545 ' HA ' ' NE2' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -83.56 -27.82 29.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 0.0 108.647 179.605 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.84 -14.16 54.82 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.428 -0.795 . . . . 0.0 108.881 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.76 -56.01 5.09 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.416 -0.802 . . . . 0.0 109.355 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.612 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -66.82 -28.13 73.64 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.578 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.437 ' CE1' ' O ' ' A' ' 82' ' ' GLU . 7.0 t80 -71.89 -40.06 69.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.538 -0.977 . . . . 0.0 109.614 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.88 -51.95 54.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.049 -1.032 . . . . 0.0 109.389 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.537 ' HB3' ' CG ' ' A' ' 39' ' ' PRO . 0.8 OUTLIER -52.18 -44.02 64.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.298 -0.876 . . . . 0.0 109.404 179.768 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.624 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 3.1 t60 -53.01 -53.73 45.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.414 -0.804 . . . . 0.0 110.14 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -82.73 -1.58 51.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.331 -0.856 . . . . 0.0 109.802 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -92.67 -1.5 56.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.719 -179.836 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 51.06 37.6 37.24 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.507 ' O ' HG23 ' A' ' 32' ' ' THR . 3.1 tp10 -128.67 -152.46 0.52 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.34 -1.094 . . . . 0.0 109.367 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.751 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.6 OUTLIER -159.28 -175.91 5.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.337 -0.852 . . . . 0.0 109.197 179.901 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 35' ' ' SER . 16.6 m -130.72 160.56 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.033 -1.042 . . . . 0.0 109.803 -179.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 53.28 -89.2 0.01 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 33' ' ' VAL . 2.1 p -177.29 25.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.324 -1.103 . . . . 0.0 109.99 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -147.84 13.16 1.02 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.056 -1.027 . . . . 0.0 109.514 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.751 ' HA ' HG22 ' A' ' 32' ' ' THR . 3.3 p 64.4 -170.25 0.19 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -0.879 . . . . 0.0 109.542 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.585 ' H ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER 170.33 -44.99 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.419 -0.801 . . . . 0.0 111.66 178.621 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.585 ' HD2' ' H ' ' A' ' 38' ' ' TYR . 34.2 Cg_endo -77.36 101.08 1.46 Allowed 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 121.314 1.342 . . . . 0.0 111.858 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.584 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -138.56 -175.27 4.07 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.396 -0.815 . . . . 0.0 109.546 178.65 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -78.55 141.97 37.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.366 -0.834 . . . . 0.0 109.73 -179.563 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.599 ' CZ ' ' HA ' ' A' ' 44' ' ' ASN . 13.7 t80 -100.61 128.86 46.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.412 -0.805 . . . . 0.0 109.284 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 44' ' ' ASN . 1.7 t30 -93.4 -4.75 50.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.192 -0.942 . . . . 0.0 109.636 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.599 ' HA ' ' CZ ' ' A' ' 42' ' ' TYR . 0.5 OUTLIER 40.06 93.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.486 -0.759 . . . . 0.0 109.951 179.952 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.464 ' O ' ' C ' ' A' ' 46' ' ' GLU . 75.4 m-85 -86.77 -38.43 16.9 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.35 -0.844 . . . . 0.0 109.842 -179.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.501 ' OE1' ' CE1' ' A' ' 48' ' ' PHE . 0.9 OUTLIER -38.7 -46.53 1.25 Allowed 'General case' 0 C--N 1.309 -1.193 0 O-C-N 121.413 -0.804 . . . . 0.0 110.039 -179.593 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.5 62.44 0.57 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 -179.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.501 ' CE1' ' OE1' ' A' ' 46' ' ' GLU . 51.7 m-85 -97.32 179.9 4.73 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.28 -1.13 . . . . 0.0 108.987 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -117.12 -41.98 2.96 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.221 -0.924 . . . . 0.0 108.89 179.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.581 ' CD2' ' HB1' ' A' ' 87' ' ' ALA . 4.4 m-85 47.33 -170.92 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.481 -0.762 . . . . 0.0 109.777 179.549 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -146.55 20.22 1.33 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.477 -0.764 . . . . 0.0 108.961 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.529 ' HB ' ' CE1' ' A' ' 56' ' ' TYR . 46.9 t -92.91 -83.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.366 -0.834 . . . . 0.0 109.569 -179.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.519 ' N ' HG12 ' A' ' 52' ' ' VAL . 69.9 m -166.87 -175.66 3.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.129 -0.982 . . . . 0.0 109.985 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.601 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -79.07 -51.19 1.32 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.51 -0.743 . . . . 0.0 111.007 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 54' ' ' SER . 33.3 Cg_endo -73.44 89.1 0.96 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.911 1.741 . . . . 0.0 109.768 -177.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.639 ' CE1' ' HB2' ' A' ' 87' ' ' ALA . 5.9 m-85 -90.04 -168.63 2.18 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.581 0.705 . . . . 0.0 110.144 -178.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.624 ' CE1' ' NE2' ' A' ' 27' ' ' HIS . 72.9 m-85 -158.66 120.29 3.48 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.176 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -88.68 137.9 31.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 110.838 -178.721 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.677 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 41.0 t-105 -161.03 137.8 6.45 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.416 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.677 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 33.1 Cg_endo -71.66 148.43 53.07 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.242 1.961 . . . . 0.0 111.446 -178.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.955 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -111.53 125.48 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.855 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.955 HD23 ' C ' ' A' ' 61' ' ' ILE . 1.5 mt -121.06 165.53 15.18 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.11 -0.994 . . . . 0.0 109.537 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.524 ' HB2' ' CZ ' ' A' ' 11' ' ' TYR . 22.9 t -129.16 48.0 2.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.469 -0.769 . . . . 0.0 109.252 179.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.35 21.8 3.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.406 -0.809 . . . . 0.0 109.396 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 54.74 44.2 80.31 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.57 116.28 5.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -1.132 . . . . 0.0 109.534 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.598 HG13 ' CZ2' ' A' ' 59' ' ' TRP . 54.3 t -54.51 148.48 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.209 -0.932 . . . . 0.0 109.43 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.574 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 58.5 t80 -56.91 154.13 9.95 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.226 -0.921 . . . . 0.0 109.572 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.414 ' N ' ' CG ' ' A' ' 68' ' ' TYR . 1.2 t -158.68 -53.2 0.06 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.361 -0.837 . . . . 0.0 109.383 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -166.31 79.49 0.12 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 72' ' ' SER . . . 162.06 142.56 3.43 Favored Glycine 0 N--CA 1.49 2.279 0 O-C-N 121.113 -1.228 . . . . 0.0 110.055 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.536 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 1.7 m 42.99 61.65 9.39 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.429 -1.042 . . . . 0.0 110.033 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.536 ' HD3' ' N ' ' A' ' 72' ' ' SER . 36.3 Cg_endo -78.89 -48.21 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.627 2.218 . . . . 0.0 110.551 179.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.495 ' CA ' ' CB ' ' A' ' 92' ' ' HIS . . . -82.06 -135.66 2.13 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.544 ' N ' ' HB2' ' A' ' 92' ' ' HIS . . . 64.76 -83.78 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.448 -1.031 . . . . 0.0 110.552 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.476 ' OD1' ' HB2' ' A' ' 6' ' ' CYS . 6.1 m-20 -119.02 139.99 50.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.757 -1.214 . . . . 0.0 109.956 -179.357 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.485 ' O ' HG12 ' A' ' 90' ' ' ILE . 69.0 mtt180 -152.09 134.19 15.03 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.596 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.0 p -114.36 138.98 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.062 -1.024 . . . . 0.0 109.288 179.771 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.606 HG12 ' N ' ' A' ' 80' ' ' PHE . 43.1 t -104.51 167.46 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.36 -0.838 . . . . 0.0 109.654 -179.618 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.606 ' N ' HG12 ' A' ' 79' ' ' VAL . 4.4 p90 -163.95 -172.82 2.95 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.398 -178.169 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.462 ' O ' ' HB3' ' A' ' 82' ' ' GLU . 46.7 t-20 -122.06 -46.52 2.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.018 -1.051 . . . . 0.0 109.653 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 81' ' ' ASN . 5.2 pt-20 166.85 -27.3 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.46 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 1.4 m-20 -100.37 27.54 5.65 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.074 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 83' ' ' ASN . 2.5 p-10 46.24 27.52 0.57 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.358 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.568 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 1.2 mt-30 -54.65 -32.02 58.47 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.568 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 85.94 105.25 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.587 0.708 . . . . 0.0 110.532 179.075 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.639 ' HB2' ' CE1' ' A' ' 56' ' ' TYR . . . -80.49 -43.44 20.82 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 156.19 159.04 9.15 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.595 HG21 ' CB ' ' A' ' 4' ' ' TYR . 58.1 t -96.39 92.37 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.185 -1.185 . . . . 0.0 109.706 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.645 HD12 ' CB ' ' A' ' 100' ' ' PHE . 0.4 OUTLIER -78.83 173.65 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.576 -0.703 . . . . 0.0 109.33 179.736 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.504 HG22 HG23 ' A' ' 101' ' ' VAL . 5.6 t -132.25 146.04 51.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.04 -1.038 . . . . 0.0 111.013 -179.035 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.592 ' CD2' ' HB2' ' A' ' 98' ' ' ASN . 0.1 OUTLIER -93.39 62.72 3.44 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.363 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 93' ' ' THR . 2.6 t 178.92 24.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.806 -179.29 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -131.44 27.22 3.78 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.729 ' HB3' ' CB ' ' A' ' 99' ' ' ASN . . . -158.92 97.28 1.4 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.222 -1.164 . . . . 0.0 110.533 -179.65 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.47 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER 36.33 54.32 1.03 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.802 -0.561 . . . . 0.0 110.331 179.316 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 93' ' ' THR . . . 122.92 -87.72 0.4 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.592 ' HB2' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -138.16 -69.52 0.44 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.181 -1.188 . . . . 0.0 109.828 179.949 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.729 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . 1.1 t30 44.82 -167.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 0.0 108.774 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.645 ' CB ' HD12 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -130.12 114.83 16.22 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.838 -1.164 . . . . 0.0 110.805 179.916 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.504 HG23 HG22 ' A' ' 91' ' ' THR . 1.6 m -130.27 128.03 63.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.375 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 101' ' ' VAL . 4.0 mt-10 -42.98 105.66 0.05 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.331 -0.856 . . . . 0.0 109.879 -179.416 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.7 107.27 3.4 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.299 -0.876 . . . . 0.0 109.562 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 109.402 179.982 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.223 0.535 . . . . 0.0 109.767 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.7 p 164.96 99.62 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.259 -0.9 . . . . 0.0 110.06 179.559 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -78.78 -2.9 41.73 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.394 -0.816 . . . . 0.0 108.992 179.472 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.597 ' CD2' HG21 ' A' ' 89' ' ' VAL . 8.0 m-85 -118.9 107.04 13.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.949 . . . . 0.0 109.681 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.607 HG23 ' O ' ' A' ' 9' ' ' ASN . 56.0 m -142.38 143.04 32.52 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.429 ' SG ' ' OD1' ' A' ' 76' ' ' ASP . 80.8 m -123.51 15.31 9.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.048 -1.033 . . . . 0.0 110.339 -179.499 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.555 ' H ' HG22 ' A' ' 5' ' ' THR . . . 167.29 -88.56 0.1 OUTLIER Glycine 0 C--N 1.28 -2.554 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.43 26.67 7.24 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.351 -1.087 . . . . 0.0 109.504 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.607 ' O ' HG23 ' A' ' 5' ' ' THR . 2.5 m-80 -106.58 131.63 53.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.706 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 1' ' ' ALA . 43.3 t -104.28 75.95 1.29 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.53 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 3.5 m-85 -83.48 126.48 32.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.852 . . . . 0.0 110.253 -179.139 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.747 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.7 OUTLIER -81.92 125.83 31.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.645 -0.659 . . . . 0.0 109.65 179.851 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.49 -22.93 0.82 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.16 -0.963 . . . . 0.0 109.194 179.659 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.97 -39.43 26.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.94 . . . . 0.0 110.097 -179.704 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.34 -35.1 75.58 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 12' ' ' SER . 2.9 t -58.81 -26.41 32.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.057 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.7 t -63.09 -43.98 97.02 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.519 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -34.47 77.97 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.083 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.888 ' CB ' HD13 ' A' ' 61' ' ' ILE . . . -84.8 -10.04 57.58 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.059 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.512 ' NE2' ' O ' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -91.88 -21.49 20.58 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.272 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.514 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -88.32 -8.84 54.49 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 26' ' ' LEU . . . -81.04 -56.16 4.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.12 -0.988 . . . . 0.0 108.835 179.679 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.439 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -61.8 -20.46 59.74 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 179.384 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.578 ' CE1' ' HA ' ' A' ' 82' ' ' GLU . 34.0 t80 -87.28 -69.84 0.66 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.375 -1.073 . . . . 0.0 109.565 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.514 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -42.54 -52.7 4.66 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.257 -0.902 . . . . 0.0 109.398 179.9 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.636 HD13 ' CB ' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -56.92 -42.63 80.3 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.427 -0.796 . . . . 0.0 109.155 179.837 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.525 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 5.3 t60 -53.65 -52.67 59.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.352 -0.843 . . . . 0.0 110.102 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 39.5 tp10 -84.38 -2.53 57.28 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.138 -0.976 . . . . 0.0 109.575 -179.56 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.435 ' HB3' ' HA ' ' A' ' 26' ' ' LEU . 38.0 t70 -94.93 -7.81 38.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.175 -0.953 . . . . 0.0 109.365 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.26 -40.12 3.04 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.746 ' O ' HG23 ' A' ' 32' ' ' THR . 1.1 mp0 -65.64 -173.9 0.18 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -1.138 . . . . 0.0 109.277 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 31' ' ' GLU . 7.2 p -161.53 -94.75 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.181 -0.95 . . . . 0.0 109.503 179.595 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.409 ' CG1' ' HB2' ' A' ' 38' ' ' TYR . 3.5 m -135.62 -114.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.982 -1.074 . . . . 0.0 109.785 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.516 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -97.42 44.75 1.83 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.5 OUTLIER 76.19 24.33 1.14 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.446 -1.032 . . . . 0.0 109.547 179.886 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -119.73 7.54 11.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -0.903 . . . . 0.0 109.677 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.453 ' HA ' ' CB ' ' A' ' 32' ' ' THR . 52.1 p 45.32 88.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.252 -0.905 . . . . 0.0 109.88 179.94 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.623 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -91.61 -40.2 0.38 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.314 -0.866 . . . . 0.0 111.736 -179.686 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 33.7 Cg_endo -76.08 109.76 2.94 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 120.986 1.124 . . . . 0.0 110.086 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.578 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -128.27 -173.23 2.89 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.203 -179.396 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -103.37 141.95 35.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.093 -1.004 . . . . 0.0 110.059 -179.622 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.485 ' CE2' ' HA ' ' A' ' 44' ' ' ASN . 68.3 t80 -107.05 160.09 15.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.205 -0.934 . . . . 0.0 109.228 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.564 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 0.4 OUTLIER -109.95 -84.98 0.55 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.095 -1.003 . . . . 0.0 109.776 -179.91 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.581 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 6.1 p30 155.99 135.07 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.581 ' CD1' ' O ' ' A' ' 44' ' ' ASN . 19.6 m-85 -152.41 -64.88 0.17 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.068 -1.02 . . . . 0.0 109.414 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -40.64 -53.87 2.68 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.374 -0.829 . . . . 0.0 109.529 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 48' ' ' PHE . . . 140.52 -73.66 0.38 Allowed Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.613 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.584 ' HB3' ' CE2' ' A' ' 50' ' ' PHE . 70.7 m-85 66.91 157.09 0.11 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.406 -1.055 . . . . 0.0 108.389 -179.873 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -108.71 27.78 9.08 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.715 -1.194 . . . . 0.0 110.381 -178.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.584 ' CE2' ' HB3' ' A' ' 48' ' ' PHE . 8.1 p90 -125.22 -174.32 3.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.984 -1.073 . . . . 0.0 109.697 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -170.08 54.81 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.268 -0.895 . . . . 0.0 109.304 -179.679 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.513 ' HB ' ' CE1' ' A' ' 56' ' ' TYR . 29.9 t -43.45 -66.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.198 -0.939 . . . . 0.0 109.524 -179.82 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.486 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -164.18 -172.89 2.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.135 -0.978 . . . . 0.0 109.767 -179.816 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.571 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -79.6 -54.97 0.9 Allowed Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.266 -0.896 . . . . 0.0 111.223 -179.255 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 54' ' ' SER . 34.4 Cg_endo -72.42 87.02 0.95 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.877 1.718 . . . . 0.0 109.979 -178.114 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.676 ' HE1' ' HB2' ' A' ' 87' ' ' ALA . 9.3 m-85 -87.13 178.1 7.0 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.233 0.54 . . . . 0.0 109.639 -179.38 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 41' ' ' LYS . 94.0 m-85 -156.71 129.56 7.77 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.364 -0.835 . . . . 0.0 109.576 179.62 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.517 ' HG3' ' ND1' ' A' ' 40' ' ' HIS . 0.2 OUTLIER -99.86 138.18 37.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -0.94 . . . . 0.0 109.663 -179.933 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.655 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 21.1 t-105 -155.69 136.64 9.1 Favored Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.655 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.8 Cg_endo -71.5 137.29 30.24 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 C-N-CA 122.168 1.912 . . . . 0.0 111.801 -178.224 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 1.013 HD12 ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -110.93 133.51 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.96 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.013 ' N ' HD12 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -131.93 158.69 40.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -0.9 . . . . 0.0 109.158 179.921 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 98.1 p -122.83 27.4 7.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.911 . . . . 0.0 108.88 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -153.87 -39.08 0.1 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.454 -0.779 . . . . 0.0 109.356 -179.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 66' ' ' ASP . . . -88.98 -9.99 67.1 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.839 ' OD1' HG23 ' A' ' 67' ' ' VAL . 67.8 t0 48.09 96.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -1.124 . . . . 0.0 109.56 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.839 HG23 ' OD1' ' A' ' 66' ' ' ASP . 2.9 t 75.62 135.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.545 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.568 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 45.9 t80 -81.39 150.34 28.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.903 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.451 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 4.8 t -165.47 -42.3 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.422 -0.799 . . . . 0.0 109.285 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -158.09 124.49 1.4 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.89 -145.29 12.65 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.85 107.77 60.9 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.285 -1.126 . . . . 0.0 109.636 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.477 ' CB ' ' OH ' ' A' ' 38' ' ' TYR . 35.7 Cg_endo -77.12 -175.63 2.76 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.534 2.156 . . . . 0.0 110.534 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.64 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 93.35 -175.64 36.3 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 71.52 -144.91 0.06 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.141 -1.211 . . . . 0.0 110.108 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.429 ' OD1' ' SG ' ' A' ' 6' ' ' CYS . 5.7 m-20 -44.11 151.54 0.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.354 -0.841 . . . . 0.0 110.986 -179.135 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.525 ' NH2' ' CE1' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -164.95 111.84 0.99 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.104 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.815 HG21 HD21 ' A' ' 86' ' ' LEU . 13.9 p -92.56 129.25 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.821 -1.175 . . . . 0.0 110.312 -178.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.622 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 55.2 t -98.39 167.36 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.467 -0.771 . . . . 0.0 109.145 179.569 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.616 ' N ' HG12 ' A' ' 79' ' ' VAL . 4.7 p90 -168.48 -170.76 1.3 Allowed 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.662 -178.082 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.456 ' ND2' ' CB ' ' A' ' 53' ' ' SER . 1.0 OUTLIER -129.71 -42.4 1.29 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.172 -0.955 . . . . 0.0 110.056 -179.341 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.578 ' HA ' ' CE1' ' A' ' 24' ' ' TYR . 7.6 pt-20 166.26 -27.31 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.737 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.46 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -100.84 26.08 7.27 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.489 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.469 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 8.5 p30 48.7 25.27 0.95 Allowed 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.45 0.643 . . . . 0.0 109.636 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.535 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 3.0 mt-30 -55.35 -36.16 66.01 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.815 HD21 HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER 83.59 104.11 0.05 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.557 0.694 . . . . 0.0 110.694 179.142 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.676 ' HB2' ' HE1' ' A' ' 56' ' ' TYR . . . -76.81 -34.0 57.96 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.783 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 150.34 151.52 5.56 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.597 HG21 ' CD2' ' A' ' 4' ' ' TYR . 85.9 t -89.34 88.07 2.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.268 -1.136 . . . . 0.0 109.696 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.555 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 0.8 OUTLIER -78.97 158.26 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.276 -0.89 . . . . 0.0 108.789 179.681 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.467 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 9.5 t -119.22 168.48 10.84 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.043 -1.036 . . . . 0.0 110.642 -179.1 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.58 ' CD2' ' O ' ' A' ' 98' ' ' ASN . 0.3 OUTLIER -120.98 68.98 0.88 Allowed 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 3.1 m -175.75 -30.37 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.401 -0.812 . . . . 0.0 110.183 -179.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.42 17.17 40.41 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.161 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.653 ' HB2' HG11 ' A' ' 101' ' ' VAL . . . -153.98 121.2 5.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -1.164 . . . . 0.0 109.482 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.476 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.9 OUTLIER 39.28 -156.38 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.367 -0.833 . . . . 0.0 109.49 179.68 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 96' ' ' SER . . . -41.39 -59.99 2.49 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 179.341 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.58 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -167.43 32.65 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.243 -1.151 . . . . 0.0 109.27 179.251 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.436 ' O ' ' O ' ' A' ' 98' ' ' ASN . 1.4 t30 -48.14 173.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.99 -1.068 . . . . 0.0 109.251 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.555 ' HB3' ' CG1' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -100.13 144.13 29.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.1 -1.0 . . . . 0.0 109.528 -179.94 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.653 HG11 ' HB2' ' A' ' 95' ' ' ALA . 10.3 m -158.02 137.19 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.377 -0.827 . . . . 0.0 108.899 179.624 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.87 96.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.098 -1.001 . . . . 0.0 109.554 -179.59 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.467 ' SG ' ' HB ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -48.41 126.77 11.97 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.298 -0.876 . . . . 0.0 109.464 179.832 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.837 -1.078 . . . . 0.0 109.483 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.471 ' O ' ' SG ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.541 0.686 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 31.4 p 38.93 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.912 0.863 . . . . 0.0 110.264 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -102.5 -1.44 30.53 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.361 -0.837 . . . . 0.0 109.307 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.695 ' CG ' HG21 ' A' ' 89' ' ' VAL . 23.0 m-85 -115.07 65.73 0.68 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.9 . . . . 0.0 109.225 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.797 HG23 ' O ' ' A' ' 5' ' ' THR . 11.5 t -86.78 92.46 8.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.94 . . . . 0.0 109.741 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.9 m -104.24 155.75 18.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.119 -0.988 . . . . 0.0 109.236 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 8' ' ' SER . . . 47.43 29.3 5.29 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.436 ' O ' ' OD1' ' A' ' 9' ' ' ASN . 5.0 m 70.44 43.84 0.76 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -1.14 . . . . 0.0 109.422 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.487 ' O ' ' HA ' ' A' ' 5' ' ' THR . 83.0 m-20 -136.97 86.33 2.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.136 -0.978 . . . . 0.0 109.547 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.472 ' HA ' ' HB ' ' A' ' 5' ' ' THR . 0.5 OUTLIER -54.9 88.26 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.498 -0.751 . . . . 0.0 109.395 179.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 63' ' ' SER . 1.9 m-85 -79.68 144.51 33.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.311 -0.868 . . . . 0.0 108.924 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.81 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -78.58 122.48 25.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.376 -0.827 . . . . 0.0 109.568 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.6 p -59.03 -26.62 64.72 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 83.4 p -78.93 -28.55 43.84 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' A' ' 12' ' ' SER . 0.5 OUTLIER -79.74 -27.4 40.55 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.081 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 12' ' ' SER . 13.5 t -66.6 -29.9 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.499 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 1.9 t -64.4 -46.21 84.26 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.93 -51.81 67.69 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.821 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -66.41 -18.81 65.58 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.585 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -71.11 -36.65 72.23 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -82.0 -1.72 49.19 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.54 -54.82 5.33 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.353 -0.842 . . . . 0.0 108.914 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.574 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -72.89 -18.5 79.01 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.44 ' O ' ' C ' ' A' ' 25' ' ' GLN . 14.6 t80 -80.22 -60.52 2.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.557 -0.966 . . . . 0.0 109.348 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.7 OUTLIER -41.64 -35.38 0.74 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.319 -0.863 . . . . 0.0 109.614 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.518 ' HA ' HD22 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -75.23 -47.13 29.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 0.0 109.65 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.583 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 11.5 t60 -56.25 -37.44 69.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.368 -0.833 . . . . 0.0 110.941 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -85.41 -31.47 22.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.027 -1.046 . . . . 0.0 109.48 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 0.5 OUTLIER -68.09 -20.51 64.95 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.274 -0.891 . . . . 0.0 109.366 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.23 -19.02 25.08 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.506 ' HB3' HD11 ' A' ' 26' ' ' LEU . 1.7 tp10 -63.01 -154.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.234 -1.156 . . . . 0.0 109.492 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.778 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -162.69 174.47 12.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.336 -0.852 . . . . 0.0 109.408 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.496 ' CG2' ' HB2' ' A' ' 38' ' ' TYR . 18.0 m -130.4 158.1 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.276 -0.89 . . . . 0.0 109.383 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.403 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . 55.63 -89.21 0.01 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER 171.04 32.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.327 -1.102 . . . . 0.0 109.725 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 37' ' ' SER . 1.6 m-80 -152.64 25.29 0.58 Allowed 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.106 -0.996 . . . . 0.0 109.666 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.778 ' HA ' HG22 ' A' ' 32' ' ' THR . 1.0 OUTLIER 47.95 92.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.018 -1.051 . . . . 0.0 108.887 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.68 ' CD2' ' CE2' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -79.34 -47.29 1.58 Allowed Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.261 -0.9 . . . . 0.0 110.765 -179.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 38' ' ' TYR . 32.6 Cg_endo -74.71 108.04 2.61 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 120.95 1.1 . . . . 0.0 109.349 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.62 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -125.74 -174.8 3.17 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.459 -179.11 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -104.6 131.28 52.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.346 -0.846 . . . . 0.0 109.42 -179.526 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.596 ' CZ ' ' HA ' ' A' ' 44' ' ' ASN . 11.9 t80 -97.33 137.83 35.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.272 -0.893 . . . . 0.0 109.259 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.523 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -89.85 -32.49 16.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.144 -0.973 . . . . 0.0 109.776 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.596 ' HA ' ' CZ ' ' A' ' 42' ' ' TYR . 20.1 t30 77.2 135.59 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.591 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.445 ' O ' ' C ' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -159.5 -38.11 0.06 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.307 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.6 OUTLIER -38.72 -73.02 0.05 Allowed 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.623 -0.673 . . . . 0.0 110.069 -179.582 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 155.41 61.72 0.01 OUTLIER Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.485 ' CD1' ' OD1' ' A' ' 44' ' ' ASN . 48.6 m-85 -90.74 -168.01 1.97 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.299 -1.118 . . . . 0.0 109.332 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 50' ' ' PHE . 5.0 p30 -145.05 26.59 1.34 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.52 ' CB ' ' OH ' ' A' ' 56' ' ' TYR . 20.9 m-30 -45.6 173.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.503 -0.748 . . . . 0.0 109.769 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.4 m -146.53 30.3 1.01 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.357 -0.839 . . . . 0.0 109.088 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.835 HG11 ' OD1' ' A' ' 81' ' ' ASN . 97.2 t -96.28 -92.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.338 -0.851 . . . . 0.0 109.545 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.497 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 66.9 m -142.63 -172.93 3.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.074 -1.016 . . . . 0.0 109.962 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.592 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -85.49 -49.25 0.56 Allowed Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.364 -0.835 . . . . 0.0 111.61 -179.175 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 54' ' ' SER . 33.5 Cg_endo -74.09 83.41 1.64 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 121.863 1.708 . . . . 0.0 110.396 -177.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.546 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 7.1 m-85 -79.38 -177.96 6.01 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.645 0.736 . . . . 0.0 110.022 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.583 ' CE2' ' NE2' ' A' ' 27' ' ' HIS . 97.6 m-85 -157.95 152.33 24.63 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.599 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 19.2 mt-10 -119.63 143.17 47.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.991 -1.068 . . . . 0.0 111.124 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.653 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 21.3 t-105 -160.75 138.81 7.21 Favored Pre-proline 0 N--CA 1.49 1.57 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.653 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.2 Cg_endo -69.22 142.59 50.74 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.338 2.025 . . . . 0.0 111.861 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.978 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -119.57 131.64 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.978 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.9 OUTLIER -123.13 167.49 13.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.191 -0.943 . . . . 0.0 109.576 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -135.72 17.47 3.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.368 -0.833 . . . . 0.0 109.25 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.25 -54.2 0.2 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.284 -0.885 . . . . 0.0 109.423 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . -67.42 -98.16 0.03 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.716 ' O ' HD12 ' A' ' 62' ' ' LEU . 3.0 t0 175.49 -162.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -1.161 . . . . 0.0 109.538 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.41 ' H ' HG23 ' A' ' 67' ' ' VAL . 8.5 t -52.55 136.47 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.304 -0.873 . . . . 0.0 109.568 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.68 ' CE2' ' CD2' ' A' ' 38' ' ' TYR . 28.9 t80 -52.92 117.84 3.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.2 -0.937 . . . . 0.0 109.254 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -177.19 74.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.404 -0.81 . . . . 0.0 109.662 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.52 62.12 0.31 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.31 -136.29 3.91 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.2 m -166.29 101.63 0.7 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.309 -1.112 . . . . 0.0 109.186 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.57 ' HG3' ' CD1' ' A' ' 68' ' ' TYR . 35.8 Cg_endo -77.82 -81.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.435 2.09 . . . . 0.0 110.685 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.39 -176.89 4.86 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . 56.47 -122.03 1.65 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.101 -1.235 . . . . 0.0 109.555 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 75' ' ' ALA . 87.2 m-20 -41.4 146.85 0.19 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.848 -1.158 . . . . 0.0 110.167 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.491 ' O ' HG12 ' A' ' 90' ' ' ILE . 2.6 tpp180 -176.37 90.12 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.455 -0.778 . . . . 0.0 109.219 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.752 HG21 HD21 ' A' ' 86' ' ' LEU . 7.5 p -65.04 144.63 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.097 -1.002 . . . . 0.0 109.547 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.605 HG23 HD13 ' A' ' 90' ' ' ILE . 24.7 t -104.84 167.48 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.345 -0.847 . . . . 0.0 109.642 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.585 ' CD1' ' OE1' ' A' ' 20' ' ' GLN . 13.8 p90 -164.53 -173.39 3.03 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.409 -178.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.835 ' OD1' HG11 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -124.07 -81.15 0.63 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.066 -1.022 . . . . 0.0 110.267 -179.395 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -158.74 21.55 0.22 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.312 -0.867 . . . . 0.0 109.484 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.471 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 4.4 m120 -140.39 23.89 2.31 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 83' ' ' ASN . 5.0 p30 52.83 19.92 1.45 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.503 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 51.8 mm-40 -60.62 -111.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.752 HD21 HG21 ' A' ' 78' ' ' VAL . 0.2 OUTLIER 172.84 110.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 110.693 178.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.588 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . . . -79.62 -38.92 32.75 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 148.69 156.71 7.24 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.695 HG21 ' CG ' ' A' ' 4' ' ' TYR . 94.8 t -87.14 113.48 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -1.155 . . . . 0.0 109.411 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.605 HD13 HG23 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -109.27 154.54 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.421 -0.8 . . . . 0.0 109.142 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 100' ' ' PHE . 4.6 t -107.79 146.82 31.67 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.033 -1.042 . . . . 0.0 110.418 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.615 ' CD2' ' HB2' ' A' ' 98' ' ' ASN . 16.1 t60 -116.76 66.05 0.72 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.451 ' HA ' ' HB3' ' A' ' 98' ' ' ASN . 1.9 m 178.42 -29.65 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.746 -0.596 . . . . 0.0 109.717 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.88 10.79 44.92 Favored Glycine 0 N--CA 1.494 2.504 0 O-C-N 120.993 -1.067 . . . . 0.0 110.638 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -141.15 147.06 37.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.016 -1.285 . . . . 0.0 109.669 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 95' ' ' ALA . 1.2 p -43.03 133.3 3.8 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 98' ' ' ASN . . . 62.84 35.03 91.42 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 107.949 -2.061 . . . . 0.0 107.949 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.615 ' HB2' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 34.71 41.66 0.06 Allowed 'General case' 0 C--N 1.309 -1.177 0 O-C-N 122.105 -0.644 . . . . 0.0 110.349 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -56.93 166.55 0.98 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.123 -0.986 . . . . 0.0 108.623 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.639 ' O ' HG13 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -91.44 147.51 22.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.933 -1.104 . . . . 0.0 109.839 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.639 HG13 ' O ' ' A' ' 100' ' ' PHE . 17.4 m -161.38 133.97 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 101' ' ' VAL . 35.8 mt-10 -43.26 135.17 3.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.964 . . . . 0.0 109.448 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 1.5 m -60.73 121.3 11.92 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.246 -0.908 . . . . 0.0 109.325 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.556 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 7.1 p 173.27 137.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.37 -0.832 . . . . 0.0 109.906 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -115.72 -29.57 6.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 0.0 109.505 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.716 ' CD2' HG21 ' A' ' 89' ' ' VAL . 13.0 m-85 -87.11 93.66 9.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.955 . . . . 0.0 109.233 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.3 m -126.76 141.08 51.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.144 -0.972 . . . . 0.0 109.869 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -143.98 14.98 1.71 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.122 0.963 . . . . 0.0 109.785 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 177.88 50.0 0.07 OUTLIER Glycine 0 C--N 1.281 -2.526 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 8' ' ' SER . 3.3 t 55.0 20.47 3.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.47 -1.018 . . . . 0.0 109.201 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.572 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 25.8 m-80 -74.5 -34.41 63.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 0.0 109.627 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 9' ' ' ASN . 46.5 t 61.52 52.03 3.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.116 -0.99 . . . . 0.0 109.621 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.572 ' CE1' ' HB3' ' A' ' 9' ' ' ASN . 7.6 m-30 -80.61 129.97 34.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.303 -0.873 . . . . 0.0 109.073 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.701 ' O ' HG23 ' A' ' 16' ' ' VAL . 3.9 m -88.57 137.96 31.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.167 -0.958 . . . . 0.0 110.11 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 p -53.55 -23.33 10.33 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.0 t -77.33 -38.16 51.0 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.357 -0.839 . . . . 0.0 108.94 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -70.86 -28.86 64.89 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 12' ' ' SER . 7.5 t -70.28 -31.2 46.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 C-N-CA 119.602 -0.839 . . . . 0.0 108.777 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.09 -45.62 92.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.598 -0.689 . . . . 0.0 109.433 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.62 -48.92 79.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 108.806 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.688 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -72.32 -12.22 61.04 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.554 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -83.9 -28.36 27.97 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.348 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -82.22 -14.55 55.36 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.438 -0.789 . . . . 0.0 109.099 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 26' ' ' LEU . . . -76.9 -52.94 8.55 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.279 -0.888 . . . . 0.0 109.062 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.556 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -66.16 -30.56 77.08 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.869 -1.693 . . . . 0.0 108.869 179.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.585 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 5.2 t80 -72.11 -70.65 0.32 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.415 -1.05 . . . . 0.0 108.982 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -40.71 -57.85 1.79 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.444 -0.785 . . . . 0.0 109.656 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -46.55 -46.44 19.35 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.048 -1.032 . . . . 0.0 109.262 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -58.81 -48.69 80.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.454 -0.779 . . . . 0.0 110.86 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -86.7 12.04 11.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.134 -0.979 . . . . 0.0 109.939 -179.151 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 55.1 t0 -104.48 -11.82 16.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.076 -1.015 . . . . 0.0 109.364 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.51 -5.12 61.53 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.44 ' HB2' HD13 ' A' ' 26' ' ' LEU . 5.5 mm-40 -87.81 -176.82 5.64 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.298 -1.119 . . . . 0.0 109.367 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.839 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -145.15 178.5 8.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -0.966 . . . . 0.0 109.677 179.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.55 HG23 ' N ' ' A' ' 34' ' ' GLY . 27.4 m -100.3 -126.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.322 -0.861 . . . . 0.0 109.441 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.55 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -43.5 -47.55 7.14 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER 163.99 -34.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -1.106 . . . . 0.0 109.638 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.449 ' N ' ' ND2' ' A' ' 36' ' ' ASN . 0.6 OUTLIER -75.96 -11.84 60.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 0.0 110.008 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.839 ' HA ' HG22 ' A' ' 32' ' ' THR . 1.1 p 69.29 121.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.026 -1.047 . . . . 0.0 108.916 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.735 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -98.3 -19.24 0.21 Allowed Pre-proline 0 N--CA 1.495 1.808 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -179.102 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.735 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 37.4 Cg_endo -79.82 102.03 1.43 Allowed 'Trans proline' 0 C--N 1.318 -1.056 0 C-N-CA 121.275 1.316 . . . . 0.0 113.426 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.589 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -128.77 137.43 51.54 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.072 -1.017 . . . . 0.0 109.748 177.184 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 2.5 ptmt -51.14 143.51 10.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 110.292 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.647 ' HD2' HG21 ' A' ' 79' ' ' VAL . 4.4 t80 -114.45 102.01 9.68 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 44' ' ' ASN . 0.3 OUTLIER -74.77 21.66 0.11 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.901 -1.124 . . . . 0.0 111.582 -178.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.558 ' HA ' ' CZ ' ' A' ' 42' ' ' TYR . 1.2 m-20 60.42 148.63 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.66 -1.275 . . . . 0.0 109.612 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.483 ' CD2' ' O ' ' A' ' 44' ' ' ASN . 0.2 OUTLIER -174.39 -57.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.933 . . . . 0.0 109.614 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.661 ' OE2' HG12 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -37.44 -55.99 1.03 Allowed 'General case' 0 C--N 1.308 -1.204 0 O-C-N 121.616 -0.677 . . . . 0.0 110.293 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.21 51.69 0.08 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.528 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 11.3 m-85 -91.43 -170.1 2.52 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.301 -1.117 . . . . 0.0 108.629 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -150.49 44.9 0.87 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.095 -1.003 . . . . 0.0 110.308 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.52 -179.5 5.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.954 -1.091 . . . . 0.0 109.236 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.4 m -153.22 56.68 0.77 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.237 -0.914 . . . . 0.0 109.466 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.688 HG21 ' O ' ' A' ' 86' ' ' LEU . 37.4 t -94.62 -27.0 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.258 -0.901 . . . . 0.0 109.647 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.532 ' HB3' ' CB ' ' A' ' 81' ' ' ASN . 4.1 t 167.55 162.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.028 -1.045 . . . . 0.0 109.57 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.591 ' CB ' ' HD3' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -75.82 -59.71 1.14 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.094 -1.004 . . . . 0.0 110.646 -179.27 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.591 ' HD3' ' CB ' ' A' ' 54' ' ' SER . 36.0 Cg_endo -71.34 84.37 0.94 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 121.959 1.773 . . . . 0.0 110.623 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.605 ' CE1' ' HB2' ' A' ' 87' ' ' ALA . 38.3 m-85 -79.62 -171.04 2.62 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.648 0.737 . . . . 0.0 109.904 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.584 ' CD2' ' O ' ' A' ' 56' ' ' TYR . 76.9 m-85 -160.82 151.04 17.79 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.481 ' OE2' ' HB2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -120.79 140.39 51.78 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.901 -1.124 . . . . 0.0 110.543 -178.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.684 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 3.7 t-105 -155.99 146.34 15.97 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.684 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.8 Cg_endo -68.32 130.58 21.48 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.098 1.866 . . . . 0.0 111.43 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.979 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -97.84 132.54 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.979 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.9 OUTLIER -123.81 165.01 18.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 0.0 109.342 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.55 ' HB2' ' CZ ' ' A' ' 11' ' ' TYR . 27.1 t -120.26 37.42 4.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 108.97 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.39 -172.91 3.07 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.404 -0.81 . . . . 0.0 109.638 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -96.28 50.48 1.66 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -150.04 147.34 27.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.09 -1.241 . . . . 0.0 109.432 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.477 HG13 ' HZ2' ' A' ' 59' ' ' TRP . 81.0 t -92.18 152.27 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.89 . . . . 0.0 109.252 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.603 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 44.4 t80 -59.79 132.17 53.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.201 -0.937 . . . . 0.0 109.573 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.1 t -155.91 20.36 0.38 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.303 -0.873 . . . . 0.0 109.246 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.5 89.75 1.41 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -162.65 -39.52 0.02 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.435 ' O ' ' OG ' ' A' ' 72' ' ' SER . 28.1 p -158.17 102.14 1.73 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.16 -1.2 . . . . 0.0 109.326 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -75.15 114.14 3.94 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.336 2.024 . . . . 0.0 110.158 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.462 ' HA2' ' CD2' ' A' ' 92' ' ' HIS . . . 109.83 -125.08 7.44 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.559 ' N ' ' HB2' ' A' ' 92' ' ' HIS . . . 51.01 -174.06 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.201 -1.176 . . . . 0.0 109.638 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.491 ' CB ' HG23 ' A' ' 61' ' ' ILE . 65.8 m-20 -37.89 143.16 0.12 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.649 0.738 . . . . 0.0 110.681 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.495 ' CA ' HG22 ' A' ' 61' ' ' ILE . 2.0 ttt180 -153.95 133.65 12.96 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.804 ' CG2' HD11 ' A' ' 86' ' ' LEU . 10.8 p -119.24 130.08 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.928 -1.107 . . . . 0.0 110.461 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.647 HG21 ' HD2' ' A' ' 42' ' ' TYR . 12.9 t -89.5 163.25 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 CA-C-O 122.298 1.047 . . . . 0.0 109.857 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.559 ' N ' ' CG1' ' A' ' 79' ' ' VAL . 34.4 p90 -159.74 -168.47 2.27 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.539 ' OD1' ' HG2' ' A' ' 82' ' ' GLU . 1.2 p30 -122.07 -44.79 2.27 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.866 -1.134 . . . . 0.0 111.004 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.585 ' O ' ' CZ ' ' A' ' 24' ' ' TYR . 2.1 pt-20 161.21 -21.54 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.419 ' C ' ' CG ' ' A' ' 84' ' ' ASN . 1.8 m-20 -92.16 20.27 6.11 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.581 ' OD1' ' CE2' ' A' ' 24' ' ' TYR . 0.0 OUTLIER 63.62 8.08 3.46 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.7 -0.625 . . . . 0.0 109.686 -179.474 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.41 ' O ' ' O ' ' A' ' 84' ' ' ASN . 13.6 mt-30 -60.66 -160.32 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.804 HD11 ' CG2' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -137.84 117.42 12.99 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.488 -1.382 . . . . 0.0 110.755 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.605 ' HB2' ' CE1' ' A' ' 56' ' ' TYR . . . -83.92 -43.23 15.47 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 170.48 163.69 24.94 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.716 HG21 ' CD2' ' A' ' 4' ' ' TYR . 75.1 t -115.93 99.22 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.021 -1.282 . . . . 0.0 109.388 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.588 ' H ' HD13 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -88.37 -173.39 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.398 -0.814 . . . . 0.0 109.401 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.589 ' O ' HG23 ' A' ' 91' ' ' THR . 5.9 t -148.9 121.43 8.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.986 -1.071 . . . . 0.0 110.213 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.559 ' HB2' ' N ' ' A' ' 75' ' ' ALA . 2.4 m-70 -78.99 79.13 5.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.549 -0.719 . . . . 0.0 109.291 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 98' ' ' ASN . 0.6 OUTLIER 177.36 -28.56 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.171 -0.956 . . . . 0.0 110.095 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.8 -16.31 16.69 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 1.064 ' HB3' ' CB ' ' A' ' 99' ' ' ASN . . . -122.52 178.15 5.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.104 -1.233 . . . . 0.0 109.412 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 98' ' ' ASN . 1.0 OUTLIER -40.95 157.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.449 -0.782 . . . . 0.0 109.31 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 96' ' ' SER . . . 43.97 -95.18 0.01 OUTLIER Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -127.28 -73.91 0.6 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.346 -1.091 . . . . 0.0 109.347 179.339 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 1.064 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . 0.9 OUTLIER 59.33 120.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.044 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.562 ' CD2' ' O ' ' A' ' 100' ' ' PHE . 38.3 p90 -98.76 117.53 33.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.843 -1.161 . . . . 0.0 110.705 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.661 HG12 ' OE2' ' A' ' 46' ' ' GLU . 18.0 m -128.91 158.2 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.513 ' N ' HG22 ' A' ' 90' ' ' ILE . 4.3 pt-20 -43.42 138.81 2.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 109.37 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.1 OUTLIER -75.73 176.8 7.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.63 -179.645 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.081 -0.962 . . . . 0.0 109.523 -179.9 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.482 ' O ' ' SG ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.414 0.626 . . . . 0.0 109.724 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 21.6 p 36.78 91.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.603 0.716 . . . . 0.0 110.224 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -97.86 1.63 48.38 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.46 ' CD2' HG21 ' A' ' 89' ' ' VAL . 16.1 m-85 -104.28 78.1 1.47 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.482 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 9' ' ' ASN . 28.1 m -84.31 93.98 8.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.427 ' O ' ' C ' ' A' ' 7' ' ' GLY . 2.8 m -120.65 155.03 34.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 109.474 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 6' ' ' CYS . . . 43.8 27.21 0.91 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 1.4 m 68.94 50.59 0.59 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.292 -1.122 . . . . 0.0 109.582 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 5' ' ' THR . 25.1 m120 -144.55 126.53 15.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.171 -0.956 . . . . 0.0 109.598 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.465 ' C ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -82.99 84.07 7.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -0.831 . . . . 0.0 109.02 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 4.2 m-30 -79.82 138.68 37.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.41 -0.806 . . . . 0.0 109.661 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.876 ' O ' HG23 ' A' ' 16' ' ' VAL . 2.0 t -80.73 123.28 28.07 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.696 -0.627 . . . . 0.0 109.92 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.18 -24.37 0.45 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 109.221 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.6 t -81.53 -41.1 22.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.983 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -67.62 -28.32 67.64 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 12' ' ' SER . 1.9 t -68.39 -29.64 44.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.575 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 21.5 t -62.63 -46.13 89.66 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -59.43 5.02 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.841 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -61.83 -16.42 50.04 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.904 ' OE1' HG11 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -73.56 -33.81 64.85 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.296 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.62 1.65 53.08 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.0 -62.28 1.73 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.249 -0.907 . . . . 0.0 109.04 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.507 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -60.89 -16.49 47.17 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -82.42 -64.91 1.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.342 -1.093 . . . . 0.0 109.248 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -47.42 -52.43 16.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.353 -0.842 . . . . 0.0 109.745 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.847 ' O ' HD12 ' A' ' 26' ' ' LEU . 2.7 tp -59.72 -38.46 81.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.292 -0.88 . . . . 0.0 109.397 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.649 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 66.1 t60 -68.7 -20.13 64.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.006 -1.059 . . . . 0.0 110.29 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 5.4 tp10 -87.19 -21.97 25.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.057 -1.027 . . . . 0.0 109.507 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 9.9 t70 -89.05 -12.26 41.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.267 -0.896 . . . . 0.0 109.502 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.35 0.84 59.01 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.533 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 5.6 tp10 -67.95 -144.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -1.175 . . . . 0.0 109.517 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.846 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -167.26 -174.6 2.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.058 -1.026 . . . . 0.0 109.619 -179.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.465 HG23 ' H ' ' A' ' 34' ' ' GLY . 2.5 m -105.03 -104.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 109.631 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -77.13 -38.19 30.49 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 2.2 t 162.83 -36.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.437 -1.037 . . . . 0.0 109.385 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.418 ' O ' ' O ' ' A' ' 37' ' ' SER . 5.4 m120 -68.82 -16.5 63.8 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.327 -0.858 . . . . 0.0 109.262 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.846 ' HA ' HG22 ' A' ' 32' ' ' THR . 8.1 t 63.09 126.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.271 -0.893 . . . . 0.0 109.431 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.651 ' H ' ' CD ' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -117.99 -27.41 0.08 OUTLIER Pre-proline 0 N--CA 1.499 2.001 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -178.56 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.651 ' CD ' ' H ' ' A' ' 38' ' ' TYR . 37.0 Cg_endo -79.34 100.72 1.35 Allowed 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 121.062 1.175 . . . . 0.0 112.724 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.597 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -135.92 160.61 38.07 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.115 -0.991 . . . . 0.0 108.747 177.439 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -62.72 139.83 58.69 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.128 -0.982 . . . . 0.0 110.232 -179.272 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.578 ' CD2' ' OD1' ' A' ' 44' ' ' ASN . 9.2 t80 -101.41 150.26 23.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.365 -0.834 . . . . 0.0 108.784 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.513 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 1.1 m-20 -107.51 -15.55 14.58 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.014 -1.054 . . . . 0.0 110.357 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.578 ' OD1' ' CD2' ' A' ' 42' ' ' TYR . 22.8 m-80 60.26 92.17 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.026 -1.046 . . . . 0.0 109.215 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -122.83 28.19 7.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.194 -0.941 . . . . 0.0 109.626 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.711 ' OE2' HG12 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -101.42 -65.67 0.96 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.46 ' N ' ' CG ' ' A' ' 46' ' ' GLU . . . 144.34 35.38 0.07 OUTLIER Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.558 ' CE1' ' OE2' ' A' ' 46' ' ' GLU . 15.9 m-85 -61.71 -171.07 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.92 6.75 4.66 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 118.102 -1.439 . . . . 0.0 110.292 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.534 ' CZ ' ' CD2' ' A' ' 48' ' ' PHE . 1.8 p90 -96.32 -169.98 2.01 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.996 -1.065 . . . . 0.0 109.347 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 50' ' ' PHE . 6.5 t 167.95 45.21 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.272 -0.893 . . . . 0.0 109.527 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -44.54 -27.73 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 109.252 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.542 ' O ' ' CE1' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -170.99 165.98 7.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.391 -0.818 . . . . 0.0 109.66 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.614 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -78.04 -51.2 1.72 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.323 -0.86 . . . . 0.0 111.044 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 54' ' ' SER . 32.9 Cg_endo -72.77 92.41 0.79 Allowed 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.856 1.704 . . . . 0.0 109.5 -177.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.822 ' CE2' ' HB1' ' A' ' 87' ' ' ALA . 2.2 m-30 -91.85 -170.96 2.72 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.961 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.649 ' CE1' ' NE2' ' A' ' 27' ' ' HIS . 61.1 m-85 -164.29 105.55 0.88 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -74.76 139.4 43.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 109.384 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.726 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 14.6 t-105 -159.84 141.03 9.24 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.726 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.4 Cg_endo -68.16 131.21 23.06 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 C-N-CA 122.156 1.904 . . . . 0.0 111.433 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.973 HD12 ' N ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -106.44 128.2 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.705 -0.622 . . . . 0.0 109.42 -179.614 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.973 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.2 mt -125.03 164.28 20.52 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.306 -0.872 . . . . 0.0 109.352 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.434 ' O ' ' OG ' ' A' ' 63' ' ' SER . 2.2 t -118.51 16.55 13.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.145 -0.972 . . . . 0.0 109.077 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.45 -156.9 0.57 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.597 -0.689 . . . . 0.0 109.487 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -116.0 54.81 0.57 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -163.32 107.17 1.03 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -1.184 . . . . 0.0 109.709 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.431 HG13 ' HZ2' ' A' ' 59' ' ' TRP . 43.5 t -47.76 160.01 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.216 -0.927 . . . . 0.0 109.099 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.617 ' HB2' ' HG2' ' A' ' 60' ' ' PRO . 6.5 t80 -49.1 119.24 3.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.915 -1.116 . . . . 0.0 109.388 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -168.08 39.41 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.432 -0.793 . . . . 0.0 109.127 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.71 -0.97 6.86 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -83.95 -153.66 17.06 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.47 131.51 74.45 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.235 -1.156 . . . . 0.0 109.408 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.413 ' O ' ' O ' ' A' ' 74' ' ' GLY . 36.4 Cg_endo -79.85 -89.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.547 2.164 . . . . 0.0 110.753 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 76' ' ' ASP . . . -59.06 -112.55 0.01 OUTLIER Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.417 ' N ' ' HB3' ' A' ' 92' ' ' HIS . . . 50.9 -87.23 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.383 -1.069 . . . . 0.0 110.415 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 74' ' ' GLY . 1.0 OUTLIER -117.32 116.37 27.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.928 -1.108 . . . . 0.0 109.988 -179.582 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.562 ' NH1' ' CE1' ' A' ' 38' ' ' TYR . 2.3 mtm-85 -128.78 138.14 51.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.139 -0.976 . . . . 0.0 109.138 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.904 HG11 ' OE1' ' A' ' 20' ' ' GLN . 9.8 p -123.62 142.85 38.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.676 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 23.4 t -110.59 165.88 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 122.188 0.994 . . . . 0.0 111.02 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.59 ' CE1' ' HB2' ' A' ' 57' ' ' TYR . 22.7 p90 -161.95 -170.48 2.54 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.258 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.45 ' O ' ' CD2' ' A' ' 57' ' ' TYR . 20.0 t30 -124.35 -82.15 0.64 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.006 -1.059 . . . . 0.0 109.929 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -158.08 18.68 0.24 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.409 -0.807 . . . . 0.0 109.6 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.487 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 2.7 m-20 -153.5 26.11 0.51 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.518 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 0.4 OUTLIER 53.4 19.65 1.7 Allowed 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.362 0.601 . . . . 0.0 109.557 -179.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.595 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -46.83 -35.32 6.19 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.093 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.636 HD21 ' NE2' ' A' ' 20' ' ' GLN . 0.0 OUTLIER 92.43 110.09 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.549 0.69 . . . . 0.0 111.152 179.044 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.822 ' HB1' ' CE2' ' A' ' 56' ' ' TYR . . . -87.42 -42.22 12.99 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 151.21 146.01 4.24 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.46 HG21 ' CD2' ' A' ' 4' ' ' TYR . 61.1 t -86.8 88.81 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.029 -1.277 . . . . 0.0 109.462 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.537 ' HB ' ' HB3' ' A' ' 100' ' ' PHE . 1.1 pt -79.39 170.24 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.315 -0.866 . . . . 0.0 108.785 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.1 t -135.97 141.26 44.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.075 -1.016 . . . . 0.0 110.274 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.601 ' CD2' ' HB2' ' A' ' 98' ' ' ASN . 2.9 t60 -92.77 76.02 4.91 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 1.2 m 171.76 148.38 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.17 -20.69 46.29 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -126.43 151.9 47.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.122 -1.222 . . . . 0.0 109.665 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 95' ' ' ALA . 20.3 m -41.57 125.78 2.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.47 -0.769 . . . . 0.0 109.321 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.487 ' O ' ' C ' ' A' ' 98' ' ' ASN . . . 65.33 40.5 96.53 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.601 ' HB2' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 32.9 52.4 0.31 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 122.053 -0.675 . . . . 0.0 110.209 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -57.27 167.39 0.93 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.214 -0.929 . . . . 0.0 109.222 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.537 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 0.5 OUTLIER -88.78 122.05 31.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.143 -0.973 . . . . 0.0 109.664 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.711 HG12 ' OE2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -136.06 152.85 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.267 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.4 OUTLIER -56.92 131.28 49.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.14 -0.975 . . . . 0.0 109.491 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 89.8 m -54.18 148.05 11.93 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.26 -0.9 . . . . 0.0 109.627 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 109.573 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.511 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.6 p 165.3 126.86 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.26 -0.9 . . . . 0.0 110.291 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -96.21 -29.68 13.9 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.616 ' CG ' HG21 ' A' ' 89' ' ' VAL . 18.0 m-85 -91.81 103.69 16.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.479 -0.763 . . . . 0.0 109.11 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.571 HG22 ' H ' ' A' ' 7' ' ' GLY . 40.4 m -125.83 123.92 39.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.096 -1.003 . . . . 0.0 109.89 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.8 m -103.57 16.91 25.28 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.093 0.949 . . . . 0.0 109.61 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.571 ' H ' HG22 ' A' ' 5' ' ' THR . . . 152.82 -88.46 0.13 Allowed Glycine 0 C--N 1.284 -2.355 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.3 m -138.4 42.14 2.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -1.146 . . . . 0.0 109.684 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.487 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 1.0 OUTLIER -103.73 -26.33 12.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.183 -0.948 . . . . 0.0 109.38 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.1 t 60.18 57.78 2.85 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.38 -0.825 . . . . 0.0 109.675 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.527 ' CE1' ' HB3' ' A' ' 63' ' ' SER . 6.2 m-30 -87.88 114.02 24.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.39 -0.819 . . . . 0.0 108.874 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -85.99 138.35 32.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.062 -1.023 . . . . 0.0 109.98 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 p -48.82 -23.13 0.97 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.369 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.8 m -77.81 -41.33 37.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.113 -0.992 . . . . 0.0 109.543 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -71.68 -28.76 63.94 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 12' ' ' SER . 41.4 t -65.32 -24.93 35.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.42 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 3.4 t -66.97 -44.59 80.08 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.72 -38.46 85.16 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.759 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -81.31 -13.99 57.81 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.573 ' OE1' ' CG ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -82.13 -27.91 32.5 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.394 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -83.32 -13.21 55.59 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.13 -50.78 20.83 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.441 -0.787 . . . . 0.0 109.266 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.574 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -77.29 -29.02 57.01 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.579 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 3.2 t80 -71.37 -27.84 63.63 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.436 -1.038 . . . . 0.0 109.114 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 1.9 tt0 -74.16 -63.04 1.31 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.112 -0.992 . . . . 0.0 108.951 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.482 ' HA ' HD12 ' A' ' 26' ' ' LEU . 1.6 tp -46.47 -34.74 5.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.349 -0.845 . . . . 0.0 108.972 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.576 ' NE2' ' CZ ' ' A' ' 57' ' ' TYR . 2.0 t60 -65.52 -59.23 4.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.477 -0.765 . . . . 0.0 110.093 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -83.02 10.22 8.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.246 -0.909 . . . . 0.0 109.759 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 45.7 t0 -95.84 -23.76 16.76 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.956 . . . . 0.0 109.61 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.97 -0.66 84.41 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.4 ' C ' ' OG1' ' A' ' 32' ' ' THR . 1.0 OUTLIER -97.56 -146.33 0.31 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.191 -1.182 . . . . 0.0 109.367 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.536 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -168.99 -177.17 2.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -0.938 . . . . 0.0 109.523 -179.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.556 HG21 ' HB2' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -92.54 -100.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 109.057 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.505 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -94.19 30.87 7.16 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 1.0 OUTLIER 78.21 1.39 2.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.525 -0.986 . . . . 0.0 109.334 -179.482 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.53 ' O ' ' CB ' ' A' ' 37' ' ' SER . 0.5 OUTLIER -93.18 -19.36 21.53 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.334 -0.853 . . . . 0.0 109.743 -179.651 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.536 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.8 OUTLIER 76.45 93.34 0.07 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 109.294 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.605 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -85.77 -43.53 0.62 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 111.238 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 32.9 Cg_endo -75.46 108.41 2.69 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 120.927 1.085 . . . . 0.0 110.045 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.616 ' CE1' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -123.79 124.68 43.23 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.3 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.539 ' HA ' ' CD1' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -49.63 125.06 10.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.387 -0.821 . . . . 0.0 110.72 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 2.1 t80 -88.83 159.45 17.71 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.433 ' O ' ' CZ ' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -169.6 35.61 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 4.2 m-20 -90.21 -171.48 3.13 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.681 0.753 . . . . 0.0 110.233 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.558 ' CG ' ' C ' ' A' ' 44' ' ' ASN . 0.2 OUTLIER -158.68 24.32 0.22 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.585 ' OE1' HG12 ' A' ' 101' ' ' VAL . 0.4 OUTLIER -36.37 -67.24 0.18 Allowed 'General case' 0 C--N 1.31 -1.144 0 O-C-N 121.784 -0.573 . . . . 0.0 110.176 -179.235 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.446 ' O ' ' OE2' ' A' ' 102' ' ' GLU . . . -167.01 41.86 0.25 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.614 ' CE1' HG22 ' A' ' 90' ' ' ILE . 65.7 m-85 -100.88 158.15 16.2 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.276 -1.132 . . . . 0.0 109.254 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -125.5 11.0 7.95 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.229 -0.92 . . . . 0.0 109.59 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.61 ' CE2' ' HB3' ' A' ' 48' ' ' PHE . 2.3 p90 -78.19 165.0 24.45 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.142 -0.973 . . . . 0.0 109.363 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 52' ' ' VAL . 33.3 t -144.39 34.76 1.19 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.214 -0.929 . . . . 0.0 109.594 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.608 HG12 ' HB3' ' A' ' 81' ' ' ASN . 59.8 t -44.41 -45.98 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.264 -0.898 . . . . 0.0 109.058 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.404 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 0.1 OUTLIER 172.5 157.0 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.765 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.6 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -59.28 -51.25 82.86 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.408 -0.807 . . . . 0.0 110.623 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 54' ' ' SER . 35.6 Cg_endo -75.6 83.15 1.96 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.046 1.83 . . . . 0.0 110.27 -178.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.608 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 48.7 m-85 -79.35 -172.02 3.0 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.322 0.582 . . . . 0.0 110.148 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.608 ' CG ' ' O ' ' A' ' 56' ' ' TYR . 34.3 m-85 -165.02 118.39 1.24 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.616 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -95.53 146.03 24.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 0.0 110.17 -179.36 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.652 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 8.8 t-105 -160.36 142.97 9.76 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.652 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.2 Cg_endo -67.79 138.67 45.52 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.067 1.844 . . . . 0.0 111.309 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.978 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -110.35 133.0 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.465 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.978 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.3 OUTLIER -125.89 169.48 12.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.312 -0.867 . . . . 0.0 109.29 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.527 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 2.2 p -122.94 28.45 7.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.309 -0.869 . . . . 0.0 109.056 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.77 -12.28 8.47 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.468 -0.77 . . . . 0.0 109.446 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.82 29.46 59.2 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 67' ' ' VAL . 5.8 t0 -102.56 -3.67 26.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -1.157 . . . . 0.0 109.758 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' A' ' 66' ' ' ASP . 3.4 t 55.55 166.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.947 . . . . 0.0 109.42 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.61 ' CD1' HD11 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -115.18 120.96 41.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.903 . . . . 0.0 109.565 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.484 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -140.01 78.57 1.67 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.874 . . . . 0.0 109.527 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 71' ' ' GLY . . . 161.34 37.42 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 70' ' ' GLY . . . 41.95 -145.52 0.74 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.8 t 64.42 74.19 0.42 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.177 -1.19 . . . . 0.0 109.533 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.5 -177.27 3.72 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.596 2.197 . . . . 0.0 110.321 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.552 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 173.84 76.19 0.05 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.597 ' HA ' ' N ' ' A' ' 92' ' ' HIS . . . 67.39 -143.12 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.205 -1.174 . . . . 0.0 109.813 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.527 ' O ' ' O ' ' A' ' 75' ' ' ALA . 49.8 m-20 14.29 113.54 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.532 ' O ' HG12 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -162.86 128.95 3.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.129 -0.982 . . . . 0.0 109.264 178.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.805 HG21 HD21 ' A' ' 86' ' ' LEU . 4.6 p -116.49 140.01 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.749 -1.219 . . . . 0.0 109.227 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -105.0 -175.36 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 122.371 1.081 . . . . 0.0 110.628 -179.235 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.573 ' CG ' ' OE1' ' A' ' 20' ' ' GLN . 26.1 p90 179.81 -169.15 0.12 Allowed 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.608 ' HB3' HG12 ' A' ' 52' ' ' VAL . 1.7 p30 -123.09 -39.73 2.46 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.998 -1.064 . . . . 0.0 110.231 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.579 ' O ' ' CZ ' ' A' ' 24' ' ' TYR . 4.4 pt-20 159.51 -26.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.474 ' O ' ' CB ' ' A' ' 84' ' ' ASN . 0.5 OUTLIER -86.33 -5.24 59.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.338 -0.851 . . . . 0.0 109.089 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 83' ' ' ASN . 7.7 t-20 74.7 30.32 1.02 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.37 -0.831 . . . . 0.0 109.702 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.564 ' HG3' ' ND2' ' A' ' 81' ' ' ASN . 0.4 OUTLIER -74.07 -25.74 60.0 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.218 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.805 HD21 HG21 ' A' ' 78' ' ' VAL . 0.2 OUTLIER 81.81 110.76 0.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.389 0.614 . . . . 0.0 110.195 179.306 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.556 ' N ' HD13 ' A' ' 86' ' ' LEU . . . -78.94 -39.49 34.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.389 -0.82 . . . . 0.0 109.048 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.524 ' O ' HG23 ' A' ' 78' ' ' VAL . . . 162.49 169.53 25.99 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.616 HG21 ' CG ' ' A' ' 4' ' ' TYR . 47.5 t -100.09 87.77 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.265 -1.138 . . . . 0.0 109.559 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.614 HG22 ' CE1' ' A' ' 48' ' ' PHE . 4.4 pt -90.15 146.28 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -0.864 . . . . 0.0 109.411 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.564 ' OG1' ' HB1' ' A' ' 75' ' ' ALA . 9.9 t -123.17 135.19 54.21 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.625 -1.297 . . . . 0.0 110.489 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.687 ' CE1' ' CE2' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -86.39 75.66 9.76 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.368 -0.833 . . . . 0.0 109.187 179.241 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.3 m -179.66 -31.87 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.335 -0.853 . . . . 0.0 109.233 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -68.43 -6.99 51.5 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.911 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -139.53 123.14 17.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.136 -1.214 . . . . 0.0 109.547 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.454 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.3 OUTLIER 47.69 -165.64 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.159 -0.963 . . . . 0.0 109.156 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 96' ' ' SER . . . -40.62 -66.29 0.88 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.601 ' O ' ' CE1' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -153.58 89.5 1.34 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.27 -1.135 . . . . 0.0 109.08 179.445 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.911 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.9 OUTLIER -112.25 141.1 46.36 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.687 ' CE2' ' CE1' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -75.08 138.05 41.85 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.994 -1.066 . . . . 0.0 109.558 -179.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.585 HG12 ' OE1' ' A' ' 46' ' ' GLU . 30.3 m -160.17 145.57 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.344 -0.848 . . . . 0.0 109.005 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.567 ' HG3' ' CD1' ' A' ' 48' ' ' PHE . 1.4 mp0 -45.46 124.26 4.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.545 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.47 130.78 40.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 109.613 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 67.6 p . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.334 -0.854 . . . . 0.0 109.514 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.495 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.8 p 164.83 124.52 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.28 -0.887 . . . . 0.0 110.06 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -104.03 -7.24 20.44 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.46 -0.775 . . . . 0.0 109.067 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.583 ' HD2' HG21 ' A' ' 16' ' ' VAL . 17.2 m-85 -104.71 110.09 22.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.936 . . . . 0.0 109.382 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 9' ' ' ASN . 82.8 p -142.31 118.4 10.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.285 -0.885 . . . . 0.0 109.804 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -124.44 11.6 8.66 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 122.317 1.056 . . . . 0.0 109.436 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 8' ' ' SER . . . -160.94 32.74 0.38 Allowed Glycine 0 C--N 1.282 -2.454 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 3.9 t 70.95 9.32 6.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.316 -1.108 . . . . 0.0 109.315 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.541 ' O ' HG22 ' A' ' 5' ' ' THR . 14.6 m-80 -78.1 178.06 7.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 109.556 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 51.8 t -127.74 70.22 1.33 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.341 -0.849 . . . . 0.0 109.084 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' A' ' 4' ' ' TYR . 3.5 m-85 -79.63 118.68 21.68 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.262 -0.899 . . . . 0.0 109.543 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.57 ' O ' HG23 ' A' ' 16' ' ' VAL . 48.8 m -80.21 133.76 36.05 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.491 -0.756 . . . . 0.0 109.958 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.95 -30.32 10.11 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 t -73.43 -38.99 65.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.362 -0.836 . . . . 0.0 109.076 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -67.95 -26.04 65.75 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.583 HG21 ' HD2' ' A' ' 4' ' ' TYR . 19.4 t -77.15 -29.08 16.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.481 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 0.2 OUTLIER -67.66 -37.84 82.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.422 -0.799 . . . . 0.0 109.382 179.688 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -47.05 86.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.133 -0.98 . . . . 0.0 108.433 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.835 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -73.25 -17.98 61.28 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.573 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -76.45 -32.13 58.25 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.438 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -79.12 -8.31 58.88 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.628 ' HB1' HG13 ' A' ' 67' ' ' VAL . . . -83.29 -55.92 4.06 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.352 -0.843 . . . . 0.0 108.843 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.627 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -68.22 -20.86 73.56 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.577 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 1.0 OUTLIER -81.84 -58.08 3.15 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.586 -0.949 . . . . 0.0 109.521 -179.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.509 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -49.15 -36.45 19.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.13 -0.981 . . . . 0.0 109.486 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.945 HD13 ' HB2' ' A' ' 31' ' ' GLU . 1.2 mm? -72.61 -40.24 66.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.351 -0.843 . . . . 0.0 109.278 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.664 ' CE1' ' CE1' ' A' ' 57' ' ' TYR . 2.6 t60 -61.38 -32.78 72.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.438 -0.789 . . . . 0.0 110.433 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.509 ' OE1' ' CZ ' ' A' ' 24' ' ' TYR . 4.2 pt-20 -86.69 -26.23 24.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.951 -1.093 . . . . 0.0 109.812 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -84.86 -6.54 59.35 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.1 -1.0 . . . . 0.0 109.547 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.79 -28.31 6.59 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.945 ' HB2' HD13 ' A' ' 26' ' ' LEU . 3.1 mm-40 -58.61 -166.94 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.172 -1.193 . . . . 0.0 109.454 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.551 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -155.83 -93.61 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.886 . . . . 0.0 109.524 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -134.67 -167.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.129 -0.982 . . . . 0.0 109.318 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -40.73 -37.41 1.3 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 t -176.37 -51.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -1.186 . . . . 0.0 109.814 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.548 ' O ' ' CB ' ' A' ' 37' ' ' SER . 35.3 m120 -51.39 -86.0 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.156 -0.965 . . . . 0.0 109.645 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.588 ' CA ' ' CG2' ' A' ' 33' ' ' VAL . 0.3 OUTLIER 160.33 -178.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.537 ' C ' ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER 175.46 -49.38 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.917 -1.114 . . . . 0.0 112.302 178.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.531 ' HD2' ' H ' ' A' ' 38' ' ' TYR . 31.4 Cg_endo -75.3 100.55 1.38 Allowed 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 121.215 1.276 . . . . 0.0 112.094 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.537 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -140.72 137.12 33.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.693 -0.629 . . . . 0.0 109.356 178.66 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -42.77 133.84 3.42 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.396 -0.815 . . . . 0.0 110.318 -179.059 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.586 ' OH ' ' CD1' ' A' ' 100' ' ' PHE . 30.2 t80 -94.09 159.43 15.16 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.385 -0.822 . . . . 0.0 109.031 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' A' ' 44' ' ' ASN . 7.9 m-80 -106.63 -39.98 5.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.073 -1.017 . . . . 0.0 110.11 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.514 ' CA ' ' CE2' ' A' ' 42' ' ' TYR . 0.1 OUTLIER 62.92 127.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.11 -0.993 . . . . 0.0 108.764 -179.49 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.482 ' O ' ' C ' ' A' ' 46' ' ' GLU . 1.4 m-85 -161.68 -36.25 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.093 -1.004 . . . . 0.0 110.052 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.482 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -34.75 -72.83 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.671 -0.643 . . . . 0.0 110.412 -179.322 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 171.2 56.46 0.04 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.535 ' CE2' HG22 ' A' ' 90' ' ' ILE . 90.6 m-85 -86.66 177.97 7.19 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.204 -1.174 . . . . 0.0 108.407 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.424 ' OD1' ' C ' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -131.19 11.25 4.99 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.986 -1.071 . . . . 0.0 110.095 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 87' ' ' ALA . 0.7 OUTLIER -88.61 -174.95 4.76 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.036 -1.04 . . . . 0.0 109.201 179.542 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.0 m -173.86 40.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.212 -0.93 . . . . 0.0 109.521 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.0 t -52.24 -39.42 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.296 -0.878 . . . . 0.0 109.284 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.5 ' OG ' ' CB ' ' A' ' 81' ' ' ASN . 32.9 p -177.86 151.37 0.69 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 109.671 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.596 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -59.2 -52.74 72.39 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.333 -0.854 . . . . 0.0 110.08 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 54' ' ' SER . 35.9 Cg_endo -75.48 86.54 1.46 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.989 1.792 . . . . 0.0 109.511 -178.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.604 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 10.6 m-85 -78.84 -169.15 1.66 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.664 ' CE1' ' CE1' ' A' ' 27' ' ' HIS . 66.0 m-85 -162.72 106.73 1.11 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 40' ' ' HIS . 4.1 pt-20 -78.87 137.22 37.57 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.743 0.782 . . . . 0.0 110.726 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.666 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 26.6 t-105 -160.82 139.82 7.71 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.666 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.8 Cg_endo -70.35 158.95 54.61 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.273 1.982 . . . . 0.0 111.749 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 1.006 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -132.41 136.6 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.525 -0.734 . . . . 0.0 109.225 -179.547 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.006 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.5 OUTLIER -121.31 174.96 6.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.106 -0.996 . . . . 0.0 109.775 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.67 31.6 4.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.911 . . . . 0.0 109.189 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.94 -58.72 2.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.376 -0.828 . . . . 0.0 109.399 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.31 52.37 0.03 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -156.67 150.55 24.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -1.175 . . . . 0.0 109.548 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.628 HG13 ' HB1' ' A' ' 22' ' ' ALA . 45.3 t -83.66 133.25 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.351 -0.843 . . . . 0.0 109.351 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.879 ' HD2' HD21 ' A' ' 62' ' ' LEU . 0.7 OUTLIER -56.06 135.67 52.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -0.954 . . . . 0.0 109.508 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.481 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -151.58 52.35 0.83 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.264 -0.897 . . . . 0.0 109.265 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.38 158.21 33.28 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.74 79.18 0.63 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.3 m 53.77 87.4 0.14 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.238 -1.154 . . . . 0.0 109.767 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.6 170.47 19.16 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.653 2.235 . . . . 0.0 110.261 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.586 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 109.14 -164.25 12.49 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 69.38 -162.08 0.18 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.29 -1.123 . . . . 0.0 110.488 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 91' ' ' THR . 38.9 m-20 -46.98 165.86 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.678 0.751 . . . . 0.0 110.787 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.514 ' O ' HG12 ' A' ' 90' ' ' ILE . 36.1 ttm180 -172.82 104.68 0.14 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.001 ' CG2' HD11 ' A' ' 86' ' ' LEU . 4.2 p -79.68 152.22 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.895 -1.128 . . . . 0.0 110.154 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.595 HG12 ' N ' ' A' ' 80' ' ' PHE . 44.7 t -120.32 165.13 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.879 0.847 . . . . 0.0 109.83 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.595 ' N ' HG12 ' A' ' 79' ' ' VAL . 8.4 p90 -165.63 -169.49 1.57 Allowed 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.746 -0.781 . . . . 0.0 109.426 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.571 ' O ' ' CE2' ' A' ' 57' ' ' TYR . 1.9 p30 -122.28 -46.47 2.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.009 -1.057 . . . . 0.0 110.48 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.577 ' O ' ' CZ ' ' A' ' 24' ' ' TYR . 0.7 OUTLIER 163.31 -23.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -179.674 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.484 ' HB3' ' OE1' ' A' ' 85' ' ' GLN . 1.9 m-20 -86.95 14.29 7.63 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.469 ' O ' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER 71.93 6.3 5.57 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.442 -0.787 . . . . 0.0 109.048 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.5 ' HB2' ' ND2' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -58.38 -162.34 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 178.766 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.001 HD11 ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -143.55 107.72 4.75 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.663 -1.273 . . . . 0.0 110.567 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.564 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . . . -69.27 -36.73 77.41 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 149.46 162.77 10.6 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.565 ' HB ' ' CD1' ' A' ' 4' ' ' TYR . 41.8 t -101.07 87.95 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -1.149 . . . . 0.0 109.547 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.557 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 0.5 OUTLIER -82.6 154.0 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.561 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.573 HG22 HG23 ' A' ' 101' ' ' VAL . 9.5 t -110.73 162.47 14.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.979 -1.075 . . . . 0.0 110.808 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.651 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 2.0 t60 -119.66 53.88 1.03 Allowed 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 40.7 m -172.55 125.82 0.5 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.497 -0.752 . . . . 0.0 109.229 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 119.72 -14.93 10.56 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 98' ' ' ASN . . . -117.74 86.41 2.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.18 -1.188 . . . . 0.0 109.546 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER 42.11 74.13 0.12 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.545 -0.722 . . . . 0.0 109.119 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.55 -76.9 0.73 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.761 -1.735 . . . . 0.0 108.761 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.651 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -150.17 -84.08 0.09 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.258 -1.142 . . . . 0.0 109.43 179.717 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.535 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 1.6 t30 63.57 152.11 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.348 -0.845 . . . . 0.0 109.124 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.592 ' O ' HG13 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -96.53 143.78 27.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 109.776 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 100' ' ' PHE . 3.7 m -158.03 131.41 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.475 -0.766 . . . . 0.0 109.159 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -45.45 126.15 6.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.34 -0.85 . . . . 0.0 109.559 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 1.3 m -49.05 165.85 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.259 -0.901 . . . . 0.0 109.645 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.489 1.482 0 O-C-N 121.27 -0.893 . . . . 0.0 109.508 -179.864 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 32.1 p -173.74 115.19 0.23 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.191 -0.943 . . . . 0.0 110.07 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -78.11 -45.38 23.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 0.0 109.212 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.583 ' CE1' ' HB ' ' A' ' 89' ' ' VAL . 28.1 m-85 -74.07 95.82 2.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.0 109.029 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -108.56 67.64 0.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 110.008 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.436 ' HB2' ' OD1' ' A' ' 76' ' ' ASP . 4.1 m -84.16 156.64 21.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 109.071 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 6' ' ' CYS . . . 44.6 -107.8 0.16 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.5 p -142.5 41.25 1.6 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.172 -1.193 . . . . 0.0 109.459 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -118.89 140.59 49.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 0.0 109.566 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -89.86 66.88 7.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -78.76 114.82 18.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 0.0 108.855 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 1.068 ' O ' HG23 ' A' ' 16' ' ' VAL . 1.0 OUTLIER -88.73 148.78 23.8 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.321 -0.862 . . . . 0.0 110.505 -179.181 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -13.39 18.38 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.85 -36.49 12.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.26 -0.9 . . . . 0.0 109.75 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.15 -30.55 62.32 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.987 -1.071 . . . . 0.0 108.117 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 1.068 HG23 ' O ' ' A' ' 12' ' ' SER . 3.8 t -62.38 -31.1 50.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.11 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 t -58.57 -45.24 89.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.282 -0.886 . . . . 0.0 109.866 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.9 m -65.73 -52.02 54.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.578 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.932 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -74.36 -6.6 49.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.287 -0.883 . . . . 0.0 109.579 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.793 ' OE1' HG22 ' A' ' 78' ' ' VAL . 4.3 tp60 -99.69 -15.85 18.38 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.39 -17.72 29.9 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.12 -57.82 3.65 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.432 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -48.42 -28.33 6.41 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.594 ' CE1' ' HA ' ' A' ' 82' ' ' GLU . 24.7 t80 -77.35 -48.4 17.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.602 -0.94 . . . . 0.0 109.596 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.403 ' O ' ' HB2' ' A' ' 29' ' ' ASP . 0.1 OUTLIER -54.09 -40.97 67.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.126 -0.984 . . . . 0.0 108.858 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.88 HD11 ' O ' ' A' ' 31' ' ' GLU . 1.9 tm? -65.84 -43.61 87.99 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.613 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 19.5 t60 -67.55 -17.9 64.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.368 -0.833 . . . . 0.0 109.765 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.95 11.19 31.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 109.579 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 1.8 t0 -122.63 -0.22 9.21 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.346 -0.846 . . . . 0.0 109.451 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.85 21.03 58.07 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.88 ' O ' HD11 ' A' ' 26' ' ' LEU . 3.4 mt-10 -102.35 -166.99 1.34 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.366 -1.079 . . . . 0.0 109.36 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.892 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -147.26 173.66 12.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.242 -0.911 . . . . 0.0 109.513 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 34' ' ' GLY . 33.8 m -89.02 -138.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.41 -0.806 . . . . 0.0 108.968 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.472 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -98.5 33.49 5.99 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.6 p -161.43 -154.3 0.34 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -1.152 . . . . 0.0 109.955 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.748 ' O ' HG21 ' A' ' 32' ' ' THR . 2.2 m120 -53.32 -60.98 2.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 110.101 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.892 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.6 OUTLIER 168.76 108.34 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.404 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.724 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.4 OUTLIER -82.51 -34.31 0.65 Allowed Pre-proline 0 C--O 1.2 -1.507 0 O-C-N 121.01 -1.056 . . . . 0.0 112.221 -178.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.763 ' HG2' HD12 ' A' ' 26' ' ' LEU . 35.9 Cg_endo -79.13 109.05 2.47 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 N-CA-C 109.874 -0.856 . . . . 0.0 109.874 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.724 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -133.58 177.53 7.63 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.601 ' HB2' ' CE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -97.51 129.73 44.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.058 -1.027 . . . . 0.0 110.456 -178.626 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.566 ' HB2' ' HG3' ' A' ' 58' ' ' GLU . 10.6 t80 -94.38 168.84 10.63 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.63 ' ND2' ' CE1' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -145.33 18.41 1.54 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.019 -1.051 . . . . 0.0 110.129 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 43' ' ' ASN . 15.2 m-80 62.03 108.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.069 -1.019 . . . . 0.0 109.738 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.63 ' CE1' ' ND2' ' A' ' 43' ' ' ASN . 3.3 m-30 -114.91 -4.9 12.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.331 -0.855 . . . . 0.0 109.44 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.552 ' CD ' ' CE1' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -110.88 -33.86 6.4 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.115 -0.991 . . . . 0.0 108.787 -179.431 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.01 28.65 2.81 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.552 ' CE1' ' CD ' ' A' ' 46' ' ' GLU . 48.3 m-85 -61.66 -168.18 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 4.8 m-20 -139.1 -44.15 0.46 Allowed 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 118.557 -1.257 . . . . 0.0 109.771 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 49' ' ' ASP . 20.0 m-85 64.17 177.58 0.18 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.323 -0.86 . . . . 0.0 109.478 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.9 -18.58 17.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.232 -0.917 . . . . 0.0 109.07 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.582 HG23 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -98.0 -176.49 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.338 -0.851 . . . . 0.0 108.896 179.609 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.477 ' HA ' ' OH ' ' A' ' 56' ' ' TYR . 12.6 t -151.37 86.42 1.35 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.108 -0.995 . . . . 0.0 109.52 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.668 ' CB ' ' HD2' ' A' ' 55' ' ' PRO . 0.3 OUTLIER -172.58 -176.56 0.34 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.072 -1.018 . . . . 0.0 109.53 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.668 ' HD2' ' CB ' ' A' ' 54' ' ' SER . 29.4 Cg_endo -71.79 96.36 0.76 Allowed 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 121.489 1.459 . . . . 0.0 108.55 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.559 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 24.0 m-85 -75.95 -170.94 1.5 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.777 0.798 . . . . 0.0 110.694 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.613 ' CE2' ' NE2' ' A' ' 27' ' ' HIS . 49.4 m-85 -150.72 147.18 27.03 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.664 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 1.2 mp0 -96.96 146.29 25.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.872 -1.142 . . . . 0.0 110.365 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.657 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 46.3 t-105 -159.45 135.7 6.36 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.657 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 31.9 Cg_endo -72.75 148.68 47.04 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 121.922 1.748 . . . . 0.0 111.115 -178.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.986 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -122.53 142.19 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.986 HD23 ' C ' ' A' ' 61' ' ' ILE . 1.4 mt -122.51 -170.67 2.12 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.249 -0.907 . . . . 0.0 109.383 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.57 54.8 0.93 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 108.928 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -157.75 -43.8 0.06 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.391 -0.818 . . . . 0.0 109.464 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.98 39.45 3.56 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.475 ' C ' HG23 ' A' ' 67' ' ' VAL . 0.5 OUTLIER -114.3 18.22 17.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -1.146 . . . . 0.0 109.464 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.475 HG23 ' C ' ' A' ' 66' ' ' ASP . 2.0 t 62.3 167.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.902 . . . . 0.0 109.693 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.631 ' HD1' HD11 ' A' ' 62' ' ' LEU . 6.1 t80 -106.86 139.13 41.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.343 -0.848 . . . . 0.0 109.591 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.8 m -122.46 -20.21 6.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.243 -0.911 . . . . 0.0 109.636 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 163.73 148.27 5.35 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 144.3 -142.95 11.51 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.445 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 20.3 m -51.89 118.15 11.26 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.217 -1.166 . . . . 0.0 109.323 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.518 ' O ' ' NH1' ' A' ' 77' ' ' ARG . 35.7 Cg_endo -77.72 -75.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.452 2.101 . . . . 0.0 110.571 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.553 ' CA ' ' HB2' ' A' ' 92' ' ' HIS . . . -59.13 -117.83 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.545 ' N ' ' HB2' ' A' ' 92' ' ' HIS . . . 49.54 -167.18 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.278 -1.131 . . . . 0.0 109.704 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.436 ' OD1' ' HB2' ' A' ' 6' ' ' CYS . 1.1 m-20 -42.04 147.82 0.21 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.276 -0.89 . . . . 0.0 109.864 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.518 ' NH1' ' O ' ' A' ' 73' ' ' PRO . 2.2 ttm180 -164.82 70.84 0.17 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.421 -0.799 . . . . 0.0 109.372 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.793 HG22 ' OE1' ' A' ' 20' ' ' GLN . 10.9 p -44.72 149.75 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 109.284 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 1.083 ' CG1' ' HB3' ' A' ' 87' ' ' ALA . 0.4 OUTLIER -121.0 171.92 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.02 -1.05 . . . . 0.0 110.338 -179.484 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.601 ' CD1' ' NE2' ' A' ' 20' ' ' GLN . 19.2 p90 -172.04 -167.52 0.49 Allowed 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.102 -178.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.522 ' N ' ' OD1' ' A' ' 81' ' ' ASN . 0.2 OUTLIER -132.54 -78.47 0.5 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.829 -1.17 . . . . 0.0 109.837 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.594 ' HA ' ' CE1' ' A' ' 24' ' ' TYR . 10.3 pt-20 -160.76 24.58 0.14 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.37 -0.831 . . . . 0.0 109.176 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.47 ' HB2' ' CG ' ' A' ' 85' ' ' GLN . 4.3 m120 -146.03 17.55 1.4 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.456 -0.777 . . . . 0.0 109.241 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.442 ' CG ' ' O ' ' A' ' 83' ' ' ASN . 8.3 p30 47.45 25.68 0.65 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.42 -0.8 . . . . 0.0 109.216 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.568 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -70.29 -27.6 64.53 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.609 HD22 ' HG2' ' A' ' 20' ' ' GLN . 0.1 OUTLIER 85.87 115.87 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.58 0.705 . . . . 0.0 110.739 179.044 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 1.083 ' HB3' ' CG1' ' A' ' 79' ' ' VAL . . . -96.3 -30.72 13.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.507 -0.746 . . . . 0.0 108.999 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.416 ' N ' ' CD1' ' A' ' 86' ' ' LEU . . . 158.08 -153.77 24.92 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.583 ' HB ' ' CE1' ' A' ' 4' ' ' TYR . 42.8 t -147.09 127.72 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.025 -1.279 . . . . 0.0 109.795 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.557 ' HB ' ' CD1' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -114.34 144.91 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.553 -0.717 . . . . 0.0 109.142 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.521 ' O ' HG23 ' A' ' 91' ' ' THR . 6.2 t -133.43 123.93 26.19 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.091 -1.006 . . . . 0.0 109.933 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.606 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -79.37 84.05 5.33 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.541 -0.724 . . . . 0.0 109.477 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 176.1 127.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.423 -0.798 . . . . 0.0 109.251 179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.98 -18.3 28.93 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.608 ' HB3' ' CB ' ' A' ' 99' ' ' ASN . . . -115.46 90.78 3.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.364 -1.08 . . . . 0.0 109.413 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.4 OUTLIER 43.95 78.95 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 109.346 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.91 -88.91 1.59 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.606 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -125.56 -90.55 0.55 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.213 -1.169 . . . . 0.0 109.376 179.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.608 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . 0.7 OUTLIER 61.08 136.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -0.961 . . . . 0.0 109.059 -179.584 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.557 ' CD1' ' HB ' ' A' ' 90' ' ' ILE . 21.8 m-85 -79.66 155.28 28.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.834 -1.166 . . . . 0.0 110.195 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -160.7 133.85 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.141 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -54.5 126.15 22.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.336 -0.853 . . . . 0.0 109.611 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 1.3 m -68.48 109.29 3.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.408 -0.808 . . . . 0.0 109.819 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.944 . . . . 0.0 109.477 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.507 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.8 p 167.14 130.33 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.218 -0.926 . . . . 0.0 110.065 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -103.87 -9.83 18.66 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.443 -0.786 . . . . 0.0 109.344 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.622 ' CD2' HG23 ' A' ' 89' ' ' VAL . 19.4 m-85 -109.54 132.16 54.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.308 -0.87 . . . . 0.0 109.247 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.448 HG23 ' H ' ' A' ' 10' ' ' CYS . 5.2 m -155.82 113.37 3.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.134 -0.979 . . . . 0.0 109.611 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.4 m -94.27 17.35 12.93 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 122.112 0.958 . . . . 0.0 109.691 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.91 -71.44 0.2 Allowed Glycine 0 C--N 1.283 -2.378 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.7 m -162.62 49.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.314 -1.11 . . . . 0.0 109.239 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.557 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . 6.9 m120 -103.12 -28.88 11.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.308 -0.87 . . . . 0.0 109.771 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.448 ' H ' HG23 ' A' ' 5' ' ' THR . 44.4 t 59.42 63.07 1.63 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.132 -0.98 . . . . 0.0 109.102 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.574 ' CE1' ' HB3' ' A' ' 63' ' ' SER . 40.8 m-85 -79.13 122.41 26.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.445 -0.784 . . . . 0.0 109.144 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.748 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -79.59 133.23 36.43 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.422 -0.799 . . . . 0.0 109.61 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.5 t -52.48 -19.93 2.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.202 -0.936 . . . . 0.0 109.063 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.54 -36.8 18.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 110.015 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -74.59 -27.13 60.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.009 -1.057 . . . . 0.0 108.194 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 12' ' ' SER . 19.3 t -69.5 -33.18 55.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -34.91 78.62 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -38.01 82.48 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.754 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -84.91 -7.67 59.07 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.571 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -90.73 -28.12 18.5 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.276 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -79.5 -11.83 59.89 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.729 ' HB1' HG13 ' A' ' 67' ' ' VAL . . . -80.22 -39.1 29.77 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.607 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -85.52 -15.46 66.06 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -88.7 -58.51 2.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.392 -1.064 . . . . 0.0 109.13 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.49 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -53.56 -35.2 60.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 109.298 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.418 ' HA ' HD22 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -68.17 -46.96 69.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.328 -0.858 . . . . 0.0 109.222 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -49.85 -42.27 47.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.413 -0.804 . . . . 0.0 110.229 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.39 -20.67 27.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.128 -0.983 . . . . 0.0 110.037 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.463 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 28.2 t0 -74.99 -20.23 59.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.128 -0.982 . . . . 0.0 109.54 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.92 19.7 78.54 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 29' ' ' ASP . 0.8 OUTLIER -103.91 -169.3 1.61 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.346 -1.09 . . . . 0.0 109.472 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.864 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -135.67 -170.69 2.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.322 -0.861 . . . . 0.0 109.288 179.71 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.596 ' H ' HG22 ' A' ' 32' ' ' THR . 64.2 t -89.86 -98.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.304 -0.873 . . . . 0.0 109.321 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -124.52 -8.64 5.77 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER 163.72 -46.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.281 -1.129 . . . . 0.0 109.315 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 37' ' ' SER . 1.6 m-80 -82.19 5.37 20.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.608 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.864 ' HA ' HG22 ' A' ' 32' ' ' THR . 81.6 p 45.29 -162.15 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.931 . . . . 0.0 108.876 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.587 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER 167.01 -44.31 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.142 -0.974 . . . . 0.0 111.911 179.243 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 31.1 Cg_endo -74.42 99.75 1.24 Allowed 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.466 1.444 . . . . 0.0 112.274 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.543 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -144.76 -173.89 4.19 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.284 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.575 ' HB2' ' CE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -96.45 126.04 41.37 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.041 -1.037 . . . . 0.0 109.966 -179.167 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.608 ' CE2' ' HA ' ' A' ' 44' ' ' ASN . 8.2 t80 -105.22 139.45 39.86 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.505 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 9.5 m120 -70.41 -46.71 63.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.171 -0.956 . . . . 0.0 110.098 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.608 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 0.2 OUTLIER 76.47 55.85 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.269 -0.894 . . . . 0.0 109.008 -179.403 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -106.09 46.84 0.9 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.269 -0.895 . . . . 0.0 109.483 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.529 ' OE2' ' CG1' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -101.12 -28.76 12.51 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.659 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.33 19.98 3.07 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.609 ' CD2' ' CZ ' ' A' ' 50' ' ' PHE . 59.7 m-85 -63.41 -169.15 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -154.43 36.54 0.42 Allowed 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 118.565 -1.254 . . . . 0.0 109.918 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.609 ' CZ ' ' CD2' ' A' ' 48' ' ' PHE . 6.7 m-85 -62.16 -175.14 0.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.038 -1.039 . . . . 0.0 109.41 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 p -144.72 35.38 1.15 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.384 -0.822 . . . . 0.0 109.038 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.543 HG13 ' HB2' ' A' ' 85' ' ' GLN . 68.8 t -92.9 -71.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.334 -0.853 . . . . 0.0 109.826 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 t -161.68 178.15 9.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.796 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.576 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -79.24 -51.45 1.26 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.349 -0.844 . . . . 0.0 110.654 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 54' ' ' SER . 34.6 Cg_endo -76.06 85.62 1.63 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 121.992 1.795 . . . . 0.0 110.352 -177.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.585 ' O ' ' CD1' ' A' ' 57' ' ' TYR . 48.2 m-85 -79.12 -178.37 6.11 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.394 0.616 . . . . 0.0 109.862 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.585 ' CD1' ' O ' ' A' ' 56' ' ' TYR . 48.3 m-85 -150.88 145.01 25.37 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -104.21 138.52 40.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.234 -0.916 . . . . 0.0 110.6 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.69 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 22.6 t-105 -160.8 138.93 7.23 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.69 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.9 Cg_endo -67.53 142.22 58.35 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.119 1.88 . . . . 0.0 111.274 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.911 HD12 ' N ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -118.63 131.67 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.729 -0.607 . . . . 0.0 109.417 -179.263 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.911 ' N ' HD12 ' A' ' 61' ' ' ILE . 2.9 mt -120.89 165.51 15.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.225 -0.922 . . . . 0.0 109.756 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.574 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 92.9 p -111.11 -1.88 16.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.086 -1.009 . . . . 0.0 108.816 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.58 -37.93 62.8 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.606 -0.683 . . . . 0.0 109.507 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.25 46.15 1.1 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.15 146.44 27.67 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.312 -1.11 . . . . 0.0 109.36 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.729 HG13 ' HB1' ' A' ' 22' ' ' ALA . 73.8 t -66.35 136.44 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.156 -0.965 . . . . 0.0 109.343 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.597 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 20.1 t80 -47.91 147.4 2.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.894 . . . . 0.0 109.638 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.574 ' HA ' HG12 ' A' ' 33' ' ' VAL . 5.4 t -174.82 54.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.529 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.2 119.45 4.62 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.1 -133.19 2.8 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.1 114.55 63.5 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.26 -1.141 . . . . 0.0 109.451 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.02 121.05 5.99 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.336 2.024 . . . . 0.0 110.362 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.516 ' O ' ' NH1' ' A' ' 77' ' ' ARG . . . 110.61 -138.48 14.95 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.558 ' N ' ' HB2' ' A' ' 92' ' ' HIS . . . 64.04 -86.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -1.116 . . . . 0.0 110.222 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.479 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 7.4 m-20 -132.52 110.48 10.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.939 -1.1 . . . . 0.0 110.157 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 60' ' ' PRO . 3.7 mpt_? -116.58 146.12 42.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.448 -0.782 . . . . 0.0 109.024 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.6 p -113.95 134.8 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.053 -1.029 . . . . 0.0 109.33 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.616 HG12 ' N ' ' A' ' 80' ' ' PHE . 58.4 t -97.4 166.04 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-O 121.95 0.881 . . . . 0.0 110.472 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.616 ' N ' HG12 ' A' ' 79' ' ' VAL . 7.1 p90 -164.83 -171.44 2.28 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -126.23 -83.47 0.62 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.842 -1.161 . . . . 0.0 109.977 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -151.43 8.59 0.53 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.418 -0.801 . . . . 0.0 110.37 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.401 ' HB3' ' HG2' ' A' ' 85' ' ' GLN . 4.8 t-20 -138.34 15.07 2.79 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.907 -1.121 . . . . 0.0 108.562 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.459 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 38.4 t30 59.04 30.97 20.92 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.42 -0.8 . . . . 0.0 109.063 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.561 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -63.84 -26.4 68.6 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.067 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.561 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER 85.81 109.0 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.488 0.661 . . . . 0.0 110.652 179.05 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.582 ' HB1' ' CD2' ' A' ' 50' ' ' PHE . . . -83.04 -37.79 23.43 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 153.01 168.25 16.69 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.622 HG23 ' CD2' ' A' ' 4' ' ' TYR . 44.9 t -104.46 102.36 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.158 -1.201 . . . . 0.0 109.343 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.556 HG22 ' CE2' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -93.31 168.44 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.428 -0.795 . . . . 0.0 109.889 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.725 HG22 HG23 ' A' ' 101' ' ' VAL . 5.4 t -106.48 -173.41 2.29 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.456 -0.778 . . . . 0.0 110.387 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.558 ' HB2' ' N ' ' A' ' 75' ' ' ALA . 0.5 OUTLIER -148.82 62.95 1.06 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 1.2 m 172.79 -28.61 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.758 -0.589 . . . . 0.0 109.883 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.9 -9.2 52.37 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 120.033 -1.079 . . . . 0.0 110.654 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -120.1 176.7 5.31 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.932 -1.334 . . . . 0.0 109.805 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.2 OUTLIER -41.53 124.37 2.43 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.676 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.18 -88.69 0.12 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 107.962 -2.055 . . . . 0.0 107.962 -178.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.554 ' HB3' ' O ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -165.56 38.24 0.06 Allowed 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.088 -1.243 . . . . 0.0 109.444 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 98' ' ' ASN . 12.3 t-20 -50.72 179.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.077 -1.015 . . . . 0.0 108.762 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -106.1 146.84 29.66 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.857 -1.152 . . . . 0.0 109.197 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.725 HG23 HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -160.27 140.88 3.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.458 ' OE2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -39.42 138.67 0.64 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.549 -0.719 . . . . 0.0 110.132 -179.119 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.454 ' SG ' ' HB ' ' A' ' 91' ' ' THR . 4.2 m -94.48 97.82 10.42 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.355 -0.841 . . . . 0.0 109.568 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 109.28 179.902 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.229 0.538 . . . . 0.0 109.654 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 32.0 p 178.2 133.02 0.07 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.356 -0.84 . . . . 0.0 109.843 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -94.96 -35.57 11.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 0.0 108.987 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.837 ' CD2' HG21 ' A' ' 89' ' ' VAL . 66.8 m-85 -92.34 81.87 4.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.36 -0.837 . . . . 0.0 109.017 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.754 HG23 ' O ' ' A' ' 5' ' ' THR . 9.8 t -93.98 89.56 6.11 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.321 -0.862 . . . . 0.0 110.149 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.436 ' CB ' ' OD1' ' A' ' 76' ' ' ASP . 0.1 OUTLIER -89.57 -165.05 1.25 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.904 . . . . 0.0 109.0 179.369 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.441 ' O ' ' OG ' ' A' ' 8' ' ' SER . . . -59.13 95.56 0.07 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.454 ' O ' ' OG ' ' A' ' 8' ' ' SER . 4.5 p 65.7 49.2 1.78 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -1.159 . . . . 0.0 109.648 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.432 ' ND2' ' OD2' ' A' ' 76' ' ' ASP . 0.2 OUTLIER -123.8 -71.85 0.7 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.358 -0.839 . . . . 0.0 109.283 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.46 ' C ' ' CB ' ' A' ' 2' ' ' CYS . 50.6 t 53.01 51.69 15.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 109.654 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.57 ' CD1' ' HB3' ' A' ' 63' ' ' SER . 4.3 m-85 -93.43 144.59 25.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.411 -0.805 . . . . 0.0 108.951 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.856 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -83.64 134.4 34.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 110.095 -179.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.2 p -50.85 -25.4 4.47 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.43 -42.63 61.78 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.316 -0.865 . . . . 0.0 108.944 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.31 -19.42 61.04 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 12' ' ' SER . 12.2 t -78.81 -29.02 14.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.454 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 0.6 OUTLIER -65.44 -34.39 78.18 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.228 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -53.7 27.54 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.731 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -62.08 -18.28 60.21 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.543 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -76.13 -37.48 57.97 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.289 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -74.64 -3.27 30.2 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.07 -63.21 1.39 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.378 -0.826 . . . . 0.0 108.776 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.631 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -62.38 -16.88 55.49 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.413 ' CD1' ' C ' ' A' ' 24' ' ' TYR . 1.1 t80 -83.34 -62.65 1.53 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.562 -0.963 . . . . 0.0 109.014 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 2.8 tt0 -48.38 -34.38 10.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.169 -0.957 . . . . 0.0 108.88 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.526 HD11 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -69.46 -44.57 70.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.506 -0.747 . . . . 0.0 109.51 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -59.27 -38.11 79.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.47 -0.769 . . . . 0.0 110.297 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -89.6 -14.79 34.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.105 -0.997 . . . . 0.0 110.352 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -83.48 -10.71 58.18 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.102 -0.999 . . . . 0.0 109.214 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 63.2 11.44 39.4 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -88.02 -144.66 0.13 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.403 -1.057 . . . . 0.0 109.057 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.526 ' N ' HD11 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -167.67 175.22 7.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.002 -1.061 . . . . 0.0 109.688 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.475 HG23 ' H ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -102.17 -94.68 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.235 -0.915 . . . . 0.0 109.87 -179.72 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.475 ' H ' HG23 ' A' ' 33' ' ' VAL . . . -88.77 32.83 4.4 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 1.2 m 67.61 8.59 6.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.195 -1.179 . . . . 0.0 109.332 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.4 ' O ' ' CB ' ' A' ' 37' ' ' SER . 2.4 m120 -102.03 -14.42 17.15 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.198 -0.939 . . . . 0.0 109.503 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.501 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.9 OUTLIER 68.28 105.15 0.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.866 . . . . 0.0 109.255 -179.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.64 ' H ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -116.66 -33.16 0.08 OUTLIER Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 114.274 1.212 . . . . 0.0 114.274 -178.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.64 ' CD ' ' H ' ' A' ' 38' ' ' TYR . 36.4 Cg_endo -80.62 101.88 1.35 Allowed 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.291 1.327 . . . . 0.0 112.734 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.594 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -135.11 -167.3 1.97 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.104 -0.997 . . . . 0.0 109.259 177.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 8.8 ptmm? -76.33 179.03 6.06 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.496 -0.753 . . . . 0.0 109.654 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.794 ' CD2' HG21 ' A' ' 79' ' ' VAL . 7.0 t80 -139.21 98.02 3.42 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.322 -0.861 . . . . 0.0 108.894 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.528 ' O ' ' CE1' ' A' ' 45' ' ' TYR . 8.1 m120 -61.29 -20.2 62.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.423 -0.798 . . . . 0.0 109.772 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.613 ' O ' ' CB ' ' A' ' 45' ' ' TYR . 10.2 p-10 40.24 -144.0 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.534 -0.729 . . . . 0.0 109.901 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.613 ' CB ' ' O ' ' A' ' 44' ' ' ASN . 18.4 m-30 107.11 -20.76 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.603 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 2.2 tm-20 -40.4 -33.46 0.26 Allowed 'General case' 0 C--N 1.309 -1.189 0 O-C-N 121.06 -1.025 . . . . 0.0 110.343 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.73 -15.74 0.72 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.603 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -104.02 159.91 15.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.104 -1.233 . . . . 0.0 108.815 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.491 ' C ' ' CG ' ' A' ' 50' ' ' PHE . 1.4 t0 -143.88 -36.3 0.35 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.199 -0.938 . . . . 0.0 109.837 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.491 ' CG ' ' C ' ' A' ' 49' ' ' ASP . 5.5 m-85 74.82 177.63 0.22 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.137 -0.977 . . . . 0.0 109.457 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.98 41.2 3.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.177 -0.952 . . . . 0.0 109.535 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.538 HG12 ' N ' ' A' ' 53' ' ' SER . 3.3 t -100.97 -72.19 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.334 -0.854 . . . . 0.0 109.337 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.538 ' N ' HG12 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -159.09 167.91 27.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.093 -1.004 . . . . 0.0 110.174 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.571 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -75.99 -52.32 2.62 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.462 -0.774 . . . . 0.0 110.364 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 54' ' ' SER . 35.5 Cg_endo -76.42 83.6 2.01 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.055 1.837 . . . . 0.0 109.72 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.633 ' CE1' ' CB ' ' A' ' 87' ' ' ALA . 31.1 m-85 -79.51 176.2 9.91 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.549 0.69 . . . . 0.0 110.05 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.574 ' CD1' ' O ' ' A' ' 81' ' ' ASN . 89.9 m-85 -142.56 129.03 20.14 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 0.3 OUTLIER -89.11 136.57 32.94 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.906 0.86 . . . . 0.0 111.063 -178.242 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.688 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 39.3 t-105 -160.39 135.79 5.83 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.688 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.6 Cg_endo -70.21 147.1 59.26 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.055 1.837 . . . . 0.0 111.272 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 1.065 HD12 ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -110.0 130.05 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.065 ' N ' HD12 ' A' ' 61' ' ' ILE . 1.1 mt -138.61 119.3 14.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.347 -0.845 . . . . 0.0 108.953 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.57 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.3 t -126.34 73.67 1.39 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.685 -0.634 . . . . 0.0 109.429 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 173.43 -31.57 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.152 -0.967 . . . . 0.0 109.371 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.18 -74.81 0.83 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.05 -150.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -1.145 . . . . 0.0 109.529 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.429 ' O ' ' N ' ' A' ' 69' ' ' SER . 13.6 t -96.51 145.1 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.336 -0.853 . . . . 0.0 109.492 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.547 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 82.3 t80 -50.28 97.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.0 109.467 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 67' ' ' VAL . 1.2 p -132.66 26.88 4.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 109.437 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.19 79.69 0.42 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -156.25 -123.12 0.78 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.8 t -127.22 102.07 24.47 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.256 -1.143 . . . . 0.0 109.246 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.516 ' HB2' ' OH ' ' A' ' 38' ' ' TYR . 34.2 Cg_endo -76.55 -159.07 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.323 2.016 . . . . 0.0 110.551 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.483 ' O ' ' N ' ' A' ' 76' ' ' ASP . . . 66.09 -145.87 48.36 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.466 ' N ' ' HB3' ' A' ' 92' ' ' HIS . . . 48.11 -95.18 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.08 -1.247 . . . . 0.0 109.768 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 91' ' ' THR . 59.7 m-20 -111.05 139.91 46.03 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.861 -1.149 . . . . 0.0 110.208 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.732 ' HA ' HG22 ' A' ' 61' ' ' ILE . 57.8 mtp180 -156.91 159.32 38.02 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.41 HG23 ' HA ' ' A' ' 89' ' ' VAL . 13.1 p -134.74 145.1 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.804 -1.185 . . . . 0.0 110.03 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.89 HG23 ' CD1' ' A' ' 90' ' ' ILE . 3.0 t -106.24 165.05 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 122.106 0.955 . . . . 0.0 109.861 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.615 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 4.0 p90 -156.09 -169.02 2.93 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.753 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.574 ' O ' ' CD1' ' A' ' 57' ' ' TYR . 10.6 t30 -107.41 -80.05 0.57 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.007 -1.058 . . . . 0.0 110.179 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.502 ' HG3' ' ND2' ' A' ' 81' ' ' ASN . 1.3 pp20? -167.85 23.62 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.428 -0.795 . . . . 0.0 109.546 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.515 ' O ' ' CB ' ' A' ' 84' ' ' ASN . 1.2 m120 -149.49 21.72 0.93 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 109.072 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 83' ' ' ASN . 0.1 OUTLIER 80.72 8.11 1.27 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.55 -0.719 . . . . 0.0 109.438 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.504 ' OE1' ' HB2' ' A' ' 83' ' ' ASN . 6.3 mp0 -56.91 -165.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -0.985 . . . . 0.0 108.943 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.424 ' O ' HG21 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -139.56 107.6 5.72 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.957 -1.089 . . . . 0.0 110.098 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.633 ' CB ' ' CE1' ' A' ' 56' ' ' TYR . . . -80.87 -43.01 20.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.427 -0.796 . . . . 0.0 108.925 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 162.26 142.47 3.4 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.837 HG21 ' CD2' ' A' ' 4' ' ' TYR . 60.1 t -81.95 97.26 3.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.116 -1.226 . . . . 0.0 109.976 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.89 ' CD1' HG23 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -78.6 179.85 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.105 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 1.098 HG22 ' O ' ' A' ' 101' ' ' VAL . 12.4 t -135.81 -131.98 0.15 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.916 -1.115 . . . . 0.0 108.457 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.817 ' CD2' ' HB2' ' A' ' 95' ' ' ALA . 0.2 OUTLIER 163.57 42.32 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 -179.657 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.4 m -77.55 97.27 4.99 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.695 0.759 . . . . 0.0 109.713 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.502 ' O ' ' C ' ' A' ' 95' ' ' ALA . . . 93.55 -29.91 7.91 Favored Glycine 0 C--N 1.297 -1.592 0 N-CA-C 107.753 -2.139 . . . . 0.0 107.753 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.817 ' HB2' ' CD2' ' A' ' 92' ' ' HIS . . . 34.45 -154.97 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.3 -0.529 . . . . 0.0 109.873 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.455 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.6 OUTLIER 46.01 47.53 12.67 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -179.034 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.98 -25.64 2.65 Favored Glycine 0 N--CA 1.483 1.828 0 N-CA-C 106.026 -2.83 . . . . 0.0 106.026 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 1.001 ' O ' HG13 ' A' ' 101' ' ' VAL . 7.8 m120 -105.65 -29.77 9.9 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.531 ' OD1' ' HG3' ' A' ' 46' ' ' GLU . 11.5 p-10 37.21 -146.1 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.706 ' CD1' ' CE1' ' A' ' 42' ' ' TYR . 5.3 m-85 -75.78 77.15 2.73 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 1.098 ' O ' HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -85.36 131.82 33.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.392 -0.818 . . . . 0.0 108.969 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -43.71 151.51 0.19 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.527 -1.358 . . . . 0.0 109.717 -179.049 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 1.2 m -75.71 92.25 2.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.924 . . . . 0.0 109.37 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.869 . . . . 0.0 109.437 -179.934 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.51 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.8 p 163.37 121.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.355 -0.841 . . . . 0.0 109.67 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -105.4 3.52 29.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.91 . . . . 0.0 109.431 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.588 ' CD1' HG21 ' A' ' 89' ' ' VAL . 11.4 m-85 -119.69 104.63 10.42 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.119 -0.988 . . . . 0.0 109.625 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.715 HG22 ' H ' ' A' ' 7' ' ' GLY . 98.5 m -143.85 123.34 13.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.093 -1.004 . . . . 0.0 109.421 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -91.97 9.81 31.56 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.163 -0.961 . . . . 0.0 109.945 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.715 ' H ' HG22 ' A' ' 5' ' ' THR . . . -177.39 -62.64 0.06 OUTLIER Glycine 0 C--N 1.282 -2.43 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.434 ' HA ' HG21 ' A' ' 5' ' ' THR . 3.6 m -174.46 30.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -1.129 . . . . 0.0 109.51 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.608 ' H ' HG23 ' A' ' 5' ' ' THR . 8.4 m-80 -80.02 -24.49 40.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.923 . . . . 0.0 109.371 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 9' ' ' ASN . 37.8 t 58.87 68.49 0.81 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.37 -0.832 . . . . 0.0 109.574 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.558 ' CE1' ' HB3' ' A' ' 9' ' ' ASN . 11.0 m-85 -89.47 132.94 34.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.131 -0.98 . . . . 0.0 109.259 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.588 ' O ' HG23 ' A' ' 16' ' ' VAL . 15.3 t -83.07 130.5 35.13 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.368 -0.832 . . . . 0.0 109.859 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 p -56.36 -17.57 8.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.304 -0.872 . . . . 0.0 109.287 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.7 -32.55 21.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.89 . . . . 0.0 109.575 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.435 ' O ' ' OG1' ' A' ' 18' ' ' THR . 0.5 OUTLIER -77.13 -37.33 54.26 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.305 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 12' ' ' SER . 28.8 t -51.9 -37.44 21.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.99 -43.29 99.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.576 -0.702 . . . . 0.0 109.339 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -59.17 -47.4 85.44 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.72 ' CB ' HD13 ' A' ' 61' ' ' ILE . . . -70.82 -15.2 62.63 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.59 ' NE2' ' CG1' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -89.65 -12.77 38.65 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.533 -0.729 . . . . 0.0 109.096 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -94.1 -20.92 19.46 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.08 -61.24 2.05 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.59 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -55.93 -24.94 43.99 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -73.83 -46.4 45.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.623 -0.928 . . . . 0.0 109.256 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -66.16 -63.63 1.04 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.373 -0.829 . . . . 0.0 108.906 179.757 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.859 HD21 ' C ' ' A' ' 32' ' ' THR . 3.3 tp -44.2 -33.93 1.7 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.302 -0.874 . . . . 0.0 109.068 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.618 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -63.86 -59.77 4.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.323 -0.861 . . . . 0.0 109.254 179.772 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.5 11.84 7.98 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.511 -0.743 . . . . 0.0 109.542 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -100.53 -24.01 14.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -0.919 . . . . 0.0 109.448 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.0 -16.76 45.57 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.43 -148.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.247 -1.149 . . . . 0.0 109.277 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.988 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.1 OUTLIER -170.61 -176.09 2.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.397 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.498 HG23 ' H ' ' A' ' 35' ' ' SER . 19.0 m -89.74 -126.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.143 -0.973 . . . . 0.0 109.606 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.403 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -130.34 -4.04 4.58 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.085 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.498 ' H ' HG23 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -109.86 -93.09 0.43 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.023 -1.281 . . . . 0.0 109.128 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -130.62 58.78 1.68 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.321 -0.862 . . . . 0.0 108.969 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.988 ' HA ' HG22 ' A' ' 32' ' ' THR . 4.2 t 57.71 -158.75 0.27 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.309 -0.87 . . . . 0.0 109.019 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.586 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER 166.84 -43.96 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 112.168 179.284 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 32.0 Cg_endo -75.2 100.66 1.39 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.353 1.368 . . . . 0.0 112.367 -178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.553 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -143.93 175.12 10.26 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.143 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -72.25 157.76 37.1 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.044 -1.035 . . . . 0.0 110.044 -179.391 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.506 ' OH ' ' CD1' ' A' ' 100' ' ' PHE . 87.3 t80 -145.93 89.6 1.91 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.438 -0.789 . . . . 0.0 109.19 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.522 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 32.3 m120 -52.29 -88.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.171 -0.956 . . . . 0.0 110.169 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.524 ' N ' ' OD1' ' A' ' 44' ' ' ASN . 2.4 p30 161.97 135.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.175 -0.953 . . . . 0.0 109.276 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -131.05 -0.91 4.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.077 -1.014 . . . . 0.0 109.862 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.497 ' O ' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -100.73 -19.35 16.07 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.191 -0.943 . . . . 0.0 108.62 -179.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.26 23.88 7.1 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.581 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 18.4 m-85 -63.85 87.16 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 50' ' ' PHE . 5.7 t70 -54.57 -32.25 58.2 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.839 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.902 ' CD2' ' HB1' ' A' ' 87' ' ' ALA . 9.8 m-30 44.93 -170.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.357 -0.84 . . . . 0.0 109.607 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -151.55 32.28 0.57 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -0.951 . . . . 0.0 109.454 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.5 t -113.48 -86.62 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.833 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.576 ' O ' ' CZ ' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -152.76 164.89 36.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.103 -0.998 . . . . 0.0 109.762 -179.77 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.59 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -62.22 -51.96 70.26 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.386 -0.821 . . . . 0.0 110.395 179.85 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 54' ' ' SER . 36.3 Cg_endo -76.18 80.77 2.6 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.072 1.848 . . . . 0.0 110.716 -178.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.576 ' CZ ' ' O ' ' A' ' 53' ' ' SER . 93.3 m-85 -78.85 -164.63 0.62 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.618 ' CE1' ' NE2' ' A' ' 27' ' ' HIS . 60.4 m-85 -156.1 113.94 3.31 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.519 -0.738 . . . . 0.0 109.266 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -82.91 137.59 34.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.254 -0.904 . . . . 0.0 110.447 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.67 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 10.0 t-105 -160.7 140.65 8.27 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.67 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.5 Cg_endo -69.75 130.52 19.5 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.202 1.935 . . . . 0.0 111.45 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.945 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -111.56 130.25 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.945 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.3 OUTLIER -120.7 168.71 11.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.157 -0.964 . . . . 0.0 109.595 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.484 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 12.3 t -121.38 26.92 8.59 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.7 -55.74 0.05 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.601 -0.687 . . . . 0.0 109.309 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 66' ' ' ASP . . . -72.95 -4.34 62.28 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.417 ' C ' ' OD1' ' A' ' 66' ' ' ASP . 49.5 t0 60.51 -99.88 0.1 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -1.161 . . . . 0.0 109.731 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.9 t -81.26 151.97 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.957 -1.089 . . . . 0.0 109.473 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.585 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 31.5 t80 -82.68 124.23 30.01 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.131 -0.98 . . . . 0.0 109.833 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 99.8 p -119.97 -3.19 10.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.464 -0.773 . . . . 0.0 109.266 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.49 130.64 3.49 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 154.39 86.47 0.06 OUTLIER Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.0 t 51.73 93.03 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.181 -1.188 . . . . 0.0 109.767 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.57 -169.4 0.77 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.708 2.272 . . . . 0.0 110.818 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.647 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 77.64 -170.17 54.93 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 71.63 -162.21 0.13 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.149 -1.206 . . . . 0.0 110.765 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.503 ' N ' ' OG1' ' A' ' 91' ' ' THR . 14.9 m-20 -36.51 154.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.547 0.689 . . . . 0.0 111.106 -178.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.603 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 10.0 ttm105 -177.92 70.4 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.484 -0.76 . . . . 0.0 109.019 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.662 ' CG2' HD11 ' A' ' 86' ' ' LEU . 1.4 p -53.72 166.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.813 -1.179 . . . . 0.0 109.741 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.731 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -126.84 176.88 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.275 -0.89 . . . . 0.0 109.838 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.611 ' CE1' ' O ' ' A' ' 57' ' ' TYR . 8.7 p90 -164.51 -171.69 2.43 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.125 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.442 ' C ' ' HG2' ' A' ' 82' ' ' GLU . 21.8 t30 -129.4 -80.08 0.56 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.038 -1.039 . . . . 0.0 110.06 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.442 ' HG2' ' C ' ' A' ' 81' ' ' ASN . 65.3 mm-40 -149.2 11.12 0.8 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.374 -0.829 . . . . 0.0 110.235 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.49 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 3.6 t-20 -147.74 15.64 1.1 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.026 -1.046 . . . . 0.0 109.567 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.49 ' OD1' ' O ' ' A' ' 83' ' ' ASN . 0.2 OUTLIER 68.16 12.42 8.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.307 -0.871 . . . . 0.0 109.363 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.547 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 1.8 mt-30 -45.95 -31.87 2.43 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.662 HD11 ' CG2' ' A' ' 78' ' ' VAL . 0.1 OUTLIER 85.13 104.1 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.479 0.657 . . . . 0.0 109.952 179.569 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.902 ' HB1' ' CD2' ' A' ' 50' ' ' PHE . . . -77.34 -33.62 55.41 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.372 -0.83 . . . . 0.0 109.14 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 149.55 160.87 9.43 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.588 HG21 ' CD1' ' A' ' 4' ' ' TYR . 4.9 t -85.97 106.06 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.203 -1.174 . . . . 0.0 110.127 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.603 ' CG1' ' O ' ' A' ' 77' ' ' ARG . 14.6 pt -108.38 138.71 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.702 HG22 HG23 ' A' ' 101' ' ' VAL . 4.4 t -120.88 175.06 6.23 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.959 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.597 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -115.36 68.62 0.71 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.407 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.535 ' HB ' ' O ' ' A' ' 92' ' ' HIS . 13.7 t 172.5 158.93 0.11 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 98.48 -21.4 46.19 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.772 -1.204 . . . . 0.0 110.403 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.753 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -125.32 -171.92 2.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.056 -1.261 . . . . 0.0 109.423 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 95' ' ' ALA . 20.4 m -42.02 111.18 0.21 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -0.842 . . . . 0.0 108.905 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 63.76 -105.68 1.16 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.597 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -132.14 35.35 3.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.241 -1.152 . . . . 0.0 108.771 178.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.753 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 4.4 t-20 -45.58 170.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.306 -0.871 . . . . 0.0 109.436 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.542 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 13.1 m-85 -92.4 149.19 21.56 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.212 -0.93 . . . . 0.0 109.534 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.702 HG23 HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -156.12 148.56 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 1.0 OUTLIER -82.38 122.08 27.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.431 -0.793 . . . . 0.0 109.857 -179.584 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.559 ' O ' HG23 ' A' ' 104' ' ' THR . 80.5 m -43.51 121.23 2.21 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.325 -0.859 . . . . 0.0 109.538 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 103' ' ' CYS . 13.7 p . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.124 -0.985 . . . . 0.0 109.535 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.432 ' C ' ' SG ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.293 0.568 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 0.8 OUTLIER 174.0 124.56 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.306 -0.871 . . . . 0.0 110.152 179.685 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -87.53 -36.39 17.62 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.356 -0.84 . . . . 0.0 109.051 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.818 ' CG ' HG21 ' A' ' 89' ' ' VAL . 41.5 m-85 -82.35 115.66 21.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.355 -0.84 . . . . 0.0 109.394 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.493 HG22 ' O ' ' A' ' 9' ' ' ASN . 1.1 p -150.18 122.88 8.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.403 -0.811 . . . . 0.0 109.643 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -112.08 10.28 20.36 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.241 1.02 . . . . 0.0 109.641 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 172.73 -96.23 0.11 Allowed Glycine 0 C--N 1.282 -2.445 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -123.2 23.4 9.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -1.109 . . . . 0.0 109.231 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.493 ' O ' HG22 ' A' ' 5' ' ' THR . 4.5 m-80 -96.76 106.57 18.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.895 . . . . 0.0 109.819 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 47.8 t -78.33 78.47 4.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.346 -0.846 . . . . 0.0 109.417 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.411 ' CE2' ' HB3' ' A' ' 9' ' ' ASN . 14.6 m-85 -98.31 110.15 22.78 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.432 -0.792 . . . . 0.0 109.003 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.584 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -84.66 128.95 34.86 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.174 -0.954 . . . . 0.0 109.956 -179.619 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 12' ' ' SER . 1.1 p -41.17 -27.6 0.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 12' ' ' SER . 5.3 t -69.74 -50.43 43.54 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.349 -0.844 . . . . 0.0 109.623 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.34 -22.74 65.58 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 12' ' ' SER . 17.8 t -78.0 -29.47 15.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.404 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 46.7 t -61.39 -46.44 90.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.568 -0.708 . . . . 0.0 109.412 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.2 -53.26 60.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.923 . . . . 0.0 108.606 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.548 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -66.97 -15.49 63.74 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.581 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -74.89 -37.99 61.99 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.531 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.8 -6.05 52.82 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.91 -62.13 1.8 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.375 -0.828 . . . . 0.0 109.075 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.565 ' HA3' ' CD2' ' A' ' 59' ' ' TRP . . . -58.33 -25.15 57.17 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.484 ' CE2' ' O ' ' A' ' 82' ' ' GLU . 2.8 t80 -73.15 -44.49 59.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.408 -1.054 . . . . 0.0 109.44 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' A' ' 26' ' ' LEU . 0.7 OUTLIER -55.7 -69.68 0.13 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.487 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.486 HD11 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -42.38 -45.19 4.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.415 -0.803 . . . . 0.0 109.971 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -52.7 -54.6 31.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.299 -0.875 . . . . 0.0 110.518 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.66 -3.07 49.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.099 -1.001 . . . . 0.0 109.9 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -87.2 8.01 25.81 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.108 -0.995 . . . . 0.0 109.618 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 48.86 27.53 6.53 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.475 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -125.67 -158.21 0.83 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.458 -1.025 . . . . 0.0 109.405 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.695 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -147.62 -174.64 4.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.915 . . . . 0.0 109.256 179.727 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' A' ' 34' ' ' GLY . 33.8 m -103.71 171.68 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.065 -1.022 . . . . 0.0 109.831 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -45.04 -38.39 6.05 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 36' ' ' ASN . 0.6 OUTLIER -78.51 175.55 10.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -1.098 . . . . 0.0 109.474 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' A' ' 37' ' ' SER . 20.2 m-20 -43.86 -48.19 8.33 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.261 -0.899 . . . . 0.0 109.115 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.695 ' HA ' HG22 ' A' ' 32' ' ' THR . 5.8 t 176.04 -164.12 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.591 ' CA ' ' CE1' ' A' ' 40' ' ' HIS . 0.2 OUTLIER 170.19 -45.12 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.083 -1.01 . . . . 0.0 112.213 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.58 ' HD2' ' H ' ' A' ' 38' ' ' TYR . 31.7 Cg_endo -75.41 97.0 1.06 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 121.002 1.134 . . . . 0.0 111.656 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.591 ' CE1' ' CA ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -139.61 -179.52 5.96 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.559 ' HA ' ' CD1' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -69.6 162.12 28.24 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.333 -0.854 . . . . 0.0 110.038 -179.32 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.616 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 18.1 t80 -127.61 152.85 47.13 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.525 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 3.3 p-10 -165.59 95.48 0.63 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.977 -1.077 . . . . 0.0 109.829 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.616 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 0.6 OUTLIER -135.71 -41.12 0.69 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.335 -0.853 . . . . 0.0 109.433 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.58 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 0.0 OUTLIER 42.65 26.47 0.07 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.402 -0.811 . . . . 0.0 110.018 179.696 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -39.95 -27.63 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 O-C-N 121.319 -0.863 . . . . 0.0 109.984 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 45' ' ' TYR . . . 167.69 -23.82 0.11 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.558 ' CZ ' ' HA ' ' A' ' 101' ' ' VAL . 0.1 OUTLIER -92.46 49.94 1.55 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.447 -1.031 . . . . 0.0 109.211 179.591 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.53 103.14 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -0.879 . . . . 0.0 109.454 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 1.053 ' CD2' ' HB1' ' A' ' 87' ' ' ALA . 12.7 m-85 -65.87 164.09 15.6 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.259 -0.901 . . . . 0.0 109.306 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.3 t -108.63 23.45 14.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 0.0 109.868 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.515 ' CG1' ' HB3' ' A' ' 81' ' ' ASN . 14.2 t -80.53 -58.48 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.091 -1.006 . . . . 0.0 109.377 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -175.38 172.12 2.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 109.682 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.595 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -69.57 -53.41 12.57 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.357 -0.839 . . . . 0.0 110.155 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 54' ' ' SER . 35.8 Cg_endo -74.82 90.39 1.07 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.972 1.781 . . . . 0.0 110.034 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.534 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 30.3 m-85 -78.61 -170.34 2.06 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.559 ' CD1' ' HA ' ' A' ' 41' ' ' LYS . 57.9 m-85 -157.7 111.92 2.61 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -82.52 139.82 33.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.454 -0.779 . . . . 0.0 110.388 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.704 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 35.7 t-105 -160.86 139.36 7.42 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.704 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 32.0 Cg_endo -71.02 145.26 49.41 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.215 1.943 . . . . 0.0 111.434 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.977 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -108.38 138.15 36.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.977 HD23 ' C ' ' A' ' 61' ' ' ILE . 1.1 mt -124.91 168.69 12.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.044 -1.035 . . . . 0.0 109.965 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.16 0.17 9.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.035 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.69 -166.54 1.42 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.383 -0.823 . . . . 0.0 109.197 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.27 59.2 0.48 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.673 ' O ' HD12 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -158.9 106.18 1.82 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.173 -1.193 . . . . 0.0 109.799 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.527 HG13 ' HZ2' ' A' ' 59' ' ' TRP . 77.5 t -52.4 143.41 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -0.893 . . . . 0.0 108.931 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.659 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 42.9 t80 -45.95 120.85 2.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.875 -1.141 . . . . 0.0 109.43 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.6 p -165.95 29.9 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.464 -0.773 . . . . 0.0 109.291 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -116.03 -67.08 0.4 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.434 ' C ' ' OG ' ' A' ' 72' ' ' SER . . . 148.47 151.44 5.46 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.434 ' OG ' ' C ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER 51.11 92.62 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.37 -1.077 . . . . 0.0 110.085 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.534 ' CD ' ' OH ' ' A' ' 38' ' ' TYR . 35.0 Cg_endo -79.11 -72.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.897 2.398 . . . . 0.0 109.642 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 101.68 98.1 2.35 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.614 ' HB2' ' HB ' ' A' ' 93' ' ' THR . . . 61.69 -149.88 0.39 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.292 -1.122 . . . . 0.0 110.262 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.542 ' O ' ' O ' ' A' ' 75' ' ' ALA . 2.4 m-20 28.29 108.62 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 121.524 0.678 . . . . 0.0 112.584 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.497 ' O ' HG12 ' A' ' 90' ' ' ILE . 2.0 ttm-85 -154.0 111.28 3.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.014 -1.053 . . . . 0.0 109.003 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 89' ' ' VAL . 7.7 p -91.34 154.99 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.059 -1.026 . . . . 0.0 109.495 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.932 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 52.6 t -120.35 166.98 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.275 -0.891 . . . . 0.0 109.923 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.615 ' N ' HG12 ' A' ' 79' ' ' VAL . 10.8 p90 -169.6 -177.32 2.69 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.755 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.543 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -124.25 -38.79 2.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.433 -0.792 . . . . 0.0 109.529 -179.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.543 ' CG ' ' O ' ' A' ' 81' ' ' ASN . 4.0 mt-10 162.44 -27.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.442 -0.786 . . . . 0.0 108.936 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.545 ' HB3' ' HG2' ' A' ' 85' ' ' GLN . 1.1 t-20 -98.58 19.76 14.05 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.516 -0.74 . . . . 0.0 109.135 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 6.2 p30 52.42 23.29 2.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.827 -0.545 . . . . 0.0 110.028 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.545 ' HG2' ' HB3' ' A' ' 83' ' ' ASN . 1.6 mt-30 -55.2 -31.82 61.73 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.547 HD22 ' HG3' ' A' ' 20' ' ' GLN . 0.1 OUTLIER 84.79 104.54 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.406 0.622 . . . . 0.0 110.912 179.135 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 1.053 ' HB1' ' CD2' ' A' ' 50' ' ' PHE . . . -73.26 -44.58 59.07 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.413 ' O ' HG23 ' A' ' 78' ' ' VAL . . . 166.43 -154.38 24.84 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.924 -1.671 . . . . 0.0 108.924 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.818 HG21 ' CG ' ' A' ' 4' ' ' TYR . 34.9 t -138.1 81.19 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.093 -1.239 . . . . 0.0 109.532 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.586 HD13 ' CG2' ' A' ' 79' ' ' VAL . 0.7 OUTLIER -80.06 152.14 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.333 -0.854 . . . . 0.0 108.802 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.421 ' CG2' HG23 ' A' ' 101' ' ' VAL . 0.8 OUTLIER -116.38 138.96 50.92 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.108 -0.995 . . . . 0.0 111.378 -178.256 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.617 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.1 OUTLIER -86.62 59.3 5.56 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.543 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.614 ' HB ' ' HB2' ' A' ' 75' ' ' ALA . 3.5 m -176.32 -31.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.208 -0.932 . . . . 0.0 109.692 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.72 -17.23 13.78 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.639 ' HB3' ' CB ' ' A' ' 99' ' ' ASN . . . -121.81 174.17 7.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -1.167 . . . . 0.0 109.747 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 95' ' ' ALA . 2.7 t -39.86 128.18 2.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.575 -0.703 . . . . 0.0 109.317 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 63.38 -88.59 0.06 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.617 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -139.44 -64.24 0.5 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -1.182 . . . . 0.0 109.552 179.685 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.639 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . 1.0 OUTLIER 47.35 -172.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.138 -0.977 . . . . 0.0 109.189 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -131.38 131.89 44.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.154 -0.966 . . . . 0.0 109.708 179.595 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.558 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 0.7 OUTLIER -147.25 131.66 10.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.353 -0.842 . . . . 0.0 108.856 179.385 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -51.97 133.79 32.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.901 . . . . 0.0 109.817 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 8.0 m -65.48 148.52 51.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.321 -0.862 . . . . 0.0 109.569 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 31.2 p . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 116.719 -1.61 . . . . 0.0 109.408 179.906 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.533 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 1.8 p 163.52 142.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.355 -0.84 . . . . 0.0 109.545 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' A' ' 3' ' ' ASP . 41.7 t0 -104.51 -41.66 5.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 109.559 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.715 ' CG ' HG21 ' A' ' 89' ' ' VAL . 34.6 m-85 -83.36 128.76 34.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.924 . . . . 0.0 109.54 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -137.19 110.38 7.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.303 -0.873 . . . . 0.0 109.274 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.3 m -106.51 13.79 27.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.12 -0.987 . . . . 0.0 109.95 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 128.73 92.59 0.71 Allowed Glycine 0 C--N 1.283 -2.369 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 54.18 27.74 8.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.368 -1.078 . . . . 0.0 109.532 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -93.59 -43.74 8.54 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.303 -0.873 . . . . 0.0 109.496 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 10' ' ' CYS . 47.8 t 49.98 49.28 20.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 109.219 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.575 ' CE1' ' OG ' ' A' ' 63' ' ' SER . 6.4 m-30 -87.38 120.6 28.84 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.433 -0.792 . . . . 0.0 109.38 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.655 ' O ' HG23 ' A' ' 16' ' ' VAL . 17.8 t -85.18 118.34 24.67 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.267 -0.895 . . . . 0.0 109.235 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.477 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 3.7 p -41.52 -26.16 0.06 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.557 -0.715 . . . . 0.0 109.614 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -61.67 -54.92 36.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.147 -0.971 . . . . 0.0 109.185 179.407 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -69.8 -25.91 64.0 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.78 HG12 ' NE2' ' A' ' 20' ' ' GLN . 18.9 t -68.24 -25.07 30.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.55 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 0.1 OUTLIER -65.45 -44.5 87.05 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.3 m -59.2 -51.16 71.18 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.467 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -65.94 -16.42 63.85 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.817 ' NE2' HG11 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -82.26 -25.14 34.35 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.611 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.37 -7.83 58.15 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.298 -0.876 . . . . 0.0 108.664 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.7 -63.72 1.28 Allowed 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.603 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -50.9 -30.17 21.64 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.484 ' O ' ' HB3' ' A' ' 27' ' ' HIS . 3.1 t80 -74.14 -56.31 5.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.386 -1.067 . . . . 0.0 108.816 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.472 ' HG2' ' OD1' ' A' ' 29' ' ' ASP . 5.0 tt0 -53.05 -67.64 0.24 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.422 -0.799 . . . . 0.0 109.126 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.482 ' HA ' HD12 ' A' ' 26' ' ' LEU . 4.8 tp -42.96 -37.21 1.8 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.301 -0.875 . . . . 0.0 109.598 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.63 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 3.2 t60 -61.51 -53.18 59.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.174 -0.954 . . . . 0.0 110.134 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -86.93 6.9 29.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.352 -0.843 . . . . 0.0 110.122 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.472 ' OD1' ' HG2' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -98.04 -16.85 19.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.022 -1.049 . . . . 0.0 109.579 -179.79 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.16 -11.15 58.77 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.594 ' HG3' ' N ' ' A' ' 32' ' ' THR . 31.9 tp10 -84.96 164.86 18.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -1.134 . . . . 0.0 109.201 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.711 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -129.85 171.44 12.72 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.498 -0.751 . . . . 0.0 109.798 -179.746 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.455 ' HB ' ' HA ' ' A' ' 69' ' ' SER . 33.0 m -81.27 166.8 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.437 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -53.87 -29.32 42.16 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.413 ' HB2' ' HA2' ' A' ' 70' ' ' GLY . 0.6 OUTLIER -73.92 -144.36 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -1.141 . . . . 0.0 109.204 179.79 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.457 ' O ' ' CB ' ' A' ' 37' ' ' SER . 2.9 m120 -102.11 60.49 0.85 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.961 -1.087 . . . . 0.0 109.803 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.711 ' HA ' HG22 ' A' ' 32' ' ' THR . 6.2 t 70.97 -168.97 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.553 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.634 ' CZ ' ' CB ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER 165.07 -41.96 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.33 -0.856 . . . . 0.0 112.206 178.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.59 ' HD2' ' H ' ' A' ' 38' ' ' TYR . 31.4 Cg_endo -75.35 100.07 1.33 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.096 1.197 . . . . 0.0 111.977 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.542 ' CD2' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -145.35 176.92 9.21 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.577 -0.702 . . . . 0.0 109.252 178.691 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.563 ' HA ' ' CD1' ' A' ' 57' ' ' TYR . 0.7 OUTLIER -59.27 161.63 5.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.32 -0.863 . . . . 0.0 109.968 -179.497 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.626 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 44.9 t80 -134.29 68.19 1.49 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.45 -0.781 . . . . 0.0 109.023 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.453 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 1.3 m-20 -86.55 61.88 7.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.18 -0.95 . . . . 0.0 109.151 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 1.8 m120 -89.74 -78.26 0.37 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.557 -0.714 . . . . 0.0 110.515 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.527 ' CB ' ' O ' ' A' ' 44' ' ' ASN . 3.1 m-85 79.49 29.19 0.33 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.47 -0.769 . . . . 0.0 108.953 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -36.24 -71.21 0.08 Allowed 'General case' 0 C--N 1.308 -1.198 0 O-C-N 121.749 -0.594 . . . . 0.0 110.23 -179.603 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.19 44.2 0.55 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.07 169.17 18.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -1.137 . . . . 0.0 109.545 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -112.51 -31.86 6.66 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.534 ' CB ' ' OH ' ' A' ' 56' ' ' TYR . 8.3 m-30 55.41 178.13 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.408 -0.808 . . . . 0.0 109.567 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.48 37.57 1.01 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.312 -0.867 . . . . 0.0 109.092 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.558 HG21 ' HA ' ' A' ' 87' ' ' ALA . 41.1 t -110.12 -82.61 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.394 -0.816 . . . . 0.0 109.708 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.528 ' N ' HG12 ' A' ' 52' ' ' VAL . 4.7 t -163.15 154.08 16.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.164 -0.96 . . . . 0.0 109.855 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.597 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -55.9 -50.66 85.94 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.398 -0.814 . . . . 0.0 110.442 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 54' ' ' SER . 35.8 Cg_endo -75.82 84.44 1.78 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.018 1.812 . . . . 0.0 110.156 -178.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.556 ' CE1' ' HB2' ' A' ' 87' ' ' ALA . 49.2 m-85 -81.81 -169.52 2.39 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.821 0.82 . . . . 0.0 109.879 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.63 ' CE1' ' NE2' ' A' ' 27' ' ' HIS . 70.2 m-85 -156.75 109.05 2.5 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.48 ' N ' ' HB2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -76.2 138.51 40.7 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.844 0.83 . . . . 0.0 110.911 -178.048 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.668 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 34.8 t-105 -160.58 137.26 6.49 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.668 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.5 Cg_endo -67.67 151.84 78.66 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.986 1.791 . . . . 0.0 110.592 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.985 ' C ' HD23 ' A' ' 62' ' ' LEU . 1.3 tp -122.13 138.7 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.421 -0.8 . . . . 0.0 110.023 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.985 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.7 OUTLIER -124.34 -175.54 3.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.385 -0.822 . . . . 0.0 108.896 179.476 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.575 ' OG ' ' CE1' ' A' ' 11' ' ' TYR . 16.6 p -146.72 55.1 1.12 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.01 -1.056 . . . . 0.0 109.636 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.31 30.94 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.464 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 47.31 90.0 0.01 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.478 ' O ' ' HB ' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -161.16 -36.33 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.256 -1.143 . . . . 0.0 110.025 -179.681 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.478 ' HB ' ' O ' ' A' ' 66' ' ' ASP . 4.4 t 71.81 140.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.119 -0.988 . . . . 0.0 108.958 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.584 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 71.9 t80 -65.45 107.03 1.54 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.113 -0.992 . . . . 0.0 110.109 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.455 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 1.2 m -123.11 30.39 6.38 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.413 ' HA2' ' HB2' ' A' ' 35' ' ' SER . . . 107.77 77.93 1.07 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -159.31 -96.69 0.12 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.3 p -123.43 94.82 46.09 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.22 -1.164 . . . . 0.0 109.858 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.634 ' CB ' ' CZ ' ' A' ' 38' ' ' TYR . 36.2 Cg_endo -79.48 -61.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.585 2.19 . . . . 0.0 110.359 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . -60.21 -146.43 0.01 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 65.03 -84.98 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.37 -1.077 . . . . 0.0 109.939 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -124.59 100.33 6.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.163 -0.96 . . . . 0.0 109.574 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.526 ' O ' HG12 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -117.68 152.47 35.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 108.893 179.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.817 HG11 ' NE2' ' A' ' 20' ' ' GLN . 1.4 p -117.2 -173.88 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.053 -1.03 . . . . 0.0 109.496 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.712 ' H ' HG22 ' A' ' 78' ' ' VAL . 6.8 t -147.21 166.8 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.167 -0.958 . . . . 0.0 110.009 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.61 ' CE1' ' HB2' ' A' ' 57' ' ' TYR . 3.8 p90 -166.61 -176.26 3.47 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.522 ' O ' ' CD2' ' A' ' 57' ' ' TYR . 11.5 t30 -118.68 -80.16 0.61 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.927 -1.108 . . . . 0.0 109.754 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -158.55 20.59 0.22 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.462 -0.774 . . . . 0.0 109.419 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.502 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 0.3 OUTLIER -150.84 18.37 0.79 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.292 -0.88 . . . . 0.0 108.842 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.502 ' OD1' ' O ' ' A' ' 83' ' ' ASN . 0.2 OUTLIER 67.34 14.16 9.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.594 -0.692 . . . . 0.0 109.349 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.504 ' O ' ' HB3' ' A' ' 86' ' ' LEU . 1.8 mt-30 -51.72 -26.85 10.23 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.777 HD12 HE21 ' A' ' 20' ' ' GLN . 0.7 OUTLIER 66.49 116.31 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.539 0.685 . . . . 0.0 110.041 179.745 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.558 ' HA ' HG21 ' A' ' 52' ' ' VAL . . . -79.05 -34.43 43.77 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.458 ' HA2' ' OH ' ' A' ' 4' ' ' TYR . . . 146.13 176.64 20.16 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.715 HG21 ' CG ' ' A' ' 4' ' ' TYR . 54.7 t -100.52 147.29 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.996 -1.296 . . . . 0.0 110.055 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.544 ' HB ' ' CB ' ' A' ' 100' ' ' PHE . 0.9 OUTLIER -141.09 162.5 22.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.537 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 75' ' ' ALA . 5.8 t -129.59 127.17 40.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.711 -1.243 . . . . 0.0 111.545 -178.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.62 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.1 OUTLIER -79.01 75.35 5.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.532 -0.73 . . . . 0.0 109.177 179.055 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 1.1 m 173.44 -28.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.204 -0.935 . . . . 0.0 109.263 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.53 -11.17 33.69 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.738 ' HB3' ' CB ' ' A' ' 99' ' ' ASN . . . -125.48 176.86 6.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.097 -1.237 . . . . 0.0 109.725 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER -42.99 131.7 4.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.411 -0.806 . . . . 0.0 109.109 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.51 -89.03 0.05 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.62 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -136.22 -79.7 0.41 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -1.118 . . . . 0.0 109.106 179.319 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.738 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . 0.3 OUTLIER 58.51 152.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.231 -0.918 . . . . 0.0 109.054 -179.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.544 ' CB ' ' HB ' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -109.02 126.99 53.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.741 -1.224 . . . . 0.0 110.58 -179.412 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -129.55 140.45 49.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.469 ' OE2' ' CE1' ' A' ' 50' ' ' PHE . 5.8 mm-40 -52.47 122.56 9.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.384 -0.823 . . . . 0.0 109.703 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 1.7 m -70.55 129.92 40.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.352 -0.842 . . . . 0.0 109.462 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 40.1 p . . . . . 0 N--CA 1.488 1.467 0 O-C-N 121.187 -0.946 . . . . 0.0 109.367 179.912 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.426 ' C ' ' SG ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.392 0.615 . . . . 0.0 109.651 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 0.8 OUTLIER 173.54 126.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.319 -0.863 . . . . 0.0 109.838 179.788 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -121.43 -3.87 9.38 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.417 -0.802 . . . . 0.0 109.29 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.677 ' CG ' HG21 ' A' ' 89' ' ' VAL . 57.4 m-85 -103.52 85.98 2.56 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.913 . . . . 0.0 109.192 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.635 HG23 ' H ' ' A' ' 10' ' ' CYS . 33.9 m -117.52 129.53 55.86 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.269 -0.894 . . . . 0.0 110.255 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.1 m -133.07 12.21 4.26 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.191 0.996 . . . . 0.0 109.156 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 8' ' ' SER . . . -176.53 35.77 0.09 OUTLIER Glycine 0 C--N 1.282 -2.454 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 7' ' ' GLY . 0.6 OUTLIER 67.6 25.0 8.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.308 -1.113 . . . . 0.0 109.16 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.474 ' O ' ' C ' ' A' ' 10' ' ' CYS . 0.9 OUTLIER -89.43 -17.63 28.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.412 -0.805 . . . . 0.0 109.746 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.635 ' H ' HG23 ' A' ' 5' ' ' THR . 0.8 OUTLIER 40.03 79.09 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 O-C-N 121.543 -0.723 . . . . 0.0 109.315 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.482 ' HB2' ' HB2' ' A' ' 4' ' ' TYR . 11.6 m-85 -78.91 134.3 36.89 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.883 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -78.58 129.57 34.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.567 -0.708 . . . . 0.0 109.804 -179.316 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -17.75 5.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.336 -0.852 . . . . 0.0 109.312 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.94 -30.69 15.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 0.0 109.571 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.47 -31.51 62.26 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 12' ' ' SER . 3.5 t -65.09 -25.44 37.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.493 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 0.1 OUTLIER -72.27 -40.15 67.84 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.537 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.77 -53.08 62.11 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.674 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -63.22 -25.42 68.32 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.574 ' OE1' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -70.09 -30.37 67.57 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.137 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -81.02 -12.68 59.31 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.632 ' HB1' HG13 ' A' ' 67' ' ' VAL . . . -81.19 -47.22 13.72 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.614 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -74.69 -28.62 62.78 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -75.65 -39.41 57.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.504 -0.998 . . . . 0.0 109.198 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.501 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 2.1 tt0 -69.73 -57.71 4.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.171 -0.955 . . . . 0.0 108.509 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.576 HD11 ' HB3' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -49.74 -36.23 24.98 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.297 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -67.37 -39.4 85.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.426 -0.796 . . . . 0.0 109.512 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.65 -2.77 47.98 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.317 -0.864 . . . . 0.0 109.057 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -101.8 0.5 35.84 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.266 -0.896 . . . . 0.0 109.509 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 54.21 26.07 34.77 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.576 ' HB3' HD11 ' A' ' 26' ' ' LEU . 1.7 mm-40 -106.06 -164.11 0.99 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.252 -1.146 . . . . 0.0 109.605 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.93 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -142.3 175.97 9.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.357 -0.839 . . . . 0.0 109.337 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.668 HG22 ' CA ' ' A' ' 37' ' ' SER . 22.3 m -87.99 -156.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.212 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -40.07 -35.9 0.77 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER 167.15 -27.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.119 -1.224 . . . . 0.0 109.549 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 37' ' ' SER . 11.1 m-80 -81.73 8.89 8.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.171 -0.956 . . . . 0.0 109.533 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.93 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.8 OUTLIER 46.2 -169.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.226 -0.921 . . . . 0.0 108.968 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.594 ' CD1' ' HD3' ' A' ' 60' ' ' PRO . 0.1 OUTLIER 169.42 -47.18 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.428 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.951 179.247 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 38' ' ' TYR . 30.7 Cg_endo -73.48 99.38 1.13 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.525 1.483 . . . . 0.0 112.453 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.557 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -144.7 175.16 10.37 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -63.04 157.66 21.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.959 -1.088 . . . . 0.0 110.213 -179.214 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.884 ' CG ' HG11 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -129.09 132.31 47.39 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.478 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.424 ' O ' ' C ' ' A' ' 44' ' ' ASN . 1.4 p-10 -123.15 -22.63 5.11 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.814 -1.179 . . . . 0.0 109.635 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.631 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 1.0 OUTLIER 45.28 -160.23 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.284 -0.885 . . . . 0.0 108.919 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.631 ' CG ' ' O ' ' A' ' 44' ' ' ASN . 0.9 OUTLIER 171.43 -26.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.536 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.3 OUTLIER -32.09 -59.85 0.28 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 121.307 0.575 . . . . 0.0 110.42 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.04 54.68 0.01 OUTLIER Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.525 ' CZ ' ' HA ' ' A' ' 101' ' ' VAL . 62.8 m-85 -108.64 142.78 38.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -1.128 . . . . 0.0 109.611 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -108.89 76.31 1.0 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -0.903 . . . . 0.0 109.615 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.478 ' HB3' ' OH ' ' A' ' 56' ' ' TYR . 18.8 m-30 -66.63 -178.53 0.72 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.188 -0.945 . . . . 0.0 109.003 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.5 t -140.41 17.38 2.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.865 . . . . 0.0 108.976 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.577 ' HB ' ' CE1' ' A' ' 56' ' ' TYR . 57.4 t -88.1 -82.67 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.44 -0.788 . . . . 0.0 109.617 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.583 ' O ' ' CE2' ' A' ' 56' ' ' TYR . 61.1 m -160.21 -174.22 4.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -0.925 . . . . 0.0 109.902 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.574 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -81.66 -52.45 0.78 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.316 -0.865 . . . . 0.0 110.717 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 54' ' ' SER . 35.2 Cg_endo -75.49 88.14 1.31 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.07 1.847 . . . . 0.0 110.201 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.791 ' CE1' ' HB2' ' A' ' 87' ' ' ALA . 21.9 m-85 -89.17 -167.89 2.01 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.587 ' CG ' ' O ' ' A' ' 56' ' ' TYR . 84.0 m-85 -160.88 114.91 2.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.507 -0.746 . . . . 0.0 109.328 179.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.451 ' CD ' ' NH1' ' A' ' 77' ' ' ARG . 3.0 pt-20 -80.0 142.41 35.03 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.292 -0.88 . . . . 0.0 110.909 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.667 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 22.1 t-105 -160.77 138.63 7.1 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.667 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 31.8 Cg_endo -70.15 161.36 46.27 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.059 1.839 . . . . 0.0 111.429 -178.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.939 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -133.34 135.74 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.679 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.939 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.3 OUTLIER -118.72 161.49 20.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -0.913 . . . . 0.0 109.608 -179.864 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.1 26.05 5.2 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.463 -0.773 . . . . 0.0 109.287 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.22 -62.72 0.78 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.359 -0.838 . . . . 0.0 109.45 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -93.15 -108.52 1.87 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 67' ' ' VAL . 8.9 t70 -179.45 134.12 0.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -1.159 . . . . 0.0 109.521 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.632 HG13 ' HB1' ' A' ' 22' ' ' ALA . 2.8 t 62.79 133.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -0.902 . . . . 0.0 109.804 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.595 ' HA ' HD11 ' A' ' 62' ' ' LEU . 43.3 t80 -75.51 105.75 6.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.015 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.1 m -112.87 16.57 19.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.131 -0.981 . . . . 0.0 109.812 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.54 52.72 0.23 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -110.95 -112.3 3.35 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.82 108.94 43.78 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.193 -1.18 . . . . 0.0 109.421 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.65 -161.81 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.467 2.112 . . . . 0.0 110.483 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 53.71 -175.76 0.32 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 91' ' ' THR . . . 61.85 -150.05 0.38 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -1.136 . . . . 0.0 110.198 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' ' 75' ' ' ALA . 12.0 m-20 -32.27 148.73 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.56 0.695 . . . . 0.0 111.435 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.577 ' NH2' ' CE2' ' A' ' 100' ' ' PHE . 8.3 ttp180 -176.38 86.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.731 ' CG2' HD11 ' A' ' 86' ' ' LEU . 8.8 p -72.38 143.16 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.894 . . . . 0.0 109.688 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.884 HG11 ' CG ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -109.19 177.63 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.105 -0.997 . . . . 0.0 109.679 179.864 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.575 ' CE1' ' O ' ' A' ' 57' ' ' TYR . 14.0 p90 -174.76 -169.19 0.4 Allowed 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.0 -178.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -128.88 -80.99 0.57 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.374 -0.829 . . . . 0.0 109.728 -179.497 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.45 ' CG ' ' C ' ' A' ' 81' ' ' ASN . 0.3 OUTLIER -158.6 19.69 0.22 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.457 -0.777 . . . . 0.0 109.412 -179.804 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.456 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 0.8 OUTLIER -150.34 28.85 0.72 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.469 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 5.4 p30 51.7 20.8 1.19 Allowed 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.542 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 2.4 mt-30 -47.53 -38.38 14.0 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.731 HD11 ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER 82.19 104.16 0.06 Allowed 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.469 0.652 . . . . 0.0 110.565 179.135 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.835 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . . . -76.24 -31.92 58.62 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 140.23 163.81 9.66 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.677 HG21 ' CG ' ' A' ' 4' ' ' TYR . 58.9 t -94.73 124.47 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.068 -1.254 . . . . 0.0 109.491 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' A' ' 100' ' ' PHE . 1.0 OUTLIER -118.14 176.31 3.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.268 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 75' ' ' ALA . 8.3 t -144.16 147.34 33.55 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.045 -1.034 . . . . 0.0 110.419 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.642 ' NE2' ' CE2' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -96.88 76.71 2.75 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.535 -0.728 . . . . 0.0 109.134 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.431 ' OG1' ' C ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 176.17 123.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 0.0 109.809 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 116.33 -0.6 20.65 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.677 ' HB3' ' CB ' ' A' ' 99' ' ' ASN . . . -139.51 93.42 2.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.13 -1.218 . . . . 0.0 109.776 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER 41.65 85.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.427 -0.796 . . . . 0.0 109.743 179.642 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.17 -77.54 2.07 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.622 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -144.54 -77.02 0.22 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.161 -1.199 . . . . 0.0 109.892 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.677 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . 0.3 OUTLIER 59.43 155.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 108.535 -179.097 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.642 ' CE2' ' NE2' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -103.69 136.98 42.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.949 -1.095 . . . . 0.0 110.267 -179.521 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 0.9 OUTLIER -146.13 157.98 11.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.167 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 103' ' ' CYS . 12.4 pt-20 -60.5 130.72 48.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.149 -0.969 . . . . 0.0 109.737 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.422 ' C ' ' O ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -42.35 114.53 0.58 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.452 -0.78 . . . . 0.0 109.635 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.136 -0.935 . . . . 0.0 109.405 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.431 ' O ' ' SG ' ' A' ' 10' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.266 0.555 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.501 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.9 OUTLIER 169.72 115.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -0.862 . . . . 0.0 109.862 179.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -78.72 -31.65 46.51 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.338 -0.851 . . . . 0.0 108.981 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.617 ' CG ' HG21 ' A' ' 89' ' ' VAL . 18.3 m-85 -98.96 96.28 7.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.38 -0.825 . . . . 0.0 108.908 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.56 HG22 ' O ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -116.61 105.69 12.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.186 -0.947 . . . . 0.0 109.873 -179.705 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.583 ' O ' ' C ' ' A' ' 7' ' ' GLY . 87.4 m -82.85 -173.87 4.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.287 -0.883 . . . . 0.0 108.867 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.583 ' C ' ' O ' ' A' ' 6' ' ' CYS . . . 7.69 -77.26 0.0 OUTLIER Glycine 0 N--CA 1.507 3.372 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 6' ' ' CYS . 3.7 p -161.08 55.36 0.29 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.228 -1.16 . . . . 0.0 109.468 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.56 ' O ' HG22 ' A' ' 5' ' ' THR . 1.5 m-20 -117.28 -144.65 0.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.353 -0.842 . . . . 0.0 109.741 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.507 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 46.5 t -162.44 60.46 0.22 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.132 -0.98 . . . . 0.0 109.152 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 63' ' ' SER . 6.1 m-85 -86.78 113.2 22.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.5 -0.75 . . . . 0.0 109.333 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.535 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -87.94 131.41 34.61 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.255 -0.903 . . . . 0.0 109.835 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 12' ' ' SER . 1.8 p -45.33 -37.17 4.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.607 -0.683 . . . . 0.0 109.445 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.4 -47.26 84.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.376 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.16 -23.94 61.36 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.689 HG11 HG21 ' A' ' 78' ' ' VAL . 63.0 t -65.19 -31.97 56.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.6 t -61.66 -45.65 93.12 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.668 -0.645 . . . . 0.0 109.449 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.07 -49.53 77.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.121 -0.987 . . . . 0.0 108.608 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.709 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -71.08 -12.85 61.73 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.587 ' OE1' ' CG ' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -80.6 -34.07 35.44 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.506 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.98 -13.65 59.94 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.884 ' HB1' HG13 ' A' ' 67' ' ' VAL . . . -72.61 -41.13 65.92 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.609 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -81.72 -32.7 29.42 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.201 -1.559 . . . . 0.0 109.201 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.493 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 9.9 t80 -67.61 -40.8 84.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.426 -1.043 . . . . 0.0 109.758 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.406 ' O ' ' C ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -60.97 -66.53 0.52 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.912 . . . . 0.0 108.966 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.554 ' CD1' ' HB3' ' A' ' 31' ' ' GLU . 0.9 OUTLIER -43.85 -44.56 6.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.458 -0.776 . . . . 0.0 109.0 179.242 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.446 ' HB3' ' O ' ' A' ' 24' ' ' TYR . 2.0 t60 -49.75 -68.06 0.21 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.738 -0.601 . . . . 0.0 110.678 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -76.68 2.23 14.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.252 -0.905 . . . . 0.0 110.004 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.464 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 1.1 m-20 -82.93 -28.89 29.58 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.195 -0.941 . . . . 0.0 109.775 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.73 -15.33 63.32 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.554 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 3.2 tp10 -83.43 -149.0 0.09 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -1.154 . . . . 0.0 109.249 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.929 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.3 OUTLIER -159.19 -172.34 3.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.133 -0.979 . . . . 0.0 109.386 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.627 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -82.94 -95.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.924 . . . . 0.0 109.496 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.469 ' H ' HG23 ' A' ' 33' ' ' VAL . . . -115.2 -20.31 5.61 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.6 OUTLIER 167.21 -42.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.157 -1.202 . . . . 0.0 109.728 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 37' ' ' SER . 95.1 m-20 -77.25 -10.3 59.33 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.216 -0.928 . . . . 0.0 109.523 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.929 ' HA ' HG22 ' A' ' 32' ' ' THR . 4.0 p 62.08 135.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 109.183 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.674 ' H ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -121.44 -33.71 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.077 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -178.748 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.674 ' CD ' ' H ' ' A' ' 38' ' ' TYR . 36.3 Cg_endo -80.31 101.5 1.34 Allowed 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 121.304 1.336 . . . . 0.0 112.611 -178.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.597 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -138.78 134.95 34.13 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.244 -0.91 . . . . 0.0 109.801 177.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.609 ' HB2' ' CE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -51.02 131.02 26.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.166 -0.959 . . . . 0.0 109.384 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.537 ' CZ ' ' HA ' ' A' ' 44' ' ' ASN . 4.1 t80 -113.51 140.84 47.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.282 -0.886 . . . . 0.0 109.172 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.509 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 3.7 m-80 -85.87 -90.63 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.191 -0.943 . . . . 0.0 109.739 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.537 ' HA ' ' CZ ' ' A' ' 42' ' ' TYR . 0.7 OUTLIER 174.49 148.05 0.07 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 109.39 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.412 ' O ' ' C ' ' A' ' 46' ' ' GLU . 11.2 m-85 -139.69 -72.61 0.38 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.239 -0.913 . . . . 0.0 109.331 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.595 ' CB ' ' CZ ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -40.34 -37.83 0.72 Allowed 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.512 -0.743 . . . . 0.0 109.853 -179.604 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.86 62.22 0.75 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.595 ' CZ ' ' CB ' ' A' ' 46' ' ' GLU . 23.9 m-85 -90.78 -168.01 1.97 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.246 -1.149 . . . . 0.0 108.885 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.34 -39.36 2.2 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.152 -0.968 . . . . 0.0 109.538 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.527 ' CB ' ' OH ' ' A' ' 56' ' ' TYR . 18.3 m-85 47.26 -168.55 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.21 -0.931 . . . . 0.0 109.393 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.83 31.76 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 109.502 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.0 t -108.52 -66.61 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.927 . . . . 0.0 109.513 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.51 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 70.7 m -165.31 -179.9 5.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.088 -1.008 . . . . 0.0 110.049 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.576 ' N ' ' CD ' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -79.51 -50.32 1.31 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.534 -0.728 . . . . 0.0 110.761 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 54' ' ' SER . 35.4 Cg_endo -75.79 81.36 2.39 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.986 1.791 . . . . 0.0 110.374 -178.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.594 ' O ' ' CD1' ' A' ' 57' ' ' TYR . 36.5 m-85 -79.27 -171.62 2.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.696 -0.628 . . . . 0.0 109.832 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.609 ' CE2' ' HB2' ' A' ' 41' ' ' LYS . 68.0 m-85 -155.4 158.44 38.64 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.509 ' HB2' ' CZ ' ' A' ' 77' ' ' ARG . 2.6 pt-20 -117.86 139.17 51.49 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.938 -1.102 . . . . 0.0 110.303 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.654 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 26.8 t-105 -159.9 138.64 7.8 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.654 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.5 Cg_endo -69.71 141.37 45.25 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.224 1.949 . . . . 0.0 111.469 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.958 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -109.31 140.3 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.958 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.9 OUTLIER -126.23 163.26 23.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.951 . . . . 0.0 109.764 -179.619 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . 9.3 t -132.99 25.91 4.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.358 -0.839 . . . . 0.0 109.351 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.69 -46.62 0.12 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.354 -0.841 . . . . 0.0 109.314 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . -78.52 -101.21 0.21 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 1.6 t0 175.61 -62.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -1.132 . . . . 0.0 109.569 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.884 HG13 ' HB1' ' A' ' 22' ' ' ALA . 11.7 t -127.84 126.18 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 109.756 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.605 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 6.2 t80 -63.44 136.31 57.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.158 -0.964 . . . . 0.0 109.304 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 p -161.44 53.31 0.26 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.55 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.498 ' O ' ' CE1' ' A' ' 68' ' ' TYR . . . 126.24 -165.96 19.21 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.74 -157.51 41.86 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.9 t -120.01 120.14 30.48 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.331 -1.099 . . . . 0.0 109.44 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.457 ' HB2' ' OH ' ' A' ' 38' ' ' TYR . 34.7 Cg_endo -77.73 172.91 14.93 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.295 1.996 . . . . 0.0 110.669 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.0 134.58 2.13 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.542 ' HA ' ' N ' ' A' ' 92' ' ' HIS . . . 55.88 -153.18 0.35 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -1.151 . . . . 0.0 109.479 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.498 ' O ' ' O ' ' A' ' 75' ' ' ALA . 45.6 m-20 20.75 106.74 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.509 ' CZ ' ' HB2' ' A' ' 58' ' ' GLU . 6.9 mtp-105 -160.06 135.38 8.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.154 -0.966 . . . . 0.0 108.584 178.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.689 HG21 HG11 ' A' ' 16' ' ' VAL . 3.9 p -123.99 135.1 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.739 -1.225 . . . . 0.0 109.638 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.626 HG23 ' CD1' ' A' ' 90' ' ' ILE . 29.9 t -92.39 166.13 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.973 0.892 . . . . 0.0 109.808 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.587 ' CG ' ' OE1' ' A' ' 20' ' ' GLN . 3.2 p90 -161.53 -178.92 6.92 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.189 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.491 ' ND2' ' HG2' ' A' ' 82' ' ' GLU . 11.8 t30 -112.48 -81.75 0.59 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 109.692 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.493 ' O ' ' CZ ' ' A' ' 24' ' ' TYR . 2.5 pt-20 -162.64 21.78 0.09 Allowed 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.483 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 2.4 m-20 -140.61 29.5 1.93 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 83' ' ' ASN . 10.5 p30 46.95 24.5 0.37 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.502 0.668 . . . . 0.0 109.22 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 26.7 mm-40 -63.61 -106.73 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 174.42 114.55 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.739 179.081 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.541 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . . . -89.79 -42.24 11.4 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 161.28 155.0 7.67 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.617 HG21 ' CG ' ' A' ' 4' ' ' TYR . 32.0 t -92.05 88.72 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.334 -1.098 . . . . 0.0 109.285 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.626 ' CD1' HG23 ' A' ' 79' ' ' VAL . 1.2 pt -90.88 156.2 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.432 -0.793 . . . . 0.0 109.527 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.579 HG22 HG23 ' A' ' 101' ' ' VAL . 13.0 t -122.2 137.01 54.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.859 -1.151 . . . . 0.0 110.245 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.642 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -81.56 67.58 7.58 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.294 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 177.54 164.02 0.58 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.045 -1.034 . . . . 0.0 109.668 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.84 22.11 75.21 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.574 ' HB3' ' CB ' ' A' ' 99' ' ' ASN . . . -155.81 51.84 0.56 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -1.149 . . . . 0.0 109.353 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.7 m 68.07 93.66 0.07 Allowed 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.53 -83.9 1.1 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.642 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -139.07 -83.18 0.28 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -1.181 . . . . 0.0 109.177 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.574 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . 1.1 m-20 61.23 137.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.329 -0.857 . . . . 0.0 109.292 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.658 ' O ' HG13 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -85.85 151.63 23.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.117 -0.989 . . . . 0.0 109.385 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.658 HG13 ' O ' ' A' ' 100' ' ' PHE . 3.2 m -160.63 136.93 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.409 -0.807 . . . . 0.0 109.073 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -53.21 123.75 12.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.243 -0.911 . . . . 0.0 109.588 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -76.04 83.0 2.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.295 -0.878 . . . . 0.0 109.688 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.127 -0.983 . . . . 0.0 109.42 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.572 ' SG ' HG22 ' A' ' 5' ' ' THR . 6.0 t 62.38 91.93 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.881 . . . . 0.0 109.836 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -105.84 2.66 27.92 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.449 -0.782 . . . . 0.0 109.032 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.553 ' CG ' HG21 ' A' ' 89' ' ' VAL . 28.8 m-85 -121.14 67.89 0.88 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.267 -0.896 . . . . 0.0 109.402 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.572 HG22 ' SG ' ' A' ' 2' ' ' CYS . 11.6 p -79.74 124.62 28.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.905 . . . . 0.0 109.192 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.1 m -113.31 17.14 18.77 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.011 0.91 . . . . 0.0 110.069 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 136.02 -93.25 0.23 Allowed Glycine 0 C--N 1.282 -2.459 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.9 m -119.82 28.66 7.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -1.102 . . . . 0.0 109.29 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.453 ' O ' ' C ' ' A' ' 10' ' ' CYS . 1.7 m120 -111.53 -36.64 5.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 109.619 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' ASN . 1.7 t 41.33 80.4 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.413 -0.804 . . . . 0.0 109.469 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.633 ' CE2' ' CB ' ' A' ' 63' ' ' SER . 2.7 m-85 -86.6 148.34 25.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -0.833 . . . . 0.0 110.148 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.833 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -80.05 128.11 33.09 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.639 -0.663 . . . . 0.0 109.839 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.3 p -56.96 -18.52 13.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.921 . . . . 0.0 108.969 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.05 -30.33 15.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.264 -0.897 . . . . 0.0 109.592 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -73.55 -30.97 63.39 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 12' ' ' SER . 3.9 t -60.82 -32.07 51.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.03 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.3 t -60.38 -46.83 88.58 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.486 -0.759 . . . . 0.0 110.031 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -42.67 93.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.103 -0.998 . . . . 0.0 108.967 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.857 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -78.2 -11.63 59.94 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.511 -0.743 . . . . 0.0 109.16 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.507 ' HB2' ' O ' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -86.67 -26.6 24.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.367 -0.833 . . . . 0.0 108.984 179.617 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -83.98 -10.19 58.11 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.382 -0.824 . . . . 0.0 109.181 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.61 -47.43 17.15 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.35 -0.844 . . . . 0.0 109.276 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.608 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -75.29 -16.86 80.37 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.481 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 6.2 t80 -87.0 -63.4 1.31 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.444 -1.033 . . . . 0.0 109.544 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 29' ' ' ASP . 0.9 OUTLIER -46.95 -58.59 3.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.272 -0.893 . . . . 0.0 109.766 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.473 ' CD1' ' HB3' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -51.73 -47.08 64.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.295 -0.878 . . . . 0.0 109.773 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.628 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 2.9 t60 -52.9 -62.19 1.81 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.389 -0.82 . . . . 0.0 110.918 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -72.28 -7.23 48.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 109.735 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 13.7 t70 -78.46 -14.23 59.47 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.196 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.94 0.28 59.79 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.473 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 2.6 tp10 -94.43 -145.27 0.25 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.3 -1.118 . . . . 0.0 109.4 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.913 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -163.62 179.51 7.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 109.573 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.484 HG23 ' N ' ' A' ' 34' ' ' GLY . 17.1 m -89.41 -120.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 109.305 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.484 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -65.57 -42.35 95.64 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER 169.72 -38.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.311 -1.111 . . . . 0.0 109.549 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 37' ' ' SER . 5.4 m120 -65.46 -11.79 46.37 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.23 -0.919 . . . . 0.0 109.674 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.913 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.7 OUTLIER 59.66 114.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.172 -0.955 . . . . 0.0 109.129 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.668 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -107.65 -27.39 0.18 Allowed Pre-proline 0 N--CA 1.498 1.966 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -178.69 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.668 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 36.5 Cg_endo -79.4 102.51 1.51 Allowed 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 121.318 1.345 . . . . 0.0 113.167 -178.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.601 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -131.2 165.31 23.62 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.16 -0.962 . . . . 0.0 109.179 177.263 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.635 ' HB2' ' CE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -73.79 132.28 42.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 109.31 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.598 ' CZ ' ' HA ' ' A' ' 44' ' ' ASN . 26.9 t80 -100.97 134.26 44.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.367 -0.833 . . . . 0.0 109.351 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -103.24 -8.64 20.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.185 -0.947 . . . . 0.0 109.728 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.598 ' HA ' ' CZ ' ' A' ' 42' ' ' TYR . 2.2 m120 62.16 175.0 0.13 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.692 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.458 ' O ' ' C ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -179.15 -45.25 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.388 -0.82 . . . . 0.0 108.986 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.576 ' OE1' ' CZ ' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -38.52 -44.4 0.95 Allowed 'General case' 0 C--N 1.307 -1.242 0 O-C-N 121.696 -0.627 . . . . 0.0 109.945 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.55 47.12 0.09 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.576 ' CZ ' ' OE1' ' A' ' 46' ' ' GLU . 16.0 m-85 -106.58 139.76 40.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -1.184 . . . . 0.0 109.379 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.64 -30.85 11.53 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.285 -0.884 . . . . 0.0 109.262 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.552 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 30.1 m-85 50.93 -170.52 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.42 -0.8 . . . . 0.0 109.743 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.21 44.42 0.48 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.362 -0.836 . . . . 0.0 109.364 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.529 HG12 ' OD1' ' A' ' 81' ' ' ASN . 54.8 t -121.53 -45.34 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.263 -0.898 . . . . 0.0 109.636 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.579 ' O ' ' CE1' ' A' ' 56' ' ' TYR . 0.6 OUTLIER 167.72 -176.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.111 -0.993 . . . . 0.0 109.936 -179.64 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.558 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -86.4 -54.41 0.4 Allowed Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.373 -0.829 . . . . 0.0 111.646 -179.051 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 54' ' ' SER . 33.7 Cg_endo -73.1 86.02 1.16 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.045 1.83 . . . . 0.0 110.607 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.65 ' CE2' ' HB1' ' A' ' 87' ' ' ALA . 3.7 m-30 -87.21 -173.5 4.44 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.461 0.648 . . . . 0.0 110.054 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.635 ' CE2' ' HB2' ' A' ' 41' ' ' LYS . 75.7 m-85 -156.63 116.67 3.57 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -77.54 140.74 39.78 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.83 0.824 . . . . 0.0 110.968 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.653 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 20.9 t-105 -160.64 137.53 6.59 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.653 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.7 Cg_endo -68.94 147.05 67.26 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.138 1.892 . . . . 0.0 111.424 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.994 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -121.09 126.0 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.536 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.994 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.3 OUTLIER -122.72 166.1 15.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.278 -0.889 . . . . 0.0 109.284 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.633 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -130.91 7.42 4.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.289 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.97 -69.85 0.54 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.259 -0.901 . . . . 0.0 109.338 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 158.31 60.61 0.01 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -175.58 139.29 0.42 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -1.17 . . . . 0.0 109.461 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.476 HG13 ' HZ2' ' A' ' 59' ' ' TRP . 91.5 t -77.3 147.6 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.0 109.441 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.547 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 0.7 OUTLIER -65.38 166.61 9.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 109.749 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.41 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 5.7 m -169.2 49.87 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.434 -0.791 . . . . 0.0 109.14 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.45 114.91 0.92 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 72' ' ' SER . . . -178.64 39.4 0.08 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 1.4 p 75.14 109.7 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.248 -1.148 . . . . 0.0 109.584 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.531 ' HA ' ' NH2' ' A' ' 77' ' ' ARG . 36.2 Cg_endo -79.41 119.68 4.23 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.49 2.127 . . . . 0.0 110.555 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.505 ' HA2' ' HB2' ' A' ' 92' ' ' HIS . . . 170.0 -168.9 41.77 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 76' ' ' ASP . . . 47.74 -154.77 0.07 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -1.166 . . . . 0.0 110.506 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 51.8 m-20 -39.53 129.26 1.9 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.549 0.69 . . . . 0.0 109.619 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.544 ' CZ ' ' HB3' ' A' ' 60' ' ' PRO . 23.4 mmt-85 -158.43 122.25 3.99 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.723 HG21 ' CG1' ' A' ' 16' ' ' VAL . 0.9 OUTLIER -105.25 148.61 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.263 -0.898 . . . . 0.0 109.812 -178.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.643 HG12 ' H ' ' A' ' 80' ' ' PHE . 2.0 t -121.52 174.55 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.962 0.886 . . . . 0.0 109.673 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.643 ' H ' HG12 ' A' ' 79' ' ' VAL . 4.4 p90 -173.92 -167.87 0.38 Allowed 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.354 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.558 ' OD1' ' CE1' ' A' ' 56' ' ' TYR . 3.1 m120 -120.49 -80.57 0.62 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.266 -0.897 . . . . 0.0 109.794 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.412 ' OE1' ' O ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -163.43 23.98 0.08 Allowed 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.471 ' O ' ' HB3' ' A' ' 84' ' ' ASN . 24.8 m-80 -148.91 16.28 0.96 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.483 -0.761 . . . . 0.0 109.056 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 83' ' ' ASN . 2.9 t-20 62.32 13.89 6.35 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.366 -0.834 . . . . 0.0 109.348 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.562 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -46.89 -32.08 3.54 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.67 -1.234 . . . . 0.0 107.67 179.315 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.562 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.2 OUTLIER 84.95 110.58 0.05 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.534 0.683 . . . . 0.0 110.528 179.211 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.65 ' HB1' ' CE2' ' A' ' 56' ' ' TYR . . . -82.63 -43.48 16.93 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.561 ' O ' HG22 ' A' ' 78' ' ' VAL . . . 158.93 -161.14 31.71 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.553 HG21 ' CG ' ' A' ' 4' ' ' TYR . 39.1 t -134.96 92.46 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -1.179 . . . . 0.0 109.252 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.573 ' HB ' ' HB3' ' A' ' 100' ' ' PHE . 0.6 OUTLIER -94.41 151.45 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.4 -0.812 . . . . 0.0 109.858 -179.668 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.2 t -125.85 134.58 51.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 109.731 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.695 ' CD2' ' CD1' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -82.61 74.64 9.57 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.323 -0.86 . . . . 0.0 108.99 179.733 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 7.9 m -169.68 135.37 1.49 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.492 -0.755 . . . . 0.0 109.466 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 93.42 24.11 22.36 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.725 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . . . -156.51 91.5 1.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.132 -1.217 . . . . 0.0 109.682 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 95' ' ' ALA . 1.7 t 43.78 79.35 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.304 -0.873 . . . . 0.0 109.314 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.62 -70.5 3.16 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.62 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -148.76 -82.15 0.12 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -1.1 . . . . 0.0 109.318 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.725 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 4.3 m-20 60.73 138.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.372 -0.83 . . . . 0.0 109.315 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.695 ' CD1' ' CD2' ' A' ' 92' ' ' HIS . 0.6 OUTLIER -79.12 148.86 32.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.058 -1.026 . . . . 0.0 109.85 -179.588 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -151.94 114.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.411 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 1.7 pt-20 -43.71 131.26 5.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.326 -0.859 . . . . 0.0 109.575 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.518 ' HB3' ' O ' ' A' ' 5' ' ' THR . 84.0 m -72.31 106.26 4.39 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.324 -0.86 . . . . 0.0 109.401 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.826 -1.083 . . . . 0.0 109.54 -179.833 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 15.3 p 176.45 98.12 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.108 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -67.66 -19.41 65.19 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.319 -0.863 . . . . 0.0 108.895 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.682 ' CG ' HG21 ' A' ' 89' ' ' VAL . 39.4 m-85 -103.46 81.55 1.93 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.654 HG22 ' O ' ' A' ' 5' ' ' THR . 46.8 m -101.1 69.44 1.3 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.397 -0.814 . . . . 0.0 110.473 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.518 ' O ' ' N ' ' A' ' 8' ' ' SER . 3.9 m -80.6 154.58 27.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.036 -1.04 . . . . 0.0 108.505 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 6' ' ' CYS . . . 44.06 -94.98 0.01 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 6' ' ' CYS . 2.4 t -159.28 40.85 0.21 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -1.114 . . . . 0.0 109.1 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.442 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 2.8 m-80 -94.88 -35.88 11.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.919 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.431 ' C ' ' CB ' ' A' ' 2' ' ' CYS . 42.3 t 56.46 59.98 3.35 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.065 -1.022 . . . . 0.0 108.637 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.587 ' CE2' ' HB2' ' A' ' 63' ' ' SER . 2.9 m-30 -89.49 144.27 26.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.432 -0.792 . . . . 0.0 110.177 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.843 ' O ' HG23 ' A' ' 16' ' ' VAL . 4.0 m -82.85 133.81 35.12 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.578 -0.701 . . . . 0.0 109.966 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.1 p -62.56 -23.39 66.97 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.0 t -79.47 -33.1 42.61 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.457 ' HB2' ' HB2' ' A' ' 12' ' ' SER . 5.4 m-20 -77.38 -27.27 52.46 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 12' ' ' SER . 25.6 t -63.58 -24.27 35.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.429 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 15.0 t -66.52 -42.83 86.67 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.7 -42.27 99.55 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.834 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -74.33 -14.44 60.89 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.539 ' OE1' ' CB ' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -82.27 -30.6 30.55 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.498 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.62 -13.69 59.7 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.474 ' HB1' HG11 ' A' ' 67' ' ' VAL . . . -73.31 -58.53 3.24 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.563 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -61.64 -22.46 61.78 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.458 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 16.8 t80 -75.84 -37.32 59.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.555 -0.967 . . . . 0.0 109.127 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -69.74 -46.34 66.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.836 . . . . 0.0 108.849 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.984 HD22 HG13 ' A' ' 33' ' ' VAL . 9.5 tp -71.54 -18.06 62.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.392 -0.817 . . . . 0.0 108.87 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.621 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 55.1 t60 -89.66 -20.5 23.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.516 -0.74 . . . . 0.0 109.397 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.17 -23.26 24.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 109.338 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -97.78 -10.09 25.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.355 -0.84 . . . . 0.0 109.508 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.75 18.74 70.62 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.564 ' CG ' ' N ' ' A' ' 32' ' ' THR . 34.1 tt0 -88.8 167.08 13.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -1.171 . . . . 0.0 109.646 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.882 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -104.01 166.68 10.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.504 -0.747 . . . . 0.0 109.412 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.984 HG13 HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -102.56 -79.06 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.062 -1.024 . . . . 0.0 109.685 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -72.62 -44.05 41.5 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.5 OUTLIER 163.32 -33.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.326 -1.102 . . . . 0.0 109.327 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 37' ' ' SER . 58.6 m-20 -76.77 -77.2 0.15 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.255 -0.903 . . . . 0.0 109.184 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.882 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.1 OUTLIER 158.1 128.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.617 ' H ' ' CD ' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -120.43 -37.31 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.838 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -178.593 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.617 ' CD ' ' H ' ' A' ' 38' ' ' TYR . 35.1 Cg_endo -80.42 101.93 1.37 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 120.975 1.117 . . . . 0.0 112.485 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.614 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -132.12 -172.05 2.79 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.365 -0.835 . . . . 0.0 109.267 178.121 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -81.74 158.22 24.26 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.824 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 1.2 t80 -121.38 124.1 43.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.102 -0.998 . . . . 0.0 109.747 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -110.24 -75.22 0.63 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 108.543 179.295 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 0.4 OUTLIER 77.15 -76.03 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.363 -0.836 . . . . 0.0 110.458 179.002 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 56.66 45.69 21.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.925 -1.109 . . . . 0.0 109.115 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.581 ' HG2' ' CE2' ' A' ' 48' ' ' PHE . 0.8 OUTLIER -94.2 -28.42 15.64 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.249 -0.907 . . . . 0.0 109.306 -179.668 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 159.84 -23.61 0.29 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.581 ' CE2' ' HG2' ' A' ' 46' ' ' GLU . 3.5 p90 -111.87 139.74 47.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.431 -1.041 . . . . 0.0 109.225 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 50' ' ' PHE . 2.4 m-20 -122.8 -23.79 4.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.682 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.517 ' CB ' ' O ' ' A' ' 49' ' ' ASP . 3.1 m-85 80.54 173.82 0.13 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.363 -0.835 . . . . 0.0 109.382 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.9 p -120.74 39.48 3.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.219 -0.925 . . . . 0.0 109.625 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.496 HG21 ' HA ' ' A' ' 87' ' ' ALA . 15.0 t -98.58 -67.14 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.157 -0.964 . . . . 0.0 109.505 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.444 ' O ' ' CE2' ' A' ' 56' ' ' TYR . 0.2 OUTLIER -165.55 174.98 9.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.097 -1.002 . . . . 0.0 109.996 -179.702 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.584 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -79.22 -51.04 1.3 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.46 -0.775 . . . . 0.0 110.61 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 54' ' ' SER . 36.2 Cg_endo -76.25 82.85 2.12 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.94 1.76 . . . . 0.0 110.208 -178.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.541 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 49.0 m-85 -79.35 -178.15 6.09 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.561 0.696 . . . . 0.0 109.712 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.621 ' CE1' ' NE2' ' A' ' 27' ' ' HIS . 97.1 m-85 -158.13 135.63 10.32 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.474 ' OE2' ' O ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -96.03 140.5 30.68 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.094 -1.003 . . . . 0.0 111.589 -178.115 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.716 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 27.5 t-105 -160.81 139.29 7.42 Favored Pre-proline 0 N--CA 1.495 1.799 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.716 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 31.6 Cg_endo -70.09 143.15 48.39 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.161 1.907 . . . . 0.0 111.321 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 1.031 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -107.02 116.29 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.56 -0.712 . . . . 0.0 109.512 -179.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.031 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.7 OUTLIER -116.94 164.04 15.3 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.296 -0.878 . . . . 0.0 108.985 179.494 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.587 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -172.48 56.32 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.55 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 177.14 36.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.271 -0.893 . . . . 0.0 109.118 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.04 -70.31 0.08 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -173.74 167.75 4.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.202 -1.175 . . . . 0.0 109.77 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.474 HG11 ' HB1' ' A' ' 22' ' ' ALA . 39.8 t -62.59 150.1 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.331 -0.856 . . . . 0.0 109.298 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.596 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 17.1 t80 -52.0 138.86 24.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.966 -1.084 . . . . 0.0 109.533 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.458 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 5.0 t -159.9 21.9 0.17 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.393 -0.817 . . . . 0.0 109.69 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 130.98 154.7 7.98 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.91 -133.5 6.8 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.97 131.07 21.98 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.145 -1.209 . . . . 0.0 109.175 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.475 ' HA ' ' OH ' ' A' ' 38' ' ' TYR . 36.2 Cg_endo -79.48 -172.57 1.57 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.406 2.071 . . . . 0.0 111.012 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.704 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 74.52 -167.74 54.68 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.704 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 77.6 -152.02 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.246 -1.149 . . . . 0.0 110.459 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.24 162.65 9.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.391 -0.818 . . . . 0.0 109.811 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.573 ' O ' HG12 ' A' ' 90' ' ' ILE . 0.9 OUTLIER 175.1 96.59 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.176 -0.952 . . . . 0.0 109.149 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.032 HG21 HD21 ' A' ' 86' ' ' LEU . 2.6 p -77.02 140.12 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.884 -1.135 . . . . 0.0 110.579 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.577 ' CG1' ' N ' ' A' ' 80' ' ' PHE . 16.7 t -92.53 169.44 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.577 ' CE1' ' O ' ' A' ' 57' ' ' TYR . 4.6 p90 -162.84 -173.31 3.43 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.629 -0.829 . . . . 0.0 109.502 -178.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.483 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 11.0 t-20 -124.0 -81.77 0.64 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.17 -0.956 . . . . 0.0 109.405 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 81' ' ' ASN . 65.9 mt-10 -156.4 12.82 0.29 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.459 -0.776 . . . . 0.0 110.317 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.5 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 0.1 OUTLIER -137.9 6.01 2.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.023 -1.048 . . . . 0.0 109.489 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.5 ' OD1' ' O ' ' A' ' 83' ' ' ASN . 0.3 OUTLIER 70.91 16.14 6.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.448 -0.783 . . . . 0.0 109.441 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.586 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -53.72 -31.29 47.69 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.383 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.032 HD21 HG21 ' A' ' 78' ' ' VAL . 0.6 OUTLIER 89.21 103.28 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.686 0.755 . . . . 0.0 110.599 179.226 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.496 ' HA ' HG21 ' A' ' 52' ' ' VAL . . . -70.97 -52.59 18.85 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.25 171.29 34.79 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.682 HG21 ' CG ' ' A' ' 4' ' ' TYR . 64.3 t -102.91 124.69 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.937 -1.331 . . . . 0.0 109.906 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.588 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 0.5 OUTLIER -125.59 153.22 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.331 -0.856 . . . . 0.0 108.696 179.553 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 99' ' ' ASN . 6.3 t -117.07 165.49 13.32 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.026 -1.046 . . . . 0.0 110.019 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.62 ' NE2' ' CD2' ' A' ' 100' ' ' PHE . 0.4 OUTLIER -121.11 67.27 0.87 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.437 -0.789 . . . . 0.0 109.28 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 7.4 m -168.81 126.22 1.01 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.462 -0.773 . . . . 0.0 109.292 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 107.96 -20.57 31.03 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 98' ' ' ASN . . . -105.83 93.94 4.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.211 -1.17 . . . . 0.0 109.681 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 95' ' ' ALA . 51.7 m 41.59 52.58 3.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.511 -0.743 . . . . 0.0 109.477 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.1 -73.29 0.21 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.602 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -144.38 -81.96 0.16 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.259 -1.142 . . . . 0.0 109.472 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 92' ' ' HIS . 0.8 OUTLIER 57.06 159.29 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.317 -0.864 . . . . 0.0 109.15 -179.519 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.62 ' CD2' ' NE2' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -96.61 145.17 25.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.902 -1.124 . . . . 0.0 110.04 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.443 ' O ' ' C ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -155.97 130.55 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.293 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 101' ' ' VAL . 2.3 pt-20 -39.98 136.83 1.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.468 -0.77 . . . . 0.0 110.124 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.99 123.83 29.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.395 -0.816 . . . . 0.0 109.382 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.1 p . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.171 -0.955 . . . . 0.0 109.38 179.844 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.443 ' O ' ' SG ' ' A' ' 10' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.598 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 0.8 OUTLIER 173.94 106.91 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.279 -0.888 . . . . 0.0 110.398 179.558 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -79.66 -14.74 58.57 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.722 ' CG ' HG21 ' A' ' 89' ' ' VAL . 16.2 m-85 -112.8 126.94 55.97 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.337 -0.852 . . . . 0.0 109.051 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 7' ' ' GLY . 1.2 m -152.83 109.32 3.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.235 -0.916 . . . . 0.0 109.744 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 103' ' ' CYS . 29.9 m -95.44 16.81 15.96 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.066 0.936 . . . . 0.0 109.557 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.468 ' O ' HG22 ' A' ' 5' ' ' THR . . . -177.65 -146.47 6.31 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 p -88.17 15.11 7.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.208 -1.172 . . . . 0.0 109.304 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -79.67 -168.18 1.49 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.322 -0.861 . . . . 0.0 109.664 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 1' ' ' ALA . 45.6 t -149.55 74.3 1.22 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.5 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 4.2 m-85 -80.44 124.6 29.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.393 -0.817 . . . . 0.0 110.041 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.772 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -83.79 124.79 31.28 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.502 -0.749 . . . . 0.0 109.63 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 12' ' ' SER . 28.3 t -46.39 -25.67 0.69 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.239 -0.913 . . . . 0.0 108.754 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.3 t -76.91 -43.36 35.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 109.285 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.41 -26.09 67.07 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.886 HG13 HG12 ' A' ' 61' ' ' ILE . 3.0 t -72.87 -32.99 42.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.91 -42.31 97.83 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -47.32 86.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 108.628 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 1.088 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -75.9 -10.59 59.55 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.635 ' NE2' ' CG ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -83.17 -30.61 27.68 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.922 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.425 ' HA ' ' HB3' ' A' ' 24' ' ' TYR . . . -80.25 -16.73 54.07 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.38 -47.27 61.7 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.557 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -73.14 -31.21 61.88 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.684 -1.766 . . . . 0.0 108.684 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.425 ' HB3' ' HA ' ' A' ' 21' ' ' ALA . 11.2 t80 -68.23 -32.15 72.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.46 -1.024 . . . . 0.0 109.171 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -73.36 -47.9 38.57 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.732 HD21 ' C ' ' A' ' 32' ' ' THR . 5.6 tp -65.25 -21.2 66.71 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -85.65 -24.76 26.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.526 -0.734 . . . . 0.0 109.516 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -88.12 -11.55 46.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.319 -0.863 . . . . 0.0 109.403 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -107.88 -11.57 15.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.374 -0.829 . . . . 0.0 109.721 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.64 14.89 77.71 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.426 ' O ' HG23 ' A' ' 32' ' ' THR . 0.3 OUTLIER -81.27 -157.17 0.16 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -1.207 . . . . 0.0 109.379 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.826 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -158.19 166.79 31.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.322 -0.861 . . . . 0.0 109.254 179.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.607 HG13 HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -110.33 -70.44 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.144 -0.973 . . . . 0.0 109.585 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 35' ' ' SER . . . -85.93 16.45 42.15 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 0.5 OUTLIER 66.36 19.73 10.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.132 -1.217 . . . . 0.0 109.114 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -120.92 5.58 10.42 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.402 -0.811 . . . . 0.0 109.293 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.826 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.3 OUTLIER 68.3 73.51 0.29 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.224 -0.922 . . . . 0.0 108.653 -179.179 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.654 ' O ' ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -71.67 -45.33 12.63 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.117 -0.99 . . . . 0.0 110.938 -179.367 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 35.3 Cg_endo -77.15 106.61 2.27 Favored 'Trans proline' 0 C--N 1.3 -1.993 0 C-N-CA 120.855 1.037 . . . . 0.0 109.873 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.654 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -127.09 -175.37 3.41 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -107.13 143.34 35.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.943 -1.098 . . . . 0.0 110.367 -179.454 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.54 ' HB3' ' CB ' ' A' ' 56' ' ' TYR . 12.0 t80 -104.11 161.59 13.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.503 -0.748 . . . . 0.0 109.245 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 44' ' ' ASN . 0.5 OUTLIER -123.83 -16.22 6.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.124 -0.985 . . . . 0.0 109.567 179.615 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.543 ' O ' ' CD2' ' A' ' 45' ' ' TYR . 0.7 OUTLIER 62.1 130.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.556 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.543 ' CD2' ' O ' ' A' ' 44' ' ' ASN . 5.6 m-85 -161.44 -38.54 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.399 -0.813 . . . . 0.0 109.126 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.818 ' OE2' HG12 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -37.93 -68.36 0.16 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.469 0.652 . . . . 0.0 110.131 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.56 61.14 0.01 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -89.62 -174.75 4.44 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.358 -1.084 . . . . 0.0 108.61 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -117.09 -20.4 9.32 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.897 -1.127 . . . . 0.0 110.043 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.511 ' C ' ' CD1' ' A' ' 50' ' ' PHE . 10.1 p90 -80.74 179.97 7.54 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.129 -0.982 . . . . 0.0 109.438 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.475 ' HA ' ' OH ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -177.4 57.08 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.259 -0.9 . . . . 0.0 109.254 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.711 HG11 ' HB2' ' A' ' 85' ' ' GLN . 42.3 t -45.03 -63.13 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.165 -0.959 . . . . 0.0 109.023 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.408 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -154.75 -178.97 7.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.312 -0.868 . . . . 0.0 109.95 179.972 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.588 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -79.7 -50.09 1.29 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.405 -0.809 . . . . 0.0 110.81 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 54' ' ' SER . 34.5 Cg_endo -75.28 83.62 1.83 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.991 1.794 . . . . 0.0 109.764 -178.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.621 ' CE1' ' HB2' ' A' ' 87' ' ' ALA . 10.1 m-85 -81.68 179.82 7.68 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.745 0.783 . . . . 0.0 110.804 -178.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.577 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 64.4 m-85 -157.26 117.12 3.43 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.624 ' HG2' HD11 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -96.66 147.66 23.66 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.266 -0.896 . . . . 0.0 110.489 -178.584 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.696 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 4.1 t-105 -160.75 143.93 9.83 Favored Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.696 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 28.4 Cg_endo -66.35 133.03 31.17 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.336 2.024 . . . . 0.0 112.091 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 1.088 HD13 ' HB3' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -118.31 115.66 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.704 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.023 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -118.58 163.75 16.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.107 -0.996 . . . . 0.0 109.13 179.761 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.1 t -131.53 36.17 3.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.484 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.73 6.8 12.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.18 -0.95 . . . . 0.0 109.618 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.71 -32.7 7.26 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.991 ' O ' HD12 ' A' ' 62' ' ' LEU . 11.9 m-20 -98.97 91.39 5.01 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.23 -1.159 . . . . 0.0 109.375 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.584 ' O ' ' CD1' ' A' ' 68' ' ' TYR . 43.4 t -65.02 156.75 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 109.857 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.589 ' HB3' ' CZ2' ' A' ' 59' ' ' TRP . 48.6 p90 39.17 -162.69 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.598 0.713 . . . . 0.0 110.023 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.492 ' N ' ' CD2' ' A' ' 68' ' ' TYR . 29.0 t 53.11 173.22 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.342 -0.849 . . . . 0.0 109.427 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.63 -160.45 15.99 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.66 41.32 2.25 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 t -161.26 85.95 1.72 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.221 -1.164 . . . . 0.0 109.306 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.557 ' HA ' ' OH ' ' A' ' 38' ' ' TYR . 35.5 Cg_endo -79.95 44.05 1.64 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.789 2.326 . . . . 0.0 111.022 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.631 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . -173.03 -167.52 33.05 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 72.28 -141.89 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.117 -1.225 . . . . 0.0 110.162 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.465 ' C ' ' O ' ' A' ' 75' ' ' ALA . 1.2 m-20 -34.2 131.14 0.31 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.444 -0.785 . . . . 0.0 111.21 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.519 ' O ' HG12 ' A' ' 90' ' ' ILE . 6.5 ttm-85 -167.24 110.11 0.68 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.469 -0.769 . . . . 0.0 108.989 179.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.797 HG23 HD11 ' A' ' 86' ' ' LEU . 4.3 p -71.95 164.62 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.069 -1.019 . . . . 0.0 109.67 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 1.021 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 4.0 t -130.52 171.36 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.973 0.892 . . . . 0.0 109.961 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.638 ' H ' HG12 ' A' ' 79' ' ' VAL . 24.0 p90 -174.02 -172.46 0.72 Allowed 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.418 ' CG ' ' N ' ' A' ' 82' ' ' GLU . 2.9 t30 -125.33 -84.9 0.64 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.962 -1.087 . . . . 0.0 109.794 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.418 ' N ' ' CG ' ' A' ' 81' ' ' ASN . 6.9 mt-10 -142.16 0.55 1.36 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.494 -0.753 . . . . 0.0 109.919 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 84' ' ' ASN . 8.7 m-20 -131.4 4.81 4.35 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 108.895 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.515 ' OD1' ' HB3' ' A' ' 20' ' ' GLN . 5.5 t30 75.1 32.43 0.77 Allowed 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.334 -0.854 . . . . 0.0 109.192 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.711 ' HB2' HG11 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -62.16 -33.16 73.98 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.46 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.797 HD11 HG23 ' A' ' 78' ' ' VAL . 0.1 OUTLIER 84.99 103.95 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.488 0.661 . . . . 0.0 110.994 178.937 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 1.021 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . . . -74.54 -27.8 60.68 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.42 ' H ' ' CD1' ' A' ' 86' ' ' LEU . . . 148.14 -149.03 21.04 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.722 HG21 ' CG ' ' A' ' 4' ' ' TYR . 72.5 t -129.85 87.71 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.254 -1.145 . . . . 0.0 109.639 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.624 HD11 ' HG2' ' A' ' 58' ' ' GLU . 12.2 pt -79.4 136.24 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.514 -0.741 . . . . 0.0 109.221 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.631 ' O ' HG23 ' A' ' 91' ' ' THR . 13.1 t -130.5 118.54 21.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.91 . . . . 0.0 110.296 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.691 ' CD2' ' CE1' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -84.01 76.42 10.06 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.368 -0.832 . . . . 0.0 108.848 179.279 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 98' ' ' ASN . 1.4 m 178.96 -30.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.553 -0.717 . . . . 0.0 109.404 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -59.04 -15.01 27.23 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.887 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . . . -117.96 163.68 16.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.186 -1.185 . . . . 0.0 109.553 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 95' ' ' ALA . 3.7 m -42.92 120.33 1.75 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 109.008 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.97 -82.84 1.64 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.654 -1.779 . . . . 0.0 108.654 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.632 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -151.9 -86.81 0.07 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.318 -1.107 . . . . 0.0 109.287 179.419 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.887 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 4.0 m-80 61.04 129.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 108.937 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.691 ' CE1' ' CD2' ' A' ' 92' ' ' HIS . 57.0 m-85 -85.33 125.58 33.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.891 -1.131 . . . . 0.0 110.292 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.818 HG12 ' OE2' ' A' ' 46' ' ' GLU . 1.2 m -142.69 137.51 27.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.497 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 24.0 pt-20 -61.52 123.61 18.35 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.164 -0.96 . . . . 0.0 109.221 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.448 ' HB3' ' HA ' ' A' ' 6' ' ' CYS . 84.7 m -56.93 161.01 3.17 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.151 -0.968 . . . . 0.0 109.398 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.479 0 O-C-N 121.22 -0.925 . . . . 0.0 109.492 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 27.2 p -178.77 88.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.145 -0.972 . . . . 0.0 109.956 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -89.9 2.72 54.71 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.296 -0.878 . . . . 0.0 109.285 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -126.57 105.74 8.94 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.112 -0.992 . . . . 0.0 109.637 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.644 HG23 ' O ' ' A' ' 5' ' ' THR . 6.0 t -136.43 106.79 6.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.892 . . . . 0.0 109.318 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.47 ' SG ' ' HB ' ' A' ' 91' ' ' THR . 57.3 m -93.47 17.14 11.99 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.17 0.986 . . . . 0.0 109.63 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.48 -111.77 0.32 Allowed Glycine 0 C--N 1.282 -2.432 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.14 3.93 12.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.15 -1.206 . . . . 0.0 109.271 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.562 ' O ' ' N ' ' A' ' 11' ' ' TYR . 3.9 m120 -92.51 68.12 4.79 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.246 -0.909 . . . . 0.0 109.411 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -49.74 89.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.567 ' CZ ' ' OG ' ' A' ' 63' ' ' SER . 4.0 m-30 -83.17 144.6 29.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.456 -0.778 . . . . 0.0 110.173 -178.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.601 ' HA ' ' HA ' ' A' ' 2' ' ' CYS . 0.1 OUTLIER -79.18 127.84 32.54 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.818 -0.551 . . . . 0.0 110.042 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.35 -43.19 61.74 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.9 m -62.68 -34.52 77.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.378 -0.826 . . . . 0.0 108.958 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -69.22 -31.1 69.45 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 12' ' ' SER . 6.7 t -58.82 -25.43 29.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.469 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 20.3 t -74.4 -40.6 61.93 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -40.44 80.36 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.74 ' CB ' HD13 ' A' ' 61' ' ' ILE . . . -77.06 -26.43 53.56 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.782 ' NE2' HG13 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -75.03 -16.62 60.59 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.056 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -92.62 -11.71 33.54 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.95 -56.2 3.95 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.581 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -69.16 -24.13 76.02 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.565 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 11.0 t80 -77.99 -53.33 7.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.501 -1.0 . . . . 0.0 109.048 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 1.1 tm0? -45.64 -47.15 14.89 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.559 ' CD1' ' N ' ' A' ' 32' ' ' THR . 1.0 OUTLIER -59.79 -48.87 79.93 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.389 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.465 ' NE2' ' CZ ' ' A' ' 57' ' ' TYR . 9.1 t60 -59.06 -14.51 9.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.264 -0.898 . . . . 0.0 110.367 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -96.0 -28.18 14.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.89 -1.131 . . . . 0.0 109.957 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.39 8.0 45.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.115 -0.99 . . . . 0.0 109.432 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 48.62 34.07 13.62 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.536 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -102.17 -147.72 0.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -1.169 . . . . 0.0 109.429 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.99 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.3 OUTLIER -157.87 -178.19 7.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.064 -1.022 . . . . 0.0 110.016 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.521 HG23 ' N ' ' A' ' 34' ' ' GLY . 25.8 m -98.81 -139.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.878 . . . . 0.0 109.515 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.521 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -42.27 -51.41 5.32 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 173.62 -31.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.263 -1.14 . . . . 0.0 109.635 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.445 ' O ' ' CB ' ' A' ' 37' ' ' SER . 5.8 m120 -74.82 -7.38 53.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.25 -0.906 . . . . 0.0 109.573 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.99 ' HA ' HG22 ' A' ' 32' ' ' THR . 2.4 p 71.84 -165.33 0.13 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -0.922 . . . . 0.0 109.481 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.591 ' CD1' ' HD3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER 167.64 -45.03 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.482 -0.761 . . . . 0.0 111.269 179.435 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 31.8 Cg_endo -76.59 100.68 1.42 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 121.482 1.455 . . . . 0.0 112.025 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.587 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -140.33 163.44 32.77 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.591 -0.693 . . . . 0.0 109.513 178.735 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -58.06 154.13 13.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.795 -1.19 . . . . 0.0 108.664 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.631 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -136.74 155.22 50.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.124 -0.985 . . . . 0.0 110.044 -178.562 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.612 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . 0.7 OUTLIER -137.82 -71.99 0.42 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.537 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.631 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 1.0 OUTLIER 80.18 -69.66 0.1 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.593 -0.692 . . . . 0.0 111.411 178.318 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.612 ' CE2' ' HB3' ' A' ' 43' ' ' ASN . 86.6 m-85 67.41 9.12 6.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 108.846 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.509 ' HB3' ' CE2' ' A' ' 48' ' ' PHE . 0.4 OUTLIER -39.33 -50.72 2.05 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 121.557 -0.715 . . . . 0.0 109.809 -179.725 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 159.37 36.71 0.02 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.509 ' CE2' ' HB3' ' A' ' 46' ' ' GLU . 7.5 m-85 -115.64 -179.91 3.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.243 -1.151 . . . . 0.0 109.346 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -128.73 -34.68 1.96 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.464 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.528 ' CB ' ' OH ' ' A' ' 56' ' ' TYR . 16.8 m-30 55.21 179.12 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 109.916 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.6 p -139.76 21.04 2.5 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.573 HG12 ' N ' ' A' ' 53' ' ' SER . 77.1 t -95.42 -92.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.544 -0.722 . . . . 0.0 109.843 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.573 ' N ' HG12 ' A' ' 52' ' ' VAL . 60.7 m -166.27 -168.84 1.29 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.976 . . . . 0.0 110.047 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.607 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -77.78 -50.74 1.89 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.614 -0.679 . . . . 0.0 111.056 -179.816 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 54' ' ' SER . 32.5 Cg_endo -73.01 92.38 0.81 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 121.897 1.731 . . . . 0.0 110.168 -177.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.607 ' CE1' ' HB2' ' A' ' 87' ' ' ALA . 17.4 m-85 -94.66 -169.15 1.96 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.589 ' O ' ' CE1' ' A' ' 80' ' ' PHE . 70.4 m-85 -161.66 106.94 1.3 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 0.3 OUTLIER -78.1 140.24 39.05 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.836 0.827 . . . . 0.0 110.921 -178.613 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.678 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 31.3 t-105 -160.35 137.02 6.52 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.678 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.9 Cg_endo -69.08 145.89 62.59 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.092 1.862 . . . . 0.0 111.484 -178.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.983 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -110.88 128.49 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.56 -0.713 . . . . 0.0 109.527 -179.339 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.983 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -124.82 161.33 26.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.153 -0.967 . . . . 0.0 109.261 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.567 ' OG ' ' CZ ' ' A' ' 11' ' ' TYR . 53.8 m -133.42 5.73 3.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.303 -0.873 . . . . 0.0 109.398 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.37 -71.48 0.73 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.917 . . . . 0.0 109.202 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 66' ' ' ASP . . . -74.32 -92.83 0.14 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 53.4 t0 179.87 -36.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.289 -1.124 . . . . 0.0 109.758 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.04 155.48 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.162 -0.961 . . . . 0.0 109.89 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.567 ' HB2' ' HG2' ' A' ' 60' ' ' PRO . 54.1 t80 -71.57 115.06 10.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.908 . . . . 0.0 109.397 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.6 t -152.74 -43.43 0.1 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.38 -0.825 . . . . 0.0 109.278 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.31 -27.44 57.9 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.419 ' O ' ' OG ' ' A' ' 72' ' ' SER . . . 101.14 -163.97 18.2 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.554 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 18.2 p 55.82 60.81 8.5 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.305 -1.115 . . . . 0.0 109.846 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 72' ' ' SER . 36.8 Cg_endo -79.59 -159.05 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.651 2.234 . . . . 0.0 110.436 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.566 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 92.2 -171.65 34.15 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 70.86 -80.85 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.482 -1.011 . . . . 0.0 110.377 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.602 ' HB3' HG23 ' A' ' 61' ' ' ILE . 54.6 m-20 -113.66 135.17 54.22 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.015 -1.053 . . . . 0.0 109.698 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.557 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 4.6 mtt180 -155.99 84.82 1.01 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.313 -0.867 . . . . 0.0 109.073 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.782 HG13 ' NE2' ' A' ' 20' ' ' GLN . 14.6 p -77.93 150.44 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.975 -1.078 . . . . 0.0 109.484 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.652 HG12 ' H ' ' A' ' 80' ' ' PHE . 3.0 t -111.62 173.35 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.364 -0.835 . . . . 0.0 109.418 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.652 ' H ' HG12 ' A' ' 79' ' ' VAL . 4.4 p90 -164.24 -171.47 2.41 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.221 -178.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.556 ' HB2' HG11 ' A' ' 52' ' ' VAL . 16.8 t30 -121.08 -83.08 0.66 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.026 -1.046 . . . . 0.0 109.99 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.565 ' O ' ' CZ ' ' A' ' 24' ' ' TYR . 42.0 mt-10 -141.91 -9.44 0.91 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.402 -0.811 . . . . 0.0 110.862 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -131.77 25.06 4.69 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.907 -1.121 . . . . 0.0 108.882 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.455 ' O ' ' C ' ' A' ' 85' ' ' GLN . 3.1 m120 62.37 21.73 12.75 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.495 -0.753 . . . . 0.0 109.506 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.568 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -44.11 -30.23 0.73 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.562 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.568 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER 85.18 103.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.553 0.692 . . . . 0.0 110.904 178.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.607 ' HB2' ' CE1' ' A' ' 56' ' ' TYR . . . -79.41 -33.21 42.85 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 139.73 145.3 4.67 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.507 HG22 ' HB ' ' A' ' 78' ' ' VAL . 61.2 t -80.57 118.88 29.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.144 -1.209 . . . . 0.0 109.282 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.674 HD12 ' HB2' ' A' ' 100' ' ' PHE . 0.4 OUTLIER -104.45 179.12 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.925 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.484 ' O ' ' O ' ' A' ' 99' ' ' ASN . 1.5 t -138.0 135.3 35.82 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.354 -1.338 . . . . 0.0 111.916 -178.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.611 ' CE1' ' CD1' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -86.19 62.34 7.38 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.553 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 93' ' ' THR . 6.8 t -176.2 25.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.385 -0.822 . . . . 0.0 110.314 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.19 10.56 17.48 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 1.026 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . . . -153.29 -174.42 4.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -1.152 . . . . 0.0 109.554 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 95' ' ' ALA . 1.9 t -42.71 113.98 0.53 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.343 -0.848 . . . . 0.0 109.718 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.46 -81.84 0.82 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.595 ' HB2' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -138.36 -76.32 0.38 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -1.138 . . . . 0.0 109.722 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 1.026 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 1.0 OUTLIER 59.94 154.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -178.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.674 ' HB2' HD12 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -114.36 118.75 34.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.711 -1.243 . . . . 0.0 110.961 -179.233 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.443 ' O ' ' C ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -125.51 139.83 50.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 107.85 -1.166 . . . . 0.0 107.85 178.357 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -41.82 140.01 1.11 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.137 -0.977 . . . . 0.0 110.347 -178.672 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.442 ' O ' ' OE1' ' A' ' 102' ' ' GLU . 0.5 OUTLIER -56.36 109.03 0.54 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.419 -0.801 . . . . 0.0 109.478 179.716 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 109.538 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 8.5 p 173.96 99.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.931 . . . . 0.0 109.862 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -101.51 -9.42 21.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.349 -0.844 . . . . 0.0 109.311 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.989 ' CG ' HG21 ' A' ' 89' ' ' VAL . 18.8 m-85 -106.14 82.15 1.72 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.115 -0.991 . . . . 0.0 109.163 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.694 HG22 ' HA ' ' A' ' 10' ' ' CYS . 76.3 p -89.83 131.51 35.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -0.852 . . . . 0.0 109.719 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.516 ' CB ' ' OD1' ' A' ' 76' ' ' ASP . 4.0 m -143.55 157.76 44.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.348 -0.845 . . . . 0.0 109.138 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 8' ' ' SER . . . 44.95 32.94 3.4 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 7' ' ' GLY . 0.6 OUTLIER 68.53 49.18 0.77 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.323 -1.104 . . . . 0.0 109.573 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.464 ' O ' ' HB ' ' A' ' 5' ' ' THR . 25.2 m120 -136.3 172.91 12.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.185 -0.947 . . . . 0.0 110.032 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.694 ' HA ' HG22 ' A' ' 5' ' ' THR . 0.4 OUTLIER -127.48 81.87 2.05 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.663 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.536 ' CE2' ' HB2' ' A' ' 63' ' ' SER . 2.9 m-85 -79.0 138.28 37.96 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.476 -0.765 . . . . 0.0 109.826 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.662 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.8 OUTLIER -79.62 124.74 28.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.607 -0.683 . . . . 0.0 109.767 -179.709 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.64 -21.94 3.01 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.559 -0.856 . . . . 0.0 108.975 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.2 t -82.28 -36.64 26.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.384 -0.822 . . . . 0.0 109.328 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -69.48 -33.79 73.39 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 12' ' ' SER . 5.0 t -58.66 -38.4 71.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.48 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 0.9 OUTLIER -63.71 -31.63 72.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.616 -0.677 . . . . 0.0 109.487 179.547 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -56.78 9.13 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.795 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -63.62 -17.25 62.69 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.57 ' OE1' ' CG ' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -77.43 -36.0 53.53 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -74.13 -6.31 46.94 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.717 ' HB1' HG22 ' A' ' 67' ' ' VAL . . . -84.19 -53.6 5.39 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.607 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -68.33 -27.77 73.59 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.484 ' C ' ' CD1' ' A' ' 24' ' ' TYR . 1.3 t80 -76.31 -60.02 2.51 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.502 -0.999 . . . . 0.0 109.599 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 14.6 mt-30 -57.58 -31.67 66.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.032 -1.042 . . . . 0.0 109.137 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.658 HD23 ' HG3' ' A' ' 39' ' ' PRO . 9.2 tp -74.01 -28.89 61.67 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 108.54 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 39' ' ' PRO . 14.0 t60 -79.5 -21.91 44.68 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.422 -0.799 . . . . 0.0 109.448 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -89.31 -31.93 17.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.322 -0.861 . . . . 0.0 109.464 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -80.93 -13.77 58.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.94 . . . . 0.0 109.579 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.24 36.34 27.61 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.859 ' O ' HG23 ' A' ' 32' ' ' THR . 0.3 OUTLIER -105.49 -158.78 0.68 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.252 -1.146 . . . . 0.0 109.791 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.859 HG23 ' O ' ' A' ' 31' ' ' GLU . 1.1 p -168.22 -172.18 1.69 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.573 HG11 ' O ' ' A' ' 68' ' ' TYR . 33.7 m -125.38 152.35 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.08 -1.012 . . . . 0.0 110.377 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 48.79 -88.54 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.541 ' N ' ' O ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -175.09 28.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.417 -1.049 . . . . 0.0 109.346 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.447 ' O ' ' OG ' ' A' ' 37' ' ' SER . 5.2 m-20 -138.0 23.64 2.82 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.339 -0.85 . . . . 0.0 109.159 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.591 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 75.8 p 48.98 -165.98 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.416 -0.803 . . . . 0.0 109.692 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.629 ' CE2' ' NH1' ' A' ' 77' ' ' ARG . 0.0 OUTLIER 168.7 -44.88 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.549 -0.719 . . . . 0.0 111.541 179.212 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.658 ' HG3' HD23 ' A' ' 26' ' ' LEU . 33.2 Cg_endo -76.77 100.75 1.43 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 121.377 1.385 . . . . 0.0 111.986 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.552 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -140.4 -170.15 2.93 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.682 -0.636 . . . . 0.0 109.349 178.642 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 11.5 ptmt -75.51 163.84 26.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.406 -0.809 . . . . 0.0 110.395 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.588 ' CE2' ' HA ' ' A' ' 44' ' ' ASN . 85.7 t80 -142.83 93.88 2.57 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 44' ' ' ASN . 0.5 OUTLIER -81.79 37.91 0.49 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.12 -0.987 . . . . 0.0 110.752 -179.053 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.588 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER 39.92 -160.99 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.216 -0.927 . . . . 0.0 109.948 179.394 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.457 ' CB ' ' O ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER 167.25 -67.31 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.4 -0.813 . . . . 0.0 109.217 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -38.96 -52.63 1.78 Allowed 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.519 -0.738 . . . . 0.0 110.016 -179.784 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.07 51.18 0.05 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.548 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 21.0 m-85 -101.09 115.09 29.66 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.178 -1.189 . . . . 0.0 109.523 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.04 88.94 7.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.411 -0.806 . . . . 0.0 109.18 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.548 ' CZ ' ' HB2' ' A' ' 48' ' ' PHE . 60.6 m-85 -78.87 -172.46 3.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.358 -0.839 . . . . 0.0 109.657 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 84.2 p -153.48 42.25 0.56 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 109.3 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.83 HG21 ' O ' ' A' ' 86' ' ' LEU . 38.3 t -114.65 -41.63 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.32 -0.862 . . . . 0.0 109.518 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.492 ' HB3' ' OD1' ' A' ' 81' ' ' ASN . 0.6 OUTLIER 176.7 -174.47 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.147 -0.971 . . . . 0.0 109.75 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.567 ' CB ' ' HD3' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -91.97 -56.24 0.25 Allowed Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.247 -0.908 . . . . 0.0 111.518 -179.231 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.567 ' HD3' ' CB ' ' A' ' 54' ' ' SER . 35.4 Cg_endo -75.17 89.3 1.18 Allowed 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.913 1.742 . . . . 0.0 110.082 -177.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 1.025 ' CE2' ' HB1' ' A' ' 87' ' ' ALA . 4.0 m-30 -84.82 -179.52 7.11 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.433 0.635 . . . . 0.0 109.982 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.583 ' O ' ' CE1' ' A' ' 80' ' ' PHE . 87.2 m-85 -151.86 130.38 12.21 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.477 -0.765 . . . . 0.0 109.098 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.513 ' OE1' ' NH2' ' A' ' 77' ' ' ARG . 12.7 pt-20 -89.11 133.7 34.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 0.0 110.917 -178.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.684 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 20.0 t-105 -160.25 139.52 8.02 Favored Pre-proline 0 N--CA 1.491 1.6 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.684 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 32.8 Cg_endo -72.11 152.88 57.06 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.482 2.121 . . . . 0.0 111.897 -178.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 1.053 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -115.48 122.3 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.053 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -117.58 169.81 9.25 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.098 -1.001 . . . . 0.0 109.429 179.611 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.536 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 6.6 t -121.26 39.06 3.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 108.799 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.64 -31.13 5.28 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.569 -0.707 . . . . 0.0 109.356 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.23 12.56 59.84 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 67' ' ' VAL . 0.6 OUTLIER -106.16 9.89 32.1 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.212 -1.169 . . . . 0.0 109.595 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.717 HG22 ' HB1' ' A' ' 22' ' ' ALA . 91.9 t 60.8 143.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.169 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.779 ' HA ' HD11 ' A' ' 62' ' ' LEU . 16.7 t80 -55.53 108.79 0.47 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.124 -0.985 . . . . 0.0 109.402 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.68 48.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.408 -0.808 . . . . 0.0 109.325 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -149.38 -52.72 0.02 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 167.78 -167.61 40.15 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.411 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 0.3 OUTLIER 60.68 68.05 1.4 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.296 -1.12 . . . . 0.0 109.324 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 72' ' ' SER . 36.3 Cg_endo -78.72 155.74 27.4 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.742 2.295 . . . . 0.0 110.944 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.713 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 74.99 -149.84 40.06 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 80.17 -77.95 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.503 -0.998 . . . . 0.0 109.989 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.516 ' OD1' ' CB ' ' A' ' 6' ' ' CYS . 41.8 m-20 -131.28 134.91 46.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.019 -1.05 . . . . 0.0 110.333 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.629 ' NH1' ' CE2' ' A' ' 38' ' ' TYR . 1.6 mtt180 -138.42 123.92 19.56 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 78' ' ' VAL . 4.7 p -112.52 120.84 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.958 -1.089 . . . . 0.0 108.896 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.814 ' CG2' HD11 ' A' ' 90' ' ' ILE . 14.8 t -79.05 170.61 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 122.083 0.944 . . . . 0.0 110.266 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.592 ' N ' HG12 ' A' ' 79' ' ' VAL . 3.2 p90 -164.19 -171.36 2.38 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.492 ' OD1' ' HB3' ' A' ' 53' ' ' SER . 7.3 t30 -123.95 -81.41 0.64 Allowed 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.229 -0.989 . . . . 0.0 109.949 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.457 ' OE2' ' O ' ' A' ' 81' ' ' ASN . 66.7 mm-40 -159.24 18.08 0.18 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.288 -0.882 . . . . 0.0 109.645 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.465 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 3.8 m-20 -136.79 24.25 3.09 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.479 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 8.5 p30 48.02 23.32 0.48 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.633 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -67.68 -90.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.444 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.83 ' O ' HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER 165.39 106.8 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.132 -0.98 . . . . 0.0 110.36 178.674 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 1.025 ' HB1' ' CE2' ' A' ' 56' ' ' TYR . . . -74.97 -42.09 58.29 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 162.74 154.13 7.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.989 HG21 ' CG ' ' A' ' 4' ' ' TYR . 40.2 t -93.3 105.33 16.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 120.843 -1.387 . . . . 0.0 110.164 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.814 HD11 ' CG2' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -99.43 172.64 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.214 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.469 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 2.8 t -145.02 141.07 28.59 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.668 -1.27 . . . . 0.0 111.261 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.528 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -88.68 55.95 3.58 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.306 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 93' ' ' THR . 5.8 t -168.4 23.09 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.157 -0.964 . . . . 0.0 110.309 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -125.81 23.99 5.83 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.849 ' HB3' ' HB3' ' A' ' 99' ' ' ASN . . . -177.89 117.93 0.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.407 -1.054 . . . . 0.0 109.506 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.459 ' O ' ' C ' ' A' ' 97' ' ' GLY . 2.5 m 46.06 -159.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.114 -0.991 . . . . 0.0 109.21 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 96' ' ' SER . . . -39.02 -50.64 2.68 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.528 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -152.12 -76.02 0.13 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.107 -1.231 . . . . 0.0 109.605 179.74 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.849 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 0.2 OUTLIER 60.91 146.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.135 -0.978 . . . . 0.0 108.772 -179.476 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.549 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -93.5 125.78 38.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.857 -1.152 . . . . 0.0 110.451 -179.51 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.543 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -145.22 137.68 21.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.512 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.45 ' O ' ' OG1' ' A' ' 104' ' ' THR . 0.0 OUTLIER -44.36 129.83 6.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.229 -0.919 . . . . 0.0 109.477 -179.598 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.469 ' SG ' ' HB ' ' A' ' 91' ' ' THR . 12.6 m -54.13 98.36 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.196 -0.94 . . . . 0.0 109.425 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 109.478 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.496 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 25.6 p 174.29 156.64 0.14 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.346 -0.846 . . . . 0.0 109.776 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.72 -40.75 2.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.344 -0.847 . . . . 0.0 109.105 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.641 ' CE1' ' CG2' ' A' ' 89' ' ' VAL . 15.1 m-85 -82.24 127.17 32.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.348 -0.845 . . . . 0.0 109.656 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.46 ' O ' ' SG ' ' A' ' 103' ' ' CYS . 0.2 OUTLIER -133.44 129.6 37.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.375 -0.828 . . . . 0.0 109.194 179.727 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 98.3 m -139.38 16.56 2.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.118 -0.989 . . . . 0.0 110.079 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.14 42.9 0.07 OUTLIER Glycine 0 C--N 1.284 -2.348 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.09 12.34 4.93 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.281 -1.129 . . . . 0.0 109.29 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.409 ' O ' HG23 ' A' ' 5' ' ' THR . 13.3 m120 -84.22 -171.97 3.91 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.216 -0.928 . . . . 0.0 109.13 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.432 ' C ' ' CB ' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -131.47 67.09 1.53 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.248 -0.908 . . . . 0.0 109.047 -179.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.5 ' CZ ' ' HB3' ' A' ' 63' ' ' SER . 36.2 m-85 -79.3 120.32 23.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.0 108.802 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.904 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -91.84 137.2 32.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.911 . . . . 0.0 110.407 -179.164 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.7 p -51.75 -21.9 3.14 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.9 t -84.45 -35.86 22.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.307 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.3 -23.5 60.29 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.904 HG23 ' O ' ' A' ' 12' ' ' SER . 2.7 t -74.58 -31.5 27.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -45.15 95.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -0.777 . . . . 0.0 109.034 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.1 m -60.09 -42.64 95.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.218 -0.926 . . . . 0.0 108.801 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.821 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -76.43 -13.28 60.12 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.475 ' NE2' ' O ' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -87.31 -21.99 25.4 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.1 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -85.59 -12.49 51.38 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.34 -56.04 4.32 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.349 -0.845 . . . . 0.0 109.261 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.591 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -66.56 -21.12 70.53 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.491 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 0.9 OUTLIER -81.38 -62.4 1.66 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.459 -1.024 . . . . 0.0 109.158 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 1.6 tt0 -44.3 -43.36 7.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.149 -0.97 . . . . 0.0 109.247 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.46 ' HA ' HD22 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -64.15 -43.84 93.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.252 -0.905 . . . . 0.0 109.12 179.726 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.621 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 28.3 t60 -68.07 -14.54 63.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.841 . . . . 0.0 110.102 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -95.65 -26.31 15.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.012 -1.055 . . . . 0.0 110.01 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 26.3 t0 -88.15 -10.48 49.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.161 -0.962 . . . . 0.0 109.73 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.09 0.78 66.46 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.414 ' C ' HD11 ' A' ' 26' ' ' LEU . 2.5 mm-40 -79.34 -169.29 1.82 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.159 -1.201 . . . . 0.0 109.281 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.995 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -127.37 178.21 6.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.774 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.567 ' CG2' ' HD3' ' A' ' 39' ' ' PRO . 60.1 t -82.31 -98.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.401 -0.812 . . . . 0.0 110.277 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.528 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -122.01 57.64 0.61 Allowed Glycine 0 N--CA 1.488 2.114 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.186 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER 78.96 -10.63 1.32 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.51 -0.994 . . . . 0.0 110.512 179.416 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -112.1 -6.8 14.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.894 -1.129 . . . . 0.0 109.515 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.995 ' HA ' HG22 ' A' ' 32' ' ' THR . 8.0 t 58.13 -175.06 0.08 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.238 -0.914 . . . . 0.0 109.316 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.588 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER 168.27 -44.94 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 111.495 179.324 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 31.8 Cg_endo -75.58 100.65 1.39 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.409 1.406 . . . . 0.0 111.976 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.533 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -144.39 -178.28 5.9 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.584 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.602 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -74.85 154.02 38.44 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.404 ' N ' ' HG2' ' A' ' 41' ' ' LYS . 19.2 t80 -125.62 145.72 50.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.992 -1.067 . . . . 0.0 110.249 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.444 ' O ' ' C ' ' A' ' 44' ' ' ASN . 41.1 t-20 -117.49 66.02 0.74 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 43' ' ' ASN . 0.6 OUTLIER -40.0 147.72 0.09 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.501 -0.749 . . . . 0.0 110.146 -179.369 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.459 ' O ' ' C ' ' A' ' 46' ' ' GLU . 98.2 m-85 -118.57 -44.73 2.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.403 -0.811 . . . . 0.0 108.999 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -38.63 -47.93 1.39 Allowed 'General case' 0 C--N 1.309 -1.18 0 O-C-N 121.599 -0.688 . . . . 0.0 109.915 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.16 48.38 0.06 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 86.7 m-85 -96.17 90.82 5.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.244 -1.151 . . . . 0.0 108.964 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.59 82.51 1.77 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.925 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.975 ' CD2' ' HB1' ' A' ' 87' ' ' ALA . 4.8 m-85 -78.33 -169.22 1.57 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.369 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.1 m -109.6 17.12 21.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.305 -0.872 . . . . 0.0 109.419 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.436 HG21 ' HA ' ' A' ' 87' ' ' ALA . 64.1 t -77.06 -60.13 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.356 -0.84 . . . . 0.0 109.48 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.42 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -172.11 161.77 5.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.105 -0.997 . . . . 0.0 109.715 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.585 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -72.18 -51.99 7.6 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.477 -0.764 . . . . 0.0 110.227 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 54' ' ' SER . 36.4 Cg_endo -76.24 87.0 1.47 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 121.939 1.759 . . . . 0.0 109.858 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.563 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 38.1 m-85 -79.04 -174.44 4.07 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.698 -0.627 . . . . 0.0 109.67 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.621 ' CE2' ' NE2' ' A' ' 27' ' ' HIS . 83.2 m-85 -154.93 134.63 12.77 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.405 ' HB2' ' NH2' ' A' ' 77' ' ' ARG . 3.9 pt-20 -96.75 144.3 26.88 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 122.053 0.93 . . . . 0.0 111.845 -177.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.698 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 32.2 t-105 -161.19 136.04 5.46 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.698 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.4 Cg_endo -69.57 147.2 63.59 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 121.864 1.709 . . . . 0.0 111.479 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.936 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -119.02 137.4 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.936 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.8 OUTLIER -120.27 172.79 7.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.128 -0.983 . . . . 0.0 109.701 -179.301 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.5 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . 5.4 p -119.45 29.64 7.51 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.187 -0.946 . . . . 0.0 108.768 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.96 -148.99 0.39 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.48 -0.762 . . . . 0.0 109.541 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -121.75 72.14 0.38 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -170.99 155.42 4.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -1.12 . . . . 0.0 109.769 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.567 HG13 ' HZ2' ' A' ' 59' ' ' TRP . 23.6 t -93.81 154.91 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.852 . . . . 0.0 109.291 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.516 ' O ' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -72.79 84.46 1.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.95 -1.094 . . . . 0.0 110.025 -179.506 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.436 ' HA ' HG12 ' A' ' 33' ' ' VAL . 14.5 t -81.0 -5.4 57.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.306 -0.871 . . . . 0.0 109.125 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -174.82 -144.14 4.78 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.17 -157.15 31.62 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.499 ' OG ' ' HD2' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -127.25 156.52 74.6 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.199 -1.177 . . . . 0.0 109.502 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.499 ' HD2' ' OG ' ' A' ' 72' ' ' SER . 35.5 Cg_endo -77.88 -175.15 2.55 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.643 2.229 . . . . 0.0 110.379 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 88.01 -167.1 35.95 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.573 ' N ' ' HB2' ' A' ' 92' ' ' HIS . . . 66.33 -83.94 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.706 -0.879 . . . . 0.0 109.987 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -137.12 157.28 47.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.044 -1.035 . . . . 0.0 109.753 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.487 ' O ' HG12 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -170.35 114.75 0.48 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.246 -0.909 . . . . 0.0 109.338 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 88' ' ' GLY . 14.1 p -90.77 134.09 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.07 -1.019 . . . . 0.0 109.173 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.842 HG23 ' CD1' ' A' ' 90' ' ' ILE . 20.1 t -98.88 165.32 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 122.174 0.988 . . . . 0.0 110.313 -179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.572 ' N ' ' CG1' ' A' ' 79' ' ' VAL . 20.1 p90 -163.16 -168.46 1.74 Allowed 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -178.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.52 ' O ' ' CB ' ' A' ' 82' ' ' GLU . 3.7 p30 -128.73 -44.38 1.34 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.791 -1.193 . . . . 0.0 110.387 -179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 0.2 OUTLIER 163.1 -25.89 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.379 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.503 ' HB3' ' HG2' ' A' ' 85' ' ' GLN . 1.2 t-20 -90.9 0.5 57.48 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.488 ' HB3' ' O ' ' A' ' 83' ' ' ASN . 37.6 t30 64.84 28.32 12.81 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.541 -0.724 . . . . 0.0 109.56 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.557 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -70.06 -27.56 64.74 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.565 HD21 HG21 ' A' ' 78' ' ' VAL . 0.3 OUTLIER 88.06 114.18 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.603 0.716 . . . . 0.0 110.197 179.42 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.975 ' HB1' ' CD2' ' A' ' 50' ' ' PHE . . . -87.38 -44.87 11.05 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.676 ' O ' HG23 ' A' ' 78' ' ' VAL . . . 166.1 -158.99 32.14 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.641 ' CG2' ' CE1' ' A' ' 4' ' ' TYR . 23.5 t -140.44 99.39 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.088 -1.243 . . . . 0.0 110.076 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.842 ' CD1' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -80.94 145.27 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.177 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.611 HG22 ' O ' ' A' ' 101' ' ' VAL . 9.7 t -130.53 132.05 45.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.867 -1.146 . . . . 0.0 110.884 -179.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.578 ' ND1' ' O ' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -91.76 79.24 5.38 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.646 -0.658 . . . . 0.0 109.534 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.0 m -175.07 118.23 0.18 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.183 -0.948 . . . . 0.0 109.603 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 113.86 2.89 23.69 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.411 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -144.87 146.53 32.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.135 -1.215 . . . . 0.0 109.731 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 95' ' ' ALA . 34.5 m -44.5 143.02 1.42 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.346 -0.846 . . . . 0.0 109.055 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.461 ' O ' ' C ' ' A' ' 98' ' ' ASN . . . 50.54 38.6 35.62 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.578 ' O ' ' ND1' ' A' ' 92' ' ' HIS . 0.2 OUTLIER 36.02 44.18 0.24 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.947 -0.737 . . . . 0.0 110.041 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -47.52 132.8 13.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.983 -1.073 . . . . 0.0 109.167 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.614 ' CD1' ' HB ' ' A' ' 90' ' ' ILE . 19.3 m-85 -60.03 134.57 57.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.034 -1.041 . . . . 0.0 109.924 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.611 ' O ' HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -137.61 130.84 42.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.865 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.477 ' CG ' ' O ' ' A' ' 102' ' ' GLU . 1.5 pt-20 -55.15 111.22 0.81 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.281 -0.887 . . . . 0.0 109.268 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 5' ' ' THR . 0.5 OUTLIER -55.33 146.38 19.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.342 -0.849 . . . . 0.0 109.917 -179.484 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 74.6 p . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.36 -0.838 . . . . 0.0 109.489 -179.993 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.439 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.258 0.551 . . . . 0.0 109.618 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.4 p 168.75 145.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.259 -0.901 . . . . 0.0 110.183 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -120.2 -27.67 5.23 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.542 -0.724 . . . . 0.0 109.086 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.621 ' CG ' HG21 ' A' ' 89' ' ' VAL . 19.4 m-85 -88.61 112.16 22.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 109.312 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.644 HG23 ' N ' ' A' ' 9' ' ' ASN . 80.1 m -140.32 120.2 13.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.341 -0.849 . . . . 0.0 109.337 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 69.3 m -118.05 16.71 14.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 122.171 0.986 . . . . 0.0 109.682 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 169.09 60.88 0.03 OUTLIER Glycine 0 C--N 1.282 -2.421 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.07 15.72 7.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.322 -1.105 . . . . 0.0 109.147 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.644 ' N ' HG23 ' A' ' 5' ' ' THR . 12.0 m-80 -81.19 131.74 35.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.415 -0.803 . . . . 0.0 109.723 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.3 t -97.83 58.89 1.42 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.836 . . . . 0.0 109.007 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.574 ' CE1' ' HB2' ' A' ' 63' ' ' SER . 7.5 m-30 -79.92 127.73 32.6 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.753 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -85.03 138.76 32.24 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.183 -0.948 . . . . 0.0 110.188 -179.223 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.46 -18.76 7.68 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.1 t -89.4 -31.24 17.84 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.521 -0.737 . . . . 0.0 109.153 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.31 -34.83 68.39 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 12' ' ' SER . 2.6 t -57.56 -35.18 49.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.04 -40.95 77.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.558 -0.714 . . . . 0.0 109.258 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.17 -55.98 13.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.332 -0.855 . . . . 0.0 109.137 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.533 ' HB3' ' CD1' ' A' ' 61' ' ' ILE . . . -71.41 -4.15 24.76 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.485 -0.759 . . . . 0.0 109.264 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.805 ' OE1' HG22 ' A' ' 78' ' ' VAL . 5.6 tp60 -101.57 -8.49 21.83 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.531 ' HB2' ' ND2' ' A' ' 84' ' ' ASN . . . -103.64 -9.14 19.41 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.333 -0.854 . . . . 0.0 109.248 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.6 -36.97 28.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 109.133 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 27' ' ' HIS . . . -72.03 -9.66 71.82 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.511 ' CE1' ' O ' ' A' ' 82' ' ' GLU . 18.4 t80 -101.36 -49.59 4.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.442 -1.034 . . . . 0.0 109.347 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -52.18 -38.58 58.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.876 . . . . 0.0 109.339 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.572 HD11 ' CB ' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -79.89 -45.11 19.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.473 -0.767 . . . . 0.0 109.138 179.754 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.575 ' ND1' ' N ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -45.41 -39.06 6.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.584 -0.697 . . . . 0.0 110.326 -179.713 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.575 ' N ' ' ND1' ' A' ' 27' ' ' HIS . 3.4 tp10 -94.29 -40.28 10.06 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.257 -0.902 . . . . 0.0 109.128 -178.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 28' ' ' GLU . 19.9 t0 -47.81 -23.76 0.82 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.434 ' N ' ' C ' ' A' ' 28' ' ' GLU . . . 80.5 14.16 80.49 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.572 ' CB ' HD11 ' A' ' 26' ' ' LEU . 0.9 OUTLIER -103.17 -170.11 1.74 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.232 -1.158 . . . . 0.0 109.176 179.789 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.983 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -137.41 174.41 10.63 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.204 -0.935 . . . . 0.0 109.648 -179.868 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.468 ' O ' ' C ' ' A' ' 34' ' ' GLY . 14.1 m -81.13 -162.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.876 . . . . 0.0 109.252 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 33' ' ' VAL . . . -34.92 -57.6 0.79 Allowed Glycine 0 N--CA 1.498 2.779 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.73 30.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.321 -1.105 . . . . 0.0 109.724 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 37' ' ' SER . 1.2 m120 -134.16 6.45 3.61 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.214 -0.929 . . . . 0.0 109.356 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.983 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.2 OUTLIER 47.39 -173.64 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.234 -0.916 . . . . 0.0 109.357 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.602 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER 164.45 -44.15 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.641 -0.662 . . . . 0.0 111.415 179.522 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 38' ' ' TYR . 30.7 Cg_endo -73.83 99.62 1.18 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 121.295 1.33 . . . . 0.0 112.294 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.575 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -141.36 179.36 6.83 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.078 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -69.36 149.67 48.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.971 -1.081 . . . . 0.0 109.797 -179.336 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.615 ' CZ ' ' HB2' ' A' ' 44' ' ' ASN . 1.5 t80 -115.3 146.57 41.38 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -156.94 91.3 1.19 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.997 -1.065 . . . . 0.0 109.711 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.615 ' HB2' ' CZ ' ' A' ' 42' ' ' TYR . 2.2 t-20 -113.88 -51.56 2.78 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.351 -0.843 . . . . 0.0 109.599 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.453 ' O ' ' C ' ' A' ' 46' ' ' GLU . 40.7 m-85 50.44 22.65 1.07 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.133 -0.98 . . . . 0.0 109.055 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 48' ' ' PHE . 1.1 tm-20 -38.7 -61.31 0.73 Allowed 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.64 -0.662 . . . . 0.0 109.992 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.42 ' C ' ' CD1' ' A' ' 48' ' ' PHE . . . -177.09 45.18 0.1 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.507 ' CZ ' ' HB3' ' A' ' 46' ' ' GLU . 0.7 OUTLIER -124.89 168.05 13.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -1.134 . . . . 0.0 109.479 -179.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 50' ' ' PHE . 11.1 t70 -124.42 68.7 1.08 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.345 -0.847 . . . . 0.0 109.156 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.541 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 17.4 m-85 -52.52 -171.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.445 -0.785 . . . . 0.0 109.859 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 99.6 p -158.12 37.29 0.25 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.387 -0.821 . . . . 0.0 109.323 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.591 HG21 ' O ' ' A' ' 86' ' ' LEU . 97.4 t -108.97 -73.79 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.227 -0.92 . . . . 0.0 109.738 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.2 177.74 8.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.173 -0.955 . . . . 0.0 110.211 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.62 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -78.99 -50.92 1.36 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.658 -0.651 . . . . 0.0 111.13 -179.88 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 54' ' ' SER . 32.4 Cg_endo -72.56 93.57 0.76 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.861 1.707 . . . . 0.0 109.881 -177.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.59 ' O ' ' CG ' ' A' ' 57' ' ' TYR . 4.5 m-85 -87.06 -176.82 5.86 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.509 0.671 . . . . 0.0 110.009 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.59 ' CG ' ' O ' ' A' ' 56' ' ' TYR . 81.7 m-85 -160.65 118.58 2.49 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.456 ' HB3' ' HB2' ' A' ' 42' ' ' TYR . 0.7 OUTLIER -83.77 142.05 30.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.142 -0.974 . . . . 0.0 111.125 -178.554 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.689 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 26.0 t-105 -161.16 139.31 7.14 Favored Pre-proline 0 N--CA 1.494 1.746 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.689 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 29.8 Cg_endo -68.35 144.61 62.64 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.003 1.802 . . . . 0.0 111.362 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 1.005 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -109.59 136.66 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.645 -0.659 . . . . 0.0 109.326 -179.501 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.005 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.3 OUTLIER -125.89 -177.7 4.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.297 -0.877 . . . . 0.0 109.417 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.574 ' HB2' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -117.57 -14.09 10.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.075 -1.016 . . . . 0.0 108.815 179.676 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.32 -58.53 3.23 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.584 -0.698 . . . . 0.0 109.189 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 114.21 10.59 13.39 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.451 ' O ' ' HB ' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -89.51 13.81 12.95 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.212 -1.169 . . . . 0.0 109.488 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.581 HG13 ' CZ2' ' A' ' 59' ' ' TRP . 99.6 t 61.77 131.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.274 -0.891 . . . . 0.0 109.527 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.569 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 34.6 t80 -46.81 107.32 0.1 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.235 -0.916 . . . . 0.0 109.469 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.3 16.07 6.09 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.175 -0.953 . . . . 0.0 109.468 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.6 65.18 0.02 OUTLIER Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -135.09 147.53 19.21 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.85 124.57 8.06 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.266 -1.138 . . . . 0.0 109.326 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.436 ' HB3' ' OH ' ' A' ' 38' ' ' TYR . 36.3 Cg_endo -78.02 150.56 26.59 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.452 2.101 . . . . 0.0 110.732 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.716 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 106.2 -175.03 21.0 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 79.84 -70.54 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.431 -1.04 . . . . 0.0 110.546 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.421 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 1.4 m-20 -134.95 152.22 51.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.741 -1.225 . . . . 0.0 110.107 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.545 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 7.4 mtt180 -163.47 105.68 0.98 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.42 -0.8 . . . . 0.0 108.981 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.805 HG22 ' OE1' ' A' ' 20' ' ' GLN . 8.1 p -89.45 144.59 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.986 -1.071 . . . . 0.0 109.479 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.582 HG12 ' N ' ' A' ' 80' ' ' PHE . 35.5 t -112.52 166.08 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.35 -0.844 . . . . 0.0 109.771 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.628 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 1.5 p90 -151.71 -178.2 6.57 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.585 ' HB3' HG12 ' A' ' 52' ' ' VAL . 16.9 p-10 -109.79 -47.16 3.39 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.019 -1.05 . . . . 0.0 109.857 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.535 ' HG2' ' ND2' ' A' ' 81' ' ' ASN . 0.6 OUTLIER 167.15 -25.07 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.502 ' HB3' ' HG2' ' A' ' 85' ' ' GLN . 1.1 t30 -92.49 8.86 36.88 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.47 -0.769 . . . . 0.0 108.967 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.531 ' ND2' ' HB2' ' A' ' 21' ' ' ALA . 25.8 t-20 63.33 13.42 7.01 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.42 -0.8 . . . . 0.0 110.137 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.566 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 3.7 mt-30 -57.13 -82.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.852 -1.155 . . . . 0.0 107.968 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.591 ' O ' HG21 ' A' ' 52' ' ' VAL . 0.1 OUTLIER 165.28 108.87 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.398 -0.814 . . . . 0.0 110.684 178.466 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.541 ' O ' ' CD1' ' A' ' 50' ' ' PHE . . . -74.97 -44.09 50.27 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 146.55 149.18 4.92 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.689 -1.765 . . . . 0.0 108.689 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.621 HG21 ' CG ' ' A' ' 4' ' ' TYR . 38.9 t -88.64 131.44 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.161 -1.199 . . . . 0.0 109.744 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.805 HD12 ' CB ' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -123.85 178.01 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.608 HG22 HG23 ' A' ' 101' ' ' VAL . 2.7 t -138.48 145.85 41.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.813 -1.179 . . . . 0.0 111.195 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.632 ' CG ' ' HB2' ' A' ' 98' ' ' ASN . 0.1 OUTLIER -93.25 76.94 4.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.621 -0.674 . . . . 0.0 109.557 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 92' ' ' HIS . 7.1 t 176.52 -27.25 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.411 -0.806 . . . . 0.0 110.434 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.531 ' HA3' HG21 ' A' ' 101' ' ' VAL . . . -65.14 -7.01 29.19 Favored Glycine 0 N--CA 1.493 2.434 0 O-C-N 121.125 -0.984 . . . . 0.0 110.673 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.994 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . . . -133.71 164.86 26.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.884 -1.362 . . . . 0.0 110.056 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 95' ' ' ALA . 11.1 p -41.7 120.95 1.61 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.58 -0.7 . . . . 0.0 109.26 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.8 -78.0 2.05 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.846 -1.701 . . . . 0.0 108.846 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.632 ' HB2' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -160.52 -68.07 0.07 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.268 -1.137 . . . . 0.0 109.551 179.751 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.994 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 0.3 OUTLIER 57.05 -173.36 0.08 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.135 -0.978 . . . . 0.0 109.142 -179.711 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.805 ' CB ' HD12 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -132.87 113.81 13.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.021 -1.049 . . . . 0.0 110.103 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.608 HG23 HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -123.64 136.74 59.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.334 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.485 ' OE2' ' HB3' ' A' ' 48' ' ' PHE . 2.2 mt-10 -56.11 120.47 7.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.286 -0.884 . . . . 0.0 109.728 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.2 176.33 0.34 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.898 . . . . 0.0 109.462 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 19.0 p . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.972 -1.014 . . . . 0.0 109.588 -179.901 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.465 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.8 p 167.17 115.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.924 . . . . 0.0 109.8 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 14.9 t70 -108.72 4.71 24.06 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.398 -0.814 . . . . 0.0 109.363 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.582 ' CD1' ' HB ' ' A' ' 89' ' ' VAL . 5.4 m-85 -104.99 71.35 0.95 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.548 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 5' ' ' THR . 8.8 t -86.84 124.44 33.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.179 -0.95 . . . . 0.0 109.388 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 92.5 m -122.24 16.66 10.67 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 122.096 0.951 . . . . 0.0 109.684 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 152.73 -62.09 0.39 Allowed Glycine 0 C--N 1.283 -2.383 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.6 m -166.98 36.03 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.347 -1.09 . . . . 0.0 109.065 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.461 ' O ' ' C ' ' A' ' 10' ' ' CYS . 2.0 m-80 -111.44 -27.74 8.49 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.356 -0.84 . . . . 0.0 109.803 -179.565 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.493 ' C ' ' HB2' ' A' ' 2' ' ' CYS . 1.1 t 40.4 76.44 0.07 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.365 -0.834 . . . . 0.0 109.311 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.424 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 2.8 m-85 -79.57 150.34 31.11 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.417 -0.802 . . . . 0.0 109.297 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.992 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -80.47 132.1 35.66 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.432 -0.793 . . . . 0.0 109.62 -179.874 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.2 p -63.33 -13.96 44.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.127 -0.983 . . . . 0.0 109.04 179.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.81 -27.05 13.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.31 -0.869 . . . . 0.0 109.028 179.695 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.525 ' HB2' ' HB2' ' A' ' 12' ' ' SER . 17.8 t0 -74.91 -34.2 62.11 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.278 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.992 HG23 ' O ' ' A' ' 12' ' ' SER . 2.8 t -56.47 -36.67 48.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.13 -41.11 87.46 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.37 -45.66 92.15 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.157 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.814 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -75.97 -8.29 56.6 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.075 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.59 ' OE1' ' CG ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -90.58 -25.96 19.92 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.383 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.96 -13.13 59.17 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.071 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.31 -57.0 3.56 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.605 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -62.11 -25.69 66.62 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 178.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.583 ' CE1' ' O ' ' A' ' 82' ' ' GLU . 10.2 t80 -75.72 -59.87 2.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.477 -1.013 . . . . 0.0 109.451 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 29' ' ' ASP . 1.8 tp60 -55.14 -61.51 2.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.859 . . . . 0.0 109.262 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.804 HD13 ' HB3' ' A' ' 31' ' ' GLU . 2.6 mm? -44.83 -37.3 3.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.392 -0.818 . . . . 0.0 109.57 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.408 ' HB3' ' O ' ' A' ' 24' ' ' TYR . 3.5 t60 -66.14 -54.79 21.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.439 -0.788 . . . . 0.0 111.182 -179.145 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -86.8 13.02 9.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.216 -0.928 . . . . 0.0 110.249 -178.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 8.0 t0 -108.35 -2.81 18.86 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.079 -1.013 . . . . 0.0 109.581 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.71 -8.76 76.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.807 ' O ' HG23 ' A' ' 32' ' ' THR . 2.4 tp10 -97.7 -152.19 0.39 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.231 -1.158 . . . . 0.0 109.474 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.821 HG22 ' CG ' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -177.27 -93.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.165 -0.96 . . . . 0.0 109.411 179.976 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -156.5 -168.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.147 -0.971 . . . . 0.0 109.476 179.835 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 35' ' ' SER . . . -63.67 87.14 0.06 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.535 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.455 ' C ' ' O ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER 40.2 43.27 1.35 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.486 -1.008 . . . . 0.0 109.788 179.772 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.417 ' O ' ' C ' ' A' ' 37' ' ' SER . 2.2 m120 -122.63 -25.25 4.74 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.103 -0.998 . . . . 0.0 109.726 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 36' ' ' ASN . 0.9 OUTLIER 45.27 76.82 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.16 -0.962 . . . . 0.0 109.211 -179.762 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.717 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -98.93 -23.37 0.22 Allowed Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -179.068 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.821 ' CG ' HG22 ' A' ' 32' ' ' THR . 37.5 Cg_endo -80.28 100.87 1.29 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 C-N-CA 121.476 1.451 . . . . 0.0 113.577 -178.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.604 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -127.53 -176.51 3.77 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.12 -0.987 . . . . 0.0 108.722 176.897 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.1 OUTLIER -100.18 144.36 29.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.097 -1.002 . . . . 0.0 109.455 179.94 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.579 ' CE2' ' HA ' ' A' ' 44' ' ' ASN . 4.4 t80 -110.52 135.94 50.42 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.201 -0.937 . . . . 0.0 109.535 -179.655 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.553 ' OD1' ' CD2' ' A' ' 45' ' ' TYR . 2.7 p30 -92.16 3.67 54.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.899 . . . . 0.0 109.893 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.579 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 7.1 p-10 42.22 104.79 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.651 0.738 . . . . 0.0 111.2 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.553 ' CD2' ' OD1' ' A' ' 43' ' ' ASN . 0.9 OUTLIER -131.88 -33.23 1.39 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.071 -1.018 . . . . 0.0 109.823 179.206 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.485 ' OE1' ' CZ ' ' A' ' 48' ' ' PHE . 0.1 OUTLIER -38.17 -53.2 1.44 Allowed 'General case' 0 C--N 1.309 -1.176 0 O-C-N 121.481 -0.762 . . . . 0.0 110.159 -179.556 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.87 48.53 0.04 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.485 ' CZ ' ' OE1' ' A' ' 46' ' ' GLU . 24.8 m-85 -104.61 144.83 31.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -1.141 . . . . 0.0 109.337 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 50' ' ' PHE . 1.1 m-20 -119.07 49.58 1.31 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.292 -0.88 . . . . 0.0 109.433 179.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.502 ' HB2' ' OH ' ' A' ' 56' ' ' TYR . 21.7 m-85 -50.36 -178.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.385 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.1 p -133.93 18.26 3.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -0.859 . . . . 0.0 109.003 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.496 HG21 ' O ' ' A' ' 86' ' ' LEU . 66.6 t -85.74 -82.0 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.372 -0.83 . . . . 0.0 109.532 -179.857 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.31 177.98 10.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.004 -1.06 . . . . 0.0 110.147 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.602 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -79.5 -52.54 1.12 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.473 -0.767 . . . . 0.0 110.884 -179.889 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 54' ' ' SER . 33.1 Cg_endo -73.07 95.11 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.016 1.81 . . . . 0.0 109.844 -177.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.595 ' CE1' ' HB2' ' A' ' 87' ' ' ALA . 5.7 m-85 -95.94 -179.28 4.64 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.63 0.728 . . . . 0.0 110.276 -178.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.577 ' CD2' ' O ' ' A' ' 81' ' ' ASN . 96.5 m-85 -152.73 131.61 12.49 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.392 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.494 ' HG3' ' CD2' ' A' ' 40' ' ' HIS . 0.5 OUTLIER -91.91 142.19 27.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 110.815 -178.837 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.681 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 24.1 t-105 -160.26 137.74 6.99 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.681 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.6 Cg_endo -69.78 149.52 66.89 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.175 1.917 . . . . 0.0 111.423 -179.042 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.975 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -120.5 129.13 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.607 -0.683 . . . . 0.0 109.349 -179.672 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.975 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.4 OUTLIER -118.84 172.29 7.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.287 179.514 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.81 27.79 6.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.117 -0.99 . . . . 0.0 108.847 179.688 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.91 -12.46 17.5 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.564 -0.71 . . . . 0.0 109.318 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.66 -10.22 68.72 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.703 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 2.9 m-20 -97.55 172.95 7.41 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.216 -1.167 . . . . 0.0 110.022 -179.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.509 HG13 ' CZ2' ' A' ' 59' ' ' TRP . 93.7 t -90.09 150.08 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.918 ' HA ' HD11 ' A' ' 62' ' ' LEU . 13.6 t80 -47.31 118.75 2.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.955 -1.091 . . . . 0.0 109.69 -179.479 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.455 ' O ' ' OG ' ' A' ' 69' ' ' SER . 1.7 t -135.38 13.88 3.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.489 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 132.57 140.59 4.48 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 137.86 -128.24 4.18 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.8 p -69.55 120.98 80.77 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.225 -1.162 . . . . 0.0 109.334 179.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.69 -57.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.279 1.986 . . . . 0.0 110.443 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.537 ' HA3' ' CB ' ' A' ' 92' ' ' HIS . . . -97.34 -113.02 3.05 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 91' ' ' THR . . . 60.23 -85.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.352 -1.087 . . . . 0.0 110.561 179.521 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.436 ' C ' ' HD2' ' A' ' 77' ' ' ARG . 36.6 m-20 -122.95 131.5 53.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.848 -1.158 . . . . 0.0 110.39 -179.173 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.523 ' NE ' ' HA2' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -151.88 106.66 3.24 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.331 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 89' ' ' VAL . 7.3 p -78.81 137.98 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 110.454 -178.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.601 HG23 HD13 ' A' ' 90' ' ' ILE . 39.8 t -97.55 166.67 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.01 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.59 ' CG ' ' OE1' ' A' ' 20' ' ' GLN . 5.7 p90 -163.46 -174.33 3.7 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 118.822 -1.151 . . . . 0.0 110.281 -178.002 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.577 ' O ' ' CD2' ' A' ' 57' ' ' TYR . 3.2 t-20 -109.11 -80.13 0.58 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.28 -0.888 . . . . 0.0 109.766 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.583 ' O ' ' CE1' ' A' ' 24' ' ' TYR . 10.8 pt-20 -161.9 23.36 0.11 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 109.448 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.453 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 4.0 t-20 -151.7 51.38 0.81 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.552 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.453 ' CG ' ' O ' ' A' ' 83' ' ' ASN . 16.6 p30 44.86 26.95 0.23 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.477 ' OE1' ' HB3' ' A' ' 81' ' ' ASN . 14.0 mt-30 -64.4 -163.18 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.206 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.496 ' O ' HG21 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -144.48 104.37 4.06 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.787 -1.196 . . . . 0.0 110.573 179.913 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.595 ' HB2' ' CE1' ' A' ' 56' ' ' TYR . . . -81.68 -36.85 28.28 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 150.91 138.34 2.82 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.582 ' HB ' ' CD1' ' A' ' 4' ' ' TYR . 36.9 t -83.04 100.0 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.181 -1.188 . . . . 0.0 109.67 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.627 ' HB ' ' HB3' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -87.01 159.83 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.4 -0.813 . . . . 0.0 108.845 179.481 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.666 HG22 HG23 ' A' ' 101' ' ' VAL . 15.1 t -122.16 159.79 26.47 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.941 -1.099 . . . . 0.0 110.886 -178.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.577 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 0.1 OUTLIER -115.5 71.9 0.78 Allowed 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.434 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.445 ' OG1' ' C ' ' A' ' 92' ' ' HIS . 0.2 OUTLIER -176.61 133.13 0.21 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.416 -0.802 . . . . 0.0 109.294 -179.812 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 94.98 -6.97 69.74 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 96' ' ' SER . . . -120.54 147.29 45.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.157 -1.202 . . . . 0.0 109.727 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 95' ' ' ALA . 49.2 m -44.03 118.09 1.38 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.28 -0.887 . . . . 0.0 108.901 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.486 ' O ' ' C ' ' A' ' 98' ' ' ASN . . . 64.36 43.7 96.47 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.219 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.577 ' O ' ' CG ' ' A' ' 92' ' ' HIS . 0.0 OUTLIER 32.92 40.75 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.987 -0.714 . . . . 0.0 110.446 179.711 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 97' ' ' GLY . 3.0 t-20 -54.69 167.55 0.35 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.141 -0.975 . . . . 0.0 109.279 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.627 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -74.83 150.38 39.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.132 -0.98 . . . . 0.0 109.344 179.993 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.666 HG23 HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -161.02 122.54 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.417 -0.802 . . . . 0.0 109.086 179.687 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 3.6 pt-20 -41.8 131.48 3.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.387 -0.821 . . . . 0.0 109.861 -179.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.457 ' SG ' ' HB ' ' A' ' 91' ' ' THR . 0.7 OUTLIER -92.81 121.41 34.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.37 -0.831 . . . . 0.0 109.253 -179.981 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.8 p . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.623 -1.18 . . . . 0.0 109.445 179.955 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.495 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.6 p 166.49 138.06 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.169 -0.957 . . . . 0.0 110.141 179.705 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -115.4 -20.05 10.44 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.381 -0.824 . . . . 0.0 109.069 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.659 ' CG ' HG21 ' A' ' 89' ' ' VAL . 13.7 m-85 -95.65 109.71 21.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.313 -0.867 . . . . 0.0 109.371 179.839 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.475 HG22 ' C ' ' A' ' 9' ' ' ASN . 1.2 p -144.25 143.79 31.2 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.966 . . . . 0.0 109.642 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.61 8.16 4.92 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.148 0.975 . . . . 0.0 109.904 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.28 55.2 0.2 Allowed Glycine 0 C--N 1.278 -2.69 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m 55.15 19.06 2.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.45 -1.029 . . . . 0.0 109.134 -179.524 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.475 ' C ' HG22 ' A' ' 5' ' ' THR . 0.6 OUTLIER -75.07 -156.88 0.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.434 -0.791 . . . . 0.0 109.091 179.929 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.4 t -155.49 58.14 0.63 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.117 -0.99 . . . . 0.0 109.766 -180.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.494 ' CZ ' ' HB3' ' A' ' 63' ' ' SER . 3.3 m-85 -84.51 115.3 22.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.341 -0.849 . . . . 0.0 108.925 179.527 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.699 ' O ' HG23 ' A' ' 16' ' ' VAL . 30.2 t -81.71 136.17 35.48 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.252 -0.905 . . . . 0.0 110.222 -179.259 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.1 p -49.05 -31.41 7.7 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.497 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.2 t -70.64 -40.99 72.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.532 -0.73 . . . . 0.0 109.278 179.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -66.42 -30.25 70.57 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.172 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 12' ' ' SER . 3.2 t -68.35 -32.9 57.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 119.519 -0.872 . . . . 0.0 108.823 179.315 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.8 -46.68 77.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.481 -0.762 . . . . 0.0 109.584 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.63 -55.66 28.23 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.2 -0.937 . . . . 0.0 109.251 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.932 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -72.05 -3.51 23.4 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.388 -0.82 . . . . 0.0 109.37 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.65 ' OE1' HG22 ' A' ' 78' ' ' VAL . 6.3 tp60 -100.96 -15.96 17.33 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 179.333 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.474 ' HA ' ' OD1' ' A' ' 84' ' ' ASN . . . -93.12 -15.1 26.4 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.05 -47.67 23.82 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.444 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -60.89 -24.91 63.23 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 179.351 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.435 ' CD2' ' OD1' ' A' ' 84' ' ' ASN . 19.9 t80 -83.21 -36.05 24.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.521 -0.987 . . . . 0.0 109.26 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -49.89 72.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.304 -0.872 . . . . 0.0 108.838 179.492 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.465 ' HA ' HD12 ' A' ' 26' ' ' LEU . 0.5 OUTLIER -61.61 -40.57 95.28 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.313 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.51 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 2.2 t60 -62.52 -20.9 65.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.389 -0.819 . . . . 0.0 109.42 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.79 -30.85 16.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.948 . . . . 0.0 109.806 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.77 9.91 33.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.127 -0.983 . . . . 0.0 109.46 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 46.8 24.12 1.75 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.1 -137.59 0.09 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.211 -1.17 . . . . 0.0 109.016 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.888 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -173.59 170.34 4.1 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.899 -1.126 . . . . 0.0 109.45 -179.938 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.489 HG21 ' CE1' ' A' ' 68' ' ' TYR . 33.2 m -83.26 -138.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.316 -0.865 . . . . 0.0 109.276 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.446 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -46.88 -49.35 17.43 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.75 -32.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.487 -1.007 . . . . 0.0 109.188 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -69.47 -8.82 50.21 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.386 -0.821 . . . . 0.0 109.79 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.888 ' HA ' HG22 ' A' ' 32' ' ' THR . 0.8 OUTLIER 67.66 -172.69 0.19 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.096 -1.002 . . . . 0.0 108.908 -179.64 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.585 ' CD1' ' HD3' ' A' ' 60' ' ' PRO . 0.2 OUTLIER 167.53 -45.05 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.186 -0.946 . . . . 0.0 112.435 179.114 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.567 ' HD2' ' H ' ' A' ' 38' ' ' TYR . 32.3 Cg_endo -74.71 100.37 1.33 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 121.416 1.41 . . . . 0.0 112.538 -178.512 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.549 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -142.53 -174.04 4.03 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.674 -0.641 . . . . 0.0 109.535 178.463 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.635 ' HB2' ' CE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -94.66 124.16 38.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.346 -0.846 . . . . 0.0 109.903 -179.398 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.47 ' CE1' ' CZ ' ' A' ' 100' ' ' PHE . 10.5 t80 -105.8 143.59 33.74 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.118 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.577 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 74.0 m-20 -78.47 -106.61 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.905 -1.122 . . . . 0.0 109.287 -179.674 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.577 ' CB ' ' O ' ' A' ' 43' ' ' ASN . 5.9 p30 154.42 95.56 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.478 -0.764 . . . . 0.0 109.188 179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 1.4 p90 -124.6 -28.15 3.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -0.981 . . . . 0.0 109.632 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.493 ' OE1' HG12 ' A' ' 101' ' ' VAL . 1.9 tm-20 -40.62 -65.7 0.39 Allowed 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.383 -0.823 . . . . 0.0 109.909 -179.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.92 59.75 0.01 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.43 ' CE1' ' HA ' ' A' ' 101' ' ' VAL . 84.8 m-85 -98.63 154.76 17.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.31 -1.112 . . . . 0.0 109.3 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.58 45.16 2.51 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.266 -0.897 . . . . 0.0 109.273 179.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.538 ' CG ' ' O ' ' A' ' 87' ' ' ALA . 14.4 m-85 -61.37 -167.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 109.869 -179.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.07 27.75 0.85 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.523 -0.736 . . . . 0.0 109.213 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.972 HG11 ' ND2' ' A' ' 81' ' ' ASN . 93.7 t -101.05 -80.08 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.191 -0.943 . . . . 0.0 109.741 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.463 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 86.6 p -158.39 178.01 10.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.169 -0.957 . . . . 0.0 110.189 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.62 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -83.3 -46.94 0.81 Allowed Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.592 -0.692 . . . . 0.0 111.536 -179.558 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 54' ' ' SER . 32.0 Cg_endo -73.03 83.93 1.37 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.899 1.733 . . . . 0.0 110.409 -178.004 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.583 ' CE1' ' CB ' ' A' ' 87' ' ' ALA . 10.1 m-85 -86.23 -175.22 5.42 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.826 0.822 . . . . 0.0 110.769 -179.156 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.635 ' CE2' ' HB2' ' A' ' 41' ' ' LYS . 47.8 m-85 -151.96 126.09 9.22 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -88.1 138.42 31.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.921 -1.112 . . . . 0.0 110.627 -178.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.665 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 21.1 t-105 -160.62 138.55 7.18 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 179.407 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.665 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.6 Cg_endo -69.54 154.47 68.56 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.33 2.02 . . . . 0.0 111.496 -178.817 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 1.008 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -129.12 129.07 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.594 -0.691 . . . . 0.0 109.823 -179.17 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.008 HD23 ' C ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -123.15 167.65 13.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.243 -0.911 . . . . 0.0 108.776 179.191 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . 84.1 p -127.92 65.97 1.36 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.101 -0.999 . . . . 0.0 109.355 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.23 25.34 0.11 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.391 -0.818 . . . . 0.0 109.57 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 51.1 45.26 51.58 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -121.89 -27.73 4.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.316 -1.108 . . . . 0.0 109.669 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.582 HG12 ' H ' ' A' ' 68' ' ' TYR . 2.5 t 62.37 174.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.14 -0.975 . . . . 0.0 109.153 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.6 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 29.0 t80 -96.4 106.0 18.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.078 -1.014 . . . . 0.0 109.682 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.48 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 0.8 OUTLIER -151.89 21.27 0.69 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.353 -0.842 . . . . 0.0 109.366 -179.977 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.17 -91.06 1.44 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.82 57.21 0.04 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.521 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -140.58 63.04 20.16 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.236 -1.155 . . . . 0.0 109.224 179.894 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.566 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 34.8 Cg_endo -78.62 163.46 26.66 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.856 2.371 . . . . 0.0 111.051 -179.607 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.564 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 131.47 133.34 3.47 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.969 -1.11 . . . . 0.0 110.544 179.236 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 70.41 -150.57 0.1 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.431 -1.041 . . . . 0.0 110.971 178.779 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.535 ' C ' ' O ' ' A' ' 75' ' ' ALA . 96.2 m-20 -7.08 126.46 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 CA-C-O 121.686 0.755 . . . . 0.0 112.837 -179.317 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.508 ' O ' HG12 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -161.89 80.71 0.56 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.962 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.694 HG21 ' CG1' ' A' ' 16' ' ' VAL . 7.5 p -62.47 145.54 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.87 -1.144 . . . . 0.0 109.303 -179.587 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.613 HG12 ' N ' ' A' ' 80' ' ' PHE . 68.2 t -113.06 165.78 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.346 -0.847 . . . . 0.0 109.843 -179.463 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.627 ' CD1' ' NE2' ' A' ' 20' ' ' GLN . 2.1 p90 -156.25 -174.98 5.19 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.56 -178.483 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.972 ' ND2' HG11 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -116.22 -82.07 0.62 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.061 -1.025 . . . . 0.0 109.967 -179.576 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -153.08 10.64 0.46 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.358 -0.839 . . . . 0.0 110.401 -179.417 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.456 ' HB3' ' HG2' ' A' ' 85' ' ' GLN . 45.3 t-20 -135.06 7.32 3.42 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.175 -0.953 . . . . 0.0 108.835 179.309 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.474 ' OD1' ' HA ' ' A' ' 21' ' ' ALA . 6.2 m-80 72.28 9.36 5.88 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.373 -0.829 . . . . 0.0 109.451 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.524 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 1.8 mm100 -49.38 -92.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.555 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.753 ' O ' HG21 ' A' ' 52' ' ' VAL . 0.1 OUTLIER 170.72 106.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 0.0 110.716 178.681 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.583 ' CB ' ' CE1' ' A' ' 56' ' ' TYR . . . -82.72 -30.86 28.81 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.292 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.503 ' O ' HG23 ' A' ' 78' ' ' VAL . . . 146.9 -165.96 28.43 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.659 HG21 ' CG ' ' A' ' 4' ' ' TYR . 73.3 t -134.1 102.24 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.312 -1.111 . . . . 0.0 109.203 179.748 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.534 ' HB ' ' HB2' ' A' ' 100' ' ' PHE . 0.4 OUTLIER -104.5 153.99 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 109.273 -179.731 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 100' ' ' PHE . 10.2 t -122.65 137.33 54.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.095 -1.003 . . . . 0.0 110.275 -179.455 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.438 ' CE1' ' CD2' ' A' ' 100' ' ' PHE . 1.8 m-70 -80.6 75.33 7.49 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.428 -0.795 . . . . 0.0 108.908 179.175 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.5 t -173.97 158.41 3.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.544 -0.723 . . . . 0.0 109.393 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 87.04 -14.58 56.91 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.802 ' HB3' ' HB2' ' A' ' 99' ' ' ASN . . . -131.67 114.78 15.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -1.137 . . . . 0.0 109.22 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.468 ' O ' ' C ' ' A' ' 97' ' ' GLY . 7.4 p 46.09 -160.5 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.008 -1.058 . . . . 0.0 108.963 -179.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 96' ' ' SER . . . -40.38 -45.12 3.25 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.468 ' O ' ' O ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -155.68 -74.89 0.1 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.213 -1.169 . . . . 0.0 109.506 179.517 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.802 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 1.3 m-80 62.34 132.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.153 -0.967 . . . . 0.0 108.62 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.534 ' HB2' ' HB ' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -92.75 141.52 28.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.921 -1.112 . . . . 0.0 109.851 -179.79 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.493 HG12 ' OE1' ' A' ' 46' ' ' GLU . 4.2 m -152.12 148.94 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.793 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 101' ' ' VAL . 0.6 OUTLIER -43.44 141.1 1.46 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.09 -1.006 . . . . 0.0 109.64 -179.675 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -55.04 144.18 24.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.399 -0.813 . . . . 0.0 109.597 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.488 1.472 0 O-C-N 121.245 -0.909 . . . . 0.0 109.514 179.891 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.321 0.581 . . . . 0.0 109.666 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 28.9 p 178.18 105.87 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.378 -0.826 . . . . 0.0 109.606 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -68.31 -52.39 34.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.97 -1.081 . . . . 0.0 109.147 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.595 ' CB ' HG21 ' A' ' 89' ' ' VAL . 60.3 m-85 -92.95 105.92 17.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.411 -0.806 . . . . 0.0 109.347 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 9' ' ' ASN . 2.3 t -134.26 128.66 34.29 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.945 -1.097 . . . . 0.0 109.836 -179.866 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.484 ' SG ' ' OG1' ' A' ' 91' ' ' THR . 2.0 t -96.34 -164.79 1.19 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.357 -0.84 . . . . 0.0 109.036 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.404 ' O ' ' CB ' ' A' ' 8' ' ' SER . . . -54.26 96.26 0.03 OUTLIER Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -179.126 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.52 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 0.8 OUTLIER 70.07 54.01 0.35 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.361 -1.082 . . . . 0.0 109.837 179.272 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 8' ' ' SER . 2.1 m120 -155.69 89.42 1.17 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.398 -0.813 . . . . 0.0 109.182 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.423 ' C ' ' CB ' ' A' ' 2' ' ' CYS . 0.4 OUTLIER -74.51 79.63 1.95 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.385 -0.822 . . . . 0.0 109.181 -179.599 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.524 ' CZ ' ' HB2' ' A' ' 63' ' ' SER . 3.2 m-85 -94.46 126.09 39.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.043 -1.036 . . . . 0.0 109.131 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.635 ' O ' HG23 ' A' ' 16' ' ' VAL . 18.6 t -89.35 130.28 35.75 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 110.118 -179.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.523 ' HG ' ' HE2' ' A' ' 4' ' ' TYR . 4.2 t -46.22 -25.84 0.68 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.505 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.7 t -69.09 -47.4 65.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.4 -0.812 . . . . 0.0 109.314 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -26.49 65.53 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.129 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 12' ' ' SER . 13.5 t -69.09 -36.03 71.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.263 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.2 t -56.64 -47.04 80.59 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.452 -0.78 . . . . 0.0 109.668 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.08 -54.03 51.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.025 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.566 ' HB3' HD13 ' A' ' 61' ' ' ILE . . . -68.22 -12.24 60.64 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.454 -0.779 . . . . 0.0 109.061 179.545 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.545 ' HA ' ' NE2' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -83.56 -27.82 29.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 0.0 108.647 179.605 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.84 -14.16 54.82 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.428 -0.795 . . . . 0.0 108.881 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.76 -56.01 5.09 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.416 -0.802 . . . . 0.0 109.355 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.612 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -66.82 -28.13 73.64 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.578 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.437 ' CE1' ' O ' ' A' ' 82' ' ' GLU . 7.0 t80 -71.89 -40.06 69.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.538 -0.977 . . . . 0.0 109.614 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.88 -51.95 54.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.049 -1.032 . . . . 0.0 109.389 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.537 ' HB3' ' CG ' ' A' ' 39' ' ' PRO . 0.8 OUTLIER -52.18 -44.02 64.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.298 -0.876 . . . . 0.0 109.404 179.768 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.624 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 3.1 t60 -53.01 -53.73 45.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.414 -0.804 . . . . 0.0 110.14 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -82.73 -1.58 51.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.331 -0.856 . . . . 0.0 109.802 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -92.67 -1.5 56.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.719 -179.836 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 51.06 37.6 37.24 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.507 ' O ' HG23 ' A' ' 32' ' ' THR . 3.1 tp10 -128.67 -152.46 0.52 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.34 -1.094 . . . . 0.0 109.367 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.751 HG22 ' HA ' ' A' ' 37' ' ' SER . 0.6 OUTLIER -159.28 -175.91 5.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.337 -0.852 . . . . 0.0 109.197 179.901 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 35' ' ' SER . 16.6 m -130.72 160.56 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.033 -1.042 . . . . 0.0 109.803 -179.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 53.28 -89.2 0.01 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 33' ' ' VAL . 2.1 p -177.29 25.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.324 -1.103 . . . . 0.0 109.99 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -147.84 13.16 1.02 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.056 -1.027 . . . . 0.0 109.514 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.751 ' HA ' HG22 ' A' ' 32' ' ' THR . 3.3 p 64.4 -170.25 0.19 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -0.879 . . . . 0.0 109.542 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.585 ' H ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER 170.33 -44.99 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.419 -0.801 . . . . 0.0 111.66 178.621 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.585 ' HD2' ' H ' ' A' ' 38' ' ' TYR . 34.2 Cg_endo -77.36 101.08 1.46 Allowed 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 121.314 1.342 . . . . 0.0 111.858 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.584 ' CE1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -138.56 -175.27 4.07 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.396 -0.815 . . . . 0.0 109.546 178.65 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -78.55 141.97 37.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.366 -0.834 . . . . 0.0 109.73 -179.563 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.599 ' CZ ' ' HA ' ' A' ' 44' ' ' ASN . 13.7 t80 -100.61 128.86 46.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.412 -0.805 . . . . 0.0 109.284 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 44' ' ' ASN . 1.7 t30 -93.4 -4.75 50.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.192 -0.942 . . . . 0.0 109.636 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.599 ' HA ' ' CZ ' ' A' ' 42' ' ' TYR . 0.5 OUTLIER 40.06 93.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.486 -0.759 . . . . 0.0 109.951 179.952 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.464 ' O ' ' C ' ' A' ' 46' ' ' GLU . 75.4 m-85 -86.77 -38.43 16.9 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.35 -0.844 . . . . 0.0 109.842 -179.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.501 ' OE1' ' CE1' ' A' ' 48' ' ' PHE . 0.9 OUTLIER -38.7 -46.53 1.25 Allowed 'General case' 0 C--N 1.309 -1.193 0 O-C-N 121.413 -0.804 . . . . 0.0 110.039 -179.593 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.5 62.44 0.57 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 -179.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.501 ' CE1' ' OE1' ' A' ' 46' ' ' GLU . 51.7 m-85 -97.32 179.9 4.73 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.28 -1.13 . . . . 0.0 108.987 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -117.12 -41.98 2.96 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.221 -0.924 . . . . 0.0 108.89 179.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.581 ' CD2' ' HB1' ' A' ' 87' ' ' ALA . 4.4 m-85 47.33 -170.92 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.481 -0.762 . . . . 0.0 109.777 179.549 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -146.55 20.22 1.33 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.477 -0.764 . . . . 0.0 108.961 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.529 ' HB ' ' CE1' ' A' ' 56' ' ' TYR . 46.9 t -92.91 -83.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.366 -0.834 . . . . 0.0 109.569 -179.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.519 ' N ' HG12 ' A' ' 52' ' ' VAL . 69.9 m -166.87 -175.66 3.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.129 -0.982 . . . . 0.0 109.985 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.601 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -79.07 -51.19 1.32 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.51 -0.743 . . . . 0.0 111.007 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 54' ' ' SER . 33.3 Cg_endo -73.44 89.1 0.96 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.911 1.741 . . . . 0.0 109.768 -177.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.639 ' CE1' ' HB2' ' A' ' 87' ' ' ALA . 5.9 m-85 -90.04 -168.63 2.18 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.581 0.705 . . . . 0.0 110.144 -178.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.624 ' CE1' ' NE2' ' A' ' 27' ' ' HIS . 72.9 m-85 -158.66 120.29 3.48 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.176 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -88.68 137.9 31.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 110.838 -178.721 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.677 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 41.0 t-105 -161.03 137.8 6.45 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.416 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.677 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 33.1 Cg_endo -71.66 148.43 53.07 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.242 1.961 . . . . 0.0 111.446 -178.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.955 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -111.53 125.48 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.855 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.955 HD23 ' C ' ' A' ' 61' ' ' ILE . 1.5 mt -121.06 165.53 15.18 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.11 -0.994 . . . . 0.0 109.537 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.524 ' HB2' ' CZ ' ' A' ' 11' ' ' TYR . 22.9 t -129.16 48.0 2.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.469 -0.769 . . . . 0.0 109.252 179.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.35 21.8 3.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.406 -0.809 . . . . 0.0 109.396 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 54.74 44.2 80.31 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.57 116.28 5.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -1.132 . . . . 0.0 109.534 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.598 HG13 ' CZ2' ' A' ' 59' ' ' TRP . 54.3 t -54.51 148.48 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.209 -0.932 . . . . 0.0 109.43 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.574 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 58.5 t80 -56.91 154.13 9.95 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.226 -0.921 . . . . 0.0 109.572 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.414 ' N ' ' CG ' ' A' ' 68' ' ' TYR . 1.2 t -158.68 -53.2 0.06 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.361 -0.837 . . . . 0.0 109.383 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -166.31 79.49 0.12 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 72' ' ' SER . . . 162.06 142.56 3.43 Favored Glycine 0 N--CA 1.49 2.279 0 O-C-N 121.113 -1.228 . . . . 0.0 110.055 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.536 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 1.7 m 42.99 61.65 9.39 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.429 -1.042 . . . . 0.0 110.033 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.536 ' HD3' ' N ' ' A' ' 72' ' ' SER . 36.3 Cg_endo -78.89 -48.21 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.627 2.218 . . . . 0.0 110.551 179.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.495 ' CA ' ' CB ' ' A' ' 92' ' ' HIS . . . -82.06 -135.66 2.13 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.544 ' N ' ' HB2' ' A' ' 92' ' ' HIS . . . 64.76 -83.78 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.448 -1.031 . . . . 0.0 110.552 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.476 ' OD1' ' HB2' ' A' ' 6' ' ' CYS . 6.1 m-20 -119.02 139.99 50.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.757 -1.214 . . . . 0.0 109.956 -179.357 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.485 ' O ' HG12 ' A' ' 90' ' ' ILE . 69.0 mtt180 -152.09 134.19 15.03 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.596 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.0 p -114.36 138.98 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.062 -1.024 . . . . 0.0 109.288 179.771 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.606 HG12 ' N ' ' A' ' 80' ' ' PHE . 43.1 t -104.51 167.46 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.36 -0.838 . . . . 0.0 109.654 -179.618 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.606 ' N ' HG12 ' A' ' 79' ' ' VAL . 4.4 p90 -163.95 -172.82 2.95 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.398 -178.169 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.462 ' O ' ' HB3' ' A' ' 82' ' ' GLU . 46.7 t-20 -122.06 -46.52 2.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.018 -1.051 . . . . 0.0 109.653 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 81' ' ' ASN . 5.2 pt-20 166.85 -27.3 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.46 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 1.4 m-20 -100.37 27.54 5.65 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.074 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 83' ' ' ASN . 2.5 p-10 46.24 27.52 0.57 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.358 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.568 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 1.2 mt-30 -54.65 -32.02 58.47 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.568 ' CB ' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 85.94 105.25 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.587 0.708 . . . . 0.0 110.532 179.075 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.639 ' HB2' ' CE1' ' A' ' 56' ' ' TYR . . . -80.49 -43.44 20.82 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 156.19 159.04 9.15 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.595 HG21 ' CB ' ' A' ' 4' ' ' TYR . 58.1 t -96.39 92.37 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.185 -1.185 . . . . 0.0 109.706 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.645 HD12 ' CB ' ' A' ' 100' ' ' PHE . 0.4 OUTLIER -78.83 173.65 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.576 -0.703 . . . . 0.0 109.33 179.736 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.504 HG22 HG23 ' A' ' 101' ' ' VAL . 5.6 t -132.25 146.04 51.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.04 -1.038 . . . . 0.0 111.013 -179.035 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.592 ' CD2' ' HB2' ' A' ' 98' ' ' ASN . 0.1 OUTLIER -93.39 62.72 3.44 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.363 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 93' ' ' THR . 2.6 t 178.92 24.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.806 -179.29 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -131.44 27.22 3.78 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.729 ' HB3' ' CB ' ' A' ' 99' ' ' ASN . . . -158.92 97.28 1.4 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.222 -1.164 . . . . 0.0 110.533 -179.65 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.47 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER 36.33 54.32 1.03 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.802 -0.561 . . . . 0.0 110.331 179.316 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 93' ' ' THR . . . 122.92 -87.72 0.4 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.592 ' HB2' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -138.16 -69.52 0.44 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.181 -1.188 . . . . 0.0 109.828 179.949 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.729 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . 1.1 t30 44.82 -167.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 0.0 108.774 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.645 ' CB ' HD12 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -130.12 114.83 16.22 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.838 -1.164 . . . . 0.0 110.805 179.916 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.504 HG23 HG22 ' A' ' 91' ' ' THR . 1.6 m -130.27 128.03 63.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.375 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 101' ' ' VAL . 4.0 mt-10 -42.98 105.66 0.05 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.331 -0.856 . . . . 0.0 109.879 -179.416 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.7 107.27 3.4 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.299 -0.876 . . . . 0.0 109.562 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 109.402 179.982 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' A' ' 2' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.223 0.535 . . . . 0.0 109.767 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 1.7 p 164.96 99.62 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.259 -0.9 . . . . 0.0 110.06 179.559 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -78.78 -2.9 41.73 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.394 -0.816 . . . . 0.0 108.992 179.472 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.597 ' CD2' HG21 ' A' ' 89' ' ' VAL . 8.0 m-85 -118.9 107.04 13.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.949 . . . . 0.0 109.681 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.607 HG23 ' O ' ' A' ' 9' ' ' ASN . 56.0 m -142.38 143.04 32.52 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.429 ' SG ' ' OD1' ' A' ' 76' ' ' ASP . 80.8 m -123.51 15.31 9.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.048 -1.033 . . . . 0.0 110.339 -179.499 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.555 ' H ' HG22 ' A' ' 5' ' ' THR . . . 167.29 -88.56 0.1 OUTLIER Glycine 0 C--N 1.28 -2.554 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.43 26.67 7.24 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.351 -1.087 . . . . 0.0 109.504 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.607 ' O ' HG23 ' A' ' 5' ' ' THR . 2.5 m-80 -106.58 131.63 53.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.706 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 1' ' ' ALA . 43.3 t -104.28 75.95 1.29 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.53 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 3.5 m-85 -83.48 126.48 32.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.852 . . . . 0.0 110.253 -179.139 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.747 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.7 OUTLIER -81.92 125.83 31.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.645 -0.659 . . . . 0.0 109.65 179.851 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.49 -22.93 0.82 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.16 -0.963 . . . . 0.0 109.194 179.659 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.97 -39.43 26.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.94 . . . . 0.0 110.097 -179.704 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.34 -35.1 75.58 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 12' ' ' SER . 2.9 t -58.81 -26.41 32.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.057 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.7 t -63.09 -43.98 97.02 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.519 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -34.47 77.97 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.083 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.888 ' CB ' HD13 ' A' ' 61' ' ' ILE . . . -84.8 -10.04 57.58 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.059 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.512 ' NE2' ' O ' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -91.88 -21.49 20.58 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.272 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.514 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -88.32 -8.84 54.49 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 26' ' ' LEU . . . -81.04 -56.16 4.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.12 -0.988 . . . . 0.0 108.835 179.679 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.439 ' HA3' ' CG ' ' A' ' 59' ' ' TRP . . . -61.8 -20.46 59.74 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 179.384 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.578 ' CE1' ' HA ' ' A' ' 82' ' ' GLU . 34.0 t80 -87.28 -69.84 0.66 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.375 -1.073 . . . . 0.0 109.565 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.514 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -42.54 -52.7 4.66 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.257 -0.902 . . . . 0.0 109.398 179.9 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.636 HD13 ' CB ' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -56.92 -42.63 80.3 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.427 -0.796 . . . . 0.0 109.155 179.837 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.525 ' NE2' ' CE2' ' A' ' 57' ' ' TYR . 5.3 t60 -53.65 -52.67 59.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.352 -0.843 . . . . 0.0 110.102 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 39.5 tp10 -84.38 -2.53 57.28 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.138 -0.976 . . . . 0.0 109.575 -179.56 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.435 ' HB3' ' HA ' ' A' ' 26' ' ' LEU . 38.0 t70 -94.93 -7.81 38.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.175 -0.953 . . . . 0.0 109.365 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.26 -40.12 3.04 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.746 ' O ' HG23 ' A' ' 32' ' ' THR . 1.1 mp0 -65.64 -173.9 0.18 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -1.138 . . . . 0.0 109.277 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 31' ' ' GLU . 7.2 p -161.53 -94.75 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.181 -0.95 . . . . 0.0 109.503 179.595 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.409 ' CG1' ' HB2' ' A' ' 38' ' ' TYR . 3.5 m -135.62 -114.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.982 -1.074 . . . . 0.0 109.785 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.516 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -97.42 44.75 1.83 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.5 OUTLIER 76.19 24.33 1.14 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.446 -1.032 . . . . 0.0 109.547 179.886 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -119.73 7.54 11.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -0.903 . . . . 0.0 109.677 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.453 ' HA ' ' CB ' ' A' ' 32' ' ' THR . 52.1 p 45.32 88.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.252 -0.905 . . . . 0.0 109.88 179.94 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.623 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -91.61 -40.2 0.38 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.314 -0.866 . . . . 0.0 111.736 -179.686 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 38' ' ' TYR . 33.7 Cg_endo -76.08 109.76 2.94 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 120.986 1.124 . . . . 0.0 110.086 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.578 ' CE1' ' O ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -128.27 -173.23 2.89 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.203 -179.396 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -103.37 141.95 35.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.093 -1.004 . . . . 0.0 110.059 -179.622 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.485 ' CE2' ' HA ' ' A' ' 44' ' ' ASN . 68.3 t80 -107.05 160.09 15.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.205 -0.934 . . . . 0.0 109.228 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.564 ' O ' ' CB ' ' A' ' 44' ' ' ASN . 0.4 OUTLIER -109.95 -84.98 0.55 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.095 -1.003 . . . . 0.0 109.776 -179.91 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.581 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 6.1 p30 155.99 135.07 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.581 ' CD1' ' O ' ' A' ' 44' ' ' ASN . 19.6 m-85 -152.41 -64.88 0.17 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.068 -1.02 . . . . 0.0 109.414 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -40.64 -53.87 2.68 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.374 -0.829 . . . . 0.0 109.529 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 48' ' ' PHE . . . 140.52 -73.66 0.38 Allowed Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.613 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.584 ' HB3' ' CE2' ' A' ' 50' ' ' PHE . 70.7 m-85 66.91 157.09 0.11 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.406 -1.055 . . . . 0.0 108.389 -179.873 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -108.71 27.78 9.08 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.715 -1.194 . . . . 0.0 110.381 -178.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.584 ' CE2' ' HB3' ' A' ' 48' ' ' PHE . 8.1 p90 -125.22 -174.32 3.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.984 -1.073 . . . . 0.0 109.697 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -170.08 54.81 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.268 -0.895 . . . . 0.0 109.304 -179.679 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.513 ' HB ' ' CE1' ' A' ' 56' ' ' TYR . 29.9 t -43.45 -66.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.198 -0.939 . . . . 0.0 109.524 -179.82 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.486 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -164.18 -172.89 2.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.135 -0.978 . . . . 0.0 109.767 -179.816 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.571 ' N ' ' HD2' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -79.6 -54.97 0.9 Allowed Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.266 -0.896 . . . . 0.0 111.223 -179.255 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 54' ' ' SER . 34.4 Cg_endo -72.42 87.02 0.95 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.877 1.718 . . . . 0.0 109.979 -178.114 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.676 ' HE1' ' HB2' ' A' ' 87' ' ' ALA . 9.3 m-85 -87.13 178.1 7.0 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.233 0.54 . . . . 0.0 109.639 -179.38 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 41' ' ' LYS . 94.0 m-85 -156.71 129.56 7.77 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.364 -0.835 . . . . 0.0 109.576 179.62 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.517 ' HG3' ' ND1' ' A' ' 40' ' ' HIS . 0.2 OUTLIER -99.86 138.18 37.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -0.94 . . . . 0.0 109.663 -179.933 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.655 ' CD2' ' HD2' ' A' ' 60' ' ' PRO . 21.1 t-105 -155.69 136.64 9.1 Favored Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.655 ' HD2' ' CD2' ' A' ' 59' ' ' TRP . 30.8 Cg_endo -71.5 137.29 30.24 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 C-N-CA 122.168 1.912 . . . . 0.0 111.801 -178.224 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 1.013 HD12 ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -110.93 133.51 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.96 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.013 ' N ' HD12 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -131.93 158.69 40.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -0.9 . . . . 0.0 109.158 179.921 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 98.1 p -122.83 27.4 7.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.911 . . . . 0.0 108.88 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -153.87 -39.08 0.1 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.454 -0.779 . . . . 0.0 109.356 -179.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 66' ' ' ASP . . . -88.98 -9.99 67.1 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.839 ' OD1' HG23 ' A' ' 67' ' ' VAL . 67.8 t0 48.09 96.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -1.124 . . . . 0.0 109.56 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.839 HG23 ' OD1' ' A' ' 66' ' ' ASP . 2.9 t 75.62 135.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.545 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.568 ' CB ' ' HG2' ' A' ' 60' ' ' PRO . 45.9 t80 -81.39 150.34 28.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.903 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.451 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 4.8 t -165.47 -42.3 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.422 -0.799 . . . . 0.0 109.285 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -158.09 124.49 1.4 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.89 -145.29 12.65 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.85 107.77 60.9 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.285 -1.126 . . . . 0.0 109.636 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.477 ' CB ' ' OH ' ' A' ' 38' ' ' TYR . 35.7 Cg_endo -77.12 -175.63 2.76 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.534 2.156 . . . . 0.0 110.534 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.64 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . 93.35 -175.64 36.3 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 74' ' ' GLY . . . 71.52 -144.91 0.06 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.141 -1.211 . . . . 0.0 110.108 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.429 ' OD1' ' SG ' ' A' ' 6' ' ' CYS . 5.7 m-20 -44.11 151.54 0.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.354 -0.841 . . . . 0.0 110.986 -179.135 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.525 ' NH2' ' CE1' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -164.95 111.84 0.99 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.104 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.815 HG21 HD21 ' A' ' 86' ' ' LEU . 13.9 p -92.56 129.25 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.821 -1.175 . . . . 0.0 110.312 -178.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.622 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 55.2 t -98.39 167.36 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.467 -0.771 . . . . 0.0 109.145 179.569 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.616 ' N ' HG12 ' A' ' 79' ' ' VAL . 4.7 p90 -168.48 -170.76 1.3 Allowed 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.662 -178.082 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.456 ' ND2' ' CB ' ' A' ' 53' ' ' SER . 1.0 OUTLIER -129.71 -42.4 1.29 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.172 -0.955 . . . . 0.0 110.056 -179.341 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.578 ' HA ' ' CE1' ' A' ' 24' ' ' TYR . 7.6 pt-20 166.26 -27.31 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.737 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.46 ' O ' ' CG ' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -100.84 26.08 7.27 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.489 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.469 ' O ' ' OD1' ' A' ' 84' ' ' ASN . 8.5 p30 48.7 25.27 0.95 Allowed 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.45 0.643 . . . . 0.0 109.636 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.535 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 3.0 mt-30 -55.35 -36.16 66.01 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.815 HD21 HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER 83.59 104.11 0.05 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.557 0.694 . . . . 0.0 110.694 179.142 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.676 ' HB2' ' HE1' ' A' ' 56' ' ' TYR . . . -76.81 -34.0 57.96 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.783 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 150.34 151.52 5.56 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.597 HG21 ' CD2' ' A' ' 4' ' ' TYR . 85.9 t -89.34 88.07 2.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.268 -1.136 . . . . 0.0 109.696 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.555 ' CG1' ' HB3' ' A' ' 100' ' ' PHE . 0.8 OUTLIER -78.97 158.26 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.276 -0.89 . . . . 0.0 108.789 179.681 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.467 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 9.5 t -119.22 168.48 10.84 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.043 -1.036 . . . . 0.0 110.642 -179.1 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.58 ' CD2' ' O ' ' A' ' 98' ' ' ASN . 0.3 OUTLIER -120.98 68.98 0.88 Allowed 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 92' ' ' HIS . 3.1 m -175.75 -30.37 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.401 -0.812 . . . . 0.0 110.183 -179.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.42 17.17 40.41 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.161 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.653 ' HB2' HG11 ' A' ' 101' ' ' VAL . . . -153.98 121.2 5.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -1.164 . . . . 0.0 109.482 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.476 ' C ' ' O ' ' A' ' 95' ' ' ALA . 0.9 OUTLIER 39.28 -156.38 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.367 -0.833 . . . . 0.0 109.49 179.68 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 96' ' ' SER . . . -41.39 -59.99 2.49 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 179.341 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.58 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -167.43 32.65 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.243 -1.151 . . . . 0.0 109.27 179.251 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.436 ' O ' ' O ' ' A' ' 98' ' ' ASN . 1.4 t30 -48.14 173.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.99 -1.068 . . . . 0.0 109.251 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.555 ' HB3' ' CG1' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -100.13 144.13 29.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.1 -1.0 . . . . 0.0 109.528 -179.94 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.653 HG11 ' HB2' ' A' ' 95' ' ' ALA . 10.3 m -158.02 137.19 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.377 -0.827 . . . . 0.0 108.899 179.624 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.87 96.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.098 -1.001 . . . . 0.0 109.554 -179.59 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.467 ' SG ' ' HB ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -48.41 126.77 11.97 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.298 -0.876 . . . . 0.0 109.464 179.832 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.837 -1.078 . . . . 0.0 109.483 179.885 . . . . . . . . 1 1 . 1 stop_ save_